data_2job_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2job _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.53 -39.76 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.609 -0.682 . . . . 0.0 109.486 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.84 95.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.528 -0.732 . . . . 0.0 109.642 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.537 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . . . -63.5 -41.12 98.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.635 -0.666 . . . . 0.0 109.745 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.58 94.54 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.548 -0.72 . . . . 0.0 109.696 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.2 t -64.38 -39.79 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.544 -0.723 . . . . 0.0 109.536 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.43 -39.62 94.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.397 -0.814 . . . . 0.0 109.749 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.39 -39.51 93.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.432 -0.793 . . . . 0.0 109.651 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.574 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -65.82 -31.24 72.09 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.543 -0.723 . . . . 0.0 110.068 179.297 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.431 HG21 HD12 ' A' ' 18' ' ' ILE . 5.2 mm -63.87 -43.42 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.431 -0.793 . . . . 0.0 109.651 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.02 -40.47 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.458 -0.776 . . . . 0.0 110.029 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.88 -25.26 75.4 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.22 36.33 4.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.321 -1.105 . . . . 0.0 110.939 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.433 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 23.8 t90 -102.95 137.76 40.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.18 -0.95 . . . . 0.0 110.984 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -168.57 1.67 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -46.34 -44.55 16.92 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.199 -0.938 . . . . 0.0 110.31 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -158.64 36.48 0.23 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.537 -0.727 . . . . 0.0 110.619 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.29 151.13 31.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.198 -0.939 . . . . 0.0 110.584 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 t -152.69 175.48 12.78 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.473 -0.767 . . . . 0.0 109.625 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.95 126.4 31.97 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.334 -0.854 . . . . 0.0 110.379 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.8 mt -111.62 124.4 52.24 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.359 -0.838 . . . . 0.0 110.206 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.472 HD11 ' HB2' ' A' ' 99' ' ' TRP . 2.5 tp 56.71 29.81 16.48 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.647 -0.658 . . . . 0.0 111.175 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.03 -6.84 82.96 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -91.09 158.79 16.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.977 -1.308 . . . . 0.0 110.222 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -84.17 138.32 33.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.423 -0.798 . . . . 0.0 110.12 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.466 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 91.5 m -142.11 167.52 21.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.364 -0.835 . . . . 0.0 110.455 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -122.89 113.38 19.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.485 -0.76 . . . . 0.0 110.718 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.551 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 1.6 t80 -114.67 130.14 56.77 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.67 162.38 35.53 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.947 -1.096 . . . . 0.0 111.733 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.26 152.68 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.86 -0.525 . . . . 0.0 109.875 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -157.17 102.42 1.9 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.11 -0.994 . . . . 0.0 110.388 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 C--N 1.313 -1.313 0 O-C-N 123.898 1.473 . . . . 0.0 111.101 -179.922 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.355 0.597 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.481 ' CD2' ' HA ' ' A' ' 70' ' ' GLN . 0.3 OUTLIER -111.58 117.4 32.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.597 -0.689 . . . . 0.0 109.887 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.11 162.81 14.53 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.605 -0.684 . . . . 0.0 109.776 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.55 157.32 29.66 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.847 -1.168 . . . . 0.0 110.287 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.474 ' CD ' ' HB3' ' A' ' 64' ' ' GLU . 0.6 OUTLIER -153.91 141.26 19.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.698 -0.884 . . . . 0.0 109.854 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.551 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 2.8 ppp? -142.74 148.77 37.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.34 -0.85 . . . . 0.0 110.903 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.514 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 47.3 p90 -155.28 171.1 20.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.836 -0.54 . . . . 0.0 109.871 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 61.7 m -121.59 91.12 48.39 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 0.0 110.808 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.514 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 46.9 Cg_endo -76.9 83.93 2.02 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.939 1.494 . . . . 0.0 109.9 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.26 -47.23 0.49 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -73.29 -53.83 9.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.533 -0.98 . . . . 0.0 110.096 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.9 t -152.67 -160.9 1.2 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.531 -0.731 . . . . 0.0 109.963 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.7 68.95 0.97 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.285 -0.884 . . . . 0.0 110.345 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.1 mt -138.88 155.83 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.386 -0.822 . . . . 0.0 110.072 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.66 166.0 25.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.464 -0.772 . . . . 0.0 110.891 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.416 ' HA3' ' N ' ' A' ' 81' ' ' PHE . . . -159.53 128.77 2.07 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.474 ' HB3' ' CD ' ' A' ' 52' ' ' ARG . 1.4 pt-20 -137.66 165.33 26.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.596 -0.943 . . . . 0.0 110.897 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.471 ' HB3' ' CG ' ' A' ' 76' ' ' LYS . . . -158.53 161.08 37.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.716 -0.615 . . . . 0.0 110.632 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.5 m -143.4 151.63 40.62 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.465 -0.772 . . . . 0.0 110.282 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.0 t -174.6 -177.31 1.16 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.65 -0.657 . . . . 0.0 110.148 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -82.77 -31.77 28.13 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.258 -0.902 . . . . 0.0 110.125 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.91 146.92 53.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.352 -0.843 . . . . 0.0 110.353 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.481 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 34.4 mt-30 -83.49 -54.78 4.71 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.516 -0.74 . . . . 0.0 110.316 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 m -75.26 -30.83 60.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.453 -0.78 . . . . 0.0 110.237 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.86 -39.7 94.25 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.32 -34.03 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.273 -1.134 . . . . 0.0 110.471 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.466 ' HA ' ' HZ ' ' A' ' 36' ' ' PHE . . . -64.78 -47.4 78.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.518 -0.739 . . . . 0.0 109.869 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.79 -32.32 77.62 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.471 ' CG ' ' HB3' ' A' ' 65' ' ' ALA . 11.5 tptp -69.55 -40.9 76.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.599 -0.942 . . . . 0.0 110.224 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.7 m -64.99 -41.04 95.76 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.471 -0.768 . . . . 0.0 109.919 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.37 -34.56 72.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.405 -0.809 . . . . 0.0 110.114 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -67.36 -39.69 85.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 110.239 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.499 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 0.7 OUTLIER -67.09 -38.47 85.76 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.453 -0.78 . . . . 0.0 109.935 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.416 ' N ' ' HA3' ' A' ' 63' ' ' GLY . 39.6 t80 -67.18 -40.48 86.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.482 -0.761 . . . . 0.0 109.445 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.449 ' HA ' ' CD1' ' A' ' 91' ' ' ILE . 55.8 t -67.14 -36.83 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.44 -0.787 . . . . 0.0 109.829 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.499 ' NH1' ' HA ' ' A' ' 80' ' ' ASP . 4.1 ttp180 -65.26 -39.2 92.34 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.369 -0.832 . . . . 0.0 110.142 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -67.49 -39.91 85.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.276 -0.89 . . . . 0.0 110.04 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.59 -29.53 62.45 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.43 -0.794 . . . . 0.0 110.139 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 1.8 t80 -74.1 -37.69 64.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.488 -0.758 . . . . 0.0 110.295 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -37.08 84.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.362 -0.836 . . . . 0.0 110.234 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -73.96 -53.92 9.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.279 -0.888 . . . . 0.0 110.054 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.87 53.27 0.07 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.0 mt -122.31 -56.92 1.79 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.364 -1.08 . . . . 0.0 110.346 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 82.4 mt -77.72 109.6 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.33 -0.856 . . . . 0.0 109.911 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.6 m -93.8 167.19 11.8 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.357 -0.839 . . . . 0.0 110.286 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -48.5 70.39 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.492 -0.755 . . . . 0.0 110.424 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -63.56 -42.59 98.34 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.537 -0.727 . . . . 0.0 110.728 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.413 ' HB3' HD12 ' A' ' 30' ' ' LEU . 7.0 mt-10 -62.08 -43.59 98.5 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.416 -0.802 . . . . 0.0 110.245 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.32 87.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.584 -0.697 . . . . 0.0 109.94 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -67.34 -38.3 84.66 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.61 -0.682 . . . . 0.0 110.313 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.99 -38.78 86.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.343 -0.848 . . . . 0.0 109.652 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.574 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 15.4 t90 -66.06 -40.94 91.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.548 -0.72 . . . . 0.0 109.861 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.445 ' HA ' ' CD ' ' A' ' 17' ' ' LYS . 16.4 mt . . . . . 0 N--CA 1.498 1.969 0 O-C-N 121.603 -0.686 . . . . 0.0 110.148 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.1 -40.83 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.05 -40.01 95.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.695 -0.628 . . . . 0.0 109.383 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.471 ' HA ' ' HG3' ' A' ' 79' ' ' LYS . . . -62.44 -41.32 98.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.71 -0.619 . . . . 0.0 109.486 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.93 97.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.617 -0.677 . . . . 0.0 109.55 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.9 t -64.59 -41.37 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.541 -0.724 . . . . 0.0 109.237 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.558 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -66.18 -38.37 87.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.665 -0.647 . . . . 0.0 109.548 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.8 m -63.85 -39.03 93.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.575 -0.703 . . . . 0.0 109.698 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.46 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 17.4 tttm -66.01 -34.63 78.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.458 -0.776 . . . . 0.0 109.843 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.5 HD13 ' HB1' ' A' ' 78' ' ' ALA . 10.1 mt -65.07 -46.8 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.5 -0.75 . . . . 0.0 109.288 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.8 t -62.72 -40.18 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.656 -0.652 . . . . 0.0 109.965 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.49 -27.85 73.55 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.6 tp -115.75 38.47 3.29 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.405 -1.056 . . . . 0.0 110.725 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -101.81 137.68 39.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.241 -0.912 . . . . 0.0 110.458 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.98 -166.92 1.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.461 -0.774 . . . . 0.0 109.215 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -49.31 -41.53 38.68 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.185 -0.947 . . . . 0.0 110.442 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.7 33.81 0.19 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.615 -0.678 . . . . 0.0 110.609 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.23 153.57 37.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.199 -0.938 . . . . 0.0 110.849 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.5 t -155.56 151.78 28.0 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.392 -0.818 . . . . 0.0 109.876 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -105.61 121.27 43.63 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.179 -0.95 . . . . 0.0 110.782 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.447 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 1.3 mt -114.29 126.83 55.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.564 -0.71 . . . . 0.0 110.053 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.474 HD13 ' HG2' ' A' ' 95' ' ' GLU . 1.7 tp 54.17 33.7 18.54 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.649 -0.657 . . . . 0.0 111.016 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.09 23.94 74.88 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -123.14 145.01 48.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -1.093 . . . . 0.0 109.942 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 123.7 24.57 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.422 -0.799 . . . . 0.0 110.404 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.466 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 83.5 m -128.43 161.94 28.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.658 -0.651 . . . . 0.0 109.25 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.553 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -116.32 117.51 30.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.358 -0.839 . . . . 0.0 110.916 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -118.75 125.19 49.09 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.75 154.58 51.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.12 -0.988 . . . . 0.0 111.496 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.5 t -137.18 142.69 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.701 -0.625 . . . . 0.0 109.872 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.81 123.95 2.48 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.243 -0.911 . . . . 0.0 110.592 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo . . . . . 0 C--N 1.313 -1.324 0 O-C-N 123.903 1.475 . . . . 0.0 110.954 179.655 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 121.465 0.65 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.467 ' CZ ' ' HG2' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -122.39 128.93 51.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 110.152 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -132.28 151.73 51.7 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.53 -0.732 . . . . 0.0 110.088 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.22 154.86 26.13 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.44 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -146.19 143.67 29.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.718 -0.872 . . . . 0.0 110.059 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.524 ' HG2' HG23 ' A' ' 77' ' ' THR . 0.4 OUTLIER -143.48 157.72 44.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.366 -0.834 . . . . 0.0 111.133 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.577 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 42.9 p90 -161.43 -175.47 4.81 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.726 -0.609 . . . . 0.0 109.773 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 58' ' ' TRP . 69.6 m -133.19 95.91 18.02 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.102 -0.999 . . . . 0.0 110.644 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.577 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.3 Cg_endo -74.32 77.97 2.75 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.991 1.522 . . . . 0.0 110.333 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.26 -45.52 0.66 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 55' ' ' CYS . 15.3 t90 -68.65 -53.32 23.13 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.475 -1.015 . . . . 0.0 110.267 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.1 t -153.64 -168.56 3.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.553 -0.717 . . . . 0.0 109.754 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.22 45.96 1.89 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.322 -0.861 . . . . 0.0 110.447 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.3 mt -121.15 150.8 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.373 -0.829 . . . . 0.0 109.851 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 ptt-85 -131.15 163.16 28.29 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.284 -0.885 . . . . 0.0 110.834 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.85 155.55 23.26 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -158.39 154.31 26.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -1.112 . . . . 0.0 110.508 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.477 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . . . -166.19 152.97 9.43 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.52 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.6 m -139.08 150.77 46.12 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 110.594 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.427 HG22 HG21 ' A' ' 73' ' ' VAL . 10.0 t -172.71 164.63 5.34 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.705 -0.622 . . . . 0.0 109.994 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -63.29 -31.75 72.98 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.506 -0.746 . . . . 0.0 110.16 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.05 136.64 56.28 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.511 -0.743 . . . . 0.0 110.63 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.467 ' HG2' ' CZ ' ' A' ' 49' ' ' TYR . 12.1 mt-30 -77.17 -56.35 4.65 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.581 -0.699 . . . . 0.0 110.362 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 t -76.67 -31.44 57.29 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.312 -0.868 . . . . 0.0 110.037 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.91 -38.36 93.99 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.427 HG21 HG22 ' A' ' 67' ' ' THR . 0.8 OUTLIER -58.19 -35.76 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.456 -1.026 . . . . 0.0 110.577 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.16 84.29 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.561 -0.712 . . . . 0.0 109.809 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -64.4 -36.37 93.11 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.477 ' HG2' ' HB3' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -70.8 -39.02 73.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.384 -1.068 . . . . 0.0 110.274 179.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.524 HG23 ' HG2' ' A' ' 53' ' ' MET . 18.7 m -66.52 -37.8 85.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.336 -0.852 . . . . 0.0 110.026 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.558 ' HB1' ' HA ' ' A' ' 15' ' ' ALA . . . -78.47 -35.49 46.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.525 -0.735 . . . . 0.0 110.232 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.471 ' HG3' ' HA ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -71.88 -38.7 69.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.386 -0.821 . . . . 0.0 109.651 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.6 -36.5 83.91 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.522 -0.737 . . . . 0.0 109.512 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -67.96 -39.89 83.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.711 . . . . 0.0 109.671 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.449 HG12 HD12 ' A' ' 91' ' ' ILE . 72.5 t -66.41 -37.76 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.542 -0.724 . . . . 0.0 109.718 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -38.62 91.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.419 -0.8 . . . . 0.0 109.669 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -38.43 72.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.535 -0.728 . . . . 0.0 109.315 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.53 -34.92 78.07 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.539 -0.725 . . . . 0.0 109.799 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.08 -38.39 82.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 109.542 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -66.87 -39.3 87.49 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.496 -0.753 . . . . 0.0 110.342 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -72.96 -54.48 8.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.404 -0.81 . . . . 0.0 110.256 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.54 54.33 0.08 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.4 mt -121.17 -49.08 2.19 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -1.091 . . . . 0.0 110.494 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.449 HD12 HG12 ' A' ' 82' ' ' VAL . 95.8 mt -94.23 112.14 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.379 -0.826 . . . . 0.0 110.199 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 4.0 m -83.14 179.5 7.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.435 -0.79 . . . . 0.0 110.411 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -75.41 -60.23 2.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.337 -0.852 . . . . 0.0 110.245 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -63.08 -38.2 90.23 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.423 -0.798 . . . . 0.0 110.153 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 17.7 tt0 -55.09 -44.89 75.28 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.749 -0.594 . . . . 0.0 110.2 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.78 94.02 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.492 -0.755 . . . . 0.0 109.786 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -38.43 89.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.562 -0.711 . . . . 0.0 109.956 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -64.89 -40.89 95.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.803 . . . . 0.0 109.599 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.46 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 15.0 t90 -68.53 -39.27 81.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.448 -0.783 . . . . 0.0 109.155 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.9 mt . . . . . 0 N--CA 1.499 1.984 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.003 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.3 t -66.19 -39.45 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.445 -0.784 . . . . 0.0 109.11 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.474 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -66.46 -38.72 87.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.673 -0.642 . . . . 0.0 109.487 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.2 95.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.652 -0.655 . . . . 0.0 109.841 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.43 -41.57 98.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.459 -0.776 . . . . 0.0 109.648 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.438 HG11 HG23 ' A' ' 82' ' ' VAL . 62.2 t -64.94 -39.2 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.448 -0.783 . . . . 0.0 109.241 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.38 -37.03 86.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.587 -0.696 . . . . 0.0 109.853 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -66.97 -39.28 87.19 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.476 -0.765 . . . . 0.0 109.58 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.549 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 16.6 tptt -66.44 -31.1 71.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.444 -0.785 . . . . 0.0 109.724 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 22' ' ' TRP . 11.2 mm -62.56 -50.4 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.412 -0.805 . . . . 0.0 109.1 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.82 -37.75 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.722 . . . . 0.0 109.878 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.58 -27.72 73.64 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.41 36.41 4.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.262 -1.14 . . . . 0.0 110.805 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.461 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 23.6 t90 -102.75 135.36 44.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.133 -0.98 . . . . 0.0 110.943 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.12 -164.02 1.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -48.86 -45.91 41.54 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.075 -1.016 . . . . 0.0 109.891 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -156.77 34.14 0.3 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.712 -0.617 . . . . 0.0 110.45 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.83 150.07 41.16 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.1 -1.0 . . . . 0.0 111.154 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.439 HG23 ' CB ' ' A' ' 34' ' ' CYS . 2.1 t -151.7 165.66 33.71 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -128.95 115.36 17.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.094 -1.004 . . . . 0.0 110.411 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mt -100.94 119.79 39.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.463 -0.773 . . . . 0.0 110.166 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.402 HD13 ' HB2' ' A' ' 99' ' ' TRP . 3.7 tp 56.67 30.45 17.52 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.743 -0.598 . . . . 0.0 111.127 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.63 -11.85 67.18 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 87.8 m-70 -83.98 146.77 27.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.128 -1.219 . . . . 0.0 110.121 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -73.79 133.0 43.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.463 -0.773 . . . . 0.0 110.02 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.439 ' CB ' HG23 ' A' ' 27' ' ' THR . 15.2 m -136.08 171.28 14.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.553 -0.717 . . . . 0.0 110.042 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.51 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -132.9 120.42 21.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.475 -0.765 . . . . 0.0 110.339 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' ' 53' ' ' MET . 40.6 t80 -122.92 135.48 54.51 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.8 p -141.78 150.99 42.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.004 -1.06 . . . . 0.0 111.598 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.1 t -137.5 130.22 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -152.71 123.94 3.66 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.079 -1.013 . . . . 0.0 110.794 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 C--N 1.313 -1.331 0 O-C-N 123.871 1.459 . . . . 0.0 110.997 179.676 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.243 0.544 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.425 ' HD2' HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -114.71 133.07 56.17 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.442 -0.786 . . . . 0.0 109.918 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -142.27 148.63 38.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.494 -0.754 . . . . 0.0 110.366 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -143.53 153.61 24.98 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -145.25 150.53 36.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.764 -0.845 . . . . 0.0 110.112 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.419 ' HB3' ' CD2' ' A' ' 36' ' ' PHE . 22.4 ptm -144.19 153.45 42.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.244 -0.91 . . . . 0.0 110.977 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.51 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 41.6 p90 -152.83 146.4 25.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.782 -0.574 . . . . 0.0 110.288 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 67.2 m -116.29 90.53 29.78 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.231 -0.918 . . . . 0.0 111.1 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -79.22 82.02 2.63 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.87 1.458 . . . . 0.0 110.266 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.89 -46.81 0.48 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.448 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 13.9 t90 -70.49 -53.5 16.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.623 -0.928 . . . . 0.0 109.912 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.4 t -158.82 -160.7 0.89 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.748 -0.595 . . . . 0.0 109.888 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.19 46.5 1.78 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.342 -0.849 . . . . 0.0 109.931 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.7 mt -122.45 144.68 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.512 -0.742 . . . . 0.0 109.882 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.49 170.96 13.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.304 -0.872 . . . . 0.0 110.92 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.11 156.55 26.99 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.493 ' HG2' ' N ' ' A' ' 65' ' ' ALA . 14.4 tt0 -163.17 154.66 17.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.516 -0.99 . . . . 0.0 109.996 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -168.56 155.0 7.12 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.031 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.465 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 7.0 m -137.02 153.29 50.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.614 -0.679 . . . . 0.0 110.382 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -175.16 159.18 2.53 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.592 -0.693 . . . . 0.0 110.49 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -36.36 71.31 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.661 -0.649 . . . . 0.0 111.332 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.59 142.95 57.91 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.326 -0.859 . . . . 0.0 110.904 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.82 -49.03 15.12 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.618 -0.676 . . . . 0.0 109.986 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.9 m -82.41 -29.38 30.82 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.479 -0.763 . . . . 0.0 109.744 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.02 -38.71 94.66 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.465 ' CG2' ' HA ' ' A' ' 66' ' ' SER . 0.8 OUTLIER -60.59 -36.65 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.395 -1.062 . . . . 0.0 110.307 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.61 -38.59 77.33 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.55 -0.719 . . . . 0.0 109.739 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.72 -32.52 78.28 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.528 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 42.6 mtpt -72.75 -40.12 66.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.473 -1.016 . . . . 0.0 110.065 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.1 m -66.44 -38.41 87.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -0.975 . . . . 0.0 109.657 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.08 -37.69 61.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.6 -0.687 . . . . 0.0 110.333 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.6 -39.19 73.95 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.357 -0.84 . . . . 0.0 109.715 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -65.75 -36.25 83.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.681 -0.637 . . . . 0.0 109.715 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -68.84 -40.19 79.54 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 0.0 109.266 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.519 ' HA ' ' CD1' ' A' ' 91' ' ' ILE . 54.6 t -65.71 -38.9 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.549 -0.719 . . . . 0.0 109.968 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -64.78 -40.29 95.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.509 -0.744 . . . . 0.0 109.949 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -67.63 -39.37 84.66 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.416 -0.803 . . . . 0.0 109.619 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 91' ' ' ILE . . . -70.52 -35.64 73.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.596 -0.69 . . . . 0.0 109.659 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -40.68 95.8 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.606 -0.684 . . . . 0.0 109.706 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.41 -35.9 78.32 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.562 -0.711 . . . . 0.0 110.456 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -74.56 -52.49 11.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.304 -0.873 . . . . 0.0 110.203 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.94 52.49 0.11 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.8 mt -122.98 -49.93 1.95 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.394 -1.062 . . . . 0.0 110.293 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.519 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 89.5 mt -86.24 81.24 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.345 -0.847 . . . . 0.0 109.505 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -64.71 153.67 38.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 109.181 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -56.47 -47.81 78.43 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.529 -0.732 . . . . 0.0 110.281 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.43 -41.11 76.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.46 -0.775 . . . . 0.0 110.476 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.8 OUTLIER -63.03 -40.57 98.14 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.492 -0.755 . . . . 0.0 110.101 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.33 -43.29 92.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.591 -0.693 . . . . 0.0 109.872 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -65.42 -39.11 91.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.544 -0.723 . . . . 0.0 109.452 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -42.36 95.05 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.715 -0.616 . . . . 0.0 109.738 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.549 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 24.1 t90 -67.51 -39.48 85.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.503 -0.748 . . . . 0.0 109.444 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.2 mt . . . . . 0 N--CA 1.499 2.001 0 O-C-N 121.714 -0.616 . . . . 0.0 109.804 179.283 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.915 0.388 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.9 t -66.04 -39.63 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.466 -0.771 . . . . 0.0 109.517 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.423 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.69 -39.29 93.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.467 -0.771 . . . . 0.0 109.904 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.68 -38.84 87.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.61 -0.681 . . . . 0.0 109.739 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.01 96.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.586 -0.697 . . . . 0.0 109.783 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.7 t -62.69 -41.68 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.426 -0.796 . . . . 0.0 109.043 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.57 -39.45 93.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.498 -0.752 . . . . 0.0 109.612 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 54.4 m -61.7 -41.31 97.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.557 -0.715 . . . . 0.0 109.658 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.606 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 6.4 tptm -67.37 -31.21 71.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.428 -0.795 . . . . 0.0 109.765 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 18' ' ' ILE . 4.8 mm -63.27 -47.26 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.395 -0.816 . . . . 0.0 109.617 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.4 t -63.62 -38.71 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.45 -0.781 . . . . 0.0 109.852 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.75 -26.89 71.88 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 tp -113.8 32.62 5.71 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.239 -1.154 . . . . 0.0 111.448 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 18.4 t90 -94.2 131.6 39.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.952 -1.092 . . . . 0.0 110.197 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.13 -172.73 2.41 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -43.53 -39.84 3.63 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.229 -0.92 . . . . 0.0 110.609 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.418 ' HB2' ' CG2' ' A' ' 37' ' ' THR . 12.4 pt-20 -164.67 37.19 0.07 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.401 0.62 . . . . 0.0 109.781 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -150.77 161.23 43.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.492 -0.755 . . . . 0.0 110.721 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.5 t -156.89 151.45 25.53 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.358 -0.838 . . . . 0.0 109.868 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.58 110.59 22.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.43 -0.794 . . . . 0.0 109.832 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.605 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 2.4 mt -105.21 123.8 48.46 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.255 -0.903 . . . . 0.0 110.559 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 tp 55.1 34.72 23.18 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.648 -0.657 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.81 7.54 87.37 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -106.1 160.48 15.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.089 -1.242 . . . . 0.0 110.025 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.79 125.79 34.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.378 -0.826 . . . . 0.0 110.198 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 84.9 m -130.77 168.21 17.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.426 -0.796 . . . . 0.0 110.261 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.2 tttm -123.55 115.05 20.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.397 -0.814 . . . . 0.0 111.378 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.5 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 1.3 t80 -115.49 122.34 45.43 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.418 ' CG2' ' HB2' ' A' ' 25' ' ' GLU . 1.9 p -140.46 158.3 44.21 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.985 -1.072 . . . . 0.0 112.203 -178.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.7 p -129.31 147.08 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.813 -0.554 . . . . 0.0 109.865 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.84 110.75 2.71 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.085 -1.009 . . . . 0.0 110.711 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.315 -1.227 0 O-C-N 123.815 1.429 . . . . 0.0 110.697 179.683 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 121.293 0.568 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.508 ' CD2' ' HA ' ' A' ' 70' ' ' GLN . 0.3 OUTLIER -128.92 142.97 50.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.301 -0.874 . . . . 0.0 110.582 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -154.11 151.04 28.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -0.827 . . . . 0.0 110.216 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.25 150.05 22.18 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.49 ' CG ' ' HB3' ' A' ' 64' ' ' GLU . 8.9 ttp180 -143.04 144.93 32.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.68 -0.894 . . . . 0.0 110.256 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.5 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 2.3 ppp? -144.04 147.1 33.38 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.436 -0.79 . . . . 0.0 110.818 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.617 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 49.2 p90 -154.29 -168.9 3.08 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.797 -0.564 . . . . 0.0 110.113 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.3 m -134.15 92.79 20.85 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.857 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.617 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 47.9 Cg_endo -72.91 80.91 1.72 Allowed 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 123.86 1.453 . . . . 0.0 110.083 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.06 -43.24 0.79 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.447 ' HB3' ' HB3' ' A' ' 55' ' ' CYS . 18.5 t90 -74.34 -52.88 10.89 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.524 -0.986 . . . . 0.0 110.425 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.9 t -153.72 -168.14 2.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.535 -0.728 . . . . 0.0 110.007 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.55 45.3 2.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.439 -0.788 . . . . 0.0 110.39 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.4 mt -117.86 156.85 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.394 -0.816 . . . . 0.0 109.466 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.78 165.99 27.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.287 -0.883 . . . . 0.0 111.339 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.55 127.36 2.29 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.49 ' HB3' ' CG ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -144.87 160.62 41.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.8 -0.824 . . . . 0.0 110.634 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.57 163.84 38.8 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.649 -0.657 . . . . 0.0 110.904 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.62 141.95 35.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.516 -0.74 . . . . 0.0 110.193 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.429 HG21 HG22 ' A' ' 73' ' ' VAL . 8.8 t -173.07 170.22 4.45 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.504 -0.748 . . . . 0.0 110.396 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.48 ' HG3' ' N ' ' A' ' 69' ' ' SER . 2.2 ptm85 -64.67 -35.09 79.92 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.438 -0.789 . . . . 0.0 110.249 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.48 ' N ' ' HG3' ' A' ' 68' ' ' ARG . 3.4 m -58.78 153.73 16.29 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.377 0.608 . . . . 0.0 110.754 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.508 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 45.2 mt-30 -101.17 -60.74 1.47 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.802 -0.561 . . . . 0.0 110.088 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -29.91 61.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.285 -0.885 . . . . 0.0 110.398 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.61 -38.75 96.37 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.429 HG22 HG21 ' A' ' 67' ' ' THR . 0.4 OUTLIER -63.54 -34.93 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.429 -1.042 . . . . 0.0 110.434 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.76 -45.75 85.07 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.355 -0.841 . . . . 0.0 109.482 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.36 -37.65 94.96 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -69.75 -38.76 76.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.609 -0.936 . . . . 0.0 109.64 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.416 HG21 ' HB3' ' A' ' 53' ' ' MET . 15.5 m -55.98 -44.47 78.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.326 -0.859 . . . . 0.0 109.245 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.35 -38.93 74.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.681 -0.637 . . . . 0.0 109.748 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -39.23 84.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.683 . . . . 0.0 110.039 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 0.7 OUTLIER -67.03 -31.14 71.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.599 -0.688 . . . . 0.0 110.185 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.4 ' CD2' ' SD ' ' A' ' 53' ' ' MET . 54.5 t80 -80.74 -36.52 31.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.045 -1.034 . . . . 0.0 109.046 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.491 ' HA ' HD11 ' A' ' 91' ' ' ILE . 46.3 t -68.05 -38.4 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.671 -0.643 . . . . 0.0 110.246 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 2.6 ptm85 -67.45 -39.19 85.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.266 -0.896 . . . . 0.0 109.557 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.4 ' N ' ' HG3' ' A' ' 83' ' ' ARG . 0.7 OUTLIER -65.91 -40.54 91.58 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.496 -0.753 . . . . 0.0 109.268 178.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.0 -32.45 70.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.644 -0.66 . . . . 0.0 109.373 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.98 -41.99 94.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.623 -0.673 . . . . 0.0 109.238 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -67.92 -37.61 81.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.521 -0.737 . . . . 0.0 110.159 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -70.89 -51.93 23.27 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.374 -0.829 . . . . 0.0 110.382 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.96 49.45 0.17 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 90' ' ' LEU . 13.0 mt -121.33 -48.59 2.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.289 -1.124 . . . . 0.0 110.405 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' A' ' 82' ' ' VAL . 81.6 mt -99.53 77.76 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.458 -0.776 . . . . 0.0 109.244 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.0 p -76.26 -176.8 3.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.496 -0.753 . . . . 0.0 110.353 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.59 -53.1 20.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.43 -0.794 . . . . 0.0 110.563 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.9 -42.53 97.4 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.416 -0.802 . . . . 0.0 110.96 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -66.54 -38.5 87.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.267 -0.895 . . . . 0.0 110.219 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.2 -39.88 86.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.397 -0.815 . . . . 0.0 109.498 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -65.72 -39.03 90.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.596 -0.69 . . . . 0.0 109.955 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -61.56 -42.77 99.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.569 -0.707 . . . . 0.0 109.439 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.606 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 20.8 t90 -67.85 -38.61 83.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.473 -0.767 . . . . 0.0 109.641 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.6 mt . . . . . 0 N--CA 1.495 1.795 0 O-C-N 121.693 -0.629 . . . . 0.0 110.193 179.519 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.15 -43.16 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.461 -0.775 . . . . 0.0 109.217 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.5 93.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.509 -0.744 . . . . 0.0 109.3 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.41 -40.75 98.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.688 -0.632 . . . . 0.0 109.792 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.29 96.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.407 -0.808 . . . . 0.0 109.668 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.11 -40.46 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.504 -0.748 . . . . 0.0 109.348 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.21 -40.14 96.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.584 -0.698 . . . . 0.0 110.127 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 t -65.04 -38.95 92.53 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.371 -0.831 . . . . 0.0 109.706 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.504 ' HD2' HD12 ' A' ' 100' ' ' LEU . 3.5 ttmm -65.98 -32.38 73.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.502 -0.749 . . . . 0.0 109.951 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mm -62.82 -48.26 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.598 -0.688 . . . . 0.0 109.981 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.15 -38.92 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.399 -0.813 . . . . 0.0 109.833 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.84 -31.22 75.25 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.44 36.78 3.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.287 -1.125 . . . . 0.0 110.796 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.407 ' HD1' ' HB ' ' A' ' 27' ' ' THR . 25.7 t90 -100.51 138.52 37.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 110.668 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -97.71 -169.66 1.87 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -43.14 -42.95 4.33 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.663 -0.648 . . . . 0.0 110.255 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -162.66 38.84 0.11 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.636 -0.665 . . . . 0.0 110.39 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -157.67 140.34 14.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.252 -0.905 . . . . 0.0 110.699 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.407 ' HB ' ' HD1' ' A' ' 22' ' ' TRP . 10.0 t -147.65 159.45 43.77 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.411 -0.806 . . . . 0.0 109.823 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -100.16 143.18 30.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.431 -0.793 . . . . 0.0 110.513 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.49 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 7.1 mt -126.34 113.21 16.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.537 -0.727 . . . . 0.0 109.43 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 30' ' ' LEU . 4.6 tp 59.36 27.06 16.05 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.69 -0.631 . . . . 0.0 110.635 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.46 -15.7 62.34 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -87.59 153.31 21.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.986 -1.302 . . . . 0.0 110.337 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -83.95 137.56 33.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.387 -0.82 . . . . 0.0 109.751 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 96.3 m -138.01 170.91 15.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.89 . . . . 0.0 111.251 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -122.3 104.5 9.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.677 -0.64 . . . . 0.0 110.025 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.506 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 3.2 t80 -109.9 132.74 53.88 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.1 p -140.8 153.98 46.05 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.099 -1.001 . . . . 0.0 111.367 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.9 p -141.53 143.85 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.663 -0.648 . . . . 0.0 109.953 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.45 128.24 6.1 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.161 -0.962 . . . . 0.0 111.235 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.521 ' HB3' ' CE1' ' A' ' 49' ' ' TYR . 49.0 Cg_endo . . . . . 0 C--N 1.314 -1.256 0 O-C-N 123.88 1.463 . . . . 0.0 110.227 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.158 0.504 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.521 ' CE1' ' HB3' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -92.95 151.7 19.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.595 -0.691 . . . . 0.0 109.99 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -149.3 149.09 30.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.395 -0.816 . . . . 0.0 110.181 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.15 161.53 29.13 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.59 137.17 13.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.782 -0.834 . . . . 0.0 109.75 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.506 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 1.4 ppp? -136.73 152.1 49.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.264 -0.898 . . . . 0.0 111.144 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.493 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 49.4 p90 -159.58 154.29 24.42 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.744 -0.598 . . . . 0.0 110.183 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 69.3 m -112.33 91.53 16.68 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.183 -0.948 . . . . 0.0 110.56 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.493 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 48.0 Cg_endo -76.11 91.79 1.09 Allowed 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.807 1.425 . . . . 0.0 110.217 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.46 -48.36 0.58 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.463 ' CH2' ' HB3' ' A' ' 90' ' ' LEU . 25.6 t90 -76.26 -53.5 8.14 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.404 -1.056 . . . . 0.0 110.376 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 t -145.46 -170.01 3.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.581 -0.699 . . . . 0.0 109.991 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.62 60.54 0.8 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.449 -0.782 . . . . 0.0 109.887 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.429 HD11 HG23 ' A' ' 61' ' ' ILE . 69.7 mt -128.12 155.08 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.481 -0.762 . . . . 0.0 109.845 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.43 160.29 39.53 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.415 -0.803 . . . . 0.0 110.492 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 135.75 7.26 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -136.2 151.82 50.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.554 -0.968 . . . . 0.0 110.112 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.446 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -163.13 135.57 5.36 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.388 -0.82 . . . . 0.0 110.56 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.515 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 1.1 m -136.71 142.65 43.12 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.546 -0.721 . . . . 0.0 110.37 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.8 t -167.44 177.48 5.98 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.573 -0.704 . . . . 0.0 110.142 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -31.32 67.74 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.33 -0.856 . . . . 0.0 110.66 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.74 143.15 58.07 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.427 -0.795 . . . . 0.0 110.916 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.484 ' HG2' ' CE1' ' A' ' 49' ' ' TYR . 38.4 mt-30 -80.65 -50.71 9.59 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.637 -0.665 . . . . 0.0 110.408 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m -86.36 -29.3 23.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.386 -0.822 . . . . 0.0 109.914 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.06 -38.97 95.1 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.515 ' CG2' ' HA ' ' A' ' 66' ' ' SER . 3.7 p -62.3 -36.83 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.407 -1.055 . . . . 0.0 110.297 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.402 ' N ' ' CG1' ' A' ' 73' ' ' VAL . . . -68.8 -44.84 72.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.55 -0.719 . . . . 0.0 109.768 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.31 -35.74 92.06 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.446 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 15.4 mmtt -69.76 -38.72 76.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.473 -1.016 . . . . 0.0 109.942 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 m -60.25 -44.91 94.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.501 -0.749 . . . . 0.0 109.498 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.91 -36.31 75.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.555 -0.716 . . . . 0.0 109.865 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -39.76 86.88 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.463 -0.773 . . . . 0.0 109.876 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.16 -40.9 98.89 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.475 -0.766 . . . . 0.0 110.086 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -69.33 -41.13 77.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.336 -0.853 . . . . 0.0 109.343 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.8 t -66.04 -38.14 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.566 -0.708 . . . . 0.0 109.591 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -38.79 87.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.514 -0.741 . . . . 0.0 109.708 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -39.27 91.22 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.386 -0.821 . . . . 0.0 109.853 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.82 -35.51 74.86 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.589 -0.694 . . . . 0.0 109.464 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -41.9 99.61 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.678 -0.639 . . . . 0.0 109.634 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -67.84 -36.97 81.29 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.499 -0.75 . . . . 0.0 110.332 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -73.49 -55.43 6.35 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.37 -0.831 . . . . 0.0 110.453 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.04 52.36 0.08 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.463 ' HB3' ' CH2' ' A' ' 58' ' ' TRP . 9.7 mt -122.95 -49.83 1.96 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.377 -1.072 . . . . 0.0 110.259 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.3 mt -97.09 101.59 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.538 -0.726 . . . . 0.0 109.55 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.585 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 32.4 m -78.23 173.78 11.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.475 -0.766 . . . . 0.0 109.965 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -71.16 -53.08 15.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.605 -0.684 . . . . 0.0 109.925 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -65.09 -29.52 70.39 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.478 -0.764 . . . . 0.0 110.57 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.0 OUTLIER -67.99 -43.5 78.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.267 -0.896 . . . . 0.0 109.821 179.377 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.29 -40.64 94.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.609 -0.682 . . . . 0.0 109.168 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -62.46 -38.98 91.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.641 -0.662 . . . . 0.0 109.763 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -40.16 94.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.572 -0.705 . . . . 0.0 109.697 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.45 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 15.6 t90 -71.08 -36.05 72.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.315 -0.865 . . . . 0.0 109.889 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.504 HD12 ' HD2' ' A' ' 17' ' ' LYS . 3.4 mm? . . . . . 0 N--CA 1.499 1.982 0 O-C-N 121.71 -0.619 . . . . 0.0 110.697 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.1 t -66.08 -40.87 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.521 -0.737 . . . . 0.0 109.185 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.42 -39.76 95.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.593 -0.692 . . . . 0.0 109.533 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.74 -41.38 99.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.684 -0.635 . . . . 0.0 109.806 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.3 -39.3 94.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.474 -0.766 . . . . 0.0 109.827 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.04 -39.93 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.425 -0.797 . . . . 0.0 109.105 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -64.06 -38.43 91.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.466 -0.771 . . . . 0.0 109.636 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.6 m -63.96 -41.31 97.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.51 -0.743 . . . . 0.0 109.595 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.598 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 1.9 ttmt -63.74 -32.8 74.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.547 -0.721 . . . . 0.0 109.898 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.44 HG23 HD11 ' A' ' 18' ' ' ILE . 5.1 mm -62.25 -48.13 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -0.875 . . . . 0.0 109.071 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.49 -40.4 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.71 -0.619 . . . . 0.0 109.429 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.79 -32.18 83.29 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.46 ' CD2' ' HB2' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -109.38 35.39 3.32 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.45 -1.029 . . . . 0.0 110.612 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 25.0 t90 -103.98 132.98 49.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.133 -0.979 . . . . 0.0 111.01 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.34 -163.85 1.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -45.78 -45.64 14.83 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.255 -0.903 . . . . 0.0 110.587 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.418 ' HB2' ' CG2' ' A' ' 37' ' ' THR . 6.6 pt-20 -157.75 35.9 0.26 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.679 -0.638 . . . . 0.0 110.5 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.41 151.88 38.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.311 -0.868 . . . . 0.0 110.668 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.9 t -153.77 172.9 16.6 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.308 -0.87 . . . . 0.0 109.866 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.46 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 3.9 mp0 -124.43 143.34 50.68 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.245 -0.909 . . . . 0.0 110.228 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.465 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 10.0 mt -127.44 113.6 16.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 109.457 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.49 HD12 ' HB2' ' A' ' 99' ' ' TRP . 1.0 OUTLIER 57.01 27.26 12.98 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.765 -0.584 . . . . 0.0 110.735 -179.244 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.84 -16.9 60.21 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -80.97 149.89 29.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.171 -1.193 . . . . 0.0 110.444 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -79.41 139.91 37.56 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.74 . . . . 0.0 109.822 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 81.4 m -139.96 166.37 24.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.515 -0.741 . . . . 0.0 110.726 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -122.15 101.09 7.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.404 -0.81 . . . . 0.0 109.835 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.561 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 4.3 t80 -108.37 131.13 55.07 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.418 ' CG2' ' HB2' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -134.75 157.16 47.43 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.302 -0.874 . . . . 0.0 111.015 -179.078 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 87.1 t -129.36 129.32 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.568 -0.707 . . . . 0.0 109.635 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -144.06 101.23 4.89 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.367 -0.833 . . . . 0.0 110.425 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.484 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 54.1 Cg_endo . . . . . 0 C--N 1.313 -1.292 0 O-C-N 123.81 1.426 . . . . 0.0 110.585 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.16 0.505 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.484 ' CD1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -96.14 157.17 16.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -0.877 . . . . 0.0 110.111 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.464 ' HG3' ' N ' ' A' ' 51' ' ' GLY . 2.1 tttt -156.6 150.17 24.59 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.254 -0.904 . . . . 0.0 109.9 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.464 ' N ' ' HG3' ' A' ' 50' ' ' LYS . . . -149.59 147.67 18.22 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.45 138.64 34.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.67 -0.9 . . . . 0.0 109.836 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.561 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 3.0 ppp? -137.95 157.73 45.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.344 -0.848 . . . . 0.0 111.25 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.423 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 49.0 p90 -160.88 145.88 14.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.844 -0.535 . . . . 0.0 109.951 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.41 ' SG ' HD13 ' A' ' 29' ' ' LEU . 76.6 m -112.49 91.2 16.21 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.261 -0.899 . . . . 0.0 110.871 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.423 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 48.3 Cg_endo -75.71 85.81 1.57 Allowed 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.78 1.411 . . . . 0.0 110.056 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.42 -50.3 0.29 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -78.16 -43.71 27.95 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.537 -0.978 . . . . 0.0 109.76 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 t -153.67 -173.85 4.73 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.278 0.561 . . . . 0.0 109.733 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.46 49.04 1.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.569 -0.707 . . . . 0.0 109.62 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.4 mt -119.02 155.99 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.473 -0.767 . . . . 0.0 110.009 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.19 160.16 38.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.447 -0.783 . . . . 0.0 110.438 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.23 148.27 19.89 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 0.9 OUTLIER -151.13 157.07 42.25 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.551 -0.97 . . . . 0.0 110.269 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.482 ' HB3' ' CG ' ' A' ' 76' ' ' LYS . . . -159.75 146.75 16.51 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.699 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.474 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -140.1 141.74 36.12 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.469 -0.769 . . . . 0.0 110.812 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 t -169.16 176.9 5.05 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.6 -0.688 . . . . 0.0 110.341 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.5 mtm-85 -73.14 -35.29 66.47 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.389 -0.82 . . . . 0.0 110.261 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.85 136.92 58.15 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.497 -0.752 . . . . 0.0 110.127 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.31 -59.11 2.88 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.584 -0.697 . . . . 0.0 110.406 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -79.17 -28.83 42.77 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.308 -0.87 . . . . 0.0 110.05 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.62 -38.14 90.83 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.474 ' CG2' ' HA ' ' A' ' 66' ' ' SER . 0.5 OUTLIER -62.07 -38.11 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.437 -1.037 . . . . 0.0 110.379 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.401 ' N ' ' CG1' ' A' ' 73' ' ' VAL . . . -66.81 -44.5 81.02 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.524 -0.735 . . . . 0.0 109.655 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.65 -37.78 95.25 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.482 ' CG ' ' HB3' ' A' ' 65' ' ' ALA . 0.1 OUTLIER -63.3 -40.1 96.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.589 -0.948 . . . . 0.0 110.282 179.559 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.9 m -63.44 -43.91 96.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.83 . . . . 0.0 109.149 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' CB ' ' HA ' ' A' ' 15' ' ' ALA . . . -66.27 -39.08 89.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.602 -0.686 . . . . 0.0 109.64 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.98 -38.96 89.89 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.34 -0.85 . . . . 0.0 109.96 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.501 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 2.8 m-20 -68.87 -29.8 68.17 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.461 -0.774 . . . . 0.0 110.172 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -78.38 -33.73 48.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.225 -0.922 . . . . 0.0 109.864 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.404 ' HA ' HD11 ' A' ' 91' ' ' ILE . 65.4 t -70.43 -38.5 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 110.476 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -70.23 -36.42 74.52 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.271 -0.893 . . . . 0.0 109.793 179.529 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.46 -40.83 93.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.6 -0.688 . . . . 0.0 109.335 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.78 -32.88 71.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.618 -0.676 . . . . 0.0 109.379 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.3 -41.1 97.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.55 -0.719 . . . . 0.0 109.513 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -65.38 -36.58 84.4 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.661 -0.649 . . . . 0.0 110.538 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -79.72 -54.13 6.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.195 -0.941 . . . . 0.0 110.28 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.72 53.72 0.07 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.414 HD21 ' HA ' ' A' ' 90' ' ' LEU . 11.1 mt -123.56 -47.78 1.96 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.375 -1.074 . . . . 0.0 110.645 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.404 HD11 ' HA ' ' A' ' 82' ' ' VAL . 80.7 mt -105.2 98.84 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.235 -0.916 . . . . 0.0 109.555 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 4.9 t -78.49 -177.06 5.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.443 -0.785 . . . . 0.0 110.556 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -70.76 -59.82 2.59 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.519 -0.738 . . . . 0.0 110.472 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -63.73 -34.67 78.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.391 -0.818 . . . . 0.0 110.63 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.404 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 1.9 mt-10 -58.79 -42.93 90.19 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.489 -0.757 . . . . 0.0 110.278 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.13 93.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.448 -0.783 . . . . 0.0 109.809 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -36.81 78.05 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.498 -0.751 . . . . 0.0 109.677 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -62.86 -42.83 99.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.522 -0.736 . . . . 0.0 109.379 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.598 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 25.3 t90 -63.97 -41.93 97.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.462 -0.774 . . . . 0.0 109.153 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.423 ' HA ' ' CE ' ' A' ' 17' ' ' LYS . 12.9 mt . . . . . 0 N--CA 1.499 2.0 0 O-C-N 121.763 -0.586 . . . . 0.0 110.155 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' ' 93' ' ' GLN . 78.2 t -68.82 -38.68 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.411 ' O ' ' HE3' ' A' ' 79' ' ' LYS . . . -63.66 -46.19 86.73 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.457 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . . . -52.05 -45.11 64.56 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.744 -0.597 . . . . 0.0 109.959 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.09 90.51 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.561 -0.712 . . . . 0.0 109.391 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.0 t -61.14 -44.25 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.589 -0.695 . . . . 0.0 109.324 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.614 ' HB2' ' HE2' ' A' ' 79' ' ' LYS . . . -58.29 -43.2 87.92 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.599 -0.688 . . . . 0.0 109.999 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.2 m -59.24 -41.8 89.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.65 -0.656 . . . . 0.0 109.484 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.632 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 1.3 tpmp? -69.74 -32.5 71.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.627 -0.671 . . . . 0.0 110.059 179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 22' ' ' TRP . 5.4 mt -72.26 -46.77 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.401 -0.812 . . . . 0.0 109.811 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.6 t -68.13 -39.03 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.395 -0.816 . . . . 0.0 110.04 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.28 -16.41 75.32 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.47 24.06 6.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.978 -1.307 . . . . 0.0 111.452 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.419 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 22.7 t90 -92.03 135.58 33.85 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.886 -1.134 . . . . 0.0 110.337 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.67 -167.19 1.46 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.534 -0.729 . . . . 0.0 109.449 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -49.77 -41.76 44.93 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.231 -0.918 . . . . 0.0 110.615 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.45 37.73 0.24 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.574 -0.704 . . . . 0.0 110.456 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -146.75 147.53 31.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.32 -0.863 . . . . 0.0 110.72 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.467 HG23 ' HB2' ' A' ' 34' ' ' CYS . 8.2 t -156.7 155.52 31.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.462 -0.774 . . . . 0.0 109.643 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -111.68 149.83 31.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.173 -0.954 . . . . 0.0 110.168 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.411 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 6.7 mt -143.28 123.85 14.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.371 -0.831 . . . . 0.0 110.022 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.497 HD11 ' HG2' ' A' ' 95' ' ' GLU . 1.7 tp 53.07 35.06 18.6 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.673 -0.642 . . . . 0.0 111.22 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.39 26.88 62.61 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -125.91 163.5 22.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -1.163 . . . . 0.0 109.996 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.0 130.4 36.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.458 -0.776 . . . . 0.0 109.893 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.539 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 68.2 m -134.08 167.22 21.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.51 -0.744 . . . . 0.0 110.079 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.571 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 0.9 OUTLIER -126.32 110.07 12.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 110.901 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.446 ' CE2' HG23 ' A' ' 77' ' ' THR . 20.0 t80 -111.11 136.09 50.66 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.38 157.88 43.53 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.061 -1.024 . . . . 0.0 111.968 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.3 t -132.82 145.04 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.15 136.55 11.38 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.238 -0.914 . . . . 0.0 110.927 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.47 ' HB3' ' CE1' ' A' ' 49' ' ' TYR . 48.1 Cg_endo . . . . . 0 C--N 1.316 -1.179 0 O-C-N 123.905 1.476 . . . . 0.0 110.406 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.288 0.566 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.47 ' CE1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -96.64 135.28 38.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.572 -0.705 . . . . 0.0 110.19 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.514 ' HA ' HG22 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -129.39 156.73 43.6 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.332 -0.855 . . . . 0.0 109.857 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.19 150.5 22.7 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.715 ' HG2' ' HB3' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -149.56 136.36 19.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.491 -1.005 . . . . 0.0 109.837 179.529 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.505 ' HG2' HG23 ' A' ' 77' ' ' THR . 1.0 OUTLIER -135.12 152.58 51.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.439 -0.788 . . . . 0.0 110.835 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.606 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 46.1 p90 -149.32 -177.13 5.67 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.576 -0.703 . . . . 0.0 110.044 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 34.7 m -133.94 93.81 19.68 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.102 -0.999 . . . . 0.0 110.701 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.606 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.6 Cg_endo -76.09 89.58 1.23 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.951 1.5 . . . . 0.0 110.107 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.27 -46.51 0.87 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -71.61 -57.78 4.08 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.476 -1.014 . . . . 0.0 110.139 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.1 t -153.96 -160.37 1.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.578 -0.701 . . . . 0.0 109.902 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.88 44.92 2.52 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.253 -0.904 . . . . 0.0 110.546 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.439 HD11 HG23 ' A' ' 61' ' ' ILE . 1.5 tt -125.15 154.4 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.25 -0.906 . . . . 0.0 109.701 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.431 ' HB3' ' CB ' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -153.68 169.21 23.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.166 -0.959 . . . . 0.0 111.202 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.434 ' HA2' ' HE2' ' A' ' 84' ' ' LYS . . . -135.45 153.03 21.09 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.715 ' HB3' ' HG2' ' A' ' 52' ' ' ARG . 1.2 pm0 -145.51 155.39 43.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.632 -0.922 . . . . 0.0 110.227 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.416 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -143.23 162.48 35.51 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.518 -0.738 . . . . 0.0 110.89 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -147.12 136.98 23.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.574 -0.704 . . . . 0.0 110.438 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.7 t -175.51 165.25 3.18 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.699 -0.625 . . . . 0.0 110.002 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -68.55 -28.13 66.69 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.182 -0.949 . . . . 0.0 110.595 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.67 149.46 50.47 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.191 -0.943 . . . . 0.0 110.463 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -83.66 -64.91 1.08 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.672 -0.642 . . . . 0.0 110.087 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 t -73.32 -22.79 60.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.26 -0.9 . . . . 0.0 110.02 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.82 -45.38 95.02 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' A' ' 50' ' ' LYS . 0.7 OUTLIER -61.04 -36.96 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.495 -1.003 . . . . 0.0 110.064 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.46 -45.08 94.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.524 -0.735 . . . . 0.0 110.034 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -60.64 -37.21 93.09 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.416 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -74.92 -37.69 61.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.391 -1.064 . . . . 0.0 110.245 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.505 HG23 ' HG2' ' A' ' 53' ' ' MET . 22.7 m -59.93 -38.04 81.24 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.195 -0.941 . . . . 0.0 109.683 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.67 -28.04 40.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.425 -0.797 . . . . 0.0 110.184 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.683 ' CE ' ' HA ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -80.76 -37.64 30.05 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.267 -0.895 . . . . 0.0 109.826 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.75 -31.51 66.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.785 -0.572 . . . . 0.0 109.694 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -70.36 -42.19 72.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 0.0 109.695 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.6 t -71.24 -30.89 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.799 . . . . 0.0 109.467 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -38.4 63.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.459 -0.776 . . . . 0.0 109.756 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.434 ' HE2' ' HA2' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -67.3 -36.78 82.2 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.33 -0.856 . . . . 0.0 109.777 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.69 -34.2 69.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.486 -0.759 . . . . 0.0 109.528 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.21 -39.28 86.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.595 -0.69 . . . . 0.0 109.585 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -64.37 -40.4 95.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.717 -0.614 . . . . 0.0 109.901 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -73.72 -57.15 4.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.425 -0.797 . . . . 0.0 109.781 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.7 53.98 0.05 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 90' ' ' LEU . 9.7 mt -123.41 -57.41 1.67 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.303 -1.116 . . . . 0.0 110.65 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 12.4 mt -92.74 115.83 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.0 110.167 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.6 t -99.46 -175.91 3.13 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.663 -0.648 . . . . 0.0 110.637 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.507 ' HA ' HG11 ' A' ' 10' ' ' VAL . 2.6 mt-30 -74.85 -52.07 12.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.423 -0.798 . . . . 0.0 110.263 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -64.15 -41.04 97.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.575 -0.703 . . . . 0.0 110.189 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.497 ' HG2' HD11 ' A' ' 30' ' ' LEU . 3.4 tt0 -56.09 -45.85 79.26 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.649 -0.657 . . . . 0.0 109.993 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.43 93.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.62 -0.675 . . . . 0.0 109.43 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.483 ' HA ' HD11 ' A' ' 100' ' ' LEU . 7.6 t30 -64.16 -37.83 88.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.643 -0.66 . . . . 0.0 109.717 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -64.97 -42.04 94.92 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.632 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 18.6 t90 -64.49 -43.1 95.21 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.162 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.483 HD11 ' HA ' ' A' ' 97' ' ' ASN . 12.2 mt . . . . . 0 N--CA 1.499 1.991 0 O-C-N 121.776 -0.578 . . . . 0.0 109.562 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 120.95 0.405 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.5 t -65.07 -41.3 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.502 -0.749 . . . . 0.0 109.31 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.59 95.14 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.597 -0.689 . . . . 0.0 109.79 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.88 98.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.548 -0.72 . . . . 0.0 109.56 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.99 98.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.634 -0.666 . . . . 0.0 109.5 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.527 HG13 ' CZ3' ' A' ' 99' ' ' TRP . 60.5 t -62.69 -41.07 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.545 -0.722 . . . . 0.0 109.299 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.52 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -63.28 -40.13 96.52 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.694 -0.629 . . . . 0.0 109.42 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 56.5 m -63.47 -38.88 92.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.649 -0.657 . . . . 0.0 109.443 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.481 ' HG3' ' HA ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -60.63 -37.79 82.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.518 -0.739 . . . . 0.0 109.356 178.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.509 HG21 HD11 ' A' ' 18' ' ' ILE . 17.1 mt -66.57 -33.33 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.678 -0.639 . . . . 0.0 109.857 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.5 t -62.51 -49.86 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.252 -0.905 . . . . 0.0 109.736 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.03 -13.12 83.38 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 120.293 -0.956 . . . . 0.0 110.82 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.519 HD23 HD22 ' A' ' 29' ' ' LEU . 11.5 tp -98.09 -23.0 15.93 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.019 -1.283 . . . . 0.0 110.825 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.551 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 17.4 t90 -67.4 131.36 45.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.73 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.96 -161.27 0.86 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -47.94 -45.07 30.67 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.132 -0.98 . . . . 0.0 110.444 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.13 36.54 0.14 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.611 -0.681 . . . . 0.0 110.848 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -156.54 155.49 32.02 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.194 -0.941 . . . . 0.0 110.027 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 t -156.41 155.29 31.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.164 -0.96 . . . . 0.0 110.132 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -116.09 109.39 17.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.4 -0.813 . . . . 0.0 109.494 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.519 HD22 HD23 ' A' ' 21' ' ' LEU . 10.7 mt -112.19 129.79 56.13 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.316 -0.865 . . . . 0.0 110.576 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.416 ' HB3' ' CD2' ' A' ' 32' ' ' HIS . 0.3 OUTLIER 60.09 30.64 20.08 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.442 -0.786 . . . . 0.0 110.301 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.02 22.21 78.43 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.416 ' CD2' ' HB3' ' A' ' 30' ' ' LEU . 50.0 m-70 -120.77 160.07 24.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.379 -1.071 . . . . 0.0 109.992 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.43 126.72 34.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.359 -0.838 . . . . 0.0 110.549 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 23.9 m -130.17 166.88 19.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.69 -0.631 . . . . 0.0 109.687 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.497 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 6.1 tptt -128.33 105.64 8.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.465 -0.772 . . . . 0.0 110.637 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.551 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 29.9 t80 -108.23 137.34 46.37 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.6 p -147.57 152.32 37.75 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.031 -1.043 . . . . 0.0 111.816 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.8 t -125.17 133.92 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.415 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -136.15 119.16 12.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.127 -0.983 . . . . 0.0 111.224 -178.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo . . . . . 0 C--N 1.315 -1.206 0 O-C-N 123.77 1.405 . . . . 0.0 110.655 179.55 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.035 0.445 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.412 ' CE2' ' HB3' ' A' ' 70' ' ' GLN . 3.3 m-85 -98.39 133.53 42.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.505 -0.747 . . . . 0.0 110.311 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.6 164.63 17.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.449 -0.782 . . . . 0.0 110.085 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -156.86 135.67 4.57 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.574 ' HG3' ' HG3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -138.92 144.82 39.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.582 -0.952 . . . . 0.0 110.426 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.543 ' HG2' HG22 ' A' ' 77' ' ' THR . 2.5 ppp? -140.49 148.74 41.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.325 -0.859 . . . . 0.0 110.315 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.497 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 44.8 p90 -152.29 146.65 25.55 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.651 -0.656 . . . . 0.0 110.41 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 98.0 m -112.38 88.93 11.54 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.303 -0.873 . . . . 0.0 110.953 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -77.59 84.33 1.99 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.843 1.444 . . . . 0.0 110.278 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.73 -46.63 0.59 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -71.35 -58.13 3.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.6 -0.941 . . . . 0.0 110.045 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.1 t -153.7 -160.66 1.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.577 -0.702 . . . . 0.0 109.941 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.87 47.69 1.61 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.397 -0.815 . . . . 0.0 110.127 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.431 HG21 ' CD1' ' A' ' 81' ' ' PHE . 72.9 mt -123.63 151.41 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.471 -0.768 . . . . 0.0 109.878 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -139.33 169.87 16.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.904 . . . . 0.0 110.962 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.35 127.58 4.03 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.574 ' HG3' ' HG3' ' A' ' 52' ' ' ARG . 1.8 mp0 -121.7 169.02 11.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.571 -0.959 . . . . 0.0 110.695 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.416 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -166.41 156.57 12.06 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.486 0.66 . . . . 0.0 111.336 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -156.44 131.86 9.39 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.633 -0.667 . . . . 0.0 110.037 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.3 t -175.63 -176.71 0.9 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.598 -0.689 . . . . 0.0 109.987 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -82.48 -39.18 22.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.221 -0.924 . . . . 0.0 110.466 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.31 135.74 52.36 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.591 -0.693 . . . . 0.0 110.607 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.412 ' HB3' ' CE2' ' A' ' 49' ' ' TYR . 15.4 pt20 -75.79 -34.96 60.22 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.628 -0.67 . . . . 0.0 110.648 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.0 m -82.22 -34.12 29.04 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.151 -0.968 . . . . 0.0 109.925 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.68 -36.74 90.75 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.99 -35.53 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.3 -1.118 . . . . 0.0 110.004 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.38 94.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.179 -0.951 . . . . 0.0 109.94 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -66.46 -39.44 94.08 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.416 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -67.6 -43.22 81.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.651 -0.911 . . . . 0.0 110.397 179.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.543 HG22 ' HG2' ' A' ' 53' ' ' MET . 94.4 m -58.99 -36.33 74.72 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.192 -0.943 . . . . 0.0 109.578 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.52 ' HB1' ' HA ' ' A' ' 15' ' ' ALA . . . -80.33 -32.71 37.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.525 -0.735 . . . . 0.0 109.876 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 75' ' ' GLY . 1.3 ttpm? -75.71 -34.47 60.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.461 -0.774 . . . . 0.0 110.102 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -39.58 86.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.481 -0.762 . . . . 0.0 109.626 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.431 ' CD1' HG21 ' A' ' 61' ' ' ILE . 51.3 t80 -70.12 -38.48 75.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.375 -0.828 . . . . 0.0 109.082 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.523 HG23 HG12 ' A' ' 14' ' ' VAL . 39.0 t -66.68 -39.15 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.652 -0.655 . . . . 0.0 109.662 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.44 -44.77 96.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.356 -0.84 . . . . 0.0 109.414 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -68.95 -37.11 78.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.53 -0.731 . . . . 0.0 109.516 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.68 -37.2 76.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.565 -0.71 . . . . 0.0 109.747 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -64.68 -41.45 96.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.582 -0.699 . . . . 0.0 109.734 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -69.19 -34.42 74.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.51 -0.744 . . . . 0.0 110.616 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.95 -51.84 12.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.271 -0.893 . . . . 0.0 110.239 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.07 52.55 0.13 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.0 mt -114.87 -48.87 2.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.267 -1.137 . . . . 0.0 110.225 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 82.4 mt -103.81 94.57 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 110.06 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 5.0 m -78.11 178.37 7.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.329 -0.857 . . . . 0.0 109.898 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -57.86 7.2 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.284 -0.885 . . . . 0.0 110.479 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -63.13 -35.56 80.68 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.24 -0.913 . . . . 0.0 110.134 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.4 OUTLIER -70.26 -32.31 70.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.393 -0.817 . . . . 0.0 109.547 178.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.7 -40.71 93.24 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.411 -0.806 . . . . 0.0 109.353 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -63.33 -46.64 85.69 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -66.01 -37.3 85.57 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.527 ' CZ3' HG13 ' A' ' 14' ' ' VAL . 58.5 t90 -65.26 -38.89 91.72 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.02 0.438 . . . . 0.0 109.855 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.481 ' HA ' ' HG3' ' A' ' 17' ' ' LYS . 11.8 mt . . . . . 0 N--CA 1.496 1.834 0 O-C-N 121.655 -0.653 . . . . 0.0 109.78 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.07 -39.65 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.78 -41.35 97.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.653 -0.655 . . . . 0.0 109.429 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.31 -41.64 93.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.681 -0.637 . . . . 0.0 109.685 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.7 99.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.525 -0.734 . . . . 0.0 109.41 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.445 HG12 HG23 ' A' ' 82' ' ' VAL . 86.9 t -65.99 -40.73 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.11 -38.56 91.1 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.459 -0.776 . . . . 0.0 109.49 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -38.56 91.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.455 -0.778 . . . . 0.0 109.44 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.628 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 4.9 tppt? -67.2 -32.3 73.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.543 -0.723 . . . . 0.0 109.686 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.468 HG13 ' HB2' ' A' ' 78' ' ' ALA . 6.5 mm -61.53 -49.38 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.416 -0.802 . . . . 0.0 109.262 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.7 t -61.66 -39.12 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.58 -0.7 . . . . 0.0 109.935 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.46 -33.41 86.39 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 tp -112.05 36.89 3.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.396 -1.061 . . . . 0.0 110.581 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -102.44 136.97 41.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 111.266 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -99.35 -166.43 1.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -51.19 -40.13 57.99 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.043 -1.035 . . . . 0.0 110.245 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -158.6 34.61 0.23 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.584 -0.698 . . . . 0.0 110.605 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -154.35 141.2 19.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.251 -0.905 . . . . 0.0 111.021 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.5 t -145.52 157.7 43.95 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.301 -0.875 . . . . 0.0 109.594 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' HIS . 9.7 mt-10 -101.23 122.95 44.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.359 -0.838 . . . . 0.0 111.229 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.563 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 7.2 mt -108.17 116.36 31.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.569 -0.707 . . . . 0.0 109.396 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.408 HD13 ' HB2' ' A' ' 99' ' ' TRP . 1.2 tp 58.48 31.1 20.61 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.784 -0.572 . . . . 0.0 110.73 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.32 -8.19 79.41 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.408 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 54.6 m-70 -91.33 163.64 14.14 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.121 -1.223 . . . . 0.0 110.273 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.58 127.98 38.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.569 -0.707 . . . . 0.0 110.324 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 64.3 m -127.61 170.74 12.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.674 -0.641 . . . . 0.0 110.04 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -123.22 99.94 6.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.543 -0.723 . . . . 0.0 110.312 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 5.4 t80 -112.53 135.08 53.66 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.23 171.37 16.59 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.11 -0.993 . . . . 0.0 110.841 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.35 135.36 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.788 -0.57 . . . . 0.0 109.619 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.25 87.22 39.25 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.286 -0.884 . . . . 0.0 110.776 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 C--N 1.312 -1.353 0 O-C-N 123.826 1.435 . . . . 0.0 110.475 179.472 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.033 0.444 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -127.99 128.7 45.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.026 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -135.54 157.39 47.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -0.941 . . . . 0.0 110.18 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.3 148.07 19.06 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.537 ' HD3' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -143.25 143.31 31.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.659 -0.906 . . . . 0.0 110.16 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.485 ' HG2' HG21 ' A' ' 77' ' ' THR . 1.6 ppp? -148.64 150.25 32.93 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.255 -0.903 . . . . 0.0 111.137 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.557 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 46.7 p90 -164.02 152.11 12.86 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.785 -0.572 . . . . 0.0 110.376 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 75.7 m -111.16 92.45 15.54 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.209 -0.932 . . . . 0.0 110.71 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.557 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 48.9 Cg_endo -74.21 88.61 1.11 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.903 1.475 . . . . 0.0 110.192 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 146.49 -47.22 0.71 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -71.1 -50.89 28.86 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.549 -0.971 . . . . 0.0 110.19 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.3 t -151.96 -169.89 3.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.632 -0.668 . . . . 0.0 109.901 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.63 61.97 0.78 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 0.0 110.367 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 84' ' ' LYS . 10.5 tt -137.91 150.52 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.336 -0.852 . . . . 0.0 109.99 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.34 155.97 49.32 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.806 . . . . 0.0 110.594 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.5 151.36 21.15 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.537 ' HB3' ' HD3' ' A' ' 52' ' ' ARG . 1.8 pp20? -156.38 158.65 37.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.391 -1.064 . . . . 0.0 110.738 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.453 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -146.42 148.36 32.21 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.586 -0.696 . . . . 0.0 110.81 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.416 ' O ' ' HB ' ' A' ' 67' ' ' THR . 1.4 m -138.04 139.14 39.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.368 -0.833 . . . . 0.0 110.331 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 66' ' ' SER . 6.1 t 179.63 -163.34 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.843 -0.535 . . . . 0.0 109.819 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.94 -23.79 14.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.4 -0.813 . . . . 0.0 110.334 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.2 m -61.91 153.32 29.46 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.108 -0.995 . . . . 0.0 110.454 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -93.15 -56.92 2.79 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.643 -0.661 . . . . 0.0 110.412 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.2 p -81.42 -28.58 34.2 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.376 -0.828 . . . . 0.0 110.475 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.1 -45.01 96.75 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 74' ' ' ALA . 2.5 p -58.8 -38.07 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.498 -1.001 . . . . 0.0 110.538 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.4 ' N ' ' CG1' ' A' ' 73' ' ' VAL . . . -65.25 -47.6 76.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.467 -0.771 . . . . 0.0 109.801 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -63.49 -39.77 98.05 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -62.87 -42.02 99.61 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.571 -0.958 . . . . 0.0 110.285 179.372 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.485 HG21 ' HG2' ' A' ' 53' ' ' MET . 47.6 m -62.12 -41.25 98.06 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.257 -0.902 . . . . 0.0 109.978 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.468 ' HB2' HG13 ' A' ' 18' ' ' ILE . . . -76.45 -36.85 57.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.526 -0.734 . . . . 0.0 110.037 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 75' ' ' GLY . 0.1 OUTLIER -69.11 -38.36 78.88 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.531 -0.731 . . . . 0.0 110.137 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -69.12 -35.54 76.51 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -66.62 -41.0 89.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.569 -0.707 . . . . 0.0 109.68 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.445 HG23 HG12 ' A' ' 14' ' ' VAL . 84.3 t -64.7 -38.62 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.538 -0.726 . . . . 0.0 109.738 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.1 tpt85 -63.82 -39.52 94.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.565 -0.71 . . . . 0.0 109.73 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.463 ' HB3' ' CD1' ' A' ' 61' ' ' ILE . 36.4 mtpt -69.35 -33.86 73.74 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.379 -0.826 . . . . 0.0 109.529 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.28 -27.69 56.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.306 -0.871 . . . . 0.0 109.231 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.48 -41.9 72.11 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.719 -0.613 . . . . 0.0 110.019 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.42 ' HG3' ' N ' ' A' ' 88' ' ' LYS . 6.0 pt20 -67.48 -36.22 80.69 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.378 -0.826 . . . . 0.0 110.585 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.43 ' HD2' HD12 ' A' ' 61' ' ' ILE . 10.5 mttt -74.4 -54.81 6.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.297 -0.877 . . . . 0.0 110.004 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.98 52.37 0.07 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.1 mt -119.32 -61.64 1.6 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.245 -1.15 . . . . 0.0 109.893 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.423 HD11 ' HA ' ' A' ' 82' ' ' VAL . 72.9 mt -89.5 75.46 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.505 -0.747 . . . . 0.0 109.237 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.2 t -62.13 178.97 0.33 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.753 -0.592 . . . . 0.0 110.535 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -62.03 -54.63 38.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.472 -0.768 . . . . 0.0 110.217 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -67.85 -29.44 68.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.623 -0.673 . . . . 0.0 110.675 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.78 -45.41 89.86 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.357 -0.84 . . . . 0.0 110.188 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.66 -38.04 89.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.514 -0.741 . . . . 0.0 109.622 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -66.65 -36.79 83.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.503 -0.748 . . . . 0.0 110.307 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -41.41 90.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.342 -0.849 . . . . 0.0 109.761 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.628 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 13.6 t90 -67.26 -40.96 86.29 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.354 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.516 HD23 ' HE3' ' A' ' 17' ' ' LYS . 43.3 mt . . . . . 0 N--CA 1.497 1.92 0 O-C-N 121.631 -0.668 . . . . 0.0 109.62 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 77.8 t -64.49 -39.56 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.596 -0.69 . . . . 0.0 109.202 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.54 -39.56 94.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.759 -0.588 . . . . 0.0 109.813 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.63 99.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.534 -0.729 . . . . 0.0 109.648 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.13 99.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.603 -0.686 . . . . 0.0 109.671 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.98 -40.8 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.521 -0.737 . . . . 0.0 109.431 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.68 -38.71 92.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.544 -0.722 . . . . 0.0 109.536 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.1 t -62.46 -41.76 98.99 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.661 -0.65 . . . . 0.0 109.627 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.44 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 11.8 tttm -65.35 -32.49 74.15 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.433 -0.792 . . . . 0.0 110.063 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 mm -64.94 -45.86 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.419 -0.801 . . . . 0.0 109.66 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.56 -40.77 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.546 -0.721 . . . . 0.0 110.206 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.18 -19.27 78.66 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.276 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 tp -120.41 21.15 11.75 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.865 -1.374 . . . . 0.0 111.945 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.538 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 18.6 t90 -90.88 137.74 32.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.902 -1.124 . . . . 0.0 109.948 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.64 -169.14 1.79 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.41 -0.806 . . . . 0.0 109.369 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -45.54 -44.04 12.42 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.153 -0.967 . . . . 0.0 110.311 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.474 ' O ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -158.39 33.31 0.24 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.579 -0.7 . . . . 0.0 110.828 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -141.5 152.73 44.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.12 -0.987 . . . . 0.0 111.001 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.425 HG21 ' CB ' ' A' ' 34' ' ' CYS . 2.1 t -155.07 167.32 30.76 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.629 -0.669 . . . . 0.0 109.476 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -136.55 119.13 15.95 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.275 -0.89 . . . . 0.0 109.992 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 mt -108.64 120.74 43.33 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.333 -0.854 . . . . 0.0 110.456 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.4 ' HB3' ' CD2' ' A' ' 32' ' ' HIS . 5.0 tp 56.52 31.06 18.3 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.582 -0.699 . . . . 0.0 111.007 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.44 -11.78 64.85 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.565 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 59.8 m-70 -84.63 141.52 30.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.028 -1.278 . . . . 0.0 110.006 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -72.2 135.74 46.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.391 -0.818 . . . . 0.0 110.305 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.425 ' CB ' HG21 ' A' ' 27' ' ' THR . 45.1 m -139.15 168.57 19.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.614 -0.679 . . . . 0.0 110.059 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER -129.7 121.21 26.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.511 -0.743 . . . . 0.0 110.051 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.538 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 26.8 t80 -120.42 136.77 54.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.555 -0.716 . . . . 0.0 109.364 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.1 p -140.36 151.0 44.64 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.061 -1.025 . . . . 0.0 111.503 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.7 t -132.64 129.25 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 mtmm -142.56 117.33 6.56 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.159 -0.963 . . . . 0.0 110.938 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 C--N 1.313 -1.289 0 O-C-N 123.954 1.502 . . . . 0.0 110.251 179.358 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.338 0.59 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.46 ' CZ ' ' HG3' ' A' ' 70' ' ' GLN . 0.5 OUTLIER -124.28 131.62 53.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.476 -0.765 . . . . 0.0 110.028 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -135.69 157.14 47.6 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.449 -0.782 . . . . 0.0 110.495 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.91 147.58 17.55 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.473 ' HD3' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -141.16 145.52 35.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.826 -0.808 . . . . 0.0 110.033 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.6 ' HG2' HG23 ' A' ' 77' ' ' THR . 2.2 ptm -143.99 151.88 40.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.078 -1.014 . . . . 0.0 111.079 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.476 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 48.6 p90 -155.84 150.56 26.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.7 -0.625 . . . . 0.0 110.32 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 87.1 m -113.53 90.49 17.83 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.214 -0.929 . . . . 0.0 110.964 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.476 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.4 Cg_endo -78.66 84.8 1.96 Allowed 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.957 1.504 . . . . 0.0 110.108 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.49 -47.6 0.41 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.565 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 19.4 t90 -77.08 -54.66 6.25 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.449 -1.03 . . . . 0.0 110.384 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -153.74 -161.83 1.33 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.558 -0.714 . . . . 0.0 110.022 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.24 48.57 1.39 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.518 -0.739 . . . . 0.0 110.212 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.4 mt -118.36 146.57 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.366 -0.834 . . . . 0.0 109.83 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.16 161.72 35.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.365 -0.835 . . . . 0.0 110.98 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.68 131.76 5.89 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.473 ' HG2' ' HD3' ' A' ' 52' ' ' ARG . 12.9 mp0 -126.44 160.25 31.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.644 -0.915 . . . . 0.0 109.914 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.438 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -171.76 152.34 3.06 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.414 -0.804 . . . . 0.0 111.188 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.1 143.44 31.13 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.516 -0.74 . . . . 0.0 110.115 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.8 t -173.25 155.42 2.92 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.52 -0.738 . . . . 0.0 110.323 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.41 -35.88 70.6 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.532 -0.73 . . . . 0.0 111.411 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.31 135.6 57.54 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.32 -0.863 . . . . 0.0 110.354 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.46 ' HG3' ' CZ ' ' A' ' 49' ' ' TYR . 4.6 mp0 -70.23 -61.39 1.79 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.705 -0.622 . . . . 0.0 109.98 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.2 t -72.93 -28.76 62.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.24 -0.913 . . . . 0.0 109.879 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.27 -39.66 92.86 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.97 -35.81 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.377 -1.072 . . . . 0.0 109.992 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.96 -39.76 87.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.433 -0.792 . . . . 0.0 110.036 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.05 -34.34 76.13 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.438 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -70.36 -42.22 72.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.62 -0.929 . . . . 0.0 110.177 179.502 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.6 HG23 ' HG2' ' A' ' 53' ' ' MET . 66.5 m -62.49 -40.01 95.33 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.286 -0.884 . . . . 0.0 109.419 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.47 -37.02 65.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.514 -0.741 . . . . 0.0 109.685 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -38.78 86.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.505 -0.747 . . . . 0.0 109.693 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -41.97 99.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.565 -0.709 . . . . 0.0 110.001 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -65.72 -40.8 92.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.443 -0.785 . . . . 0.0 109.973 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.442 ' HA ' HD13 ' A' ' 91' ' ' ILE . 97.1 t -66.1 -36.04 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.484 -0.76 . . . . 0.0 109.915 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -67.04 -40.66 87.23 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.47 -0.769 . . . . 0.0 109.982 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -37.11 80.56 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.535 -0.728 . . . . 0.0 109.869 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.98 -35.27 76.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.385 -0.822 . . . . 0.0 110.134 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.9 -36.22 72.64 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.477 -0.764 . . . . 0.0 109.687 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -63.1 -29.05 70.5 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.601 -0.687 . . . . 0.0 110.412 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -55.29 3.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.43 -0.794 . . . . 0.0 110.332 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 136.61 56.53 0.06 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.5 mt -125.44 -46.41 1.76 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.336 -1.096 . . . . 0.0 110.579 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 82' ' ' VAL . 89.0 mt -96.78 112.38 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 109.741 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.5 m -91.25 162.63 14.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.542 -0.724 . . . . 0.0 110.353 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -63.29 -53.72 48.34 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.526 -0.734 . . . . 0.0 110.259 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -61.64 -42.74 99.31 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.481 -0.762 . . . . 0.0 110.733 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -59.27 -41.66 89.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.317 -0.864 . . . . 0.0 110.176 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.06 -40.24 97.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.381 -0.824 . . . . 0.0 109.741 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -64.21 -39.88 94.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.567 -0.708 . . . . 0.0 109.868 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -63.26 -40.48 97.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.668 -0.645 . . . . 0.0 109.745 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.44 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 15.1 t90 -68.45 -36.54 79.17 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.591 -0.693 . . . . 0.0 109.9 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 14.1 mt . . . . . 0 N--CA 1.499 1.982 0 O-C-N 121.699 -0.626 . . . . 0.0 110.548 179.535 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.4 t -68.5 -38.79 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.413 ' HB3' ' HG2' ' A' ' 79' ' ' LYS . . . -64.19 -39.74 94.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.611 -0.681 . . . . 0.0 109.647 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.58 -41.56 99.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.551 -0.718 . . . . 0.0 109.79 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.49 -40.43 89.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.397 -0.814 . . . . 0.0 109.693 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.407 HG11 ' CZ3' ' A' ' 99' ' ' TRP . 95.0 t -64.96 -40.78 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.439 -0.788 . . . . 0.0 109.137 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -62.13 -40.27 95.35 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.687 -0.633 . . . . 0.0 109.75 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 t -61.39 -41.78 97.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.563 -0.711 . . . . 0.0 109.755 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 14.4 tttm -68.36 -30.44 69.39 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.472 -0.767 . . . . 0.0 110.215 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.414 HG21 ' HB1' ' A' ' 78' ' ' ALA . 12.9 mm -68.1 -44.32 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.423 -0.798 . . . . 0.0 109.702 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.77 -39.24 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.342 -0.849 . . . . 0.0 110.196 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.57 -27.58 69.14 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.68 28.73 8.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.1 -1.235 . . . . 0.0 111.613 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -95.65 132.69 40.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.929 -1.107 . . . . 0.0 110.48 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -98.09 -166.04 1.33 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -48.0 -41.95 26.71 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.161 -0.962 . . . . 0.0 110.26 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -161.97 37.83 0.12 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.725 -0.609 . . . . 0.0 110.261 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -146.12 158.83 43.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.188 -0.945 . . . . 0.0 111.205 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.541 HG21 ' HB2' ' A' ' 34' ' ' CYS . 8.0 t -163.61 154.3 15.97 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.682 -0.636 . . . . 0.0 109.406 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -110.94 111.11 22.01 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.21 -0.932 . . . . 0.0 110.302 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.421 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 2.8 mt -107.06 128.86 54.75 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.355 -0.841 . . . . 0.0 110.763 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.7 tp 54.48 36.0 24.63 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.599 -0.688 . . . . 0.0 111.17 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.32 23.49 78.01 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 51.6 m-70 -123.14 151.67 41.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -1.087 . . . . 0.0 109.895 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.46 127.43 32.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.312 -0.868 . . . . 0.0 110.597 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.541 ' HB2' HG21 ' A' ' 27' ' ' THR . 59.9 m -129.33 171.25 12.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.685 -0.635 . . . . 0.0 109.996 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.479 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 7.9 tptm -128.06 100.68 5.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.526 -0.734 . . . . 0.0 110.276 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 3.8 t80 -112.85 136.1 52.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.755 -0.591 . . . . 0.0 109.703 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.01 170.85 16.85 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.343 -0.848 . . . . 0.0 111.045 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.466 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 76.0 t -133.41 130.64 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -137.84 93.74 11.96 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.158 -0.964 . . . . 0.0 111.192 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.446 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 56.5 Cg_endo . . . . . 0 C--N 1.312 -1.355 0 O-C-N 123.916 1.482 . . . . 0.0 110.316 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.336 0.589 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.532 ' CE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -108.98 156.86 19.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.456 -0.778 . . . . 0.0 110.195 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -156.78 149.75 23.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.312 -0.867 . . . . 0.0 110.189 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -145.87 149.97 22.15 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.409 ' HD3' ' CB ' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -148.42 145.05 27.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.7 -0.882 . . . . 0.0 110.113 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.452 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 5.4 ptm -144.54 151.3 38.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.374 -0.829 . . . . 0.0 111.123 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.479 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 42.8 p90 -153.93 147.93 25.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.786 -0.571 . . . . 0.0 109.888 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 87.5 m -111.58 89.9 11.6 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.222 -0.924 . . . . 0.0 111.449 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -77.06 85.72 1.73 Allowed 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.856 1.451 . . . . 0.0 110.091 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.83 -46.63 0.64 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.536 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 12.1 t90 -70.31 -57.43 4.88 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.672 -0.899 . . . . 0.0 109.996 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -152.1 -164.37 1.95 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.61 -0.681 . . . . 0.0 109.901 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.63 56.83 0.88 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.356 -0.84 . . . . 0.0 109.767 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.516 HD11 ' HE2' ' A' ' 88' ' ' LYS . 31.7 mt -130.55 158.71 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.608 -0.683 . . . . 0.0 109.699 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -135.93 171.04 15.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.45 -0.781 . . . . 0.0 110.695 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.56 127.96 1.83 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.409 ' CB ' ' HD3' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -147.48 156.06 42.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.608 -0.937 . . . . 0.0 110.709 -179.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.563 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -158.4 155.57 28.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.458 -0.776 . . . . 0.0 110.614 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.42 145.45 50.3 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.418 -0.801 . . . . 0.0 110.688 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 t -172.7 152.29 2.49 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.629 -0.669 . . . . 0.0 109.67 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -26.97 61.23 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.361 -0.837 . . . . 0.0 111.346 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.8 133.24 51.55 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.28 -0.888 . . . . 0.0 110.618 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.532 ' HA ' ' CE2' ' A' ' 49' ' ' TYR . 1.0 OUTLIER -70.36 -53.12 17.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.56 -0.712 . . . . 0.0 110.559 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.9 m -80.88 -28.31 36.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.331 -0.856 . . . . 0.0 110.082 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.17 -44.16 98.49 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.37 -36.37 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.461 -1.023 . . . . 0.0 110.321 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.414 ' HA ' ' HZ ' ' A' ' 36' ' ' PHE . . . -71.75 -43.3 66.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.589 -0.694 . . . . 0.0 109.653 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.58 -38.5 93.37 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.563 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -65.38 -40.47 93.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.643 -0.916 . . . . 0.0 109.996 179.433 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.3 m -60.19 -43.51 95.84 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.542 -0.724 . . . . 0.0 109.32 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 15' ' ' ALA . . . -68.7 -37.57 79.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.624 -0.673 . . . . 0.0 109.76 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.413 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -64.79 -40.17 94.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.559 -0.713 . . . . 0.0 109.61 179.231 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.53 -40.41 94.55 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.666 . . . . 0.0 110.049 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -70.18 -38.51 75.39 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.426 -0.797 . . . . 0.0 110.004 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.405 ' CG1' ' HA ' ' A' ' 11' ' ' ALA . 85.7 t -71.86 -33.4 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 0.0 110.027 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -41.27 80.67 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.282 -0.886 . . . . 0.0 109.361 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -36.67 67.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.494 -0.754 . . . . 0.0 108.983 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.37 -37.01 80.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.449 -0.782 . . . . 0.0 109.271 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -43.47 98.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.548 -0.72 . . . . 0.0 109.352 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -68.21 -37.1 80.52 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.659 -0.651 . . . . 0.0 110.534 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.516 ' HE2' HD11 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -72.37 -52.19 17.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.327 -0.858 . . . . 0.0 110.474 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.4 53.99 0.1 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.4 mt -129.0 -49.88 1.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.487 -1.008 . . . . 0.0 110.521 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.5 mm -94.51 90.81 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 109.833 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -77.78 169.63 17.97 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.552 -0.718 . . . . 0.0 109.705 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -54.47 31.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.404 -0.81 . . . . 0.0 110.462 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -69.29 -36.91 77.54 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.406 -0.809 . . . . 0.0 110.563 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.0 OUTLIER -62.4 -43.19 99.42 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.293 -0.879 . . . . 0.0 110.054 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.85 87.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.444 -0.785 . . . . 0.0 109.12 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -62.93 -41.15 99.38 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.81 -0.556 . . . . 0.0 109.889 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -41.46 96.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.445 -0.785 . . . . 0.0 109.288 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.462 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 29.6 t90 -66.74 -36.64 82.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.349 -0.844 . . . . 0.0 109.069 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.1 tp . . . . . 0 N--CA 1.494 1.775 0 O-C-N 121.932 -0.48 . . . . 0.0 109.955 179.573 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.41 HG12 ' HG2' ' A' ' 93' ' ' GLN . 64.4 t -67.04 -42.07 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.1 94.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.582 -0.699 . . . . 0.0 109.186 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.39 94.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.711 -0.618 . . . . 0.0 109.715 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.76 94.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.561 -0.712 . . . . 0.0 110.02 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.45 -39.65 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.329 -0.857 . . . . 0.0 109.237 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.517 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . . . -66.68 -39.25 88.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.542 -0.724 . . . . 0.0 109.902 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 p -65.63 -35.97 82.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.406 -0.808 . . . . 0.0 109.923 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.568 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 4.7 tptt -65.78 -35.49 80.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.473 -0.767 . . . . 0.0 109.7 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.491 HD13 HG23 ' A' ' 18' ' ' ILE . 4.9 mt -65.52 -47.11 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.507 -0.746 . . . . 0.0 109.18 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.6 t -64.45 -39.49 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.523 -0.736 . . . . 0.0 110.051 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.58 -25.01 75.2 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.8 tp -120.68 31.39 6.45 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.289 -1.124 . . . . 0.0 111.021 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.412 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 23.5 t90 -93.28 136.71 33.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.987 -1.07 . . . . 0.0 110.479 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.07 -167.79 1.56 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.605 -0.685 . . . . 0.0 109.253 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.81 -43.02 18.03 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.24 -0.913 . . . . 0.0 110.206 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 1.4 pp20? -159.5 33.56 0.19 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.479 -0.763 . . . . 0.0 110.848 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -140.81 147.9 39.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.129 -0.982 . . . . 0.0 110.78 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 34' ' ' CYS . 9.2 t -154.71 161.95 41.33 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.437 -0.789 . . . . 0.0 109.553 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -111.35 152.72 26.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.197 -0.939 . . . . 0.0 110.183 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.532 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 3.4 mt -146.18 119.02 8.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.405 -0.81 . . . . 0.0 109.971 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 tp 54.71 32.48 17.45 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.779 -0.576 . . . . 0.0 111.188 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.29 22.28 63.17 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 70.0 m-70 -124.89 147.14 48.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -1.143 . . . . 0.0 110.151 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.83 132.92 40.69 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.435 -0.79 . . . . 0.0 110.416 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 84.4 m -135.37 164.34 27.99 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.561 -0.712 . . . . 0.0 110.179 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.556 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 1.5 tptt -117.9 124.01 47.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.343 -0.848 . . . . 0.0 110.53 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.459 ' CZ ' ' HB ' ' A' ' 77' ' ' THR . 7.3 t80 -124.49 123.93 41.19 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.709 -0.619 . . . . 0.0 109.512 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.3 p -131.37 154.32 48.74 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.202 -0.937 . . . . 0.0 111.578 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 p -122.29 142.35 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.632 -0.667 . . . . 0.0 109.75 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.57 107.56 4.08 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.081 -1.012 . . . . 0.0 110.868 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 C--N 1.315 -1.224 0 O-C-N 123.762 1.401 . . . . 0.0 110.509 179.336 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 121.341 0.591 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 67' ' ' THR . 1.7 m-85 -122.57 132.13 54.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.548 -0.72 . . . . 0.0 109.95 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -132.26 162.99 29.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.427 -0.796 . . . . 0.0 110.381 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -158.0 141.95 8.14 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.53 147.36 52.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.799 -0.824 . . . . 0.0 109.805 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.443 ' HG2' HG22 ' A' ' 77' ' ' THR . 2.4 ppp? -149.05 157.24 43.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.109 -0.995 . . . . 0.0 111.05 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.556 ' CE2' ' HB3' ' A' ' 35' ' ' LYS . 47.3 p90 -164.5 176.6 8.84 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.826 -0.546 . . . . 0.0 110.117 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 67.5 m -129.06 94.86 32.78 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.213 -0.929 . . . . 0.0 110.614 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.439 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.8 Cg_endo -77.01 81.61 2.56 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.902 1.475 . . . . 0.0 110.468 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.36 -46.24 0.64 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.465 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 12.6 t90 -68.61 -57.72 5.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.604 -0.939 . . . . 0.0 110.155 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -150.64 -166.23 2.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.471 -0.768 . . . . 0.0 109.939 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.19 50.6 1.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.382 -0.824 . . . . 0.0 110.225 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.4 mt -123.01 149.53 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.739 . . . . 0.0 109.781 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -129.37 165.58 21.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -0.902 . . . . 0.0 111.0 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.22 152.5 24.1 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -153.2 158.77 42.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.482 -1.01 . . . . 0.0 110.069 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -168.63 148.55 4.45 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.989 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.7 m -137.61 147.53 45.09 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.612 -0.68 . . . . 0.0 110.107 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 6.6 t -170.97 171.37 5.92 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.584 -0.698 . . . . 0.0 110.11 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -69.16 -42.24 76.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.423 -0.798 . . . . 0.0 111.26 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.74 138.97 57.77 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.358 -0.839 . . . . 0.0 110.848 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.445 ' O ' HG12 ' A' ' 73' ' ' VAL . 19.5 tt0 -73.01 -52.14 15.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.76 -0.587 . . . . 0.0 110.282 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.0 m -72.46 -34.8 68.0 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.311 -0.868 . . . . 0.0 110.106 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.04 -36.63 92.59 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 70' ' ' GLN . 0.4 OUTLIER -63.3 -37.91 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.364 -1.08 . . . . 0.0 110.392 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.66 -38.02 80.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.462 -0.774 . . . . 0.0 109.835 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.82 95.59 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.487 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 4.0 tttm -68.1 -40.91 82.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.539 -0.977 . . . . 0.0 110.402 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.459 ' HB ' ' CZ ' ' A' ' 36' ' ' PHE . 62.1 m -61.48 -38.22 86.48 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.074 -1.016 . . . . 0.0 109.871 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.517 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . . . -77.36 -36.17 53.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.585 -0.697 . . . . 0.0 109.899 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -68.64 -39.08 80.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.357 -0.839 . . . . 0.0 109.858 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -67.46 -34.5 77.32 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.514 -0.741 . . . . 0.0 109.562 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.429 ' CD2' ' SD ' ' A' ' 53' ' ' MET . 41.7 t80 -68.07 -41.16 82.35 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.487 -0.758 . . . . 0.0 109.702 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.515 ' HA ' HD13 ' A' ' 91' ' ' ILE . 83.9 t -66.87 -36.47 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.496 -0.752 . . . . 0.0 109.496 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.26 -41.67 99.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.601 -0.687 . . . . 0.0 109.456 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.68 -40.11 88.41 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.47 -0.769 . . . . 0.0 109.34 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.24 -35.35 77.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.79 -0.569 . . . . 0.0 109.647 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.68 -35.94 81.34 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.646 -0.659 . . . . 0.0 109.689 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -61.59 -39.9 92.83 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.633 -0.667 . . . . 0.0 110.207 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -82.17 -59.1 2.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.439 -0.788 . . . . 0.0 110.176 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.43 51.16 0.05 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.0 mt -115.11 -46.47 2.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.33 -1.1 . . . . 0.0 110.297 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.515 HD13 ' HA ' ' A' ' 82' ' ' VAL . 89.9 mt -106.66 89.96 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.434 -0.792 . . . . 0.0 109.936 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 17.0 m -71.62 163.87 26.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.436 -0.79 . . . . 0.0 109.632 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.41 ' HG2' HG12 ' A' ' 10' ' ' VAL . 7.2 tm0? -60.29 -51.15 70.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.438 -0.789 . . . . 0.0 110.105 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -41.81 96.39 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.726 -0.609 . . . . 0.0 110.315 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.3 OUTLIER -59.15 -41.53 88.54 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.493 -0.754 . . . . 0.0 110.037 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.12 98.21 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.489 -0.757 . . . . 0.0 109.669 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.429 ' HA ' HD12 ' A' ' 100' ' ' LEU . 9.5 t30 -63.06 -42.63 99.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.548 -0.72 . . . . 0.0 109.614 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -40.28 91.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.574 -0.703 . . . . 0.0 109.598 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.568 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 24.3 t90 -65.42 -38.37 89.71 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.738 -0.601 . . . . 0.0 109.622 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.493 ' HA ' ' HD3' ' A' ' 17' ' ' LYS . 4.3 mt . . . . . 0 N--CA 1.499 1.999 0 O-C-N 121.749 -0.594 . . . . 0.0 110.261 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.0 t -69.35 -39.62 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.52 -0.737 . . . . 0.0 109.033 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.19 -40.71 86.55 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.63 -40.7 92.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.618 -0.676 . . . . 0.0 109.795 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.42 -43.16 97.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.555 -0.716 . . . . 0.0 109.528 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.0 t -62.43 -44.52 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.564 -0.71 . . . . 0.0 109.309 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.33 92.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.631 -0.668 . . . . 0.0 109.99 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 t -63.55 -38.66 91.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.515 -0.741 . . . . 0.0 110.042 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.545 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 7.1 tttt -67.0 -33.83 76.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.95 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.437 HD11 ' CE ' ' A' ' 53' ' ' MET . 10.2 mt -61.48 -48.31 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.449 -0.782 . . . . 0.0 109.757 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.3 t -62.14 -39.13 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.389 -0.819 . . . . 0.0 109.978 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.66 -28.29 73.25 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 tp -115.78 37.3 3.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.363 -1.081 . . . . 0.0 110.95 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -99.19 135.16 41.0 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.187 -0.946 . . . . 0.0 110.617 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.1 mtt-85 -98.49 -167.29 1.48 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -48.37 -43.23 33.46 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.984 -1.072 . . . . 0.0 110.385 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -158.89 36.5 0.22 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.641 -0.662 . . . . 0.0 110.476 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -150.33 157.79 43.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.305 -0.872 . . . . 0.0 110.49 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.1 t -157.6 -179.81 8.52 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.337 -0.852 . . . . 0.0 109.868 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -127.44 143.0 51.26 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.437 -0.789 . . . . 0.0 110.231 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.473 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 3.1 mt -137.54 123.49 20.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.296 -0.877 . . . . 0.0 109.835 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 tp 56.39 30.09 16.33 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.736 -0.603 . . . . 0.0 111.066 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.31 19.01 65.39 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -118.61 163.69 16.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.151 -1.205 . . . . 0.0 110.208 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.2 133.98 34.21 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.477 -0.765 . . . . 0.0 109.896 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.539 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 90.1 m -135.41 165.8 24.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.466 -0.771 . . . . 0.0 110.875 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.33 118.29 31.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.547 -0.72 . . . . 0.0 110.387 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -129.32 126.51 39.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.577 -0.702 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.19 171.45 18.48 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.033 -1.042 . . . . 0.0 111.293 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.61 148.42 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.931 -0.48 . . . . 0.0 109.971 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -157.62 117.39 1.95 Allowed Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.21 -0.931 . . . . 0.0 110.36 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 C--N 1.314 -1.257 0 O-C-N 123.821 1.432 . . . . 0.0 110.885 179.873 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.148 0.499 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.48 130.19 46.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.425 -0.797 . . . . 0.0 109.984 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -130.84 164.68 24.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.414 -0.803 . . . . 0.0 110.087 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -155.83 152.14 23.61 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.39 134.02 19.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.429 -1.042 . . . . 0.0 110.161 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.437 ' CE ' HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -138.95 158.74 43.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.495 -0.753 . . . . 0.0 110.82 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.597 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 43.9 p90 -168.81 -169.1 0.95 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.774 -0.579 . . . . 0.0 109.984 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 68.2 m -133.18 94.42 20.31 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.253 -0.905 . . . . 0.0 110.708 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.597 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.0 Cg_endo -74.87 80.94 2.28 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.986 1.519 . . . . 0.0 110.21 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.34 -45.09 0.64 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -70.77 -55.56 8.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.649 -0.912 . . . . 0.0 110.09 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -151.14 -165.93 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.497 -0.752 . . . . 0.0 109.744 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.57 47.74 1.57 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.299 -0.876 . . . . 0.0 110.183 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.1 mt -123.44 150.9 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.345 -0.847 . . . . 0.0 109.993 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.71 164.38 30.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.316 -0.865 . . . . 0.0 111.328 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.87 130.27 3.83 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.35 170.09 16.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.436 -1.038 . . . . 0.0 111.095 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -166.34 173.02 10.42 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.385 0.612 . . . . 0.0 110.836 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.43 148.48 24.58 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.391 -0.818 . . . . 0.0 110.87 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.5 t -171.22 169.17 6.51 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.661 -0.649 . . . . 0.0 110.138 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -37.94 88.68 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.288 -0.882 . . . . 0.0 110.529 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.3 t -67.56 162.95 22.27 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.498 -0.751 . . . . 0.0 110.859 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.412 ' O ' HG12 ' A' ' 73' ' ' VAL . 34.0 mt-30 -97.81 -56.24 2.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.899 -0.5 . . . . 0.0 110.122 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 m -67.24 -29.65 69.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.399 -0.813 . . . . 0.0 110.519 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.04 -41.14 97.85 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 110.174 -1.171 . . . . 0.0 110.174 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 70' ' ' GLN . 0.5 OUTLIER -65.51 -34.09 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.455 -1.027 . . . . 0.0 110.47 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.04 -39.38 86.94 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.632 -0.667 . . . . 0.0 110.375 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.07 -33.43 69.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.529 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 8.5 mmmt -73.45 -39.62 64.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.524 -0.986 . . . . 0.0 110.432 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.62 -45.45 81.51 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.105 -0.997 . . . . 0.0 109.641 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.404 ' HB3' HD12 ' A' ' 18' ' ' ILE . . . -72.3 -34.92 68.51 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.736 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HA ' ' HZ1' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -72.95 -36.45 67.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.445 -0.784 . . . . 0.0 110.702 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.91 -35.23 74.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.451 -0.781 . . . . 0.0 110.315 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -71.09 -40.5 71.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 110.243 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.455 ' HA ' ' CD1' ' A' ' 91' ' ' ILE . 68.8 t -67.62 -35.06 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.297 -0.877 . . . . 0.0 109.814 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -68.4 -39.07 81.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.515 -0.741 . . . . 0.0 109.733 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.471 ' HE3' ' HB2' ' A' ' 84' ' ' LYS . 1.6 tppp? -64.24 -41.13 97.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.553 -0.717 . . . . 0.0 110.109 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.513 ' HB1' HD13 ' A' ' 91' ' ' ILE . . . -69.98 -34.51 73.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.503 -0.748 . . . . 0.0 109.643 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -40.76 95.68 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.682 -0.636 . . . . 0.0 109.646 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -66.5 -38.46 87.3 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.547 -0.72 . . . . 0.0 110.362 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.64 -50.36 21.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.376 -0.827 . . . . 0.0 110.4 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.91 53.49 0.13 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 90' ' ' LEU . 12.4 mt -125.74 -51.59 1.59 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.364 -1.08 . . . . 0.0 110.447 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.513 HD13 ' HB1' ' A' ' 85' ' ' ALA . 74.5 mt -86.75 104.85 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.714 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 58.2 m -83.77 171.98 12.65 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.527 -0.733 . . . . 0.0 109.971 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -68.16 -56.91 7.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.469 -0.769 . . . . 0.0 110.357 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -37.35 87.3 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.437 -0.789 . . . . 0.0 110.489 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 1.4 mm-40 -53.67 -42.15 67.6 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.455 -0.778 . . . . 0.0 110.017 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.77 -40.28 96.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.471 -0.768 . . . . 0.0 109.523 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -68.24 -38.77 82.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.694 -0.629 . . . . 0.0 109.395 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -62.89 -40.05 96.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.587 -0.695 . . . . 0.0 109.836 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.545 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 28.1 t90 -71.98 -39.03 69.58 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.4 tp . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.782 -0.574 . . . . 0.0 109.647 179.044 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.12 -41.5 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.723 . . . . 0.0 109.121 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.415 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . . . -63.58 -39.75 95.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.662 -0.649 . . . . 0.0 109.823 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.61 -40.47 96.99 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.537 -0.727 . . . . 0.0 109.765 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.51 -40.77 97.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.502 -0.749 . . . . 0.0 109.667 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.435 HG11 HD13 ' A' ' 91' ' ' ILE . 90.6 t -61.62 -42.31 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.583 -0.698 . . . . 0.0 109.227 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.96 95.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.617 -0.677 . . . . 0.0 109.597 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 t -61.31 -38.93 88.61 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.606 -0.684 . . . . 0.0 109.809 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.466 ' HD3' HD21 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -67.12 -36.1 81.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 109.6 179.324 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.3 mm -58.22 -41.9 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.465 -0.772 . . . . 0.0 110.39 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.65 -45.88 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.384 -0.822 . . . . 0.0 110.096 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.09 -15.8 79.82 Favored Glycine 0 N--CA 1.501 2.981 0 C-N-CA 120.26 -0.971 . . . . 0.0 111.035 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.411 HD22 HD22 ' A' ' 29' ' ' LEU . 15.4 tp -99.06 -21.5 16.16 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.118 -1.225 . . . . 0.0 111.285 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.59 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 21.9 t90 -65.7 130.89 44.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 0.0 111.197 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.9 ttt-85 -99.47 -160.97 0.84 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -48.55 -45.98 38.25 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.165 -0.959 . . . . 0.0 110.198 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.93 29.29 0.31 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.47 -0.769 . . . . 0.0 111.249 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.49 157.48 43.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.046 -1.034 . . . . 0.0 110.953 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.8 t -153.81 145.53 23.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.497 -0.752 . . . . 0.0 109.651 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.22 108.24 19.56 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.385 -0.822 . . . . 0.0 109.794 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 29' ' ' LEU . 6.3 mt -114.05 129.37 56.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.183 -0.948 . . . . 0.0 110.924 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.401 ' HB3' ' CD2' ' A' ' 32' ' ' HIS . 0.4 OUTLIER 58.73 28.58 17.49 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.505 -0.747 . . . . 0.0 110.899 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.31 21.56 77.52 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.401 ' CD2' ' HB3' ' A' ' 30' ' ' LEU . 58.6 m-70 -121.18 155.28 34.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.442 -1.034 . . . . 0.0 109.916 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -86.43 116.2 24.43 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.172 -0.955 . . . . 0.0 109.68 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.1 m -116.16 173.51 6.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.574 -0.703 . . . . 0.0 109.66 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.508 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 4.9 tptt -132.87 108.96 9.28 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.525 -0.734 . . . . 0.0 111.065 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.59 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 47.4 t80 -108.82 139.25 43.9 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 p -144.65 152.91 41.15 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.931 -1.105 . . . . 0.0 111.721 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 88.3 t -133.2 123.17 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -138.21 117.41 9.73 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.185 -0.947 . . . . 0.0 110.664 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.41 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 55.2 Cg_endo . . . . . 0 C--N 1.312 -1.377 0 O-C-N 124.018 1.536 . . . . 0.0 110.633 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.321 0.581 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.41 ' CD1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -109.87 131.34 55.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.452 -0.78 . . . . 0.0 109.664 179.317 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -129.42 159.65 35.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.19 -0.944 . . . . 0.0 110.457 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.56 142.82 9.51 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.465 ' HG2' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -138.77 149.99 45.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.922 -0.752 . . . . 0.0 109.85 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.0 ptm -145.69 156.44 43.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.966 -1.084 . . . . 0.0 111.433 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.616 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 23.4 p90 -166.42 164.56 17.34 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.885 -0.51 . . . . 0.0 110.301 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.3 m -128.08 98.42 27.03 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.248 -0.908 . . . . 0.0 110.312 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.616 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.6 Cg_endo -75.13 84.65 1.65 Allowed 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.833 1.438 . . . . 0.0 110.577 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 143.22 -43.99 0.99 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -70.19 -59.84 2.64 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.472 -1.016 . . . . 0.0 110.1 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.3 t -150.07 -170.11 3.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.464 -0.773 . . . . 0.0 110.044 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.53 41.06 2.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.509 -0.744 . . . . 0.0 110.302 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.411 ' CD1' ' HB3' ' A' ' 84' ' ' LYS . 2.7 tt -118.24 153.97 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.51 -0.744 . . . . 0.0 109.666 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.09 171.62 14.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.103 -0.998 . . . . 0.0 111.405 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.547 ' HA3' ' HB2' ' A' ' 81' ' ' PHE . . . -141.2 126.91 3.21 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.465 ' HG2' ' HG2' ' A' ' 52' ' ' ARG . 6.2 mt-10 -135.57 153.01 51.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.459 -1.024 . . . . 0.0 110.441 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.52 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -170.7 164.43 8.12 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.592 -0.693 . . . . 0.0 110.713 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.411 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 1.0 OUTLIER -153.05 149.95 28.66 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.459 -0.776 . . . . 0.0 111.03 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.7 t -173.89 156.98 2.91 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 mtm105 -60.5 -24.27 65.19 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.263 -0.898 . . . . 0.0 111.026 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.25 139.45 54.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.237 -0.914 . . . . 0.0 110.545 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -75.82 -53.72 8.03 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.531 -0.731 . . . . 0.0 110.358 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 t -81.07 -30.34 34.77 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.392 -0.818 . . . . 0.0 109.937 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.93 -36.52 88.24 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.411 ' CG2' ' HA ' ' A' ' 66' ' ' SER . 0.5 OUTLIER -63.16 -35.41 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.446 -1.032 . . . . 0.0 110.344 179.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.47 87.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.441 -0.787 . . . . 0.0 110.119 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.06 -30.91 71.95 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.52 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -73.55 -39.96 64.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.55 -0.971 . . . . 0.0 110.235 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.3 m -64.59 -40.17 95.04 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.279 -0.888 . . . . 0.0 109.117 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.17 -39.27 86.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.623 -0.673 . . . . 0.0 109.657 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -59.75 -41.75 91.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.536 -0.727 . . . . 0.0 110.007 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.87 -41.22 95.84 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.462 -0.774 . . . . 0.0 109.653 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.547 ' HB2' ' HA3' ' A' ' 63' ' ' GLY . 43.3 t80 -69.7 -38.39 76.96 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.55 -0.719 . . . . 0.0 109.813 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.0 -37.79 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.417 -0.802 . . . . 0.0 109.93 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.37 -40.02 85.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.303 -0.873 . . . . 0.0 109.67 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.411 ' HB3' ' CD1' ' A' ' 61' ' ' ILE . 77.7 mttt -67.71 -40.22 84.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.536 -0.727 . . . . 0.0 109.388 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.78 -36.81 81.14 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.632 -0.667 . . . . 0.0 109.774 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 11' ' ' ALA . 0.9 OUTLIER -68.53 -33.38 74.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.594 -0.691 . . . . 0.0 109.956 179.192 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -64.25 -31.23 72.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.384 -0.823 . . . . 0.0 110.653 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.3 -66.83 0.89 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.379 -0.826 . . . . 0.0 110.135 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 151.39 51.6 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.3 mt -112.0 -38.97 4.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.229 -1.159 . . . . 0.0 110.472 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.435 HD13 HG11 ' A' ' 14' ' ' VAL . 80.9 mt -103.82 69.42 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 109.757 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 72.1 m -73.3 -178.61 3.02 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.516 -0.74 . . . . 0.0 110.353 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.62 -59.68 3.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.199 -0.938 . . . . 0.0 110.651 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -63.25 -39.63 95.15 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.359 -0.838 . . . . 0.0 109.94 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 11.4 mt-10 -61.57 -42.66 99.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.576 -0.703 . . . . 0.0 109.493 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.06 -37.03 81.22 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.619 -0.676 . . . . 0.0 109.714 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -62.2 -44.79 95.8 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -30.96 63.45 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.513 -0.742 . . . . 0.0 109.011 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.416 ' CZ3' HG12 ' A' ' 14' ' ' VAL . 30.2 t90 -68.55 -40.4 80.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.705 -0.622 . . . . 0.0 109.958 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.466 HD21 ' HD3' ' A' ' 17' ' ' LYS . 21.2 mt . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.533 -0.729 . . . . 0.0 110.346 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 120.984 0.421 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.05 -42.09 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.525 -0.734 . . . . 0.0 109.459 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.13 -36.9 77.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.514 -0.742 . . . . 0.0 109.485 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.6 89.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.642 -0.661 . . . . 0.0 109.79 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.81 -41.17 95.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.404 -0.81 . . . . 0.0 109.46 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.598 HG11 ' CZ3' ' A' ' 99' ' ' TRP . 25.5 t -62.32 -40.7 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.639 -0.663 . . . . 0.0 109.41 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . . . -63.87 -39.39 94.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.573 -0.705 . . . . 0.0 109.408 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.8 m -62.5 -39.53 93.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.65 -0.656 . . . . 0.0 109.684 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.417 ' HB3' ' HZ3' ' A' ' 99' ' ' TRP . 0.5 OUTLIER -63.39 -37.78 88.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.506 -0.747 . . . . 0.0 109.773 179.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.478 HD12 ' HB2' ' A' ' 78' ' ' ALA . 2.5 mt -61.84 -37.51 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.556 -0.715 . . . . 0.0 109.984 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.2 t -63.67 -48.58 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.232 -0.917 . . . . 0.0 109.789 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.4 -15.42 81.48 Favored Glycine 0 N--CA 1.5 2.918 0 C-N-CA 120.271 -0.966 . . . . 0.0 110.698 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.44 HD22 HD21 ' A' ' 29' ' ' LEU . 11.9 tp -99.38 -16.83 18.27 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.232 -1.158 . . . . 0.0 111.203 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.571 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 24.5 t90 -69.44 137.02 52.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.177 -0.952 . . . . 0.0 111.308 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.49 -162.2 0.87 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -45.68 -45.17 13.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.309 -0.869 . . . . 0.0 110.635 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.5 31.83 0.19 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.437 -0.79 . . . . 0.0 111.28 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -153.15 162.76 40.94 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.066 -1.021 . . . . 0.0 110.792 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.4 t -157.44 144.28 18.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.395 -0.816 . . . . 0.0 109.996 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.56 109.4 21.01 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.517 -0.739 . . . . 0.0 109.621 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.444 ' HB3' ' HZ2' ' A' ' 99' ' ' TRP . 7.9 mt -114.04 130.34 56.56 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.221 -0.924 . . . . 0.0 110.797 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.441 ' CD1' ' HD1' ' A' ' 99' ' ' TRP . 7.1 tp 56.58 30.33 17.13 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.563 -0.71 . . . . 0.0 110.671 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.82 24.84 73.31 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 59.6 m-70 -124.54 159.89 29.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -1.038 . . . . 0.0 109.723 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -91.46 121.92 33.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 110.545 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 23.0 m -122.36 164.14 18.49 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.461 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 5.5 tptm -125.58 110.48 13.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.36 -0.838 . . . . 0.0 111.146 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.571 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 12.8 t80 -110.66 138.49 46.98 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.9 p -143.05 157.43 44.54 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.025 -1.047 . . . . 0.0 111.389 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.437 HG12 ' HD3' ' A' ' 40' ' ' PRO . 99.6 t -129.09 130.06 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.63 -0.669 . . . . 0.0 109.872 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 83.67 64.71 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 0.0 110.451 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.437 ' HD3' HG12 ' A' ' 38' ' ' VAL . 55.5 Cg_endo . . . . . 0 C--N 1.31 -1.448 0 O-C-N 123.855 1.45 . . . . 0.0 110.627 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.217 0.532 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.58 ' CD2' ' HA ' ' A' ' 70' ' ' GLN . 2.1 m-85 -105.72 131.7 52.76 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.555 -0.715 . . . . 0.0 110.42 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.93 156.57 37.79 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.399 -0.813 . . . . 0.0 109.597 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -159.46 141.16 7.32 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.569 -1.301 . . . . 0.0 110.671 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HG3' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -141.03 146.96 37.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.88 -0.776 . . . . 0.0 109.756 179.5 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.572 ' HG2' HG21 ' A' ' 77' ' ' THR . 5.1 ptm -139.05 155.92 47.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 111.327 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.461 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 45.6 p90 -155.91 145.75 21.26 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.916 -0.49 . . . . 0.0 109.797 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 87.3 m -111.98 89.42 11.6 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.236 -0.915 . . . . 0.0 111.066 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -77.74 82.85 2.3 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 123.703 1.37 . . . . 0.0 110.149 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.34 -45.14 0.61 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 11.2 t90 -75.0 -63.28 1.3 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.533 -0.98 . . . . 0.0 110.096 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.2 t -142.41 -162.92 1.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.5 -0.75 . . . . 0.0 109.52 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.7 44.95 2.5 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.296 -0.878 . . . . 0.0 110.395 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.491 HG22 ' HB3' ' A' ' 84' ' ' LYS . 74.0 mt -123.14 140.71 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.361 -0.837 . . . . 0.0 110.234 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.57 170.88 10.49 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.414 -0.804 . . . . 0.0 110.514 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.02 136.21 4.69 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.414 ' HB2' ' HG3' ' A' ' 52' ' ' ARG . 13.1 tt0 -139.6 161.19 38.12 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.809 -0.818 . . . . 0.0 110.357 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.411 ' HB2' ' HB3' ' A' ' 76' ' ' LYS . . . -165.89 151.01 8.59 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.768 -0.582 . . . . 0.0 110.229 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.406 ' HA ' HG22 ' A' ' 73' ' ' VAL . 0.7 OUTLIER -141.71 142.07 33.31 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.426 -0.796 . . . . 0.0 110.601 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.6 t -168.03 172.65 8.66 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.404 -0.81 . . . . 0.0 110.224 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -71.18 -24.8 62.3 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.371 -0.831 . . . . 0.0 110.904 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.74 139.73 56.69 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.277 -0.889 . . . . 0.0 110.743 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.58 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 5.8 tt0 -76.27 -53.78 7.73 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.724 -0.61 . . . . 0.0 110.349 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -84.26 -30.29 25.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.43 -0.794 . . . . 0.0 110.02 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.68 -39.4 93.44 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' A' ' 66' ' ' SER . 3.3 p -61.56 -37.39 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.371 -1.076 . . . . 0.0 110.5 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.92 82.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.526 -0.734 . . . . 0.0 110.036 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.97 -36.91 91.7 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 8.1 mttp -66.61 -39.94 88.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.519 -0.989 . . . . 0.0 110.267 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.572 HG21 ' HG2' ' A' ' 53' ' ' MET . 53.4 m -63.49 -42.16 98.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.269 -0.895 . . . . 0.0 109.02 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . . . -70.2 -38.59 75.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.579 -0.7 . . . . 0.0 109.541 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.543 ' O ' HG11 ' A' ' 82' ' ' VAL . 7.3 ttmt -62.82 -39.69 95.1 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.613 -0.679 . . . . 0.0 110.157 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -68.54 -38.56 80.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 0.0 109.738 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -70.81 -38.42 73.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 109.422 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.543 HG11 ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -68.77 -34.29 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.391 -0.818 . . . . 0.0 109.748 179.45 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -42.14 89.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.292 -0.88 . . . . 0.0 109.211 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.491 ' HB3' HG22 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -67.2 -39.06 86.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.565 -0.709 . . . . 0.0 109.195 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.85 -34.86 77.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.706 -0.621 . . . . 0.0 109.669 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.44 ' CE2' HG23 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -65.53 -39.57 91.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.673 -0.642 . . . . 0.0 109.316 178.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -64.83 -40.18 94.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.633 -0.667 . . . . 0.0 110.448 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -75.51 -54.09 7.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.419 -0.801 . . . . 0.0 110.297 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.01 53.98 0.08 OUTLIER Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.6 mt -118.83 -48.83 2.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.307 -1.113 . . . . 0.0 110.171 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.44 HG23 ' CE2' ' A' ' 86' ' ' PHE . 35.1 mm -88.9 75.77 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.365 -0.834 . . . . 0.0 109.706 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.627 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 19.6 t -73.9 175.91 6.89 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.431 -0.793 . . . . 0.0 110.287 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -67.2 -58.75 4.27 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.292 -0.88 . . . . 0.0 110.834 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -65.57 -39.76 92.03 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.415 -0.803 . . . . 0.0 110.08 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.627 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 0.7 OUTLIER -64.09 -39.6 94.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.635 -0.665 . . . . 0.0 109.69 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.44 80.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.503 -0.748 . . . . 0.0 109.328 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -63.25 -46.04 88.76 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -36.09 73.43 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.598 ' CZ3' HG11 ' A' ' 14' ' ' VAL . 50.7 t90 -62.76 -41.75 99.36 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.1 mt . . . . . 0 N--CA 1.495 1.818 0 O-C-N 121.56 -0.712 . . . . 0.0 109.733 179.409 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.165 0.507 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.5 114.48 9.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.464 -0.773 . . . . 0.0 110.122 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.43 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 45.4 p90 -132.6 142.97 49.38 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.433 -0.792 . . . . 0.0 110.495 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 3' ' ' TYR . 97.5 t 62.61 -71.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 O-C-N 122.044 -0.41 . . . . 0.0 110.895 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 3' ' ' TYR . 1.0 OUTLIER -86.48 62.8 7.63 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.106 -0.996 . . . . 0.0 110.27 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.05 -42.76 98.04 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -62.37 -36.33 81.91 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.585 -0.95 . . . . 0.0 110.717 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -67.38 -38.58 84.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.301 -0.875 . . . . 0.0 109.396 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.64 -39.86 91.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.539 -0.725 . . . . 0.0 109.517 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.53 -39.76 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.609 -0.682 . . . . 0.0 109.486 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.84 95.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.528 -0.732 . . . . 0.0 109.642 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.537 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . . . -63.5 -41.12 98.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.635 -0.666 . . . . 0.0 109.745 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.58 94.54 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.548 -0.72 . . . . 0.0 109.696 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.2 t -64.38 -39.79 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.544 -0.723 . . . . 0.0 109.536 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.43 -39.62 94.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.397 -0.814 . . . . 0.0 109.749 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.39 -39.51 93.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.432 -0.793 . . . . 0.0 109.651 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.574 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -65.82 -31.24 72.09 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.543 -0.723 . . . . 0.0 110.068 179.297 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.431 HG21 HD12 ' A' ' 18' ' ' ILE . 5.2 mm -63.87 -43.42 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.431 -0.793 . . . . 0.0 109.651 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.02 -40.47 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.458 -0.776 . . . . 0.0 110.029 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.88 -25.26 75.4 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.22 36.33 4.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.321 -1.105 . . . . 0.0 110.939 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.433 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 23.8 t90 -102.95 137.76 40.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.18 -0.95 . . . . 0.0 110.984 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -168.57 1.67 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -46.34 -44.55 16.92 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.199 -0.938 . . . . 0.0 110.31 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -158.64 36.48 0.23 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.537 -0.727 . . . . 0.0 110.619 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.29 151.13 31.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.198 -0.939 . . . . 0.0 110.584 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 t -152.69 175.48 12.78 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.473 -0.767 . . . . 0.0 109.625 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.95 126.4 31.97 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.334 -0.854 . . . . 0.0 110.379 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.8 mt -111.62 124.4 52.24 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.359 -0.838 . . . . 0.0 110.206 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.472 HD11 ' HB2' ' A' ' 99' ' ' TRP . 2.5 tp 56.71 29.81 16.48 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.647 -0.658 . . . . 0.0 111.175 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.03 -6.84 82.96 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -91.09 158.79 16.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.977 -1.308 . . . . 0.0 110.222 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -84.17 138.32 33.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.423 -0.798 . . . . 0.0 110.12 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.466 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 91.5 m -142.11 167.52 21.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.364 -0.835 . . . . 0.0 110.455 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -122.89 113.38 19.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.485 -0.76 . . . . 0.0 110.718 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.551 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 1.6 t80 -114.67 130.14 56.77 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.67 162.38 35.53 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.947 -1.096 . . . . 0.0 111.733 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.26 152.68 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.86 -0.525 . . . . 0.0 109.875 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -157.17 102.42 1.9 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.11 -0.994 . . . . 0.0 110.388 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -78.08 151.04 26.82 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.898 1.473 . . . . 0.0 111.101 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -126.17 -173.31 2.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.61 -0.681 . . . . 0.0 109.634 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.72 144.72 37.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.636 -0.665 . . . . 0.0 111.099 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -115.21 173.6 6.42 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 -45.35 -33.21 2.38 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.685 -0.634 . . . . 0.0 111.289 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -155.34 41.53 0.43 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.535 -0.728 . . . . 0.0 110.314 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -158.65 170.34 22.39 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.204 -0.935 . . . . 0.0 110.998 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 80.3 t -133.21 124.31 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -114.12 147.78 38.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.202 -0.936 . . . . 0.0 111.07 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.481 ' CD2' ' HA ' ' A' ' 70' ' ' GLN . 0.3 OUTLIER -111.58 117.4 32.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.597 -0.689 . . . . 0.0 109.887 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.11 162.81 14.53 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.605 -0.684 . . . . 0.0 109.776 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.55 157.32 29.66 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.847 -1.168 . . . . 0.0 110.287 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.474 ' CD ' ' HB3' ' A' ' 64' ' ' GLU . 0.6 OUTLIER -153.91 141.26 19.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.698 -0.884 . . . . 0.0 109.854 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.551 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 2.8 ppp? -142.74 148.77 37.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.34 -0.85 . . . . 0.0 110.903 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.514 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 47.3 p90 -155.28 171.1 20.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.836 -0.54 . . . . 0.0 109.871 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 61.7 m -121.59 91.12 48.39 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 0.0 110.808 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.514 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 46.9 Cg_endo -76.9 83.93 2.02 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.939 1.494 . . . . 0.0 109.9 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.26 -47.23 0.49 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -73.29 -53.83 9.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.533 -0.98 . . . . 0.0 110.096 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.9 t -152.67 -160.9 1.2 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.531 -0.731 . . . . 0.0 109.963 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.7 68.95 0.97 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.285 -0.884 . . . . 0.0 110.345 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.1 mt -138.88 155.83 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.386 -0.822 . . . . 0.0 110.072 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.66 166.0 25.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.464 -0.772 . . . . 0.0 110.891 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.416 ' HA3' ' N ' ' A' ' 81' ' ' PHE . . . -159.53 128.77 2.07 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.474 ' HB3' ' CD ' ' A' ' 52' ' ' ARG . 1.4 pt-20 -137.66 165.33 26.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.596 -0.943 . . . . 0.0 110.897 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.471 ' HB3' ' CG ' ' A' ' 76' ' ' LYS . . . -158.53 161.08 37.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.716 -0.615 . . . . 0.0 110.632 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.5 m -143.4 151.63 40.62 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.465 -0.772 . . . . 0.0 110.282 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.0 t -174.6 -177.31 1.16 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.65 -0.657 . . . . 0.0 110.148 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -82.77 -31.77 28.13 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.258 -0.902 . . . . 0.0 110.125 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.91 146.92 53.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.352 -0.843 . . . . 0.0 110.353 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.481 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 34.4 mt-30 -83.49 -54.78 4.71 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.516 -0.74 . . . . 0.0 110.316 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 m -75.26 -30.83 60.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.453 -0.78 . . . . 0.0 110.237 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.86 -39.7 94.25 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.32 -34.03 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.273 -1.134 . . . . 0.0 110.471 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.466 ' HA ' ' HZ ' ' A' ' 36' ' ' PHE . . . -64.78 -47.4 78.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.518 -0.739 . . . . 0.0 109.869 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.79 -32.32 77.62 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.471 ' CG ' ' HB3' ' A' ' 65' ' ' ALA . 11.5 tptp -69.55 -40.9 76.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.599 -0.942 . . . . 0.0 110.224 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.7 m -64.99 -41.04 95.76 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.471 -0.768 . . . . 0.0 109.919 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.37 -34.56 72.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.405 -0.809 . . . . 0.0 110.114 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -67.36 -39.69 85.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 110.239 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.499 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 0.7 OUTLIER -67.09 -38.47 85.76 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.453 -0.78 . . . . 0.0 109.935 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.416 ' N ' ' HA3' ' A' ' 63' ' ' GLY . 39.6 t80 -67.18 -40.48 86.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.482 -0.761 . . . . 0.0 109.445 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.449 ' HA ' ' CD1' ' A' ' 91' ' ' ILE . 55.8 t -67.14 -36.83 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.44 -0.787 . . . . 0.0 109.829 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.499 ' NH1' ' HA ' ' A' ' 80' ' ' ASP . 4.1 ttp180 -65.26 -39.2 92.34 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.369 -0.832 . . . . 0.0 110.142 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -67.49 -39.91 85.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.276 -0.89 . . . . 0.0 110.04 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.59 -29.53 62.45 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.43 -0.794 . . . . 0.0 110.139 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 1.8 t80 -74.1 -37.69 64.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.488 -0.758 . . . . 0.0 110.295 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -37.08 84.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.362 -0.836 . . . . 0.0 110.234 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -73.96 -53.92 9.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.279 -0.888 . . . . 0.0 110.054 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.87 53.27 0.07 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.0 mt -122.31 -56.92 1.79 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.364 -1.08 . . . . 0.0 110.346 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 82.4 mt -77.72 109.6 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.33 -0.856 . . . . 0.0 109.911 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.6 m -93.8 167.19 11.8 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.357 -0.839 . . . . 0.0 110.286 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -48.5 70.39 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.492 -0.755 . . . . 0.0 110.424 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -63.56 -42.59 98.34 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.537 -0.727 . . . . 0.0 110.728 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.413 ' HB3' HD12 ' A' ' 30' ' ' LEU . 7.0 mt-10 -62.08 -43.59 98.5 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.416 -0.802 . . . . 0.0 110.245 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.32 87.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.584 -0.697 . . . . 0.0 109.94 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -67.34 -38.3 84.66 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.61 -0.682 . . . . 0.0 110.313 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.99 -38.78 86.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.343 -0.848 . . . . 0.0 109.652 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.574 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 15.4 t90 -66.06 -40.94 91.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.548 -0.72 . . . . 0.0 109.861 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.445 ' HA ' ' CD ' ' A' ' 17' ' ' LYS . 16.4 mt -66.81 -32.93 74.53 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.603 -0.686 . . . . 0.0 110.148 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 74.5 m -66.26 -55.51 15.78 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.538 -0.726 . . . . 0.0 110.107 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.7 p . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.425 179.738 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 121.137 0.494 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.14 171.06 15.06 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.507 -0.746 . . . . 0.0 110.372 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.93 -62.57 1.32 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.311 -0.868 . . . . 0.0 110.226 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.62 18.36 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.395 -0.815 . . . . 0.0 110.753 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -96.58 85.92 3.99 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.217 -0.927 . . . . 0.0 109.973 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.05 50.82 0.04 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -59.24 -35.74 74.21 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.643 -0.916 . . . . 0.0 110.17 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.458 ' HG3' ' HE2' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -65.6 -36.25 83.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.48 -0.762 . . . . 0.0 109.807 179.272 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.01 -42.7 89.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.433 -0.792 . . . . 0.0 109.445 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.1 -40.83 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.05 -40.01 95.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.695 -0.628 . . . . 0.0 109.383 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.471 ' HA ' ' HG3' ' A' ' 79' ' ' LYS . . . -62.44 -41.32 98.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.71 -0.619 . . . . 0.0 109.486 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.93 97.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.617 -0.677 . . . . 0.0 109.55 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.9 t -64.59 -41.37 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.541 -0.724 . . . . 0.0 109.237 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.558 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -66.18 -38.37 87.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.665 -0.647 . . . . 0.0 109.548 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.8 m -63.85 -39.03 93.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.575 -0.703 . . . . 0.0 109.698 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.46 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 17.4 tttm -66.01 -34.63 78.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.458 -0.776 . . . . 0.0 109.843 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.5 HD13 ' HB1' ' A' ' 78' ' ' ALA . 10.1 mt -65.07 -46.8 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.5 -0.75 . . . . 0.0 109.288 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.8 t -62.72 -40.18 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.656 -0.652 . . . . 0.0 109.965 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.49 -27.85 73.55 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.6 tp -115.75 38.47 3.29 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.405 -1.056 . . . . 0.0 110.725 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -101.81 137.68 39.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.241 -0.912 . . . . 0.0 110.458 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.98 -166.92 1.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.461 -0.774 . . . . 0.0 109.215 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -49.31 -41.53 38.68 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.185 -0.947 . . . . 0.0 110.442 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.7 33.81 0.19 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.615 -0.678 . . . . 0.0 110.609 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.23 153.57 37.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.199 -0.938 . . . . 0.0 110.849 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.5 t -155.56 151.78 28.0 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.392 -0.818 . . . . 0.0 109.876 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -105.61 121.27 43.63 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.179 -0.95 . . . . 0.0 110.782 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.447 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 1.3 mt -114.29 126.83 55.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.564 -0.71 . . . . 0.0 110.053 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.474 HD13 ' HG2' ' A' ' 95' ' ' GLU . 1.7 tp 54.17 33.7 18.54 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.649 -0.657 . . . . 0.0 111.016 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.09 23.94 74.88 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -123.14 145.01 48.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -1.093 . . . . 0.0 109.942 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 123.7 24.57 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.422 -0.799 . . . . 0.0 110.404 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.466 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 83.5 m -128.43 161.94 28.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.658 -0.651 . . . . 0.0 109.25 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.553 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -116.32 117.51 30.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.358 -0.839 . . . . 0.0 110.916 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -118.75 125.19 49.09 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.75 154.58 51.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.12 -0.988 . . . . 0.0 111.496 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.5 t -137.18 142.69 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.701 -0.625 . . . . 0.0 109.872 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.81 123.95 2.48 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.243 -0.911 . . . . 0.0 110.592 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -78.56 158.55 28.75 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 O-C-N 123.903 1.475 . . . . 0.0 110.954 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -133.3 -168.39 2.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.629 -0.67 . . . . 0.0 109.765 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.51 146.62 49.57 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.537 0.684 . . . . 0.0 110.803 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.64 174.07 6.48 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -41.28 -33.93 0.44 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.894 -0.504 . . . . 0.0 111.511 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -162.3 42.37 0.13 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.46 -0.775 . . . . 0.0 110.48 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -165.11 154.17 12.49 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.113 -0.992 . . . . 0.0 111.224 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.5 t -99.35 122.07 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.493 -0.754 . . . . 0.0 109.03 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -110.26 162.65 14.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.215 -0.928 . . . . 0.0 111.139 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.467 ' CZ ' ' HG2' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -122.39 128.93 51.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 110.152 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -132.28 151.73 51.7 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.53 -0.732 . . . . 0.0 110.088 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.22 154.86 26.13 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.44 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -146.19 143.67 29.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.718 -0.872 . . . . 0.0 110.059 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.524 ' HG2' HG23 ' A' ' 77' ' ' THR . 0.4 OUTLIER -143.48 157.72 44.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.366 -0.834 . . . . 0.0 111.133 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.577 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 42.9 p90 -161.43 -175.47 4.81 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.726 -0.609 . . . . 0.0 109.773 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 58' ' ' TRP . 69.6 m -133.19 95.91 18.02 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.102 -0.999 . . . . 0.0 110.644 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.577 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.3 Cg_endo -74.32 77.97 2.75 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.991 1.522 . . . . 0.0 110.333 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.26 -45.52 0.66 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 55' ' ' CYS . 15.3 t90 -68.65 -53.32 23.13 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.475 -1.015 . . . . 0.0 110.267 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.1 t -153.64 -168.56 3.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.553 -0.717 . . . . 0.0 109.754 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.22 45.96 1.89 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.322 -0.861 . . . . 0.0 110.447 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.3 mt -121.15 150.8 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.373 -0.829 . . . . 0.0 109.851 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 ptt-85 -131.15 163.16 28.29 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.284 -0.885 . . . . 0.0 110.834 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.85 155.55 23.26 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -158.39 154.31 26.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -1.112 . . . . 0.0 110.508 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.477 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . . . -166.19 152.97 9.43 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.52 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.6 m -139.08 150.77 46.12 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 110.594 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.427 HG22 HG21 ' A' ' 73' ' ' VAL . 10.0 t -172.71 164.63 5.34 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.705 -0.622 . . . . 0.0 109.994 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -63.29 -31.75 72.98 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.506 -0.746 . . . . 0.0 110.16 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.05 136.64 56.28 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.511 -0.743 . . . . 0.0 110.63 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.467 ' HG2' ' CZ ' ' A' ' 49' ' ' TYR . 12.1 mt-30 -77.17 -56.35 4.65 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.581 -0.699 . . . . 0.0 110.362 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 t -76.67 -31.44 57.29 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.312 -0.868 . . . . 0.0 110.037 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.91 -38.36 93.99 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.427 HG21 HG22 ' A' ' 67' ' ' THR . 0.8 OUTLIER -58.19 -35.76 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.456 -1.026 . . . . 0.0 110.577 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.16 84.29 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.561 -0.712 . . . . 0.0 109.809 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -64.4 -36.37 93.11 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.477 ' HG2' ' HB3' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -70.8 -39.02 73.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.384 -1.068 . . . . 0.0 110.274 179.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.524 HG23 ' HG2' ' A' ' 53' ' ' MET . 18.7 m -66.52 -37.8 85.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.336 -0.852 . . . . 0.0 110.026 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.558 ' HB1' ' HA ' ' A' ' 15' ' ' ALA . . . -78.47 -35.49 46.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.525 -0.735 . . . . 0.0 110.232 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.471 ' HG3' ' HA ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -71.88 -38.7 69.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.386 -0.821 . . . . 0.0 109.651 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.6 -36.5 83.91 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.522 -0.737 . . . . 0.0 109.512 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -67.96 -39.89 83.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.711 . . . . 0.0 109.671 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.449 HG12 HD12 ' A' ' 91' ' ' ILE . 72.5 t -66.41 -37.76 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.542 -0.724 . . . . 0.0 109.718 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -38.62 91.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.419 -0.8 . . . . 0.0 109.669 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -38.43 72.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.535 -0.728 . . . . 0.0 109.315 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.53 -34.92 78.07 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.539 -0.725 . . . . 0.0 109.799 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.08 -38.39 82.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 109.542 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -66.87 -39.3 87.49 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.496 -0.753 . . . . 0.0 110.342 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -72.96 -54.48 8.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.404 -0.81 . . . . 0.0 110.256 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.54 54.33 0.08 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.4 mt -121.17 -49.08 2.19 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -1.091 . . . . 0.0 110.494 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.449 HD12 HG12 ' A' ' 82' ' ' VAL . 95.8 mt -94.23 112.14 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.379 -0.826 . . . . 0.0 110.199 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 4.0 m -83.14 179.5 7.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.435 -0.79 . . . . 0.0 110.411 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -75.41 -60.23 2.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.337 -0.852 . . . . 0.0 110.245 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -63.08 -38.2 90.23 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.423 -0.798 . . . . 0.0 110.153 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 17.7 tt0 -55.09 -44.89 75.28 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.749 -0.594 . . . . 0.0 110.2 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.78 94.02 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.492 -0.755 . . . . 0.0 109.786 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -38.43 89.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.562 -0.711 . . . . 0.0 109.956 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -64.89 -40.89 95.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.803 . . . . 0.0 109.599 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.46 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 15.0 t90 -68.53 -39.27 81.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.448 -0.783 . . . . 0.0 109.155 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.9 mt -55.05 -40.78 70.64 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.1 m -72.45 -43.74 63.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.549 -0.719 . . . . 0.0 109.807 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.219 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 120.935 0.398 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.97 75.3 0.28 Allowed 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.332 0.587 . . . . 0.0 110.739 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -147.75 156.31 42.61 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.28 -0.887 . . . . 0.0 110.519 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.6 p -131.84 32.28 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.458 -0.776 . . . . 0.0 110.579 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 58.65 -173.28 0.1 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.521 -0.737 . . . . 0.0 111.359 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -108.71 -63.62 0.55 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -58.96 -46.59 87.66 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.614 -0.933 . . . . 0.0 110.01 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.09 -39.36 85.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.774 -0.579 . . . . 0.0 109.949 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.63 -41.25 98.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.586 -0.696 . . . . 0.0 109.722 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.3 t -66.19 -39.45 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.445 -0.784 . . . . 0.0 109.11 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.474 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -66.46 -38.72 87.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.673 -0.642 . . . . 0.0 109.487 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.2 95.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.652 -0.655 . . . . 0.0 109.841 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.43 -41.57 98.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.459 -0.776 . . . . 0.0 109.648 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.438 HG11 HG23 ' A' ' 82' ' ' VAL . 62.2 t -64.94 -39.2 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.448 -0.783 . . . . 0.0 109.241 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.38 -37.03 86.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.587 -0.696 . . . . 0.0 109.853 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -66.97 -39.28 87.19 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.476 -0.765 . . . . 0.0 109.58 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.549 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 16.6 tptt -66.44 -31.1 71.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.444 -0.785 . . . . 0.0 109.724 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 22' ' ' TRP . 11.2 mm -62.56 -50.4 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.412 -0.805 . . . . 0.0 109.1 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.82 -37.75 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.722 . . . . 0.0 109.878 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.58 -27.72 73.64 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.41 36.41 4.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.262 -1.14 . . . . 0.0 110.805 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.461 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 23.6 t90 -102.75 135.36 44.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.133 -0.98 . . . . 0.0 110.943 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.12 -164.02 1.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -48.86 -45.91 41.54 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.075 -1.016 . . . . 0.0 109.891 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -156.77 34.14 0.3 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.712 -0.617 . . . . 0.0 110.45 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.83 150.07 41.16 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.1 -1.0 . . . . 0.0 111.154 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.439 HG23 ' CB ' ' A' ' 34' ' ' CYS . 2.1 t -151.7 165.66 33.71 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -128.95 115.36 17.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.094 -1.004 . . . . 0.0 110.411 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mt -100.94 119.79 39.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.463 -0.773 . . . . 0.0 110.166 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.402 HD13 ' HB2' ' A' ' 99' ' ' TRP . 3.7 tp 56.67 30.45 17.52 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.743 -0.598 . . . . 0.0 111.127 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.63 -11.85 67.18 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 87.8 m-70 -83.98 146.77 27.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.128 -1.219 . . . . 0.0 110.121 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -73.79 133.0 43.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.463 -0.773 . . . . 0.0 110.02 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.439 ' CB ' HG23 ' A' ' 27' ' ' THR . 15.2 m -136.08 171.28 14.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.553 -0.717 . . . . 0.0 110.042 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.51 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -132.9 120.42 21.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.475 -0.765 . . . . 0.0 110.339 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' ' 53' ' ' MET . 40.6 t80 -122.92 135.48 54.51 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.8 p -141.78 150.99 42.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.004 -1.06 . . . . 0.0 111.598 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.1 t -137.5 130.22 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -152.71 123.94 3.66 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.079 -1.013 . . . . 0.0 110.794 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -77.08 151.29 30.4 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.871 1.459 . . . . 0.0 110.997 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.539 ' CE2' ' HB3' ' A' ' 50' ' ' LYS . 20.7 m-85 -121.32 -170.35 2.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.643 -0.661 . . . . 0.0 109.499 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.19 143.37 50.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.48 -0.763 . . . . 0.0 111.135 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.443 ' HD2' ' CE2' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -116.79 177.65 4.63 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.305 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -39.59 -41.76 1.08 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.849 -0.532 . . . . 0.0 111.4 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.64 37.8 0.37 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.403 -0.811 . . . . 0.0 110.737 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -160.29 141.97 12.59 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.161 -0.962 . . . . 0.0 110.979 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 80.0 t -97.33 125.2 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.397 -0.815 . . . . 0.0 109.472 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.443 ' CE2' ' HD2' ' A' ' 43' ' ' LYS . 44.7 m-85 -109.61 158.38 18.1 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.407 -0.808 . . . . 0.0 110.768 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.425 ' HD2' HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -114.71 133.07 56.17 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.442 -0.786 . . . . 0.0 109.918 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.539 ' HB3' ' CE2' ' A' ' 41' ' ' TYR . 49.1 tttt -142.27 148.63 38.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.494 -0.754 . . . . 0.0 110.366 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -143.53 153.61 24.98 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -145.25 150.53 36.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.764 -0.845 . . . . 0.0 110.112 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.419 ' HB3' ' CD2' ' A' ' 36' ' ' PHE . 22.4 ptm -144.19 153.45 42.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.244 -0.91 . . . . 0.0 110.977 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.51 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 41.6 p90 -152.83 146.4 25.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.782 -0.574 . . . . 0.0 110.288 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 67.2 m -116.29 90.53 29.78 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.231 -0.918 . . . . 0.0 111.1 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -79.22 82.02 2.63 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.87 1.458 . . . . 0.0 110.266 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.89 -46.81 0.48 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.448 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 13.9 t90 -70.49 -53.5 16.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.623 -0.928 . . . . 0.0 109.912 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.4 t -158.82 -160.7 0.89 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.748 -0.595 . . . . 0.0 109.888 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.19 46.5 1.78 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.342 -0.849 . . . . 0.0 109.931 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.7 mt -122.45 144.68 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.512 -0.742 . . . . 0.0 109.882 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.49 170.96 13.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.304 -0.872 . . . . 0.0 110.92 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.11 156.55 26.99 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.493 ' HG2' ' N ' ' A' ' 65' ' ' ALA . 14.4 tt0 -163.17 154.66 17.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.516 -0.99 . . . . 0.0 109.996 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -168.56 155.0 7.12 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.031 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.465 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 7.0 m -137.02 153.29 50.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.614 -0.679 . . . . 0.0 110.382 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -175.16 159.18 2.53 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.592 -0.693 . . . . 0.0 110.49 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -36.36 71.31 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.661 -0.649 . . . . 0.0 111.332 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.59 142.95 57.91 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.326 -0.859 . . . . 0.0 110.904 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.82 -49.03 15.12 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.618 -0.676 . . . . 0.0 109.986 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.9 m -82.41 -29.38 30.82 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.479 -0.763 . . . . 0.0 109.744 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.02 -38.71 94.66 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.465 ' CG2' ' HA ' ' A' ' 66' ' ' SER . 0.8 OUTLIER -60.59 -36.65 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.395 -1.062 . . . . 0.0 110.307 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.61 -38.59 77.33 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.55 -0.719 . . . . 0.0 109.739 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.72 -32.52 78.28 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.528 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 42.6 mtpt -72.75 -40.12 66.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.473 -1.016 . . . . 0.0 110.065 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.1 m -66.44 -38.41 87.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -0.975 . . . . 0.0 109.657 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.08 -37.69 61.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.6 -0.687 . . . . 0.0 110.333 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.6 -39.19 73.95 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.357 -0.84 . . . . 0.0 109.715 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -65.75 -36.25 83.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.681 -0.637 . . . . 0.0 109.715 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -68.84 -40.19 79.54 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 0.0 109.266 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.519 ' HA ' ' CD1' ' A' ' 91' ' ' ILE . 54.6 t -65.71 -38.9 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.549 -0.719 . . . . 0.0 109.968 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -64.78 -40.29 95.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.509 -0.744 . . . . 0.0 109.949 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -67.63 -39.37 84.66 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.416 -0.803 . . . . 0.0 109.619 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 91' ' ' ILE . . . -70.52 -35.64 73.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.596 -0.69 . . . . 0.0 109.659 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -40.68 95.8 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.606 -0.684 . . . . 0.0 109.706 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.41 -35.9 78.32 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.562 -0.711 . . . . 0.0 110.456 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -74.56 -52.49 11.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.304 -0.873 . . . . 0.0 110.203 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.94 52.49 0.11 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.8 mt -122.98 -49.93 1.95 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.394 -1.062 . . . . 0.0 110.293 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.519 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 89.5 mt -86.24 81.24 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.345 -0.847 . . . . 0.0 109.505 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -64.71 153.67 38.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 109.181 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -56.47 -47.81 78.43 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.529 -0.732 . . . . 0.0 110.281 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.43 -41.11 76.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.46 -0.775 . . . . 0.0 110.476 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.8 OUTLIER -63.03 -40.57 98.14 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.492 -0.755 . . . . 0.0 110.101 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.33 -43.29 92.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.591 -0.693 . . . . 0.0 109.872 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -65.42 -39.11 91.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.544 -0.723 . . . . 0.0 109.452 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -42.36 95.05 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.715 -0.616 . . . . 0.0 109.738 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.549 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 24.1 t90 -67.51 -39.48 85.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.503 -0.748 . . . . 0.0 109.444 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.2 mt -58.65 -35.99 73.41 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.714 -0.616 . . . . 0.0 109.804 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.5 m -62.44 -38.34 89.36 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.629 -0.669 . . . . 0.0 110.376 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.6 p . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 117.8 -1.095 . . . . 0.0 110.321 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.831 0.348 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.24 119.07 17.94 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.375 -0.828 . . . . 0.0 110.307 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -159.25 -53.72 0.06 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.399 -0.813 . . . . 0.0 110.468 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.1 p -75.02 142.44 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.453 -0.78 . . . . 0.0 110.468 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -137.18 146.92 45.5 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.47 -0.769 . . . . 0.0 110.396 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.09 -73.01 0.2 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -59.69 -46.43 89.08 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.598 -0.942 . . . . 0.0 110.583 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -61.21 -42.96 99.5 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.491 -0.756 . . . . 0.0 109.615 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.12 -40.17 88.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.651 -0.655 . . . . 0.0 110.226 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.9 t -66.04 -39.63 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.466 -0.771 . . . . 0.0 109.517 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.423 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.69 -39.29 93.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.467 -0.771 . . . . 0.0 109.904 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.68 -38.84 87.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.61 -0.681 . . . . 0.0 109.739 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.01 96.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.586 -0.697 . . . . 0.0 109.783 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.7 t -62.69 -41.68 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.426 -0.796 . . . . 0.0 109.043 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.57 -39.45 93.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.498 -0.752 . . . . 0.0 109.612 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 54.4 m -61.7 -41.31 97.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.557 -0.715 . . . . 0.0 109.658 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.606 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 6.4 tptm -67.37 -31.21 71.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.428 -0.795 . . . . 0.0 109.765 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 18' ' ' ILE . 4.8 mm -63.27 -47.26 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.395 -0.816 . . . . 0.0 109.617 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.4 t -63.62 -38.71 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.45 -0.781 . . . . 0.0 109.852 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.75 -26.89 71.88 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 tp -113.8 32.62 5.71 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.239 -1.154 . . . . 0.0 111.448 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 18.4 t90 -94.2 131.6 39.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.952 -1.092 . . . . 0.0 110.197 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.13 -172.73 2.41 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -43.53 -39.84 3.63 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.229 -0.92 . . . . 0.0 110.609 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.418 ' HB2' ' CG2' ' A' ' 37' ' ' THR . 12.4 pt-20 -164.67 37.19 0.07 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.401 0.62 . . . . 0.0 109.781 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -150.77 161.23 43.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.492 -0.755 . . . . 0.0 110.721 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.5 t -156.89 151.45 25.53 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.358 -0.838 . . . . 0.0 109.868 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.58 110.59 22.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.43 -0.794 . . . . 0.0 109.832 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.605 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 2.4 mt -105.21 123.8 48.46 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.255 -0.903 . . . . 0.0 110.559 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 tp 55.1 34.72 23.18 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.648 -0.657 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.81 7.54 87.37 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -106.1 160.48 15.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.089 -1.242 . . . . 0.0 110.025 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.79 125.79 34.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.378 -0.826 . . . . 0.0 110.198 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 84.9 m -130.77 168.21 17.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.426 -0.796 . . . . 0.0 110.261 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.2 tttm -123.55 115.05 20.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.397 -0.814 . . . . 0.0 111.378 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.5 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 1.3 t80 -115.49 122.34 45.43 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.418 ' CG2' ' HB2' ' A' ' 25' ' ' GLU . 1.9 p -140.46 158.3 44.21 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.985 -1.072 . . . . 0.0 112.203 -178.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.7 p -129.31 147.08 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.813 -0.554 . . . . 0.0 109.865 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.84 110.75 2.71 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.085 -1.009 . . . . 0.0 110.711 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -79.92 158.19 24.13 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.815 1.429 . . . . 0.0 110.697 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.483 ' CE2' ' HB3' ' A' ' 50' ' ' LYS . 18.9 m-85 -126.44 -176.5 3.69 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.492 -0.755 . . . . 0.0 109.778 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.98 143.02 31.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.602 -0.686 . . . . 0.0 110.841 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.28 177.98 4.61 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.422 ' HD2' ' HA ' ' A' ' 44' ' ' ARG . 17.8 mmm180 -42.13 -36.76 1.25 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.858 -0.526 . . . . 0.0 111.545 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.35 39.34 0.35 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.389 -0.819 . . . . 0.0 110.612 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -157.12 135.87 11.58 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.107 -0.996 . . . . 0.0 111.257 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.6 t -98.36 125.18 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.436 -0.79 . . . . 0.0 109.212 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -107.73 161.14 15.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.515 -0.74 . . . . 0.0 110.686 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.508 ' CD2' ' HA ' ' A' ' 70' ' ' GLN . 0.3 OUTLIER -128.92 142.97 50.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.301 -0.874 . . . . 0.0 110.582 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.483 ' HB3' ' CE2' ' A' ' 41' ' ' TYR . 30.9 tttt -154.11 151.04 28.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -0.827 . . . . 0.0 110.216 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.25 150.05 22.18 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.49 ' CG ' ' HB3' ' A' ' 64' ' ' GLU . 8.9 ttp180 -143.04 144.93 32.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.68 -0.894 . . . . 0.0 110.256 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.5 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 2.3 ppp? -144.04 147.1 33.38 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.436 -0.79 . . . . 0.0 110.818 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.617 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 49.2 p90 -154.29 -168.9 3.08 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.797 -0.564 . . . . 0.0 110.113 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.3 m -134.15 92.79 20.85 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.857 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.617 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 47.9 Cg_endo -72.91 80.91 1.72 Allowed 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 123.86 1.453 . . . . 0.0 110.083 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.06 -43.24 0.79 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.447 ' HB3' ' HB3' ' A' ' 55' ' ' CYS . 18.5 t90 -74.34 -52.88 10.89 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.524 -0.986 . . . . 0.0 110.425 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.9 t -153.72 -168.14 2.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.535 -0.728 . . . . 0.0 110.007 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.55 45.3 2.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.439 -0.788 . . . . 0.0 110.39 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.4 mt -117.86 156.85 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.394 -0.816 . . . . 0.0 109.466 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.78 165.99 27.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.287 -0.883 . . . . 0.0 111.339 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.55 127.36 2.29 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.49 ' HB3' ' CG ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -144.87 160.62 41.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.8 -0.824 . . . . 0.0 110.634 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.57 163.84 38.8 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.649 -0.657 . . . . 0.0 110.904 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.62 141.95 35.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.516 -0.74 . . . . 0.0 110.193 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.429 HG21 HG22 ' A' ' 73' ' ' VAL . 8.8 t -173.07 170.22 4.45 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.504 -0.748 . . . . 0.0 110.396 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.48 ' HG3' ' N ' ' A' ' 69' ' ' SER . 2.2 ptm85 -64.67 -35.09 79.92 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.438 -0.789 . . . . 0.0 110.249 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.48 ' N ' ' HG3' ' A' ' 68' ' ' ARG . 3.4 m -58.78 153.73 16.29 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.377 0.608 . . . . 0.0 110.754 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.508 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 45.2 mt-30 -101.17 -60.74 1.47 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.802 -0.561 . . . . 0.0 110.088 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -29.91 61.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.285 -0.885 . . . . 0.0 110.398 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.61 -38.75 96.37 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.429 HG22 HG21 ' A' ' 67' ' ' THR . 0.4 OUTLIER -63.54 -34.93 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.429 -1.042 . . . . 0.0 110.434 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.76 -45.75 85.07 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.355 -0.841 . . . . 0.0 109.482 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.36 -37.65 94.96 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -69.75 -38.76 76.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.609 -0.936 . . . . 0.0 109.64 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.416 HG21 ' HB3' ' A' ' 53' ' ' MET . 15.5 m -55.98 -44.47 78.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.326 -0.859 . . . . 0.0 109.245 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.35 -38.93 74.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.681 -0.637 . . . . 0.0 109.748 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -39.23 84.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.683 . . . . 0.0 110.039 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 0.7 OUTLIER -67.03 -31.14 71.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.599 -0.688 . . . . 0.0 110.185 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.4 ' CD2' ' SD ' ' A' ' 53' ' ' MET . 54.5 t80 -80.74 -36.52 31.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.045 -1.034 . . . . 0.0 109.046 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.491 ' HA ' HD11 ' A' ' 91' ' ' ILE . 46.3 t -68.05 -38.4 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.671 -0.643 . . . . 0.0 110.246 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 2.6 ptm85 -67.45 -39.19 85.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.266 -0.896 . . . . 0.0 109.557 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.4 ' N ' ' HG3' ' A' ' 83' ' ' ARG . 0.7 OUTLIER -65.91 -40.54 91.58 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.496 -0.753 . . . . 0.0 109.268 178.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.0 -32.45 70.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.644 -0.66 . . . . 0.0 109.373 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.98 -41.99 94.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.623 -0.673 . . . . 0.0 109.238 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -67.92 -37.61 81.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.521 -0.737 . . . . 0.0 110.159 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -70.89 -51.93 23.27 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.374 -0.829 . . . . 0.0 110.382 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.96 49.45 0.17 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 90' ' ' LEU . 13.0 mt -121.33 -48.59 2.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.289 -1.124 . . . . 0.0 110.405 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' A' ' 82' ' ' VAL . 81.6 mt -99.53 77.76 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.458 -0.776 . . . . 0.0 109.244 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.0 p -76.26 -176.8 3.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.496 -0.753 . . . . 0.0 110.353 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.59 -53.1 20.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.43 -0.794 . . . . 0.0 110.563 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.9 -42.53 97.4 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.416 -0.802 . . . . 0.0 110.96 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -66.54 -38.5 87.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.267 -0.895 . . . . 0.0 110.219 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.2 -39.88 86.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.397 -0.815 . . . . 0.0 109.498 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -65.72 -39.03 90.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.596 -0.69 . . . . 0.0 109.955 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -61.56 -42.77 99.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.569 -0.707 . . . . 0.0 109.439 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.606 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 20.8 t90 -67.85 -38.61 83.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.473 -0.767 . . . . 0.0 109.641 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.6 mt -68.04 -38.79 82.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.693 -0.629 . . . . 0.0 110.193 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 102' ' ' SER . 57.9 m -70.41 -47.84 58.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.42 -0.8 . . . . 0.0 110.277 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 101' ' ' SER . 40.0 m . . . . . 0 N--CA 1.501 2.117 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.765 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.103 0.478 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.54 -66.63 1.06 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.436 -0.79 . . . . 0.0 110.075 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -94.5 118.6 31.92 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.364 -0.835 . . . . 0.0 110.293 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 m -94.62 54.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.426 -0.796 . . . . 0.0 110.188 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -98.67 28.65 4.12 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.355 -0.84 . . . . 0.0 110.673 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.62 -51.92 52.53 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -64.07 -43.69 94.7 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.614 -0.933 . . . . 0.0 109.827 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -62.29 -38.76 90.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.497 -0.752 . . . . 0.0 109.806 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.5 -40.79 97.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.584 -0.697 . . . . 0.0 109.884 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.15 -43.16 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.461 -0.775 . . . . 0.0 109.217 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.5 93.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.509 -0.744 . . . . 0.0 109.3 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.41 -40.75 98.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.688 -0.632 . . . . 0.0 109.792 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.29 96.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.407 -0.808 . . . . 0.0 109.668 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.11 -40.46 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.504 -0.748 . . . . 0.0 109.348 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.21 -40.14 96.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.584 -0.698 . . . . 0.0 110.127 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 t -65.04 -38.95 92.53 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.371 -0.831 . . . . 0.0 109.706 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.504 ' HD2' HD12 ' A' ' 100' ' ' LEU . 3.5 ttmm -65.98 -32.38 73.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.502 -0.749 . . . . 0.0 109.951 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mm -62.82 -48.26 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.598 -0.688 . . . . 0.0 109.981 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.15 -38.92 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.399 -0.813 . . . . 0.0 109.833 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.84 -31.22 75.25 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.44 36.78 3.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.287 -1.125 . . . . 0.0 110.796 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.407 ' HD1' ' HB ' ' A' ' 27' ' ' THR . 25.7 t90 -100.51 138.52 37.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 110.668 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -97.71 -169.66 1.87 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -43.14 -42.95 4.33 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.663 -0.648 . . . . 0.0 110.255 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -162.66 38.84 0.11 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.636 -0.665 . . . . 0.0 110.39 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -157.67 140.34 14.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.252 -0.905 . . . . 0.0 110.699 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.407 ' HB ' ' HD1' ' A' ' 22' ' ' TRP . 10.0 t -147.65 159.45 43.77 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.411 -0.806 . . . . 0.0 109.823 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -100.16 143.18 30.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.431 -0.793 . . . . 0.0 110.513 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.49 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 7.1 mt -126.34 113.21 16.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.537 -0.727 . . . . 0.0 109.43 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 30' ' ' LEU . 4.6 tp 59.36 27.06 16.05 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.69 -0.631 . . . . 0.0 110.635 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.46 -15.7 62.34 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -87.59 153.31 21.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.986 -1.302 . . . . 0.0 110.337 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -83.95 137.56 33.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.387 -0.82 . . . . 0.0 109.751 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 96.3 m -138.01 170.91 15.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.89 . . . . 0.0 111.251 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -122.3 104.5 9.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.677 -0.64 . . . . 0.0 110.025 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.506 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 3.2 t80 -109.9 132.74 53.88 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.1 p -140.8 153.98 46.05 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.099 -1.001 . . . . 0.0 111.367 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.9 p -141.53 143.85 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.663 -0.648 . . . . 0.0 109.953 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.45 128.24 6.1 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.161 -0.962 . . . . 0.0 111.235 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.521 ' HB3' ' CE1' ' A' ' 49' ' ' TYR . 49.0 Cg_endo -76.93 148.84 28.47 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.88 1.463 . . . . 0.0 110.227 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.428 ' CE2' ' HB3' ' A' ' 50' ' ' LYS . 27.8 m-85 -134.43 -171.89 2.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.283 -0.885 . . . . 0.0 110.345 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 tp -151.01 145.79 25.78 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.5 0.666 . . . . 0.0 110.88 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -112.46 -179.79 3.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.703 -0.623 . . . . 0.0 109.398 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -41.56 -38.12 1.27 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.867 -0.52 . . . . 0.0 111.522 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.73 45.57 0.47 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.395 -0.815 . . . . 0.0 110.502 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.437 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -162.15 166.38 25.72 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.104 -0.997 . . . . 0.0 111.402 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.68 136.04 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.536 -0.727 . . . . 0.0 109.222 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 46' ' ' GLN . 45.0 m-85 -138.26 127.84 24.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.412 -0.805 . . . . 0.0 110.211 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.521 ' CE1' ' HB3' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -92.95 151.7 19.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.595 -0.691 . . . . 0.0 109.99 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HB3' ' CE2' ' A' ' 41' ' ' TYR . 8.7 ttpp -149.3 149.09 30.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.395 -0.816 . . . . 0.0 110.181 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.15 161.53 29.13 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.59 137.17 13.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.782 -0.834 . . . . 0.0 109.75 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.506 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 1.4 ppp? -136.73 152.1 49.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.264 -0.898 . . . . 0.0 111.144 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.493 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 49.4 p90 -159.58 154.29 24.42 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.744 -0.598 . . . . 0.0 110.183 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 69.3 m -112.33 91.53 16.68 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.183 -0.948 . . . . 0.0 110.56 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.493 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 48.0 Cg_endo -76.11 91.79 1.09 Allowed 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.807 1.425 . . . . 0.0 110.217 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.46 -48.36 0.58 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.463 ' CH2' ' HB3' ' A' ' 90' ' ' LEU . 25.6 t90 -76.26 -53.5 8.14 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.404 -1.056 . . . . 0.0 110.376 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 t -145.46 -170.01 3.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.581 -0.699 . . . . 0.0 109.991 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.62 60.54 0.8 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.449 -0.782 . . . . 0.0 109.887 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.429 HD11 HG23 ' A' ' 61' ' ' ILE . 69.7 mt -128.12 155.08 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.481 -0.762 . . . . 0.0 109.845 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.43 160.29 39.53 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.415 -0.803 . . . . 0.0 110.492 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 135.75 7.26 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -136.2 151.82 50.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.554 -0.968 . . . . 0.0 110.112 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.446 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -163.13 135.57 5.36 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.388 -0.82 . . . . 0.0 110.56 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.515 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 1.1 m -136.71 142.65 43.12 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.546 -0.721 . . . . 0.0 110.37 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.8 t -167.44 177.48 5.98 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.573 -0.704 . . . . 0.0 110.142 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -31.32 67.74 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.33 -0.856 . . . . 0.0 110.66 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.74 143.15 58.07 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.427 -0.795 . . . . 0.0 110.916 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.484 ' HG2' ' CE1' ' A' ' 49' ' ' TYR . 38.4 mt-30 -80.65 -50.71 9.59 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.637 -0.665 . . . . 0.0 110.408 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m -86.36 -29.3 23.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.386 -0.822 . . . . 0.0 109.914 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.06 -38.97 95.1 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.515 ' CG2' ' HA ' ' A' ' 66' ' ' SER . 3.7 p -62.3 -36.83 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.407 -1.055 . . . . 0.0 110.297 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.402 ' N ' ' CG1' ' A' ' 73' ' ' VAL . . . -68.8 -44.84 72.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.55 -0.719 . . . . 0.0 109.768 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.31 -35.74 92.06 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.446 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 15.4 mmtt -69.76 -38.72 76.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.473 -1.016 . . . . 0.0 109.942 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 m -60.25 -44.91 94.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.501 -0.749 . . . . 0.0 109.498 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.91 -36.31 75.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.555 -0.716 . . . . 0.0 109.865 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -39.76 86.88 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.463 -0.773 . . . . 0.0 109.876 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.16 -40.9 98.89 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.475 -0.766 . . . . 0.0 110.086 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -69.33 -41.13 77.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.336 -0.853 . . . . 0.0 109.343 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.8 t -66.04 -38.14 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.566 -0.708 . . . . 0.0 109.591 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -38.79 87.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.514 -0.741 . . . . 0.0 109.708 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -39.27 91.22 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.386 -0.821 . . . . 0.0 109.853 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.82 -35.51 74.86 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.589 -0.694 . . . . 0.0 109.464 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -41.9 99.61 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.678 -0.639 . . . . 0.0 109.634 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -67.84 -36.97 81.29 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.499 -0.75 . . . . 0.0 110.332 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -73.49 -55.43 6.35 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.37 -0.831 . . . . 0.0 110.453 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.04 52.36 0.08 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.463 ' HB3' ' CH2' ' A' ' 58' ' ' TRP . 9.7 mt -122.95 -49.83 1.96 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.377 -1.072 . . . . 0.0 110.259 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.3 mt -97.09 101.59 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.538 -0.726 . . . . 0.0 109.55 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.585 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 32.4 m -78.23 173.78 11.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.475 -0.766 . . . . 0.0 109.965 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -71.16 -53.08 15.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.605 -0.684 . . . . 0.0 109.925 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -65.09 -29.52 70.39 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.478 -0.764 . . . . 0.0 110.57 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.0 OUTLIER -67.99 -43.5 78.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.267 -0.896 . . . . 0.0 109.821 179.377 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.29 -40.64 94.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.609 -0.682 . . . . 0.0 109.168 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -62.46 -38.98 91.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.641 -0.662 . . . . 0.0 109.763 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -40.16 94.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.572 -0.705 . . . . 0.0 109.697 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.45 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 15.6 t90 -71.08 -36.05 72.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.315 -0.865 . . . . 0.0 109.889 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.504 HD12 ' HD2' ' A' ' 17' ' ' LYS . 3.4 mm? -71.12 -33.97 70.61 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.71 -0.619 . . . . 0.0 110.697 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 74.5 p -69.29 -42.91 74.84 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.203 -0.936 . . . . 0.0 110.467 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.499 1.977 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.788 179.854 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 120.928 0.394 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.08 -176.42 4.12 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.467 -0.771 . . . . 0.0 110.251 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -71.01 100.62 2.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.428 -0.795 . . . . 0.0 109.968 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.78 78.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.523 -0.736 . . . . 0.0 109.98 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -101.13 177.19 5.01 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.322 -0.862 . . . . 0.0 110.356 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.02 -8.85 7.57 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 120.192 -1.004 . . . . 0.0 110.956 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -54.86 -45.89 74.63 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 118.748 1.274 . . . . 0.0 110.257 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.49 -37.55 87.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.714 -0.616 . . . . 0.0 109.707 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.71 -40.1 94.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.65 -0.656 . . . . 0.0 109.945 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.1 t -66.08 -40.87 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.521 -0.737 . . . . 0.0 109.185 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.42 -39.76 95.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.593 -0.692 . . . . 0.0 109.533 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.74 -41.38 99.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.684 -0.635 . . . . 0.0 109.806 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.3 -39.3 94.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.474 -0.766 . . . . 0.0 109.827 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.04 -39.93 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.425 -0.797 . . . . 0.0 109.105 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -64.06 -38.43 91.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.466 -0.771 . . . . 0.0 109.636 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.6 m -63.96 -41.31 97.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.51 -0.743 . . . . 0.0 109.595 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.598 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 1.9 ttmt -63.74 -32.8 74.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.547 -0.721 . . . . 0.0 109.898 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.44 HG23 HD11 ' A' ' 18' ' ' ILE . 5.1 mm -62.25 -48.13 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -0.875 . . . . 0.0 109.071 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.49 -40.4 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.71 -0.619 . . . . 0.0 109.429 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.79 -32.18 83.29 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.46 ' CD2' ' HB2' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -109.38 35.39 3.32 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.45 -1.029 . . . . 0.0 110.612 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 25.0 t90 -103.98 132.98 49.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.133 -0.979 . . . . 0.0 111.01 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.34 -163.85 1.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -45.78 -45.64 14.83 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.255 -0.903 . . . . 0.0 110.587 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.418 ' HB2' ' CG2' ' A' ' 37' ' ' THR . 6.6 pt-20 -157.75 35.9 0.26 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.679 -0.638 . . . . 0.0 110.5 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.41 151.88 38.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.311 -0.868 . . . . 0.0 110.668 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.9 t -153.77 172.9 16.6 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.308 -0.87 . . . . 0.0 109.866 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.46 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 3.9 mp0 -124.43 143.34 50.68 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.245 -0.909 . . . . 0.0 110.228 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.465 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 10.0 mt -127.44 113.6 16.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 109.457 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.49 HD12 ' HB2' ' A' ' 99' ' ' TRP . 1.0 OUTLIER 57.01 27.26 12.98 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.765 -0.584 . . . . 0.0 110.735 -179.244 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.84 -16.9 60.21 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -80.97 149.89 29.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.171 -1.193 . . . . 0.0 110.444 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -79.41 139.91 37.56 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.74 . . . . 0.0 109.822 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 81.4 m -139.96 166.37 24.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.515 -0.741 . . . . 0.0 110.726 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -122.15 101.09 7.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.404 -0.81 . . . . 0.0 109.835 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.561 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 4.3 t80 -108.37 131.13 55.07 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.418 ' CG2' ' HB2' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -134.75 157.16 47.43 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.302 -0.874 . . . . 0.0 111.015 -179.078 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 87.1 t -129.36 129.32 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.568 -0.707 . . . . 0.0 109.635 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -144.06 101.23 4.89 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.367 -0.833 . . . . 0.0 110.425 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.484 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 54.1 Cg_endo -75.25 161.88 37.35 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.81 1.426 . . . . 0.0 110.585 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -126.53 -174.34 3.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.421 -0.799 . . . . 0.0 109.929 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.73 143.17 48.32 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.36 0.6 . . . . 0.0 110.374 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -117.72 174.83 5.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.595 -0.691 . . . . 0.0 109.835 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -43.91 -36.11 2.27 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.911 -0.493 . . . . 0.0 111.105 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -154.9 37.31 0.4 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.489 -0.757 . . . . 0.0 110.957 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.52 137.9 6.02 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.879 -1.138 . . . . 0.0 111.312 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.45 123.81 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.486 -0.759 . . . . 0.0 109.493 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -112.31 143.67 43.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.375 -0.828 . . . . 0.0 110.332 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.484 ' CD1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -96.14 157.17 16.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -0.877 . . . . 0.0 110.111 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.464 ' HG3' ' N ' ' A' ' 51' ' ' GLY . 2.1 tttt -156.6 150.17 24.59 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.254 -0.904 . . . . 0.0 109.9 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.464 ' N ' ' HG3' ' A' ' 50' ' ' LYS . . . -149.59 147.67 18.22 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.45 138.64 34.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.67 -0.9 . . . . 0.0 109.836 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.561 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 3.0 ppp? -137.95 157.73 45.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.344 -0.848 . . . . 0.0 111.25 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.423 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 49.0 p90 -160.88 145.88 14.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.844 -0.535 . . . . 0.0 109.951 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.41 ' SG ' HD13 ' A' ' 29' ' ' LEU . 76.6 m -112.49 91.2 16.21 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.261 -0.899 . . . . 0.0 110.871 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.423 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 48.3 Cg_endo -75.71 85.81 1.57 Allowed 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.78 1.411 . . . . 0.0 110.056 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.42 -50.3 0.29 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -78.16 -43.71 27.95 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.537 -0.978 . . . . 0.0 109.76 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 t -153.67 -173.85 4.73 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.278 0.561 . . . . 0.0 109.733 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.46 49.04 1.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.569 -0.707 . . . . 0.0 109.62 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.4 mt -119.02 155.99 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.473 -0.767 . . . . 0.0 110.009 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.19 160.16 38.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.447 -0.783 . . . . 0.0 110.438 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.23 148.27 19.89 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 0.9 OUTLIER -151.13 157.07 42.25 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.551 -0.97 . . . . 0.0 110.269 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.482 ' HB3' ' CG ' ' A' ' 76' ' ' LYS . . . -159.75 146.75 16.51 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.699 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.474 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -140.1 141.74 36.12 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.469 -0.769 . . . . 0.0 110.812 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 t -169.16 176.9 5.05 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.6 -0.688 . . . . 0.0 110.341 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.5 mtm-85 -73.14 -35.29 66.47 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.389 -0.82 . . . . 0.0 110.261 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.85 136.92 58.15 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.497 -0.752 . . . . 0.0 110.127 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.31 -59.11 2.88 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.584 -0.697 . . . . 0.0 110.406 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -79.17 -28.83 42.77 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.308 -0.87 . . . . 0.0 110.05 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.62 -38.14 90.83 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.474 ' CG2' ' HA ' ' A' ' 66' ' ' SER . 0.5 OUTLIER -62.07 -38.11 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.437 -1.037 . . . . 0.0 110.379 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.401 ' N ' ' CG1' ' A' ' 73' ' ' VAL . . . -66.81 -44.5 81.02 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.524 -0.735 . . . . 0.0 109.655 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.65 -37.78 95.25 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.482 ' CG ' ' HB3' ' A' ' 65' ' ' ALA . 0.1 OUTLIER -63.3 -40.1 96.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.589 -0.948 . . . . 0.0 110.282 179.559 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.9 m -63.44 -43.91 96.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.83 . . . . 0.0 109.149 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' CB ' ' HA ' ' A' ' 15' ' ' ALA . . . -66.27 -39.08 89.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.602 -0.686 . . . . 0.0 109.64 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.98 -38.96 89.89 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.34 -0.85 . . . . 0.0 109.96 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.501 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 2.8 m-20 -68.87 -29.8 68.17 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.461 -0.774 . . . . 0.0 110.172 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -78.38 -33.73 48.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.225 -0.922 . . . . 0.0 109.864 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.404 ' HA ' HD11 ' A' ' 91' ' ' ILE . 65.4 t -70.43 -38.5 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 110.476 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -70.23 -36.42 74.52 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.271 -0.893 . . . . 0.0 109.793 179.529 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.46 -40.83 93.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.6 -0.688 . . . . 0.0 109.335 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.78 -32.88 71.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.618 -0.676 . . . . 0.0 109.379 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.3 -41.1 97.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.55 -0.719 . . . . 0.0 109.513 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -65.38 -36.58 84.4 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.661 -0.649 . . . . 0.0 110.538 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -79.72 -54.13 6.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.195 -0.941 . . . . 0.0 110.28 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.72 53.72 0.07 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.414 HD21 ' HA ' ' A' ' 90' ' ' LEU . 11.1 mt -123.56 -47.78 1.96 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.375 -1.074 . . . . 0.0 110.645 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.404 HD11 ' HA ' ' A' ' 82' ' ' VAL . 80.7 mt -105.2 98.84 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.235 -0.916 . . . . 0.0 109.555 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 4.9 t -78.49 -177.06 5.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.443 -0.785 . . . . 0.0 110.556 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -70.76 -59.82 2.59 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.519 -0.738 . . . . 0.0 110.472 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -63.73 -34.67 78.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.391 -0.818 . . . . 0.0 110.63 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.404 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 1.9 mt-10 -58.79 -42.93 90.19 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.489 -0.757 . . . . 0.0 110.278 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.13 93.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.448 -0.783 . . . . 0.0 109.809 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -36.81 78.05 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.498 -0.751 . . . . 0.0 109.677 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -62.86 -42.83 99.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.522 -0.736 . . . . 0.0 109.379 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.598 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 25.3 t90 -63.97 -41.93 97.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.462 -0.774 . . . . 0.0 109.153 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.423 ' HA ' ' CE ' ' A' ' 17' ' ' LYS . 12.9 mt -59.39 -37.04 76.96 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.763 -0.586 . . . . 0.0 110.155 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.8 m -65.92 -38.6 89.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.51 -0.744 . . . . 0.0 110.316 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.504 2.237 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.847 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 120.917 0.389 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.94 -175.58 2.75 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.404 -0.81 . . . . 0.0 110.207 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.476 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -102.2 -165.24 1.17 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.365 -0.835 . . . . 0.0 110.335 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 3' ' ' TYR . 23.9 t 68.79 -65.59 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 O-C-N 121.96 -0.463 . . . . 0.0 110.948 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -97.94 57.79 1.32 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.093 -1.004 . . . . 0.0 110.104 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.39 -37.88 93.86 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -63.59 -42.79 98.24 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.402 -1.058 . . . . 0.0 109.878 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.65 -37.21 83.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.808 -0.558 . . . . 0.0 110.328 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.65 -43.26 80.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.564 -0.71 . . . . 0.0 109.895 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' ' 93' ' ' GLN . 78.2 t -68.82 -38.68 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.411 ' O ' ' HE3' ' A' ' 79' ' ' LYS . . . -63.66 -46.19 86.73 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.457 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . . . -52.05 -45.11 64.56 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.744 -0.597 . . . . 0.0 109.959 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.09 90.51 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.561 -0.712 . . . . 0.0 109.391 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.0 t -61.14 -44.25 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.589 -0.695 . . . . 0.0 109.324 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.614 ' HB2' ' HE2' ' A' ' 79' ' ' LYS . . . -58.29 -43.2 87.92 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.599 -0.688 . . . . 0.0 109.999 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.2 m -59.24 -41.8 89.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.65 -0.656 . . . . 0.0 109.484 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.632 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 1.3 tpmp? -69.74 -32.5 71.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.627 -0.671 . . . . 0.0 110.059 179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 22' ' ' TRP . 5.4 mt -72.26 -46.77 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.401 -0.812 . . . . 0.0 109.811 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.6 t -68.13 -39.03 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.395 -0.816 . . . . 0.0 110.04 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.28 -16.41 75.32 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.47 24.06 6.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.978 -1.307 . . . . 0.0 111.452 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.419 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 22.7 t90 -92.03 135.58 33.85 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.886 -1.134 . . . . 0.0 110.337 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.67 -167.19 1.46 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.534 -0.729 . . . . 0.0 109.449 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -49.77 -41.76 44.93 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.231 -0.918 . . . . 0.0 110.615 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.45 37.73 0.24 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.574 -0.704 . . . . 0.0 110.456 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -146.75 147.53 31.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.32 -0.863 . . . . 0.0 110.72 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.467 HG23 ' HB2' ' A' ' 34' ' ' CYS . 8.2 t -156.7 155.52 31.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.462 -0.774 . . . . 0.0 109.643 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -111.68 149.83 31.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.173 -0.954 . . . . 0.0 110.168 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.411 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 6.7 mt -143.28 123.85 14.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.371 -0.831 . . . . 0.0 110.022 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.497 HD11 ' HG2' ' A' ' 95' ' ' GLU . 1.7 tp 53.07 35.06 18.6 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.673 -0.642 . . . . 0.0 111.22 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.39 26.88 62.61 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -125.91 163.5 22.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -1.163 . . . . 0.0 109.996 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.0 130.4 36.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.458 -0.776 . . . . 0.0 109.893 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.539 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 68.2 m -134.08 167.22 21.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.51 -0.744 . . . . 0.0 110.079 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.571 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 0.9 OUTLIER -126.32 110.07 12.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 110.901 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.446 ' CE2' HG23 ' A' ' 77' ' ' THR . 20.0 t80 -111.11 136.09 50.66 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.38 157.88 43.53 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.061 -1.024 . . . . 0.0 111.968 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.3 t -132.82 145.04 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.15 136.55 11.38 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.238 -0.914 . . . . 0.0 110.927 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.47 ' HB3' ' CE1' ' A' ' 49' ' ' TYR . 48.1 Cg_endo -78.2 154.16 28.55 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.905 1.476 . . . . 0.0 110.406 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -142.64 -169.26 2.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.355 -0.84 . . . . 0.0 110.736 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.4 tp -142.67 160.52 40.14 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.384 0.612 . . . . 0.0 110.693 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.18 178.0 7.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.532 -0.73 . . . . 0.0 109.669 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.439 ' HB3' ' CD2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -40.92 -37.82 0.86 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.884 -0.51 . . . . 0.0 111.799 -179.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 44' ' ' ARG . 11.1 p90 -156.08 35.85 0.34 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.348 -0.845 . . . . 0.0 111.417 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.438 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -162.52 162.58 27.44 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.865 -1.147 . . . . 0.0 111.152 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.4 t -101.83 141.79 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.424 -0.798 . . . . 0.0 109.379 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 46' ' ' GLN . 33.6 m-85 -140.51 136.22 32.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.255 -0.903 . . . . 0.0 110.404 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.47 ' CE1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -96.64 135.28 38.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.572 -0.705 . . . . 0.0 110.19 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.514 ' HA ' HG22 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -129.39 156.73 43.6 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.332 -0.855 . . . . 0.0 109.857 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.19 150.5 22.7 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.715 ' HG2' ' HB3' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -149.56 136.36 19.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.491 -1.005 . . . . 0.0 109.837 179.529 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.505 ' HG2' HG23 ' A' ' 77' ' ' THR . 1.0 OUTLIER -135.12 152.58 51.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.439 -0.788 . . . . 0.0 110.835 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.606 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 46.1 p90 -149.32 -177.13 5.67 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.576 -0.703 . . . . 0.0 110.044 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 34.7 m -133.94 93.81 19.68 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.102 -0.999 . . . . 0.0 110.701 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.606 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.6 Cg_endo -76.09 89.58 1.23 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.951 1.5 . . . . 0.0 110.107 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.27 -46.51 0.87 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -71.61 -57.78 4.08 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.476 -1.014 . . . . 0.0 110.139 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.1 t -153.96 -160.37 1.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.578 -0.701 . . . . 0.0 109.902 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.88 44.92 2.52 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.253 -0.904 . . . . 0.0 110.546 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.439 HD11 HG23 ' A' ' 61' ' ' ILE . 1.5 tt -125.15 154.4 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.25 -0.906 . . . . 0.0 109.701 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.431 ' HB3' ' CB ' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -153.68 169.21 23.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.166 -0.959 . . . . 0.0 111.202 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.434 ' HA2' ' HE2' ' A' ' 84' ' ' LYS . . . -135.45 153.03 21.09 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.715 ' HB3' ' HG2' ' A' ' 52' ' ' ARG . 1.2 pm0 -145.51 155.39 43.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.632 -0.922 . . . . 0.0 110.227 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.416 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -143.23 162.48 35.51 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.518 -0.738 . . . . 0.0 110.89 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -147.12 136.98 23.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.574 -0.704 . . . . 0.0 110.438 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.7 t -175.51 165.25 3.18 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.699 -0.625 . . . . 0.0 110.002 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -68.55 -28.13 66.69 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.182 -0.949 . . . . 0.0 110.595 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.67 149.46 50.47 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.191 -0.943 . . . . 0.0 110.463 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -83.66 -64.91 1.08 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.672 -0.642 . . . . 0.0 110.087 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 t -73.32 -22.79 60.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.26 -0.9 . . . . 0.0 110.02 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.82 -45.38 95.02 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' A' ' 50' ' ' LYS . 0.7 OUTLIER -61.04 -36.96 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.495 -1.003 . . . . 0.0 110.064 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.46 -45.08 94.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.524 -0.735 . . . . 0.0 110.034 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -60.64 -37.21 93.09 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.416 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -74.92 -37.69 61.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.391 -1.064 . . . . 0.0 110.245 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.505 HG23 ' HG2' ' A' ' 53' ' ' MET . 22.7 m -59.93 -38.04 81.24 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.195 -0.941 . . . . 0.0 109.683 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.67 -28.04 40.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.425 -0.797 . . . . 0.0 110.184 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.683 ' CE ' ' HA ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -80.76 -37.64 30.05 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.267 -0.895 . . . . 0.0 109.826 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.75 -31.51 66.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.785 -0.572 . . . . 0.0 109.694 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -70.36 -42.19 72.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 0.0 109.695 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.6 t -71.24 -30.89 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.799 . . . . 0.0 109.467 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -38.4 63.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.459 -0.776 . . . . 0.0 109.756 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.434 ' HE2' ' HA2' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -67.3 -36.78 82.2 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.33 -0.856 . . . . 0.0 109.777 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.69 -34.2 69.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.486 -0.759 . . . . 0.0 109.528 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.21 -39.28 86.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.595 -0.69 . . . . 0.0 109.585 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -64.37 -40.4 95.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.717 -0.614 . . . . 0.0 109.901 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -73.72 -57.15 4.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.425 -0.797 . . . . 0.0 109.781 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.7 53.98 0.05 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 90' ' ' LEU . 9.7 mt -123.41 -57.41 1.67 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.303 -1.116 . . . . 0.0 110.65 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 12.4 mt -92.74 115.83 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.0 110.167 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.6 t -99.46 -175.91 3.13 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.663 -0.648 . . . . 0.0 110.637 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.507 ' HA ' HG11 ' A' ' 10' ' ' VAL . 2.6 mt-30 -74.85 -52.07 12.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.423 -0.798 . . . . 0.0 110.263 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -64.15 -41.04 97.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.575 -0.703 . . . . 0.0 110.189 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.497 ' HG2' HD11 ' A' ' 30' ' ' LEU . 3.4 tt0 -56.09 -45.85 79.26 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.649 -0.657 . . . . 0.0 109.993 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.43 93.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.62 -0.675 . . . . 0.0 109.43 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.483 ' HA ' HD11 ' A' ' 100' ' ' LEU . 7.6 t30 -64.16 -37.83 88.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.643 -0.66 . . . . 0.0 109.717 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -64.97 -42.04 94.92 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.632 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 18.6 t90 -64.49 -43.1 95.21 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.162 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.483 HD11 ' HA ' ' A' ' 97' ' ' ASN . 12.2 mt -53.59 -38.04 63.56 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.776 -0.578 . . . . 0.0 109.562 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.3 t -79.48 -43.38 23.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.617 -0.677 . . . . 0.0 109.731 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.997 179.428 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 120.888 0.375 . . . . 0.0 110.459 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.49 147.72 47.49 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.37 -0.831 . . . . 0.0 110.483 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -108.42 145.36 34.72 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.502 -0.749 . . . . 0.0 110.196 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 p -137.24 138.7 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.361 -0.837 . . . . 0.0 110.304 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -84.1 -42.19 16.33 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.419 -0.801 . . . . 0.0 110.407 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.18 0.49 86.95 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -58.46 -48.52 80.47 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.174 -1.192 . . . . 0.0 110.262 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.17 -39.35 82.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.592 -0.693 . . . . 0.0 110.108 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.39 -39.68 94.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.587 -0.695 . . . . 0.0 109.983 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.5 t -65.07 -41.3 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.502 -0.749 . . . . 0.0 109.31 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.59 95.14 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.597 -0.689 . . . . 0.0 109.79 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.88 98.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.548 -0.72 . . . . 0.0 109.56 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.99 98.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.634 -0.666 . . . . 0.0 109.5 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.527 HG13 ' CZ3' ' A' ' 99' ' ' TRP . 60.5 t -62.69 -41.07 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.545 -0.722 . . . . 0.0 109.299 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.52 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -63.28 -40.13 96.52 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.694 -0.629 . . . . 0.0 109.42 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 56.5 m -63.47 -38.88 92.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.649 -0.657 . . . . 0.0 109.443 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.481 ' HG3' ' HA ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -60.63 -37.79 82.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.518 -0.739 . . . . 0.0 109.356 178.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.509 HG21 HD11 ' A' ' 18' ' ' ILE . 17.1 mt -66.57 -33.33 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.678 -0.639 . . . . 0.0 109.857 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.5 t -62.51 -49.86 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.252 -0.905 . . . . 0.0 109.736 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.03 -13.12 83.38 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 120.293 -0.956 . . . . 0.0 110.82 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.519 HD23 HD22 ' A' ' 29' ' ' LEU . 11.5 tp -98.09 -23.0 15.93 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.019 -1.283 . . . . 0.0 110.825 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.551 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 17.4 t90 -67.4 131.36 45.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.73 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.96 -161.27 0.86 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -47.94 -45.07 30.67 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.132 -0.98 . . . . 0.0 110.444 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.13 36.54 0.14 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.611 -0.681 . . . . 0.0 110.848 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -156.54 155.49 32.02 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.194 -0.941 . . . . 0.0 110.027 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 t -156.41 155.29 31.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.164 -0.96 . . . . 0.0 110.132 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -116.09 109.39 17.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.4 -0.813 . . . . 0.0 109.494 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.519 HD22 HD23 ' A' ' 21' ' ' LEU . 10.7 mt -112.19 129.79 56.13 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.316 -0.865 . . . . 0.0 110.576 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.416 ' HB3' ' CD2' ' A' ' 32' ' ' HIS . 0.3 OUTLIER 60.09 30.64 20.08 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.442 -0.786 . . . . 0.0 110.301 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.02 22.21 78.43 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.416 ' CD2' ' HB3' ' A' ' 30' ' ' LEU . 50.0 m-70 -120.77 160.07 24.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.379 -1.071 . . . . 0.0 109.992 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.43 126.72 34.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.359 -0.838 . . . . 0.0 110.549 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 23.9 m -130.17 166.88 19.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.69 -0.631 . . . . 0.0 109.687 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.497 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 6.1 tptt -128.33 105.64 8.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.465 -0.772 . . . . 0.0 110.637 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.551 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 29.9 t80 -108.23 137.34 46.37 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.6 p -147.57 152.32 37.75 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.031 -1.043 . . . . 0.0 111.816 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.8 t -125.17 133.92 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.415 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -136.15 119.16 12.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.127 -0.983 . . . . 0.0 111.224 -178.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -78.99 154.29 25.69 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.77 1.405 . . . . 0.0 110.655 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -140.77 -170.6 3.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.285 -0.884 . . . . 0.0 110.207 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.49 160.47 43.04 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.406 0.622 . . . . 0.0 110.772 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.65 177.0 7.55 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.65 -0.656 . . . . 0.0 109.649 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -42.61 -38.28 1.96 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.82 -0.55 . . . . 0.0 111.276 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.19 45.28 0.49 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.487 -0.758 . . . . 0.0 109.994 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.64 171.07 17.47 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.235 -0.916 . . . . 0.0 111.125 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.7 t -121.47 133.46 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.532 -0.73 . . . . 0.0 109.368 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -130.3 124.5 32.49 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.334 -0.854 . . . . 0.0 110.161 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.412 ' CE2' ' HB3' ' A' ' 70' ' ' GLN . 3.3 m-85 -98.39 133.53 42.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.505 -0.747 . . . . 0.0 110.311 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.6 164.63 17.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.449 -0.782 . . . . 0.0 110.085 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -156.86 135.67 4.57 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.574 ' HG3' ' HG3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -138.92 144.82 39.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.582 -0.952 . . . . 0.0 110.426 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.543 ' HG2' HG22 ' A' ' 77' ' ' THR . 2.5 ppp? -140.49 148.74 41.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.325 -0.859 . . . . 0.0 110.315 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.497 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 44.8 p90 -152.29 146.65 25.55 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.651 -0.656 . . . . 0.0 110.41 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 98.0 m -112.38 88.93 11.54 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.303 -0.873 . . . . 0.0 110.953 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -77.59 84.33 1.99 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.843 1.444 . . . . 0.0 110.278 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.73 -46.63 0.59 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -71.35 -58.13 3.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.6 -0.941 . . . . 0.0 110.045 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.1 t -153.7 -160.66 1.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.577 -0.702 . . . . 0.0 109.941 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.87 47.69 1.61 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.397 -0.815 . . . . 0.0 110.127 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.431 HG21 ' CD1' ' A' ' 81' ' ' PHE . 72.9 mt -123.63 151.41 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.471 -0.768 . . . . 0.0 109.878 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -139.33 169.87 16.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.904 . . . . 0.0 110.962 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.35 127.58 4.03 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.574 ' HG3' ' HG3' ' A' ' 52' ' ' ARG . 1.8 mp0 -121.7 169.02 11.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.571 -0.959 . . . . 0.0 110.695 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.416 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -166.41 156.57 12.06 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.486 0.66 . . . . 0.0 111.336 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -156.44 131.86 9.39 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.633 -0.667 . . . . 0.0 110.037 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.3 t -175.63 -176.71 0.9 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.598 -0.689 . . . . 0.0 109.987 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -82.48 -39.18 22.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.221 -0.924 . . . . 0.0 110.466 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.31 135.74 52.36 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.591 -0.693 . . . . 0.0 110.607 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.412 ' HB3' ' CE2' ' A' ' 49' ' ' TYR . 15.4 pt20 -75.79 -34.96 60.22 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.628 -0.67 . . . . 0.0 110.648 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.0 m -82.22 -34.12 29.04 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.151 -0.968 . . . . 0.0 109.925 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.68 -36.74 90.75 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.99 -35.53 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.3 -1.118 . . . . 0.0 110.004 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.38 94.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.179 -0.951 . . . . 0.0 109.94 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -66.46 -39.44 94.08 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.416 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -67.6 -43.22 81.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.651 -0.911 . . . . 0.0 110.397 179.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.543 HG22 ' HG2' ' A' ' 53' ' ' MET . 94.4 m -58.99 -36.33 74.72 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.192 -0.943 . . . . 0.0 109.578 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.52 ' HB1' ' HA ' ' A' ' 15' ' ' ALA . . . -80.33 -32.71 37.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.525 -0.735 . . . . 0.0 109.876 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 75' ' ' GLY . 1.3 ttpm? -75.71 -34.47 60.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.461 -0.774 . . . . 0.0 110.102 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -39.58 86.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.481 -0.762 . . . . 0.0 109.626 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.431 ' CD1' HG21 ' A' ' 61' ' ' ILE . 51.3 t80 -70.12 -38.48 75.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.375 -0.828 . . . . 0.0 109.082 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.523 HG23 HG12 ' A' ' 14' ' ' VAL . 39.0 t -66.68 -39.15 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.652 -0.655 . . . . 0.0 109.662 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.44 -44.77 96.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.356 -0.84 . . . . 0.0 109.414 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -68.95 -37.11 78.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.53 -0.731 . . . . 0.0 109.516 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.68 -37.2 76.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.565 -0.71 . . . . 0.0 109.747 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -64.68 -41.45 96.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.582 -0.699 . . . . 0.0 109.734 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -69.19 -34.42 74.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.51 -0.744 . . . . 0.0 110.616 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.95 -51.84 12.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.271 -0.893 . . . . 0.0 110.239 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.07 52.55 0.13 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.0 mt -114.87 -48.87 2.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.267 -1.137 . . . . 0.0 110.225 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 82.4 mt -103.81 94.57 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 110.06 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 5.0 m -78.11 178.37 7.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.329 -0.857 . . . . 0.0 109.898 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -57.86 7.2 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.284 -0.885 . . . . 0.0 110.479 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -63.13 -35.56 80.68 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.24 -0.913 . . . . 0.0 110.134 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.4 OUTLIER -70.26 -32.31 70.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.393 -0.817 . . . . 0.0 109.547 178.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.7 -40.71 93.24 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.411 -0.806 . . . . 0.0 109.353 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -63.33 -46.64 85.69 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -66.01 -37.3 85.57 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.527 ' CZ3' HG13 ' A' ' 14' ' ' VAL . 58.5 t90 -65.26 -38.89 91.72 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.02 0.438 . . . . 0.0 109.855 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.481 ' HA ' ' HG3' ' A' ' 17' ' ' LYS . 11.8 mt -66.92 -38.94 87.12 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.655 -0.653 . . . . 0.0 109.78 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 62.3 m -74.84 -45.28 44.27 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.366 -0.834 . . . . 0.0 110.326 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.821 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.284 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.079 0.466 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.35 44.62 0.71 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.549 -0.72 . . . . 0.0 110.324 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -163.38 127.09 2.79 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.401 -0.812 . . . . 0.0 110.149 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.461 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 32.2 m -121.08 160.88 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.555 -0.716 . . . . 0.0 110.453 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.0 tm0? -101.27 -46.17 5.12 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.359 -0.838 . . . . 0.0 110.151 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.69 -68.49 0.03 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -69.42 -27.8 65.59 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.55 -0.971 . . . . 0.0 110.38 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.461 ' HB3' ' CG1' ' A' ' 4' ' ' VAL . 1.4 mm-40 -59.95 -35.28 74.61 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.369 -0.832 . . . . 0.0 109.702 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.99 -40.89 87.47 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.486 -0.759 . . . . 0.0 109.334 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.07 -39.65 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.78 -41.35 97.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.653 -0.655 . . . . 0.0 109.429 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.31 -41.64 93.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.681 -0.637 . . . . 0.0 109.685 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.7 99.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.525 -0.734 . . . . 0.0 109.41 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.445 HG12 HG23 ' A' ' 82' ' ' VAL . 86.9 t -65.99 -40.73 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.11 -38.56 91.1 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.459 -0.776 . . . . 0.0 109.49 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -38.56 91.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.455 -0.778 . . . . 0.0 109.44 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.628 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 4.9 tppt? -67.2 -32.3 73.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.543 -0.723 . . . . 0.0 109.686 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.468 HG13 ' HB2' ' A' ' 78' ' ' ALA . 6.5 mm -61.53 -49.38 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.416 -0.802 . . . . 0.0 109.262 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.7 t -61.66 -39.12 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.58 -0.7 . . . . 0.0 109.935 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.46 -33.41 86.39 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 tp -112.05 36.89 3.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.396 -1.061 . . . . 0.0 110.581 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -102.44 136.97 41.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 111.266 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -99.35 -166.43 1.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -51.19 -40.13 57.99 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.043 -1.035 . . . . 0.0 110.245 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -158.6 34.61 0.23 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.584 -0.698 . . . . 0.0 110.605 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -154.35 141.2 19.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.251 -0.905 . . . . 0.0 111.021 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.5 t -145.52 157.7 43.95 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.301 -0.875 . . . . 0.0 109.594 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' HIS . 9.7 mt-10 -101.23 122.95 44.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.359 -0.838 . . . . 0.0 111.229 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.563 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 7.2 mt -108.17 116.36 31.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.569 -0.707 . . . . 0.0 109.396 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.408 HD13 ' HB2' ' A' ' 99' ' ' TRP . 1.2 tp 58.48 31.1 20.61 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.784 -0.572 . . . . 0.0 110.73 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.32 -8.19 79.41 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.408 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 54.6 m-70 -91.33 163.64 14.14 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.121 -1.223 . . . . 0.0 110.273 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.58 127.98 38.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.569 -0.707 . . . . 0.0 110.324 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 64.3 m -127.61 170.74 12.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.674 -0.641 . . . . 0.0 110.04 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -123.22 99.94 6.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.543 -0.723 . . . . 0.0 110.312 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 5.4 t80 -112.53 135.08 53.66 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.23 171.37 16.59 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.11 -0.993 . . . . 0.0 110.841 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.35 135.36 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.788 -0.57 . . . . 0.0 109.619 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.25 87.22 39.25 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.286 -0.884 . . . . 0.0 110.776 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -79.55 158.97 25.46 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.826 1.435 . . . . 0.0 110.475 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -123.66 -179.94 4.55 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.375 -0.828 . . . . 0.0 110.195 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.83 146.95 29.31 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.681 -0.637 . . . . 0.0 110.654 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.53 176.59 8.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.643 -0.66 . . . . 0.0 109.742 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -42.37 -39.48 2.19 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -152.04 30.49 0.56 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.366 -0.834 . . . . 0.0 110.772 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -144.99 135.87 24.68 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.134 -0.979 . . . . 0.0 110.526 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.45 HG12 ' CE1' ' A' ' 49' ' ' TYR . 18.3 t -114.75 118.21 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.287 -0.883 . . . . 0.0 109.472 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -98.44 154.76 17.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.515 -0.74 . . . . 0.0 110.102 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.45 ' CE1' HG12 ' A' ' 47' ' ' VAL . 46.5 m-85 -127.99 128.7 45.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.026 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -135.54 157.39 47.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -0.941 . . . . 0.0 110.18 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.3 148.07 19.06 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.537 ' HD3' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -143.25 143.31 31.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.659 -0.906 . . . . 0.0 110.16 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.485 ' HG2' HG21 ' A' ' 77' ' ' THR . 1.6 ppp? -148.64 150.25 32.93 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.255 -0.903 . . . . 0.0 111.137 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.557 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 46.7 p90 -164.02 152.11 12.86 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.785 -0.572 . . . . 0.0 110.376 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 75.7 m -111.16 92.45 15.54 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.209 -0.932 . . . . 0.0 110.71 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.557 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 48.9 Cg_endo -74.21 88.61 1.11 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.903 1.475 . . . . 0.0 110.192 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 146.49 -47.22 0.71 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -71.1 -50.89 28.86 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.549 -0.971 . . . . 0.0 110.19 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.3 t -151.96 -169.89 3.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.632 -0.668 . . . . 0.0 109.901 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.63 61.97 0.78 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 0.0 110.367 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 84' ' ' LYS . 10.5 tt -137.91 150.52 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.336 -0.852 . . . . 0.0 109.99 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.34 155.97 49.32 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.806 . . . . 0.0 110.594 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.5 151.36 21.15 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.537 ' HB3' ' HD3' ' A' ' 52' ' ' ARG . 1.8 pp20? -156.38 158.65 37.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.391 -1.064 . . . . 0.0 110.738 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.453 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -146.42 148.36 32.21 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.586 -0.696 . . . . 0.0 110.81 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.416 ' O ' ' HB ' ' A' ' 67' ' ' THR . 1.4 m -138.04 139.14 39.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.368 -0.833 . . . . 0.0 110.331 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 66' ' ' SER . 6.1 t 179.63 -163.34 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.843 -0.535 . . . . 0.0 109.819 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.94 -23.79 14.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.4 -0.813 . . . . 0.0 110.334 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.2 m -61.91 153.32 29.46 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.108 -0.995 . . . . 0.0 110.454 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -93.15 -56.92 2.79 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.643 -0.661 . . . . 0.0 110.412 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.2 p -81.42 -28.58 34.2 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.376 -0.828 . . . . 0.0 110.475 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.1 -45.01 96.75 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 74' ' ' ALA . 2.5 p -58.8 -38.07 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.498 -1.001 . . . . 0.0 110.538 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.4 ' N ' ' CG1' ' A' ' 73' ' ' VAL . . . -65.25 -47.6 76.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.467 -0.771 . . . . 0.0 109.801 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -63.49 -39.77 98.05 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -62.87 -42.02 99.61 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.571 -0.958 . . . . 0.0 110.285 179.372 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.485 HG21 ' HG2' ' A' ' 53' ' ' MET . 47.6 m -62.12 -41.25 98.06 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.257 -0.902 . . . . 0.0 109.978 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.468 ' HB2' HG13 ' A' ' 18' ' ' ILE . . . -76.45 -36.85 57.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.526 -0.734 . . . . 0.0 110.037 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 75' ' ' GLY . 0.1 OUTLIER -69.11 -38.36 78.88 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.531 -0.731 . . . . 0.0 110.137 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -69.12 -35.54 76.51 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -66.62 -41.0 89.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.569 -0.707 . . . . 0.0 109.68 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.445 HG23 HG12 ' A' ' 14' ' ' VAL . 84.3 t -64.7 -38.62 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.538 -0.726 . . . . 0.0 109.738 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.1 tpt85 -63.82 -39.52 94.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.565 -0.71 . . . . 0.0 109.73 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.463 ' HB3' ' CD1' ' A' ' 61' ' ' ILE . 36.4 mtpt -69.35 -33.86 73.74 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.379 -0.826 . . . . 0.0 109.529 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.28 -27.69 56.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.306 -0.871 . . . . 0.0 109.231 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.48 -41.9 72.11 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.719 -0.613 . . . . 0.0 110.019 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.42 ' HG3' ' N ' ' A' ' 88' ' ' LYS . 6.0 pt20 -67.48 -36.22 80.69 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.378 -0.826 . . . . 0.0 110.585 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.43 ' HD2' HD12 ' A' ' 61' ' ' ILE . 10.5 mttt -74.4 -54.81 6.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.297 -0.877 . . . . 0.0 110.004 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.98 52.37 0.07 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.1 mt -119.32 -61.64 1.6 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.245 -1.15 . . . . 0.0 109.893 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.423 HD11 ' HA ' ' A' ' 82' ' ' VAL . 72.9 mt -89.5 75.46 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.505 -0.747 . . . . 0.0 109.237 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.2 t -62.13 178.97 0.33 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.753 -0.592 . . . . 0.0 110.535 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -62.03 -54.63 38.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.472 -0.768 . . . . 0.0 110.217 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -67.85 -29.44 68.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.623 -0.673 . . . . 0.0 110.675 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.78 -45.41 89.86 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.357 -0.84 . . . . 0.0 110.188 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.66 -38.04 89.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.514 -0.741 . . . . 0.0 109.622 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -66.65 -36.79 83.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.503 -0.748 . . . . 0.0 110.307 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -41.41 90.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.342 -0.849 . . . . 0.0 109.761 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.628 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 13.6 t90 -67.26 -40.96 86.29 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.354 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.516 HD23 ' HE3' ' A' ' 17' ' ' LYS . 43.3 mt -57.12 -38.31 73.26 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.631 -0.668 . . . . 0.0 109.62 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.6 t -76.78 -42.8 39.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.493 -0.754 . . . . 0.0 109.757 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.408 -0.806 . . . . 0.0 110.172 179.86 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.471 0.653 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.43 170.68 19.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.268 -0.895 . . . . 0.0 110.514 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 68.67 -67.01 0.22 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 122.02 -0.425 . . . . 0.0 111.045 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.5 t -80.18 137.82 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.214 -0.929 . . . . 0.0 109.93 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.97 151.28 45.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.452 -0.78 . . . . 0.0 110.754 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.58 -22.23 60.53 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -60.4 -46.08 91.28 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.224 -1.163 . . . . 0.0 110.458 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -60.87 -39.55 89.61 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.337 -0.852 . . . . 0.0 109.986 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.69 -40.87 97.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.514 -0.741 . . . . 0.0 109.642 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 77.8 t -64.49 -39.56 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.596 -0.69 . . . . 0.0 109.202 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.54 -39.56 94.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.759 -0.588 . . . . 0.0 109.813 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.63 99.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.534 -0.729 . . . . 0.0 109.648 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.13 99.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.603 -0.686 . . . . 0.0 109.671 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.98 -40.8 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.521 -0.737 . . . . 0.0 109.431 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.68 -38.71 92.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.544 -0.722 . . . . 0.0 109.536 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.1 t -62.46 -41.76 98.99 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.661 -0.65 . . . . 0.0 109.627 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.44 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 11.8 tttm -65.35 -32.49 74.15 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.433 -0.792 . . . . 0.0 110.063 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 mm -64.94 -45.86 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.419 -0.801 . . . . 0.0 109.66 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.56 -40.77 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.546 -0.721 . . . . 0.0 110.206 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.18 -19.27 78.66 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.276 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 tp -120.41 21.15 11.75 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.865 -1.374 . . . . 0.0 111.945 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.538 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 18.6 t90 -90.88 137.74 32.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.902 -1.124 . . . . 0.0 109.948 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.64 -169.14 1.79 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.41 -0.806 . . . . 0.0 109.369 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -45.54 -44.04 12.42 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.153 -0.967 . . . . 0.0 110.311 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.474 ' O ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -158.39 33.31 0.24 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.579 -0.7 . . . . 0.0 110.828 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -141.5 152.73 44.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.12 -0.987 . . . . 0.0 111.001 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.425 HG21 ' CB ' ' A' ' 34' ' ' CYS . 2.1 t -155.07 167.32 30.76 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.629 -0.669 . . . . 0.0 109.476 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -136.55 119.13 15.95 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.275 -0.89 . . . . 0.0 109.992 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 mt -108.64 120.74 43.33 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.333 -0.854 . . . . 0.0 110.456 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.4 ' HB3' ' CD2' ' A' ' 32' ' ' HIS . 5.0 tp 56.52 31.06 18.3 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.582 -0.699 . . . . 0.0 111.007 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.44 -11.78 64.85 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.565 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 59.8 m-70 -84.63 141.52 30.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.028 -1.278 . . . . 0.0 110.006 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -72.2 135.74 46.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.391 -0.818 . . . . 0.0 110.305 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.425 ' CB ' HG21 ' A' ' 27' ' ' THR . 45.1 m -139.15 168.57 19.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.614 -0.679 . . . . 0.0 110.059 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER -129.7 121.21 26.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.511 -0.743 . . . . 0.0 110.051 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.538 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 26.8 t80 -120.42 136.77 54.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.555 -0.716 . . . . 0.0 109.364 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.1 p -140.36 151.0 44.64 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.061 -1.025 . . . . 0.0 111.503 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.7 t -132.64 129.25 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 mtmm -142.56 117.33 6.56 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.159 -0.963 . . . . 0.0 110.938 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.03 157.62 34.27 Favored 'Trans proline' 0 C--N 1.313 -1.289 0 O-C-N 123.954 1.502 . . . . 0.0 110.251 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -131.79 -169.2 2.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.418 -0.801 . . . . 0.0 110.091 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 tp -139.21 144.29 38.43 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.543 0.687 . . . . 0.0 111.009 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -115.15 177.8 4.52 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -40.73 -39.71 1.15 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.907 -0.496 . . . . 0.0 111.204 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -157.45 47.33 0.4 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.543 -0.723 . . . . 0.0 110.218 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.83 149.86 13.08 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.111 -0.993 . . . . 0.0 111.45 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 79.6 t -98.48 136.81 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.508 -0.745 . . . . 0.0 109.157 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -124.54 159.85 29.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.32 -0.862 . . . . 0.0 110.773 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.46 ' CZ ' ' HG3' ' A' ' 70' ' ' GLN . 0.5 OUTLIER -124.28 131.62 53.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.476 -0.765 . . . . 0.0 110.028 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -135.69 157.14 47.6 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.449 -0.782 . . . . 0.0 110.495 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.91 147.58 17.55 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.473 ' HD3' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -141.16 145.52 35.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.826 -0.808 . . . . 0.0 110.033 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.6 ' HG2' HG23 ' A' ' 77' ' ' THR . 2.2 ptm -143.99 151.88 40.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.078 -1.014 . . . . 0.0 111.079 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.476 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 48.6 p90 -155.84 150.56 26.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.7 -0.625 . . . . 0.0 110.32 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 87.1 m -113.53 90.49 17.83 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.214 -0.929 . . . . 0.0 110.964 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.476 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.4 Cg_endo -78.66 84.8 1.96 Allowed 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.957 1.504 . . . . 0.0 110.108 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.49 -47.6 0.41 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.565 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 19.4 t90 -77.08 -54.66 6.25 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.449 -1.03 . . . . 0.0 110.384 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -153.74 -161.83 1.33 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.558 -0.714 . . . . 0.0 110.022 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.24 48.57 1.39 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.518 -0.739 . . . . 0.0 110.212 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.4 mt -118.36 146.57 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.366 -0.834 . . . . 0.0 109.83 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.16 161.72 35.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.365 -0.835 . . . . 0.0 110.98 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.68 131.76 5.89 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.473 ' HG2' ' HD3' ' A' ' 52' ' ' ARG . 12.9 mp0 -126.44 160.25 31.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.644 -0.915 . . . . 0.0 109.914 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.438 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -171.76 152.34 3.06 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.414 -0.804 . . . . 0.0 111.188 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.1 143.44 31.13 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.516 -0.74 . . . . 0.0 110.115 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.8 t -173.25 155.42 2.92 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.52 -0.738 . . . . 0.0 110.323 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.41 -35.88 70.6 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.532 -0.73 . . . . 0.0 111.411 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.31 135.6 57.54 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.32 -0.863 . . . . 0.0 110.354 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.46 ' HG3' ' CZ ' ' A' ' 49' ' ' TYR . 4.6 mp0 -70.23 -61.39 1.79 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.705 -0.622 . . . . 0.0 109.98 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.2 t -72.93 -28.76 62.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.24 -0.913 . . . . 0.0 109.879 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.27 -39.66 92.86 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.97 -35.81 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.377 -1.072 . . . . 0.0 109.992 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.96 -39.76 87.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.433 -0.792 . . . . 0.0 110.036 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.05 -34.34 76.13 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.438 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -70.36 -42.22 72.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.62 -0.929 . . . . 0.0 110.177 179.502 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.6 HG23 ' HG2' ' A' ' 53' ' ' MET . 66.5 m -62.49 -40.01 95.33 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.286 -0.884 . . . . 0.0 109.419 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.47 -37.02 65.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.514 -0.741 . . . . 0.0 109.685 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -38.78 86.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.505 -0.747 . . . . 0.0 109.693 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -41.97 99.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.565 -0.709 . . . . 0.0 110.001 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -65.72 -40.8 92.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.443 -0.785 . . . . 0.0 109.973 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.442 ' HA ' HD13 ' A' ' 91' ' ' ILE . 97.1 t -66.1 -36.04 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.484 -0.76 . . . . 0.0 109.915 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -67.04 -40.66 87.23 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.47 -0.769 . . . . 0.0 109.982 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -37.11 80.56 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.535 -0.728 . . . . 0.0 109.869 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.98 -35.27 76.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.385 -0.822 . . . . 0.0 110.134 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.9 -36.22 72.64 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.477 -0.764 . . . . 0.0 109.687 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -63.1 -29.05 70.5 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.601 -0.687 . . . . 0.0 110.412 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -55.29 3.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.43 -0.794 . . . . 0.0 110.332 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 136.61 56.53 0.06 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.5 mt -125.44 -46.41 1.76 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.336 -1.096 . . . . 0.0 110.579 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 82' ' ' VAL . 89.0 mt -96.78 112.38 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 109.741 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.5 m -91.25 162.63 14.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.542 -0.724 . . . . 0.0 110.353 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -63.29 -53.72 48.34 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.526 -0.734 . . . . 0.0 110.259 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -61.64 -42.74 99.31 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.481 -0.762 . . . . 0.0 110.733 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -59.27 -41.66 89.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.317 -0.864 . . . . 0.0 110.176 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.06 -40.24 97.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.381 -0.824 . . . . 0.0 109.741 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -64.21 -39.88 94.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.567 -0.708 . . . . 0.0 109.868 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -63.26 -40.48 97.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.668 -0.645 . . . . 0.0 109.745 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.44 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 15.1 t90 -68.45 -36.54 79.17 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.591 -0.693 . . . . 0.0 109.9 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 14.1 mt -66.71 -30.91 71.26 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.699 -0.626 . . . . 0.0 110.548 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.3 m -55.4 -41.67 73.0 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.429 -0.795 . . . . 0.0 110.582 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.436 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 120.75 0.309 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.19 -155.47 0.34 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.566 -0.709 . . . . 0.0 110.454 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -67.51 140.54 57.03 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.306 -0.872 . . . . 0.0 110.32 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.4 t -116.93 -50.63 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.447 -0.783 . . . . 0.0 110.444 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -80.97 155.85 26.23 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.239 -0.913 . . . . 0.0 110.433 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.65 -82.42 0.04 OUTLIER Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -65.14 -21.75 66.83 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.417 -1.049 . . . . 0.0 110.799 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -40.05 85.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.233 -0.917 . . . . 0.0 109.401 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.28 -39.45 71.52 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.4 t -68.5 -38.79 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.413 ' HB3' ' HG2' ' A' ' 79' ' ' LYS . . . -64.19 -39.74 94.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.611 -0.681 . . . . 0.0 109.647 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.58 -41.56 99.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.551 -0.718 . . . . 0.0 109.79 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.49 -40.43 89.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.397 -0.814 . . . . 0.0 109.693 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.407 HG11 ' CZ3' ' A' ' 99' ' ' TRP . 95.0 t -64.96 -40.78 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.439 -0.788 . . . . 0.0 109.137 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -62.13 -40.27 95.35 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.687 -0.633 . . . . 0.0 109.75 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 t -61.39 -41.78 97.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.563 -0.711 . . . . 0.0 109.755 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 14.4 tttm -68.36 -30.44 69.39 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.472 -0.767 . . . . 0.0 110.215 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.414 HG21 ' HB1' ' A' ' 78' ' ' ALA . 12.9 mm -68.1 -44.32 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.423 -0.798 . . . . 0.0 109.702 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.77 -39.24 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.342 -0.849 . . . . 0.0 110.196 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.57 -27.58 69.14 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.68 28.73 8.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.1 -1.235 . . . . 0.0 111.613 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -95.65 132.69 40.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.929 -1.107 . . . . 0.0 110.48 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -98.09 -166.04 1.33 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -48.0 -41.95 26.71 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.161 -0.962 . . . . 0.0 110.26 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -161.97 37.83 0.12 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.725 -0.609 . . . . 0.0 110.261 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -146.12 158.83 43.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.188 -0.945 . . . . 0.0 111.205 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.541 HG21 ' HB2' ' A' ' 34' ' ' CYS . 8.0 t -163.61 154.3 15.97 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.682 -0.636 . . . . 0.0 109.406 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -110.94 111.11 22.01 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.21 -0.932 . . . . 0.0 110.302 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.421 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 2.8 mt -107.06 128.86 54.75 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.355 -0.841 . . . . 0.0 110.763 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.7 tp 54.48 36.0 24.63 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.599 -0.688 . . . . 0.0 111.17 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.32 23.49 78.01 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 51.6 m-70 -123.14 151.67 41.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -1.087 . . . . 0.0 109.895 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.46 127.43 32.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.312 -0.868 . . . . 0.0 110.597 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.541 ' HB2' HG21 ' A' ' 27' ' ' THR . 59.9 m -129.33 171.25 12.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.685 -0.635 . . . . 0.0 109.996 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.479 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 7.9 tptm -128.06 100.68 5.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.526 -0.734 . . . . 0.0 110.276 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 3.8 t80 -112.85 136.1 52.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.755 -0.591 . . . . 0.0 109.703 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.01 170.85 16.85 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.343 -0.848 . . . . 0.0 111.045 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.466 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 76.0 t -133.41 130.64 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -137.84 93.74 11.96 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.158 -0.964 . . . . 0.0 111.192 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.446 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 56.5 Cg_endo -77.57 169.75 20.44 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.916 1.482 . . . . 0.0 110.316 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -151.7 -178.21 6.57 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.255 -0.903 . . . . 0.0 110.443 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.69 150.62 34.96 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.395 0.617 . . . . 0.0 110.637 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -120.53 177.97 4.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.793 -0.567 . . . . 0.0 109.618 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -40.42 -40.26 1.16 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.877 -0.514 . . . . 0.0 111.563 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -155.56 36.1 0.37 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.328 -0.858 . . . . 0.0 110.993 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.86 145.87 10.83 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.987 -1.071 . . . . 0.0 110.884 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.06 122.83 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.282 -0.886 . . . . 0.0 109.355 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -108.69 150.84 26.99 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.487 -0.758 . . . . 0.0 110.756 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.532 ' CE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -108.98 156.86 19.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.456 -0.778 . . . . 0.0 110.195 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -156.78 149.75 23.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.312 -0.867 . . . . 0.0 110.189 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -145.87 149.97 22.15 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.409 ' HD3' ' CB ' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -148.42 145.05 27.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.7 -0.882 . . . . 0.0 110.113 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.452 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 5.4 ptm -144.54 151.3 38.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.374 -0.829 . . . . 0.0 111.123 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.479 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 42.8 p90 -153.93 147.93 25.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.786 -0.571 . . . . 0.0 109.888 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 87.5 m -111.58 89.9 11.6 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.222 -0.924 . . . . 0.0 111.449 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -77.06 85.72 1.73 Allowed 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.856 1.451 . . . . 0.0 110.091 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.83 -46.63 0.64 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.536 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 12.1 t90 -70.31 -57.43 4.88 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.672 -0.899 . . . . 0.0 109.996 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -152.1 -164.37 1.95 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.61 -0.681 . . . . 0.0 109.901 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.63 56.83 0.88 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.356 -0.84 . . . . 0.0 109.767 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.516 HD11 ' HE2' ' A' ' 88' ' ' LYS . 31.7 mt -130.55 158.71 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.608 -0.683 . . . . 0.0 109.699 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -135.93 171.04 15.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.45 -0.781 . . . . 0.0 110.695 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.56 127.96 1.83 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.409 ' CB ' ' HD3' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -147.48 156.06 42.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.608 -0.937 . . . . 0.0 110.709 -179.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.563 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -158.4 155.57 28.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.458 -0.776 . . . . 0.0 110.614 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.42 145.45 50.3 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.418 -0.801 . . . . 0.0 110.688 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 t -172.7 152.29 2.49 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.629 -0.669 . . . . 0.0 109.67 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -26.97 61.23 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.361 -0.837 . . . . 0.0 111.346 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.8 133.24 51.55 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.28 -0.888 . . . . 0.0 110.618 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.532 ' HA ' ' CE2' ' A' ' 49' ' ' TYR . 1.0 OUTLIER -70.36 -53.12 17.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.56 -0.712 . . . . 0.0 110.559 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.9 m -80.88 -28.31 36.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.331 -0.856 . . . . 0.0 110.082 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.17 -44.16 98.49 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.37 -36.37 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.461 -1.023 . . . . 0.0 110.321 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.414 ' HA ' ' HZ ' ' A' ' 36' ' ' PHE . . . -71.75 -43.3 66.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.589 -0.694 . . . . 0.0 109.653 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.58 -38.5 93.37 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.563 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -65.38 -40.47 93.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.643 -0.916 . . . . 0.0 109.996 179.433 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.3 m -60.19 -43.51 95.84 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.542 -0.724 . . . . 0.0 109.32 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 15' ' ' ALA . . . -68.7 -37.57 79.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.624 -0.673 . . . . 0.0 109.76 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.413 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -64.79 -40.17 94.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.559 -0.713 . . . . 0.0 109.61 179.231 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.53 -40.41 94.55 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.666 . . . . 0.0 110.049 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -70.18 -38.51 75.39 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.426 -0.797 . . . . 0.0 110.004 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.405 ' CG1' ' HA ' ' A' ' 11' ' ' ALA . 85.7 t -71.86 -33.4 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 0.0 110.027 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -41.27 80.67 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.282 -0.886 . . . . 0.0 109.361 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -36.67 67.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.494 -0.754 . . . . 0.0 108.983 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.37 -37.01 80.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.449 -0.782 . . . . 0.0 109.271 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -43.47 98.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.548 -0.72 . . . . 0.0 109.352 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -68.21 -37.1 80.52 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.659 -0.651 . . . . 0.0 110.534 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.516 ' HE2' HD11 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -72.37 -52.19 17.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.327 -0.858 . . . . 0.0 110.474 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.4 53.99 0.1 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.4 mt -129.0 -49.88 1.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.487 -1.008 . . . . 0.0 110.521 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.5 mm -94.51 90.81 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 109.833 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -77.78 169.63 17.97 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.552 -0.718 . . . . 0.0 109.705 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -54.47 31.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.404 -0.81 . . . . 0.0 110.462 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -69.29 -36.91 77.54 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.406 -0.809 . . . . 0.0 110.563 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.0 OUTLIER -62.4 -43.19 99.42 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.293 -0.879 . . . . 0.0 110.054 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.85 87.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.444 -0.785 . . . . 0.0 109.12 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -62.93 -41.15 99.38 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.81 -0.556 . . . . 0.0 109.889 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -41.46 96.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.445 -0.785 . . . . 0.0 109.288 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.462 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 29.6 t90 -66.74 -36.64 82.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.349 -0.844 . . . . 0.0 109.069 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.1 tp -58.71 -43.48 90.1 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.932 -0.48 . . . . 0.0 109.955 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 99.6 p -78.65 -48.26 15.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.527 -0.733 . . . . 0.0 109.814 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 117.777 -1.106 . . . . 0.0 109.887 179.754 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.061 0.457 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.53 126.49 19.49 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.41 -0.806 . . . . 0.0 110.471 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -157.71 -59.46 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.516 -0.74 . . . . 0.0 110.287 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.9 p -101.16 -28.98 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.42 -0.8 . . . . 0.0 110.36 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -116.57 140.3 49.53 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.311 -0.868 . . . . 0.0 110.149 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 141.92 57.4 0.03 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -87.85 -37.79 16.23 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.549 -0.971 . . . . 0.0 110.305 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -62.45 -37.38 85.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.73 . . . . 0.0 110.164 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.1 -40.85 97.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.546 -0.721 . . . . 0.0 109.72 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.41 HG12 ' HG2' ' A' ' 93' ' ' GLN . 64.4 t -67.04 -42.07 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.1 94.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.582 -0.699 . . . . 0.0 109.186 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.39 94.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.711 -0.618 . . . . 0.0 109.715 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.76 94.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.561 -0.712 . . . . 0.0 110.02 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.45 -39.65 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.329 -0.857 . . . . 0.0 109.237 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.517 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . . . -66.68 -39.25 88.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.542 -0.724 . . . . 0.0 109.902 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 p -65.63 -35.97 82.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.406 -0.808 . . . . 0.0 109.923 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.568 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 4.7 tptt -65.78 -35.49 80.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.473 -0.767 . . . . 0.0 109.7 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.491 HD13 HG23 ' A' ' 18' ' ' ILE . 4.9 mt -65.52 -47.11 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.507 -0.746 . . . . 0.0 109.18 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.6 t -64.45 -39.49 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.523 -0.736 . . . . 0.0 110.051 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.58 -25.01 75.2 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.8 tp -120.68 31.39 6.45 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.289 -1.124 . . . . 0.0 111.021 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.412 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 23.5 t90 -93.28 136.71 33.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.987 -1.07 . . . . 0.0 110.479 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.07 -167.79 1.56 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.605 -0.685 . . . . 0.0 109.253 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.81 -43.02 18.03 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.24 -0.913 . . . . 0.0 110.206 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 1.4 pp20? -159.5 33.56 0.19 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.479 -0.763 . . . . 0.0 110.848 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -140.81 147.9 39.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.129 -0.982 . . . . 0.0 110.78 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 34' ' ' CYS . 9.2 t -154.71 161.95 41.33 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.437 -0.789 . . . . 0.0 109.553 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -111.35 152.72 26.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.197 -0.939 . . . . 0.0 110.183 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.532 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 3.4 mt -146.18 119.02 8.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.405 -0.81 . . . . 0.0 109.971 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 tp 54.71 32.48 17.45 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.779 -0.576 . . . . 0.0 111.188 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.29 22.28 63.17 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 70.0 m-70 -124.89 147.14 48.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -1.143 . . . . 0.0 110.151 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.83 132.92 40.69 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.435 -0.79 . . . . 0.0 110.416 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 84.4 m -135.37 164.34 27.99 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.561 -0.712 . . . . 0.0 110.179 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.556 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 1.5 tptt -117.9 124.01 47.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.343 -0.848 . . . . 0.0 110.53 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.459 ' CZ ' ' HB ' ' A' ' 77' ' ' THR . 7.3 t80 -124.49 123.93 41.19 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.709 -0.619 . . . . 0.0 109.512 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.3 p -131.37 154.32 48.74 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.202 -0.937 . . . . 0.0 111.578 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 p -122.29 142.35 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.632 -0.667 . . . . 0.0 109.75 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.57 107.56 4.08 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.081 -1.012 . . . . 0.0 110.868 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -78.49 161.26 28.4 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 O-C-N 123.762 1.401 . . . . 0.0 110.509 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -132.17 -175.71 3.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.393 -0.817 . . . . 0.0 109.813 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.05 159.61 42.87 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.532 0.682 . . . . 0.0 110.946 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.85 176.36 8.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.745 -0.597 . . . . 0.0 109.586 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 61.8 mtt-85 -43.6 -35.48 1.76 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.661 -0.649 . . . . 0.0 111.032 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.57 42.14 0.42 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.539 -0.726 . . . . 0.0 110.018 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -151.99 152.16 32.11 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.304 -0.872 . . . . 0.0 111.208 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.1 t -122.77 139.58 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -135.57 156.62 48.59 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.348 -0.845 . . . . 0.0 110.911 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 67' ' ' THR . 1.7 m-85 -122.57 132.13 54.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.548 -0.72 . . . . 0.0 109.95 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -132.26 162.99 29.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.427 -0.796 . . . . 0.0 110.381 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -158.0 141.95 8.14 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.53 147.36 52.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.799 -0.824 . . . . 0.0 109.805 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.443 ' HG2' HG22 ' A' ' 77' ' ' THR . 2.4 ppp? -149.05 157.24 43.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.109 -0.995 . . . . 0.0 111.05 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.556 ' CE2' ' HB3' ' A' ' 35' ' ' LYS . 47.3 p90 -164.5 176.6 8.84 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.826 -0.546 . . . . 0.0 110.117 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 67.5 m -129.06 94.86 32.78 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.213 -0.929 . . . . 0.0 110.614 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.439 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.8 Cg_endo -77.01 81.61 2.56 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.902 1.475 . . . . 0.0 110.468 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.36 -46.24 0.64 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.465 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 12.6 t90 -68.61 -57.72 5.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.604 -0.939 . . . . 0.0 110.155 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -150.64 -166.23 2.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.471 -0.768 . . . . 0.0 109.939 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.19 50.6 1.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.382 -0.824 . . . . 0.0 110.225 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.4 mt -123.01 149.53 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.739 . . . . 0.0 109.781 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -129.37 165.58 21.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -0.902 . . . . 0.0 111.0 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.22 152.5 24.1 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -153.2 158.77 42.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.482 -1.01 . . . . 0.0 110.069 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -168.63 148.55 4.45 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.989 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.7 m -137.61 147.53 45.09 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.612 -0.68 . . . . 0.0 110.107 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 6.6 t -170.97 171.37 5.92 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.584 -0.698 . . . . 0.0 110.11 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -69.16 -42.24 76.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.423 -0.798 . . . . 0.0 111.26 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.74 138.97 57.77 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.358 -0.839 . . . . 0.0 110.848 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.445 ' O ' HG12 ' A' ' 73' ' ' VAL . 19.5 tt0 -73.01 -52.14 15.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.76 -0.587 . . . . 0.0 110.282 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.0 m -72.46 -34.8 68.0 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.311 -0.868 . . . . 0.0 110.106 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.04 -36.63 92.59 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 70' ' ' GLN . 0.4 OUTLIER -63.3 -37.91 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.364 -1.08 . . . . 0.0 110.392 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.66 -38.02 80.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.462 -0.774 . . . . 0.0 109.835 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.82 95.59 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.487 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 4.0 tttm -68.1 -40.91 82.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.539 -0.977 . . . . 0.0 110.402 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.459 ' HB ' ' CZ ' ' A' ' 36' ' ' PHE . 62.1 m -61.48 -38.22 86.48 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.074 -1.016 . . . . 0.0 109.871 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.517 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . . . -77.36 -36.17 53.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.585 -0.697 . . . . 0.0 109.899 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -68.64 -39.08 80.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.357 -0.839 . . . . 0.0 109.858 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -67.46 -34.5 77.32 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.514 -0.741 . . . . 0.0 109.562 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.429 ' CD2' ' SD ' ' A' ' 53' ' ' MET . 41.7 t80 -68.07 -41.16 82.35 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.487 -0.758 . . . . 0.0 109.702 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.515 ' HA ' HD13 ' A' ' 91' ' ' ILE . 83.9 t -66.87 -36.47 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.496 -0.752 . . . . 0.0 109.496 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.26 -41.67 99.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.601 -0.687 . . . . 0.0 109.456 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.68 -40.11 88.41 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.47 -0.769 . . . . 0.0 109.34 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.24 -35.35 77.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.79 -0.569 . . . . 0.0 109.647 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.68 -35.94 81.34 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.646 -0.659 . . . . 0.0 109.689 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -61.59 -39.9 92.83 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.633 -0.667 . . . . 0.0 110.207 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -82.17 -59.1 2.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.439 -0.788 . . . . 0.0 110.176 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.43 51.16 0.05 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.0 mt -115.11 -46.47 2.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.33 -1.1 . . . . 0.0 110.297 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.515 HD13 ' HA ' ' A' ' 82' ' ' VAL . 89.9 mt -106.66 89.96 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.434 -0.792 . . . . 0.0 109.936 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 17.0 m -71.62 163.87 26.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.436 -0.79 . . . . 0.0 109.632 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.41 ' HG2' HG12 ' A' ' 10' ' ' VAL . 7.2 tm0? -60.29 -51.15 70.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.438 -0.789 . . . . 0.0 110.105 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -41.81 96.39 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.726 -0.609 . . . . 0.0 110.315 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.3 OUTLIER -59.15 -41.53 88.54 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.493 -0.754 . . . . 0.0 110.037 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.12 98.21 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.489 -0.757 . . . . 0.0 109.669 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.429 ' HA ' HD12 ' A' ' 100' ' ' LEU . 9.5 t30 -63.06 -42.63 99.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.548 -0.72 . . . . 0.0 109.614 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -40.28 91.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.574 -0.703 . . . . 0.0 109.598 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.568 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 24.3 t90 -65.42 -38.37 89.71 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.738 -0.601 . . . . 0.0 109.622 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.493 ' HA ' ' HD3' ' A' ' 17' ' ' LYS . 4.3 mt -65.06 -39.28 93.04 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.749 -0.594 . . . . 0.0 110.261 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.2 m -79.43 -51.15 9.74 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.495 -0.753 . . . . 0.0 110.491 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.504 2.239 0 CA-C-O 118.059 -0.972 . . . . 0.0 111.356 -179.966 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.448 0.642 . . . . 0.0 110.291 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.83 140.14 30.67 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.171 -0.956 . . . . 0.0 110.272 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -79.01 145.68 33.77 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.501 -0.75 . . . . 0.0 110.13 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.47 150.33 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.42 -0.8 . . . . 0.0 110.365 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -103.81 173.76 6.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.482 -0.761 . . . . 0.0 110.238 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.95 -68.16 0.81 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -67.59 -36.79 81.55 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.559 -0.965 . . . . 0.0 110.23 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.69 -36.53 82.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.46 -0.775 . . . . 0.0 110.022 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.3 -41.89 84.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.494 -0.754 . . . . 0.0 109.841 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.0 t -69.35 -39.62 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.52 -0.737 . . . . 0.0 109.033 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.19 -40.71 86.55 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.63 -40.7 92.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.618 -0.676 . . . . 0.0 109.795 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.42 -43.16 97.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.555 -0.716 . . . . 0.0 109.528 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.0 t -62.43 -44.52 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.564 -0.71 . . . . 0.0 109.309 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.33 92.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.631 -0.668 . . . . 0.0 109.99 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 t -63.55 -38.66 91.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.515 -0.741 . . . . 0.0 110.042 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.545 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 7.1 tttt -67.0 -33.83 76.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.95 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.437 HD11 ' CE ' ' A' ' 53' ' ' MET . 10.2 mt -61.48 -48.31 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.449 -0.782 . . . . 0.0 109.757 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.3 t -62.14 -39.13 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.389 -0.819 . . . . 0.0 109.978 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.66 -28.29 73.25 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 tp -115.78 37.3 3.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.363 -1.081 . . . . 0.0 110.95 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -99.19 135.16 41.0 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.187 -0.946 . . . . 0.0 110.617 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.1 mtt-85 -98.49 -167.29 1.48 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -48.37 -43.23 33.46 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.984 -1.072 . . . . 0.0 110.385 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -158.89 36.5 0.22 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.641 -0.662 . . . . 0.0 110.476 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -150.33 157.79 43.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.305 -0.872 . . . . 0.0 110.49 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.1 t -157.6 -179.81 8.52 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.337 -0.852 . . . . 0.0 109.868 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -127.44 143.0 51.26 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.437 -0.789 . . . . 0.0 110.231 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.473 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 3.1 mt -137.54 123.49 20.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.296 -0.877 . . . . 0.0 109.835 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 tp 56.39 30.09 16.33 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.736 -0.603 . . . . 0.0 111.066 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.31 19.01 65.39 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -118.61 163.69 16.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.151 -1.205 . . . . 0.0 110.208 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.2 133.98 34.21 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.477 -0.765 . . . . 0.0 109.896 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.539 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 90.1 m -135.41 165.8 24.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.466 -0.771 . . . . 0.0 110.875 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.33 118.29 31.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.547 -0.72 . . . . 0.0 110.387 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -129.32 126.51 39.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.577 -0.702 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.19 171.45 18.48 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.033 -1.042 . . . . 0.0 111.293 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.61 148.42 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.931 -0.48 . . . . 0.0 109.971 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -157.62 117.39 1.95 Allowed Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.21 -0.931 . . . . 0.0 110.36 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.33 154.06 36.07 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.821 1.432 . . . . 0.0 110.885 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.499 ' CE2' ' HB3' ' A' ' 50' ' ' LYS . 31.0 m-85 -128.43 -168.96 1.99 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.573 -0.704 . . . . 0.0 109.454 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.31 147.75 42.04 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.554 0.692 . . . . 0.0 110.826 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.66 177.16 4.8 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -38.43 -41.47 0.65 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 122.023 -0.423 . . . . 0.0 111.523 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.2 35.0 0.38 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.477 -0.764 . . . . 0.0 110.899 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.66 141.01 15.43 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.079 -1.013 . . . . 0.0 110.838 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 72.9 t -97.01 148.18 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.388 -0.82 . . . . 0.0 109.702 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -140.85 151.45 44.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.423 -0.798 . . . . 0.0 110.82 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.48 130.19 46.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.425 -0.797 . . . . 0.0 109.984 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.499 ' HB3' ' CE2' ' A' ' 41' ' ' TYR . 5.3 tttp -130.84 164.68 24.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.414 -0.803 . . . . 0.0 110.087 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -155.83 152.14 23.61 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.39 134.02 19.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.429 -1.042 . . . . 0.0 110.161 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.437 ' CE ' HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -138.95 158.74 43.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.495 -0.753 . . . . 0.0 110.82 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.597 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 43.9 p90 -168.81 -169.1 0.95 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.774 -0.579 . . . . 0.0 109.984 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 68.2 m -133.18 94.42 20.31 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.253 -0.905 . . . . 0.0 110.708 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.597 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.0 Cg_endo -74.87 80.94 2.28 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.986 1.519 . . . . 0.0 110.21 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.34 -45.09 0.64 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -70.77 -55.56 8.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.649 -0.912 . . . . 0.0 110.09 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -151.14 -165.93 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.497 -0.752 . . . . 0.0 109.744 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.57 47.74 1.57 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.299 -0.876 . . . . 0.0 110.183 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.1 mt -123.44 150.9 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.345 -0.847 . . . . 0.0 109.993 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.71 164.38 30.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.316 -0.865 . . . . 0.0 111.328 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.87 130.27 3.83 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.35 170.09 16.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.436 -1.038 . . . . 0.0 111.095 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -166.34 173.02 10.42 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.385 0.612 . . . . 0.0 110.836 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.43 148.48 24.58 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.391 -0.818 . . . . 0.0 110.87 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.5 t -171.22 169.17 6.51 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.661 -0.649 . . . . 0.0 110.138 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -37.94 88.68 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.288 -0.882 . . . . 0.0 110.529 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.3 t -67.56 162.95 22.27 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.498 -0.751 . . . . 0.0 110.859 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.412 ' O ' HG12 ' A' ' 73' ' ' VAL . 34.0 mt-30 -97.81 -56.24 2.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.899 -0.5 . . . . 0.0 110.122 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 m -67.24 -29.65 69.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.399 -0.813 . . . . 0.0 110.519 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.04 -41.14 97.85 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 110.174 -1.171 . . . . 0.0 110.174 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 70' ' ' GLN . 0.5 OUTLIER -65.51 -34.09 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.455 -1.027 . . . . 0.0 110.47 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.04 -39.38 86.94 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.632 -0.667 . . . . 0.0 110.375 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.07 -33.43 69.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.529 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 8.5 mmmt -73.45 -39.62 64.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.524 -0.986 . . . . 0.0 110.432 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.62 -45.45 81.51 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.105 -0.997 . . . . 0.0 109.641 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.404 ' HB3' HD12 ' A' ' 18' ' ' ILE . . . -72.3 -34.92 68.51 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.736 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HA ' ' HZ1' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -72.95 -36.45 67.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.445 -0.784 . . . . 0.0 110.702 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.91 -35.23 74.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.451 -0.781 . . . . 0.0 110.315 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -71.09 -40.5 71.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 110.243 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.455 ' HA ' ' CD1' ' A' ' 91' ' ' ILE . 68.8 t -67.62 -35.06 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.297 -0.877 . . . . 0.0 109.814 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -68.4 -39.07 81.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.515 -0.741 . . . . 0.0 109.733 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.471 ' HE3' ' HB2' ' A' ' 84' ' ' LYS . 1.6 tppp? -64.24 -41.13 97.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.553 -0.717 . . . . 0.0 110.109 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.513 ' HB1' HD13 ' A' ' 91' ' ' ILE . . . -69.98 -34.51 73.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.503 -0.748 . . . . 0.0 109.643 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -40.76 95.68 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.682 -0.636 . . . . 0.0 109.646 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -66.5 -38.46 87.3 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.547 -0.72 . . . . 0.0 110.362 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.64 -50.36 21.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.376 -0.827 . . . . 0.0 110.4 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.91 53.49 0.13 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 90' ' ' LEU . 12.4 mt -125.74 -51.59 1.59 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.364 -1.08 . . . . 0.0 110.447 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.513 HD13 ' HB1' ' A' ' 85' ' ' ALA . 74.5 mt -86.75 104.85 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.714 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 58.2 m -83.77 171.98 12.65 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.527 -0.733 . . . . 0.0 109.971 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -68.16 -56.91 7.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.469 -0.769 . . . . 0.0 110.357 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -37.35 87.3 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.437 -0.789 . . . . 0.0 110.489 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 1.4 mm-40 -53.67 -42.15 67.6 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.455 -0.778 . . . . 0.0 110.017 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.77 -40.28 96.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.471 -0.768 . . . . 0.0 109.523 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -68.24 -38.77 82.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.694 -0.629 . . . . 0.0 109.395 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -62.89 -40.05 96.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.587 -0.695 . . . . 0.0 109.836 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.545 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 28.1 t90 -71.98 -39.03 69.58 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.4 tp -66.66 -39.58 88.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.782 -0.574 . . . . 0.0 109.647 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.5 t -72.32 -58.1 3.68 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.757 -0.589 . . . . 0.0 110.257 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.041 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.618 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.203 0.525 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.44 125.73 40.25 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.428 -0.795 . . . . 0.0 110.25 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -96.42 -53.58 3.55 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.482 -0.761 . . . . 0.0 110.168 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 99.8 t -103.39 155.84 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.427 -0.796 . . . . 0.0 109.916 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.8 172.79 5.96 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.37 -0.831 . . . . 0.0 110.161 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.98 -59.33 0.24 Allowed Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -57.07 -40.94 77.87 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.682 -0.893 . . . . 0.0 110.229 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.04 -38.65 89.52 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.479 -0.763 . . . . 0.0 109.841 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.49 -40.3 95.41 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.572 -0.705 . . . . 0.0 109.632 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.12 -41.5 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.723 . . . . 0.0 109.121 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.415 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . . . -63.58 -39.75 95.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.662 -0.649 . . . . 0.0 109.823 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.61 -40.47 96.99 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.537 -0.727 . . . . 0.0 109.765 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.51 -40.77 97.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.502 -0.749 . . . . 0.0 109.667 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.435 HG11 HD13 ' A' ' 91' ' ' ILE . 90.6 t -61.62 -42.31 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.583 -0.698 . . . . 0.0 109.227 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.96 95.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.617 -0.677 . . . . 0.0 109.597 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 t -61.31 -38.93 88.61 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.606 -0.684 . . . . 0.0 109.809 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.466 ' HD3' HD21 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -67.12 -36.1 81.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 109.6 179.324 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.3 mm -58.22 -41.9 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.465 -0.772 . . . . 0.0 110.39 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.65 -45.88 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.384 -0.822 . . . . 0.0 110.096 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.09 -15.8 79.82 Favored Glycine 0 N--CA 1.501 2.981 0 C-N-CA 120.26 -0.971 . . . . 0.0 111.035 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.411 HD22 HD22 ' A' ' 29' ' ' LEU . 15.4 tp -99.06 -21.5 16.16 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.118 -1.225 . . . . 0.0 111.285 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.59 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 21.9 t90 -65.7 130.89 44.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 0.0 111.197 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.9 ttt-85 -99.47 -160.97 0.84 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -48.55 -45.98 38.25 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.165 -0.959 . . . . 0.0 110.198 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.93 29.29 0.31 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.47 -0.769 . . . . 0.0 111.249 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.49 157.48 43.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.046 -1.034 . . . . 0.0 110.953 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.8 t -153.81 145.53 23.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.497 -0.752 . . . . 0.0 109.651 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.22 108.24 19.56 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.385 -0.822 . . . . 0.0 109.794 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 29' ' ' LEU . 6.3 mt -114.05 129.37 56.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.183 -0.948 . . . . 0.0 110.924 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.401 ' HB3' ' CD2' ' A' ' 32' ' ' HIS . 0.4 OUTLIER 58.73 28.58 17.49 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.505 -0.747 . . . . 0.0 110.899 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.31 21.56 77.52 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.401 ' CD2' ' HB3' ' A' ' 30' ' ' LEU . 58.6 m-70 -121.18 155.28 34.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.442 -1.034 . . . . 0.0 109.916 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -86.43 116.2 24.43 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.172 -0.955 . . . . 0.0 109.68 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.1 m -116.16 173.51 6.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.574 -0.703 . . . . 0.0 109.66 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.508 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 4.9 tptt -132.87 108.96 9.28 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.525 -0.734 . . . . 0.0 111.065 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.59 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 47.4 t80 -108.82 139.25 43.9 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 p -144.65 152.91 41.15 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.931 -1.105 . . . . 0.0 111.721 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 88.3 t -133.2 123.17 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -138.21 117.41 9.73 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.185 -0.947 . . . . 0.0 110.664 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.41 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 55.2 Cg_endo -81.49 157.52 19.27 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 124.018 1.536 . . . . 0.0 110.633 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -133.11 -169.17 2.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.61 -0.681 . . . . 0.0 109.22 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.08 149.16 50.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.475 -0.765 . . . . 0.0 110.897 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 44' ' ' ARG . 1.3 tttm -123.08 179.61 4.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.818 -0.551 . . . . 0.0 109.773 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 43' ' ' LYS . 12.6 mmt-85 -35.37 -45.94 0.35 Allowed 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 121.045 0.45 . . . . 0.0 111.582 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -155.07 37.3 0.4 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.57 -0.707 . . . . 0.0 110.774 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -156.0 142.44 18.52 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.167 -0.958 . . . . 0.0 111.049 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.5 t -97.38 124.44 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.463 -0.773 . . . . 0.0 109.251 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -109.35 149.7 29.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.395 -0.816 . . . . 0.0 110.88 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.41 ' CD1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -109.87 131.34 55.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.452 -0.78 . . . . 0.0 109.664 179.317 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -129.42 159.65 35.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.19 -0.944 . . . . 0.0 110.457 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.56 142.82 9.51 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.465 ' HG2' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -138.77 149.99 45.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.922 -0.752 . . . . 0.0 109.85 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.0 ptm -145.69 156.44 43.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.966 -1.084 . . . . 0.0 111.433 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.616 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 23.4 p90 -166.42 164.56 17.34 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.885 -0.51 . . . . 0.0 110.301 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.3 m -128.08 98.42 27.03 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.248 -0.908 . . . . 0.0 110.312 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.616 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.6 Cg_endo -75.13 84.65 1.65 Allowed 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.833 1.438 . . . . 0.0 110.577 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 143.22 -43.99 0.99 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -70.19 -59.84 2.64 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.472 -1.016 . . . . 0.0 110.1 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.3 t -150.07 -170.11 3.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.464 -0.773 . . . . 0.0 110.044 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.53 41.06 2.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.509 -0.744 . . . . 0.0 110.302 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.411 ' CD1' ' HB3' ' A' ' 84' ' ' LYS . 2.7 tt -118.24 153.97 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.51 -0.744 . . . . 0.0 109.666 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.09 171.62 14.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.103 -0.998 . . . . 0.0 111.405 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.547 ' HA3' ' HB2' ' A' ' 81' ' ' PHE . . . -141.2 126.91 3.21 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.465 ' HG2' ' HG2' ' A' ' 52' ' ' ARG . 6.2 mt-10 -135.57 153.01 51.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.459 -1.024 . . . . 0.0 110.441 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.52 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -170.7 164.43 8.12 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.592 -0.693 . . . . 0.0 110.713 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.411 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 1.0 OUTLIER -153.05 149.95 28.66 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.459 -0.776 . . . . 0.0 111.03 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.7 t -173.89 156.98 2.91 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 mtm105 -60.5 -24.27 65.19 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.263 -0.898 . . . . 0.0 111.026 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.25 139.45 54.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.237 -0.914 . . . . 0.0 110.545 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -75.82 -53.72 8.03 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.531 -0.731 . . . . 0.0 110.358 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 t -81.07 -30.34 34.77 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.392 -0.818 . . . . 0.0 109.937 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.93 -36.52 88.24 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.411 ' CG2' ' HA ' ' A' ' 66' ' ' SER . 0.5 OUTLIER -63.16 -35.41 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.446 -1.032 . . . . 0.0 110.344 179.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.47 87.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.441 -0.787 . . . . 0.0 110.119 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.06 -30.91 71.95 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.52 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -73.55 -39.96 64.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.55 -0.971 . . . . 0.0 110.235 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.3 m -64.59 -40.17 95.04 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.279 -0.888 . . . . 0.0 109.117 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.17 -39.27 86.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.623 -0.673 . . . . 0.0 109.657 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -59.75 -41.75 91.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.536 -0.727 . . . . 0.0 110.007 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.87 -41.22 95.84 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.462 -0.774 . . . . 0.0 109.653 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.547 ' HB2' ' HA3' ' A' ' 63' ' ' GLY . 43.3 t80 -69.7 -38.39 76.96 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.55 -0.719 . . . . 0.0 109.813 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.0 -37.79 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.417 -0.802 . . . . 0.0 109.93 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.37 -40.02 85.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.303 -0.873 . . . . 0.0 109.67 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.411 ' HB3' ' CD1' ' A' ' 61' ' ' ILE . 77.7 mttt -67.71 -40.22 84.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.536 -0.727 . . . . 0.0 109.388 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.78 -36.81 81.14 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.632 -0.667 . . . . 0.0 109.774 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 11' ' ' ALA . 0.9 OUTLIER -68.53 -33.38 74.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.594 -0.691 . . . . 0.0 109.956 179.192 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -64.25 -31.23 72.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.384 -0.823 . . . . 0.0 110.653 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.3 -66.83 0.89 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.379 -0.826 . . . . 0.0 110.135 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 151.39 51.6 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.3 mt -112.0 -38.97 4.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.229 -1.159 . . . . 0.0 110.472 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.435 HD13 HG11 ' A' ' 14' ' ' VAL . 80.9 mt -103.82 69.42 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 109.757 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 72.1 m -73.3 -178.61 3.02 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.516 -0.74 . . . . 0.0 110.353 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.62 -59.68 3.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.199 -0.938 . . . . 0.0 110.651 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -63.25 -39.63 95.15 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.359 -0.838 . . . . 0.0 109.94 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 11.4 mt-10 -61.57 -42.66 99.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.576 -0.703 . . . . 0.0 109.493 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.06 -37.03 81.22 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.619 -0.676 . . . . 0.0 109.714 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -62.2 -44.79 95.8 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -30.96 63.45 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.513 -0.742 . . . . 0.0 109.011 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.416 ' CZ3' HG12 ' A' ' 14' ' ' VAL . 30.2 t90 -68.55 -40.4 80.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.705 -0.622 . . . . 0.0 109.958 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.466 HD21 ' HD3' ' A' ' 17' ' ' LYS . 21.2 mt -81.99 -31.89 30.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.533 -0.729 . . . . 0.0 110.346 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 43.9 t -88.31 -67.64 0.82 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.454 -0.779 . . . . 0.0 110.587 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.118 0 CA-C-O 118.137 -0.935 . . . . 0.0 110.762 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 120.836 0.35 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.89 85.64 2.14 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.383 -0.823 . . . . 0.0 110.108 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.0 t80 58.61 89.9 0.05 Allowed 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.344 0.592 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 p -116.95 155.89 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.316 -0.865 . . . . 0.0 110.363 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -81.42 147.65 29.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.456 -0.778 . . . . 0.0 109.946 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.9 39.08 0.39 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -62.12 -37.53 85.47 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.456 -1.026 . . . . 0.0 109.834 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -63.83 -41.84 97.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.686 -0.634 . . . . 0.0 109.47 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.37 92.55 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.729 -0.607 . . . . 0.0 110.013 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.05 -42.09 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.525 -0.734 . . . . 0.0 109.459 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.13 -36.9 77.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.514 -0.742 . . . . 0.0 109.485 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.6 89.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.642 -0.661 . . . . 0.0 109.79 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.81 -41.17 95.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.404 -0.81 . . . . 0.0 109.46 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.598 HG11 ' CZ3' ' A' ' 99' ' ' TRP . 25.5 t -62.32 -40.7 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.639 -0.663 . . . . 0.0 109.41 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . . . -63.87 -39.39 94.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.573 -0.705 . . . . 0.0 109.408 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.8 m -62.5 -39.53 93.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.65 -0.656 . . . . 0.0 109.684 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.417 ' HB3' ' HZ3' ' A' ' 99' ' ' TRP . 0.5 OUTLIER -63.39 -37.78 88.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.506 -0.747 . . . . 0.0 109.773 179.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.478 HD12 ' HB2' ' A' ' 78' ' ' ALA . 2.5 mt -61.84 -37.51 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.556 -0.715 . . . . 0.0 109.984 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.2 t -63.67 -48.58 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.232 -0.917 . . . . 0.0 109.789 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.4 -15.42 81.48 Favored Glycine 0 N--CA 1.5 2.918 0 C-N-CA 120.271 -0.966 . . . . 0.0 110.698 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.44 HD22 HD21 ' A' ' 29' ' ' LEU . 11.9 tp -99.38 -16.83 18.27 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.232 -1.158 . . . . 0.0 111.203 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.571 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 24.5 t90 -69.44 137.02 52.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.177 -0.952 . . . . 0.0 111.308 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.49 -162.2 0.87 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -45.68 -45.17 13.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.309 -0.869 . . . . 0.0 110.635 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.5 31.83 0.19 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.437 -0.79 . . . . 0.0 111.28 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -153.15 162.76 40.94 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.066 -1.021 . . . . 0.0 110.792 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.4 t -157.44 144.28 18.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.395 -0.816 . . . . 0.0 109.996 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.56 109.4 21.01 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.517 -0.739 . . . . 0.0 109.621 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.444 ' HB3' ' HZ2' ' A' ' 99' ' ' TRP . 7.9 mt -114.04 130.34 56.56 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.221 -0.924 . . . . 0.0 110.797 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.441 ' CD1' ' HD1' ' A' ' 99' ' ' TRP . 7.1 tp 56.58 30.33 17.13 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.563 -0.71 . . . . 0.0 110.671 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.82 24.84 73.31 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 59.6 m-70 -124.54 159.89 29.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -1.038 . . . . 0.0 109.723 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -91.46 121.92 33.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 110.545 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 23.0 m -122.36 164.14 18.49 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.461 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 5.5 tptm -125.58 110.48 13.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.36 -0.838 . . . . 0.0 111.146 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.571 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 12.8 t80 -110.66 138.49 46.98 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.9 p -143.05 157.43 44.54 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.025 -1.047 . . . . 0.0 111.389 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.437 HG12 ' HD3' ' A' ' 40' ' ' PRO . 99.6 t -129.09 130.06 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.63 -0.669 . . . . 0.0 109.872 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 83.67 64.71 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 0.0 110.451 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.437 ' HD3' HG12 ' A' ' 38' ' ' VAL . 55.5 Cg_endo -79.49 158.82 25.65 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.855 1.45 . . . . 0.0 110.627 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.481 ' CE1' ' HB2' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -139.65 177.34 8.01 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.232 -0.918 . . . . 0.0 110.128 178.529 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.418 ' HG ' HG21 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -136.67 155.72 49.5 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.568 0.699 . . . . 0.0 111.257 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.96 178.68 6.49 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -41.46 -38.89 1.37 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.875 -0.516 . . . . 0.0 111.622 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.99 28.15 0.47 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.307 -0.871 . . . . 0.0 110.737 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -142.58 140.05 31.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.097 -1.002 . . . . 0.0 110.913 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.418 HG21 ' HG ' ' A' ' 42' ' ' LEU . 38.3 t -121.06 125.08 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.443 -0.786 . . . . 0.0 109.411 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.481 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 62.5 m-85 -119.68 139.03 52.88 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.331 -0.856 . . . . 0.0 110.58 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.58 ' CD2' ' HA ' ' A' ' 70' ' ' GLN . 2.1 m-85 -105.72 131.7 52.76 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.555 -0.715 . . . . 0.0 110.42 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.93 156.57 37.79 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.399 -0.813 . . . . 0.0 109.597 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -159.46 141.16 7.32 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.569 -1.301 . . . . 0.0 110.671 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HG3' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -141.03 146.96 37.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.88 -0.776 . . . . 0.0 109.756 179.5 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.572 ' HG2' HG21 ' A' ' 77' ' ' THR . 5.1 ptm -139.05 155.92 47.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 111.327 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.461 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 45.6 p90 -155.91 145.75 21.26 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.916 -0.49 . . . . 0.0 109.797 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 87.3 m -111.98 89.42 11.6 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.236 -0.915 . . . . 0.0 111.066 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -77.74 82.85 2.3 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 123.703 1.37 . . . . 0.0 110.149 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.34 -45.14 0.61 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 11.2 t90 -75.0 -63.28 1.3 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.533 -0.98 . . . . 0.0 110.096 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.2 t -142.41 -162.92 1.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.5 -0.75 . . . . 0.0 109.52 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.7 44.95 2.5 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.296 -0.878 . . . . 0.0 110.395 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.491 HG22 ' HB3' ' A' ' 84' ' ' LYS . 74.0 mt -123.14 140.71 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.361 -0.837 . . . . 0.0 110.234 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.57 170.88 10.49 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.414 -0.804 . . . . 0.0 110.514 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.02 136.21 4.69 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.414 ' HB2' ' HG3' ' A' ' 52' ' ' ARG . 13.1 tt0 -139.6 161.19 38.12 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.809 -0.818 . . . . 0.0 110.357 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.411 ' HB2' ' HB3' ' A' ' 76' ' ' LYS . . . -165.89 151.01 8.59 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.768 -0.582 . . . . 0.0 110.229 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.406 ' HA ' HG22 ' A' ' 73' ' ' VAL . 0.7 OUTLIER -141.71 142.07 33.31 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.426 -0.796 . . . . 0.0 110.601 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.6 t -168.03 172.65 8.66 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.404 -0.81 . . . . 0.0 110.224 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -71.18 -24.8 62.3 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.371 -0.831 . . . . 0.0 110.904 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.74 139.73 56.69 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.277 -0.889 . . . . 0.0 110.743 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.58 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 5.8 tt0 -76.27 -53.78 7.73 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.724 -0.61 . . . . 0.0 110.349 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -84.26 -30.29 25.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.43 -0.794 . . . . 0.0 110.02 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.68 -39.4 93.44 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' A' ' 66' ' ' SER . 3.3 p -61.56 -37.39 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.371 -1.076 . . . . 0.0 110.5 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.92 82.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.526 -0.734 . . . . 0.0 110.036 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.97 -36.91 91.7 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 8.1 mttp -66.61 -39.94 88.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.519 -0.989 . . . . 0.0 110.267 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.572 HG21 ' HG2' ' A' ' 53' ' ' MET . 53.4 m -63.49 -42.16 98.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.269 -0.895 . . . . 0.0 109.02 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . . . -70.2 -38.59 75.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.579 -0.7 . . . . 0.0 109.541 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.543 ' O ' HG11 ' A' ' 82' ' ' VAL . 7.3 ttmt -62.82 -39.69 95.1 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.613 -0.679 . . . . 0.0 110.157 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -68.54 -38.56 80.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 0.0 109.738 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -70.81 -38.42 73.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 109.422 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.543 HG11 ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -68.77 -34.29 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.391 -0.818 . . . . 0.0 109.748 179.45 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -42.14 89.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.292 -0.88 . . . . 0.0 109.211 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.491 ' HB3' HG22 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -67.2 -39.06 86.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.565 -0.709 . . . . 0.0 109.195 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.85 -34.86 77.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.706 -0.621 . . . . 0.0 109.669 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.44 ' CE2' HG23 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -65.53 -39.57 91.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.673 -0.642 . . . . 0.0 109.316 178.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -64.83 -40.18 94.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.633 -0.667 . . . . 0.0 110.448 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -75.51 -54.09 7.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.419 -0.801 . . . . 0.0 110.297 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.01 53.98 0.08 OUTLIER Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.6 mt -118.83 -48.83 2.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.307 -1.113 . . . . 0.0 110.171 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.44 HG23 ' CE2' ' A' ' 86' ' ' PHE . 35.1 mm -88.9 75.77 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.365 -0.834 . . . . 0.0 109.706 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.627 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 19.6 t -73.9 175.91 6.89 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.431 -0.793 . . . . 0.0 110.287 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -67.2 -58.75 4.27 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.292 -0.88 . . . . 0.0 110.834 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -65.57 -39.76 92.03 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.415 -0.803 . . . . 0.0 110.08 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.627 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 0.7 OUTLIER -64.09 -39.6 94.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.635 -0.665 . . . . 0.0 109.69 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.44 80.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.503 -0.748 . . . . 0.0 109.328 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -63.25 -46.04 88.76 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -36.09 73.43 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.598 ' CZ3' HG11 ' A' ' 14' ' ' VAL . 50.7 t90 -62.76 -41.75 99.36 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.1 mt -73.53 -32.5 64.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.56 -0.712 . . . . 0.0 109.733 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.1 m -62.96 -48.1 80.35 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.415 -0.803 . . . . 0.0 109.647 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.165 179.415 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 14' ' ' VAL . 46.9 t -63.53 -39.76 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.609 -0.682 . . . . 0.0 109.486 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.471 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -63.88 -39.84 95.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.528 -0.732 . . . . 0.0 109.642 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.593 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . . . -63.5 -41.12 98.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.635 -0.666 . . . . 0.0 109.745 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.58 94.54 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.548 -0.72 . . . . 0.0 109.696 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 10' ' ' VAL . 79.2 t -64.38 -39.79 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.544 -0.723 . . . . 0.0 109.536 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.473 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -64.43 -39.62 94.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.397 -0.814 . . . . 0.0 109.749 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.39 -39.51 93.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.432 -0.793 . . . . 0.0 109.651 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.768 ' HD2' HD23 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -65.82 -31.24 72.09 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.543 -0.723 . . . . 0.0 110.068 179.297 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.546 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.2 mm -63.87 -43.42 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.431 -0.793 . . . . 0.0 109.651 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.689 HG22 ' HB1' ' A' ' 74' ' ' ALA . 54.6 t -68.02 -40.47 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.458 -0.776 . . . . 0.0 110.029 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.88 -25.26 75.4 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.22 36.33 4.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.321 -1.105 . . . . 0.0 110.939 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 23.8 t90 -102.95 137.76 40.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.18 -0.95 . . . . 0.0 110.984 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -168.57 1.67 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -46.34 -44.55 16.92 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.199 -0.938 . . . . 0.0 110.31 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.401 ' HB2' ' CG2' ' A' ' 37' ' ' THR . 12.9 pt-20 -158.64 36.48 0.23 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.537 -0.727 . . . . 0.0 110.619 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.29 151.13 31.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.198 -0.939 . . . . 0.0 110.584 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 t -152.69 175.48 12.78 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.473 -0.767 . . . . 0.0 109.625 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.95 126.4 31.97 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.334 -0.854 . . . . 0.0 110.379 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.546 ' HG ' HD11 ' A' ' 18' ' ' ILE . 2.8 mt -111.62 124.4 52.24 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.359 -0.838 . . . . 0.0 110.206 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.466 HD12 ' HB2' ' A' ' 99' ' ' TRP . 2.5 tp 56.71 29.81 16.48 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.647 -0.658 . . . . 0.0 111.175 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.03 -6.84 82.96 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -91.09 158.79 16.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.977 -1.308 . . . . 0.0 110.222 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -84.17 138.32 33.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.423 -0.798 . . . . 0.0 110.12 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.535 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 91.5 m -142.11 167.52 21.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.364 -0.835 . . . . 0.0 110.455 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -122.89 113.38 19.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.485 -0.76 . . . . 0.0 110.718 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 1.6 t80 -114.67 130.14 56.77 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -140.67 162.38 35.53 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.947 -1.096 . . . . 0.0 111.733 -178.709 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.26 152.68 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.86 -0.525 . . . . 0.0 109.875 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -157.17 102.42 1.9 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.11 -0.994 . . . . 0.0 110.388 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 C--N 1.313 -1.313 0 O-C-N 123.898 1.473 . . . . 0.0 111.101 -179.922 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.355 0.597 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.499 ' O ' HG21 ' A' ' 73' ' ' VAL . 0.3 OUTLIER -111.58 117.4 32.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.597 -0.689 . . . . 0.0 109.887 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.11 162.81 14.53 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.605 -0.684 . . . . 0.0 109.776 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.55 157.32 29.66 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.847 -1.168 . . . . 0.0 110.287 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.487 ' CD ' ' HB3' ' A' ' 64' ' ' GLU . 0.6 OUTLIER -153.91 141.26 19.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.698 -0.884 . . . . 0.0 109.854 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.575 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 2.8 ppp? -142.74 148.77 37.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.34 -0.85 . . . . 0.0 110.903 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.51 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 47.3 p90 -155.28 171.1 20.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.836 -0.54 . . . . 0.0 109.871 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 61.7 m -121.59 91.12 48.39 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 0.0 110.808 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.535 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 46.9 Cg_endo -76.9 83.93 2.02 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.939 1.494 . . . . 0.0 109.9 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.26 -47.23 0.49 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -73.29 -53.83 9.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.533 -0.98 . . . . 0.0 110.096 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.9 t -152.67 -160.9 1.2 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.531 -0.731 . . . . 0.0 109.963 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.7 68.95 0.97 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.285 -0.884 . . . . 0.0 110.345 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.446 HD12 HD12 ' A' ' 90' ' ' LEU . 41.1 mt -138.88 155.83 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.386 -0.822 . . . . 0.0 110.072 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.66 166.0 25.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.464 -0.772 . . . . 0.0 110.891 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.433 ' HA3' ' N ' ' A' ' 81' ' ' PHE . . . -159.53 128.77 2.07 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.487 ' HB3' ' CD ' ' A' ' 52' ' ' ARG . 1.4 pt-20 -137.66 165.33 26.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.596 -0.943 . . . . 0.0 110.897 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.564 ' HB1' ' CG ' ' A' ' 76' ' ' LYS . . . -158.53 161.08 37.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.716 -0.615 . . . . 0.0 110.632 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.5 m -143.4 151.63 40.62 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.465 -0.772 . . . . 0.0 110.282 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.0 t -174.6 -177.31 1.16 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.65 -0.657 . . . . 0.0 110.148 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -82.77 -31.77 28.13 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.258 -0.902 . . . . 0.0 110.125 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.91 146.92 53.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.352 -0.843 . . . . 0.0 110.353 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.493 ' O ' HG12 ' A' ' 73' ' ' VAL . 34.4 mt-30 -83.49 -54.78 4.71 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.516 -0.74 . . . . 0.0 110.316 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 m -75.26 -30.83 60.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.453 -0.78 . . . . 0.0 110.237 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.86 -39.7 94.25 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 49' ' ' TYR . 0.8 OUTLIER -63.32 -34.03 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.273 -1.134 . . . . 0.0 110.471 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.689 ' HB1' HG22 ' A' ' 19' ' ' VAL . . . -64.78 -47.4 78.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.518 -0.739 . . . . 0.0 109.869 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.79 -32.32 77.62 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.564 ' CG ' ' HB1' ' A' ' 65' ' ' ALA . 11.5 tptp -69.55 -40.9 76.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.599 -0.942 . . . . 0.0 110.224 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.535 HG22 ' HG2' ' A' ' 53' ' ' MET . 5.7 m -64.99 -41.04 95.76 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.471 -0.768 . . . . 0.0 109.919 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.525 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -70.37 -34.56 72.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.405 -0.809 . . . . 0.0 110.114 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.593 ' HE3' ' HA ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -67.36 -39.69 85.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 110.239 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.471 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 0.7 OUTLIER -67.09 -38.47 85.76 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.453 -0.78 . . . . 0.0 109.935 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.433 ' N ' ' HA3' ' A' ' 63' ' ' GLY . 39.6 t80 -67.18 -40.48 86.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.482 -0.761 . . . . 0.0 109.445 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.48 ' HA ' ' CD1' ' A' ' 91' ' ' ILE . 55.8 t -67.14 -36.83 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.44 -0.787 . . . . 0.0 109.829 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.471 ' NH1' ' HA ' ' A' ' 80' ' ' ASP . 4.1 ttp180 -65.26 -39.2 92.34 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.369 -0.832 . . . . 0.0 110.142 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -67.49 -39.91 85.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.276 -0.89 . . . . 0.0 110.04 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.819 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -73.59 -29.53 62.45 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.43 -0.794 . . . . 0.0 110.139 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 1.8 t80 -74.1 -37.69 64.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.488 -0.758 . . . . 0.0 110.295 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -37.08 84.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.362 -0.836 . . . . 0.0 110.234 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -73.96 -53.92 9.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.279 -0.888 . . . . 0.0 110.054 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.87 53.27 0.07 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' A' ' 90' ' ' LEU . 11.0 mt -122.31 -56.92 1.79 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.364 -1.08 . . . . 0.0 110.346 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.819 HD12 ' HB3' ' A' ' 85' ' ' ALA . 82.4 mt -77.72 109.6 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.33 -0.856 . . . . 0.0 109.911 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.6 m -93.8 167.19 11.8 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.357 -0.839 . . . . 0.0 110.286 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -48.5 70.39 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.492 -0.755 . . . . 0.0 110.424 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -63.56 -42.59 98.34 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.537 -0.727 . . . . 0.0 110.728 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.08 -43.59 98.5 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.416 -0.802 . . . . 0.0 110.245 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.32 87.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.584 -0.697 . . . . 0.0 109.94 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -67.34 -38.3 84.66 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.61 -0.682 . . . . 0.0 110.313 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.99 -38.78 86.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.343 -0.848 . . . . 0.0 109.652 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.578 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 15.4 t90 -66.06 -40.94 91.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.548 -0.72 . . . . 0.0 109.861 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.768 HD23 ' HD2' ' A' ' 17' ' ' LYS . 16.4 mt . . . . . 0 N--CA 1.498 1.969 0 O-C-N 121.603 -0.686 . . . . 0.0 110.148 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 14' ' ' VAL . 99.1 t -66.1 -40.83 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.05 -40.01 95.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.695 -0.628 . . . . 0.0 109.383 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.463 ' HA ' ' HG3' ' A' ' 79' ' ' LYS . . . -62.44 -41.32 98.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.71 -0.619 . . . . 0.0 109.486 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.93 97.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.617 -0.677 . . . . 0.0 109.55 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 10' ' ' VAL . 84.9 t -64.59 -41.37 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.541 -0.724 . . . . 0.0 109.237 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.18 -38.37 87.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.665 -0.647 . . . . 0.0 109.548 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.8 m -63.85 -39.03 93.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.575 -0.703 . . . . 0.0 109.698 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.46 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 17.4 tttm -66.01 -34.63 78.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.458 -0.776 . . . . 0.0 109.843 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.884 HD12 ' HB1' ' A' ' 78' ' ' ALA . 10.1 mt -65.07 -46.8 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.5 -0.75 . . . . 0.0 109.288 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.8 t -62.72 -40.18 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.656 -0.652 . . . . 0.0 109.965 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.49 -27.85 73.55 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.6 tp -115.75 38.47 3.29 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.405 -1.056 . . . . 0.0 110.725 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -101.81 137.68 39.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.241 -0.912 . . . . 0.0 110.458 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.98 -166.92 1.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.461 -0.774 . . . . 0.0 109.215 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -49.31 -41.53 38.68 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.185 -0.947 . . . . 0.0 110.442 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.7 33.81 0.19 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.615 -0.678 . . . . 0.0 110.609 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.23 153.57 37.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.199 -0.938 . . . . 0.0 110.849 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.5 t -155.56 151.78 28.0 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.392 -0.818 . . . . 0.0 109.876 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -105.61 121.27 43.63 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.179 -0.95 . . . . 0.0 110.782 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.608 HD21 HD11 ' A' ' 18' ' ' ILE . 1.3 mt -114.29 126.83 55.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.564 -0.71 . . . . 0.0 110.053 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.544 HD11 ' HG2' ' A' ' 95' ' ' GLU . 1.7 tp 54.17 33.7 18.54 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.649 -0.657 . . . . 0.0 111.016 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.09 23.94 74.88 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -123.14 145.01 48.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -1.093 . . . . 0.0 109.942 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 123.7 24.57 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.422 -0.799 . . . . 0.0 110.404 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.517 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 83.5 m -128.43 161.94 28.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.658 -0.651 . . . . 0.0 109.25 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.57 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -116.32 117.51 30.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.358 -0.839 . . . . 0.0 110.916 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.456 ' HE2' ' HB2' ' A' ' 78' ' ' ALA . 7.0 t80 -118.75 125.19 49.09 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.75 154.58 51.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.12 -0.988 . . . . 0.0 111.496 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.5 t -137.18 142.69 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.701 -0.625 . . . . 0.0 109.872 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.81 123.95 2.48 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.243 -0.911 . . . . 0.0 110.592 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HB3' ' CD2' ' A' ' 49' ' ' TYR . 51.2 Cg_endo . . . . . 0 C--N 1.313 -1.324 0 O-C-N 123.903 1.475 . . . . 0.0 110.954 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 121.465 0.65 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.486 ' CZ ' ' HG2' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -122.39 128.93 51.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 110.152 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -132.28 151.73 51.7 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.53 -0.732 . . . . 0.0 110.088 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.22 154.86 26.13 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.44 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.425 ' HD3' ' HB2' ' A' ' 64' ' ' GLU . 8.0 ttp180 -146.19 143.67 29.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.718 -0.872 . . . . 0.0 110.059 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.885 ' HG2' HG22 ' A' ' 77' ' ' THR . 0.4 OUTLIER -143.48 157.72 44.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.366 -0.834 . . . . 0.0 111.133 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.57 ' CE2' ' HB3' ' A' ' 35' ' ' LYS . 42.9 p90 -161.43 -175.47 4.81 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.726 -0.609 . . . . 0.0 109.773 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 58' ' ' TRP . 69.6 m -133.19 95.91 18.02 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.102 -0.999 . . . . 0.0 110.644 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.564 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.3 Cg_endo -74.32 77.97 2.75 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.991 1.522 . . . . 0.0 110.333 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.26 -45.52 0.66 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.522 ' HB3' ' HB3' ' A' ' 55' ' ' CYS . 15.3 t90 -68.65 -53.32 23.13 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.475 -1.015 . . . . 0.0 110.267 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.1 t -153.64 -168.56 3.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.553 -0.717 . . . . 0.0 109.754 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.22 45.96 1.89 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.322 -0.861 . . . . 0.0 110.447 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.3 mt -121.15 150.8 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.373 -0.829 . . . . 0.0 109.851 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 ptt-85 -131.15 163.16 28.29 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.284 -0.885 . . . . 0.0 110.834 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.85 155.55 23.26 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.425 ' HB2' ' HD3' ' A' ' 52' ' ' ARG . 6.7 tt0 -158.39 154.31 26.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -1.112 . . . . 0.0 110.508 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.664 ' HB1' ' HG2' ' A' ' 76' ' ' LYS . . . -166.19 152.97 9.43 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.52 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.422 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 3.6 m -139.08 150.77 46.12 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 110.594 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.502 HG22 HG23 ' A' ' 73' ' ' VAL . 10.0 t -172.71 164.63 5.34 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.705 -0.622 . . . . 0.0 109.994 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -63.29 -31.75 72.98 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.506 -0.746 . . . . 0.0 110.16 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.05 136.64 56.28 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.511 -0.743 . . . . 0.0 110.63 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.501 ' O ' HG12 ' A' ' 73' ' ' VAL . 12.1 mt-30 -77.17 -56.35 4.65 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.581 -0.699 . . . . 0.0 110.362 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 t -76.67 -31.44 57.29 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.312 -0.868 . . . . 0.0 110.037 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.91 -38.36 93.99 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.502 HG23 HG22 ' A' ' 67' ' ' THR . 0.8 OUTLIER -58.19 -35.76 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.456 -1.026 . . . . 0.0 110.577 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.16 84.29 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.561 -0.712 . . . . 0.0 109.809 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -64.4 -36.37 93.11 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.664 ' HG2' ' HB1' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -70.8 -39.02 73.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.384 -1.068 . . . . 0.0 110.274 179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.885 HG22 ' HG2' ' A' ' 53' ' ' MET . 18.7 m -66.52 -37.8 85.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.336 -0.852 . . . . 0.0 110.026 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.884 ' HB1' HD12 ' A' ' 18' ' ' ILE . . . -78.47 -35.49 46.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.525 -0.735 . . . . 0.0 110.232 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.463 ' HG3' ' HA ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -71.88 -38.7 69.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.386 -0.821 . . . . 0.0 109.651 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.6 -36.5 83.91 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.522 -0.737 . . . . 0.0 109.512 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -67.96 -39.89 83.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.711 . . . . 0.0 109.671 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 78' ' ' ALA . 72.5 t -66.41 -37.76 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.542 -0.724 . . . . 0.0 109.718 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -38.62 91.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.419 -0.8 . . . . 0.0 109.669 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -38.43 72.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.535 -0.728 . . . . 0.0 109.315 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.405 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -67.53 -34.92 78.07 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.539 -0.725 . . . . 0.0 109.799 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.08 -38.39 82.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 109.542 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -66.87 -39.3 87.49 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.496 -0.753 . . . . 0.0 110.342 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -72.96 -54.48 8.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.404 -0.81 . . . . 0.0 110.256 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.54 54.33 0.08 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.498 ' HA ' HD23 ' A' ' 90' ' ' LEU . 8.4 mt -121.17 -49.08 2.19 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -1.091 . . . . 0.0 110.494 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.405 HD12 ' HB3' ' A' ' 85' ' ' ALA . 95.8 mt -94.23 112.14 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.379 -0.826 . . . . 0.0 110.199 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 4.0 m -83.14 179.5 7.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.435 -0.79 . . . . 0.0 110.411 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -75.41 -60.23 2.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.337 -0.852 . . . . 0.0 110.245 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -63.08 -38.2 90.23 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.423 -0.798 . . . . 0.0 110.153 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 17.7 tt0 -55.09 -44.89 75.28 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.749 -0.594 . . . . 0.0 110.2 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.78 94.02 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.492 -0.755 . . . . 0.0 109.786 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.533 ' HA ' HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -65.41 -38.43 89.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.562 -0.711 . . . . 0.0 109.956 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -64.89 -40.89 95.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.803 . . . . 0.0 109.599 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.46 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 15.0 t90 -68.53 -39.27 81.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.448 -0.783 . . . . 0.0 109.155 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.533 HD12 ' HA ' ' A' ' 97' ' ' ASN . 24.9 mt . . . . . 0 N--CA 1.499 1.984 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.3 t -66.19 -39.45 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.445 -0.784 . . . . 0.0 109.11 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.695 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -66.46 -38.72 87.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.673 -0.642 . . . . 0.0 109.487 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.2 95.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.652 -0.655 . . . . 0.0 109.841 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.43 -41.57 98.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.459 -0.776 . . . . 0.0 109.648 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 10' ' ' VAL . 62.2 t -64.94 -39.2 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.448 -0.783 . . . . 0.0 109.241 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.38 -37.03 86.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.587 -0.696 . . . . 0.0 109.853 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -66.97 -39.28 87.19 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.476 -0.765 . . . . 0.0 109.58 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.553 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 16.6 tptt -66.44 -31.1 71.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.444 -0.785 . . . . 0.0 109.724 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.585 HG21 ' HB2' ' A' ' 78' ' ' ALA . 11.2 mm -62.56 -50.4 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.412 -0.805 . . . . 0.0 109.1 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.82 -37.75 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.722 . . . . 0.0 109.878 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.58 -27.72 73.64 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.41 36.41 4.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.262 -1.14 . . . . 0.0 110.805 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.476 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 23.6 t90 -102.75 135.36 44.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.133 -0.98 . . . . 0.0 110.943 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.12 -164.02 1.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -48.86 -45.91 41.54 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.075 -1.016 . . . . 0.0 109.891 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -156.77 34.14 0.3 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.712 -0.617 . . . . 0.0 110.45 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.83 150.07 41.16 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.1 -1.0 . . . . 0.0 111.154 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.542 HG23 ' CB ' ' A' ' 34' ' ' CYS . 2.1 t -151.7 165.66 33.71 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -128.95 115.36 17.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.094 -1.004 . . . . 0.0 110.411 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.509 HD12 ' SG ' ' A' ' 34' ' ' CYS . 3.7 mt -100.94 119.79 39.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.463 -0.773 . . . . 0.0 110.166 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' A' ' 99' ' ' TRP . 3.7 tp 56.67 30.45 17.52 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.743 -0.598 . . . . 0.0 111.127 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.63 -11.85 67.18 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 38.8 m80 -83.98 146.77 27.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.128 -1.219 . . . . 0.0 110.121 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -73.79 133.0 43.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.463 -0.773 . . . . 0.0 110.02 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.542 ' CB ' HG23 ' A' ' 27' ' ' THR . 15.2 m -136.08 171.28 14.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.553 -0.717 . . . . 0.0 110.042 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.524 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -132.9 120.42 21.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.475 -0.765 . . . . 0.0 110.339 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.453 ' HB2' HG21 ' A' ' 27' ' ' THR . 40.6 t80 -122.92 135.48 54.51 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.8 p -141.78 150.99 42.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.004 -1.06 . . . . 0.0 111.598 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.1 t -137.5 130.22 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -152.71 123.94 3.66 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.079 -1.013 . . . . 0.0 110.794 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.407 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 52.8 Cg_endo . . . . . 0 C--N 1.313 -1.331 0 O-C-N 123.871 1.459 . . . . 0.0 110.997 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.243 0.544 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.407 ' CD1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -114.71 133.07 56.17 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.442 -0.786 . . . . 0.0 109.918 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -142.27 148.63 38.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.494 -0.754 . . . . 0.0 110.366 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -143.53 153.61 24.98 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -145.25 150.53 36.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.764 -0.845 . . . . 0.0 110.112 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.442 ' HB3' ' CD2' ' A' ' 36' ' ' PHE . 22.4 ptm -144.19 153.45 42.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.244 -0.91 . . . . 0.0 110.977 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.524 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 41.6 p90 -152.83 146.4 25.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.782 -0.574 . . . . 0.0 110.288 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 67.2 m -116.29 90.53 29.78 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.231 -0.918 . . . . 0.0 111.1 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -79.22 82.02 2.63 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.87 1.458 . . . . 0.0 110.266 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.89 -46.81 0.48 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 13.9 t90 -70.49 -53.5 16.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.623 -0.928 . . . . 0.0 109.912 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.45 HG21 ' CD1' ' A' ' 90' ' ' LEU . 7.4 t -158.82 -160.7 0.89 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.748 -0.595 . . . . 0.0 109.888 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.19 46.5 1.78 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.342 -0.849 . . . . 0.0 109.931 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.429 HD12 HD12 ' A' ' 90' ' ' LEU . 59.7 mt -122.45 144.68 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.512 -0.742 . . . . 0.0 109.882 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.49 170.96 13.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.304 -0.872 . . . . 0.0 110.92 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.11 156.55 26.99 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.511 ' HG2' ' N ' ' A' ' 65' ' ' ALA . 14.4 tt0 -163.17 154.66 17.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.516 -0.99 . . . . 0.0 109.996 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.561 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -168.56 155.0 7.12 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.031 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.569 ' HA ' HG23 ' A' ' 73' ' ' VAL . 7.0 m -137.02 153.29 50.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.614 -0.679 . . . . 0.0 110.382 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -175.16 159.18 2.53 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.592 -0.693 . . . . 0.0 110.49 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -36.36 71.31 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.661 -0.649 . . . . 0.0 111.332 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.59 142.95 57.91 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.326 -0.859 . . . . 0.0 110.904 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.439 ' O ' HG12 ' A' ' 73' ' ' VAL . 0.9 OUTLIER -77.82 -49.03 15.12 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.618 -0.676 . . . . 0.0 109.986 179.601 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.9 m -82.41 -29.38 30.82 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.479 -0.763 . . . . 0.0 109.744 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.02 -38.71 94.66 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' A' ' 66' ' ' SER . 0.8 OUTLIER -60.59 -36.65 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.395 -1.062 . . . . 0.0 110.307 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.61 -38.59 77.33 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.55 -0.719 . . . . 0.0 109.739 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.72 -32.52 78.28 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.561 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 42.6 mtpt -72.75 -40.12 66.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.473 -1.016 . . . . 0.0 110.065 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.1 m -66.44 -38.41 87.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -0.975 . . . . 0.0 109.657 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.585 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -75.08 -37.69 61.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.6 -0.687 . . . . 0.0 110.333 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.6 -39.19 73.95 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.357 -0.84 . . . . 0.0 109.715 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -65.75 -36.25 83.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.681 -0.637 . . . . 0.0 109.715 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -68.84 -40.19 79.54 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 0.0 109.266 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.695 HG11 ' HA ' ' A' ' 11' ' ' ALA . 54.6 t -65.71 -38.9 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.549 -0.719 . . . . 0.0 109.968 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -64.78 -40.29 95.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.509 -0.744 . . . . 0.0 109.949 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -67.63 -39.37 84.66 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.416 -0.803 . . . . 0.0 109.619 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.565 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -70.52 -35.64 73.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.596 -0.69 . . . . 0.0 109.659 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -40.68 95.8 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.606 -0.684 . . . . 0.0 109.706 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.41 -35.9 78.32 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.562 -0.711 . . . . 0.0 110.456 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -74.56 -52.49 11.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.304 -0.873 . . . . 0.0 110.203 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.94 52.49 0.11 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 90' ' ' LEU . 11.8 mt -122.98 -49.93 1.95 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.394 -1.062 . . . . 0.0 110.293 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.565 HD12 ' HB3' ' A' ' 85' ' ' ALA . 89.5 mt -86.24 81.24 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.345 -0.847 . . . . 0.0 109.505 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -64.71 153.67 38.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 109.181 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -56.47 -47.81 78.43 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.529 -0.732 . . . . 0.0 110.281 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.43 -41.11 76.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.46 -0.775 . . . . 0.0 110.476 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.8 OUTLIER -63.03 -40.57 98.14 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.492 -0.755 . . . . 0.0 110.101 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.33 -43.29 92.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.591 -0.693 . . . . 0.0 109.872 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -65.42 -39.11 91.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.544 -0.723 . . . . 0.0 109.452 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -42.36 95.05 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.715 -0.616 . . . . 0.0 109.738 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.553 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 24.1 t90 -67.51 -39.48 85.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.503 -0.748 . . . . 0.0 109.444 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.2 mt . . . . . 0 N--CA 1.499 2.001 0 O-C-N 121.714 -0.616 . . . . 0.0 109.804 179.283 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.915 0.388 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.644 HG21 ' HG2' ' A' ' 93' ' ' GLN . 85.9 t -66.04 -39.63 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.466 -0.771 . . . . 0.0 109.517 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.569 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -64.69 -39.29 93.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.467 -0.771 . . . . 0.0 109.904 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.68 -38.84 87.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.61 -0.681 . . . . 0.0 109.739 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.01 96.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.586 -0.697 . . . . 0.0 109.783 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 10' ' ' VAL . 77.7 t -62.69 -41.68 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.426 -0.796 . . . . 0.0 109.043 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.57 -39.45 93.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.498 -0.752 . . . . 0.0 109.612 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 54.4 m -61.7 -41.31 97.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.557 -0.715 . . . . 0.0 109.658 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.613 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 6.4 tptm -67.37 -31.21 71.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.428 -0.795 . . . . 0.0 109.765 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.638 HG21 ' HB2' ' A' ' 78' ' ' ALA . 4.8 mm -63.27 -47.26 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.395 -0.816 . . . . 0.0 109.617 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.4 t -63.62 -38.71 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.45 -0.781 . . . . 0.0 109.852 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.75 -26.89 71.88 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 tp -113.8 32.62 5.71 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.239 -1.154 . . . . 0.0 111.448 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 18.4 t90 -94.2 131.6 39.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.952 -1.092 . . . . 0.0 110.197 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.13 -172.73 2.41 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -43.53 -39.84 3.63 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.229 -0.92 . . . . 0.0 110.609 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.431 ' HB2' ' CG2' ' A' ' 37' ' ' THR . 12.4 pt-20 -164.67 37.19 0.07 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.401 0.62 . . . . 0.0 109.781 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -150.77 161.23 43.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.492 -0.755 . . . . 0.0 110.721 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.568 HG23 ' HB2' ' A' ' 34' ' ' CYS . 14.5 t -156.89 151.45 25.53 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.358 -0.838 . . . . 0.0 109.868 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.58 110.59 22.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.43 -0.794 . . . . 0.0 109.832 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.619 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 2.4 mt -105.21 123.8 48.46 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.255 -0.903 . . . . 0.0 110.559 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.736 HD11 ' HG3' ' A' ' 95' ' ' GLU . 2.8 tp 55.1 34.72 23.18 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.648 -0.657 . . . . 0.0 110.862 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.81 7.54 87.37 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -106.1 160.48 15.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.089 -1.242 . . . . 0.0 110.025 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.79 125.79 34.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.378 -0.826 . . . . 0.0 110.198 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.659 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 84.9 m -130.77 168.21 17.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.426 -0.796 . . . . 0.0 110.261 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.403 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 9.2 tttm -123.55 115.05 20.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.397 -0.814 . . . . 0.0 111.378 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 1.3 t80 -115.49 122.34 45.43 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 25' ' ' GLU . 1.9 p -140.46 158.3 44.21 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.985 -1.072 . . . . 0.0 112.203 -178.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 8.7 p -129.31 147.08 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.813 -0.554 . . . . 0.0 109.865 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.84 110.75 2.71 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.085 -1.009 . . . . 0.0 110.711 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.315 -1.227 0 O-C-N 123.815 1.429 . . . . 0.0 110.697 179.683 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 121.293 0.568 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.519 ' CD2' ' HA ' ' A' ' 70' ' ' GLN . 0.3 OUTLIER -128.92 142.97 50.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.301 -0.874 . . . . 0.0 110.582 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -154.11 151.04 28.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -0.827 . . . . 0.0 110.216 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -148.25 150.05 22.18 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.509 ' CG ' ' HB3' ' A' ' 64' ' ' GLU . 8.9 ttp180 -143.04 144.93 32.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.68 -0.894 . . . . 0.0 110.256 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.614 ' HG2' HG22 ' A' ' 77' ' ' THR . 2.3 ppp? -144.04 147.1 33.38 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.436 -0.79 . . . . 0.0 110.818 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.607 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 49.2 p90 -154.29 -168.9 3.08 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.797 -0.564 . . . . 0.0 110.113 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.3 m -134.15 92.79 20.85 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.857 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.659 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 47.9 Cg_endo -72.91 80.91 1.72 Allowed 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 123.86 1.453 . . . . 0.0 110.083 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.06 -43.24 0.79 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 55' ' ' CYS . 18.5 t90 -74.34 -52.88 10.89 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.524 -0.986 . . . . 0.0 110.425 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.437 HG21 ' CD1' ' A' ' 90' ' ' LEU . 7.9 t -153.72 -168.14 2.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.535 -0.728 . . . . 0.0 110.007 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.55 45.3 2.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.439 -0.788 . . . . 0.0 110.39 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.579 HD12 HD12 ' A' ' 90' ' ' LEU . 69.4 mt -117.86 156.85 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.394 -0.816 . . . . 0.0 109.466 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.78 165.99 27.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.287 -0.883 . . . . 0.0 111.339 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.55 127.36 2.29 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.509 ' HB3' ' CG ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -144.87 160.62 41.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.8 -0.824 . . . . 0.0 110.634 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.57 163.84 38.8 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.649 -0.657 . . . . 0.0 110.904 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.62 141.95 35.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.516 -0.74 . . . . 0.0 110.193 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.457 HG22 HG23 ' A' ' 73' ' ' VAL . 8.8 t -173.07 170.22 4.45 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.504 -0.748 . . . . 0.0 110.396 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.499 ' HG3' ' N ' ' A' ' 69' ' ' SER . 2.2 ptm85 -64.67 -35.09 79.92 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.438 -0.789 . . . . 0.0 110.249 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.499 ' N ' ' HG3' ' A' ' 68' ' ' ARG . 3.4 m -58.78 153.73 16.29 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.377 0.608 . . . . 0.0 110.754 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.519 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 45.2 mt-30 -101.17 -60.74 1.47 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.802 -0.561 . . . . 0.0 110.088 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -29.91 61.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.285 -0.885 . . . . 0.0 110.398 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.61 -38.75 96.37 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.457 HG23 HG22 ' A' ' 67' ' ' THR . 0.4 OUTLIER -63.54 -34.93 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.429 -1.042 . . . . 0.0 110.434 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.76 -45.75 85.07 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.355 -0.841 . . . . 0.0 109.482 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.36 -37.65 94.96 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -69.75 -38.76 76.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.609 -0.936 . . . . 0.0 109.64 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.614 HG22 ' HG2' ' A' ' 53' ' ' MET . 15.5 m -55.98 -44.47 78.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.326 -0.859 . . . . 0.0 109.245 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.638 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -70.35 -38.93 74.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.681 -0.637 . . . . 0.0 109.748 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -39.23 84.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.683 . . . . 0.0 110.039 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 0.7 OUTLIER -67.03 -31.14 71.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.599 -0.688 . . . . 0.0 110.185 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.4 ' CD2' ' SD ' ' A' ' 53' ' ' MET . 54.5 t80 -80.74 -36.52 31.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.045 -1.034 . . . . 0.0 109.046 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 11' ' ' ALA . 46.3 t -68.05 -38.4 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.671 -0.643 . . . . 0.0 110.246 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 2.6 ptm85 -67.45 -39.19 85.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.266 -0.896 . . . . 0.0 109.557 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.417 ' N ' ' HG3' ' A' ' 83' ' ' ARG . 0.7 OUTLIER -65.91 -40.54 91.58 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.496 -0.753 . . . . 0.0 109.268 178.721 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.562 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -70.0 -32.45 70.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.644 -0.66 . . . . 0.0 109.373 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.98 -41.99 94.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.623 -0.673 . . . . 0.0 109.238 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -67.92 -37.61 81.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.521 -0.737 . . . . 0.0 110.159 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.419 ' CD ' HD11 ' A' ' 61' ' ' ILE . 1.7 mmpp? -70.89 -51.93 23.27 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.374 -0.829 . . . . 0.0 110.382 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.96 49.45 0.17 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.579 HD12 HD12 ' A' ' 61' ' ' ILE . 13.0 mt -121.33 -48.59 2.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.289 -1.124 . . . . 0.0 110.405 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.562 HD12 ' HB3' ' A' ' 85' ' ' ALA . 81.6 mt -99.53 77.76 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.458 -0.776 . . . . 0.0 109.244 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.0 p -76.26 -176.8 3.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.496 -0.753 . . . . 0.0 110.353 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.644 ' HG2' HG21 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -69.59 -53.1 20.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.43 -0.794 . . . . 0.0 110.563 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.9 -42.53 97.4 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.416 -0.802 . . . . 0.0 110.96 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.736 ' HG3' HD11 ' A' ' 30' ' ' LEU . 1.7 tp10 -66.54 -38.5 87.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.267 -0.895 . . . . 0.0 110.219 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.2 -39.88 86.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.397 -0.815 . . . . 0.0 109.498 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -65.72 -39.03 90.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.596 -0.69 . . . . 0.0 109.955 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -61.56 -42.77 99.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.569 -0.707 . . . . 0.0 109.439 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.613 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 20.8 t90 -67.85 -38.61 83.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.473 -0.767 . . . . 0.0 109.641 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.583 HD23 ' HD3' ' A' ' 17' ' ' LYS . 50.6 mt . . . . . 0 N--CA 1.495 1.795 0 O-C-N 121.693 -0.629 . . . . 0.0 110.193 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 14' ' ' VAL . 84.5 t -64.15 -43.16 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.461 -0.775 . . . . 0.0 109.217 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.512 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -65.08 -39.5 93.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.509 -0.744 . . . . 0.0 109.3 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.41 -40.75 98.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.688 -0.632 . . . . 0.0 109.792 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.29 96.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.407 -0.808 . . . . 0.0 109.668 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 10' ' ' VAL . 91.2 t -64.11 -40.46 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.504 -0.748 . . . . 0.0 109.348 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.21 -40.14 96.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.584 -0.698 . . . . 0.0 110.127 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 t -65.04 -38.95 92.53 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.371 -0.831 . . . . 0.0 109.706 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.517 ' HD2' HD22 ' A' ' 100' ' ' LEU . 3.5 ttmm -65.98 -32.38 73.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.502 -0.749 . . . . 0.0 109.951 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.756 HD11 ' HG ' ' A' ' 29' ' ' LEU . 3.3 mm -62.82 -48.26 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.598 -0.688 . . . . 0.0 109.981 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.15 -38.92 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.399 -0.813 . . . . 0.0 109.833 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.84 -31.22 75.25 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.44 36.78 3.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.287 -1.125 . . . . 0.0 110.796 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.552 ' HH2' HG12 ' A' ' 38' ' ' VAL . 25.7 t90 -100.51 138.52 37.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 110.668 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -97.71 -169.66 1.87 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -43.14 -42.95 4.33 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.663 -0.648 . . . . 0.0 110.255 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -162.66 38.84 0.11 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.636 -0.665 . . . . 0.0 110.39 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -157.67 140.34 14.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.252 -0.905 . . . . 0.0 110.699 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.473 HG21 HD12 ' A' ' 18' ' ' ILE . 10.0 t -147.65 159.45 43.77 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.411 -0.806 . . . . 0.0 109.823 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -100.16 143.18 30.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.431 -0.793 . . . . 0.0 110.513 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.756 ' HG ' HD11 ' A' ' 18' ' ' ILE . 7.1 mt -126.34 113.21 16.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.537 -0.727 . . . . 0.0 109.43 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' ' 99' ' ' TRP . 4.6 tp 59.36 27.06 16.05 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.69 -0.631 . . . . 0.0 110.635 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.46 -15.7 62.34 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.0 m80 -87.59 153.31 21.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.986 -1.302 . . . . 0.0 110.337 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -83.95 137.56 33.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.387 -0.82 . . . . 0.0 109.751 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 29' ' ' LEU . 96.3 m -138.01 170.91 15.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.89 . . . . 0.0 111.251 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -122.3 104.5 9.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.677 -0.64 . . . . 0.0 110.025 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.53 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 3.2 t80 -109.9 132.74 53.88 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.1 p -140.8 153.98 46.05 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.099 -1.001 . . . . 0.0 111.367 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.552 HG12 ' HH2' ' A' ' 22' ' ' TRP . 4.9 p -141.53 143.85 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.663 -0.648 . . . . 0.0 109.953 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.45 128.24 6.1 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.161 -0.962 . . . . 0.0 111.235 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.542 ' HB3' ' CE1' ' A' ' 49' ' ' TYR . 49.0 Cg_endo . . . . . 0 C--N 1.314 -1.256 0 O-C-N 123.88 1.463 . . . . 0.0 110.227 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.158 0.504 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.542 ' CE1' ' HB3' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -92.95 151.7 19.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.595 -0.691 . . . . 0.0 109.99 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -149.3 149.09 30.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.395 -0.816 . . . . 0.0 110.181 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.15 161.53 29.13 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.59 137.17 13.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.782 -0.834 . . . . 0.0 109.75 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.555 ' HG2' HG22 ' A' ' 77' ' ' THR . 1.4 ppp? -136.73 152.1 49.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.264 -0.898 . . . . 0.0 111.144 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.487 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 49.4 p90 -159.58 154.29 24.42 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.744 -0.598 . . . . 0.0 110.183 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 69.3 m -112.33 91.53 16.68 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.183 -0.948 . . . . 0.0 110.56 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.487 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 48.0 Cg_endo -76.11 91.79 1.09 Allowed 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.807 1.425 . . . . 0.0 110.217 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.46 -48.36 0.58 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.516 ' CZ2' HD22 ' A' ' 90' ' ' LEU . 25.6 t90 -76.26 -53.5 8.14 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.404 -1.056 . . . . 0.0 110.376 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 t -145.46 -170.01 3.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.581 -0.699 . . . . 0.0 109.991 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.62 60.54 0.8 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.449 -0.782 . . . . 0.0 109.887 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.7 mt -128.12 155.08 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.481 -0.762 . . . . 0.0 109.845 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.43 160.29 39.53 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.415 -0.803 . . . . 0.0 110.492 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 135.75 7.26 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -136.2 151.82 50.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.554 -0.968 . . . . 0.0 110.112 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.66 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -163.13 135.57 5.36 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.388 -0.82 . . . . 0.0 110.56 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.575 ' HA ' HG23 ' A' ' 73' ' ' VAL . 1.1 m -136.71 142.65 43.12 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.546 -0.721 . . . . 0.0 110.37 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.8 t -167.44 177.48 5.98 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.573 -0.704 . . . . 0.0 110.142 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -31.32 67.74 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.33 -0.856 . . . . 0.0 110.66 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.74 143.15 58.07 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.427 -0.795 . . . . 0.0 110.916 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.543 ' O ' HG12 ' A' ' 73' ' ' VAL . 38.4 mt-30 -80.65 -50.71 9.59 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.637 -0.665 . . . . 0.0 110.408 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m -86.36 -29.3 23.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.386 -0.822 . . . . 0.0 109.914 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.06 -38.97 95.1 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.575 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.7 p -62.3 -36.83 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.407 -1.055 . . . . 0.0 110.297 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.426 ' HB1' ' HZ ' ' A' ' 36' ' ' PHE . . . -68.8 -44.84 72.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.55 -0.719 . . . . 0.0 109.768 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.31 -35.74 92.06 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.66 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 15.4 mmtt -69.76 -38.72 76.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.473 -1.016 . . . . 0.0 109.942 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.555 HG22 ' HG2' ' A' ' 53' ' ' MET . 3.4 m -60.25 -44.91 94.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.501 -0.749 . . . . 0.0 109.498 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.459 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -69.91 -36.31 75.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.555 -0.716 . . . . 0.0 109.865 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -39.76 86.88 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.463 -0.773 . . . . 0.0 109.876 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.16 -40.9 98.89 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.475 -0.766 . . . . 0.0 110.086 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -69.33 -41.13 77.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.336 -0.853 . . . . 0.0 109.343 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 11' ' ' ALA . 49.8 t -66.04 -38.14 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.566 -0.708 . . . . 0.0 109.591 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -38.79 87.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.514 -0.741 . . . . 0.0 109.708 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -39.27 91.22 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.386 -0.821 . . . . 0.0 109.853 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.641 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -69.82 -35.51 74.86 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.589 -0.694 . . . . 0.0 109.464 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -41.9 99.61 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.678 -0.639 . . . . 0.0 109.634 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -67.84 -36.97 81.29 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.499 -0.75 . . . . 0.0 110.332 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -73.49 -55.43 6.35 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.37 -0.831 . . . . 0.0 110.453 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.04 52.36 0.08 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.516 HD22 ' CZ2' ' A' ' 58' ' ' TRP . 9.7 mt -122.95 -49.83 1.96 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.377 -1.072 . . . . 0.0 110.259 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.641 HD12 ' HB3' ' A' ' 85' ' ' ALA . 96.3 mt -97.09 101.59 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.538 -0.726 . . . . 0.0 109.55 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.614 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 32.4 m -78.23 173.78 11.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.475 -0.766 . . . . 0.0 109.965 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -71.16 -53.08 15.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.605 -0.684 . . . . 0.0 109.925 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -65.09 -29.52 70.39 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.478 -0.764 . . . . 0.0 110.57 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.0 OUTLIER -67.99 -43.5 78.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.267 -0.896 . . . . 0.0 109.821 179.377 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.406 ' O ' HD23 ' A' ' 100' ' ' LEU . . . -61.29 -40.64 94.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.609 -0.682 . . . . 0.0 109.168 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -62.46 -38.98 91.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.641 -0.662 . . . . 0.0 109.763 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -40.16 94.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.572 -0.705 . . . . 0.0 109.697 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.513 ' HB2' HD12 ' A' ' 30' ' ' LEU . 15.6 t90 -71.08 -36.05 72.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.315 -0.865 . . . . 0.0 109.889 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.517 HD22 ' HD2' ' A' ' 17' ' ' LYS . 3.4 mm? . . . . . 0 N--CA 1.499 1.982 0 O-C-N 121.71 -0.619 . . . . 0.0 110.697 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 14' ' ' VAL . 95.1 t -66.08 -40.87 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.521 -0.737 . . . . 0.0 109.185 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.42 -39.76 95.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.593 -0.692 . . . . 0.0 109.533 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.74 -41.38 99.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.684 -0.635 . . . . 0.0 109.806 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.3 -39.3 94.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.474 -0.766 . . . . 0.0 109.827 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.643 ' CG2' ' HB1' ' A' ' 96' ' ' ALA . 61.2 t -66.04 -39.93 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.425 -0.797 . . . . 0.0 109.105 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.576 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -64.06 -38.43 91.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.466 -0.771 . . . . 0.0 109.636 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.6 m -63.96 -41.31 97.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.51 -0.743 . . . . 0.0 109.595 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.602 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 1.9 ttmt -63.74 -32.8 74.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.547 -0.721 . . . . 0.0 109.898 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.6 HG21 ' HB2' ' A' ' 78' ' ' ALA . 5.1 mm -62.25 -48.13 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -0.875 . . . . 0.0 109.071 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.49 -40.4 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.71 -0.619 . . . . 0.0 109.429 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.79 -32.18 83.29 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.484 HD23 ' HB2' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -109.38 35.39 3.32 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.45 -1.029 . . . . 0.0 110.612 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.403 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 25.0 t90 -103.98 132.98 49.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.133 -0.979 . . . . 0.0 111.01 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.34 -163.85 1.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -45.78 -45.64 14.83 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.255 -0.903 . . . . 0.0 110.587 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.435 ' HB2' ' CG2' ' A' ' 37' ' ' THR . 6.6 pt-20 -157.75 35.9 0.26 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.679 -0.638 . . . . 0.0 110.5 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.41 151.88 38.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.311 -0.868 . . . . 0.0 110.668 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.447 HG23 ' HB2' ' A' ' 34' ' ' CYS . 7.9 t -153.77 172.9 16.6 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.308 -0.87 . . . . 0.0 109.866 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.484 ' HB2' HD23 ' A' ' 21' ' ' LEU . 3.9 mp0 -124.43 143.34 50.68 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.245 -0.909 . . . . 0.0 110.228 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.746 HD12 ' SG ' ' A' ' 55' ' ' CYS . 10.0 mt -127.44 113.6 16.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 109.457 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 99' ' ' TRP . 1.0 OUTLIER 57.01 27.26 12.98 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.765 -0.584 . . . . 0.0 110.735 -179.244 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.84 -16.9 60.21 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -80.97 149.89 29.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.171 -1.193 . . . . 0.0 110.444 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -79.41 139.91 37.56 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.74 . . . . 0.0 109.822 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 81.4 m -139.96 166.37 24.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.515 -0.741 . . . . 0.0 110.726 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -122.15 101.09 7.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.404 -0.81 . . . . 0.0 109.835 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.583 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 4.3 t80 -108.37 131.13 55.07 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.435 ' CG2' ' HB2' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -134.75 157.16 47.43 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.302 -0.874 . . . . 0.0 111.015 -179.078 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.403 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 87.1 t -129.36 129.32 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.568 -0.707 . . . . 0.0 109.635 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -144.06 101.23 4.89 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.367 -0.833 . . . . 0.0 110.425 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.507 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 54.1 Cg_endo . . . . . 0 C--N 1.313 -1.292 0 O-C-N 123.81 1.426 . . . . 0.0 110.585 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.16 0.505 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.507 ' CD1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -96.14 157.17 16.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -0.877 . . . . 0.0 110.111 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.48 ' HG3' ' N ' ' A' ' 51' ' ' GLY . 2.1 tttt -156.6 150.17 24.59 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.254 -0.904 . . . . 0.0 109.9 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.48 ' N ' ' HG3' ' A' ' 50' ' ' LYS . . . -149.59 147.67 18.22 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.45 138.64 34.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.67 -0.9 . . . . 0.0 109.836 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.583 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 3.0 ppp? -137.95 157.73 45.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.344 -0.848 . . . . 0.0 111.25 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.427 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 49.0 p90 -160.88 145.88 14.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.844 -0.535 . . . . 0.0 109.951 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.746 ' SG ' HD12 ' A' ' 29' ' ' LEU . 76.6 m -112.49 91.2 16.21 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.261 -0.899 . . . . 0.0 110.871 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.427 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 48.3 Cg_endo -75.71 85.81 1.57 Allowed 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.78 1.411 . . . . 0.0 110.056 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.42 -50.3 0.29 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -78.16 -43.71 27.95 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.537 -0.978 . . . . 0.0 109.76 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.419 ' HB ' HD11 ' A' ' 90' ' ' LEU . 10.1 t -153.67 -173.85 4.73 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.278 0.561 . . . . 0.0 109.733 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.46 49.04 1.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.569 -0.707 . . . . 0.0 109.62 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.4 mt -119.02 155.99 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.473 -0.767 . . . . 0.0 110.009 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.19 160.16 38.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.447 -0.783 . . . . 0.0 110.438 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.23 148.27 19.89 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 0.9 OUTLIER -151.13 157.07 42.25 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.551 -0.97 . . . . 0.0 110.269 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.443 ' HB1' ' CG ' ' A' ' 76' ' ' LYS . . . -159.75 146.75 16.51 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.699 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.511 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -140.1 141.74 36.12 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.469 -0.769 . . . . 0.0 110.812 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.605 HG22 HG23 ' A' ' 73' ' ' VAL . 9.3 t -169.16 176.9 5.05 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.6 -0.688 . . . . 0.0 110.341 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.5 mtm-85 -73.14 -35.29 66.47 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.389 -0.82 . . . . 0.0 110.261 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.85 136.92 58.15 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.497 -0.752 . . . . 0.0 110.127 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.409 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 1.0 OUTLIER -74.31 -59.11 2.88 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.584 -0.697 . . . . 0.0 110.406 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -79.17 -28.83 42.77 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.308 -0.87 . . . . 0.0 110.05 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.62 -38.14 90.83 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.605 HG23 HG22 ' A' ' 67' ' ' THR . 0.5 OUTLIER -62.07 -38.11 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.437 -1.037 . . . . 0.0 110.379 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HA ' ' HZ ' ' A' ' 36' ' ' PHE . . . -66.81 -44.5 81.02 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.524 -0.735 . . . . 0.0 109.655 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.65 -37.78 95.25 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.443 ' CG ' ' HB1' ' A' ' 65' ' ' ALA . 0.1 OUTLIER -63.3 -40.1 96.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.589 -0.948 . . . . 0.0 110.282 179.559 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.9 m -63.44 -43.91 96.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.83 . . . . 0.0 109.149 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.6 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -66.27 -39.08 89.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.602 -0.686 . . . . 0.0 109.64 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.98 -38.96 89.89 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.34 -0.85 . . . . 0.0 109.96 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.518 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 2.8 m-20 -68.87 -29.8 68.17 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.461 -0.774 . . . . 0.0 110.172 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -78.38 -33.73 48.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.225 -0.922 . . . . 0.0 109.864 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 78' ' ' ALA . 65.4 t -70.43 -38.5 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 110.476 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -70.23 -36.42 74.52 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.271 -0.893 . . . . 0.0 109.793 179.529 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.46 -40.83 93.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.6 -0.688 . . . . 0.0 109.335 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.719 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -69.78 -32.88 71.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.618 -0.676 . . . . 0.0 109.379 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.3 -41.1 97.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.55 -0.719 . . . . 0.0 109.513 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -65.38 -36.58 84.4 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.661 -0.649 . . . . 0.0 110.538 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -79.72 -54.13 6.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.195 -0.941 . . . . 0.0 110.28 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.72 53.72 0.07 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' A' ' 90' ' ' LEU . 11.1 mt -123.56 -47.78 1.96 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.375 -1.074 . . . . 0.0 110.645 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.719 HD12 ' HB3' ' A' ' 85' ' ' ALA . 80.7 mt -105.2 98.84 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.235 -0.916 . . . . 0.0 109.555 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 4.9 t -78.49 -177.06 5.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.443 -0.785 . . . . 0.0 110.556 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -70.76 -59.82 2.59 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.519 -0.738 . . . . 0.0 110.472 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -63.73 -34.67 78.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.391 -0.818 . . . . 0.0 110.63 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 1.9 mt-10 -58.79 -42.93 90.19 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.489 -0.757 . . . . 0.0 110.278 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.643 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -63.09 -39.13 93.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.448 -0.783 . . . . 0.0 109.809 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -36.81 78.05 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.498 -0.751 . . . . 0.0 109.677 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -62.86 -42.83 99.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.522 -0.736 . . . . 0.0 109.379 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.675 ' HB2' HD12 ' A' ' 30' ' ' LEU . 25.3 t90 -63.97 -41.93 97.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.462 -0.774 . . . . 0.0 109.153 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HA ' ' CE ' ' A' ' 17' ' ' LYS . 12.9 mt . . . . . 0 N--CA 1.499 2.0 0 O-C-N 121.763 -0.586 . . . . 0.0 110.155 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.598 HG11 ' HA ' ' A' ' 93' ' ' GLN . 78.2 t -68.82 -38.68 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.544 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -63.66 -46.19 86.73 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.481 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . . . -52.05 -45.11 64.56 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.744 -0.597 . . . . 0.0 109.959 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.09 90.51 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.561 -0.712 . . . . 0.0 109.391 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 10' ' ' VAL . 89.0 t -61.14 -44.25 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.589 -0.695 . . . . 0.0 109.324 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.958 ' HB2' ' HE2' ' A' ' 79' ' ' LYS . . . -58.29 -43.2 87.92 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.599 -0.688 . . . . 0.0 109.999 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.2 m -59.24 -41.8 89.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.65 -0.656 . . . . 0.0 109.484 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.638 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 1.3 tpmp? -69.74 -32.5 71.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.627 -0.671 . . . . 0.0 110.059 179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 22' ' ' TRP . 5.4 mt -72.26 -46.77 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.401 -0.812 . . . . 0.0 109.811 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.6 t -68.13 -39.03 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.395 -0.816 . . . . 0.0 110.04 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.28 -16.41 75.32 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.47 24.06 6.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.978 -1.307 . . . . 0.0 111.452 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.437 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 22.7 t90 -92.03 135.58 33.85 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.886 -1.134 . . . . 0.0 110.337 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.67 -167.19 1.46 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.534 -0.729 . . . . 0.0 109.449 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -49.77 -41.76 44.93 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.231 -0.918 . . . . 0.0 110.615 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.45 37.73 0.24 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.574 -0.704 . . . . 0.0 110.456 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -146.75 147.53 31.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.32 -0.863 . . . . 0.0 110.72 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.547 HG21 ' HB2' ' A' ' 36' ' ' PHE . 8.2 t -156.7 155.52 31.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.462 -0.774 . . . . 0.0 109.643 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -111.68 149.83 31.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.173 -0.954 . . . . 0.0 110.168 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.423 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 6.7 mt -143.28 123.85 14.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.371 -0.831 . . . . 0.0 110.022 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.453 HD12 ' HB2' ' A' ' 99' ' ' TRP . 1.7 tp 53.07 35.06 18.6 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.673 -0.642 . . . . 0.0 111.22 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.39 26.88 62.61 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -125.91 163.5 22.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -1.163 . . . . 0.0 109.996 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.0 130.4 36.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.458 -0.776 . . . . 0.0 109.893 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.6 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 68.2 m -134.08 167.22 21.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.51 -0.744 . . . . 0.0 110.079 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.591 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 0.9 OUTLIER -126.32 110.07 12.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 110.901 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.547 ' HB2' HG21 ' A' ' 27' ' ' THR . 20.0 t80 -111.11 136.09 50.66 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.38 157.88 43.53 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.061 -1.024 . . . . 0.0 111.968 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.3 t -132.82 145.04 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.15 136.55 11.38 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.238 -0.914 . . . . 0.0 110.927 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.484 ' HB3' ' CE1' ' A' ' 49' ' ' TYR . 48.1 Cg_endo . . . . . 0 C--N 1.316 -1.179 0 O-C-N 123.905 1.476 . . . . 0.0 110.406 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.288 0.566 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -96.64 135.28 38.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.572 -0.705 . . . . 0.0 110.19 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.558 ' HA ' HG21 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -129.39 156.73 43.6 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.332 -0.855 . . . . 0.0 109.857 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.19 150.5 22.7 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.753 ' HG2' ' HB3' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -149.56 136.36 19.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.491 -1.005 . . . . 0.0 109.837 179.529 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.705 ' HG2' HG22 ' A' ' 77' ' ' THR . 1.0 OUTLIER -135.12 152.58 51.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.439 -0.788 . . . . 0.0 110.835 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.603 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 46.1 p90 -149.32 -177.13 5.67 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.576 -0.703 . . . . 0.0 110.044 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 34.7 m -133.94 93.81 19.68 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.102 -0.999 . . . . 0.0 110.701 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.603 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.6 Cg_endo -76.09 89.58 1.23 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.951 1.5 . . . . 0.0 110.107 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.27 -46.51 0.87 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.436 ' CZ2' HD22 ' A' ' 30' ' ' LEU . 10.4 t90 -71.61 -57.78 4.08 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.476 -1.014 . . . . 0.0 110.139 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.496 HG21 HD13 ' A' ' 90' ' ' LEU . 8.1 t -153.96 -160.37 1.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.578 -0.701 . . . . 0.0 109.902 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.88 44.92 2.52 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.253 -0.904 . . . . 0.0 110.546 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.63 HD11 ' HG3' ' A' ' 88' ' ' LYS . 1.5 tt -125.15 154.4 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.25 -0.906 . . . . 0.0 109.701 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.451 ' HB3' ' CB ' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -153.68 169.21 23.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.166 -0.959 . . . . 0.0 111.202 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.457 ' HA2' ' HE2' ' A' ' 84' ' ' LYS . . . -135.45 153.03 21.09 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.753 ' HB3' ' HG2' ' A' ' 52' ' ' ARG . 1.2 pm0 -145.51 155.39 43.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.632 -0.922 . . . . 0.0 110.227 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -143.23 162.48 35.51 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.518 -0.738 . . . . 0.0 110.89 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -147.12 136.98 23.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.574 -0.704 . . . . 0.0 110.438 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.7 t -175.51 165.25 3.18 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.699 -0.625 . . . . 0.0 110.002 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -68.55 -28.13 66.69 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.182 -0.949 . . . . 0.0 110.595 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.67 149.46 50.47 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.191 -0.943 . . . . 0.0 110.463 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.426 ' O ' HG12 ' A' ' 73' ' ' VAL . 6.6 mp0 -83.66 -64.91 1.08 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.672 -0.642 . . . . 0.0 110.087 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 t -73.32 -22.79 60.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.26 -0.9 . . . . 0.0 110.02 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.82 -45.38 95.02 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' A' ' 50' ' ' LYS . 0.7 OUTLIER -61.04 -36.96 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.495 -1.003 . . . . 0.0 110.064 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.46 -45.08 94.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.524 -0.735 . . . . 0.0 110.034 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -60.64 -37.21 93.09 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.442 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -74.92 -37.69 61.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.391 -1.064 . . . . 0.0 110.245 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.705 HG22 ' HG2' ' A' ' 53' ' ' MET . 22.7 m -59.93 -38.04 81.24 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.195 -0.941 . . . . 0.0 109.683 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.67 -28.04 40.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.425 -0.797 . . . . 0.0 110.184 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.958 ' HE2' ' HB2' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -80.76 -37.64 30.05 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.267 -0.895 . . . . 0.0 109.826 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.75 -31.51 66.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.785 -0.572 . . . . 0.0 109.694 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 35.4 t80 -70.36 -42.19 72.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 0.0 109.695 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 11' ' ' ALA . 58.6 t -71.24 -30.89 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.799 . . . . 0.0 109.467 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -38.4 63.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.459 -0.776 . . . . 0.0 109.756 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.457 ' HE2' ' HA2' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -67.3 -36.78 82.2 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.33 -0.856 . . . . 0.0 109.777 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.669 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -71.69 -34.2 69.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.486 -0.759 . . . . 0.0 109.528 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.21 -39.28 86.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.595 -0.69 . . . . 0.0 109.585 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -64.37 -40.4 95.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.717 -0.614 . . . . 0.0 109.901 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.63 ' HG3' HD11 ' A' ' 61' ' ' ILE . 9.1 mmmt -73.72 -57.15 4.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.425 -0.797 . . . . 0.0 109.781 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.7 53.98 0.05 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.496 HD13 HG21 ' A' ' 59' ' ' THR . 9.7 mt -123.41 -57.41 1.67 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.303 -1.116 . . . . 0.0 110.65 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.669 HD12 ' HB3' ' A' ' 85' ' ' ALA . 12.4 mt -92.74 115.83 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.0 110.167 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.6 t -99.46 -175.91 3.13 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.663 -0.648 . . . . 0.0 110.637 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.598 ' HA ' HG11 ' A' ' 10' ' ' VAL . 2.6 mt-30 -74.85 -52.07 12.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.423 -0.798 . . . . 0.0 110.263 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -64.15 -41.04 97.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.575 -0.703 . . . . 0.0 110.189 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -56.09 -45.85 79.26 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.649 -0.657 . . . . 0.0 109.993 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.43 93.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.62 -0.675 . . . . 0.0 109.43 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -64.16 -37.83 88.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.643 -0.66 . . . . 0.0 109.717 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -64.97 -42.04 94.92 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.638 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 18.6 t90 -64.49 -43.1 95.21 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.162 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.462 HD23 ' HD2' ' A' ' 17' ' ' LYS . 12.2 mt . . . . . 0 N--CA 1.499 1.991 0 O-C-N 121.776 -0.578 . . . . 0.0 109.562 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 120.95 0.405 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 14' ' ' VAL . 65.5 t -65.07 -41.3 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.502 -0.749 . . . . 0.0 109.31 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.493 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -63.11 -39.59 95.14 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.597 -0.689 . . . . 0.0 109.79 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.88 98.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.548 -0.72 . . . . 0.0 109.56 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.99 98.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.634 -0.666 . . . . 0.0 109.5 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 10' ' ' VAL . 60.5 t -62.69 -41.07 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.545 -0.722 . . . . 0.0 109.299 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.588 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -63.28 -40.13 96.52 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.694 -0.629 . . . . 0.0 109.42 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 56.5 m -63.47 -38.88 92.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.649 -0.657 . . . . 0.0 109.443 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.516 ' HB3' ' HZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.63 -37.79 82.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.518 -0.739 . . . . 0.0 109.356 178.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.784 HD12 ' HB1' ' A' ' 78' ' ' ALA . 17.1 mt -66.57 -33.33 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.678 -0.639 . . . . 0.0 109.857 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.5 t -62.51 -49.86 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.252 -0.905 . . . . 0.0 109.736 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.03 -13.12 83.38 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 120.293 -0.956 . . . . 0.0 110.82 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.688 HD21 ' O ' ' A' ' 28' ' ' GLU . 11.5 tp -98.09 -23.0 15.93 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.019 -1.283 . . . . 0.0 110.825 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.554 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 17.4 t90 -67.4 131.36 45.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.73 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.96 -161.27 0.86 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -47.94 -45.07 30.67 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.132 -0.98 . . . . 0.0 110.444 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.13 36.54 0.14 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.611 -0.681 . . . . 0.0 110.848 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -156.54 155.49 32.02 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.194 -0.941 . . . . 0.0 110.027 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.571 HG23 ' HB2' ' A' ' 34' ' ' CYS . 7.2 t -156.41 155.29 31.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.164 -0.96 . . . . 0.0 110.132 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.688 ' O ' HD21 ' A' ' 21' ' ' LEU . 8.0 mp0 -116.09 109.39 17.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.4 -0.813 . . . . 0.0 109.494 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.533 HD23 ' C ' ' A' ' 28' ' ' GLU . 10.7 mt -112.19 129.79 56.13 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.316 -0.865 . . . . 0.0 110.576 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.874 HD12 ' HD1' ' A' ' 99' ' ' TRP . 0.3 OUTLIER 60.09 30.64 20.08 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.442 -0.786 . . . . 0.0 110.301 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.02 22.21 78.43 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.557 ' CE1' HD23 ' A' ' 30' ' ' LEU . 33.4 m170 -120.77 160.07 24.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.379 -1.071 . . . . 0.0 109.992 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.43 126.72 34.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.359 -0.838 . . . . 0.0 110.549 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.571 ' HB2' HG23 ' A' ' 27' ' ' THR . 23.9 m -130.17 166.88 19.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.69 -0.631 . . . . 0.0 109.687 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 6.1 tptt -128.33 105.64 8.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.465 -0.772 . . . . 0.0 110.637 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.554 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 29.9 t80 -108.23 137.34 46.37 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.6 p -147.57 152.32 37.75 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.031 -1.043 . . . . 0.0 111.816 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.8 t -125.17 133.92 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.415 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -136.15 119.16 12.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.127 -0.983 . . . . 0.0 111.224 -178.687 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo . . . . . 0 C--N 1.315 -1.206 0 O-C-N 123.77 1.405 . . . . 0.0 110.655 179.55 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.035 0.445 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 70' ' ' GLN . 3.3 m-85 -98.39 133.53 42.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.505 -0.747 . . . . 0.0 110.311 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.6 164.63 17.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.449 -0.782 . . . . 0.0 110.085 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -156.86 135.67 4.57 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.596 ' HG3' ' HG3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -138.92 144.82 39.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.582 -0.952 . . . . 0.0 110.426 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.584 ' HG2' HG22 ' A' ' 77' ' ' THR . 2.5 ppp? -140.49 148.74 41.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.325 -0.859 . . . . 0.0 110.315 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.509 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 44.8 p90 -152.29 146.65 25.55 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.651 -0.656 . . . . 0.0 110.41 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 98.0 m -112.38 88.93 11.54 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.303 -0.873 . . . . 0.0 110.953 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -77.59 84.33 1.99 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.843 1.444 . . . . 0.0 110.278 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.73 -46.63 0.59 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 10.3 t90 -71.35 -58.13 3.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.6 -0.941 . . . . 0.0 110.045 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.429 HG21 ' CD1' ' A' ' 90' ' ' LEU . 9.1 t -153.7 -160.66 1.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.577 -0.702 . . . . 0.0 109.941 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.87 47.69 1.61 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.397 -0.815 . . . . 0.0 110.127 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.406 HG22 ' CD1' ' A' ' 81' ' ' PHE . 72.9 mt -123.63 151.41 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.471 -0.768 . . . . 0.0 109.878 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -139.33 169.87 16.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.904 . . . . 0.0 110.962 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.557 ' O ' HG23 ' A' ' 77' ' ' THR . . . -137.35 127.58 4.03 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.596 ' HG3' ' HG3' ' A' ' 52' ' ' ARG . 1.8 mp0 -121.7 169.02 11.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.571 -0.959 . . . . 0.0 110.695 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.441 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -166.41 156.57 12.06 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.486 0.66 . . . . 0.0 111.336 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -156.44 131.86 9.39 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.633 -0.667 . . . . 0.0 110.037 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.3 t -175.63 -176.71 0.9 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.598 -0.689 . . . . 0.0 109.987 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -82.48 -39.18 22.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.221 -0.924 . . . . 0.0 110.466 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.31 135.74 52.36 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.591 -0.693 . . . . 0.0 110.607 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.434 ' HB3' ' CE2' ' A' ' 49' ' ' TYR . 15.4 pt20 -75.79 -34.96 60.22 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.628 -0.67 . . . . 0.0 110.648 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.0 m -82.22 -34.12 29.04 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.151 -0.968 . . . . 0.0 109.925 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.68 -36.74 90.75 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 70' ' ' GLN . 0.3 OUTLIER -69.99 -35.53 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.3 -1.118 . . . . 0.0 110.004 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.38 94.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.179 -0.951 . . . . 0.0 109.94 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -66.46 -39.44 94.08 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.441 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -67.6 -43.22 81.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.651 -0.911 . . . . 0.0 110.397 179.472 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.584 HG22 ' HG2' ' A' ' 53' ' ' MET . 94.4 m -58.99 -36.33 74.72 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.192 -0.943 . . . . 0.0 109.578 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.784 ' HB1' HD12 ' A' ' 18' ' ' ILE . . . -80.33 -32.71 37.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.525 -0.735 . . . . 0.0 109.876 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 75' ' ' GLY . 1.3 ttpm? -75.71 -34.47 60.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.461 -0.774 . . . . 0.0 110.102 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -39.58 86.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.481 -0.762 . . . . 0.0 109.626 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.406 ' CD1' HG22 ' A' ' 61' ' ' ILE . 51.3 t80 -70.12 -38.48 75.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.375 -0.828 . . . . 0.0 109.082 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.493 HG11 ' HA ' ' A' ' 11' ' ' ALA . 39.0 t -66.68 -39.15 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.652 -0.655 . . . . 0.0 109.662 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.44 -44.77 96.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.356 -0.84 . . . . 0.0 109.414 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -68.95 -37.11 78.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.53 -0.731 . . . . 0.0 109.516 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.68 -37.2 76.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.565 -0.71 . . . . 0.0 109.747 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -64.68 -41.45 96.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.582 -0.699 . . . . 0.0 109.734 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -69.19 -34.42 74.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.51 -0.744 . . . . 0.0 110.616 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.95 -51.84 12.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.271 -0.893 . . . . 0.0 110.239 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.07 52.55 0.13 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 90' ' ' LEU . 6.0 mt -114.87 -48.87 2.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.267 -1.137 . . . . 0.0 110.225 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.451 HD13 HG11 ' A' ' 14' ' ' VAL . 82.4 mt -103.81 94.57 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 110.06 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.486 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 5.0 m -78.11 178.37 7.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.329 -0.857 . . . . 0.0 109.898 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -57.86 7.2 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.284 -0.885 . . . . 0.0 110.479 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -63.13 -35.56 80.68 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.24 -0.913 . . . . 0.0 110.134 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.4 OUTLIER -70.26 -32.31 70.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.393 -0.817 . . . . 0.0 109.547 178.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.7 -40.71 93.24 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.411 -0.806 . . . . 0.0 109.353 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -63.33 -46.64 85.69 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -66.01 -37.3 85.57 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.874 ' HD1' HD12 ' A' ' 30' ' ' LEU . 58.5 t90 -65.26 -38.89 91.72 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.02 0.438 . . . . 0.0 109.855 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.509 ' HA ' ' HG3' ' A' ' 17' ' ' LYS . 11.8 mt . . . . . 0 N--CA 1.496 1.834 0 O-C-N 121.655 -0.653 . . . . 0.0 109.78 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 14' ' ' VAL . 40.2 t -63.07 -39.65 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.78 -41.35 97.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.653 -0.655 . . . . 0.0 109.429 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.31 -41.64 93.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.681 -0.637 . . . . 0.0 109.685 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.7 99.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.525 -0.734 . . . . 0.0 109.41 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 10' ' ' VAL . 86.9 t -65.99 -40.73 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -65.11 -38.56 91.1 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.459 -0.776 . . . . 0.0 109.49 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -38.56 91.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.455 -0.778 . . . . 0.0 109.44 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.663 ' HE3' HD23 ' A' ' 100' ' ' LEU . 4.9 tppt? -67.2 -32.3 73.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.543 -0.723 . . . . 0.0 109.686 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.544 HG21 ' HB2' ' A' ' 78' ' ' ALA . 6.5 mm -61.53 -49.38 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.416 -0.802 . . . . 0.0 109.262 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.7 t -61.66 -39.12 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.58 -0.7 . . . . 0.0 109.935 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.46 -33.41 86.39 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 tp -112.05 36.89 3.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.396 -1.061 . . . . 0.0 110.581 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.408 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 25.2 t90 -102.44 136.97 41.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 111.266 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -99.35 -166.43 1.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -51.19 -40.13 57.99 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.043 -1.035 . . . . 0.0 110.245 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -158.6 34.61 0.23 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.584 -0.698 . . . . 0.0 110.605 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -154.35 141.2 19.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.251 -0.905 . . . . 0.0 111.021 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.5 t -145.52 157.7 43.95 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.301 -0.875 . . . . 0.0 109.594 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 32' ' ' HIS . 9.7 mt-10 -101.23 122.95 44.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.359 -0.838 . . . . 0.0 111.229 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.622 HD12 ' SG ' ' A' ' 34' ' ' CYS . 7.2 mt -108.17 116.36 31.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.569 -0.707 . . . . 0.0 109.396 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.632 HD11 ' HG3' ' A' ' 95' ' ' GLU . 1.2 tp 58.48 31.1 20.61 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.784 -0.572 . . . . 0.0 110.73 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.32 -8.19 79.41 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 29.0 m80 -91.33 163.64 14.14 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.121 -1.223 . . . . 0.0 110.273 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.58 127.98 38.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.569 -0.707 . . . . 0.0 110.324 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.622 ' SG ' HD12 ' A' ' 29' ' ' LEU . 64.3 m -127.61 170.74 12.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.674 -0.641 . . . . 0.0 110.04 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -123.22 99.94 6.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.543 -0.723 . . . . 0.0 110.312 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.492 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 5.4 t80 -112.53 135.08 53.66 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.23 171.37 16.59 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.11 -0.993 . . . . 0.0 110.841 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.452 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 44.7 t -129.35 135.36 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.788 -0.57 . . . . 0.0 109.619 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.25 87.22 39.25 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.286 -0.884 . . . . 0.0 110.776 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 C--N 1.312 -1.353 0 O-C-N 123.826 1.435 . . . . 0.0 110.475 179.472 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.033 0.444 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -127.99 128.7 45.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.026 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -135.54 157.39 47.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -0.941 . . . . 0.0 110.18 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -149.3 148.07 19.06 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.572 ' HD3' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -143.25 143.31 31.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.659 -0.906 . . . . 0.0 110.16 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.53 ' HG2' HG22 ' A' ' 77' ' ' THR . 1.6 ppp? -148.64 150.25 32.93 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.255 -0.903 . . . . 0.0 111.137 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.553 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 46.7 p90 -164.02 152.11 12.86 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.785 -0.572 . . . . 0.0 110.376 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 75.7 m -111.16 92.45 15.54 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.209 -0.932 . . . . 0.0 110.71 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.553 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 48.9 Cg_endo -74.21 88.61 1.11 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.903 1.475 . . . . 0.0 110.192 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 146.49 -47.22 0.71 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -71.1 -50.89 28.86 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.549 -0.971 . . . . 0.0 110.19 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.515 ' CB ' HD11 ' A' ' 90' ' ' LEU . 14.3 t -151.96 -169.89 3.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.632 -0.668 . . . . 0.0 109.901 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.63 61.97 0.78 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 0.0 110.367 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.733 HD11 ' HB3' ' A' ' 84' ' ' LYS . 10.5 tt -137.91 150.52 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.336 -0.852 . . . . 0.0 109.99 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.34 155.97 49.32 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.806 . . . . 0.0 110.594 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.5 151.36 21.15 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.572 ' HB3' ' HD3' ' A' ' 52' ' ' ARG . 1.8 pp20? -156.38 158.65 37.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.391 -1.064 . . . . 0.0 110.738 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.48 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -146.42 148.36 32.21 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.586 -0.696 . . . . 0.0 110.81 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.427 ' O ' ' HB ' ' A' ' 67' ' ' THR . 1.4 m -138.04 139.14 39.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.368 -0.833 . . . . 0.0 110.331 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 66' ' ' SER . 6.1 t 179.63 -163.34 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.843 -0.535 . . . . 0.0 109.819 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.94 -23.79 14.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.4 -0.813 . . . . 0.0 110.334 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.2 m -61.91 153.32 29.46 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.108 -0.995 . . . . 0.0 110.454 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.455 ' O ' HG12 ' A' ' 73' ' ' VAL . 38.5 tt0 -93.15 -56.92 2.79 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.643 -0.661 . . . . 0.0 110.412 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.2 p -81.42 -28.58 34.2 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.376 -0.828 . . . . 0.0 110.475 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.1 -45.01 96.75 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 70' ' ' GLN . 2.5 p -58.8 -38.07 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.498 -1.001 . . . . 0.0 110.538 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.4 ' N ' ' CG1' ' A' ' 73' ' ' VAL . . . -65.25 -47.6 76.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.467 -0.771 . . . . 0.0 109.801 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -63.49 -39.77 98.05 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.48 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -62.87 -42.02 99.61 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.571 -0.958 . . . . 0.0 110.285 179.372 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.53 HG22 ' HG2' ' A' ' 53' ' ' MET . 47.6 m -62.12 -41.25 98.06 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.257 -0.902 . . . . 0.0 109.978 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.615 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -76.45 -36.85 57.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.526 -0.734 . . . . 0.0 110.037 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 75' ' ' GLY . 0.1 OUTLIER -69.11 -38.36 78.88 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.531 -0.731 . . . . 0.0 110.137 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -69.12 -35.54 76.51 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.442 ' CE2' HG23 ' A' ' 61' ' ' ILE . 42.7 t80 -66.62 -41.0 89.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.569 -0.707 . . . . 0.0 109.68 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 78' ' ' ALA . 84.3 t -64.7 -38.62 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.538 -0.726 . . . . 0.0 109.738 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.1 tpt85 -63.82 -39.52 94.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.565 -0.71 . . . . 0.0 109.73 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.733 ' HB3' HD11 ' A' ' 61' ' ' ILE . 36.4 mtpt -69.35 -33.86 73.74 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.379 -0.826 . . . . 0.0 109.529 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.47 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -76.28 -27.69 56.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.306 -0.871 . . . . 0.0 109.231 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.48 -41.9 72.11 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.719 -0.613 . . . . 0.0 110.019 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.435 ' HG3' ' N ' ' A' ' 88' ' ' LYS . 6.0 pt20 -67.48 -36.22 80.69 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.378 -0.826 . . . . 0.0 110.585 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.715 ' HD2' HD12 ' A' ' 61' ' ' ILE . 10.5 mttt -74.4 -54.81 6.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.297 -0.877 . . . . 0.0 110.004 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.98 52.37 0.07 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.515 HD11 ' CB ' ' A' ' 59' ' ' THR . 6.1 mt -119.32 -61.64 1.6 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.245 -1.15 . . . . 0.0 109.893 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 82' ' ' VAL . 72.9 mt -89.5 75.46 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.505 -0.747 . . . . 0.0 109.237 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.2 t -62.13 178.97 0.33 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.753 -0.592 . . . . 0.0 110.535 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -62.03 -54.63 38.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.472 -0.768 . . . . 0.0 110.217 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -67.85 -29.44 68.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.623 -0.673 . . . . 0.0 110.675 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.632 ' HG3' HD11 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -63.78 -45.41 89.86 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.357 -0.84 . . . . 0.0 110.188 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.66 -38.04 89.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.514 -0.741 . . . . 0.0 109.622 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -66.65 -36.79 83.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.503 -0.748 . . . . 0.0 110.307 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -41.41 90.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.342 -0.849 . . . . 0.0 109.761 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.639 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 13.6 t90 -67.26 -40.96 86.29 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.354 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.663 HD23 ' HE3' ' A' ' 17' ' ' LYS . 43.3 mt . . . . . 0 N--CA 1.497 1.92 0 O-C-N 121.631 -0.668 . . . . 0.0 109.62 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.466 ' O ' HG23 ' A' ' 14' ' ' VAL . 77.8 t -64.49 -39.56 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.596 -0.69 . . . . 0.0 109.202 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.686 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -63.54 -39.56 94.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.759 -0.588 . . . . 0.0 109.813 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.63 99.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.534 -0.729 . . . . 0.0 109.648 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.13 99.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.603 -0.686 . . . . 0.0 109.671 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 10' ' ' VAL . 91.5 t -62.98 -40.8 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.521 -0.737 . . . . 0.0 109.431 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.68 -38.71 92.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.544 -0.722 . . . . 0.0 109.536 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.1 t -62.46 -41.76 98.99 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.661 -0.65 . . . . 0.0 109.627 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.44 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 11.8 tttm -65.35 -32.49 74.15 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.433 -0.792 . . . . 0.0 110.063 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.495 HG21 ' HB2' ' A' ' 78' ' ' ALA . 8.7 mm -64.94 -45.86 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.419 -0.801 . . . . 0.0 109.66 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.56 -40.77 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.546 -0.721 . . . . 0.0 110.206 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.18 -19.27 78.66 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.276 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 tp -120.41 21.15 11.75 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.865 -1.374 . . . . 0.0 111.945 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.547 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 18.6 t90 -90.88 137.74 32.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.902 -1.124 . . . . 0.0 109.948 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.64 -169.14 1.79 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.41 -0.806 . . . . 0.0 109.369 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -45.54 -44.04 12.42 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.153 -0.967 . . . . 0.0 110.311 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.475 ' O ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -158.39 33.31 0.24 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.579 -0.7 . . . . 0.0 110.828 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -141.5 152.73 44.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.12 -0.987 . . . . 0.0 111.001 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.541 HG23 ' CB ' ' A' ' 34' ' ' CYS . 2.1 t -155.07 167.32 30.76 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.629 -0.669 . . . . 0.0 109.476 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -136.55 119.13 15.95 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.275 -0.89 . . . . 0.0 109.992 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.595 HD13 ' CE2' ' A' ' 81' ' ' PHE . 5.2 mt -108.64 120.74 43.33 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.333 -0.854 . . . . 0.0 110.456 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp 56.52 31.06 18.3 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.582 -0.699 . . . . 0.0 111.007 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.44 -11.78 64.85 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.594 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 30.3 m80 -84.63 141.52 30.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.028 -1.278 . . . . 0.0 110.006 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -72.2 135.74 46.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.391 -0.818 . . . . 0.0 110.305 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.546 ' SG ' HD12 ' A' ' 29' ' ' LEU . 45.1 m -139.15 168.57 19.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.614 -0.679 . . . . 0.0 110.059 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.475 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER -129.7 121.21 26.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.511 -0.743 . . . . 0.0 110.051 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.547 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 26.8 t80 -120.42 136.77 54.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.555 -0.716 . . . . 0.0 109.364 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.1 p -140.36 151.0 44.64 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.061 -1.025 . . . . 0.0 111.503 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.7 t -132.64 129.25 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 mtmm -142.56 117.33 6.56 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.159 -0.963 . . . . 0.0 110.938 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 C--N 1.313 -1.289 0 O-C-N 123.954 1.502 . . . . 0.0 110.251 179.358 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.338 0.59 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.485 ' CZ ' ' HG3' ' A' ' 70' ' ' GLN . 0.5 OUTLIER -124.28 131.62 53.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.476 -0.765 . . . . 0.0 110.028 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -135.69 157.14 47.6 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.449 -0.782 . . . . 0.0 110.495 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.91 147.58 17.55 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.491 ' HD3' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -141.16 145.52 35.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.826 -0.808 . . . . 0.0 110.033 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.646 ' HG2' HG22 ' A' ' 77' ' ' THR . 2.2 ptm -143.99 151.88 40.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.078 -1.014 . . . . 0.0 111.079 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.472 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 48.6 p90 -155.84 150.56 26.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.7 -0.625 . . . . 0.0 110.32 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 87.1 m -113.53 90.49 17.83 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.214 -0.929 . . . . 0.0 110.964 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.472 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.4 Cg_endo -78.66 84.8 1.96 Allowed 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.957 1.504 . . . . 0.0 110.108 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.49 -47.6 0.41 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.594 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 19.4 t90 -77.08 -54.66 6.25 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.449 -1.03 . . . . 0.0 110.384 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.556 HG21 HD13 ' A' ' 90' ' ' LEU . 8.9 t -153.74 -161.83 1.33 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.558 -0.714 . . . . 0.0 110.022 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.24 48.57 1.39 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.518 -0.739 . . . . 0.0 110.212 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.735 HD12 HD12 ' A' ' 90' ' ' LEU . 34.4 mt -118.36 146.57 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.366 -0.834 . . . . 0.0 109.83 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.16 161.72 35.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.365 -0.835 . . . . 0.0 110.98 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.68 131.76 5.89 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HG2' ' HD3' ' A' ' 52' ' ' ARG . 12.9 mp0 -126.44 160.25 31.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.644 -0.915 . . . . 0.0 109.914 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.738 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -171.76 152.34 3.06 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.414 -0.804 . . . . 0.0 111.188 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.1 143.44 31.13 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.516 -0.74 . . . . 0.0 110.115 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.8 t -173.25 155.42 2.92 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.52 -0.738 . . . . 0.0 110.323 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.41 -35.88 70.6 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.532 -0.73 . . . . 0.0 111.411 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.406 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 0.9 OUTLIER -62.31 135.6 57.54 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.32 -0.863 . . . . 0.0 110.354 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.509 ' O ' HG12 ' A' ' 73' ' ' VAL . 4.6 mp0 -70.23 -61.39 1.79 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.705 -0.622 . . . . 0.0 109.98 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.2 t -72.93 -28.76 62.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.24 -0.913 . . . . 0.0 109.879 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -58.27 -39.66 92.86 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 70' ' ' GLN . 0.5 OUTLIER -64.97 -35.81 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.377 -1.072 . . . . 0.0 109.992 179.563 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.96 -39.76 87.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.433 -0.792 . . . . 0.0 110.036 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.05 -34.34 76.13 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.738 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -70.36 -42.22 72.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.62 -0.929 . . . . 0.0 110.177 179.502 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.646 HG22 ' HG2' ' A' ' 53' ' ' MET . 66.5 m -62.49 -40.01 95.33 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.286 -0.884 . . . . 0.0 109.419 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -73.47 -37.02 65.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.514 -0.741 . . . . 0.0 109.685 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -38.78 86.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.505 -0.747 . . . . 0.0 109.693 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -41.97 99.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.565 -0.709 . . . . 0.0 110.001 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.595 ' CE2' HD13 ' A' ' 29' ' ' LEU . 51.5 t80 -65.72 -40.8 92.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.443 -0.785 . . . . 0.0 109.973 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.686 HG11 ' HA ' ' A' ' 11' ' ' ALA . 97.1 t -66.1 -36.04 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.484 -0.76 . . . . 0.0 109.915 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -67.04 -40.66 87.23 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.47 -0.769 . . . . 0.0 109.982 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -37.11 80.56 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.535 -0.728 . . . . 0.0 109.869 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.707 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -68.98 -35.27 76.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.385 -0.822 . . . . 0.0 110.134 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.9 -36.22 72.64 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.477 -0.764 . . . . 0.0 109.687 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -63.1 -29.05 70.5 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.601 -0.687 . . . . 0.0 110.412 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -55.29 3.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.43 -0.794 . . . . 0.0 110.332 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 136.61 56.53 0.06 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.735 HD12 HD12 ' A' ' 61' ' ' ILE . 11.5 mt -125.44 -46.41 1.76 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.336 -1.096 . . . . 0.0 110.579 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.707 HD12 ' HB3' ' A' ' 85' ' ' ALA . 89.0 mt -96.78 112.38 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 109.741 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.5 m -91.25 162.63 14.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.542 -0.724 . . . . 0.0 110.353 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -63.29 -53.72 48.34 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.526 -0.734 . . . . 0.0 110.259 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -61.64 -42.74 99.31 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.481 -0.762 . . . . 0.0 110.733 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -59.27 -41.66 89.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.317 -0.864 . . . . 0.0 110.176 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.06 -40.24 97.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.381 -0.824 . . . . 0.0 109.741 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -64.21 -39.88 94.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.567 -0.708 . . . . 0.0 109.868 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -63.26 -40.48 97.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.668 -0.645 . . . . 0.0 109.745 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.44 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 15.1 t90 -68.45 -36.54 79.17 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.591 -0.693 . . . . 0.0 109.9 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.428 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 14.1 mt . . . . . 0 N--CA 1.499 1.982 0 O-C-N 121.699 -0.626 . . . . 0.0 110.548 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.536 ' O ' HG23 ' A' ' 14' ' ' VAL . 97.4 t -68.5 -38.79 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.809 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -64.19 -39.74 94.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.611 -0.681 . . . . 0.0 109.647 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.58 -41.56 99.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.551 -0.718 . . . . 0.0 109.79 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.49 -40.43 89.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.397 -0.814 . . . . 0.0 109.693 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 10' ' ' VAL . 95.0 t -64.96 -40.78 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.439 -0.788 . . . . 0.0 109.137 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -62.13 -40.27 95.35 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.687 -0.633 . . . . 0.0 109.75 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 t -61.39 -41.78 97.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.563 -0.711 . . . . 0.0 109.755 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.461 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 14.4 tttm -68.36 -30.44 69.39 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.472 -0.767 . . . . 0.0 110.215 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.533 HG21 ' HB2' ' A' ' 78' ' ' ALA . 12.9 mm -68.1 -44.32 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.423 -0.798 . . . . 0.0 109.702 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.77 -39.24 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.342 -0.849 . . . . 0.0 110.196 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.57 -27.58 69.14 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.68 28.73 8.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.1 -1.235 . . . . 0.0 111.613 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -95.65 132.69 40.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.929 -1.107 . . . . 0.0 110.48 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -98.09 -166.04 1.33 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -48.0 -41.95 26.71 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.161 -0.962 . . . . 0.0 110.26 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -161.97 37.83 0.12 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.725 -0.609 . . . . 0.0 110.261 179.566 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -146.12 158.83 43.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.188 -0.945 . . . . 0.0 111.205 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.562 HG23 ' HB2' ' A' ' 34' ' ' CYS . 8.0 t -163.61 154.3 15.97 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.682 -0.636 . . . . 0.0 109.406 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -110.94 111.11 22.01 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.21 -0.932 . . . . 0.0 110.302 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.446 HD21 HD11 ' A' ' 18' ' ' ILE . 2.8 mt -107.06 128.86 54.75 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.355 -0.841 . . . . 0.0 110.763 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 30' ' ' LEU . 4.7 tp 54.48 36.0 24.63 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.599 -0.688 . . . . 0.0 111.17 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.32 23.49 78.01 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.567 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 34.2 m170 -123.14 151.67 41.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -1.087 . . . . 0.0 109.895 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.46 127.43 32.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.312 -0.868 . . . . 0.0 110.597 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.562 ' HB2' HG23 ' A' ' 27' ' ' THR . 59.9 m -129.33 171.25 12.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.685 -0.635 . . . . 0.0 109.996 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 7.9 tptm -128.06 100.68 5.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.526 -0.734 . . . . 0.0 110.276 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.474 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 3.8 t80 -112.85 136.1 52.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.755 -0.591 . . . . 0.0 109.703 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.01 170.85 16.85 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.343 -0.848 . . . . 0.0 111.045 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.506 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 76.0 t -133.41 130.64 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -137.84 93.74 11.96 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.158 -0.964 . . . . 0.0 111.192 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.477 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 56.5 Cg_endo . . . . . 0 C--N 1.312 -1.355 0 O-C-N 123.916 1.482 . . . . 0.0 110.316 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.336 0.589 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.548 ' CE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -108.98 156.86 19.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.456 -0.778 . . . . 0.0 110.195 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -156.78 149.75 23.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.312 -0.867 . . . . 0.0 110.189 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -145.87 149.97 22.15 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HD3' ' CB ' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -148.42 145.05 27.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.7 -0.882 . . . . 0.0 110.113 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.508 ' HG2' HG22 ' A' ' 77' ' ' THR . 5.4 ptm -144.54 151.3 38.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.374 -0.829 . . . . 0.0 111.123 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.496 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 42.8 p90 -153.93 147.93 25.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.786 -0.571 . . . . 0.0 109.888 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 58' ' ' TRP . 87.5 m -111.58 89.9 11.6 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.222 -0.924 . . . . 0.0 111.449 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -77.06 85.72 1.73 Allowed 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.856 1.451 . . . . 0.0 110.091 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.83 -46.63 0.64 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.567 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 12.1 t90 -70.31 -57.43 4.88 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.672 -0.899 . . . . 0.0 109.996 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -152.1 -164.37 1.95 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.61 -0.681 . . . . 0.0 109.901 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.63 56.83 0.88 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.356 -0.84 . . . . 0.0 109.767 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.565 HD11 ' HE2' ' A' ' 88' ' ' LYS . 31.7 mt -130.55 158.71 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.608 -0.683 . . . . 0.0 109.699 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -135.93 171.04 15.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.45 -0.781 . . . . 0.0 110.695 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.56 127.96 1.83 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.432 ' CB ' ' HD3' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -147.48 156.06 42.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.608 -0.937 . . . . 0.0 110.709 -179.655 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.582 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -158.4 155.57 28.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.458 -0.776 . . . . 0.0 110.614 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.501 ' HA ' HG23 ' A' ' 73' ' ' VAL . 0.7 OUTLIER -133.42 145.45 50.3 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.418 -0.801 . . . . 0.0 110.688 -179.809 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 t -172.7 152.29 2.49 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.629 -0.669 . . . . 0.0 109.67 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -26.97 61.23 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.361 -0.837 . . . . 0.0 111.346 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.8 133.24 51.55 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.28 -0.888 . . . . 0.0 110.618 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.548 ' HA ' ' CE2' ' A' ' 49' ' ' TYR . 1.0 OUTLIER -70.36 -53.12 17.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.56 -0.712 . . . . 0.0 110.559 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.9 m -80.88 -28.31 36.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.331 -0.856 . . . . 0.0 110.082 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.17 -44.16 98.49 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' A' ' 66' ' ' SER . 0.5 OUTLIER -58.37 -36.37 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.461 -1.023 . . . . 0.0 110.321 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.449 ' HA ' ' HZ ' ' A' ' 36' ' ' PHE . . . -71.75 -43.3 66.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.589 -0.694 . . . . 0.0 109.653 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.58 -38.5 93.37 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.582 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -65.38 -40.47 93.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.643 -0.916 . . . . 0.0 109.996 179.433 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.508 HG22 ' HG2' ' A' ' 53' ' ' MET . 23.3 m -60.19 -43.51 95.84 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.542 -0.724 . . . . 0.0 109.32 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.533 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -68.7 -37.57 79.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.624 -0.673 . . . . 0.0 109.76 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.79 -40.17 94.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.559 -0.713 . . . . 0.0 109.61 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.53 -40.41 94.55 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.666 . . . . 0.0 110.049 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -70.18 -38.51 75.39 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.426 -0.797 . . . . 0.0 110.004 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.825 HG13 HG21 ' A' ' 91' ' ' ILE . 85.7 t -71.86 -33.4 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 0.0 110.027 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -41.27 80.67 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.282 -0.886 . . . . 0.0 109.361 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -36.67 67.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.494 -0.754 . . . . 0.0 108.983 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.37 -37.01 80.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.449 -0.782 . . . . 0.0 109.271 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -43.47 98.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.548 -0.72 . . . . 0.0 109.352 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -68.21 -37.1 80.52 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.659 -0.651 . . . . 0.0 110.534 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.565 ' HE2' HD11 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -72.37 -52.19 17.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.327 -0.858 . . . . 0.0 110.474 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.4 53.99 0.1 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 90' ' ' LEU . 12.4 mt -129.0 -49.88 1.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.487 -1.008 . . . . 0.0 110.521 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.825 HG21 HG13 ' A' ' 82' ' ' VAL . 32.5 mm -94.51 90.81 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 109.833 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -77.78 169.63 17.97 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.552 -0.718 . . . . 0.0 109.705 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.515 ' HG3' HG21 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -64.64 -54.47 31.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.404 -0.81 . . . . 0.0 110.462 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -69.29 -36.91 77.54 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.406 -0.809 . . . . 0.0 110.563 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.0 OUTLIER -62.4 -43.19 99.42 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.293 -0.879 . . . . 0.0 110.054 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.85 87.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.444 -0.785 . . . . 0.0 109.12 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -62.93 -41.15 99.38 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.81 -0.556 . . . . 0.0 109.889 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -41.46 96.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.445 -0.785 . . . . 0.0 109.288 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.461 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 29.6 t90 -66.74 -36.64 82.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.349 -0.844 . . . . 0.0 109.069 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 100' ' ' LEU . 21.1 tp . . . . . 0 N--CA 1.494 1.775 0 O-C-N 121.932 -0.48 . . . . 0.0 109.955 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 14' ' ' VAL . 64.4 t -67.04 -42.07 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.1 94.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.582 -0.699 . . . . 0.0 109.186 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.39 94.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.711 -0.618 . . . . 0.0 109.715 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.478 ' O ' HD21 ' A' ' 100' ' ' LEU . . . -62.5 -39.76 94.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.561 -0.712 . . . . 0.0 110.02 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.605 ' CG2' ' HB1' ' A' ' 96' ' ' ALA . 48.8 t -69.45 -39.65 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.329 -0.857 . . . . 0.0 109.237 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.68 -39.25 88.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.542 -0.724 . . . . 0.0 109.902 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 p -65.63 -35.97 82.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.406 -0.808 . . . . 0.0 109.923 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.79 ' HD3' HD23 ' A' ' 100' ' ' LEU . 4.7 tptt -65.78 -35.49 80.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.473 -0.767 . . . . 0.0 109.7 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.772 HD12 ' HB1' ' A' ' 78' ' ' ALA . 4.9 mt -65.52 -47.11 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.507 -0.746 . . . . 0.0 109.18 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.6 t -64.45 -39.49 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.523 -0.736 . . . . 0.0 110.051 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.58 -25.01 75.2 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.8 tp -120.68 31.39 6.45 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.289 -1.124 . . . . 0.0 111.021 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.423 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 23.5 t90 -93.28 136.71 33.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.987 -1.07 . . . . 0.0 110.479 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.07 -167.79 1.56 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.605 -0.685 . . . . 0.0 109.253 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.81 -43.02 18.03 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.24 -0.913 . . . . 0.0 110.206 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 1.4 pp20? -159.5 33.56 0.19 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.479 -0.763 . . . . 0.0 110.848 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -140.81 147.9 39.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.129 -0.982 . . . . 0.0 110.78 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 t -154.71 161.95 41.33 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.437 -0.789 . . . . 0.0 109.553 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -111.35 152.72 26.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.197 -0.939 . . . . 0.0 110.183 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.546 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 3.4 mt -146.18 119.02 8.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.405 -0.81 . . . . 0.0 109.971 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 tp 54.71 32.48 17.45 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.779 -0.576 . . . . 0.0 111.188 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.29 22.28 63.17 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 34.9 m80 -124.89 147.14 48.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -1.143 . . . . 0.0 110.151 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.83 132.92 40.69 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.435 -0.79 . . . . 0.0 110.416 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.546 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 84.4 m -135.37 164.34 27.99 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.561 -0.712 . . . . 0.0 110.179 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.573 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 1.5 tptt -117.9 124.01 47.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.343 -0.848 . . . . 0.0 110.53 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.465 ' CZ ' ' HB ' ' A' ' 77' ' ' THR . 7.3 t80 -124.49 123.93 41.19 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.709 -0.619 . . . . 0.0 109.512 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.3 p -131.37 154.32 48.74 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.202 -0.937 . . . . 0.0 111.578 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 p -122.29 142.35 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.632 -0.667 . . . . 0.0 109.75 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.57 107.56 4.08 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.081 -1.012 . . . . 0.0 110.868 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 C--N 1.315 -1.224 0 O-C-N 123.762 1.401 . . . . 0.0 110.509 179.336 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 121.341 0.591 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 67' ' ' THR . 1.7 m-85 -122.57 132.13 54.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.548 -0.72 . . . . 0.0 109.95 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -132.26 162.99 29.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.427 -0.796 . . . . 0.0 110.381 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -158.0 141.95 8.14 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.53 147.36 52.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.799 -0.824 . . . . 0.0 109.805 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.674 ' HG2' HG22 ' A' ' 77' ' ' THR . 2.4 ppp? -149.05 157.24 43.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.109 -0.995 . . . . 0.0 111.05 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.573 ' CE2' ' HB3' ' A' ' 35' ' ' LYS . 47.3 p90 -164.5 176.6 8.84 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.826 -0.546 . . . . 0.0 110.117 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 58' ' ' TRP . 67.5 m -129.06 94.86 32.78 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.213 -0.929 . . . . 0.0 110.614 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 49.8 Cg_endo -77.01 81.61 2.56 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.902 1.475 . . . . 0.0 110.468 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.36 -46.24 0.64 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.494 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 12.6 t90 -68.61 -57.72 5.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.604 -0.939 . . . . 0.0 110.155 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -150.64 -166.23 2.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.471 -0.768 . . . . 0.0 109.939 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.19 50.6 1.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.382 -0.824 . . . . 0.0 110.225 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.4 mt -123.01 149.53 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.739 . . . . 0.0 109.781 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -129.37 165.58 21.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -0.902 . . . . 0.0 111.0 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.22 152.5 24.1 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 65' ' ' ALA . 27.3 tt0 -153.2 158.77 42.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.482 -1.01 . . . . 0.0 110.069 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.553 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -168.63 148.55 4.45 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.989 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.415 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 1.7 m -137.61 147.53 45.09 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.612 -0.68 . . . . 0.0 110.107 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.431 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 6.6 t -170.97 171.37 5.92 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.584 -0.698 . . . . 0.0 110.11 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -69.16 -42.24 76.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.423 -0.798 . . . . 0.0 111.26 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.74 138.97 57.77 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.358 -0.839 . . . . 0.0 110.848 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.566 ' O ' HG12 ' A' ' 73' ' ' VAL . 19.5 tt0 -73.01 -52.14 15.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.76 -0.587 . . . . 0.0 110.282 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.0 m -72.46 -34.8 68.0 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.311 -0.868 . . . . 0.0 110.106 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.04 -36.63 92.59 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 70' ' ' GLN . 0.4 OUTLIER -63.3 -37.91 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.364 -1.08 . . . . 0.0 110.392 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.66 -38.02 80.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.462 -0.774 . . . . 0.0 109.835 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.82 95.59 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.553 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 4.0 tttm -68.1 -40.91 82.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.539 -0.977 . . . . 0.0 110.402 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.674 HG22 ' HG2' ' A' ' 53' ' ' MET . 62.1 m -61.48 -38.22 86.48 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.074 -1.016 . . . . 0.0 109.871 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.772 ' HB1' HD12 ' A' ' 18' ' ' ILE . . . -77.36 -36.17 53.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.585 -0.697 . . . . 0.0 109.899 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -68.64 -39.08 80.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.357 -0.839 . . . . 0.0 109.858 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -67.46 -34.5 77.32 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.514 -0.741 . . . . 0.0 109.562 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.429 ' CD2' ' SD ' ' A' ' 53' ' ' MET . 41.7 t80 -68.07 -41.16 82.35 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.487 -0.758 . . . . 0.0 109.702 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.541 HG13 HG21 ' A' ' 91' ' ' ILE . 83.9 t -66.87 -36.47 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.496 -0.752 . . . . 0.0 109.496 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.26 -41.67 99.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.601 -0.687 . . . . 0.0 109.456 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.68 -40.11 88.41 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.47 -0.769 . . . . 0.0 109.34 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.64 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -68.24 -35.35 77.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.79 -0.569 . . . . 0.0 109.647 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.68 -35.94 81.34 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.646 -0.659 . . . . 0.0 109.689 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -61.59 -39.9 92.83 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.633 -0.667 . . . . 0.0 110.207 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -82.17 -59.1 2.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.439 -0.788 . . . . 0.0 110.176 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.43 51.16 0.05 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.483 ' HA ' HD23 ' A' ' 90' ' ' LEU . 10.0 mt -115.11 -46.47 2.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.33 -1.1 . . . . 0.0 110.297 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 85' ' ' ALA . 89.9 mt -106.66 89.96 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.434 -0.792 . . . . 0.0 109.936 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 17.0 m -71.62 163.87 26.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.436 -0.79 . . . . 0.0 109.632 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.432 ' HG2' HG11 ' A' ' 10' ' ' VAL . 7.2 tm0? -60.29 -51.15 70.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.438 -0.789 . . . . 0.0 110.105 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -41.81 96.39 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.726 -0.609 . . . . 0.0 110.315 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.3 OUTLIER -59.15 -41.53 88.54 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.493 -0.754 . . . . 0.0 110.037 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.605 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -61.39 -42.12 98.21 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.489 -0.757 . . . . 0.0 109.669 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -63.06 -42.63 99.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.548 -0.72 . . . . 0.0 109.614 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -40.28 91.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.574 -0.703 . . . . 0.0 109.598 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.581 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 24.3 t90 -65.42 -38.37 89.71 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.738 -0.601 . . . . 0.0 109.622 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.79 HD23 ' HD3' ' A' ' 17' ' ' LYS . 4.3 mt . . . . . 0 N--CA 1.499 1.999 0 O-C-N 121.749 -0.594 . . . . 0.0 110.261 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.0 t -69.35 -39.62 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.52 -0.737 . . . . 0.0 109.033 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.535 ' HB1' ' HE2' ' A' ' 79' ' ' LYS . . . -67.19 -40.71 86.55 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.63 -40.7 92.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.618 -0.676 . . . . 0.0 109.795 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.42 -43.16 97.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.555 -0.716 . . . . 0.0 109.528 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.681 ' CG2' ' HB1' ' A' ' 96' ' ' ALA . 44.0 t -62.43 -44.52 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.564 -0.71 . . . . 0.0 109.309 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.33 92.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.631 -0.668 . . . . 0.0 109.99 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 t -63.55 -38.66 91.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.515 -0.741 . . . . 0.0 110.042 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.549 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 7.1 tttt -67.0 -33.83 76.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.95 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.614 HD12 ' HB1' ' A' ' 78' ' ' ALA . 10.2 mt -61.48 -48.31 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.449 -0.782 . . . . 0.0 109.757 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.3 t -62.14 -39.13 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.389 -0.819 . . . . 0.0 109.978 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.66 -28.29 73.25 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 tp -115.78 37.3 3.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.363 -1.081 . . . . 0.0 110.95 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -99.19 135.16 41.0 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.187 -0.946 . . . . 0.0 110.617 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.1 mtt-85 -98.49 -167.29 1.48 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -48.37 -43.23 33.46 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.984 -1.072 . . . . 0.0 110.385 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -158.89 36.5 0.22 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.641 -0.662 . . . . 0.0 110.476 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -150.33 157.79 43.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.305 -0.872 . . . . 0.0 110.49 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.403 HG23 ' HB2' ' A' ' 34' ' ' CYS . 12.1 t -157.6 -179.81 8.52 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.337 -0.852 . . . . 0.0 109.868 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -127.44 143.0 51.26 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.437 -0.789 . . . . 0.0 110.231 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.482 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 3.1 mt -137.54 123.49 20.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.296 -0.877 . . . . 0.0 109.835 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.544 HD22 ' HZ2' ' A' ' 58' ' ' TRP . 4.0 tp 56.39 30.09 16.33 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.736 -0.603 . . . . 0.0 111.066 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.31 19.01 65.39 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -118.61 163.69 16.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.151 -1.205 . . . . 0.0 110.208 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.2 133.98 34.21 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.477 -0.765 . . . . 0.0 109.896 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.617 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 90.1 m -135.41 165.8 24.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.466 -0.771 . . . . 0.0 110.875 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.33 118.29 31.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.547 -0.72 . . . . 0.0 110.387 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -129.32 126.51 39.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.577 -0.702 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.19 171.45 18.48 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.033 -1.042 . . . . 0.0 111.293 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.61 148.42 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.931 -0.48 . . . . 0.0 109.971 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -157.62 117.39 1.95 Allowed Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.21 -0.931 . . . . 0.0 110.36 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 C--N 1.314 -1.257 0 O-C-N 123.821 1.432 . . . . 0.0 110.885 179.873 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.148 0.499 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.48 130.19 46.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.425 -0.797 . . . . 0.0 109.984 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -130.84 164.68 24.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.414 -0.803 . . . . 0.0 110.087 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -155.83 152.14 23.61 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.39 134.02 19.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.429 -1.042 . . . . 0.0 110.161 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.418 ' CE ' HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -138.95 158.74 43.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.495 -0.753 . . . . 0.0 110.82 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.584 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 43.9 p90 -168.81 -169.1 0.95 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.774 -0.579 . . . . 0.0 109.984 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 68.2 m -133.18 94.42 20.31 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.253 -0.905 . . . . 0.0 110.708 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.617 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 49.0 Cg_endo -74.87 80.94 2.28 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.986 1.519 . . . . 0.0 110.21 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.34 -45.09 0.64 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.544 ' HZ2' HD22 ' A' ' 30' ' ' LEU . 13.0 t90 -70.77 -55.56 8.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.649 -0.912 . . . . 0.0 110.09 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -151.14 -165.93 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.497 -0.752 . . . . 0.0 109.744 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.57 47.74 1.57 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.299 -0.876 . . . . 0.0 110.183 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.51 HD12 HD12 ' A' ' 90' ' ' LEU . 23.1 mt -123.44 150.9 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.345 -0.847 . . . . 0.0 109.993 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.71 164.38 30.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.316 -0.865 . . . . 0.0 111.328 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.87 130.27 3.83 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.35 170.09 16.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.436 -1.038 . . . . 0.0 111.095 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.556 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -166.34 173.02 10.42 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.385 0.612 . . . . 0.0 110.836 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.43 148.48 24.58 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.391 -0.818 . . . . 0.0 110.87 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.5 t -171.22 169.17 6.51 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.661 -0.649 . . . . 0.0 110.138 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -37.94 88.68 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.288 -0.882 . . . . 0.0 110.529 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.3 t -67.56 162.95 22.27 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.498 -0.751 . . . . 0.0 110.859 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.553 ' O ' HG12 ' A' ' 73' ' ' VAL . 34.0 mt-30 -97.81 -56.24 2.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.899 -0.5 . . . . 0.0 110.122 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 m -67.24 -29.65 69.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.399 -0.813 . . . . 0.0 110.519 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.04 -41.14 97.85 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 110.174 -1.171 . . . . 0.0 110.174 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 70' ' ' GLN . 0.5 OUTLIER -65.51 -34.09 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.455 -1.027 . . . . 0.0 110.47 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.04 -39.38 86.94 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.632 -0.667 . . . . 0.0 110.375 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.07 -33.43 69.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.556 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 8.5 mmmt -73.45 -39.62 64.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.524 -0.986 . . . . 0.0 110.432 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.62 -45.45 81.51 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.105 -0.997 . . . . 0.0 109.641 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.614 ' HB1' HD12 ' A' ' 18' ' ' ILE . . . -72.3 -34.92 68.51 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.736 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.574 ' HZ2' ' HA ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -72.95 -36.45 67.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.445 -0.784 . . . . 0.0 110.702 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.91 -35.23 74.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.451 -0.781 . . . . 0.0 110.315 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.44 ' CE2' HD13 ' A' ' 29' ' ' LEU . 61.1 t80 -71.09 -40.5 71.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 110.243 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.52 HG13 HD13 ' A' ' 91' ' ' ILE . 68.8 t -67.62 -35.06 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.297 -0.877 . . . . 0.0 109.814 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -68.4 -39.07 81.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.515 -0.741 . . . . 0.0 109.733 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.46 ' HB2' ' HE3' ' A' ' 84' ' ' LYS . 1.6 tppp? -64.24 -41.13 97.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.553 -0.717 . . . . 0.0 110.109 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.71 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -69.98 -34.51 73.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.503 -0.748 . . . . 0.0 109.643 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -40.76 95.68 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.682 -0.636 . . . . 0.0 109.646 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -66.5 -38.46 87.3 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.547 -0.72 . . . . 0.0 110.362 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.64 -50.36 21.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.376 -0.827 . . . . 0.0 110.4 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.91 53.49 0.13 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.51 HD12 HD12 ' A' ' 61' ' ' ILE . 12.4 mt -125.74 -51.59 1.59 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.364 -1.08 . . . . 0.0 110.447 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.71 HD12 ' HB3' ' A' ' 85' ' ' ALA . 74.5 mt -86.75 104.85 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.714 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 58.2 m -83.77 171.98 12.65 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.527 -0.733 . . . . 0.0 109.971 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -68.16 -56.91 7.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.469 -0.769 . . . . 0.0 110.357 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -37.35 87.3 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.437 -0.789 . . . . 0.0 110.489 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 1.4 mm-40 -53.67 -42.15 67.6 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.455 -0.778 . . . . 0.0 110.017 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.681 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -63.77 -40.28 96.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.471 -0.768 . . . . 0.0 109.523 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -68.24 -38.77 82.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.694 -0.629 . . . . 0.0 109.395 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -62.89 -40.05 96.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.587 -0.695 . . . . 0.0 109.836 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.549 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 28.1 t90 -71.98 -39.03 69.58 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.4 tp . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.782 -0.574 . . . . 0.0 109.647 179.044 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.7 t -63.12 -41.5 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.723 . . . . 0.0 109.121 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.58 -39.75 95.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.662 -0.649 . . . . 0.0 109.823 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.61 -40.47 96.99 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.537 -0.727 . . . . 0.0 109.765 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.51 -40.77 97.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.502 -0.749 . . . . 0.0 109.667 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.615 HG21 ' CG2' ' A' ' 91' ' ' ILE . 90.6 t -61.62 -42.31 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.583 -0.698 . . . . 0.0 109.227 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.96 95.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.617 -0.677 . . . . 0.0 109.597 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 t -61.31 -38.93 88.61 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.606 -0.684 . . . . 0.0 109.809 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.439 ' HD3' HD23 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -67.12 -36.1 81.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 109.6 179.324 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.547 HG21 ' HB2' ' A' ' 78' ' ' ALA . 21.3 mm -58.22 -41.9 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.465 -0.772 . . . . 0.0 110.39 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.65 -45.88 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.384 -0.822 . . . . 0.0 110.096 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.09 -15.8 79.82 Favored Glycine 0 N--CA 1.501 2.981 0 C-N-CA 120.26 -0.971 . . . . 0.0 111.035 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.652 HD21 ' O ' ' A' ' 28' ' ' GLU . 15.4 tp -99.06 -21.5 16.16 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.118 -1.225 . . . . 0.0 111.285 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.595 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 21.9 t90 -65.7 130.89 44.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 0.0 111.197 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.9 ttt-85 -99.47 -160.97 0.84 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -48.55 -45.98 38.25 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.165 -0.959 . . . . 0.0 110.198 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.93 29.29 0.31 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.47 -0.769 . . . . 0.0 111.249 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.49 157.48 43.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.046 -1.034 . . . . 0.0 110.953 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.493 HG23 ' HB2' ' A' ' 34' ' ' CYS . 12.8 t -153.81 145.53 23.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.497 -0.752 . . . . 0.0 109.651 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.71 ' C ' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -102.22 108.24 19.56 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.385 -0.822 . . . . 0.0 109.794 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 28' ' ' GLU . 6.3 mt -114.05 129.37 56.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.183 -0.948 . . . . 0.0 110.924 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.839 HD12 ' HD1' ' A' ' 99' ' ' TRP . 0.4 OUTLIER 58.73 28.58 17.49 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.505 -0.747 . . . . 0.0 110.899 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.31 21.56 77.52 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.641 ' CE1' HD23 ' A' ' 30' ' ' LEU . 34.6 m170 -121.18 155.28 34.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.442 -1.034 . . . . 0.0 109.916 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -86.43 116.2 24.43 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.172 -0.955 . . . . 0.0 109.68 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.493 ' HB2' HG23 ' A' ' 27' ' ' THR . 20.1 m -116.16 173.51 6.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.574 -0.703 . . . . 0.0 109.66 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 4.9 tptt -132.87 108.96 9.28 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.525 -0.734 . . . . 0.0 111.065 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.595 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 47.4 t80 -108.82 139.25 43.9 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 p -144.65 152.91 41.15 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.931 -1.105 . . . . 0.0 111.721 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.412 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 88.3 t -133.2 123.17 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -138.21 117.41 9.73 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.185 -0.947 . . . . 0.0 110.664 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 55.2 Cg_endo . . . . . 0 C--N 1.312 -1.377 0 O-C-N 124.018 1.536 . . . . 0.0 110.633 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.321 0.581 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.431 ' CD1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -109.87 131.34 55.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.452 -0.78 . . . . 0.0 109.664 179.317 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -129.42 159.65 35.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.19 -0.944 . . . . 0.0 110.457 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -153.56 142.82 9.51 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.455 ' HG2' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -138.77 149.99 45.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.922 -0.752 . . . . 0.0 109.85 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.0 ptm -145.69 156.44 43.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.966 -1.084 . . . . 0.0 111.433 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.613 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 23.4 p90 -166.42 164.56 17.34 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.885 -0.51 . . . . 0.0 110.301 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.3 m -128.08 98.42 27.03 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.248 -0.908 . . . . 0.0 110.312 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.613 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.6 Cg_endo -75.13 84.65 1.65 Allowed 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.833 1.438 . . . . 0.0 110.577 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 143.22 -43.99 0.99 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -70.19 -59.84 2.64 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.472 -1.016 . . . . 0.0 110.1 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.3 t -150.07 -170.11 3.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.464 -0.773 . . . . 0.0 110.044 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.53 41.06 2.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.509 -0.744 . . . . 0.0 110.302 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.432 HD11 ' HB3' ' A' ' 84' ' ' LYS . 2.7 tt -118.24 153.97 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.51 -0.744 . . . . 0.0 109.666 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.09 171.62 14.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.103 -0.998 . . . . 0.0 111.405 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.557 ' HA3' ' HB2' ' A' ' 81' ' ' PHE . . . -141.2 126.91 3.21 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.455 ' HG2' ' HG2' ' A' ' 52' ' ' ARG . 6.2 mt-10 -135.57 153.01 51.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.459 -1.024 . . . . 0.0 110.441 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.483 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -170.7 164.43 8.12 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.592 -0.693 . . . . 0.0 110.713 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.476 ' HA ' HG23 ' A' ' 73' ' ' VAL . 1.0 OUTLIER -153.05 149.95 28.66 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.459 -0.776 . . . . 0.0 111.03 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.414 HG22 HG23 ' A' ' 73' ' ' VAL . 9.7 t -173.89 156.98 2.91 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 mtm105 -60.5 -24.27 65.19 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.263 -0.898 . . . . 0.0 111.026 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.25 139.45 54.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.237 -0.914 . . . . 0.0 110.545 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.401 ' O ' HG12 ' A' ' 73' ' ' VAL . 70.7 mt-30 -75.82 -53.72 8.03 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.531 -0.731 . . . . 0.0 110.358 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 t -81.07 -30.34 34.77 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.392 -0.818 . . . . 0.0 109.937 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.93 -36.52 88.24 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 66' ' ' SER . 0.5 OUTLIER -63.16 -35.41 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.446 -1.032 . . . . 0.0 110.344 179.644 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.47 87.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.441 -0.787 . . . . 0.0 110.119 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.06 -30.91 71.95 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.483 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -73.55 -39.96 64.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.55 -0.971 . . . . 0.0 110.235 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 63' ' ' GLY . 99.3 m -64.59 -40.17 95.04 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.279 -0.888 . . . . 0.0 109.117 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.547 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -67.17 -39.27 86.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.623 -0.673 . . . . 0.0 109.657 178.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -59.75 -41.75 91.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.536 -0.727 . . . . 0.0 110.007 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.87 -41.22 95.84 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.462 -0.774 . . . . 0.0 109.653 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.557 ' HB2' ' HA3' ' A' ' 63' ' ' GLY . 43.3 t80 -69.7 -38.39 76.96 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.55 -0.719 . . . . 0.0 109.813 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.0 -37.79 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.417 -0.802 . . . . 0.0 109.93 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.37 -40.02 85.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.303 -0.873 . . . . 0.0 109.67 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HB3' HD11 ' A' ' 61' ' ' ILE . 77.7 mttt -67.71 -40.22 84.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.536 -0.727 . . . . 0.0 109.388 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.45 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -67.78 -36.81 81.14 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.632 -0.667 . . . . 0.0 109.774 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -33.38 74.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.594 -0.691 . . . . 0.0 109.956 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -64.25 -31.23 72.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.384 -0.823 . . . . 0.0 110.653 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.3 -66.83 0.89 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.379 -0.826 . . . . 0.0 110.135 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 151.39 51.6 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 90' ' ' LEU . 6.3 mt -112.0 -38.97 4.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.229 -1.159 . . . . 0.0 110.472 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.615 ' CG2' HG21 ' A' ' 14' ' ' VAL . 80.9 mt -103.82 69.42 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 109.757 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.544 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 72.1 m -73.3 -178.61 3.02 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.516 -0.74 . . . . 0.0 110.353 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.62 -59.68 3.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.199 -0.938 . . . . 0.0 110.651 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -63.25 -39.63 95.15 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.359 -0.838 . . . . 0.0 109.94 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 11.4 mt-10 -61.57 -42.66 99.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.576 -0.703 . . . . 0.0 109.493 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.06 -37.03 81.22 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.619 -0.676 . . . . 0.0 109.714 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -62.2 -44.79 95.8 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -30.96 63.45 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.513 -0.742 . . . . 0.0 109.011 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.839 ' HD1' HD12 ' A' ' 30' ' ' LEU . 30.2 t90 -68.55 -40.4 80.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.705 -0.622 . . . . 0.0 109.958 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.439 HD23 ' HD3' ' A' ' 17' ' ' LYS . 21.2 mt . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.533 -0.729 . . . . 0.0 110.346 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 120.984 0.421 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.05 -42.09 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.525 -0.734 . . . . 0.0 109.459 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.54 ' HB1' ' CG1' ' A' ' 82' ' ' VAL . . . -69.13 -36.9 77.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.514 -0.742 . . . . 0.0 109.485 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.6 89.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.642 -0.661 . . . . 0.0 109.79 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.81 -41.17 95.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.404 -0.81 . . . . 0.0 109.46 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.579 HG13 ' CZ3' ' A' ' 99' ' ' TRP . 25.5 t -62.32 -40.7 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.639 -0.663 . . . . 0.0 109.41 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.542 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -63.87 -39.39 94.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.573 -0.705 . . . . 0.0 109.408 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.8 m -62.5 -39.53 93.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.65 -0.656 . . . . 0.0 109.684 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.448 ' HB3' ' HZ3' ' A' ' 99' ' ' TRP . 0.5 OUTLIER -63.39 -37.78 88.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.506 -0.747 . . . . 0.0 109.773 179.328 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.501 HD12 ' HB1' ' A' ' 78' ' ' ALA . 2.5 mt -61.84 -37.51 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.556 -0.715 . . . . 0.0 109.984 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.2 t -63.67 -48.58 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.232 -0.917 . . . . 0.0 109.789 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.4 -15.42 81.48 Favored Glycine 0 N--CA 1.5 2.918 0 C-N-CA 120.271 -0.966 . . . . 0.0 110.698 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.66 HD21 ' O ' ' A' ' 28' ' ' GLU . 11.9 tp -99.38 -16.83 18.27 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.232 -1.158 . . . . 0.0 111.203 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.582 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 24.5 t90 -69.44 137.02 52.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.177 -0.952 . . . . 0.0 111.308 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.49 -162.2 0.87 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -45.68 -45.17 13.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.309 -0.869 . . . . 0.0 110.635 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.5 31.83 0.19 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.437 -0.79 . . . . 0.0 111.28 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -153.15 162.76 40.94 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.066 -1.021 . . . . 0.0 110.792 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.611 HG23 ' HB2' ' A' ' 34' ' ' CYS . 11.4 t -157.44 144.28 18.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.395 -0.816 . . . . 0.0 109.996 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.675 ' C ' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -102.56 109.4 21.01 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.517 -0.739 . . . . 0.0 109.621 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.675 HD23 ' C ' ' A' ' 28' ' ' GLU . 7.9 mt -114.04 130.34 56.56 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.221 -0.924 . . . . 0.0 110.797 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.525 HD22 ' CZ2' ' A' ' 58' ' ' TRP . 7.1 tp 56.58 30.33 17.13 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.563 -0.71 . . . . 0.0 110.671 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.82 24.84 73.31 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.515 ' CE1' HD23 ' A' ' 30' ' ' LEU . 35.2 m170 -124.54 159.89 29.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -1.038 . . . . 0.0 109.723 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -91.46 121.92 33.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 110.545 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.611 ' HB2' HG23 ' A' ' 27' ' ' THR . 23.0 m -122.36 164.14 18.49 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 5.5 tptm -125.58 110.48 13.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.36 -0.838 . . . . 0.0 111.146 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.582 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 12.8 t80 -110.66 138.49 46.98 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.9 p -143.05 157.43 44.54 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.025 -1.047 . . . . 0.0 111.389 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.451 HG12 ' HD3' ' A' ' 40' ' ' PRO . 99.6 t -129.09 130.06 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.63 -0.669 . . . . 0.0 109.872 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 83.67 64.71 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 0.0 110.451 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.451 ' HD3' HG12 ' A' ' 38' ' ' VAL . 55.5 Cg_endo . . . . . 0 C--N 1.31 -1.448 0 O-C-N 123.855 1.45 . . . . 0.0 110.627 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.217 0.532 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.599 ' CD2' ' HA ' ' A' ' 70' ' ' GLN . 2.1 m-85 -105.72 131.7 52.76 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.555 -0.715 . . . . 0.0 110.42 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.93 156.57 37.79 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.399 -0.813 . . . . 0.0 109.597 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -159.46 141.16 7.32 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.569 -1.301 . . . . 0.0 110.671 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HG3' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -141.03 146.96 37.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.88 -0.776 . . . . 0.0 109.756 179.5 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.579 ' HG2' HG22 ' A' ' 77' ' ' THR . 5.1 ptm -139.05 155.92 47.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 111.327 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.474 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 45.6 p90 -155.91 145.75 21.26 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.916 -0.49 . . . . 0.0 109.797 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 87.3 m -111.98 89.42 11.6 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.236 -0.915 . . . . 0.0 111.066 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -77.74 82.85 2.3 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 123.703 1.37 . . . . 0.0 110.149 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.34 -45.14 0.61 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.525 ' CZ2' HD22 ' A' ' 30' ' ' LEU . 11.2 t90 -75.0 -63.28 1.3 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.533 -0.98 . . . . 0.0 110.096 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.2 t -142.41 -162.92 1.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.5 -0.75 . . . . 0.0 109.52 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.7 44.95 2.5 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.296 -0.878 . . . . 0.0 110.395 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.505 HG23 ' HD3' ' A' ' 84' ' ' LYS . 74.0 mt -123.14 140.71 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.361 -0.837 . . . . 0.0 110.234 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.57 170.88 10.49 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.414 -0.804 . . . . 0.0 110.514 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.02 136.21 4.69 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.405 ' HB2' ' HG3' ' A' ' 52' ' ' ARG . 13.1 tt0 -139.6 161.19 38.12 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.809 -0.818 . . . . 0.0 110.357 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.469 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -165.89 151.01 8.59 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.768 -0.582 . . . . 0.0 110.229 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.406 ' HA ' HG23 ' A' ' 73' ' ' VAL . 0.7 OUTLIER -141.71 142.07 33.31 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.426 -0.796 . . . . 0.0 110.601 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.6 t -168.03 172.65 8.66 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.404 -0.81 . . . . 0.0 110.224 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -71.18 -24.8 62.3 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.371 -0.831 . . . . 0.0 110.904 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.74 139.73 56.69 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.277 -0.889 . . . . 0.0 110.743 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.599 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 5.8 tt0 -76.27 -53.78 7.73 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.724 -0.61 . . . . 0.0 110.349 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -84.26 -30.29 25.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.43 -0.794 . . . . 0.0 110.02 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.68 -39.4 93.44 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 70' ' ' GLN . 3.3 p -61.56 -37.39 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.371 -1.076 . . . . 0.0 110.5 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.92 82.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.526 -0.734 . . . . 0.0 110.036 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.97 -36.91 91.7 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.469 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 8.1 mttp -66.61 -39.94 88.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.519 -0.989 . . . . 0.0 110.267 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.579 HG22 ' HG2' ' A' ' 53' ' ' MET . 53.4 m -63.49 -42.16 98.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.269 -0.895 . . . . 0.0 109.02 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.542 ' HB1' ' HA ' ' A' ' 15' ' ' ALA . . . -70.2 -38.59 75.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.579 -0.7 . . . . 0.0 109.541 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.567 ' O ' HG12 ' A' ' 82' ' ' VAL . 7.3 ttmt -62.82 -39.69 95.1 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.613 -0.679 . . . . 0.0 110.157 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -68.54 -38.56 80.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 0.0 109.738 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -70.81 -38.42 73.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 109.422 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -68.77 -34.29 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.391 -0.818 . . . . 0.0 109.748 179.45 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -42.14 89.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.292 -0.88 . . . . 0.0 109.211 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.505 ' HD3' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -67.2 -39.06 86.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.565 -0.709 . . . . 0.0 109.195 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.85 -34.86 77.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.706 -0.621 . . . . 0.0 109.669 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.53 -39.57 91.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.673 -0.642 . . . . 0.0 109.316 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -64.83 -40.18 94.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.633 -0.667 . . . . 0.0 110.448 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -75.51 -54.09 7.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.419 -0.801 . . . . 0.0 110.297 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.01 53.98 0.08 OUTLIER Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.521 ' HA ' HD23 ' A' ' 90' ' ' LEU . 7.6 mt -118.83 -48.83 2.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.307 -1.113 . . . . 0.0 110.171 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 35.1 mm -88.9 75.77 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.365 -0.834 . . . . 0.0 109.706 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.628 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 19.6 t -73.9 175.91 6.89 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.431 -0.793 . . . . 0.0 110.287 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -67.2 -58.75 4.27 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.292 -0.88 . . . . 0.0 110.834 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -65.57 -39.76 92.03 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.415 -0.803 . . . . 0.0 110.08 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 0.7 OUTLIER -64.09 -39.6 94.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.635 -0.665 . . . . 0.0 109.69 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.44 80.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.503 -0.748 . . . . 0.0 109.328 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -63.25 -46.04 88.76 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -36.09 73.43 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.579 ' CZ3' HG13 ' A' ' 14' ' ' VAL . 50.7 t90 -62.76 -41.75 99.36 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.1 mt . . . . . 0 N--CA 1.495 1.818 0 O-C-N 121.56 -0.712 . . . . 0.0 109.733 179.409 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.165 0.507 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.5 114.48 9.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.464 -0.773 . . . . 0.0 110.122 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.443 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 45.4 p90 -132.6 142.97 49.38 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.433 -0.792 . . . . 0.0 110.495 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 3' ' ' TYR . 97.5 t 62.61 -71.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 O-C-N 122.044 -0.41 . . . . 0.0 110.895 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 3' ' ' TYR . 1.0 OUTLIER -86.48 62.8 7.63 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.106 -0.996 . . . . 0.0 110.27 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.05 -42.76 98.04 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -62.37 -36.33 81.91 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.585 -0.95 . . . . 0.0 110.717 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -67.38 -38.58 84.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.301 -0.875 . . . . 0.0 109.396 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.64 -39.86 91.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.539 -0.725 . . . . 0.0 109.517 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 14' ' ' VAL . 46.9 t -63.53 -39.76 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.609 -0.682 . . . . 0.0 109.486 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.471 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -63.88 -39.84 95.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.528 -0.732 . . . . 0.0 109.642 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.593 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . . . -63.5 -41.12 98.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.635 -0.666 . . . . 0.0 109.745 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.58 94.54 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.548 -0.72 . . . . 0.0 109.696 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 10' ' ' VAL . 79.2 t -64.38 -39.79 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.544 -0.723 . . . . 0.0 109.536 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.473 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -64.43 -39.62 94.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.397 -0.814 . . . . 0.0 109.749 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.39 -39.51 93.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.432 -0.793 . . . . 0.0 109.651 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.768 ' HD2' HD23 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -65.82 -31.24 72.09 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.543 -0.723 . . . . 0.0 110.068 179.297 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.546 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.2 mm -63.87 -43.42 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.431 -0.793 . . . . 0.0 109.651 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.689 HG22 ' HB1' ' A' ' 74' ' ' ALA . 54.6 t -68.02 -40.47 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.458 -0.776 . . . . 0.0 110.029 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.88 -25.26 75.4 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.22 36.33 4.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.321 -1.105 . . . . 0.0 110.939 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 23.8 t90 -102.95 137.76 40.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.18 -0.95 . . . . 0.0 110.984 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -168.57 1.67 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -46.34 -44.55 16.92 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.199 -0.938 . . . . 0.0 110.31 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.401 ' HB2' ' CG2' ' A' ' 37' ' ' THR . 12.9 pt-20 -158.64 36.48 0.23 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.537 -0.727 . . . . 0.0 110.619 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.29 151.13 31.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.198 -0.939 . . . . 0.0 110.584 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 t -152.69 175.48 12.78 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.473 -0.767 . . . . 0.0 109.625 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.95 126.4 31.97 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.334 -0.854 . . . . 0.0 110.379 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.546 ' HG ' HD11 ' A' ' 18' ' ' ILE . 2.8 mt -111.62 124.4 52.24 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.359 -0.838 . . . . 0.0 110.206 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.466 HD12 ' HB2' ' A' ' 99' ' ' TRP . 2.5 tp 56.71 29.81 16.48 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.647 -0.658 . . . . 0.0 111.175 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.03 -6.84 82.96 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -91.09 158.79 16.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.977 -1.308 . . . . 0.0 110.222 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -84.17 138.32 33.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.423 -0.798 . . . . 0.0 110.12 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.535 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 91.5 m -142.11 167.52 21.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.364 -0.835 . . . . 0.0 110.455 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -122.89 113.38 19.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.485 -0.76 . . . . 0.0 110.718 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 1.6 t80 -114.67 130.14 56.77 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -140.67 162.38 35.53 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.947 -1.096 . . . . 0.0 111.733 -178.709 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.26 152.68 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.86 -0.525 . . . . 0.0 109.875 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -157.17 102.42 1.9 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.11 -0.994 . . . . 0.0 110.388 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -78.08 151.04 26.82 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.898 1.473 . . . . 0.0 111.101 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -126.17 -173.31 2.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.61 -0.681 . . . . 0.0 109.634 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.419 ' CD1' HG22 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -139.72 144.72 37.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.636 -0.665 . . . . 0.0 111.099 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -115.21 173.6 6.42 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 -45.35 -33.21 2.38 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.685 -0.634 . . . . 0.0 111.289 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -155.34 41.53 0.43 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.535 -0.728 . . . . 0.0 110.314 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -158.65 170.34 22.39 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.204 -0.935 . . . . 0.0 110.998 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.419 HG22 ' CD1' ' A' ' 42' ' ' LEU . 80.3 t -133.21 124.31 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -114.12 147.78 38.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.202 -0.936 . . . . 0.0 111.07 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.499 ' O ' HG21 ' A' ' 73' ' ' VAL . 0.3 OUTLIER -111.58 117.4 32.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.597 -0.689 . . . . 0.0 109.887 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.11 162.81 14.53 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.605 -0.684 . . . . 0.0 109.776 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.55 157.32 29.66 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.847 -1.168 . . . . 0.0 110.287 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.487 ' CD ' ' HB3' ' A' ' 64' ' ' GLU . 0.6 OUTLIER -153.91 141.26 19.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.698 -0.884 . . . . 0.0 109.854 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.575 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 2.8 ppp? -142.74 148.77 37.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.34 -0.85 . . . . 0.0 110.903 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.51 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 47.3 p90 -155.28 171.1 20.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.836 -0.54 . . . . 0.0 109.871 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 61.7 m -121.59 91.12 48.39 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 0.0 110.808 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.535 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 46.9 Cg_endo -76.9 83.93 2.02 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.939 1.494 . . . . 0.0 109.9 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.26 -47.23 0.49 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -73.29 -53.83 9.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.533 -0.98 . . . . 0.0 110.096 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.9 t -152.67 -160.9 1.2 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.531 -0.731 . . . . 0.0 109.963 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.7 68.95 0.97 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.285 -0.884 . . . . 0.0 110.345 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.446 HD12 HD12 ' A' ' 90' ' ' LEU . 41.1 mt -138.88 155.83 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.386 -0.822 . . . . 0.0 110.072 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.66 166.0 25.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.464 -0.772 . . . . 0.0 110.891 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.433 ' HA3' ' N ' ' A' ' 81' ' ' PHE . . . -159.53 128.77 2.07 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.487 ' HB3' ' CD ' ' A' ' 52' ' ' ARG . 1.4 pt-20 -137.66 165.33 26.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.596 -0.943 . . . . 0.0 110.897 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.564 ' HB1' ' CG ' ' A' ' 76' ' ' LYS . . . -158.53 161.08 37.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.716 -0.615 . . . . 0.0 110.632 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.5 m -143.4 151.63 40.62 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.465 -0.772 . . . . 0.0 110.282 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.0 t -174.6 -177.31 1.16 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.65 -0.657 . . . . 0.0 110.148 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -82.77 -31.77 28.13 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.258 -0.902 . . . . 0.0 110.125 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.91 146.92 53.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.352 -0.843 . . . . 0.0 110.353 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.493 ' O ' HG12 ' A' ' 73' ' ' VAL . 34.4 mt-30 -83.49 -54.78 4.71 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.516 -0.74 . . . . 0.0 110.316 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 m -75.26 -30.83 60.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.453 -0.78 . . . . 0.0 110.237 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.86 -39.7 94.25 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 49' ' ' TYR . 0.8 OUTLIER -63.32 -34.03 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.273 -1.134 . . . . 0.0 110.471 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.689 ' HB1' HG22 ' A' ' 19' ' ' VAL . . . -64.78 -47.4 78.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.518 -0.739 . . . . 0.0 109.869 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.79 -32.32 77.62 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.564 ' CG ' ' HB1' ' A' ' 65' ' ' ALA . 11.5 tptp -69.55 -40.9 76.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.599 -0.942 . . . . 0.0 110.224 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.535 HG22 ' HG2' ' A' ' 53' ' ' MET . 5.7 m -64.99 -41.04 95.76 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.471 -0.768 . . . . 0.0 109.919 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.525 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -70.37 -34.56 72.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.405 -0.809 . . . . 0.0 110.114 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.593 ' HE3' ' HA ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -67.36 -39.69 85.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 110.239 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.471 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 0.7 OUTLIER -67.09 -38.47 85.76 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.453 -0.78 . . . . 0.0 109.935 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.433 ' N ' ' HA3' ' A' ' 63' ' ' GLY . 39.6 t80 -67.18 -40.48 86.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.482 -0.761 . . . . 0.0 109.445 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.48 ' HA ' ' CD1' ' A' ' 91' ' ' ILE . 55.8 t -67.14 -36.83 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.44 -0.787 . . . . 0.0 109.829 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.471 ' NH1' ' HA ' ' A' ' 80' ' ' ASP . 4.1 ttp180 -65.26 -39.2 92.34 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.369 -0.832 . . . . 0.0 110.142 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -67.49 -39.91 85.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.276 -0.89 . . . . 0.0 110.04 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.819 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -73.59 -29.53 62.45 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.43 -0.794 . . . . 0.0 110.139 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 1.8 t80 -74.1 -37.69 64.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.488 -0.758 . . . . 0.0 110.295 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -37.08 84.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.362 -0.836 . . . . 0.0 110.234 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -73.96 -53.92 9.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.279 -0.888 . . . . 0.0 110.054 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.87 53.27 0.07 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' A' ' 90' ' ' LEU . 11.0 mt -122.31 -56.92 1.79 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.364 -1.08 . . . . 0.0 110.346 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.819 HD12 ' HB3' ' A' ' 85' ' ' ALA . 82.4 mt -77.72 109.6 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.33 -0.856 . . . . 0.0 109.911 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.6 m -93.8 167.19 11.8 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.357 -0.839 . . . . 0.0 110.286 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.22 -48.5 70.39 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.492 -0.755 . . . . 0.0 110.424 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -63.56 -42.59 98.34 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.537 -0.727 . . . . 0.0 110.728 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.08 -43.59 98.5 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.416 -0.802 . . . . 0.0 110.245 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.32 87.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.584 -0.697 . . . . 0.0 109.94 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -67.34 -38.3 84.66 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.61 -0.682 . . . . 0.0 110.313 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.99 -38.78 86.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.343 -0.848 . . . . 0.0 109.652 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.578 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 15.4 t90 -66.06 -40.94 91.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.548 -0.72 . . . . 0.0 109.861 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.768 HD23 ' HD2' ' A' ' 17' ' ' LYS . 16.4 mt -66.81 -32.93 74.53 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.603 -0.686 . . . . 0.0 110.148 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 74.5 m -66.26 -55.51 15.78 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.538 -0.726 . . . . 0.0 110.107 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.7 p . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.425 179.738 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 121.137 0.494 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.14 171.06 15.06 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.507 -0.746 . . . . 0.0 110.372 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.93 -62.57 1.32 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.311 -0.868 . . . . 0.0 110.226 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.62 18.36 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.395 -0.815 . . . . 0.0 110.753 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -96.58 85.92 3.99 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.217 -0.927 . . . . 0.0 109.973 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.05 50.82 0.04 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -59.24 -35.74 74.21 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.643 -0.916 . . . . 0.0 110.17 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.497 ' HG3' ' HE2' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -65.6 -36.25 83.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.48 -0.762 . . . . 0.0 109.807 179.272 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.01 -42.7 89.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.433 -0.792 . . . . 0.0 109.445 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 14' ' ' VAL . 99.1 t -66.1 -40.83 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.05 -40.01 95.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.695 -0.628 . . . . 0.0 109.383 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.463 ' HA ' ' HG3' ' A' ' 79' ' ' LYS . . . -62.44 -41.32 98.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.71 -0.619 . . . . 0.0 109.486 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.93 97.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.617 -0.677 . . . . 0.0 109.55 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 10' ' ' VAL . 84.9 t -64.59 -41.37 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.541 -0.724 . . . . 0.0 109.237 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.18 -38.37 87.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.665 -0.647 . . . . 0.0 109.548 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.8 m -63.85 -39.03 93.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.575 -0.703 . . . . 0.0 109.698 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.46 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 17.4 tttm -66.01 -34.63 78.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.458 -0.776 . . . . 0.0 109.843 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.884 HD12 ' HB1' ' A' ' 78' ' ' ALA . 10.1 mt -65.07 -46.8 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.5 -0.75 . . . . 0.0 109.288 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.8 t -62.72 -40.18 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.656 -0.652 . . . . 0.0 109.965 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.49 -27.85 73.55 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.6 tp -115.75 38.47 3.29 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.405 -1.056 . . . . 0.0 110.725 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -101.81 137.68 39.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.241 -0.912 . . . . 0.0 110.458 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.98 -166.92 1.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.461 -0.774 . . . . 0.0 109.215 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -49.31 -41.53 38.68 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.185 -0.947 . . . . 0.0 110.442 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.7 33.81 0.19 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.615 -0.678 . . . . 0.0 110.609 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.23 153.57 37.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.199 -0.938 . . . . 0.0 110.849 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.5 t -155.56 151.78 28.0 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.392 -0.818 . . . . 0.0 109.876 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -105.61 121.27 43.63 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.179 -0.95 . . . . 0.0 110.782 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.608 HD21 HD11 ' A' ' 18' ' ' ILE . 1.3 mt -114.29 126.83 55.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.564 -0.71 . . . . 0.0 110.053 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.544 HD11 ' HG2' ' A' ' 95' ' ' GLU . 1.7 tp 54.17 33.7 18.54 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.649 -0.657 . . . . 0.0 111.016 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.09 23.94 74.88 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -123.14 145.01 48.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -1.093 . . . . 0.0 109.942 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 123.7 24.57 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.422 -0.799 . . . . 0.0 110.404 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.517 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 83.5 m -128.43 161.94 28.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.658 -0.651 . . . . 0.0 109.25 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.57 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -116.32 117.51 30.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.358 -0.839 . . . . 0.0 110.916 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.456 ' HE2' ' HB2' ' A' ' 78' ' ' ALA . 7.0 t80 -118.75 125.19 49.09 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.75 154.58 51.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.12 -0.988 . . . . 0.0 111.496 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.5 t -137.18 142.69 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.701 -0.625 . . . . 0.0 109.872 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.81 123.95 2.48 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.243 -0.911 . . . . 0.0 110.592 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HB3' ' CD2' ' A' ' 49' ' ' TYR . 51.2 Cg_endo -78.56 158.55 28.75 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 O-C-N 123.903 1.475 . . . . 0.0 110.954 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -133.3 -168.39 2.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.629 -0.67 . . . . 0.0 109.765 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -125.51 146.62 49.57 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.537 0.684 . . . . 0.0 110.803 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.407 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -118.64 174.07 6.48 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -41.28 -33.93 0.44 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.894 -0.504 . . . . 0.0 111.511 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -162.3 42.37 0.13 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.46 -0.775 . . . . 0.0 110.48 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -165.11 154.17 12.49 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.113 -0.992 . . . . 0.0 111.224 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.5 t -99.35 122.07 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.493 -0.754 . . . . 0.0 109.03 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -110.26 162.65 14.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.215 -0.928 . . . . 0.0 111.139 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.486 ' CZ ' ' HG2' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -122.39 128.93 51.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 110.152 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -132.28 151.73 51.7 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.53 -0.732 . . . . 0.0 110.088 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.22 154.86 26.13 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.44 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.425 ' HD3' ' HB2' ' A' ' 64' ' ' GLU . 8.0 ttp180 -146.19 143.67 29.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.718 -0.872 . . . . 0.0 110.059 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.885 ' HG2' HG22 ' A' ' 77' ' ' THR . 0.4 OUTLIER -143.48 157.72 44.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.366 -0.834 . . . . 0.0 111.133 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.57 ' CE2' ' HB3' ' A' ' 35' ' ' LYS . 42.9 p90 -161.43 -175.47 4.81 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.726 -0.609 . . . . 0.0 109.773 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 58' ' ' TRP . 69.6 m -133.19 95.91 18.02 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.102 -0.999 . . . . 0.0 110.644 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.564 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.3 Cg_endo -74.32 77.97 2.75 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.991 1.522 . . . . 0.0 110.333 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.26 -45.52 0.66 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.522 ' HB3' ' HB3' ' A' ' 55' ' ' CYS . 15.3 t90 -68.65 -53.32 23.13 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.475 -1.015 . . . . 0.0 110.267 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.1 t -153.64 -168.56 3.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.553 -0.717 . . . . 0.0 109.754 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.22 45.96 1.89 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.322 -0.861 . . . . 0.0 110.447 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.3 mt -121.15 150.8 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.373 -0.829 . . . . 0.0 109.851 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 ptt-85 -131.15 163.16 28.29 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.284 -0.885 . . . . 0.0 110.834 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.85 155.55 23.26 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.425 ' HB2' ' HD3' ' A' ' 52' ' ' ARG . 6.7 tt0 -158.39 154.31 26.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -1.112 . . . . 0.0 110.508 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.664 ' HB1' ' HG2' ' A' ' 76' ' ' LYS . . . -166.19 152.97 9.43 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.52 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.422 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 3.6 m -139.08 150.77 46.12 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 110.594 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.502 HG22 HG23 ' A' ' 73' ' ' VAL . 10.0 t -172.71 164.63 5.34 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.705 -0.622 . . . . 0.0 109.994 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -63.29 -31.75 72.98 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.506 -0.746 . . . . 0.0 110.16 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.05 136.64 56.28 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.511 -0.743 . . . . 0.0 110.63 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.501 ' O ' HG12 ' A' ' 73' ' ' VAL . 12.1 mt-30 -77.17 -56.35 4.65 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.581 -0.699 . . . . 0.0 110.362 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 t -76.67 -31.44 57.29 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.312 -0.868 . . . . 0.0 110.037 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.91 -38.36 93.99 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.502 HG23 HG22 ' A' ' 67' ' ' THR . 0.8 OUTLIER -58.19 -35.76 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.456 -1.026 . . . . 0.0 110.577 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.16 84.29 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.561 -0.712 . . . . 0.0 109.809 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -64.4 -36.37 93.11 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.664 ' HG2' ' HB1' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -70.8 -39.02 73.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.384 -1.068 . . . . 0.0 110.274 179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.885 HG22 ' HG2' ' A' ' 53' ' ' MET . 18.7 m -66.52 -37.8 85.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.336 -0.852 . . . . 0.0 110.026 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.884 ' HB1' HD12 ' A' ' 18' ' ' ILE . . . -78.47 -35.49 46.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.525 -0.735 . . . . 0.0 110.232 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.497 ' HE2' ' HG3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -71.88 -38.7 69.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.386 -0.821 . . . . 0.0 109.651 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.6 -36.5 83.91 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.522 -0.737 . . . . 0.0 109.512 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -67.96 -39.89 83.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.711 . . . . 0.0 109.671 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 78' ' ' ALA . 72.5 t -66.41 -37.76 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.542 -0.724 . . . . 0.0 109.718 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -38.62 91.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.419 -0.8 . . . . 0.0 109.669 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -38.43 72.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.535 -0.728 . . . . 0.0 109.315 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.405 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -67.53 -34.92 78.07 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.539 -0.725 . . . . 0.0 109.799 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.08 -38.39 82.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 109.542 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -66.87 -39.3 87.49 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.496 -0.753 . . . . 0.0 110.342 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -72.96 -54.48 8.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.404 -0.81 . . . . 0.0 110.256 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.54 54.33 0.08 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.498 ' HA ' HD23 ' A' ' 90' ' ' LEU . 8.4 mt -121.17 -49.08 2.19 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -1.091 . . . . 0.0 110.494 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.405 HD12 ' HB3' ' A' ' 85' ' ' ALA . 95.8 mt -94.23 112.14 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.379 -0.826 . . . . 0.0 110.199 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 4.0 m -83.14 179.5 7.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.435 -0.79 . . . . 0.0 110.411 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -75.41 -60.23 2.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.337 -0.852 . . . . 0.0 110.245 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -63.08 -38.2 90.23 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.423 -0.798 . . . . 0.0 110.153 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 17.7 tt0 -55.09 -44.89 75.28 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.749 -0.594 . . . . 0.0 110.2 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.78 94.02 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.492 -0.755 . . . . 0.0 109.786 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.533 ' HA ' HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -65.41 -38.43 89.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.562 -0.711 . . . . 0.0 109.956 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -64.89 -40.89 95.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.803 . . . . 0.0 109.599 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.46 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 15.0 t90 -68.53 -39.27 81.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.448 -0.783 . . . . 0.0 109.155 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.533 HD12 ' HA ' ' A' ' 97' ' ' ASN . 24.9 mt -55.05 -40.78 70.64 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.1 m -72.45 -43.74 63.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.549 -0.719 . . . . 0.0 109.807 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.219 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 120.935 0.398 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.97 75.3 0.28 Allowed 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.332 0.587 . . . . 0.0 110.739 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -147.75 156.31 42.61 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.28 -0.887 . . . . 0.0 110.519 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' A' ' 9' ' ' ALA . 10.6 p -131.84 32.28 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.458 -0.776 . . . . 0.0 110.579 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 58.65 -173.28 0.1 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.521 -0.737 . . . . 0.0 111.359 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -108.71 -63.62 0.55 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -58.96 -46.59 87.66 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.614 -0.933 . . . . 0.0 110.01 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.09 -39.36 85.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.774 -0.579 . . . . 0.0 109.949 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -62.63 -41.25 98.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.586 -0.696 . . . . 0.0 109.722 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.3 t -66.19 -39.45 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.445 -0.784 . . . . 0.0 109.11 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.695 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -66.46 -38.72 87.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.673 -0.642 . . . . 0.0 109.487 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.2 95.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.652 -0.655 . . . . 0.0 109.841 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.43 -41.57 98.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.459 -0.776 . . . . 0.0 109.648 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 10' ' ' VAL . 62.2 t -64.94 -39.2 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.448 -0.783 . . . . 0.0 109.241 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.38 -37.03 86.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.587 -0.696 . . . . 0.0 109.853 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -66.97 -39.28 87.19 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.476 -0.765 . . . . 0.0 109.58 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.553 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 16.6 tptt -66.44 -31.1 71.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.444 -0.785 . . . . 0.0 109.724 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.585 HG21 ' HB2' ' A' ' 78' ' ' ALA . 11.2 mm -62.56 -50.4 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.412 -0.805 . . . . 0.0 109.1 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.82 -37.75 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.722 . . . . 0.0 109.878 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.58 -27.72 73.64 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.41 36.41 4.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.262 -1.14 . . . . 0.0 110.805 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.476 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 23.6 t90 -102.75 135.36 44.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.133 -0.98 . . . . 0.0 110.943 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.12 -164.02 1.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -48.86 -45.91 41.54 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.075 -1.016 . . . . 0.0 109.891 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -156.77 34.14 0.3 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.712 -0.617 . . . . 0.0 110.45 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.83 150.07 41.16 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.1 -1.0 . . . . 0.0 111.154 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.542 HG23 ' CB ' ' A' ' 34' ' ' CYS . 2.1 t -151.7 165.66 33.71 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -128.95 115.36 17.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.094 -1.004 . . . . 0.0 110.411 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.509 HD12 ' SG ' ' A' ' 34' ' ' CYS . 3.7 mt -100.94 119.79 39.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.463 -0.773 . . . . 0.0 110.166 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' A' ' 99' ' ' TRP . 3.7 tp 56.67 30.45 17.52 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.743 -0.598 . . . . 0.0 111.127 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.63 -11.85 67.18 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 38.8 m80 -83.98 146.77 27.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.128 -1.219 . . . . 0.0 110.121 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -73.79 133.0 43.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.463 -0.773 . . . . 0.0 110.02 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.542 ' CB ' HG23 ' A' ' 27' ' ' THR . 15.2 m -136.08 171.28 14.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.553 -0.717 . . . . 0.0 110.042 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.524 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -132.9 120.42 21.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.475 -0.765 . . . . 0.0 110.339 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.453 ' HB2' HG21 ' A' ' 27' ' ' THR . 40.6 t80 -122.92 135.48 54.51 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.8 p -141.78 150.99 42.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.004 -1.06 . . . . 0.0 111.598 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.1 t -137.5 130.22 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -152.71 123.94 3.66 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.079 -1.013 . . . . 0.0 110.794 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.407 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 52.8 Cg_endo -77.08 151.29 30.4 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.871 1.459 . . . . 0.0 110.997 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 50' ' ' LYS . 20.7 m-85 -121.32 -170.35 2.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.643 -0.661 . . . . 0.0 109.499 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.46 ' CD1' HG22 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -131.19 143.37 50.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.48 -0.763 . . . . 0.0 111.135 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.45 ' HD2' ' CE2' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -116.79 177.65 4.63 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.305 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -39.59 -41.76 1.08 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.849 -0.532 . . . . 0.0 111.4 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.64 37.8 0.37 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.403 -0.811 . . . . 0.0 110.737 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -160.29 141.97 12.59 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.161 -0.962 . . . . 0.0 110.979 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.46 HG22 ' CD1' ' A' ' 42' ' ' LEU . 80.0 t -97.33 125.2 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.397 -0.815 . . . . 0.0 109.472 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.45 ' CE2' ' HD2' ' A' ' 43' ' ' LYS . 44.7 m-85 -109.61 158.38 18.1 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.407 -0.808 . . . . 0.0 110.768 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.407 ' CD1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -114.71 133.07 56.17 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.442 -0.786 . . . . 0.0 109.918 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.557 ' HB3' ' CE2' ' A' ' 41' ' ' TYR . 49.1 tttt -142.27 148.63 38.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.494 -0.754 . . . . 0.0 110.366 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -143.53 153.61 24.98 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -145.25 150.53 36.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.764 -0.845 . . . . 0.0 110.112 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.442 ' HB3' ' CD2' ' A' ' 36' ' ' PHE . 22.4 ptm -144.19 153.45 42.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.244 -0.91 . . . . 0.0 110.977 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.524 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 41.6 p90 -152.83 146.4 25.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.782 -0.574 . . . . 0.0 110.288 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 67.2 m -116.29 90.53 29.78 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.231 -0.918 . . . . 0.0 111.1 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -79.22 82.02 2.63 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.87 1.458 . . . . 0.0 110.266 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.89 -46.81 0.48 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 13.9 t90 -70.49 -53.5 16.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.623 -0.928 . . . . 0.0 109.912 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.45 HG21 ' CD1' ' A' ' 90' ' ' LEU . 7.4 t -158.82 -160.7 0.89 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.748 -0.595 . . . . 0.0 109.888 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.19 46.5 1.78 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.342 -0.849 . . . . 0.0 109.931 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.429 HD12 HD12 ' A' ' 90' ' ' LEU . 59.7 mt -122.45 144.68 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.512 -0.742 . . . . 0.0 109.882 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.49 170.96 13.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.304 -0.872 . . . . 0.0 110.92 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.11 156.55 26.99 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.511 ' HG2' ' N ' ' A' ' 65' ' ' ALA . 14.4 tt0 -163.17 154.66 17.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.516 -0.99 . . . . 0.0 109.996 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.561 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -168.56 155.0 7.12 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.031 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.569 ' HA ' HG23 ' A' ' 73' ' ' VAL . 7.0 m -137.02 153.29 50.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.614 -0.679 . . . . 0.0 110.382 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -175.16 159.18 2.53 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.592 -0.693 . . . . 0.0 110.49 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -36.36 71.31 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.661 -0.649 . . . . 0.0 111.332 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.59 142.95 57.91 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.326 -0.859 . . . . 0.0 110.904 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.439 ' O ' HG12 ' A' ' 73' ' ' VAL . 0.9 OUTLIER -77.82 -49.03 15.12 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.618 -0.676 . . . . 0.0 109.986 179.601 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.9 m -82.41 -29.38 30.82 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.479 -0.763 . . . . 0.0 109.744 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.02 -38.71 94.66 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' A' ' 66' ' ' SER . 0.8 OUTLIER -60.59 -36.65 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.395 -1.062 . . . . 0.0 110.307 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.61 -38.59 77.33 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.55 -0.719 . . . . 0.0 109.739 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.72 -32.52 78.28 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.561 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 42.6 mtpt -72.75 -40.12 66.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.473 -1.016 . . . . 0.0 110.065 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.1 m -66.44 -38.41 87.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -0.975 . . . . 0.0 109.657 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.585 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -75.08 -37.69 61.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.6 -0.687 . . . . 0.0 110.333 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.6 -39.19 73.95 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.357 -0.84 . . . . 0.0 109.715 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -65.75 -36.25 83.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.681 -0.637 . . . . 0.0 109.715 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -68.84 -40.19 79.54 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 0.0 109.266 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.695 HG11 ' HA ' ' A' ' 11' ' ' ALA . 54.6 t -65.71 -38.9 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.549 -0.719 . . . . 0.0 109.968 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -64.78 -40.29 95.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.509 -0.744 . . . . 0.0 109.949 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -67.63 -39.37 84.66 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.416 -0.803 . . . . 0.0 109.619 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.565 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -70.52 -35.64 73.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.596 -0.69 . . . . 0.0 109.659 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -40.68 95.8 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.606 -0.684 . . . . 0.0 109.706 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.41 -35.9 78.32 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.562 -0.711 . . . . 0.0 110.456 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -74.56 -52.49 11.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.304 -0.873 . . . . 0.0 110.203 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.94 52.49 0.11 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 90' ' ' LEU . 11.8 mt -122.98 -49.93 1.95 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.394 -1.062 . . . . 0.0 110.293 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.565 HD12 ' HB3' ' A' ' 85' ' ' ALA . 89.5 mt -86.24 81.24 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.345 -0.847 . . . . 0.0 109.505 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -64.71 153.67 38.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 109.181 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -56.47 -47.81 78.43 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.529 -0.732 . . . . 0.0 110.281 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.43 -41.11 76.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.46 -0.775 . . . . 0.0 110.476 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.8 OUTLIER -63.03 -40.57 98.14 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.492 -0.755 . . . . 0.0 110.101 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.33 -43.29 92.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.591 -0.693 . . . . 0.0 109.872 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -65.42 -39.11 91.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.544 -0.723 . . . . 0.0 109.452 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -42.36 95.05 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.715 -0.616 . . . . 0.0 109.738 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.553 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 24.1 t90 -67.51 -39.48 85.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.503 -0.748 . . . . 0.0 109.444 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.2 mt -58.65 -35.99 73.41 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.714 -0.616 . . . . 0.0 109.804 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.5 m -62.44 -38.34 89.36 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.629 -0.669 . . . . 0.0 110.376 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.6 p . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 117.8 -1.095 . . . . 0.0 110.321 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.831 0.348 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.24 119.07 17.94 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.375 -0.828 . . . . 0.0 110.307 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -159.25 -53.72 0.06 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.399 -0.813 . . . . 0.0 110.468 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.1 p -75.02 142.44 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.453 -0.78 . . . . 0.0 110.468 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -137.18 146.92 45.5 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.47 -0.769 . . . . 0.0 110.396 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 10' ' ' VAL . . . 162.09 -73.01 0.2 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -59.69 -46.43 89.08 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.598 -0.942 . . . . 0.0 110.583 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -61.21 -42.96 99.5 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.491 -0.756 . . . . 0.0 109.615 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.12 -40.17 88.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.651 -0.655 . . . . 0.0 110.226 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.644 HG21 ' HG2' ' A' ' 93' ' ' GLN . 85.9 t -66.04 -39.63 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.466 -0.771 . . . . 0.0 109.517 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.569 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -64.69 -39.29 93.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.467 -0.771 . . . . 0.0 109.904 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.68 -38.84 87.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.61 -0.681 . . . . 0.0 109.739 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.01 96.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.586 -0.697 . . . . 0.0 109.783 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 10' ' ' VAL . 77.7 t -62.69 -41.68 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.426 -0.796 . . . . 0.0 109.043 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.57 -39.45 93.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.498 -0.752 . . . . 0.0 109.612 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 54.4 m -61.7 -41.31 97.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.557 -0.715 . . . . 0.0 109.658 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.613 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 6.4 tptm -67.37 -31.21 71.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.428 -0.795 . . . . 0.0 109.765 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.638 HG21 ' HB2' ' A' ' 78' ' ' ALA . 4.8 mm -63.27 -47.26 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.395 -0.816 . . . . 0.0 109.617 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.4 t -63.62 -38.71 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.45 -0.781 . . . . 0.0 109.852 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.75 -26.89 71.88 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 tp -113.8 32.62 5.71 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.239 -1.154 . . . . 0.0 111.448 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 18.4 t90 -94.2 131.6 39.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.952 -1.092 . . . . 0.0 110.197 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.13 -172.73 2.41 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -43.53 -39.84 3.63 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.229 -0.92 . . . . 0.0 110.609 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.431 ' HB2' ' CG2' ' A' ' 37' ' ' THR . 12.4 pt-20 -164.67 37.19 0.07 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.401 0.62 . . . . 0.0 109.781 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -150.77 161.23 43.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.492 -0.755 . . . . 0.0 110.721 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.568 HG23 ' HB2' ' A' ' 34' ' ' CYS . 14.5 t -156.89 151.45 25.53 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.358 -0.838 . . . . 0.0 109.868 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.58 110.59 22.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.43 -0.794 . . . . 0.0 109.832 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.619 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 2.4 mt -105.21 123.8 48.46 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.255 -0.903 . . . . 0.0 110.559 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.736 HD11 ' HG3' ' A' ' 95' ' ' GLU . 2.8 tp 55.1 34.72 23.18 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.648 -0.657 . . . . 0.0 110.862 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.81 7.54 87.37 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -106.1 160.48 15.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.089 -1.242 . . . . 0.0 110.025 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.79 125.79 34.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.378 -0.826 . . . . 0.0 110.198 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.659 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 84.9 m -130.77 168.21 17.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.426 -0.796 . . . . 0.0 110.261 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.403 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 9.2 tttm -123.55 115.05 20.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.397 -0.814 . . . . 0.0 111.378 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 1.3 t80 -115.49 122.34 45.43 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 25' ' ' GLU . 1.9 p -140.46 158.3 44.21 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.985 -1.072 . . . . 0.0 112.203 -178.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 8.7 p -129.31 147.08 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.813 -0.554 . . . . 0.0 109.865 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.84 110.75 2.71 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.085 -1.009 . . . . 0.0 110.711 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -79.92 158.19 24.13 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.815 1.429 . . . . 0.0 110.697 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.509 ' CE2' ' HB3' ' A' ' 50' ' ' LYS . 18.9 m-85 -126.44 -176.5 3.69 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.492 -0.755 . . . . 0.0 109.778 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.98 143.02 31.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.602 -0.686 . . . . 0.0 110.841 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.28 177.98 4.61 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -42.13 -36.76 1.25 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.858 -0.526 . . . . 0.0 111.545 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.35 39.34 0.35 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.389 -0.819 . . . . 0.0 110.612 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -157.12 135.87 11.58 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.107 -0.996 . . . . 0.0 111.257 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.6 t -98.36 125.18 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.436 -0.79 . . . . 0.0 109.212 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -107.73 161.14 15.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.515 -0.74 . . . . 0.0 110.686 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.519 ' CD2' ' HA ' ' A' ' 70' ' ' GLN . 0.3 OUTLIER -128.92 142.97 50.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.301 -0.874 . . . . 0.0 110.582 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.509 ' HB3' ' CE2' ' A' ' 41' ' ' TYR . 30.9 tttt -154.11 151.04 28.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -0.827 . . . . 0.0 110.216 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -148.25 150.05 22.18 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.509 ' CG ' ' HB3' ' A' ' 64' ' ' GLU . 8.9 ttp180 -143.04 144.93 32.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.68 -0.894 . . . . 0.0 110.256 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.614 ' HG2' HG22 ' A' ' 77' ' ' THR . 2.3 ppp? -144.04 147.1 33.38 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.436 -0.79 . . . . 0.0 110.818 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.607 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 49.2 p90 -154.29 -168.9 3.08 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.797 -0.564 . . . . 0.0 110.113 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.3 m -134.15 92.79 20.85 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.857 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.659 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 47.9 Cg_endo -72.91 80.91 1.72 Allowed 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 123.86 1.453 . . . . 0.0 110.083 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.06 -43.24 0.79 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 55' ' ' CYS . 18.5 t90 -74.34 -52.88 10.89 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.524 -0.986 . . . . 0.0 110.425 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.437 HG21 ' CD1' ' A' ' 90' ' ' LEU . 7.9 t -153.72 -168.14 2.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.535 -0.728 . . . . 0.0 110.007 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.55 45.3 2.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.439 -0.788 . . . . 0.0 110.39 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.579 HD12 HD12 ' A' ' 90' ' ' LEU . 69.4 mt -117.86 156.85 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.394 -0.816 . . . . 0.0 109.466 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.78 165.99 27.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.287 -0.883 . . . . 0.0 111.339 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.55 127.36 2.29 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.509 ' HB3' ' CG ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -144.87 160.62 41.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.8 -0.824 . . . . 0.0 110.634 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.57 163.84 38.8 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.649 -0.657 . . . . 0.0 110.904 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.62 141.95 35.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.516 -0.74 . . . . 0.0 110.193 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.457 HG22 HG23 ' A' ' 73' ' ' VAL . 8.8 t -173.07 170.22 4.45 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.504 -0.748 . . . . 0.0 110.396 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.499 ' HG3' ' N ' ' A' ' 69' ' ' SER . 2.2 ptm85 -64.67 -35.09 79.92 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.438 -0.789 . . . . 0.0 110.249 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.499 ' N ' ' HG3' ' A' ' 68' ' ' ARG . 3.4 m -58.78 153.73 16.29 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.377 0.608 . . . . 0.0 110.754 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.519 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 45.2 mt-30 -101.17 -60.74 1.47 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.802 -0.561 . . . . 0.0 110.088 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -29.91 61.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.285 -0.885 . . . . 0.0 110.398 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.61 -38.75 96.37 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.457 HG23 HG22 ' A' ' 67' ' ' THR . 0.4 OUTLIER -63.54 -34.93 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.429 -1.042 . . . . 0.0 110.434 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.76 -45.75 85.07 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.355 -0.841 . . . . 0.0 109.482 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.36 -37.65 94.96 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -69.75 -38.76 76.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.609 -0.936 . . . . 0.0 109.64 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.614 HG22 ' HG2' ' A' ' 53' ' ' MET . 15.5 m -55.98 -44.47 78.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.326 -0.859 . . . . 0.0 109.245 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.638 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -70.35 -38.93 74.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.681 -0.637 . . . . 0.0 109.748 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -39.23 84.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.683 . . . . 0.0 110.039 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 0.7 OUTLIER -67.03 -31.14 71.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.599 -0.688 . . . . 0.0 110.185 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.4 ' CD2' ' SD ' ' A' ' 53' ' ' MET . 54.5 t80 -80.74 -36.52 31.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.045 -1.034 . . . . 0.0 109.046 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 11' ' ' ALA . 46.3 t -68.05 -38.4 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.671 -0.643 . . . . 0.0 110.246 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 2.6 ptm85 -67.45 -39.19 85.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.266 -0.896 . . . . 0.0 109.557 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.417 ' N ' ' HG3' ' A' ' 83' ' ' ARG . 0.7 OUTLIER -65.91 -40.54 91.58 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.496 -0.753 . . . . 0.0 109.268 178.721 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.562 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -70.0 -32.45 70.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.644 -0.66 . . . . 0.0 109.373 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.98 -41.99 94.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.623 -0.673 . . . . 0.0 109.238 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -67.92 -37.61 81.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.521 -0.737 . . . . 0.0 110.159 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.419 ' CD ' HD11 ' A' ' 61' ' ' ILE . 1.7 mmpp? -70.89 -51.93 23.27 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.374 -0.829 . . . . 0.0 110.382 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.96 49.45 0.17 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.579 HD12 HD12 ' A' ' 61' ' ' ILE . 13.0 mt -121.33 -48.59 2.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.289 -1.124 . . . . 0.0 110.405 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.562 HD12 ' HB3' ' A' ' 85' ' ' ALA . 81.6 mt -99.53 77.76 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.458 -0.776 . . . . 0.0 109.244 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.0 p -76.26 -176.8 3.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.496 -0.753 . . . . 0.0 110.353 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.644 ' HG2' HG21 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -69.59 -53.1 20.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.43 -0.794 . . . . 0.0 110.563 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.9 -42.53 97.4 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.416 -0.802 . . . . 0.0 110.96 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.736 ' HG3' HD11 ' A' ' 30' ' ' LEU . 1.7 tp10 -66.54 -38.5 87.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.267 -0.895 . . . . 0.0 110.219 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.2 -39.88 86.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.397 -0.815 . . . . 0.0 109.498 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -65.72 -39.03 90.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.596 -0.69 . . . . 0.0 109.955 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -61.56 -42.77 99.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.569 -0.707 . . . . 0.0 109.439 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.613 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 20.8 t90 -67.85 -38.61 83.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.473 -0.767 . . . . 0.0 109.641 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.583 HD23 ' HD3' ' A' ' 17' ' ' LYS . 50.6 mt -68.04 -38.79 82.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.693 -0.629 . . . . 0.0 110.193 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 102' ' ' SER . 57.9 m -70.41 -47.84 58.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.42 -0.8 . . . . 0.0 110.277 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 101' ' ' SER . 40.0 m . . . . . 0 N--CA 1.501 2.117 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.765 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.103 0.478 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.54 -66.63 1.06 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.436 -0.79 . . . . 0.0 110.075 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -94.5 118.6 31.92 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.364 -0.835 . . . . 0.0 110.293 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 m -94.62 54.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.426 -0.796 . . . . 0.0 110.188 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -98.67 28.65 4.12 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.355 -0.84 . . . . 0.0 110.673 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 10' ' ' VAL . . . -62.62 -51.92 52.53 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -64.07 -43.69 94.7 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.614 -0.933 . . . . 0.0 109.827 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -62.29 -38.76 90.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.497 -0.752 . . . . 0.0 109.806 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.5 -40.79 97.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.584 -0.697 . . . . 0.0 109.884 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 14' ' ' VAL . 84.5 t -64.15 -43.16 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.461 -0.775 . . . . 0.0 109.217 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.512 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -65.08 -39.5 93.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.509 -0.744 . . . . 0.0 109.3 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.41 -40.75 98.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.688 -0.632 . . . . 0.0 109.792 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.29 96.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.407 -0.808 . . . . 0.0 109.668 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 10' ' ' VAL . 91.2 t -64.11 -40.46 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.504 -0.748 . . . . 0.0 109.348 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.21 -40.14 96.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.584 -0.698 . . . . 0.0 110.127 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 t -65.04 -38.95 92.53 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.371 -0.831 . . . . 0.0 109.706 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.517 ' HD2' HD22 ' A' ' 100' ' ' LEU . 3.5 ttmm -65.98 -32.38 73.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.502 -0.749 . . . . 0.0 109.951 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.756 HD11 ' HG ' ' A' ' 29' ' ' LEU . 3.3 mm -62.82 -48.26 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.598 -0.688 . . . . 0.0 109.981 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.15 -38.92 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.399 -0.813 . . . . 0.0 109.833 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.84 -31.22 75.25 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.44 36.78 3.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.287 -1.125 . . . . 0.0 110.796 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.552 ' HH2' HG12 ' A' ' 38' ' ' VAL . 25.7 t90 -100.51 138.52 37.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 110.668 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -97.71 -169.66 1.87 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -43.14 -42.95 4.33 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.663 -0.648 . . . . 0.0 110.255 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -162.66 38.84 0.11 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.636 -0.665 . . . . 0.0 110.39 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -157.67 140.34 14.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.252 -0.905 . . . . 0.0 110.699 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.473 HG21 HD12 ' A' ' 18' ' ' ILE . 10.0 t -147.65 159.45 43.77 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.411 -0.806 . . . . 0.0 109.823 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -100.16 143.18 30.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.431 -0.793 . . . . 0.0 110.513 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.756 ' HG ' HD11 ' A' ' 18' ' ' ILE . 7.1 mt -126.34 113.21 16.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.537 -0.727 . . . . 0.0 109.43 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' ' 99' ' ' TRP . 4.6 tp 59.36 27.06 16.05 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.69 -0.631 . . . . 0.0 110.635 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.46 -15.7 62.34 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.0 m80 -87.59 153.31 21.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.986 -1.302 . . . . 0.0 110.337 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -83.95 137.56 33.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.387 -0.82 . . . . 0.0 109.751 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 29' ' ' LEU . 96.3 m -138.01 170.91 15.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.89 . . . . 0.0 111.251 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -122.3 104.5 9.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.677 -0.64 . . . . 0.0 110.025 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.53 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 3.2 t80 -109.9 132.74 53.88 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.1 p -140.8 153.98 46.05 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.099 -1.001 . . . . 0.0 111.367 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.552 HG12 ' HH2' ' A' ' 22' ' ' TRP . 4.9 p -141.53 143.85 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.663 -0.648 . . . . 0.0 109.953 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.45 128.24 6.1 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.161 -0.962 . . . . 0.0 111.235 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.542 ' HB3' ' CE1' ' A' ' 49' ' ' TYR . 49.0 Cg_endo -76.93 148.84 28.47 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.88 1.463 . . . . 0.0 110.227 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.449 ' CE2' ' HB3' ' A' ' 50' ' ' LYS . 27.8 m-85 -134.43 -171.89 2.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.283 -0.885 . . . . 0.0 110.345 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.471 HD11 HG22 ' A' ' 47' ' ' VAL . 2.4 tp -151.01 145.79 25.78 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.5 0.666 . . . . 0.0 110.88 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -112.46 -179.79 3.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.703 -0.623 . . . . 0.0 109.398 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -41.56 -38.12 1.27 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.867 -0.52 . . . . 0.0 111.522 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.73 45.57 0.47 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.395 -0.815 . . . . 0.0 110.502 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.452 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -162.15 166.38 25.72 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.104 -0.997 . . . . 0.0 111.402 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.471 HG22 HD11 ' A' ' 42' ' ' LEU . 41.0 t -114.68 136.04 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.536 -0.727 . . . . 0.0 109.222 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.452 ' CE2' ' HB3' ' A' ' 46' ' ' GLN . 45.0 m-85 -138.26 127.84 24.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.412 -0.805 . . . . 0.0 110.211 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.542 ' CE1' ' HB3' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -92.95 151.7 19.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.595 -0.691 . . . . 0.0 109.99 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.449 ' HB3' ' CE2' ' A' ' 41' ' ' TYR . 8.7 ttpp -149.3 149.09 30.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.395 -0.816 . . . . 0.0 110.181 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.15 161.53 29.13 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.59 137.17 13.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.782 -0.834 . . . . 0.0 109.75 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.555 ' HG2' HG22 ' A' ' 77' ' ' THR . 1.4 ppp? -136.73 152.1 49.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.264 -0.898 . . . . 0.0 111.144 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.487 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 49.4 p90 -159.58 154.29 24.42 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.744 -0.598 . . . . 0.0 110.183 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 69.3 m -112.33 91.53 16.68 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.183 -0.948 . . . . 0.0 110.56 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.487 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 48.0 Cg_endo -76.11 91.79 1.09 Allowed 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.807 1.425 . . . . 0.0 110.217 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.46 -48.36 0.58 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.516 ' CZ2' HD22 ' A' ' 90' ' ' LEU . 25.6 t90 -76.26 -53.5 8.14 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.404 -1.056 . . . . 0.0 110.376 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 t -145.46 -170.01 3.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.581 -0.699 . . . . 0.0 109.991 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.62 60.54 0.8 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.449 -0.782 . . . . 0.0 109.887 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.7 mt -128.12 155.08 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.481 -0.762 . . . . 0.0 109.845 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.43 160.29 39.53 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.415 -0.803 . . . . 0.0 110.492 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 135.75 7.26 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -136.2 151.82 50.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.554 -0.968 . . . . 0.0 110.112 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.66 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -163.13 135.57 5.36 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.388 -0.82 . . . . 0.0 110.56 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.575 ' HA ' HG23 ' A' ' 73' ' ' VAL . 1.1 m -136.71 142.65 43.12 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.546 -0.721 . . . . 0.0 110.37 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.8 t -167.44 177.48 5.98 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.573 -0.704 . . . . 0.0 110.142 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -31.32 67.74 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.33 -0.856 . . . . 0.0 110.66 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.74 143.15 58.07 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.427 -0.795 . . . . 0.0 110.916 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.543 ' O ' HG12 ' A' ' 73' ' ' VAL . 38.4 mt-30 -80.65 -50.71 9.59 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.637 -0.665 . . . . 0.0 110.408 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m -86.36 -29.3 23.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.386 -0.822 . . . . 0.0 109.914 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.06 -38.97 95.1 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.575 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.7 p -62.3 -36.83 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.407 -1.055 . . . . 0.0 110.297 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.426 ' HB1' ' HZ ' ' A' ' 36' ' ' PHE . . . -68.8 -44.84 72.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.55 -0.719 . . . . 0.0 109.768 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.31 -35.74 92.06 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.66 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 15.4 mmtt -69.76 -38.72 76.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.473 -1.016 . . . . 0.0 109.942 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.555 HG22 ' HG2' ' A' ' 53' ' ' MET . 3.4 m -60.25 -44.91 94.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.501 -0.749 . . . . 0.0 109.498 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.459 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -69.91 -36.31 75.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.555 -0.716 . . . . 0.0 109.865 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -39.76 86.88 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.463 -0.773 . . . . 0.0 109.876 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.16 -40.9 98.89 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.475 -0.766 . . . . 0.0 110.086 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -69.33 -41.13 77.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.336 -0.853 . . . . 0.0 109.343 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 11' ' ' ALA . 49.8 t -66.04 -38.14 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.566 -0.708 . . . . 0.0 109.591 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -38.79 87.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.514 -0.741 . . . . 0.0 109.708 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -39.27 91.22 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.386 -0.821 . . . . 0.0 109.853 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.641 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -69.82 -35.51 74.86 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.589 -0.694 . . . . 0.0 109.464 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -41.9 99.61 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.678 -0.639 . . . . 0.0 109.634 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -67.84 -36.97 81.29 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.499 -0.75 . . . . 0.0 110.332 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -73.49 -55.43 6.35 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.37 -0.831 . . . . 0.0 110.453 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.04 52.36 0.08 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.516 HD22 ' CZ2' ' A' ' 58' ' ' TRP . 9.7 mt -122.95 -49.83 1.96 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.377 -1.072 . . . . 0.0 110.259 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.641 HD12 ' HB3' ' A' ' 85' ' ' ALA . 96.3 mt -97.09 101.59 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.538 -0.726 . . . . 0.0 109.55 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.614 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 32.4 m -78.23 173.78 11.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.475 -0.766 . . . . 0.0 109.965 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -71.16 -53.08 15.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.605 -0.684 . . . . 0.0 109.925 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -65.09 -29.52 70.39 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.478 -0.764 . . . . 0.0 110.57 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.0 OUTLIER -67.99 -43.5 78.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.267 -0.896 . . . . 0.0 109.821 179.377 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.406 ' O ' HD23 ' A' ' 100' ' ' LEU . . . -61.29 -40.64 94.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.609 -0.682 . . . . 0.0 109.168 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -62.46 -38.98 91.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.641 -0.662 . . . . 0.0 109.763 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -40.16 94.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.572 -0.705 . . . . 0.0 109.697 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.513 ' HB2' HD12 ' A' ' 30' ' ' LEU . 15.6 t90 -71.08 -36.05 72.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.315 -0.865 . . . . 0.0 109.889 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.517 HD22 ' HD2' ' A' ' 17' ' ' LYS . 3.4 mm? -71.12 -33.97 70.61 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.71 -0.619 . . . . 0.0 110.697 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 74.5 p -69.29 -42.91 74.84 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.203 -0.936 . . . . 0.0 110.467 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.499 1.977 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.788 179.854 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 120.928 0.394 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.08 -176.42 4.12 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.467 -0.771 . . . . 0.0 110.251 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -71.01 100.62 2.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.428 -0.795 . . . . 0.0 109.968 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 4' ' ' VAL . 7.1 p -143.78 78.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.523 -0.736 . . . . 0.0 109.98 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -101.13 177.19 5.01 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.322 -0.862 . . . . 0.0 110.356 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.02 -8.85 7.57 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 120.192 -1.004 . . . . 0.0 110.956 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -54.86 -45.89 74.63 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 118.748 1.274 . . . . 0.0 110.257 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.49 -37.55 87.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.714 -0.616 . . . . 0.0 109.707 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.71 -40.1 94.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.65 -0.656 . . . . 0.0 109.945 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 14' ' ' VAL . 95.1 t -66.08 -40.87 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.521 -0.737 . . . . 0.0 109.185 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.42 -39.76 95.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.593 -0.692 . . . . 0.0 109.533 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.74 -41.38 99.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.684 -0.635 . . . . 0.0 109.806 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.3 -39.3 94.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.474 -0.766 . . . . 0.0 109.827 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.643 ' CG2' ' HB1' ' A' ' 96' ' ' ALA . 61.2 t -66.04 -39.93 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.425 -0.797 . . . . 0.0 109.105 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.576 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -64.06 -38.43 91.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.466 -0.771 . . . . 0.0 109.636 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.6 m -63.96 -41.31 97.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.51 -0.743 . . . . 0.0 109.595 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.602 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 1.9 ttmt -63.74 -32.8 74.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.547 -0.721 . . . . 0.0 109.898 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.6 HG21 ' HB2' ' A' ' 78' ' ' ALA . 5.1 mm -62.25 -48.13 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -0.875 . . . . 0.0 109.071 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.49 -40.4 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.71 -0.619 . . . . 0.0 109.429 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.79 -32.18 83.29 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.484 HD23 ' HB2' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -109.38 35.39 3.32 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.45 -1.029 . . . . 0.0 110.612 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.403 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 25.0 t90 -103.98 132.98 49.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.133 -0.979 . . . . 0.0 111.01 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.34 -163.85 1.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -45.78 -45.64 14.83 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.255 -0.903 . . . . 0.0 110.587 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.435 ' HB2' ' CG2' ' A' ' 37' ' ' THR . 6.6 pt-20 -157.75 35.9 0.26 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.679 -0.638 . . . . 0.0 110.5 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.41 151.88 38.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.311 -0.868 . . . . 0.0 110.668 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.447 HG23 ' HB2' ' A' ' 34' ' ' CYS . 7.9 t -153.77 172.9 16.6 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.308 -0.87 . . . . 0.0 109.866 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.484 ' HB2' HD23 ' A' ' 21' ' ' LEU . 3.9 mp0 -124.43 143.34 50.68 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.245 -0.909 . . . . 0.0 110.228 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.746 HD12 ' SG ' ' A' ' 55' ' ' CYS . 10.0 mt -127.44 113.6 16.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 109.457 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 99' ' ' TRP . 1.0 OUTLIER 57.01 27.26 12.98 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.765 -0.584 . . . . 0.0 110.735 -179.244 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.84 -16.9 60.21 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -80.97 149.89 29.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.171 -1.193 . . . . 0.0 110.444 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -79.41 139.91 37.56 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.74 . . . . 0.0 109.822 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 81.4 m -139.96 166.37 24.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.515 -0.741 . . . . 0.0 110.726 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -122.15 101.09 7.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.404 -0.81 . . . . 0.0 109.835 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.583 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 4.3 t80 -108.37 131.13 55.07 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.435 ' CG2' ' HB2' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -134.75 157.16 47.43 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.302 -0.874 . . . . 0.0 111.015 -179.078 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.403 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 87.1 t -129.36 129.32 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.568 -0.707 . . . . 0.0 109.635 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -144.06 101.23 4.89 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.367 -0.833 . . . . 0.0 110.425 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.507 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 54.1 Cg_endo -75.25 161.88 37.35 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.81 1.426 . . . . 0.0 110.585 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -126.53 -174.34 3.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.421 -0.799 . . . . 0.0 109.929 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.405 ' CD1' HG22 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -133.73 143.17 48.32 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.36 0.6 . . . . 0.0 110.374 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -117.72 174.83 5.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.595 -0.691 . . . . 0.0 109.835 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -43.91 -36.11 2.27 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.911 -0.493 . . . . 0.0 111.105 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -154.9 37.31 0.4 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.489 -0.757 . . . . 0.0 110.957 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.52 137.9 6.02 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.879 -1.138 . . . . 0.0 111.312 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.405 HG22 ' CD1' ' A' ' 42' ' ' LEU . 45.0 t -101.45 123.81 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.486 -0.759 . . . . 0.0 109.493 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -112.31 143.67 43.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.375 -0.828 . . . . 0.0 110.332 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.507 ' CD1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -96.14 157.17 16.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -0.877 . . . . 0.0 110.111 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.48 ' HG3' ' N ' ' A' ' 51' ' ' GLY . 2.1 tttt -156.6 150.17 24.59 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.254 -0.904 . . . . 0.0 109.9 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.48 ' N ' ' HG3' ' A' ' 50' ' ' LYS . . . -149.59 147.67 18.22 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.45 138.64 34.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.67 -0.9 . . . . 0.0 109.836 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.583 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 3.0 ppp? -137.95 157.73 45.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.344 -0.848 . . . . 0.0 111.25 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.427 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 49.0 p90 -160.88 145.88 14.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.844 -0.535 . . . . 0.0 109.951 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.746 ' SG ' HD12 ' A' ' 29' ' ' LEU . 76.6 m -112.49 91.2 16.21 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.261 -0.899 . . . . 0.0 110.871 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.427 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 48.3 Cg_endo -75.71 85.81 1.57 Allowed 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.78 1.411 . . . . 0.0 110.056 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.42 -50.3 0.29 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -78.16 -43.71 27.95 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.537 -0.978 . . . . 0.0 109.76 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.419 ' HB ' HD11 ' A' ' 90' ' ' LEU . 10.1 t -153.67 -173.85 4.73 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.278 0.561 . . . . 0.0 109.733 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.46 49.04 1.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.569 -0.707 . . . . 0.0 109.62 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.4 mt -119.02 155.99 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.473 -0.767 . . . . 0.0 110.009 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.19 160.16 38.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.447 -0.783 . . . . 0.0 110.438 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.23 148.27 19.89 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 0.9 OUTLIER -151.13 157.07 42.25 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.551 -0.97 . . . . 0.0 110.269 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.443 ' HB1' ' CG ' ' A' ' 76' ' ' LYS . . . -159.75 146.75 16.51 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.699 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.511 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -140.1 141.74 36.12 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.469 -0.769 . . . . 0.0 110.812 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.605 HG22 HG23 ' A' ' 73' ' ' VAL . 9.3 t -169.16 176.9 5.05 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.6 -0.688 . . . . 0.0 110.341 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.5 mtm-85 -73.14 -35.29 66.47 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.389 -0.82 . . . . 0.0 110.261 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.85 136.92 58.15 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.497 -0.752 . . . . 0.0 110.127 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.409 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 1.0 OUTLIER -74.31 -59.11 2.88 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.584 -0.697 . . . . 0.0 110.406 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -79.17 -28.83 42.77 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.308 -0.87 . . . . 0.0 110.05 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.62 -38.14 90.83 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.605 HG23 HG22 ' A' ' 67' ' ' THR . 0.5 OUTLIER -62.07 -38.11 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.437 -1.037 . . . . 0.0 110.379 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HA ' ' HZ ' ' A' ' 36' ' ' PHE . . . -66.81 -44.5 81.02 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.524 -0.735 . . . . 0.0 109.655 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.65 -37.78 95.25 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.443 ' CG ' ' HB1' ' A' ' 65' ' ' ALA . 0.1 OUTLIER -63.3 -40.1 96.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.589 -0.948 . . . . 0.0 110.282 179.559 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.9 m -63.44 -43.91 96.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.83 . . . . 0.0 109.149 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.6 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -66.27 -39.08 89.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.602 -0.686 . . . . 0.0 109.64 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.98 -38.96 89.89 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.34 -0.85 . . . . 0.0 109.96 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.518 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 2.8 m-20 -68.87 -29.8 68.17 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.461 -0.774 . . . . 0.0 110.172 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -78.38 -33.73 48.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.225 -0.922 . . . . 0.0 109.864 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 78' ' ' ALA . 65.4 t -70.43 -38.5 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 110.476 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -70.23 -36.42 74.52 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.271 -0.893 . . . . 0.0 109.793 179.529 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.46 -40.83 93.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.6 -0.688 . . . . 0.0 109.335 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.719 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -69.78 -32.88 71.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.618 -0.676 . . . . 0.0 109.379 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.3 -41.1 97.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.55 -0.719 . . . . 0.0 109.513 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -65.38 -36.58 84.4 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.661 -0.649 . . . . 0.0 110.538 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -79.72 -54.13 6.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.195 -0.941 . . . . 0.0 110.28 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.72 53.72 0.07 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' A' ' 90' ' ' LEU . 11.1 mt -123.56 -47.78 1.96 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.375 -1.074 . . . . 0.0 110.645 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.719 HD12 ' HB3' ' A' ' 85' ' ' ALA . 80.7 mt -105.2 98.84 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.235 -0.916 . . . . 0.0 109.555 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 4.9 t -78.49 -177.06 5.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.443 -0.785 . . . . 0.0 110.556 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -70.76 -59.82 2.59 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.519 -0.738 . . . . 0.0 110.472 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -63.73 -34.67 78.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.391 -0.818 . . . . 0.0 110.63 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 1.9 mt-10 -58.79 -42.93 90.19 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.489 -0.757 . . . . 0.0 110.278 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.643 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -63.09 -39.13 93.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.448 -0.783 . . . . 0.0 109.809 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -36.81 78.05 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.498 -0.751 . . . . 0.0 109.677 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -62.86 -42.83 99.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.522 -0.736 . . . . 0.0 109.379 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.675 ' HB2' HD12 ' A' ' 30' ' ' LEU . 25.3 t90 -63.97 -41.93 97.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.462 -0.774 . . . . 0.0 109.153 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HA ' ' CE ' ' A' ' 17' ' ' LYS . 12.9 mt -59.39 -37.04 76.96 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.763 -0.586 . . . . 0.0 110.155 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.8 m -65.92 -38.6 89.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.51 -0.744 . . . . 0.0 110.316 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.504 2.237 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.847 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 120.917 0.389 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.94 -175.58 2.75 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.404 -0.81 . . . . 0.0 110.207 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.489 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -102.2 -165.24 1.17 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.365 -0.835 . . . . 0.0 110.335 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 3' ' ' TYR . 23.9 t 68.79 -65.59 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 O-C-N 121.96 -0.463 . . . . 0.0 110.948 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -97.94 57.79 1.32 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.093 -1.004 . . . . 0.0 110.104 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.39 -37.88 93.86 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -63.59 -42.79 98.24 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.402 -1.058 . . . . 0.0 109.878 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.65 -37.21 83.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.808 -0.558 . . . . 0.0 110.328 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.65 -43.26 80.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.564 -0.71 . . . . 0.0 109.895 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.598 HG11 ' HA ' ' A' ' 93' ' ' GLN . 78.2 t -68.82 -38.68 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.544 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -63.66 -46.19 86.73 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.481 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . . . -52.05 -45.11 64.56 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.744 -0.597 . . . . 0.0 109.959 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.09 90.51 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.561 -0.712 . . . . 0.0 109.391 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 10' ' ' VAL . 89.0 t -61.14 -44.25 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.589 -0.695 . . . . 0.0 109.324 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.958 ' HB2' ' HE2' ' A' ' 79' ' ' LYS . . . -58.29 -43.2 87.92 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.599 -0.688 . . . . 0.0 109.999 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.2 m -59.24 -41.8 89.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.65 -0.656 . . . . 0.0 109.484 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.638 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 1.3 tpmp? -69.74 -32.5 71.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.627 -0.671 . . . . 0.0 110.059 179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 22' ' ' TRP . 5.4 mt -72.26 -46.77 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.401 -0.812 . . . . 0.0 109.811 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.6 t -68.13 -39.03 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.395 -0.816 . . . . 0.0 110.04 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.28 -16.41 75.32 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.47 24.06 6.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.978 -1.307 . . . . 0.0 111.452 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.437 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 22.7 t90 -92.03 135.58 33.85 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.886 -1.134 . . . . 0.0 110.337 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.67 -167.19 1.46 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.534 -0.729 . . . . 0.0 109.449 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -49.77 -41.76 44.93 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.231 -0.918 . . . . 0.0 110.615 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.45 37.73 0.24 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.574 -0.704 . . . . 0.0 110.456 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -146.75 147.53 31.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.32 -0.863 . . . . 0.0 110.72 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.547 HG21 ' HB2' ' A' ' 36' ' ' PHE . 8.2 t -156.7 155.52 31.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.462 -0.774 . . . . 0.0 109.643 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -111.68 149.83 31.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.173 -0.954 . . . . 0.0 110.168 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.423 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 6.7 mt -143.28 123.85 14.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.371 -0.831 . . . . 0.0 110.022 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.453 HD12 ' HB2' ' A' ' 99' ' ' TRP . 1.7 tp 53.07 35.06 18.6 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.673 -0.642 . . . . 0.0 111.22 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.39 26.88 62.61 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -125.91 163.5 22.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -1.163 . . . . 0.0 109.996 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.0 130.4 36.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.458 -0.776 . . . . 0.0 109.893 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.6 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 68.2 m -134.08 167.22 21.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.51 -0.744 . . . . 0.0 110.079 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.591 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 0.9 OUTLIER -126.32 110.07 12.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 110.901 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.547 ' HB2' HG21 ' A' ' 27' ' ' THR . 20.0 t80 -111.11 136.09 50.66 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.38 157.88 43.53 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.061 -1.024 . . . . 0.0 111.968 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.3 t -132.82 145.04 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.15 136.55 11.38 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.238 -0.914 . . . . 0.0 110.927 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.484 ' HB3' ' CE1' ' A' ' 49' ' ' TYR . 48.1 Cg_endo -78.2 154.16 28.55 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.905 1.476 . . . . 0.0 110.406 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -142.64 -169.26 2.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.355 -0.84 . . . . 0.0 110.736 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.4 tp -142.67 160.52 40.14 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.384 0.612 . . . . 0.0 110.693 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.18 178.0 7.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.532 -0.73 . . . . 0.0 109.669 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.452 ' HB3' ' CD2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -40.92 -37.82 0.86 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.884 -0.51 . . . . 0.0 111.799 -179.479 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.452 ' CD2' ' HB3' ' A' ' 44' ' ' ARG . 11.1 p90 -156.08 35.85 0.34 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.348 -0.845 . . . . 0.0 111.417 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.459 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -162.52 162.58 27.44 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.865 -1.147 . . . . 0.0 111.152 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.4 t -101.83 141.79 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.424 -0.798 . . . . 0.0 109.379 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 46' ' ' GLN . 33.6 m-85 -140.51 136.22 32.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.255 -0.903 . . . . 0.0 110.404 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -96.64 135.28 38.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.572 -0.705 . . . . 0.0 110.19 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.558 ' HA ' HG21 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -129.39 156.73 43.6 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.332 -0.855 . . . . 0.0 109.857 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.19 150.5 22.7 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.753 ' HG2' ' HB3' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -149.56 136.36 19.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.491 -1.005 . . . . 0.0 109.837 179.529 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.705 ' HG2' HG22 ' A' ' 77' ' ' THR . 1.0 OUTLIER -135.12 152.58 51.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.439 -0.788 . . . . 0.0 110.835 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.603 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 46.1 p90 -149.32 -177.13 5.67 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.576 -0.703 . . . . 0.0 110.044 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 34.7 m -133.94 93.81 19.68 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.102 -0.999 . . . . 0.0 110.701 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.603 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.6 Cg_endo -76.09 89.58 1.23 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.951 1.5 . . . . 0.0 110.107 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.27 -46.51 0.87 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.436 ' CZ2' HD22 ' A' ' 30' ' ' LEU . 10.4 t90 -71.61 -57.78 4.08 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.476 -1.014 . . . . 0.0 110.139 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.496 HG21 HD13 ' A' ' 90' ' ' LEU . 8.1 t -153.96 -160.37 1.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.578 -0.701 . . . . 0.0 109.902 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.88 44.92 2.52 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.253 -0.904 . . . . 0.0 110.546 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.63 HD11 ' HG3' ' A' ' 88' ' ' LYS . 1.5 tt -125.15 154.4 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.25 -0.906 . . . . 0.0 109.701 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.451 ' HB3' ' CB ' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -153.68 169.21 23.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.166 -0.959 . . . . 0.0 111.202 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.457 ' HA2' ' HE2' ' A' ' 84' ' ' LYS . . . -135.45 153.03 21.09 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.753 ' HB3' ' HG2' ' A' ' 52' ' ' ARG . 1.2 pm0 -145.51 155.39 43.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.632 -0.922 . . . . 0.0 110.227 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -143.23 162.48 35.51 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.518 -0.738 . . . . 0.0 110.89 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -147.12 136.98 23.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.574 -0.704 . . . . 0.0 110.438 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.7 t -175.51 165.25 3.18 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.699 -0.625 . . . . 0.0 110.002 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -68.55 -28.13 66.69 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.182 -0.949 . . . . 0.0 110.595 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.67 149.46 50.47 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.191 -0.943 . . . . 0.0 110.463 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.426 ' O ' HG12 ' A' ' 73' ' ' VAL . 6.6 mp0 -83.66 -64.91 1.08 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.672 -0.642 . . . . 0.0 110.087 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 t -73.32 -22.79 60.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.26 -0.9 . . . . 0.0 110.02 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.82 -45.38 95.02 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' A' ' 50' ' ' LYS . 0.7 OUTLIER -61.04 -36.96 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.495 -1.003 . . . . 0.0 110.064 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.46 -45.08 94.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.524 -0.735 . . . . 0.0 110.034 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -60.64 -37.21 93.09 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.442 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -74.92 -37.69 61.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.391 -1.064 . . . . 0.0 110.245 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.705 HG22 ' HG2' ' A' ' 53' ' ' MET . 22.7 m -59.93 -38.04 81.24 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.195 -0.941 . . . . 0.0 109.683 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.67 -28.04 40.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.425 -0.797 . . . . 0.0 110.184 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.958 ' HE2' ' HB2' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -80.76 -37.64 30.05 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.267 -0.895 . . . . 0.0 109.826 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.75 -31.51 66.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.785 -0.572 . . . . 0.0 109.694 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 35.4 t80 -70.36 -42.19 72.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 0.0 109.695 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 11' ' ' ALA . 58.6 t -71.24 -30.89 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.799 . . . . 0.0 109.467 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -38.4 63.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.459 -0.776 . . . . 0.0 109.756 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.457 ' HE2' ' HA2' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -67.3 -36.78 82.2 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.33 -0.856 . . . . 0.0 109.777 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.669 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -71.69 -34.2 69.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.486 -0.759 . . . . 0.0 109.528 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.21 -39.28 86.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.595 -0.69 . . . . 0.0 109.585 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -64.37 -40.4 95.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.717 -0.614 . . . . 0.0 109.901 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.63 ' HG3' HD11 ' A' ' 61' ' ' ILE . 9.1 mmmt -73.72 -57.15 4.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.425 -0.797 . . . . 0.0 109.781 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.7 53.98 0.05 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.496 HD13 HG21 ' A' ' 59' ' ' THR . 9.7 mt -123.41 -57.41 1.67 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.303 -1.116 . . . . 0.0 110.65 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.669 HD12 ' HB3' ' A' ' 85' ' ' ALA . 12.4 mt -92.74 115.83 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.0 110.167 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.6 t -99.46 -175.91 3.13 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.663 -0.648 . . . . 0.0 110.637 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.598 ' HA ' HG11 ' A' ' 10' ' ' VAL . 2.6 mt-30 -74.85 -52.07 12.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.423 -0.798 . . . . 0.0 110.263 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -64.15 -41.04 97.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.575 -0.703 . . . . 0.0 110.189 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -56.09 -45.85 79.26 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.649 -0.657 . . . . 0.0 109.993 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.43 93.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.62 -0.675 . . . . 0.0 109.43 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -64.16 -37.83 88.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.643 -0.66 . . . . 0.0 109.717 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -64.97 -42.04 94.92 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.638 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 18.6 t90 -64.49 -43.1 95.21 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.162 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.462 HD23 ' HD2' ' A' ' 17' ' ' LYS . 12.2 mt -53.59 -38.04 63.56 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.776 -0.578 . . . . 0.0 109.562 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.3 t -79.48 -43.38 23.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.617 -0.677 . . . . 0.0 109.731 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.997 179.428 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 120.888 0.375 . . . . 0.0 110.459 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.49 147.72 47.49 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.37 -0.831 . . . . 0.0 110.483 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -108.42 145.36 34.72 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.502 -0.749 . . . . 0.0 110.196 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 p -137.24 138.7 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.361 -0.837 . . . . 0.0 110.304 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -84.1 -42.19 16.33 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.419 -0.801 . . . . 0.0 110.407 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.18 0.49 86.95 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -58.46 -48.52 80.47 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.174 -1.192 . . . . 0.0 110.262 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.17 -39.35 82.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.592 -0.693 . . . . 0.0 110.108 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.39 -39.68 94.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.587 -0.695 . . . . 0.0 109.983 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 14' ' ' VAL . 65.5 t -65.07 -41.3 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.502 -0.749 . . . . 0.0 109.31 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.493 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -63.11 -39.59 95.14 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.597 -0.689 . . . . 0.0 109.79 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.88 98.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.548 -0.72 . . . . 0.0 109.56 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.99 98.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.634 -0.666 . . . . 0.0 109.5 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 10' ' ' VAL . 60.5 t -62.69 -41.07 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.545 -0.722 . . . . 0.0 109.299 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.588 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -63.28 -40.13 96.52 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.694 -0.629 . . . . 0.0 109.42 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 56.5 m -63.47 -38.88 92.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.649 -0.657 . . . . 0.0 109.443 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.516 ' HB3' ' HZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.63 -37.79 82.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.518 -0.739 . . . . 0.0 109.356 178.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.784 HD12 ' HB1' ' A' ' 78' ' ' ALA . 17.1 mt -66.57 -33.33 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.678 -0.639 . . . . 0.0 109.857 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.5 t -62.51 -49.86 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.252 -0.905 . . . . 0.0 109.736 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.03 -13.12 83.38 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 120.293 -0.956 . . . . 0.0 110.82 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.688 HD21 ' O ' ' A' ' 28' ' ' GLU . 11.5 tp -98.09 -23.0 15.93 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.019 -1.283 . . . . 0.0 110.825 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.554 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 17.4 t90 -67.4 131.36 45.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.73 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.96 -161.27 0.86 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -47.94 -45.07 30.67 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.132 -0.98 . . . . 0.0 110.444 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.13 36.54 0.14 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.611 -0.681 . . . . 0.0 110.848 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -156.54 155.49 32.02 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.194 -0.941 . . . . 0.0 110.027 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.571 HG23 ' HB2' ' A' ' 34' ' ' CYS . 7.2 t -156.41 155.29 31.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.164 -0.96 . . . . 0.0 110.132 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.688 ' O ' HD21 ' A' ' 21' ' ' LEU . 8.0 mp0 -116.09 109.39 17.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.4 -0.813 . . . . 0.0 109.494 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.533 HD23 ' C ' ' A' ' 28' ' ' GLU . 10.7 mt -112.19 129.79 56.13 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.316 -0.865 . . . . 0.0 110.576 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.874 HD12 ' HD1' ' A' ' 99' ' ' TRP . 0.3 OUTLIER 60.09 30.64 20.08 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.442 -0.786 . . . . 0.0 110.301 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.02 22.21 78.43 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.557 ' CE1' HD23 ' A' ' 30' ' ' LEU . 33.4 m170 -120.77 160.07 24.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.379 -1.071 . . . . 0.0 109.992 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.43 126.72 34.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.359 -0.838 . . . . 0.0 110.549 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.571 ' HB2' HG23 ' A' ' 27' ' ' THR . 23.9 m -130.17 166.88 19.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.69 -0.631 . . . . 0.0 109.687 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 6.1 tptt -128.33 105.64 8.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.465 -0.772 . . . . 0.0 110.637 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.554 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 29.9 t80 -108.23 137.34 46.37 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.6 p -147.57 152.32 37.75 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.031 -1.043 . . . . 0.0 111.816 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.8 t -125.17 133.92 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.415 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -136.15 119.16 12.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.127 -0.983 . . . . 0.0 111.224 -178.687 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -78.99 154.29 25.69 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.77 1.405 . . . . 0.0 110.655 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -140.77 -170.6 3.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.285 -0.884 . . . . 0.0 110.207 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.49 160.47 43.04 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.406 0.622 . . . . 0.0 110.772 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.65 177.0 7.55 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.65 -0.656 . . . . 0.0 109.649 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -42.61 -38.28 1.96 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.82 -0.55 . . . . 0.0 111.276 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.19 45.28 0.49 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.487 -0.758 . . . . 0.0 109.994 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.64 171.07 17.47 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.235 -0.916 . . . . 0.0 111.125 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.7 t -121.47 133.46 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.532 -0.73 . . . . 0.0 109.368 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -130.3 124.5 32.49 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.334 -0.854 . . . . 0.0 110.161 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 70' ' ' GLN . 3.3 m-85 -98.39 133.53 42.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.505 -0.747 . . . . 0.0 110.311 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.6 164.63 17.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.449 -0.782 . . . . 0.0 110.085 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -156.86 135.67 4.57 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.596 ' HG3' ' HG3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -138.92 144.82 39.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.582 -0.952 . . . . 0.0 110.426 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.584 ' HG2' HG22 ' A' ' 77' ' ' THR . 2.5 ppp? -140.49 148.74 41.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.325 -0.859 . . . . 0.0 110.315 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.509 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 44.8 p90 -152.29 146.65 25.55 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.651 -0.656 . . . . 0.0 110.41 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 98.0 m -112.38 88.93 11.54 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.303 -0.873 . . . . 0.0 110.953 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -77.59 84.33 1.99 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.843 1.444 . . . . 0.0 110.278 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.73 -46.63 0.59 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 10.3 t90 -71.35 -58.13 3.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.6 -0.941 . . . . 0.0 110.045 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.429 HG21 ' CD1' ' A' ' 90' ' ' LEU . 9.1 t -153.7 -160.66 1.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.577 -0.702 . . . . 0.0 109.941 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.87 47.69 1.61 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.397 -0.815 . . . . 0.0 110.127 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.406 HG22 ' CD1' ' A' ' 81' ' ' PHE . 72.9 mt -123.63 151.41 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.471 -0.768 . . . . 0.0 109.878 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -139.33 169.87 16.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.904 . . . . 0.0 110.962 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.557 ' O ' HG23 ' A' ' 77' ' ' THR . . . -137.35 127.58 4.03 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.596 ' HG3' ' HG3' ' A' ' 52' ' ' ARG . 1.8 mp0 -121.7 169.02 11.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.571 -0.959 . . . . 0.0 110.695 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.441 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -166.41 156.57 12.06 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.486 0.66 . . . . 0.0 111.336 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -156.44 131.86 9.39 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.633 -0.667 . . . . 0.0 110.037 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.3 t -175.63 -176.71 0.9 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.598 -0.689 . . . . 0.0 109.987 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -82.48 -39.18 22.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.221 -0.924 . . . . 0.0 110.466 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.31 135.74 52.36 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.591 -0.693 . . . . 0.0 110.607 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.434 ' HB3' ' CE2' ' A' ' 49' ' ' TYR . 15.4 pt20 -75.79 -34.96 60.22 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.628 -0.67 . . . . 0.0 110.648 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.0 m -82.22 -34.12 29.04 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.151 -0.968 . . . . 0.0 109.925 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.68 -36.74 90.75 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 70' ' ' GLN . 0.3 OUTLIER -69.99 -35.53 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.3 -1.118 . . . . 0.0 110.004 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.38 94.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.179 -0.951 . . . . 0.0 109.94 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -66.46 -39.44 94.08 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.441 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -67.6 -43.22 81.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.651 -0.911 . . . . 0.0 110.397 179.472 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.584 HG22 ' HG2' ' A' ' 53' ' ' MET . 94.4 m -58.99 -36.33 74.72 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.192 -0.943 . . . . 0.0 109.578 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.784 ' HB1' HD12 ' A' ' 18' ' ' ILE . . . -80.33 -32.71 37.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.525 -0.735 . . . . 0.0 109.876 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 75' ' ' GLY . 1.3 ttpm? -75.71 -34.47 60.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.461 -0.774 . . . . 0.0 110.102 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -39.58 86.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.481 -0.762 . . . . 0.0 109.626 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.406 ' CD1' HG22 ' A' ' 61' ' ' ILE . 51.3 t80 -70.12 -38.48 75.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.375 -0.828 . . . . 0.0 109.082 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.493 HG11 ' HA ' ' A' ' 11' ' ' ALA . 39.0 t -66.68 -39.15 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.652 -0.655 . . . . 0.0 109.662 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.44 -44.77 96.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.356 -0.84 . . . . 0.0 109.414 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -68.95 -37.11 78.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.53 -0.731 . . . . 0.0 109.516 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.68 -37.2 76.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.565 -0.71 . . . . 0.0 109.747 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -64.68 -41.45 96.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.582 -0.699 . . . . 0.0 109.734 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -69.19 -34.42 74.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.51 -0.744 . . . . 0.0 110.616 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.95 -51.84 12.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.271 -0.893 . . . . 0.0 110.239 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.07 52.55 0.13 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 90' ' ' LEU . 6.0 mt -114.87 -48.87 2.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.267 -1.137 . . . . 0.0 110.225 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.451 HD13 HG11 ' A' ' 14' ' ' VAL . 82.4 mt -103.81 94.57 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 110.06 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.486 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 5.0 m -78.11 178.37 7.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.329 -0.857 . . . . 0.0 109.898 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -57.86 7.2 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.284 -0.885 . . . . 0.0 110.479 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -63.13 -35.56 80.68 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.24 -0.913 . . . . 0.0 110.134 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.4 OUTLIER -70.26 -32.31 70.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.393 -0.817 . . . . 0.0 109.547 178.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.7 -40.71 93.24 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.411 -0.806 . . . . 0.0 109.353 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -63.33 -46.64 85.69 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -66.01 -37.3 85.57 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.874 ' HD1' HD12 ' A' ' 30' ' ' LEU . 58.5 t90 -65.26 -38.89 91.72 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.02 0.438 . . . . 0.0 109.855 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.509 ' HA ' ' HG3' ' A' ' 17' ' ' LYS . 11.8 mt -66.92 -38.94 87.12 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.655 -0.653 . . . . 0.0 109.78 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 62.3 m -74.84 -45.28 44.27 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.366 -0.834 . . . . 0.0 110.326 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.821 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.284 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.079 0.466 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.35 44.62 0.71 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.549 -0.72 . . . . 0.0 110.324 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -163.38 127.09 2.79 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.401 -0.812 . . . . 0.0 110.149 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.565 HG12 ' HB3' ' A' ' 8' ' ' GLU . 32.2 m -121.08 160.88 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.555 -0.716 . . . . 0.0 110.453 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.0 tm0? -101.27 -46.17 5.12 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.359 -0.838 . . . . 0.0 110.151 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.69 -68.49 0.03 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -69.42 -27.8 65.59 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.55 -0.971 . . . . 0.0 110.38 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.565 ' HB3' HG12 ' A' ' 4' ' ' VAL . 1.4 mm-40 -59.95 -35.28 74.61 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.369 -0.832 . . . . 0.0 109.702 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.99 -40.89 87.47 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.486 -0.759 . . . . 0.0 109.334 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 14' ' ' VAL . 40.2 t -63.07 -39.65 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.78 -41.35 97.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.653 -0.655 . . . . 0.0 109.429 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.31 -41.64 93.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.681 -0.637 . . . . 0.0 109.685 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.7 99.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.525 -0.734 . . . . 0.0 109.41 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 10' ' ' VAL . 86.9 t -65.99 -40.73 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -65.11 -38.56 91.1 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.459 -0.776 . . . . 0.0 109.49 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -38.56 91.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.455 -0.778 . . . . 0.0 109.44 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.663 ' HE3' HD23 ' A' ' 100' ' ' LEU . 4.9 tppt? -67.2 -32.3 73.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.543 -0.723 . . . . 0.0 109.686 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.544 HG21 ' HB2' ' A' ' 78' ' ' ALA . 6.5 mm -61.53 -49.38 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.416 -0.802 . . . . 0.0 109.262 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.7 t -61.66 -39.12 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.58 -0.7 . . . . 0.0 109.935 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.46 -33.41 86.39 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 tp -112.05 36.89 3.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.396 -1.061 . . . . 0.0 110.581 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.408 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 25.2 t90 -102.44 136.97 41.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 111.266 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -99.35 -166.43 1.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -51.19 -40.13 57.99 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.043 -1.035 . . . . 0.0 110.245 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -158.6 34.61 0.23 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.584 -0.698 . . . . 0.0 110.605 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -154.35 141.2 19.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.251 -0.905 . . . . 0.0 111.021 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.5 t -145.52 157.7 43.95 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.301 -0.875 . . . . 0.0 109.594 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 32' ' ' HIS . 9.7 mt-10 -101.23 122.95 44.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.359 -0.838 . . . . 0.0 111.229 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.622 HD12 ' SG ' ' A' ' 34' ' ' CYS . 7.2 mt -108.17 116.36 31.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.569 -0.707 . . . . 0.0 109.396 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.632 HD11 ' HG3' ' A' ' 95' ' ' GLU . 1.2 tp 58.48 31.1 20.61 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.784 -0.572 . . . . 0.0 110.73 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.32 -8.19 79.41 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 29.0 m80 -91.33 163.64 14.14 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.121 -1.223 . . . . 0.0 110.273 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.58 127.98 38.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.569 -0.707 . . . . 0.0 110.324 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.622 ' SG ' HD12 ' A' ' 29' ' ' LEU . 64.3 m -127.61 170.74 12.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.674 -0.641 . . . . 0.0 110.04 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -123.22 99.94 6.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.543 -0.723 . . . . 0.0 110.312 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.492 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 5.4 t80 -112.53 135.08 53.66 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.23 171.37 16.59 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.11 -0.993 . . . . 0.0 110.841 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.452 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 44.7 t -129.35 135.36 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.788 -0.57 . . . . 0.0 109.619 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.25 87.22 39.25 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.286 -0.884 . . . . 0.0 110.776 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -79.55 158.97 25.46 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.826 1.435 . . . . 0.0 110.475 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -123.66 -179.94 4.55 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.375 -0.828 . . . . 0.0 110.195 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.783 HD12 HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -147.83 146.95 29.31 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.681 -0.637 . . . . 0.0 110.654 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.53 176.59 8.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.643 -0.66 . . . . 0.0 109.742 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -42.37 -39.48 2.19 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.4 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 35.3 p90 -152.04 30.49 0.56 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.366 -0.834 . . . . 0.0 110.772 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 45' ' ' PHE . 50.6 mt-30 -144.99 135.87 24.68 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.134 -0.979 . . . . 0.0 110.526 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.783 HG13 HD12 ' A' ' 42' ' ' LEU . 18.3 t -114.75 118.21 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.287 -0.883 . . . . 0.0 109.472 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -98.44 154.76 17.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.515 -0.74 . . . . 0.0 110.102 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -127.99 128.7 45.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.026 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -135.54 157.39 47.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -0.941 . . . . 0.0 110.18 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -149.3 148.07 19.06 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.572 ' HD3' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -143.25 143.31 31.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.659 -0.906 . . . . 0.0 110.16 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.53 ' HG2' HG22 ' A' ' 77' ' ' THR . 1.6 ppp? -148.64 150.25 32.93 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.255 -0.903 . . . . 0.0 111.137 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.553 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 46.7 p90 -164.02 152.11 12.86 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.785 -0.572 . . . . 0.0 110.376 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 75.7 m -111.16 92.45 15.54 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.209 -0.932 . . . . 0.0 110.71 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.553 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 48.9 Cg_endo -74.21 88.61 1.11 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.903 1.475 . . . . 0.0 110.192 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 146.49 -47.22 0.71 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -71.1 -50.89 28.86 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.549 -0.971 . . . . 0.0 110.19 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.515 ' CB ' HD11 ' A' ' 90' ' ' LEU . 14.3 t -151.96 -169.89 3.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.632 -0.668 . . . . 0.0 109.901 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.63 61.97 0.78 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 0.0 110.367 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.733 HD11 ' HB3' ' A' ' 84' ' ' LYS . 10.5 tt -137.91 150.52 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.336 -0.852 . . . . 0.0 109.99 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.34 155.97 49.32 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.806 . . . . 0.0 110.594 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.5 151.36 21.15 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.572 ' HB3' ' HD3' ' A' ' 52' ' ' ARG . 1.8 pp20? -156.38 158.65 37.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.391 -1.064 . . . . 0.0 110.738 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.48 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -146.42 148.36 32.21 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.586 -0.696 . . . . 0.0 110.81 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.427 ' O ' ' HB ' ' A' ' 67' ' ' THR . 1.4 m -138.04 139.14 39.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.368 -0.833 . . . . 0.0 110.331 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 66' ' ' SER . 6.1 t 179.63 -163.34 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.843 -0.535 . . . . 0.0 109.819 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.94 -23.79 14.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.4 -0.813 . . . . 0.0 110.334 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.2 m -61.91 153.32 29.46 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.108 -0.995 . . . . 0.0 110.454 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.455 ' O ' HG12 ' A' ' 73' ' ' VAL . 38.5 tt0 -93.15 -56.92 2.79 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.643 -0.661 . . . . 0.0 110.412 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.2 p -81.42 -28.58 34.2 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.376 -0.828 . . . . 0.0 110.475 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.1 -45.01 96.75 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 70' ' ' GLN . 2.5 p -58.8 -38.07 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.498 -1.001 . . . . 0.0 110.538 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.4 ' N ' ' CG1' ' A' ' 73' ' ' VAL . . . -65.25 -47.6 76.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.467 -0.771 . . . . 0.0 109.801 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -63.49 -39.77 98.05 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.48 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -62.87 -42.02 99.61 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.571 -0.958 . . . . 0.0 110.285 179.372 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.53 HG22 ' HG2' ' A' ' 53' ' ' MET . 47.6 m -62.12 -41.25 98.06 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.257 -0.902 . . . . 0.0 109.978 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.615 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -76.45 -36.85 57.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.526 -0.734 . . . . 0.0 110.037 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 75' ' ' GLY . 0.1 OUTLIER -69.11 -38.36 78.88 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.531 -0.731 . . . . 0.0 110.137 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -69.12 -35.54 76.51 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.442 ' CE2' HG23 ' A' ' 61' ' ' ILE . 42.7 t80 -66.62 -41.0 89.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.569 -0.707 . . . . 0.0 109.68 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 78' ' ' ALA . 84.3 t -64.7 -38.62 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.538 -0.726 . . . . 0.0 109.738 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.1 tpt85 -63.82 -39.52 94.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.565 -0.71 . . . . 0.0 109.73 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.733 ' HB3' HD11 ' A' ' 61' ' ' ILE . 36.4 mtpt -69.35 -33.86 73.74 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.379 -0.826 . . . . 0.0 109.529 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.47 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -76.28 -27.69 56.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.306 -0.871 . . . . 0.0 109.231 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.48 -41.9 72.11 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.719 -0.613 . . . . 0.0 110.019 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.435 ' HG3' ' N ' ' A' ' 88' ' ' LYS . 6.0 pt20 -67.48 -36.22 80.69 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.378 -0.826 . . . . 0.0 110.585 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.715 ' HD2' HD12 ' A' ' 61' ' ' ILE . 10.5 mttt -74.4 -54.81 6.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.297 -0.877 . . . . 0.0 110.004 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.98 52.37 0.07 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.515 HD11 ' CB ' ' A' ' 59' ' ' THR . 6.1 mt -119.32 -61.64 1.6 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.245 -1.15 . . . . 0.0 109.893 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 82' ' ' VAL . 72.9 mt -89.5 75.46 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.505 -0.747 . . . . 0.0 109.237 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.2 t -62.13 178.97 0.33 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.753 -0.592 . . . . 0.0 110.535 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -62.03 -54.63 38.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.472 -0.768 . . . . 0.0 110.217 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -67.85 -29.44 68.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.623 -0.673 . . . . 0.0 110.675 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.632 ' HG3' HD11 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -63.78 -45.41 89.86 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.357 -0.84 . . . . 0.0 110.188 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.66 -38.04 89.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.514 -0.741 . . . . 0.0 109.622 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -66.65 -36.79 83.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.503 -0.748 . . . . 0.0 110.307 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -41.41 90.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.342 -0.849 . . . . 0.0 109.761 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.639 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 13.6 t90 -67.26 -40.96 86.29 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.354 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.663 HD23 ' HE3' ' A' ' 17' ' ' LYS . 43.3 mt -57.12 -38.31 73.26 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.631 -0.668 . . . . 0.0 109.62 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.6 t -76.78 -42.8 39.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.493 -0.754 . . . . 0.0 109.757 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.408 -0.806 . . . . 0.0 110.172 179.86 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.471 0.653 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.43 170.68 19.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.268 -0.895 . . . . 0.0 110.514 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 68.67 -67.01 0.22 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 122.02 -0.425 . . . . 0.0 111.045 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.5 t -80.18 137.82 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.214 -0.929 . . . . 0.0 109.93 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.97 151.28 45.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.452 -0.78 . . . . 0.0 110.754 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.58 -22.23 60.53 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -60.4 -46.08 91.28 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.224 -1.163 . . . . 0.0 110.458 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -60.87 -39.55 89.61 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.337 -0.852 . . . . 0.0 109.986 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.69 -40.87 97.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.514 -0.741 . . . . 0.0 109.642 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.466 ' O ' HG23 ' A' ' 14' ' ' VAL . 77.8 t -64.49 -39.56 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.596 -0.69 . . . . 0.0 109.202 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.686 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -63.54 -39.56 94.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.759 -0.588 . . . . 0.0 109.813 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.63 99.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.534 -0.729 . . . . 0.0 109.648 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.13 99.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.603 -0.686 . . . . 0.0 109.671 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 10' ' ' VAL . 91.5 t -62.98 -40.8 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.521 -0.737 . . . . 0.0 109.431 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.68 -38.71 92.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.544 -0.722 . . . . 0.0 109.536 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.1 t -62.46 -41.76 98.99 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.661 -0.65 . . . . 0.0 109.627 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.44 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 11.8 tttm -65.35 -32.49 74.15 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.433 -0.792 . . . . 0.0 110.063 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.495 HG21 ' HB2' ' A' ' 78' ' ' ALA . 8.7 mm -64.94 -45.86 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.419 -0.801 . . . . 0.0 109.66 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.56 -40.77 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.546 -0.721 . . . . 0.0 110.206 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.18 -19.27 78.66 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.276 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 tp -120.41 21.15 11.75 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.865 -1.374 . . . . 0.0 111.945 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.547 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 18.6 t90 -90.88 137.74 32.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.902 -1.124 . . . . 0.0 109.948 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.64 -169.14 1.79 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.41 -0.806 . . . . 0.0 109.369 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -45.54 -44.04 12.42 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.153 -0.967 . . . . 0.0 110.311 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.475 ' O ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -158.39 33.31 0.24 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.579 -0.7 . . . . 0.0 110.828 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -141.5 152.73 44.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.12 -0.987 . . . . 0.0 111.001 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.541 HG23 ' CB ' ' A' ' 34' ' ' CYS . 2.1 t -155.07 167.32 30.76 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.629 -0.669 . . . . 0.0 109.476 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -136.55 119.13 15.95 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.275 -0.89 . . . . 0.0 109.992 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.595 HD13 ' CE2' ' A' ' 81' ' ' PHE . 5.2 mt -108.64 120.74 43.33 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.333 -0.854 . . . . 0.0 110.456 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp 56.52 31.06 18.3 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.582 -0.699 . . . . 0.0 111.007 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.44 -11.78 64.85 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.594 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 30.3 m80 -84.63 141.52 30.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.028 -1.278 . . . . 0.0 110.006 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -72.2 135.74 46.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.391 -0.818 . . . . 0.0 110.305 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.546 ' SG ' HD12 ' A' ' 29' ' ' LEU . 45.1 m -139.15 168.57 19.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.614 -0.679 . . . . 0.0 110.059 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.475 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER -129.7 121.21 26.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.511 -0.743 . . . . 0.0 110.051 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.547 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 26.8 t80 -120.42 136.77 54.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.555 -0.716 . . . . 0.0 109.364 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.1 p -140.36 151.0 44.64 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.061 -1.025 . . . . 0.0 111.503 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.7 t -132.64 129.25 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 mtmm -142.56 117.33 6.56 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.159 -0.963 . . . . 0.0 110.938 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.03 157.62 34.27 Favored 'Trans proline' 0 C--N 1.313 -1.289 0 O-C-N 123.954 1.502 . . . . 0.0 110.251 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -131.79 -169.2 2.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.418 -0.801 . . . . 0.0 110.091 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 tp -139.21 144.29 38.43 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.543 0.687 . . . . 0.0 111.009 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.404 ' HD3' ' CE2' ' A' ' 48' ' ' TYR . 5.9 tptt -115.15 177.8 4.52 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -40.73 -39.71 1.15 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.907 -0.496 . . . . 0.0 111.204 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -157.45 47.33 0.4 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.543 -0.723 . . . . 0.0 110.218 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.83 149.86 13.08 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.111 -0.993 . . . . 0.0 111.45 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 79.6 t -98.48 136.81 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.508 -0.745 . . . . 0.0 109.157 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.404 ' CE2' ' HD3' ' A' ' 43' ' ' LYS . 15.6 m-85 -124.54 159.85 29.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.32 -0.862 . . . . 0.0 110.773 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.485 ' CZ ' ' HG3' ' A' ' 70' ' ' GLN . 0.5 OUTLIER -124.28 131.62 53.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.476 -0.765 . . . . 0.0 110.028 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -135.69 157.14 47.6 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.449 -0.782 . . . . 0.0 110.495 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.91 147.58 17.55 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.491 ' HD3' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -141.16 145.52 35.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.826 -0.808 . . . . 0.0 110.033 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.646 ' HG2' HG22 ' A' ' 77' ' ' THR . 2.2 ptm -143.99 151.88 40.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.078 -1.014 . . . . 0.0 111.079 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.472 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 48.6 p90 -155.84 150.56 26.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.7 -0.625 . . . . 0.0 110.32 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 87.1 m -113.53 90.49 17.83 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.214 -0.929 . . . . 0.0 110.964 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.472 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.4 Cg_endo -78.66 84.8 1.96 Allowed 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.957 1.504 . . . . 0.0 110.108 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.49 -47.6 0.41 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.594 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 19.4 t90 -77.08 -54.66 6.25 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.449 -1.03 . . . . 0.0 110.384 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.556 HG21 HD13 ' A' ' 90' ' ' LEU . 8.9 t -153.74 -161.83 1.33 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.558 -0.714 . . . . 0.0 110.022 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.24 48.57 1.39 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.518 -0.739 . . . . 0.0 110.212 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.735 HD12 HD12 ' A' ' 90' ' ' LEU . 34.4 mt -118.36 146.57 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.366 -0.834 . . . . 0.0 109.83 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.16 161.72 35.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.365 -0.835 . . . . 0.0 110.98 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.68 131.76 5.89 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HG2' ' HD3' ' A' ' 52' ' ' ARG . 12.9 mp0 -126.44 160.25 31.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.644 -0.915 . . . . 0.0 109.914 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.738 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -171.76 152.34 3.06 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.414 -0.804 . . . . 0.0 111.188 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.1 143.44 31.13 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.516 -0.74 . . . . 0.0 110.115 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.8 t -173.25 155.42 2.92 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.52 -0.738 . . . . 0.0 110.323 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.41 -35.88 70.6 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.532 -0.73 . . . . 0.0 111.411 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.406 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 0.9 OUTLIER -62.31 135.6 57.54 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.32 -0.863 . . . . 0.0 110.354 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.509 ' O ' HG12 ' A' ' 73' ' ' VAL . 4.6 mp0 -70.23 -61.39 1.79 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.705 -0.622 . . . . 0.0 109.98 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.2 t -72.93 -28.76 62.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.24 -0.913 . . . . 0.0 109.879 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -58.27 -39.66 92.86 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 70' ' ' GLN . 0.5 OUTLIER -64.97 -35.81 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.377 -1.072 . . . . 0.0 109.992 179.563 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.96 -39.76 87.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.433 -0.792 . . . . 0.0 110.036 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.05 -34.34 76.13 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.738 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -70.36 -42.22 72.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.62 -0.929 . . . . 0.0 110.177 179.502 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.646 HG22 ' HG2' ' A' ' 53' ' ' MET . 66.5 m -62.49 -40.01 95.33 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.286 -0.884 . . . . 0.0 109.419 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -73.47 -37.02 65.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.514 -0.741 . . . . 0.0 109.685 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -38.78 86.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.505 -0.747 . . . . 0.0 109.693 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -41.97 99.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.565 -0.709 . . . . 0.0 110.001 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.595 ' CE2' HD13 ' A' ' 29' ' ' LEU . 51.5 t80 -65.72 -40.8 92.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.443 -0.785 . . . . 0.0 109.973 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.686 HG11 ' HA ' ' A' ' 11' ' ' ALA . 97.1 t -66.1 -36.04 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.484 -0.76 . . . . 0.0 109.915 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -67.04 -40.66 87.23 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.47 -0.769 . . . . 0.0 109.982 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -37.11 80.56 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.535 -0.728 . . . . 0.0 109.869 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.707 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -68.98 -35.27 76.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.385 -0.822 . . . . 0.0 110.134 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.9 -36.22 72.64 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.477 -0.764 . . . . 0.0 109.687 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -63.1 -29.05 70.5 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.601 -0.687 . . . . 0.0 110.412 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -55.29 3.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.43 -0.794 . . . . 0.0 110.332 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 136.61 56.53 0.06 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.735 HD12 HD12 ' A' ' 61' ' ' ILE . 11.5 mt -125.44 -46.41 1.76 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.336 -1.096 . . . . 0.0 110.579 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.707 HD12 ' HB3' ' A' ' 85' ' ' ALA . 89.0 mt -96.78 112.38 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 109.741 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.5 m -91.25 162.63 14.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.542 -0.724 . . . . 0.0 110.353 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -63.29 -53.72 48.34 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.526 -0.734 . . . . 0.0 110.259 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -61.64 -42.74 99.31 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.481 -0.762 . . . . 0.0 110.733 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -59.27 -41.66 89.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.317 -0.864 . . . . 0.0 110.176 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.06 -40.24 97.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.381 -0.824 . . . . 0.0 109.741 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -64.21 -39.88 94.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.567 -0.708 . . . . 0.0 109.868 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -63.26 -40.48 97.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.668 -0.645 . . . . 0.0 109.745 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.44 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 15.1 t90 -68.45 -36.54 79.17 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.591 -0.693 . . . . 0.0 109.9 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.428 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 14.1 mt -66.71 -30.91 71.26 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.699 -0.626 . . . . 0.0 110.548 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.3 m -55.4 -41.67 73.0 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.429 -0.795 . . . . 0.0 110.582 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.436 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 2.6 mt-10 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 120.75 0.309 . . . . 0.0 110.534 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 1' ' ' GLU . . . 58.19 -155.47 0.34 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.566 -0.709 . . . . 0.0 110.454 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -67.51 140.54 57.03 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.306 -0.872 . . . . 0.0 110.32 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.4 t -116.93 -50.63 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.447 -0.783 . . . . 0.0 110.444 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -80.97 155.85 26.23 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.239 -0.913 . . . . 0.0 110.433 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.65 -82.42 0.04 OUTLIER Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -65.14 -21.75 66.83 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.417 -1.049 . . . . 0.0 110.799 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -40.05 85.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.233 -0.917 . . . . 0.0 109.401 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.28 -39.45 71.52 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.536 ' O ' HG23 ' A' ' 14' ' ' VAL . 97.4 t -68.5 -38.79 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.809 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -64.19 -39.74 94.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.611 -0.681 . . . . 0.0 109.647 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.58 -41.56 99.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.551 -0.718 . . . . 0.0 109.79 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.49 -40.43 89.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.397 -0.814 . . . . 0.0 109.693 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 10' ' ' VAL . 95.0 t -64.96 -40.78 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.439 -0.788 . . . . 0.0 109.137 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -62.13 -40.27 95.35 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.687 -0.633 . . . . 0.0 109.75 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 t -61.39 -41.78 97.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.563 -0.711 . . . . 0.0 109.755 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.461 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 14.4 tttm -68.36 -30.44 69.39 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.472 -0.767 . . . . 0.0 110.215 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.533 HG21 ' HB2' ' A' ' 78' ' ' ALA . 12.9 mm -68.1 -44.32 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.423 -0.798 . . . . 0.0 109.702 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.77 -39.24 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.342 -0.849 . . . . 0.0 110.196 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.57 -27.58 69.14 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.68 28.73 8.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.1 -1.235 . . . . 0.0 111.613 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -95.65 132.69 40.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.929 -1.107 . . . . 0.0 110.48 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -98.09 -166.04 1.33 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -48.0 -41.95 26.71 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.161 -0.962 . . . . 0.0 110.26 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -161.97 37.83 0.12 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.725 -0.609 . . . . 0.0 110.261 179.566 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -146.12 158.83 43.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.188 -0.945 . . . . 0.0 111.205 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.562 HG23 ' HB2' ' A' ' 34' ' ' CYS . 8.0 t -163.61 154.3 15.97 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.682 -0.636 . . . . 0.0 109.406 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -110.94 111.11 22.01 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.21 -0.932 . . . . 0.0 110.302 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.446 HD21 HD11 ' A' ' 18' ' ' ILE . 2.8 mt -107.06 128.86 54.75 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.355 -0.841 . . . . 0.0 110.763 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 30' ' ' LEU . 4.7 tp 54.48 36.0 24.63 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.599 -0.688 . . . . 0.0 111.17 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.32 23.49 78.01 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.567 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 34.2 m170 -123.14 151.67 41.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -1.087 . . . . 0.0 109.895 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.46 127.43 32.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.312 -0.868 . . . . 0.0 110.597 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.562 ' HB2' HG23 ' A' ' 27' ' ' THR . 59.9 m -129.33 171.25 12.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.685 -0.635 . . . . 0.0 109.996 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 7.9 tptm -128.06 100.68 5.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.526 -0.734 . . . . 0.0 110.276 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.474 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 3.8 t80 -112.85 136.1 52.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.755 -0.591 . . . . 0.0 109.703 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.01 170.85 16.85 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.343 -0.848 . . . . 0.0 111.045 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.506 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 76.0 t -133.41 130.64 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -137.84 93.74 11.96 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.158 -0.964 . . . . 0.0 111.192 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.477 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 56.5 Cg_endo -77.57 169.75 20.44 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.916 1.482 . . . . 0.0 110.316 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -151.7 -178.21 6.57 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.255 -0.903 . . . . 0.0 110.443 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.69 150.62 34.96 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.395 0.617 . . . . 0.0 110.637 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -120.53 177.97 4.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.793 -0.567 . . . . 0.0 109.618 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -40.42 -40.26 1.16 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.877 -0.514 . . . . 0.0 111.563 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -155.56 36.1 0.37 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.328 -0.858 . . . . 0.0 110.993 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.86 145.87 10.83 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.987 -1.071 . . . . 0.0 110.884 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.06 122.83 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.282 -0.886 . . . . 0.0 109.355 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -108.69 150.84 26.99 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.487 -0.758 . . . . 0.0 110.756 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.548 ' CE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -108.98 156.86 19.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.456 -0.778 . . . . 0.0 110.195 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -156.78 149.75 23.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.312 -0.867 . . . . 0.0 110.189 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -145.87 149.97 22.15 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HD3' ' CB ' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -148.42 145.05 27.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.7 -0.882 . . . . 0.0 110.113 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.508 ' HG2' HG22 ' A' ' 77' ' ' THR . 5.4 ptm -144.54 151.3 38.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.374 -0.829 . . . . 0.0 111.123 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.496 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 42.8 p90 -153.93 147.93 25.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.786 -0.571 . . . . 0.0 109.888 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 58' ' ' TRP . 87.5 m -111.58 89.9 11.6 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.222 -0.924 . . . . 0.0 111.449 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -77.06 85.72 1.73 Allowed 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.856 1.451 . . . . 0.0 110.091 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.83 -46.63 0.64 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.567 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 12.1 t90 -70.31 -57.43 4.88 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.672 -0.899 . . . . 0.0 109.996 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -152.1 -164.37 1.95 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.61 -0.681 . . . . 0.0 109.901 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.63 56.83 0.88 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.356 -0.84 . . . . 0.0 109.767 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.565 HD11 ' HE2' ' A' ' 88' ' ' LYS . 31.7 mt -130.55 158.71 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.608 -0.683 . . . . 0.0 109.699 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -135.93 171.04 15.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.45 -0.781 . . . . 0.0 110.695 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.56 127.96 1.83 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.432 ' CB ' ' HD3' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -147.48 156.06 42.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.608 -0.937 . . . . 0.0 110.709 -179.655 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.582 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -158.4 155.57 28.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.458 -0.776 . . . . 0.0 110.614 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.501 ' HA ' HG23 ' A' ' 73' ' ' VAL . 0.7 OUTLIER -133.42 145.45 50.3 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.418 -0.801 . . . . 0.0 110.688 -179.809 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 t -172.7 152.29 2.49 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.629 -0.669 . . . . 0.0 109.67 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -26.97 61.23 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.361 -0.837 . . . . 0.0 111.346 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.8 133.24 51.55 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.28 -0.888 . . . . 0.0 110.618 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.548 ' HA ' ' CE2' ' A' ' 49' ' ' TYR . 1.0 OUTLIER -70.36 -53.12 17.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.56 -0.712 . . . . 0.0 110.559 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.9 m -80.88 -28.31 36.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.331 -0.856 . . . . 0.0 110.082 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.17 -44.16 98.49 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' A' ' 66' ' ' SER . 0.5 OUTLIER -58.37 -36.37 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.461 -1.023 . . . . 0.0 110.321 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.449 ' HA ' ' HZ ' ' A' ' 36' ' ' PHE . . . -71.75 -43.3 66.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.589 -0.694 . . . . 0.0 109.653 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.58 -38.5 93.37 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.582 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -65.38 -40.47 93.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.643 -0.916 . . . . 0.0 109.996 179.433 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.508 HG22 ' HG2' ' A' ' 53' ' ' MET . 23.3 m -60.19 -43.51 95.84 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.542 -0.724 . . . . 0.0 109.32 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.533 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -68.7 -37.57 79.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.624 -0.673 . . . . 0.0 109.76 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.79 -40.17 94.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.559 -0.713 . . . . 0.0 109.61 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.53 -40.41 94.55 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.666 . . . . 0.0 110.049 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -70.18 -38.51 75.39 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.426 -0.797 . . . . 0.0 110.004 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.825 HG13 HG21 ' A' ' 91' ' ' ILE . 85.7 t -71.86 -33.4 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 0.0 110.027 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -41.27 80.67 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.282 -0.886 . . . . 0.0 109.361 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -36.67 67.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.494 -0.754 . . . . 0.0 108.983 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.37 -37.01 80.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.449 -0.782 . . . . 0.0 109.271 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -43.47 98.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.548 -0.72 . . . . 0.0 109.352 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -68.21 -37.1 80.52 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.659 -0.651 . . . . 0.0 110.534 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.565 ' HE2' HD11 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -72.37 -52.19 17.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.327 -0.858 . . . . 0.0 110.474 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.4 53.99 0.1 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 90' ' ' LEU . 12.4 mt -129.0 -49.88 1.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.487 -1.008 . . . . 0.0 110.521 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.825 HG21 HG13 ' A' ' 82' ' ' VAL . 32.5 mm -94.51 90.81 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 109.833 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -77.78 169.63 17.97 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.552 -0.718 . . . . 0.0 109.705 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.515 ' HG3' HG21 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -64.64 -54.47 31.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.404 -0.81 . . . . 0.0 110.462 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -69.29 -36.91 77.54 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.406 -0.809 . . . . 0.0 110.563 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.0 OUTLIER -62.4 -43.19 99.42 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.293 -0.879 . . . . 0.0 110.054 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.85 87.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.444 -0.785 . . . . 0.0 109.12 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -62.93 -41.15 99.38 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.81 -0.556 . . . . 0.0 109.889 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -41.46 96.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.445 -0.785 . . . . 0.0 109.288 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.461 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 29.6 t90 -66.74 -36.64 82.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.349 -0.844 . . . . 0.0 109.069 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 100' ' ' LEU . 21.1 tp -58.71 -43.48 90.1 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.932 -0.48 . . . . 0.0 109.955 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 99.6 p -78.65 -48.26 15.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.527 -0.733 . . . . 0.0 109.814 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 117.777 -1.106 . . . . 0.0 109.887 179.754 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.061 0.457 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.53 126.49 19.49 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.41 -0.806 . . . . 0.0 110.471 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -157.71 -59.46 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.516 -0.74 . . . . 0.0 110.287 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.9 p -101.16 -28.98 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.42 -0.8 . . . . 0.0 110.36 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -116.57 140.3 49.53 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.311 -0.868 . . . . 0.0 110.149 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 141.92 57.4 0.03 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -87.85 -37.79 16.23 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.549 -0.971 . . . . 0.0 110.305 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -62.45 -37.38 85.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.73 . . . . 0.0 110.164 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.1 -40.85 97.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.546 -0.721 . . . . 0.0 109.72 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 14' ' ' VAL . 64.4 t -67.04 -42.07 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.1 94.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.582 -0.699 . . . . 0.0 109.186 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.39 94.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.711 -0.618 . . . . 0.0 109.715 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.478 ' O ' HD21 ' A' ' 100' ' ' LEU . . . -62.5 -39.76 94.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.561 -0.712 . . . . 0.0 110.02 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.605 ' CG2' ' HB1' ' A' ' 96' ' ' ALA . 48.8 t -69.45 -39.65 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.329 -0.857 . . . . 0.0 109.237 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.68 -39.25 88.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.542 -0.724 . . . . 0.0 109.902 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 p -65.63 -35.97 82.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.406 -0.808 . . . . 0.0 109.923 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.79 ' HD3' HD23 ' A' ' 100' ' ' LEU . 4.7 tptt -65.78 -35.49 80.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.473 -0.767 . . . . 0.0 109.7 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.772 HD12 ' HB1' ' A' ' 78' ' ' ALA . 4.9 mt -65.52 -47.11 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.507 -0.746 . . . . 0.0 109.18 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.6 t -64.45 -39.49 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.523 -0.736 . . . . 0.0 110.051 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.58 -25.01 75.2 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.8 tp -120.68 31.39 6.45 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.289 -1.124 . . . . 0.0 111.021 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.423 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 23.5 t90 -93.28 136.71 33.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.987 -1.07 . . . . 0.0 110.479 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.07 -167.79 1.56 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.605 -0.685 . . . . 0.0 109.253 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.81 -43.02 18.03 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.24 -0.913 . . . . 0.0 110.206 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 1.4 pp20? -159.5 33.56 0.19 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.479 -0.763 . . . . 0.0 110.848 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -140.81 147.9 39.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.129 -0.982 . . . . 0.0 110.78 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 t -154.71 161.95 41.33 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.437 -0.789 . . . . 0.0 109.553 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -111.35 152.72 26.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.197 -0.939 . . . . 0.0 110.183 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.546 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 3.4 mt -146.18 119.02 8.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.405 -0.81 . . . . 0.0 109.971 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 tp 54.71 32.48 17.45 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.779 -0.576 . . . . 0.0 111.188 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.29 22.28 63.17 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 34.9 m80 -124.89 147.14 48.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -1.143 . . . . 0.0 110.151 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.83 132.92 40.69 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.435 -0.79 . . . . 0.0 110.416 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.546 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 84.4 m -135.37 164.34 27.99 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.561 -0.712 . . . . 0.0 110.179 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.573 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 1.5 tptt -117.9 124.01 47.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.343 -0.848 . . . . 0.0 110.53 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.465 ' CZ ' ' HB ' ' A' ' 77' ' ' THR . 7.3 t80 -124.49 123.93 41.19 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.709 -0.619 . . . . 0.0 109.512 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.3 p -131.37 154.32 48.74 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.202 -0.937 . . . . 0.0 111.578 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 p -122.29 142.35 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.632 -0.667 . . . . 0.0 109.75 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.57 107.56 4.08 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.081 -1.012 . . . . 0.0 110.868 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -78.49 161.26 28.4 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 O-C-N 123.762 1.401 . . . . 0.0 110.509 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -132.17 -175.71 3.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.393 -0.817 . . . . 0.0 109.813 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.05 159.61 42.87 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.532 0.682 . . . . 0.0 110.946 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -135.85 176.36 8.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.745 -0.597 . . . . 0.0 109.586 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 61.8 mtt-85 -43.6 -35.48 1.76 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.661 -0.649 . . . . 0.0 111.032 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.57 42.14 0.42 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.539 -0.726 . . . . 0.0 110.018 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 43' ' ' LYS . 1.8 mt-30 -151.99 152.16 32.11 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.304 -0.872 . . . . 0.0 111.208 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.1 t -122.77 139.58 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -135.57 156.62 48.59 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.348 -0.845 . . . . 0.0 110.911 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 67' ' ' THR . 1.7 m-85 -122.57 132.13 54.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.548 -0.72 . . . . 0.0 109.95 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -132.26 162.99 29.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.427 -0.796 . . . . 0.0 110.381 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -158.0 141.95 8.14 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.53 147.36 52.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.799 -0.824 . . . . 0.0 109.805 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.674 ' HG2' HG22 ' A' ' 77' ' ' THR . 2.4 ppp? -149.05 157.24 43.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.109 -0.995 . . . . 0.0 111.05 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.573 ' CE2' ' HB3' ' A' ' 35' ' ' LYS . 47.3 p90 -164.5 176.6 8.84 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.826 -0.546 . . . . 0.0 110.117 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 58' ' ' TRP . 67.5 m -129.06 94.86 32.78 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.213 -0.929 . . . . 0.0 110.614 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 49.8 Cg_endo -77.01 81.61 2.56 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.902 1.475 . . . . 0.0 110.468 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.36 -46.24 0.64 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.494 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 12.6 t90 -68.61 -57.72 5.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.604 -0.939 . . . . 0.0 110.155 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -150.64 -166.23 2.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.471 -0.768 . . . . 0.0 109.939 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.19 50.6 1.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.382 -0.824 . . . . 0.0 110.225 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.4 mt -123.01 149.53 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.739 . . . . 0.0 109.781 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -129.37 165.58 21.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -0.902 . . . . 0.0 111.0 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.22 152.5 24.1 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 65' ' ' ALA . 27.3 tt0 -153.2 158.77 42.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.482 -1.01 . . . . 0.0 110.069 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.553 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -168.63 148.55 4.45 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.989 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.415 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 1.7 m -137.61 147.53 45.09 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.612 -0.68 . . . . 0.0 110.107 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.431 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 6.6 t -170.97 171.37 5.92 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.584 -0.698 . . . . 0.0 110.11 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -69.16 -42.24 76.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.423 -0.798 . . . . 0.0 111.26 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.74 138.97 57.77 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.358 -0.839 . . . . 0.0 110.848 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.566 ' O ' HG12 ' A' ' 73' ' ' VAL . 19.5 tt0 -73.01 -52.14 15.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.76 -0.587 . . . . 0.0 110.282 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.0 m -72.46 -34.8 68.0 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.311 -0.868 . . . . 0.0 110.106 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.04 -36.63 92.59 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 70' ' ' GLN . 0.4 OUTLIER -63.3 -37.91 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.364 -1.08 . . . . 0.0 110.392 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.66 -38.02 80.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.462 -0.774 . . . . 0.0 109.835 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.82 95.59 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.553 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 4.0 tttm -68.1 -40.91 82.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.539 -0.977 . . . . 0.0 110.402 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.674 HG22 ' HG2' ' A' ' 53' ' ' MET . 62.1 m -61.48 -38.22 86.48 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.074 -1.016 . . . . 0.0 109.871 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.772 ' HB1' HD12 ' A' ' 18' ' ' ILE . . . -77.36 -36.17 53.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.585 -0.697 . . . . 0.0 109.899 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -68.64 -39.08 80.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.357 -0.839 . . . . 0.0 109.858 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -67.46 -34.5 77.32 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.514 -0.741 . . . . 0.0 109.562 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.429 ' CD2' ' SD ' ' A' ' 53' ' ' MET . 41.7 t80 -68.07 -41.16 82.35 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.487 -0.758 . . . . 0.0 109.702 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.541 HG13 HG21 ' A' ' 91' ' ' ILE . 83.9 t -66.87 -36.47 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.496 -0.752 . . . . 0.0 109.496 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.26 -41.67 99.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.601 -0.687 . . . . 0.0 109.456 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.68 -40.11 88.41 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.47 -0.769 . . . . 0.0 109.34 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.64 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -68.24 -35.35 77.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.79 -0.569 . . . . 0.0 109.647 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.68 -35.94 81.34 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.646 -0.659 . . . . 0.0 109.689 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -61.59 -39.9 92.83 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.633 -0.667 . . . . 0.0 110.207 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -82.17 -59.1 2.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.439 -0.788 . . . . 0.0 110.176 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.43 51.16 0.05 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.483 ' HA ' HD23 ' A' ' 90' ' ' LEU . 10.0 mt -115.11 -46.47 2.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.33 -1.1 . . . . 0.0 110.297 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 85' ' ' ALA . 89.9 mt -106.66 89.96 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.434 -0.792 . . . . 0.0 109.936 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 17.0 m -71.62 163.87 26.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.436 -0.79 . . . . 0.0 109.632 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.432 ' HG2' HG11 ' A' ' 10' ' ' VAL . 7.2 tm0? -60.29 -51.15 70.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.438 -0.789 . . . . 0.0 110.105 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -41.81 96.39 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.726 -0.609 . . . . 0.0 110.315 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.3 OUTLIER -59.15 -41.53 88.54 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.493 -0.754 . . . . 0.0 110.037 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.605 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -61.39 -42.12 98.21 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.489 -0.757 . . . . 0.0 109.669 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -63.06 -42.63 99.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.548 -0.72 . . . . 0.0 109.614 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -40.28 91.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.574 -0.703 . . . . 0.0 109.598 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.581 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 24.3 t90 -65.42 -38.37 89.71 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.738 -0.601 . . . . 0.0 109.622 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.79 HD23 ' HD3' ' A' ' 17' ' ' LYS . 4.3 mt -65.06 -39.28 93.04 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.749 -0.594 . . . . 0.0 110.261 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.2 m -79.43 -51.15 9.74 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.495 -0.753 . . . . 0.0 110.491 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.504 2.239 0 CA-C-O 118.059 -0.972 . . . . 0.0 111.356 -179.966 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.448 0.642 . . . . 0.0 110.291 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.83 140.14 30.67 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.171 -0.956 . . . . 0.0 110.272 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -79.01 145.68 33.77 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.501 -0.75 . . . . 0.0 110.13 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.47 150.33 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.42 -0.8 . . . . 0.0 110.365 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 8' ' ' GLU . 17.6 mt-30 -103.81 173.76 6.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.482 -0.761 . . . . 0.0 110.238 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.95 -68.16 0.81 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -67.59 -36.79 81.55 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.559 -0.965 . . . . 0.0 110.23 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -66.69 -36.53 82.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.46 -0.775 . . . . 0.0 110.022 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.3 -41.89 84.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.494 -0.754 . . . . 0.0 109.841 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.0 t -69.35 -39.62 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.52 -0.737 . . . . 0.0 109.033 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.535 ' HB1' ' HE2' ' A' ' 79' ' ' LYS . . . -67.19 -40.71 86.55 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.63 -40.7 92.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.618 -0.676 . . . . 0.0 109.795 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.42 -43.16 97.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.555 -0.716 . . . . 0.0 109.528 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.681 ' CG2' ' HB1' ' A' ' 96' ' ' ALA . 44.0 t -62.43 -44.52 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.564 -0.71 . . . . 0.0 109.309 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.33 92.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.631 -0.668 . . . . 0.0 109.99 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 t -63.55 -38.66 91.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.515 -0.741 . . . . 0.0 110.042 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.549 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 7.1 tttt -67.0 -33.83 76.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.95 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.614 HD12 ' HB1' ' A' ' 78' ' ' ALA . 10.2 mt -61.48 -48.31 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.449 -0.782 . . . . 0.0 109.757 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.3 t -62.14 -39.13 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.389 -0.819 . . . . 0.0 109.978 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.66 -28.29 73.25 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 tp -115.78 37.3 3.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.363 -1.081 . . . . 0.0 110.95 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -99.19 135.16 41.0 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.187 -0.946 . . . . 0.0 110.617 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.1 mtt-85 -98.49 -167.29 1.48 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -48.37 -43.23 33.46 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.984 -1.072 . . . . 0.0 110.385 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -158.89 36.5 0.22 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.641 -0.662 . . . . 0.0 110.476 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -150.33 157.79 43.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.305 -0.872 . . . . 0.0 110.49 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.403 HG23 ' HB2' ' A' ' 34' ' ' CYS . 12.1 t -157.6 -179.81 8.52 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.337 -0.852 . . . . 0.0 109.868 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -127.44 143.0 51.26 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.437 -0.789 . . . . 0.0 110.231 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.482 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 3.1 mt -137.54 123.49 20.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.296 -0.877 . . . . 0.0 109.835 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.544 HD22 ' HZ2' ' A' ' 58' ' ' TRP . 4.0 tp 56.39 30.09 16.33 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.736 -0.603 . . . . 0.0 111.066 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.31 19.01 65.39 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -118.61 163.69 16.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.151 -1.205 . . . . 0.0 110.208 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.2 133.98 34.21 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.477 -0.765 . . . . 0.0 109.896 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.617 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 90.1 m -135.41 165.8 24.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.466 -0.771 . . . . 0.0 110.875 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.33 118.29 31.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.547 -0.72 . . . . 0.0 110.387 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -129.32 126.51 39.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.577 -0.702 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.19 171.45 18.48 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.033 -1.042 . . . . 0.0 111.293 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.61 148.42 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.931 -0.48 . . . . 0.0 109.971 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -157.62 117.39 1.95 Allowed Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.21 -0.931 . . . . 0.0 110.36 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.33 154.06 36.07 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.821 1.432 . . . . 0.0 110.885 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.517 ' CE2' ' HB3' ' A' ' 50' ' ' LYS . 31.0 m-85 -128.43 -168.96 1.99 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.573 -0.704 . . . . 0.0 109.454 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.31 147.75 42.04 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.554 0.692 . . . . 0.0 110.826 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.66 177.16 4.8 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -38.43 -41.47 0.65 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 122.023 -0.423 . . . . 0.0 111.523 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.2 35.0 0.38 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.477 -0.764 . . . . 0.0 110.899 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.66 141.01 15.43 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.079 -1.013 . . . . 0.0 110.838 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 72.9 t -97.01 148.18 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.388 -0.82 . . . . 0.0 109.702 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -140.85 151.45 44.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.423 -0.798 . . . . 0.0 110.82 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.48 130.19 46.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.425 -0.797 . . . . 0.0 109.984 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.517 ' HB3' ' CE2' ' A' ' 41' ' ' TYR . 5.3 tttp -130.84 164.68 24.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.414 -0.803 . . . . 0.0 110.087 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -155.83 152.14 23.61 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.39 134.02 19.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.429 -1.042 . . . . 0.0 110.161 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.418 ' CE ' HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -138.95 158.74 43.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.495 -0.753 . . . . 0.0 110.82 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.584 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 43.9 p90 -168.81 -169.1 0.95 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.774 -0.579 . . . . 0.0 109.984 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 68.2 m -133.18 94.42 20.31 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.253 -0.905 . . . . 0.0 110.708 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.617 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 49.0 Cg_endo -74.87 80.94 2.28 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.986 1.519 . . . . 0.0 110.21 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.34 -45.09 0.64 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.544 ' HZ2' HD22 ' A' ' 30' ' ' LEU . 13.0 t90 -70.77 -55.56 8.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.649 -0.912 . . . . 0.0 110.09 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -151.14 -165.93 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.497 -0.752 . . . . 0.0 109.744 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.57 47.74 1.57 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.299 -0.876 . . . . 0.0 110.183 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.51 HD12 HD12 ' A' ' 90' ' ' LEU . 23.1 mt -123.44 150.9 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.345 -0.847 . . . . 0.0 109.993 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.71 164.38 30.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.316 -0.865 . . . . 0.0 111.328 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.87 130.27 3.83 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.35 170.09 16.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.436 -1.038 . . . . 0.0 111.095 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.556 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -166.34 173.02 10.42 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.385 0.612 . . . . 0.0 110.836 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.43 148.48 24.58 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.391 -0.818 . . . . 0.0 110.87 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.5 t -171.22 169.17 6.51 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.661 -0.649 . . . . 0.0 110.138 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -37.94 88.68 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.288 -0.882 . . . . 0.0 110.529 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.3 t -67.56 162.95 22.27 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.498 -0.751 . . . . 0.0 110.859 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.553 ' O ' HG12 ' A' ' 73' ' ' VAL . 34.0 mt-30 -97.81 -56.24 2.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.899 -0.5 . . . . 0.0 110.122 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 m -67.24 -29.65 69.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.399 -0.813 . . . . 0.0 110.519 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.04 -41.14 97.85 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 110.174 -1.171 . . . . 0.0 110.174 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 70' ' ' GLN . 0.5 OUTLIER -65.51 -34.09 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.455 -1.027 . . . . 0.0 110.47 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.04 -39.38 86.94 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.632 -0.667 . . . . 0.0 110.375 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.07 -33.43 69.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.556 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 8.5 mmmt -73.45 -39.62 64.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.524 -0.986 . . . . 0.0 110.432 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.62 -45.45 81.51 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.105 -0.997 . . . . 0.0 109.641 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.614 ' HB1' HD12 ' A' ' 18' ' ' ILE . . . -72.3 -34.92 68.51 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.736 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.574 ' HZ2' ' HA ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -72.95 -36.45 67.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.445 -0.784 . . . . 0.0 110.702 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.91 -35.23 74.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.451 -0.781 . . . . 0.0 110.315 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.44 ' CE2' HD13 ' A' ' 29' ' ' LEU . 61.1 t80 -71.09 -40.5 71.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 110.243 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.52 HG13 HD13 ' A' ' 91' ' ' ILE . 68.8 t -67.62 -35.06 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.297 -0.877 . . . . 0.0 109.814 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -68.4 -39.07 81.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.515 -0.741 . . . . 0.0 109.733 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.46 ' HB2' ' HE3' ' A' ' 84' ' ' LYS . 1.6 tppp? -64.24 -41.13 97.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.553 -0.717 . . . . 0.0 110.109 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.71 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -69.98 -34.51 73.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.503 -0.748 . . . . 0.0 109.643 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -40.76 95.68 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.682 -0.636 . . . . 0.0 109.646 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -66.5 -38.46 87.3 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.547 -0.72 . . . . 0.0 110.362 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.64 -50.36 21.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.376 -0.827 . . . . 0.0 110.4 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.91 53.49 0.13 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.51 HD12 HD12 ' A' ' 61' ' ' ILE . 12.4 mt -125.74 -51.59 1.59 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.364 -1.08 . . . . 0.0 110.447 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.71 HD12 ' HB3' ' A' ' 85' ' ' ALA . 74.5 mt -86.75 104.85 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.714 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 58.2 m -83.77 171.98 12.65 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.527 -0.733 . . . . 0.0 109.971 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -68.16 -56.91 7.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.469 -0.769 . . . . 0.0 110.357 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -37.35 87.3 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.437 -0.789 . . . . 0.0 110.489 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 1.4 mm-40 -53.67 -42.15 67.6 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.455 -0.778 . . . . 0.0 110.017 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.681 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -63.77 -40.28 96.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.471 -0.768 . . . . 0.0 109.523 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -68.24 -38.77 82.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.694 -0.629 . . . . 0.0 109.395 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -62.89 -40.05 96.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.587 -0.695 . . . . 0.0 109.836 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.549 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 28.1 t90 -71.98 -39.03 69.58 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.4 tp -66.66 -39.58 88.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.782 -0.574 . . . . 0.0 109.647 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.5 t -72.32 -58.1 3.68 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.757 -0.589 . . . . 0.0 110.257 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.041 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.618 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.203 0.525 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.44 125.73 40.25 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.428 -0.795 . . . . 0.0 110.25 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -96.42 -53.58 3.55 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.482 -0.761 . . . . 0.0 110.168 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 99.8 t -103.39 155.84 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.427 -0.796 . . . . 0.0 109.916 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.8 172.79 5.96 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.37 -0.831 . . . . 0.0 110.161 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.98 -59.33 0.24 Allowed Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -57.07 -40.94 77.87 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.682 -0.893 . . . . 0.0 110.229 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.04 -38.65 89.52 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.479 -0.763 . . . . 0.0 109.841 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.49 -40.3 95.41 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.572 -0.705 . . . . 0.0 109.632 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.7 t -63.12 -41.5 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.723 . . . . 0.0 109.121 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.58 -39.75 95.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.662 -0.649 . . . . 0.0 109.823 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.61 -40.47 96.99 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.537 -0.727 . . . . 0.0 109.765 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.51 -40.77 97.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.502 -0.749 . . . . 0.0 109.667 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.615 HG21 ' CG2' ' A' ' 91' ' ' ILE . 90.6 t -61.62 -42.31 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.583 -0.698 . . . . 0.0 109.227 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.96 95.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.617 -0.677 . . . . 0.0 109.597 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 t -61.31 -38.93 88.61 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.606 -0.684 . . . . 0.0 109.809 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.439 ' HD3' HD23 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -67.12 -36.1 81.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 109.6 179.324 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.547 HG21 ' HB2' ' A' ' 78' ' ' ALA . 21.3 mm -58.22 -41.9 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.465 -0.772 . . . . 0.0 110.39 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.65 -45.88 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.384 -0.822 . . . . 0.0 110.096 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.09 -15.8 79.82 Favored Glycine 0 N--CA 1.501 2.981 0 C-N-CA 120.26 -0.971 . . . . 0.0 111.035 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.652 HD21 ' O ' ' A' ' 28' ' ' GLU . 15.4 tp -99.06 -21.5 16.16 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.118 -1.225 . . . . 0.0 111.285 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.595 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 21.9 t90 -65.7 130.89 44.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 0.0 111.197 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.9 ttt-85 -99.47 -160.97 0.84 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -48.55 -45.98 38.25 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.165 -0.959 . . . . 0.0 110.198 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.93 29.29 0.31 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.47 -0.769 . . . . 0.0 111.249 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.49 157.48 43.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.046 -1.034 . . . . 0.0 110.953 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.493 HG23 ' HB2' ' A' ' 34' ' ' CYS . 12.8 t -153.81 145.53 23.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.497 -0.752 . . . . 0.0 109.651 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.71 ' C ' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -102.22 108.24 19.56 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.385 -0.822 . . . . 0.0 109.794 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 28' ' ' GLU . 6.3 mt -114.05 129.37 56.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.183 -0.948 . . . . 0.0 110.924 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.839 HD12 ' HD1' ' A' ' 99' ' ' TRP . 0.4 OUTLIER 58.73 28.58 17.49 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.505 -0.747 . . . . 0.0 110.899 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.31 21.56 77.52 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.641 ' CE1' HD23 ' A' ' 30' ' ' LEU . 34.6 m170 -121.18 155.28 34.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.442 -1.034 . . . . 0.0 109.916 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -86.43 116.2 24.43 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.172 -0.955 . . . . 0.0 109.68 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.493 ' HB2' HG23 ' A' ' 27' ' ' THR . 20.1 m -116.16 173.51 6.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.574 -0.703 . . . . 0.0 109.66 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 4.9 tptt -132.87 108.96 9.28 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.525 -0.734 . . . . 0.0 111.065 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.595 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 47.4 t80 -108.82 139.25 43.9 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 p -144.65 152.91 41.15 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.931 -1.105 . . . . 0.0 111.721 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.412 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 88.3 t -133.2 123.17 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -138.21 117.41 9.73 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.185 -0.947 . . . . 0.0 110.664 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 55.2 Cg_endo -81.49 157.52 19.27 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 124.018 1.536 . . . . 0.0 110.633 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -133.11 -169.17 2.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.61 -0.681 . . . . 0.0 109.22 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.08 149.16 50.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.475 -0.765 . . . . 0.0 110.897 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 44' ' ' ARG . 1.3 tttm -123.08 179.61 4.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.818 -0.551 . . . . 0.0 109.773 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 43' ' ' LYS . 12.6 mmt-85 -35.37 -45.94 0.35 Allowed 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 121.045 0.45 . . . . 0.0 111.582 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -155.07 37.3 0.4 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.57 -0.707 . . . . 0.0 110.774 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -156.0 142.44 18.52 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.167 -0.958 . . . . 0.0 111.049 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.5 t -97.38 124.44 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.463 -0.773 . . . . 0.0 109.251 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -109.35 149.7 29.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.395 -0.816 . . . . 0.0 110.88 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.431 ' CD1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -109.87 131.34 55.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.452 -0.78 . . . . 0.0 109.664 179.317 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -129.42 159.65 35.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.19 -0.944 . . . . 0.0 110.457 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -153.56 142.82 9.51 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.455 ' HG2' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -138.77 149.99 45.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.922 -0.752 . . . . 0.0 109.85 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.0 ptm -145.69 156.44 43.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.966 -1.084 . . . . 0.0 111.433 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.613 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 23.4 p90 -166.42 164.56 17.34 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.885 -0.51 . . . . 0.0 110.301 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.3 m -128.08 98.42 27.03 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.248 -0.908 . . . . 0.0 110.312 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.613 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.6 Cg_endo -75.13 84.65 1.65 Allowed 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.833 1.438 . . . . 0.0 110.577 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 143.22 -43.99 0.99 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -70.19 -59.84 2.64 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.472 -1.016 . . . . 0.0 110.1 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.3 t -150.07 -170.11 3.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.464 -0.773 . . . . 0.0 110.044 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.53 41.06 2.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.509 -0.744 . . . . 0.0 110.302 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.432 HD11 ' HB3' ' A' ' 84' ' ' LYS . 2.7 tt -118.24 153.97 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.51 -0.744 . . . . 0.0 109.666 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.09 171.62 14.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.103 -0.998 . . . . 0.0 111.405 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.557 ' HA3' ' HB2' ' A' ' 81' ' ' PHE . . . -141.2 126.91 3.21 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.455 ' HG2' ' HG2' ' A' ' 52' ' ' ARG . 6.2 mt-10 -135.57 153.01 51.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.459 -1.024 . . . . 0.0 110.441 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.483 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -170.7 164.43 8.12 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.592 -0.693 . . . . 0.0 110.713 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.476 ' HA ' HG23 ' A' ' 73' ' ' VAL . 1.0 OUTLIER -153.05 149.95 28.66 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.459 -0.776 . . . . 0.0 111.03 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.414 HG22 HG23 ' A' ' 73' ' ' VAL . 9.7 t -173.89 156.98 2.91 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 mtm105 -60.5 -24.27 65.19 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.263 -0.898 . . . . 0.0 111.026 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.25 139.45 54.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.237 -0.914 . . . . 0.0 110.545 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.401 ' O ' HG12 ' A' ' 73' ' ' VAL . 70.7 mt-30 -75.82 -53.72 8.03 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.531 -0.731 . . . . 0.0 110.358 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 t -81.07 -30.34 34.77 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.392 -0.818 . . . . 0.0 109.937 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.93 -36.52 88.24 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 66' ' ' SER . 0.5 OUTLIER -63.16 -35.41 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.446 -1.032 . . . . 0.0 110.344 179.644 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.47 87.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.441 -0.787 . . . . 0.0 110.119 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.06 -30.91 71.95 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.483 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -73.55 -39.96 64.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.55 -0.971 . . . . 0.0 110.235 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 63' ' ' GLY . 99.3 m -64.59 -40.17 95.04 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.279 -0.888 . . . . 0.0 109.117 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.547 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -67.17 -39.27 86.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.623 -0.673 . . . . 0.0 109.657 178.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -59.75 -41.75 91.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.536 -0.727 . . . . 0.0 110.007 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.87 -41.22 95.84 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.462 -0.774 . . . . 0.0 109.653 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.557 ' HB2' ' HA3' ' A' ' 63' ' ' GLY . 43.3 t80 -69.7 -38.39 76.96 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.55 -0.719 . . . . 0.0 109.813 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.0 -37.79 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.417 -0.802 . . . . 0.0 109.93 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.37 -40.02 85.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.303 -0.873 . . . . 0.0 109.67 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HB3' HD11 ' A' ' 61' ' ' ILE . 77.7 mttt -67.71 -40.22 84.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.536 -0.727 . . . . 0.0 109.388 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.45 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -67.78 -36.81 81.14 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.632 -0.667 . . . . 0.0 109.774 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -33.38 74.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.594 -0.691 . . . . 0.0 109.956 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -64.25 -31.23 72.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.384 -0.823 . . . . 0.0 110.653 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.3 -66.83 0.89 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.379 -0.826 . . . . 0.0 110.135 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 151.39 51.6 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 90' ' ' LEU . 6.3 mt -112.0 -38.97 4.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.229 -1.159 . . . . 0.0 110.472 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.615 ' CG2' HG21 ' A' ' 14' ' ' VAL . 80.9 mt -103.82 69.42 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 109.757 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.544 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 72.1 m -73.3 -178.61 3.02 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.516 -0.74 . . . . 0.0 110.353 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.62 -59.68 3.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.199 -0.938 . . . . 0.0 110.651 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -63.25 -39.63 95.15 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.359 -0.838 . . . . 0.0 109.94 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 11.4 mt-10 -61.57 -42.66 99.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.576 -0.703 . . . . 0.0 109.493 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.06 -37.03 81.22 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.619 -0.676 . . . . 0.0 109.714 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -62.2 -44.79 95.8 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -30.96 63.45 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.513 -0.742 . . . . 0.0 109.011 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.839 ' HD1' HD12 ' A' ' 30' ' ' LEU . 30.2 t90 -68.55 -40.4 80.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.705 -0.622 . . . . 0.0 109.958 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.439 HD23 ' HD3' ' A' ' 17' ' ' LYS . 21.2 mt -81.99 -31.89 30.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.533 -0.729 . . . . 0.0 110.346 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 43.9 t -88.31 -67.64 0.82 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.454 -0.779 . . . . 0.0 110.587 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.118 0 CA-C-O 118.137 -0.935 . . . . 0.0 110.762 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 120.836 0.35 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.89 85.64 2.14 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.383 -0.823 . . . . 0.0 110.108 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.0 t80 58.61 89.9 0.05 Allowed 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.344 0.592 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 p -116.95 155.89 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.316 -0.865 . . . . 0.0 110.363 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -81.42 147.65 29.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.456 -0.778 . . . . 0.0 109.946 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 10' ' ' VAL . . . -161.9 39.08 0.39 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -62.12 -37.53 85.47 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.456 -1.026 . . . . 0.0 109.834 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -63.83 -41.84 97.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.686 -0.634 . . . . 0.0 109.47 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.37 92.55 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.729 -0.607 . . . . 0.0 110.013 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 6' ' ' GLY . 94.4 t -65.05 -42.09 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.525 -0.734 . . . . 0.0 109.459 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.54 ' HB1' ' CG1' ' A' ' 82' ' ' VAL . . . -69.13 -36.9 77.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.514 -0.742 . . . . 0.0 109.485 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.6 89.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.642 -0.661 . . . . 0.0 109.79 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.81 -41.17 95.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.404 -0.81 . . . . 0.0 109.46 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.579 HG13 ' CZ3' ' A' ' 99' ' ' TRP . 25.5 t -62.32 -40.7 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.639 -0.663 . . . . 0.0 109.41 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.542 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -63.87 -39.39 94.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.573 -0.705 . . . . 0.0 109.408 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.8 m -62.5 -39.53 93.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.65 -0.656 . . . . 0.0 109.684 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.448 ' HB3' ' HZ3' ' A' ' 99' ' ' TRP . 0.5 OUTLIER -63.39 -37.78 88.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.506 -0.747 . . . . 0.0 109.773 179.328 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.501 HD12 ' HB1' ' A' ' 78' ' ' ALA . 2.5 mt -61.84 -37.51 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.556 -0.715 . . . . 0.0 109.984 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.2 t -63.67 -48.58 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.232 -0.917 . . . . 0.0 109.789 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.4 -15.42 81.48 Favored Glycine 0 N--CA 1.5 2.918 0 C-N-CA 120.271 -0.966 . . . . 0.0 110.698 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.66 HD21 ' O ' ' A' ' 28' ' ' GLU . 11.9 tp -99.38 -16.83 18.27 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.232 -1.158 . . . . 0.0 111.203 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.582 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 24.5 t90 -69.44 137.02 52.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.177 -0.952 . . . . 0.0 111.308 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.49 -162.2 0.87 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -45.68 -45.17 13.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.309 -0.869 . . . . 0.0 110.635 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.5 31.83 0.19 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.437 -0.79 . . . . 0.0 111.28 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -153.15 162.76 40.94 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.066 -1.021 . . . . 0.0 110.792 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.611 HG23 ' HB2' ' A' ' 34' ' ' CYS . 11.4 t -157.44 144.28 18.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.395 -0.816 . . . . 0.0 109.996 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.675 ' C ' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -102.56 109.4 21.01 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.517 -0.739 . . . . 0.0 109.621 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.675 HD23 ' C ' ' A' ' 28' ' ' GLU . 7.9 mt -114.04 130.34 56.56 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.221 -0.924 . . . . 0.0 110.797 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.525 HD22 ' CZ2' ' A' ' 58' ' ' TRP . 7.1 tp 56.58 30.33 17.13 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.563 -0.71 . . . . 0.0 110.671 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.82 24.84 73.31 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.515 ' CE1' HD23 ' A' ' 30' ' ' LEU . 35.2 m170 -124.54 159.89 29.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -1.038 . . . . 0.0 109.723 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -91.46 121.92 33.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 110.545 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.611 ' HB2' HG23 ' A' ' 27' ' ' THR . 23.0 m -122.36 164.14 18.49 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 5.5 tptm -125.58 110.48 13.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.36 -0.838 . . . . 0.0 111.146 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.582 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 12.8 t80 -110.66 138.49 46.98 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.9 p -143.05 157.43 44.54 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.025 -1.047 . . . . 0.0 111.389 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.451 HG12 ' HD3' ' A' ' 40' ' ' PRO . 99.6 t -129.09 130.06 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.63 -0.669 . . . . 0.0 109.872 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 83.67 64.71 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 0.0 110.451 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.451 ' HD3' HG12 ' A' ' 38' ' ' VAL . 55.5 Cg_endo -79.49 158.82 25.65 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.855 1.45 . . . . 0.0 110.627 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -139.65 177.34 8.01 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.232 -0.918 . . . . 0.0 110.128 178.529 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.489 ' CD1' HG22 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -136.67 155.72 49.5 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.568 0.699 . . . . 0.0 111.257 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.96 178.68 6.49 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -41.46 -38.89 1.37 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.875 -0.516 . . . . 0.0 111.622 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.99 28.15 0.47 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.307 -0.871 . . . . 0.0 110.737 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -142.58 140.05 31.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.097 -1.002 . . . . 0.0 110.913 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.489 HG22 ' CD1' ' A' ' 42' ' ' LEU . 38.3 t -121.06 125.08 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.443 -0.786 . . . . 0.0 109.411 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.507 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 62.5 m-85 -119.68 139.03 52.88 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.331 -0.856 . . . . 0.0 110.58 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.599 ' CD2' ' HA ' ' A' ' 70' ' ' GLN . 2.1 m-85 -105.72 131.7 52.76 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.555 -0.715 . . . . 0.0 110.42 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.93 156.57 37.79 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.399 -0.813 . . . . 0.0 109.597 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -159.46 141.16 7.32 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.569 -1.301 . . . . 0.0 110.671 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HG3' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -141.03 146.96 37.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.88 -0.776 . . . . 0.0 109.756 179.5 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.579 ' HG2' HG22 ' A' ' 77' ' ' THR . 5.1 ptm -139.05 155.92 47.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 111.327 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.474 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 45.6 p90 -155.91 145.75 21.26 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.916 -0.49 . . . . 0.0 109.797 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 87.3 m -111.98 89.42 11.6 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.236 -0.915 . . . . 0.0 111.066 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -77.74 82.85 2.3 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 123.703 1.37 . . . . 0.0 110.149 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.34 -45.14 0.61 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.525 ' CZ2' HD22 ' A' ' 30' ' ' LEU . 11.2 t90 -75.0 -63.28 1.3 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.533 -0.98 . . . . 0.0 110.096 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.2 t -142.41 -162.92 1.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.5 -0.75 . . . . 0.0 109.52 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.7 44.95 2.5 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.296 -0.878 . . . . 0.0 110.395 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.505 HG23 ' HD3' ' A' ' 84' ' ' LYS . 74.0 mt -123.14 140.71 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.361 -0.837 . . . . 0.0 110.234 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.57 170.88 10.49 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.414 -0.804 . . . . 0.0 110.514 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.02 136.21 4.69 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.405 ' HB2' ' HG3' ' A' ' 52' ' ' ARG . 13.1 tt0 -139.6 161.19 38.12 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.809 -0.818 . . . . 0.0 110.357 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.469 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -165.89 151.01 8.59 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.768 -0.582 . . . . 0.0 110.229 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.406 ' HA ' HG23 ' A' ' 73' ' ' VAL . 0.7 OUTLIER -141.71 142.07 33.31 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.426 -0.796 . . . . 0.0 110.601 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.6 t -168.03 172.65 8.66 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.404 -0.81 . . . . 0.0 110.224 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -71.18 -24.8 62.3 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.371 -0.831 . . . . 0.0 110.904 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.74 139.73 56.69 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.277 -0.889 . . . . 0.0 110.743 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.599 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 5.8 tt0 -76.27 -53.78 7.73 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.724 -0.61 . . . . 0.0 110.349 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -84.26 -30.29 25.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.43 -0.794 . . . . 0.0 110.02 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.68 -39.4 93.44 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 70' ' ' GLN . 3.3 p -61.56 -37.39 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.371 -1.076 . . . . 0.0 110.5 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.92 82.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.526 -0.734 . . . . 0.0 110.036 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.97 -36.91 91.7 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.469 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 8.1 mttp -66.61 -39.94 88.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.519 -0.989 . . . . 0.0 110.267 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.579 HG22 ' HG2' ' A' ' 53' ' ' MET . 53.4 m -63.49 -42.16 98.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.269 -0.895 . . . . 0.0 109.02 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.542 ' HB1' ' HA ' ' A' ' 15' ' ' ALA . . . -70.2 -38.59 75.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.579 -0.7 . . . . 0.0 109.541 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.567 ' O ' HG12 ' A' ' 82' ' ' VAL . 7.3 ttmt -62.82 -39.69 95.1 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.613 -0.679 . . . . 0.0 110.157 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -68.54 -38.56 80.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 0.0 109.738 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -70.81 -38.42 73.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 109.422 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -68.77 -34.29 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.391 -0.818 . . . . 0.0 109.748 179.45 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -42.14 89.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.292 -0.88 . . . . 0.0 109.211 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.505 ' HD3' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -67.2 -39.06 86.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.565 -0.709 . . . . 0.0 109.195 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.85 -34.86 77.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.706 -0.621 . . . . 0.0 109.669 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.53 -39.57 91.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.673 -0.642 . . . . 0.0 109.316 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -64.83 -40.18 94.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.633 -0.667 . . . . 0.0 110.448 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -75.51 -54.09 7.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.419 -0.801 . . . . 0.0 110.297 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.01 53.98 0.08 OUTLIER Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.521 ' HA ' HD23 ' A' ' 90' ' ' LEU . 7.6 mt -118.83 -48.83 2.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.307 -1.113 . . . . 0.0 110.171 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 35.1 mm -88.9 75.77 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.365 -0.834 . . . . 0.0 109.706 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.628 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 19.6 t -73.9 175.91 6.89 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.431 -0.793 . . . . 0.0 110.287 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -67.2 -58.75 4.27 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.292 -0.88 . . . . 0.0 110.834 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -65.57 -39.76 92.03 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.415 -0.803 . . . . 0.0 110.08 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 0.7 OUTLIER -64.09 -39.6 94.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.635 -0.665 . . . . 0.0 109.69 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.44 80.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.503 -0.748 . . . . 0.0 109.328 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -63.25 -46.04 88.76 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -36.09 73.43 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.579 ' CZ3' HG13 ' A' ' 14' ' ' VAL . 50.7 t90 -62.76 -41.75 99.36 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.1 mt -73.53 -32.5 64.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.56 -0.712 . . . . 0.0 109.733 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.1 m -62.96 -48.1 80.35 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.415 -0.803 . . . . 0.0 109.647 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.165 179.415 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 14' ' ' VAL . 46.9 t -63.53 -39.76 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.609 -0.682 . . . . 0.0 109.486 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.471 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -63.88 -39.84 95.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.528 -0.732 . . . . 0.0 109.642 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.593 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . . . -63.5 -41.12 98.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.635 -0.666 . . . . 0.0 109.745 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.58 94.54 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.548 -0.72 . . . . 0.0 109.696 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 10' ' ' VAL . 79.2 t -64.38 -39.79 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.544 -0.723 . . . . 0.0 109.536 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.473 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -64.43 -39.62 94.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.397 -0.814 . . . . 0.0 109.749 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.39 -39.51 93.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.432 -0.793 . . . . 0.0 109.651 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.768 ' HD2' HD23 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -65.82 -31.24 72.09 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.543 -0.723 . . . . 0.0 110.068 179.297 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.546 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.2 mm -63.87 -43.42 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.431 -0.793 . . . . 0.0 109.651 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.689 HG22 ' HB1' ' A' ' 74' ' ' ALA . 54.6 t -68.02 -40.47 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.458 -0.776 . . . . 0.0 110.029 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.88 -25.26 75.4 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.22 36.33 4.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.321 -1.105 . . . . 0.0 110.939 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 23.8 t90 -102.95 137.76 40.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.18 -0.95 . . . . 0.0 110.984 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -168.57 1.67 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -46.34 -44.55 16.92 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.199 -0.938 . . . . 0.0 110.31 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.401 ' HB2' ' CG2' ' A' ' 37' ' ' THR . 12.9 pt-20 -158.64 36.48 0.23 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.537 -0.727 . . . . 0.0 110.619 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.29 151.13 31.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.198 -0.939 . . . . 0.0 110.584 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 t -152.69 175.48 12.78 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.473 -0.767 . . . . 0.0 109.625 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.95 126.4 31.97 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.334 -0.854 . . . . 0.0 110.379 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.546 ' HG ' HD11 ' A' ' 18' ' ' ILE . 2.8 mt -111.62 124.4 52.24 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.359 -0.838 . . . . 0.0 110.206 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.466 HD12 ' HB2' ' A' ' 99' ' ' TRP . 2.5 tp 56.71 29.81 16.48 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.647 -0.658 . . . . 0.0 111.175 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.03 -6.84 82.96 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -91.09 158.79 16.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.977 -1.308 . . . . 0.0 110.222 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -84.17 138.32 33.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.423 -0.798 . . . . 0.0 110.12 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.535 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 91.5 m -142.11 167.52 21.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.364 -0.835 . . . . 0.0 110.455 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -122.89 113.38 19.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.485 -0.76 . . . . 0.0 110.718 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 1.6 t80 -114.67 130.14 56.77 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -140.67 162.38 35.53 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.947 -1.096 . . . . 0.0 111.733 -178.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.26 152.68 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.86 -0.525 . . . . 0.0 109.875 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -157.17 102.42 1.9 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.11 -0.994 . . . . 0.0 110.388 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 C--N 1.313 -1.313 0 O-C-N 123.898 1.473 . . . . 0.0 111.101 -179.922 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.355 0.597 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.499 ' O ' HG21 ' A' ' 73' ' ' VAL . 0.3 OUTLIER -111.58 117.4 32.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.597 -0.689 . . . . 0.0 109.887 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.11 162.81 14.53 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.605 -0.684 . . . . 0.0 109.776 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.55 157.32 29.66 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.847 -1.168 . . . . 0.0 110.287 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.487 ' CD ' ' HB3' ' A' ' 64' ' ' GLU . 0.6 OUTLIER -153.91 141.26 19.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.698 -0.884 . . . . 0.0 109.854 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.575 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 2.8 ppp? -142.74 148.77 37.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.34 -0.85 . . . . 0.0 110.903 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.51 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 47.3 p90 -155.28 171.1 20.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.836 -0.54 . . . . 0.0 109.871 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 61.7 m -121.59 91.12 48.39 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 0.0 110.808 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.535 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 46.9 Cg_endo -76.9 83.93 2.02 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.939 1.494 . . . . 0.0 109.9 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.26 -47.23 0.49 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -73.29 -53.83 9.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.533 -0.98 . . . . 0.0 110.096 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.9 t -152.67 -160.9 1.2 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.531 -0.731 . . . . 0.0 109.963 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.7 68.95 0.97 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.285 -0.884 . . . . 0.0 110.345 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.446 HD12 HD12 ' A' ' 90' ' ' LEU . 41.1 mt -138.88 155.83 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.386 -0.822 . . . . 0.0 110.072 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.66 166.0 25.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.464 -0.772 . . . . 0.0 110.891 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.433 ' HA3' ' N ' ' A' ' 81' ' ' PHE . . . -159.53 128.77 2.07 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.487 ' HB3' ' CD ' ' A' ' 52' ' ' ARG . 1.4 pt-20 -137.66 165.33 26.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.596 -0.943 . . . . 0.0 110.897 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.564 ' HB1' ' CG ' ' A' ' 76' ' ' LYS . . . -158.53 161.08 37.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.716 -0.615 . . . . 0.0 110.632 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.5 m -143.4 151.63 40.62 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.465 -0.772 . . . . 0.0 110.282 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.0 t -174.6 -177.31 1.16 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.65 -0.657 . . . . 0.0 110.148 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -82.77 -31.77 28.13 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.258 -0.902 . . . . 0.0 110.125 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.91 146.92 53.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.352 -0.843 . . . . 0.0 110.353 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.493 ' O ' HG12 ' A' ' 73' ' ' VAL . 34.4 mt-30 -83.49 -54.78 4.71 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.516 -0.74 . . . . 0.0 110.316 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 m -75.26 -30.83 60.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.453 -0.78 . . . . 0.0 110.237 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.86 -39.7 94.25 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 49' ' ' TYR . 0.8 OUTLIER -63.32 -34.03 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.273 -1.134 . . . . 0.0 110.471 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.689 ' HB1' HG22 ' A' ' 19' ' ' VAL . . . -64.78 -47.4 78.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.518 -0.739 . . . . 0.0 109.869 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.79 -32.32 77.62 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.564 ' CG ' ' HB1' ' A' ' 65' ' ' ALA . 11.5 tptp -69.55 -40.9 76.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.599 -0.942 . . . . 0.0 110.224 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.535 HG22 ' HG2' ' A' ' 53' ' ' MET . 5.7 m -64.99 -41.04 95.76 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.471 -0.768 . . . . 0.0 109.919 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.525 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -70.37 -34.56 72.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.405 -0.809 . . . . 0.0 110.114 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.593 ' HE3' ' HA ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -67.36 -39.69 85.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 110.239 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.471 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 0.7 OUTLIER -67.09 -38.47 85.76 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.453 -0.78 . . . . 0.0 109.935 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.433 ' N ' ' HA3' ' A' ' 63' ' ' GLY . 39.6 t80 -67.18 -40.48 86.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.482 -0.761 . . . . 0.0 109.445 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.48 ' HA ' ' CD1' ' A' ' 91' ' ' ILE . 55.8 t -67.14 -36.83 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.44 -0.787 . . . . 0.0 109.829 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.471 ' NH1' ' HA ' ' A' ' 80' ' ' ASP . 4.1 ttp180 -65.26 -39.2 92.34 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.369 -0.832 . . . . 0.0 110.142 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -67.49 -39.91 85.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.276 -0.89 . . . . 0.0 110.04 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.819 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -73.59 -29.53 62.45 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.43 -0.794 . . . . 0.0 110.139 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 1.8 t80 -74.1 -37.69 64.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.488 -0.758 . . . . 0.0 110.295 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -37.08 84.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.362 -0.836 . . . . 0.0 110.234 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -73.96 -53.92 9.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.279 -0.888 . . . . 0.0 110.054 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.87 53.27 0.07 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' A' ' 90' ' ' LEU . 11.0 mt -122.31 -56.92 1.79 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.364 -1.08 . . . . 0.0 110.346 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.819 HD12 ' HB3' ' A' ' 85' ' ' ALA . 82.4 mt -77.72 109.6 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.33 -0.856 . . . . 0.0 109.911 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.6 m -93.8 167.19 11.8 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.357 -0.839 . . . . 0.0 110.286 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -48.5 70.39 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.492 -0.755 . . . . 0.0 110.424 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -63.56 -42.59 98.34 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.537 -0.727 . . . . 0.0 110.728 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.08 -43.59 98.5 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.416 -0.802 . . . . 0.0 110.245 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.32 87.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.584 -0.697 . . . . 0.0 109.94 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -67.34 -38.3 84.66 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.61 -0.682 . . . . 0.0 110.313 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.99 -38.78 86.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.343 -0.848 . . . . 0.0 109.652 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.578 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 15.4 t90 -66.06 -40.94 91.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.548 -0.72 . . . . 0.0 109.861 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.768 HD23 ' HD2' ' A' ' 17' ' ' LYS . 16.4 mt . . . . . 0 N--CA 1.498 1.969 0 O-C-N 121.603 -0.686 . . . . 0.0 110.148 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 14' ' ' VAL . 99.1 t -66.1 -40.83 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.05 -40.01 95.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.695 -0.628 . . . . 0.0 109.383 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.463 ' HA ' ' HG3' ' A' ' 79' ' ' LYS . . . -62.44 -41.32 98.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.71 -0.619 . . . . 0.0 109.486 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.93 97.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.617 -0.677 . . . . 0.0 109.55 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 10' ' ' VAL . 84.9 t -64.59 -41.37 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.541 -0.724 . . . . 0.0 109.237 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.18 -38.37 87.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.665 -0.647 . . . . 0.0 109.548 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.8 m -63.85 -39.03 93.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.575 -0.703 . . . . 0.0 109.698 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.46 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 17.4 tttm -66.01 -34.63 78.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.458 -0.776 . . . . 0.0 109.843 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.884 HD12 ' HB1' ' A' ' 78' ' ' ALA . 10.1 mt -65.07 -46.8 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.5 -0.75 . . . . 0.0 109.288 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.8 t -62.72 -40.18 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.656 -0.652 . . . . 0.0 109.965 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.49 -27.85 73.55 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.6 tp -115.75 38.47 3.29 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.405 -1.056 . . . . 0.0 110.725 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -101.81 137.68 39.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.241 -0.912 . . . . 0.0 110.458 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.98 -166.92 1.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.461 -0.774 . . . . 0.0 109.215 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -49.31 -41.53 38.68 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.185 -0.947 . . . . 0.0 110.442 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.7 33.81 0.19 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.615 -0.678 . . . . 0.0 110.609 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.23 153.57 37.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.199 -0.938 . . . . 0.0 110.849 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.5 t -155.56 151.78 28.0 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.392 -0.818 . . . . 0.0 109.876 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -105.61 121.27 43.63 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.179 -0.95 . . . . 0.0 110.782 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.608 HD21 HD11 ' A' ' 18' ' ' ILE . 1.3 mt -114.29 126.83 55.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.564 -0.71 . . . . 0.0 110.053 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.544 HD11 ' HG2' ' A' ' 95' ' ' GLU . 1.7 tp 54.17 33.7 18.54 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.649 -0.657 . . . . 0.0 111.016 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.09 23.94 74.88 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.405 ' CD2' ' HB3' ' A' ' 30' ' ' LEU . 39.7 m-70 -123.14 145.01 48.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -1.093 . . . . 0.0 109.942 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 123.7 24.57 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.422 -0.799 . . . . 0.0 110.404 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.517 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 83.5 m -128.43 161.94 28.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.658 -0.651 . . . . 0.0 109.25 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.57 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -116.32 117.51 30.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.358 -0.839 . . . . 0.0 110.916 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.456 ' HE2' ' HB2' ' A' ' 78' ' ' ALA . 7.0 t80 -118.75 125.19 49.09 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.75 154.58 51.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.12 -0.988 . . . . 0.0 111.496 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.5 t -137.18 142.69 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.701 -0.625 . . . . 0.0 109.872 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.81 123.95 2.48 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.243 -0.911 . . . . 0.0 110.592 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HB3' ' CD2' ' A' ' 49' ' ' TYR . 51.2 Cg_endo . . . . . 0 C--N 1.313 -1.324 0 O-C-N 123.903 1.475 . . . . 0.0 110.954 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 121.465 0.65 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.486 ' CZ ' ' HG2' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -122.39 128.93 51.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 110.152 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -132.28 151.73 51.7 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.53 -0.732 . . . . 0.0 110.088 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.22 154.86 26.13 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.44 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.425 ' HD3' ' HB2' ' A' ' 64' ' ' GLU . 8.0 ttp180 -146.19 143.67 29.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.718 -0.872 . . . . 0.0 110.059 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.885 ' HG2' HG22 ' A' ' 77' ' ' THR . 0.4 OUTLIER -143.48 157.72 44.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.366 -0.834 . . . . 0.0 111.133 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.57 ' CE2' ' HB3' ' A' ' 35' ' ' LYS . 42.9 p90 -161.43 -175.47 4.81 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.726 -0.609 . . . . 0.0 109.773 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 58' ' ' TRP . 69.6 m -133.19 95.91 18.02 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.102 -0.999 . . . . 0.0 110.644 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.564 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.3 Cg_endo -74.32 77.97 2.75 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.991 1.522 . . . . 0.0 110.333 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.26 -45.52 0.66 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.522 ' HB3' ' HB3' ' A' ' 55' ' ' CYS . 15.3 t90 -68.65 -53.32 23.13 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.475 -1.015 . . . . 0.0 110.267 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.1 t -153.64 -168.56 3.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.553 -0.717 . . . . 0.0 109.754 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.22 45.96 1.89 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.322 -0.861 . . . . 0.0 110.447 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.3 mt -121.15 150.8 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.373 -0.829 . . . . 0.0 109.851 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 ptt-85 -131.15 163.16 28.29 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.284 -0.885 . . . . 0.0 110.834 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.85 155.55 23.26 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.425 ' HB2' ' HD3' ' A' ' 52' ' ' ARG . 6.7 tt0 -158.39 154.31 26.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -1.112 . . . . 0.0 110.508 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.664 ' HB1' ' HG2' ' A' ' 76' ' ' LYS . . . -166.19 152.97 9.43 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.52 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.422 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 3.6 m -139.08 150.77 46.12 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 110.594 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.502 HG22 HG23 ' A' ' 73' ' ' VAL . 10.0 t -172.71 164.63 5.34 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.705 -0.622 . . . . 0.0 109.994 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -63.29 -31.75 72.98 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.506 -0.746 . . . . 0.0 110.16 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.05 136.64 56.28 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.511 -0.743 . . . . 0.0 110.63 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.501 ' O ' HG12 ' A' ' 73' ' ' VAL . 12.1 mt-30 -77.17 -56.35 4.65 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.581 -0.699 . . . . 0.0 110.362 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 t -76.67 -31.44 57.29 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.312 -0.868 . . . . 0.0 110.037 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.91 -38.36 93.99 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.502 HG23 HG22 ' A' ' 67' ' ' THR . 0.8 OUTLIER -58.19 -35.76 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.456 -1.026 . . . . 0.0 110.577 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.16 84.29 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.561 -0.712 . . . . 0.0 109.809 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -64.4 -36.37 93.11 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.664 ' HG2' ' HB1' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -70.8 -39.02 73.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.384 -1.068 . . . . 0.0 110.274 179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.885 HG22 ' HG2' ' A' ' 53' ' ' MET . 18.7 m -66.52 -37.8 85.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.336 -0.852 . . . . 0.0 110.026 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.884 ' HB1' HD12 ' A' ' 18' ' ' ILE . . . -78.47 -35.49 46.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.525 -0.735 . . . . 0.0 110.232 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.463 ' HG3' ' HA ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -71.88 -38.7 69.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.386 -0.821 . . . . 0.0 109.651 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.6 -36.5 83.91 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.522 -0.737 . . . . 0.0 109.512 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -67.96 -39.89 83.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.711 . . . . 0.0 109.671 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 78' ' ' ALA . 72.5 t -66.41 -37.76 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.542 -0.724 . . . . 0.0 109.718 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -38.62 91.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.419 -0.8 . . . . 0.0 109.669 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -38.43 72.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.535 -0.728 . . . . 0.0 109.315 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.405 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -67.53 -34.92 78.07 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.539 -0.725 . . . . 0.0 109.799 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.08 -38.39 82.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 109.542 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -66.87 -39.3 87.49 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.496 -0.753 . . . . 0.0 110.342 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -72.96 -54.48 8.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.404 -0.81 . . . . 0.0 110.256 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.54 54.33 0.08 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.498 ' HA ' HD23 ' A' ' 90' ' ' LEU . 8.4 mt -121.17 -49.08 2.19 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -1.091 . . . . 0.0 110.494 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.405 HD12 ' HB3' ' A' ' 85' ' ' ALA . 95.8 mt -94.23 112.14 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.379 -0.826 . . . . 0.0 110.199 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 4.0 m -83.14 179.5 7.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.435 -0.79 . . . . 0.0 110.411 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -75.41 -60.23 2.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.337 -0.852 . . . . 0.0 110.245 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -63.08 -38.2 90.23 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.423 -0.798 . . . . 0.0 110.153 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 17.7 tt0 -55.09 -44.89 75.28 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.749 -0.594 . . . . 0.0 110.2 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.78 94.02 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.492 -0.755 . . . . 0.0 109.786 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.533 ' HA ' HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -65.41 -38.43 89.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.562 -0.711 . . . . 0.0 109.956 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -64.89 -40.89 95.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.803 . . . . 0.0 109.599 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.46 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 15.0 t90 -68.53 -39.27 81.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.448 -0.783 . . . . 0.0 109.155 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.533 HD12 ' HA ' ' A' ' 97' ' ' ASN . 24.9 mt . . . . . 0 N--CA 1.499 1.984 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.3 t -66.19 -39.45 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.445 -0.784 . . . . 0.0 109.11 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.695 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -66.46 -38.72 87.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.673 -0.642 . . . . 0.0 109.487 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.2 95.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.652 -0.655 . . . . 0.0 109.841 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.43 -41.57 98.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.459 -0.776 . . . . 0.0 109.648 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 10' ' ' VAL . 62.2 t -64.94 -39.2 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.448 -0.783 . . . . 0.0 109.241 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.38 -37.03 86.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.587 -0.696 . . . . 0.0 109.853 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -66.97 -39.28 87.19 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.476 -0.765 . . . . 0.0 109.58 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.553 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 16.6 tptt -66.44 -31.1 71.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.444 -0.785 . . . . 0.0 109.724 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.585 HG21 ' HB2' ' A' ' 78' ' ' ALA . 11.2 mm -62.56 -50.4 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.412 -0.805 . . . . 0.0 109.1 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.82 -37.75 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.722 . . . . 0.0 109.878 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.58 -27.72 73.64 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.41 36.41 4.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.262 -1.14 . . . . 0.0 110.805 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.476 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 23.6 t90 -102.75 135.36 44.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.133 -0.98 . . . . 0.0 110.943 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.12 -164.02 1.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -48.86 -45.91 41.54 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.075 -1.016 . . . . 0.0 109.891 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -156.77 34.14 0.3 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.712 -0.617 . . . . 0.0 110.45 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.83 150.07 41.16 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.1 -1.0 . . . . 0.0 111.154 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.542 HG23 ' CB ' ' A' ' 34' ' ' CYS . 2.1 t -151.7 165.66 33.71 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -128.95 115.36 17.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.094 -1.004 . . . . 0.0 110.411 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.509 HD12 ' SG ' ' A' ' 34' ' ' CYS . 3.7 mt -100.94 119.79 39.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.463 -0.773 . . . . 0.0 110.166 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' A' ' 99' ' ' TRP . 3.7 tp 56.67 30.45 17.52 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.743 -0.598 . . . . 0.0 111.127 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.63 -11.85 67.18 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 87.8 m-70 -83.98 146.77 27.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.128 -1.219 . . . . 0.0 110.121 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -73.79 133.0 43.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.463 -0.773 . . . . 0.0 110.02 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.542 ' CB ' HG23 ' A' ' 27' ' ' THR . 15.2 m -136.08 171.28 14.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.553 -0.717 . . . . 0.0 110.042 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.524 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -132.9 120.42 21.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.475 -0.765 . . . . 0.0 110.339 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.453 ' HB2' HG21 ' A' ' 27' ' ' THR . 40.6 t80 -122.92 135.48 54.51 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.8 p -141.78 150.99 42.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.004 -1.06 . . . . 0.0 111.598 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.1 t -137.5 130.22 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -152.71 123.94 3.66 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.079 -1.013 . . . . 0.0 110.794 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.407 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 52.8 Cg_endo . . . . . 0 C--N 1.313 -1.331 0 O-C-N 123.871 1.459 . . . . 0.0 110.997 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.243 0.544 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.407 ' CD1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -114.71 133.07 56.17 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.442 -0.786 . . . . 0.0 109.918 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -142.27 148.63 38.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.494 -0.754 . . . . 0.0 110.366 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -143.53 153.61 24.98 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -145.25 150.53 36.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.764 -0.845 . . . . 0.0 110.112 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.442 ' HB3' ' CD2' ' A' ' 36' ' ' PHE . 22.4 ptm -144.19 153.45 42.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.244 -0.91 . . . . 0.0 110.977 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.524 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 41.6 p90 -152.83 146.4 25.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.782 -0.574 . . . . 0.0 110.288 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 67.2 m -116.29 90.53 29.78 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.231 -0.918 . . . . 0.0 111.1 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -79.22 82.02 2.63 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.87 1.458 . . . . 0.0 110.266 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.89 -46.81 0.48 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 13.9 t90 -70.49 -53.5 16.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.623 -0.928 . . . . 0.0 109.912 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.45 HG21 ' CD1' ' A' ' 90' ' ' LEU . 7.4 t -158.82 -160.7 0.89 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.748 -0.595 . . . . 0.0 109.888 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.19 46.5 1.78 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.342 -0.849 . . . . 0.0 109.931 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.429 HD12 HD12 ' A' ' 90' ' ' LEU . 59.7 mt -122.45 144.68 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.512 -0.742 . . . . 0.0 109.882 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.49 170.96 13.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.304 -0.872 . . . . 0.0 110.92 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.11 156.55 26.99 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.511 ' HG2' ' N ' ' A' ' 65' ' ' ALA . 14.4 tt0 -163.17 154.66 17.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.516 -0.99 . . . . 0.0 109.996 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.561 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -168.56 155.0 7.12 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.031 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.569 ' HA ' HG23 ' A' ' 73' ' ' VAL . 7.0 m -137.02 153.29 50.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.614 -0.679 . . . . 0.0 110.382 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -175.16 159.18 2.53 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.592 -0.693 . . . . 0.0 110.49 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -36.36 71.31 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.661 -0.649 . . . . 0.0 111.332 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.59 142.95 57.91 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.326 -0.859 . . . . 0.0 110.904 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.439 ' O ' HG12 ' A' ' 73' ' ' VAL . 0.9 OUTLIER -77.82 -49.03 15.12 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.618 -0.676 . . . . 0.0 109.986 179.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.9 m -82.41 -29.38 30.82 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.479 -0.763 . . . . 0.0 109.744 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.02 -38.71 94.66 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' A' ' 66' ' ' SER . 0.8 OUTLIER -60.59 -36.65 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.395 -1.062 . . . . 0.0 110.307 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.61 -38.59 77.33 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.55 -0.719 . . . . 0.0 109.739 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.72 -32.52 78.28 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.561 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 42.6 mtpt -72.75 -40.12 66.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.473 -1.016 . . . . 0.0 110.065 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.1 m -66.44 -38.41 87.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -0.975 . . . . 0.0 109.657 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.585 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -75.08 -37.69 61.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.6 -0.687 . . . . 0.0 110.333 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.6 -39.19 73.95 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.357 -0.84 . . . . 0.0 109.715 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -65.75 -36.25 83.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.681 -0.637 . . . . 0.0 109.715 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -68.84 -40.19 79.54 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 0.0 109.266 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.695 HG11 ' HA ' ' A' ' 11' ' ' ALA . 54.6 t -65.71 -38.9 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.549 -0.719 . . . . 0.0 109.968 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -64.78 -40.29 95.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.509 -0.744 . . . . 0.0 109.949 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -67.63 -39.37 84.66 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.416 -0.803 . . . . 0.0 109.619 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.565 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -70.52 -35.64 73.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.596 -0.69 . . . . 0.0 109.659 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -40.68 95.8 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.606 -0.684 . . . . 0.0 109.706 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.41 -35.9 78.32 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.562 -0.711 . . . . 0.0 110.456 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -74.56 -52.49 11.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.304 -0.873 . . . . 0.0 110.203 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.94 52.49 0.11 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 90' ' ' LEU . 11.8 mt -122.98 -49.93 1.95 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.394 -1.062 . . . . 0.0 110.293 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.565 HD12 ' HB3' ' A' ' 85' ' ' ALA . 89.5 mt -86.24 81.24 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.345 -0.847 . . . . 0.0 109.505 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -64.71 153.67 38.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 109.181 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.433 ' NE2' HG21 ' A' ' 10' ' ' VAL . 1.8 mt-30 -56.47 -47.81 78.43 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.529 -0.732 . . . . 0.0 110.281 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.43 -41.11 76.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.46 -0.775 . . . . 0.0 110.476 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.8 OUTLIER -63.03 -40.57 98.14 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.492 -0.755 . . . . 0.0 110.101 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.33 -43.29 92.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.591 -0.693 . . . . 0.0 109.872 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -65.42 -39.11 91.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.544 -0.723 . . . . 0.0 109.452 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -42.36 95.05 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.715 -0.616 . . . . 0.0 109.738 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.553 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 24.1 t90 -67.51 -39.48 85.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.503 -0.748 . . . . 0.0 109.444 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.2 mt . . . . . 0 N--CA 1.499 2.001 0 O-C-N 121.714 -0.616 . . . . 0.0 109.804 179.283 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.915 0.388 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.644 HG21 ' HG2' ' A' ' 93' ' ' GLN . 85.9 t -66.04 -39.63 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.466 -0.771 . . . . 0.0 109.517 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.569 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -64.69 -39.29 93.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.467 -0.771 . . . . 0.0 109.904 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.68 -38.84 87.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.61 -0.681 . . . . 0.0 109.739 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.01 96.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.586 -0.697 . . . . 0.0 109.783 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 10' ' ' VAL . 77.7 t -62.69 -41.68 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.426 -0.796 . . . . 0.0 109.043 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.57 -39.45 93.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.498 -0.752 . . . . 0.0 109.612 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 54.4 m -61.7 -41.31 97.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.557 -0.715 . . . . 0.0 109.658 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.613 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 6.4 tptm -67.37 -31.21 71.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.428 -0.795 . . . . 0.0 109.765 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.638 HG21 ' HB2' ' A' ' 78' ' ' ALA . 4.8 mm -63.27 -47.26 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.395 -0.816 . . . . 0.0 109.617 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.4 t -63.62 -38.71 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.45 -0.781 . . . . 0.0 109.852 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.75 -26.89 71.88 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 tp -113.8 32.62 5.71 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.239 -1.154 . . . . 0.0 111.448 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 18.4 t90 -94.2 131.6 39.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.952 -1.092 . . . . 0.0 110.197 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.13 -172.73 2.41 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -43.53 -39.84 3.63 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.229 -0.92 . . . . 0.0 110.609 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.431 ' HB2' ' CG2' ' A' ' 37' ' ' THR . 12.4 pt-20 -164.67 37.19 0.07 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.401 0.62 . . . . 0.0 109.781 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -150.77 161.23 43.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.492 -0.755 . . . . 0.0 110.721 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.568 HG23 ' HB2' ' A' ' 34' ' ' CYS . 14.5 t -156.89 151.45 25.53 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.358 -0.838 . . . . 0.0 109.868 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.58 110.59 22.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.43 -0.794 . . . . 0.0 109.832 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.619 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 2.4 mt -105.21 123.8 48.46 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.255 -0.903 . . . . 0.0 110.559 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.736 HD11 ' HG3' ' A' ' 95' ' ' GLU . 2.8 tp 55.1 34.72 23.18 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.648 -0.657 . . . . 0.0 110.862 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.81 7.54 87.37 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -106.1 160.48 15.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.089 -1.242 . . . . 0.0 110.025 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.79 125.79 34.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.378 -0.826 . . . . 0.0 110.198 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.659 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 84.9 m -130.77 168.21 17.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.426 -0.796 . . . . 0.0 110.261 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.403 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 9.2 tttm -123.55 115.05 20.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.397 -0.814 . . . . 0.0 111.378 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 1.3 t80 -115.49 122.34 45.43 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 25' ' ' GLU . 1.9 p -140.46 158.3 44.21 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.985 -1.072 . . . . 0.0 112.203 -178.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 8.7 p -129.31 147.08 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.813 -0.554 . . . . 0.0 109.865 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.84 110.75 2.71 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.085 -1.009 . . . . 0.0 110.711 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.315 -1.227 0 O-C-N 123.815 1.429 . . . . 0.0 110.697 179.683 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 121.293 0.568 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.519 ' CD2' ' HA ' ' A' ' 70' ' ' GLN . 0.3 OUTLIER -128.92 142.97 50.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.301 -0.874 . . . . 0.0 110.582 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -154.11 151.04 28.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -0.827 . . . . 0.0 110.216 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -148.25 150.05 22.18 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.509 ' CG ' ' HB3' ' A' ' 64' ' ' GLU . 8.9 ttp180 -143.04 144.93 32.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.68 -0.894 . . . . 0.0 110.256 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.614 ' HG2' HG22 ' A' ' 77' ' ' THR . 2.3 ppp? -144.04 147.1 33.38 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.436 -0.79 . . . . 0.0 110.818 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.607 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 49.2 p90 -154.29 -168.9 3.08 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.797 -0.564 . . . . 0.0 110.113 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.3 m -134.15 92.79 20.85 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.857 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.659 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 47.9 Cg_endo -72.91 80.91 1.72 Allowed 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 123.86 1.453 . . . . 0.0 110.083 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.06 -43.24 0.79 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 55' ' ' CYS . 18.5 t90 -74.34 -52.88 10.89 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.524 -0.986 . . . . 0.0 110.425 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.437 HG21 ' CD1' ' A' ' 90' ' ' LEU . 7.9 t -153.72 -168.14 2.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.535 -0.728 . . . . 0.0 110.007 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.55 45.3 2.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.439 -0.788 . . . . 0.0 110.39 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.579 HD12 HD12 ' A' ' 90' ' ' LEU . 69.4 mt -117.86 156.85 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.394 -0.816 . . . . 0.0 109.466 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.78 165.99 27.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.287 -0.883 . . . . 0.0 111.339 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.55 127.36 2.29 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.509 ' HB3' ' CG ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -144.87 160.62 41.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.8 -0.824 . . . . 0.0 110.634 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.57 163.84 38.8 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.649 -0.657 . . . . 0.0 110.904 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.62 141.95 35.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.516 -0.74 . . . . 0.0 110.193 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.457 HG22 HG23 ' A' ' 73' ' ' VAL . 8.8 t -173.07 170.22 4.45 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.504 -0.748 . . . . 0.0 110.396 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.499 ' HG3' ' N ' ' A' ' 69' ' ' SER . 2.2 ptm85 -64.67 -35.09 79.92 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.438 -0.789 . . . . 0.0 110.249 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.499 ' N ' ' HG3' ' A' ' 68' ' ' ARG . 3.4 m -58.78 153.73 16.29 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.377 0.608 . . . . 0.0 110.754 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.519 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 45.2 mt-30 -101.17 -60.74 1.47 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.802 -0.561 . . . . 0.0 110.088 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -29.91 61.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.285 -0.885 . . . . 0.0 110.398 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.61 -38.75 96.37 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.457 HG23 HG22 ' A' ' 67' ' ' THR . 0.4 OUTLIER -63.54 -34.93 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.429 -1.042 . . . . 0.0 110.434 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.76 -45.75 85.07 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.355 -0.841 . . . . 0.0 109.482 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.36 -37.65 94.96 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -69.75 -38.76 76.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.609 -0.936 . . . . 0.0 109.64 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.614 HG22 ' HG2' ' A' ' 53' ' ' MET . 15.5 m -55.98 -44.47 78.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.326 -0.859 . . . . 0.0 109.245 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.638 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -70.35 -38.93 74.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.681 -0.637 . . . . 0.0 109.748 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -39.23 84.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.683 . . . . 0.0 110.039 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 0.7 OUTLIER -67.03 -31.14 71.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.599 -0.688 . . . . 0.0 110.185 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.4 ' CD2' ' SD ' ' A' ' 53' ' ' MET . 54.5 t80 -80.74 -36.52 31.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.045 -1.034 . . . . 0.0 109.046 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 11' ' ' ALA . 46.3 t -68.05 -38.4 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.671 -0.643 . . . . 0.0 110.246 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 2.6 ptm85 -67.45 -39.19 85.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.266 -0.896 . . . . 0.0 109.557 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.417 ' N ' ' HG3' ' A' ' 83' ' ' ARG . 0.7 OUTLIER -65.91 -40.54 91.58 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.496 -0.753 . . . . 0.0 109.268 178.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.562 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -70.0 -32.45 70.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.644 -0.66 . . . . 0.0 109.373 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.98 -41.99 94.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.623 -0.673 . . . . 0.0 109.238 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -67.92 -37.61 81.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.521 -0.737 . . . . 0.0 110.159 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.419 ' CD ' HD11 ' A' ' 61' ' ' ILE . 1.7 mmpp? -70.89 -51.93 23.27 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.374 -0.829 . . . . 0.0 110.382 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.96 49.45 0.17 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.579 HD12 HD12 ' A' ' 61' ' ' ILE . 13.0 mt -121.33 -48.59 2.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.289 -1.124 . . . . 0.0 110.405 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.562 HD12 ' HB3' ' A' ' 85' ' ' ALA . 81.6 mt -99.53 77.76 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.458 -0.776 . . . . 0.0 109.244 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.0 p -76.26 -176.8 3.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.496 -0.753 . . . . 0.0 110.353 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.644 ' HG2' HG21 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -69.59 -53.1 20.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.43 -0.794 . . . . 0.0 110.563 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.9 -42.53 97.4 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.416 -0.802 . . . . 0.0 110.96 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.736 ' HG3' HD11 ' A' ' 30' ' ' LEU . 1.7 tp10 -66.54 -38.5 87.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.267 -0.895 . . . . 0.0 110.219 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.2 -39.88 86.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.397 -0.815 . . . . 0.0 109.498 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -65.72 -39.03 90.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.596 -0.69 . . . . 0.0 109.955 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -61.56 -42.77 99.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.569 -0.707 . . . . 0.0 109.439 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.613 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 20.8 t90 -67.85 -38.61 83.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.473 -0.767 . . . . 0.0 109.641 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.583 HD23 ' HD3' ' A' ' 17' ' ' LYS . 50.6 mt . . . . . 0 N--CA 1.495 1.795 0 O-C-N 121.693 -0.629 . . . . 0.0 110.193 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 14' ' ' VAL . 84.5 t -64.15 -43.16 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.461 -0.775 . . . . 0.0 109.217 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.512 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -65.08 -39.5 93.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.509 -0.744 . . . . 0.0 109.3 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.41 -40.75 98.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.688 -0.632 . . . . 0.0 109.792 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.29 96.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.407 -0.808 . . . . 0.0 109.668 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 10' ' ' VAL . 91.2 t -64.11 -40.46 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.504 -0.748 . . . . 0.0 109.348 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.21 -40.14 96.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.584 -0.698 . . . . 0.0 110.127 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 t -65.04 -38.95 92.53 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.371 -0.831 . . . . 0.0 109.706 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.517 ' HD2' HD22 ' A' ' 100' ' ' LEU . 3.5 ttmm -65.98 -32.38 73.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.502 -0.749 . . . . 0.0 109.951 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.756 HD11 ' HG ' ' A' ' 29' ' ' LEU . 3.3 mm -62.82 -48.26 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.598 -0.688 . . . . 0.0 109.981 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.15 -38.92 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.399 -0.813 . . . . 0.0 109.833 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.84 -31.22 75.25 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.44 36.78 3.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.287 -1.125 . . . . 0.0 110.796 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.552 ' HH2' HG12 ' A' ' 38' ' ' VAL . 25.7 t90 -100.51 138.52 37.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 110.668 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -97.71 -169.66 1.87 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -43.14 -42.95 4.33 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.663 -0.648 . . . . 0.0 110.255 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -162.66 38.84 0.11 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.636 -0.665 . . . . 0.0 110.39 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -157.67 140.34 14.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.252 -0.905 . . . . 0.0 110.699 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.473 HG21 HD12 ' A' ' 18' ' ' ILE . 10.0 t -147.65 159.45 43.77 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.411 -0.806 . . . . 0.0 109.823 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -100.16 143.18 30.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.431 -0.793 . . . . 0.0 110.513 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.756 ' HG ' HD11 ' A' ' 18' ' ' ILE . 7.1 mt -126.34 113.21 16.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.537 -0.727 . . . . 0.0 109.43 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' ' 99' ' ' TRP . 4.6 tp 59.36 27.06 16.05 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.69 -0.631 . . . . 0.0 110.635 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.46 -15.7 62.34 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -87.59 153.31 21.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.986 -1.302 . . . . 0.0 110.337 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -83.95 137.56 33.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.387 -0.82 . . . . 0.0 109.751 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 29' ' ' LEU . 96.3 m -138.01 170.91 15.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.89 . . . . 0.0 111.251 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -122.3 104.5 9.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.677 -0.64 . . . . 0.0 110.025 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.53 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 3.2 t80 -109.9 132.74 53.88 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.1 p -140.8 153.98 46.05 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.099 -1.001 . . . . 0.0 111.367 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.552 HG12 ' HH2' ' A' ' 22' ' ' TRP . 4.9 p -141.53 143.85 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.663 -0.648 . . . . 0.0 109.953 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.45 128.24 6.1 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.161 -0.962 . . . . 0.0 111.235 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.542 ' HB3' ' CE1' ' A' ' 49' ' ' TYR . 49.0 Cg_endo . . . . . 0 C--N 1.314 -1.256 0 O-C-N 123.88 1.463 . . . . 0.0 110.227 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.158 0.504 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.542 ' CE1' ' HB3' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -92.95 151.7 19.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.595 -0.691 . . . . 0.0 109.99 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -149.3 149.09 30.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.395 -0.816 . . . . 0.0 110.181 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.15 161.53 29.13 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.59 137.17 13.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.782 -0.834 . . . . 0.0 109.75 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.555 ' HG2' HG22 ' A' ' 77' ' ' THR . 1.4 ppp? -136.73 152.1 49.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.264 -0.898 . . . . 0.0 111.144 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.487 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 49.4 p90 -159.58 154.29 24.42 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.744 -0.598 . . . . 0.0 110.183 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 69.3 m -112.33 91.53 16.68 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.183 -0.948 . . . . 0.0 110.56 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.487 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 48.0 Cg_endo -76.11 91.79 1.09 Allowed 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.807 1.425 . . . . 0.0 110.217 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.46 -48.36 0.58 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.516 ' CZ2' HD22 ' A' ' 90' ' ' LEU . 25.6 t90 -76.26 -53.5 8.14 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.404 -1.056 . . . . 0.0 110.376 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 t -145.46 -170.01 3.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.581 -0.699 . . . . 0.0 109.991 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.62 60.54 0.8 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.449 -0.782 . . . . 0.0 109.887 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.7 mt -128.12 155.08 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.481 -0.762 . . . . 0.0 109.845 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.43 160.29 39.53 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.415 -0.803 . . . . 0.0 110.492 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 135.75 7.26 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -136.2 151.82 50.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.554 -0.968 . . . . 0.0 110.112 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.66 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -163.13 135.57 5.36 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.388 -0.82 . . . . 0.0 110.56 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.575 ' HA ' HG23 ' A' ' 73' ' ' VAL . 1.1 m -136.71 142.65 43.12 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.546 -0.721 . . . . 0.0 110.37 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.8 t -167.44 177.48 5.98 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.573 -0.704 . . . . 0.0 110.142 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -31.32 67.74 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.33 -0.856 . . . . 0.0 110.66 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.74 143.15 58.07 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.427 -0.795 . . . . 0.0 110.916 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.543 ' O ' HG12 ' A' ' 73' ' ' VAL . 38.4 mt-30 -80.65 -50.71 9.59 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.637 -0.665 . . . . 0.0 110.408 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m -86.36 -29.3 23.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.386 -0.822 . . . . 0.0 109.914 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.06 -38.97 95.1 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.575 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.7 p -62.3 -36.83 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.407 -1.055 . . . . 0.0 110.297 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.426 ' HB1' ' HZ ' ' A' ' 36' ' ' PHE . . . -68.8 -44.84 72.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.55 -0.719 . . . . 0.0 109.768 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.31 -35.74 92.06 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.66 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 15.4 mmtt -69.76 -38.72 76.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.473 -1.016 . . . . 0.0 109.942 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.555 HG22 ' HG2' ' A' ' 53' ' ' MET . 3.4 m -60.25 -44.91 94.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.501 -0.749 . . . . 0.0 109.498 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.459 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -69.91 -36.31 75.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.555 -0.716 . . . . 0.0 109.865 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -39.76 86.88 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.463 -0.773 . . . . 0.0 109.876 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.16 -40.9 98.89 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.475 -0.766 . . . . 0.0 110.086 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -69.33 -41.13 77.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.336 -0.853 . . . . 0.0 109.343 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 11' ' ' ALA . 49.8 t -66.04 -38.14 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.566 -0.708 . . . . 0.0 109.591 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -38.79 87.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.514 -0.741 . . . . 0.0 109.708 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -39.27 91.22 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.386 -0.821 . . . . 0.0 109.853 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.641 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -69.82 -35.51 74.86 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.589 -0.694 . . . . 0.0 109.464 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -41.9 99.61 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.678 -0.639 . . . . 0.0 109.634 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -67.84 -36.97 81.29 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.499 -0.75 . . . . 0.0 110.332 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -73.49 -55.43 6.35 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.37 -0.831 . . . . 0.0 110.453 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.04 52.36 0.08 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.516 HD22 ' CZ2' ' A' ' 58' ' ' TRP . 9.7 mt -122.95 -49.83 1.96 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.377 -1.072 . . . . 0.0 110.259 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.641 HD12 ' HB3' ' A' ' 85' ' ' ALA . 96.3 mt -97.09 101.59 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.538 -0.726 . . . . 0.0 109.55 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.614 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 32.4 m -78.23 173.78 11.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.475 -0.766 . . . . 0.0 109.965 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -71.16 -53.08 15.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.605 -0.684 . . . . 0.0 109.925 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -65.09 -29.52 70.39 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.478 -0.764 . . . . 0.0 110.57 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.0 OUTLIER -67.99 -43.5 78.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.267 -0.896 . . . . 0.0 109.821 179.377 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.406 ' O ' HD23 ' A' ' 100' ' ' LEU . . . -61.29 -40.64 94.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.609 -0.682 . . . . 0.0 109.168 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -62.46 -38.98 91.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.641 -0.662 . . . . 0.0 109.763 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -40.16 94.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.572 -0.705 . . . . 0.0 109.697 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.513 ' HB2' HD12 ' A' ' 30' ' ' LEU . 15.6 t90 -71.08 -36.05 72.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.315 -0.865 . . . . 0.0 109.889 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.517 HD22 ' HD2' ' A' ' 17' ' ' LYS . 3.4 mm? . . . . . 0 N--CA 1.499 1.982 0 O-C-N 121.71 -0.619 . . . . 0.0 110.697 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 14' ' ' VAL . 95.1 t -66.08 -40.87 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.521 -0.737 . . . . 0.0 109.185 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.42 -39.76 95.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.593 -0.692 . . . . 0.0 109.533 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.74 -41.38 99.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.684 -0.635 . . . . 0.0 109.806 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.3 -39.3 94.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.474 -0.766 . . . . 0.0 109.827 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.643 ' CG2' ' HB1' ' A' ' 96' ' ' ALA . 61.2 t -66.04 -39.93 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.425 -0.797 . . . . 0.0 109.105 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.576 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -64.06 -38.43 91.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.466 -0.771 . . . . 0.0 109.636 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.6 m -63.96 -41.31 97.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.51 -0.743 . . . . 0.0 109.595 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.602 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 1.9 ttmt -63.74 -32.8 74.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.547 -0.721 . . . . 0.0 109.898 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.6 HG21 ' HB2' ' A' ' 78' ' ' ALA . 5.1 mm -62.25 -48.13 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -0.875 . . . . 0.0 109.071 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.49 -40.4 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.71 -0.619 . . . . 0.0 109.429 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.79 -32.18 83.29 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.484 HD23 ' HB2' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -109.38 35.39 3.32 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.45 -1.029 . . . . 0.0 110.612 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.403 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 25.0 t90 -103.98 132.98 49.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.133 -0.979 . . . . 0.0 111.01 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.34 -163.85 1.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -45.78 -45.64 14.83 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.255 -0.903 . . . . 0.0 110.587 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.435 ' HB2' ' CG2' ' A' ' 37' ' ' THR . 6.6 pt-20 -157.75 35.9 0.26 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.679 -0.638 . . . . 0.0 110.5 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.41 151.88 38.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.311 -0.868 . . . . 0.0 110.668 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.447 HG23 ' HB2' ' A' ' 34' ' ' CYS . 7.9 t -153.77 172.9 16.6 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.308 -0.87 . . . . 0.0 109.866 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.484 ' HB2' HD23 ' A' ' 21' ' ' LEU . 3.9 mp0 -124.43 143.34 50.68 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.245 -0.909 . . . . 0.0 110.228 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.746 HD12 ' SG ' ' A' ' 55' ' ' CYS . 10.0 mt -127.44 113.6 16.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 109.457 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 99' ' ' TRP . 1.0 OUTLIER 57.01 27.26 12.98 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.765 -0.584 . . . . 0.0 110.735 -179.244 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.84 -16.9 60.21 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -80.97 149.89 29.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.171 -1.193 . . . . 0.0 110.444 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -79.41 139.91 37.56 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.74 . . . . 0.0 109.822 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 81.4 m -139.96 166.37 24.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.515 -0.741 . . . . 0.0 110.726 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -122.15 101.09 7.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.404 -0.81 . . . . 0.0 109.835 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.583 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 4.3 t80 -108.37 131.13 55.07 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.435 ' CG2' ' HB2' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -134.75 157.16 47.43 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.302 -0.874 . . . . 0.0 111.015 -179.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.403 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 87.1 t -129.36 129.32 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.568 -0.707 . . . . 0.0 109.635 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -144.06 101.23 4.89 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.367 -0.833 . . . . 0.0 110.425 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.507 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 54.1 Cg_endo . . . . . 0 C--N 1.313 -1.292 0 O-C-N 123.81 1.426 . . . . 0.0 110.585 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.16 0.505 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.507 ' CD1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -96.14 157.17 16.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -0.877 . . . . 0.0 110.111 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.48 ' HG3' ' N ' ' A' ' 51' ' ' GLY . 2.1 tttt -156.6 150.17 24.59 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.254 -0.904 . . . . 0.0 109.9 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.48 ' N ' ' HG3' ' A' ' 50' ' ' LYS . . . -149.59 147.67 18.22 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.45 138.64 34.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.67 -0.9 . . . . 0.0 109.836 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.583 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 3.0 ppp? -137.95 157.73 45.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.344 -0.848 . . . . 0.0 111.25 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.427 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 49.0 p90 -160.88 145.88 14.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.844 -0.535 . . . . 0.0 109.951 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.746 ' SG ' HD12 ' A' ' 29' ' ' LEU . 76.6 m -112.49 91.2 16.21 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.261 -0.899 . . . . 0.0 110.871 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.427 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 48.3 Cg_endo -75.71 85.81 1.57 Allowed 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.78 1.411 . . . . 0.0 110.056 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.42 -50.3 0.29 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -78.16 -43.71 27.95 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.537 -0.978 . . . . 0.0 109.76 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.419 ' HB ' HD11 ' A' ' 90' ' ' LEU . 10.1 t -153.67 -173.85 4.73 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.278 0.561 . . . . 0.0 109.733 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.46 49.04 1.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.569 -0.707 . . . . 0.0 109.62 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.4 mt -119.02 155.99 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.473 -0.767 . . . . 0.0 110.009 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.19 160.16 38.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.447 -0.783 . . . . 0.0 110.438 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.23 148.27 19.89 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 0.9 OUTLIER -151.13 157.07 42.25 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.551 -0.97 . . . . 0.0 110.269 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.443 ' HB1' ' CG ' ' A' ' 76' ' ' LYS . . . -159.75 146.75 16.51 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.699 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.511 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -140.1 141.74 36.12 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.469 -0.769 . . . . 0.0 110.812 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.605 HG22 HG23 ' A' ' 73' ' ' VAL . 9.3 t -169.16 176.9 5.05 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.6 -0.688 . . . . 0.0 110.341 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.5 mtm-85 -73.14 -35.29 66.47 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.389 -0.82 . . . . 0.0 110.261 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.85 136.92 58.15 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.497 -0.752 . . . . 0.0 110.127 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.409 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 1.0 OUTLIER -74.31 -59.11 2.88 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.584 -0.697 . . . . 0.0 110.406 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -79.17 -28.83 42.77 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.308 -0.87 . . . . 0.0 110.05 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.62 -38.14 90.83 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.605 HG23 HG22 ' A' ' 67' ' ' THR . 0.5 OUTLIER -62.07 -38.11 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.437 -1.037 . . . . 0.0 110.379 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HA ' ' HZ ' ' A' ' 36' ' ' PHE . . . -66.81 -44.5 81.02 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.524 -0.735 . . . . 0.0 109.655 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.65 -37.78 95.25 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.443 ' CG ' ' HB1' ' A' ' 65' ' ' ALA . 0.1 OUTLIER -63.3 -40.1 96.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.589 -0.948 . . . . 0.0 110.282 179.559 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.9 m -63.44 -43.91 96.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.83 . . . . 0.0 109.149 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.6 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -66.27 -39.08 89.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.602 -0.686 . . . . 0.0 109.64 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.98 -38.96 89.89 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.34 -0.85 . . . . 0.0 109.96 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.518 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 2.8 m-20 -68.87 -29.8 68.17 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.461 -0.774 . . . . 0.0 110.172 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -78.38 -33.73 48.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.225 -0.922 . . . . 0.0 109.864 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 78' ' ' ALA . 65.4 t -70.43 -38.5 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 110.476 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -70.23 -36.42 74.52 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.271 -0.893 . . . . 0.0 109.793 179.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.46 -40.83 93.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.6 -0.688 . . . . 0.0 109.335 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.719 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -69.78 -32.88 71.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.618 -0.676 . . . . 0.0 109.379 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.3 -41.1 97.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.55 -0.719 . . . . 0.0 109.513 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -65.38 -36.58 84.4 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.661 -0.649 . . . . 0.0 110.538 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -79.72 -54.13 6.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.195 -0.941 . . . . 0.0 110.28 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.72 53.72 0.07 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' A' ' 90' ' ' LEU . 11.1 mt -123.56 -47.78 1.96 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.375 -1.074 . . . . 0.0 110.645 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.719 HD12 ' HB3' ' A' ' 85' ' ' ALA . 80.7 mt -105.2 98.84 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.235 -0.916 . . . . 0.0 109.555 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 4.9 t -78.49 -177.06 5.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.443 -0.785 . . . . 0.0 110.556 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -70.76 -59.82 2.59 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.519 -0.738 . . . . 0.0 110.472 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -63.73 -34.67 78.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.391 -0.818 . . . . 0.0 110.63 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 1.9 mt-10 -58.79 -42.93 90.19 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.489 -0.757 . . . . 0.0 110.278 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.643 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -63.09 -39.13 93.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.448 -0.783 . . . . 0.0 109.809 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -36.81 78.05 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.498 -0.751 . . . . 0.0 109.677 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -62.86 -42.83 99.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.522 -0.736 . . . . 0.0 109.379 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.675 ' HB2' HD12 ' A' ' 30' ' ' LEU . 25.3 t90 -63.97 -41.93 97.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.462 -0.774 . . . . 0.0 109.153 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HA ' ' CE ' ' A' ' 17' ' ' LYS . 12.9 mt . . . . . 0 N--CA 1.499 2.0 0 O-C-N 121.763 -0.586 . . . . 0.0 110.155 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.598 HG11 ' HA ' ' A' ' 93' ' ' GLN . 78.2 t -68.82 -38.68 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.544 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -63.66 -46.19 86.73 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.481 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . . . -52.05 -45.11 64.56 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.744 -0.597 . . . . 0.0 109.959 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.09 90.51 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.561 -0.712 . . . . 0.0 109.391 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 10' ' ' VAL . 89.0 t -61.14 -44.25 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.589 -0.695 . . . . 0.0 109.324 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.958 ' HB2' ' HE2' ' A' ' 79' ' ' LYS . . . -58.29 -43.2 87.92 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.599 -0.688 . . . . 0.0 109.999 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.2 m -59.24 -41.8 89.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.65 -0.656 . . . . 0.0 109.484 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.638 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 1.3 tpmp? -69.74 -32.5 71.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.627 -0.671 . . . . 0.0 110.059 179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 22' ' ' TRP . 5.4 mt -72.26 -46.77 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.401 -0.812 . . . . 0.0 109.811 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.6 t -68.13 -39.03 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.395 -0.816 . . . . 0.0 110.04 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.28 -16.41 75.32 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.47 24.06 6.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.978 -1.307 . . . . 0.0 111.452 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.437 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 22.7 t90 -92.03 135.58 33.85 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.886 -1.134 . . . . 0.0 110.337 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.67 -167.19 1.46 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.534 -0.729 . . . . 0.0 109.449 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -49.77 -41.76 44.93 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.231 -0.918 . . . . 0.0 110.615 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.45 37.73 0.24 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.574 -0.704 . . . . 0.0 110.456 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -146.75 147.53 31.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.32 -0.863 . . . . 0.0 110.72 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.547 HG21 ' HB2' ' A' ' 36' ' ' PHE . 8.2 t -156.7 155.52 31.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.462 -0.774 . . . . 0.0 109.643 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -111.68 149.83 31.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.173 -0.954 . . . . 0.0 110.168 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.423 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 6.7 mt -143.28 123.85 14.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.371 -0.831 . . . . 0.0 110.022 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.453 HD12 ' HB2' ' A' ' 99' ' ' TRP . 1.7 tp 53.07 35.06 18.6 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.673 -0.642 . . . . 0.0 111.22 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.39 26.88 62.61 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -125.91 163.5 22.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -1.163 . . . . 0.0 109.996 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.0 130.4 36.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.458 -0.776 . . . . 0.0 109.893 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.6 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 68.2 m -134.08 167.22 21.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.51 -0.744 . . . . 0.0 110.079 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.591 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 0.9 OUTLIER -126.32 110.07 12.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 110.901 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.547 ' HB2' HG21 ' A' ' 27' ' ' THR . 20.0 t80 -111.11 136.09 50.66 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.38 157.88 43.53 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.061 -1.024 . . . . 0.0 111.968 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.3 t -132.82 145.04 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.15 136.55 11.38 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.238 -0.914 . . . . 0.0 110.927 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.484 ' HB3' ' CE1' ' A' ' 49' ' ' TYR . 48.1 Cg_endo . . . . . 0 C--N 1.316 -1.179 0 O-C-N 123.905 1.476 . . . . 0.0 110.406 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.288 0.566 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -96.64 135.28 38.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.572 -0.705 . . . . 0.0 110.19 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.558 ' HA ' HG21 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -129.39 156.73 43.6 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.332 -0.855 . . . . 0.0 109.857 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.19 150.5 22.7 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.753 ' HG2' ' HB3' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -149.56 136.36 19.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.491 -1.005 . . . . 0.0 109.837 179.529 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.705 ' HG2' HG22 ' A' ' 77' ' ' THR . 1.0 OUTLIER -135.12 152.58 51.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.439 -0.788 . . . . 0.0 110.835 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.603 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 46.1 p90 -149.32 -177.13 5.67 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.576 -0.703 . . . . 0.0 110.044 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 34.7 m -133.94 93.81 19.68 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.102 -0.999 . . . . 0.0 110.701 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.603 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.6 Cg_endo -76.09 89.58 1.23 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.951 1.5 . . . . 0.0 110.107 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.27 -46.51 0.87 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.436 ' CZ2' HD22 ' A' ' 30' ' ' LEU . 10.4 t90 -71.61 -57.78 4.08 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.476 -1.014 . . . . 0.0 110.139 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.496 HG21 HD13 ' A' ' 90' ' ' LEU . 8.1 t -153.96 -160.37 1.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.578 -0.701 . . . . 0.0 109.902 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.88 44.92 2.52 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.253 -0.904 . . . . 0.0 110.546 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.63 HD11 ' HG3' ' A' ' 88' ' ' LYS . 1.5 tt -125.15 154.4 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.25 -0.906 . . . . 0.0 109.701 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.451 ' HB3' ' CB ' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -153.68 169.21 23.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.166 -0.959 . . . . 0.0 111.202 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.457 ' HA2' ' HE2' ' A' ' 84' ' ' LYS . . . -135.45 153.03 21.09 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.753 ' HB3' ' HG2' ' A' ' 52' ' ' ARG . 1.2 pm0 -145.51 155.39 43.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.632 -0.922 . . . . 0.0 110.227 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -143.23 162.48 35.51 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.518 -0.738 . . . . 0.0 110.89 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -147.12 136.98 23.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.574 -0.704 . . . . 0.0 110.438 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.7 t -175.51 165.25 3.18 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.699 -0.625 . . . . 0.0 110.002 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -68.55 -28.13 66.69 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.182 -0.949 . . . . 0.0 110.595 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.67 149.46 50.47 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.191 -0.943 . . . . 0.0 110.463 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.426 ' O ' HG12 ' A' ' 73' ' ' VAL . 6.6 mp0 -83.66 -64.91 1.08 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.672 -0.642 . . . . 0.0 110.087 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 t -73.32 -22.79 60.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.26 -0.9 . . . . 0.0 110.02 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.82 -45.38 95.02 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' A' ' 50' ' ' LYS . 0.7 OUTLIER -61.04 -36.96 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.495 -1.003 . . . . 0.0 110.064 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.46 -45.08 94.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.524 -0.735 . . . . 0.0 110.034 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -60.64 -37.21 93.09 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.442 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -74.92 -37.69 61.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.391 -1.064 . . . . 0.0 110.245 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.705 HG22 ' HG2' ' A' ' 53' ' ' MET . 22.7 m -59.93 -38.04 81.24 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.195 -0.941 . . . . 0.0 109.683 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.67 -28.04 40.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.425 -0.797 . . . . 0.0 110.184 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.958 ' HE2' ' HB2' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -80.76 -37.64 30.05 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.267 -0.895 . . . . 0.0 109.826 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.75 -31.51 66.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.785 -0.572 . . . . 0.0 109.694 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 35.4 t80 -70.36 -42.19 72.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 0.0 109.695 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 11' ' ' ALA . 58.6 t -71.24 -30.89 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.799 . . . . 0.0 109.467 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -38.4 63.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.459 -0.776 . . . . 0.0 109.756 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.457 ' HE2' ' HA2' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -67.3 -36.78 82.2 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.33 -0.856 . . . . 0.0 109.777 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.669 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -71.69 -34.2 69.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.486 -0.759 . . . . 0.0 109.528 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.21 -39.28 86.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.595 -0.69 . . . . 0.0 109.585 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -64.37 -40.4 95.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.717 -0.614 . . . . 0.0 109.901 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.63 ' HG3' HD11 ' A' ' 61' ' ' ILE . 9.1 mmmt -73.72 -57.15 4.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.425 -0.797 . . . . 0.0 109.781 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.7 53.98 0.05 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.496 HD13 HG21 ' A' ' 59' ' ' THR . 9.7 mt -123.41 -57.41 1.67 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.303 -1.116 . . . . 0.0 110.65 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.669 HD12 ' HB3' ' A' ' 85' ' ' ALA . 12.4 mt -92.74 115.83 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.0 110.167 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.6 t -99.46 -175.91 3.13 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.663 -0.648 . . . . 0.0 110.637 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.598 ' HA ' HG11 ' A' ' 10' ' ' VAL . 2.6 mt-30 -74.85 -52.07 12.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.423 -0.798 . . . . 0.0 110.263 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -64.15 -41.04 97.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.575 -0.703 . . . . 0.0 110.189 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -56.09 -45.85 79.26 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.649 -0.657 . . . . 0.0 109.993 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.43 93.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.62 -0.675 . . . . 0.0 109.43 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -64.16 -37.83 88.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.643 -0.66 . . . . 0.0 109.717 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -64.97 -42.04 94.92 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.638 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 18.6 t90 -64.49 -43.1 95.21 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.162 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.462 HD23 ' HD2' ' A' ' 17' ' ' LYS . 12.2 mt . . . . . 0 N--CA 1.499 1.991 0 O-C-N 121.776 -0.578 . . . . 0.0 109.562 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 120.95 0.405 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 14' ' ' VAL . 65.5 t -65.07 -41.3 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.502 -0.749 . . . . 0.0 109.31 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.493 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -63.11 -39.59 95.14 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.597 -0.689 . . . . 0.0 109.79 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.88 98.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.548 -0.72 . . . . 0.0 109.56 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.99 98.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.634 -0.666 . . . . 0.0 109.5 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 10' ' ' VAL . 60.5 t -62.69 -41.07 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.545 -0.722 . . . . 0.0 109.299 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.588 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -63.28 -40.13 96.52 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.694 -0.629 . . . . 0.0 109.42 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 56.5 m -63.47 -38.88 92.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.649 -0.657 . . . . 0.0 109.443 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.516 ' HB3' ' HZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.63 -37.79 82.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.518 -0.739 . . . . 0.0 109.356 178.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.784 HD12 ' HB1' ' A' ' 78' ' ' ALA . 17.1 mt -66.57 -33.33 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.678 -0.639 . . . . 0.0 109.857 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.5 t -62.51 -49.86 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.252 -0.905 . . . . 0.0 109.736 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.03 -13.12 83.38 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 120.293 -0.956 . . . . 0.0 110.82 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.688 HD21 ' O ' ' A' ' 28' ' ' GLU . 11.5 tp -98.09 -23.0 15.93 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.019 -1.283 . . . . 0.0 110.825 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.554 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 17.4 t90 -67.4 131.36 45.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.73 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.96 -161.27 0.86 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -47.94 -45.07 30.67 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.132 -0.98 . . . . 0.0 110.444 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.13 36.54 0.14 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.611 -0.681 . . . . 0.0 110.848 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -156.54 155.49 32.02 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.194 -0.941 . . . . 0.0 110.027 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.571 HG23 ' HB2' ' A' ' 34' ' ' CYS . 7.2 t -156.41 155.29 31.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.164 -0.96 . . . . 0.0 110.132 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.688 ' O ' HD21 ' A' ' 21' ' ' LEU . 8.0 mp0 -116.09 109.39 17.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.4 -0.813 . . . . 0.0 109.494 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.533 HD23 ' C ' ' A' ' 28' ' ' GLU . 10.7 mt -112.19 129.79 56.13 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.316 -0.865 . . . . 0.0 110.576 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.874 HD12 ' HD1' ' A' ' 99' ' ' TRP . 0.3 OUTLIER 60.09 30.64 20.08 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.442 -0.786 . . . . 0.0 110.301 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.02 22.21 78.43 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 30' ' ' LEU . 50.0 m-70 -120.77 160.07 24.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.379 -1.071 . . . . 0.0 109.992 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.43 126.72 34.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.359 -0.838 . . . . 0.0 110.549 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.571 ' HB2' HG23 ' A' ' 27' ' ' THR . 23.9 m -130.17 166.88 19.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.69 -0.631 . . . . 0.0 109.687 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 6.1 tptt -128.33 105.64 8.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.465 -0.772 . . . . 0.0 110.637 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.554 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 29.9 t80 -108.23 137.34 46.37 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.6 p -147.57 152.32 37.75 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.031 -1.043 . . . . 0.0 111.816 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.8 t -125.17 133.92 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.415 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -136.15 119.16 12.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.127 -0.983 . . . . 0.0 111.224 -178.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo . . . . . 0 C--N 1.315 -1.206 0 O-C-N 123.77 1.405 . . . . 0.0 110.655 179.55 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.035 0.445 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 70' ' ' GLN . 3.3 m-85 -98.39 133.53 42.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.505 -0.747 . . . . 0.0 110.311 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.6 164.63 17.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.449 -0.782 . . . . 0.0 110.085 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -156.86 135.67 4.57 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.596 ' HG3' ' HG3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -138.92 144.82 39.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.582 -0.952 . . . . 0.0 110.426 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.584 ' HG2' HG22 ' A' ' 77' ' ' THR . 2.5 ppp? -140.49 148.74 41.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.325 -0.859 . . . . 0.0 110.315 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.509 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 44.8 p90 -152.29 146.65 25.55 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.651 -0.656 . . . . 0.0 110.41 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 98.0 m -112.38 88.93 11.54 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.303 -0.873 . . . . 0.0 110.953 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -77.59 84.33 1.99 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.843 1.444 . . . . 0.0 110.278 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.73 -46.63 0.59 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 10.3 t90 -71.35 -58.13 3.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.6 -0.941 . . . . 0.0 110.045 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.429 HG21 ' CD1' ' A' ' 90' ' ' LEU . 9.1 t -153.7 -160.66 1.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.577 -0.702 . . . . 0.0 109.941 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.87 47.69 1.61 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.397 -0.815 . . . . 0.0 110.127 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.406 HG22 ' CD1' ' A' ' 81' ' ' PHE . 72.9 mt -123.63 151.41 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.471 -0.768 . . . . 0.0 109.878 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -139.33 169.87 16.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.904 . . . . 0.0 110.962 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.557 ' O ' HG23 ' A' ' 77' ' ' THR . . . -137.35 127.58 4.03 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.596 ' HG3' ' HG3' ' A' ' 52' ' ' ARG . 1.8 mp0 -121.7 169.02 11.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.571 -0.959 . . . . 0.0 110.695 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.441 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -166.41 156.57 12.06 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.486 0.66 . . . . 0.0 111.336 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -156.44 131.86 9.39 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.633 -0.667 . . . . 0.0 110.037 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.3 t -175.63 -176.71 0.9 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.598 -0.689 . . . . 0.0 109.987 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -82.48 -39.18 22.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.221 -0.924 . . . . 0.0 110.466 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.31 135.74 52.36 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.591 -0.693 . . . . 0.0 110.607 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.434 ' HB3' ' CE2' ' A' ' 49' ' ' TYR . 15.4 pt20 -75.79 -34.96 60.22 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.628 -0.67 . . . . 0.0 110.648 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.0 m -82.22 -34.12 29.04 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.151 -0.968 . . . . 0.0 109.925 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.68 -36.74 90.75 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 70' ' ' GLN . 0.3 OUTLIER -69.99 -35.53 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.3 -1.118 . . . . 0.0 110.004 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.38 94.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.179 -0.951 . . . . 0.0 109.94 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -66.46 -39.44 94.08 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.441 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -67.6 -43.22 81.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.651 -0.911 . . . . 0.0 110.397 179.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.584 HG22 ' HG2' ' A' ' 53' ' ' MET . 94.4 m -58.99 -36.33 74.72 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.192 -0.943 . . . . 0.0 109.578 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.784 ' HB1' HD12 ' A' ' 18' ' ' ILE . . . -80.33 -32.71 37.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.525 -0.735 . . . . 0.0 109.876 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 75' ' ' GLY . 1.3 ttpm? -75.71 -34.47 60.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.461 -0.774 . . . . 0.0 110.102 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -39.58 86.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.481 -0.762 . . . . 0.0 109.626 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.406 ' CD1' HG22 ' A' ' 61' ' ' ILE . 51.3 t80 -70.12 -38.48 75.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.375 -0.828 . . . . 0.0 109.082 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.493 HG11 ' HA ' ' A' ' 11' ' ' ALA . 39.0 t -66.68 -39.15 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.652 -0.655 . . . . 0.0 109.662 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.44 -44.77 96.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.356 -0.84 . . . . 0.0 109.414 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -68.95 -37.11 78.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.53 -0.731 . . . . 0.0 109.516 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.68 -37.2 76.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.565 -0.71 . . . . 0.0 109.747 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -64.68 -41.45 96.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.582 -0.699 . . . . 0.0 109.734 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -69.19 -34.42 74.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.51 -0.744 . . . . 0.0 110.616 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.95 -51.84 12.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.271 -0.893 . . . . 0.0 110.239 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.07 52.55 0.13 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 90' ' ' LEU . 6.0 mt -114.87 -48.87 2.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.267 -1.137 . . . . 0.0 110.225 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.451 HD13 HG11 ' A' ' 14' ' ' VAL . 82.4 mt -103.81 94.57 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 110.06 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.486 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 5.0 m -78.11 178.37 7.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.329 -0.857 . . . . 0.0 109.898 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -57.86 7.2 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.284 -0.885 . . . . 0.0 110.479 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -63.13 -35.56 80.68 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.24 -0.913 . . . . 0.0 110.134 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.4 OUTLIER -70.26 -32.31 70.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.393 -0.817 . . . . 0.0 109.547 178.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.7 -40.71 93.24 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.411 -0.806 . . . . 0.0 109.353 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -63.33 -46.64 85.69 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -66.01 -37.3 85.57 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.874 ' HD1' HD12 ' A' ' 30' ' ' LEU . 58.5 t90 -65.26 -38.89 91.72 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.02 0.438 . . . . 0.0 109.855 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.509 ' HA ' ' HG3' ' A' ' 17' ' ' LYS . 11.8 mt . . . . . 0 N--CA 1.496 1.834 0 O-C-N 121.655 -0.653 . . . . 0.0 109.78 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 14' ' ' VAL . 40.2 t -63.07 -39.65 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.78 -41.35 97.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.653 -0.655 . . . . 0.0 109.429 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.31 -41.64 93.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.681 -0.637 . . . . 0.0 109.685 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.7 99.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.525 -0.734 . . . . 0.0 109.41 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 10' ' ' VAL . 86.9 t -65.99 -40.73 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -65.11 -38.56 91.1 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.459 -0.776 . . . . 0.0 109.49 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -38.56 91.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.455 -0.778 . . . . 0.0 109.44 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.663 ' HE3' HD23 ' A' ' 100' ' ' LEU . 4.9 tppt? -67.2 -32.3 73.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.543 -0.723 . . . . 0.0 109.686 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.544 HG21 ' HB2' ' A' ' 78' ' ' ALA . 6.5 mm -61.53 -49.38 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.416 -0.802 . . . . 0.0 109.262 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.7 t -61.66 -39.12 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.58 -0.7 . . . . 0.0 109.935 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.46 -33.41 86.39 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 tp -112.05 36.89 3.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.396 -1.061 . . . . 0.0 110.581 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.408 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 25.2 t90 -102.44 136.97 41.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 111.266 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -99.35 -166.43 1.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -51.19 -40.13 57.99 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.043 -1.035 . . . . 0.0 110.245 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -158.6 34.61 0.23 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.584 -0.698 . . . . 0.0 110.605 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -154.35 141.2 19.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.251 -0.905 . . . . 0.0 111.021 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.5 t -145.52 157.7 43.95 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.301 -0.875 . . . . 0.0 109.594 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 32' ' ' HIS . 9.7 mt-10 -101.23 122.95 44.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.359 -0.838 . . . . 0.0 111.229 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.622 HD12 ' SG ' ' A' ' 34' ' ' CYS . 7.2 mt -108.17 116.36 31.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.569 -0.707 . . . . 0.0 109.396 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.632 HD11 ' HG3' ' A' ' 95' ' ' GLU . 1.2 tp 58.48 31.1 20.61 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.784 -0.572 . . . . 0.0 110.73 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.32 -8.19 79.41 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 54.6 m-70 -91.33 163.64 14.14 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.121 -1.223 . . . . 0.0 110.273 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.58 127.98 38.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.569 -0.707 . . . . 0.0 110.324 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.622 ' SG ' HD12 ' A' ' 29' ' ' LEU . 64.3 m -127.61 170.74 12.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.674 -0.641 . . . . 0.0 110.04 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -123.22 99.94 6.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.543 -0.723 . . . . 0.0 110.312 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.492 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 5.4 t80 -112.53 135.08 53.66 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.23 171.37 16.59 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.11 -0.993 . . . . 0.0 110.841 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.452 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 44.7 t -129.35 135.36 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.788 -0.57 . . . . 0.0 109.619 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.25 87.22 39.25 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.286 -0.884 . . . . 0.0 110.776 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 C--N 1.312 -1.353 0 O-C-N 123.826 1.435 . . . . 0.0 110.475 179.472 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.033 0.444 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -127.99 128.7 45.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.026 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -135.54 157.39 47.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -0.941 . . . . 0.0 110.18 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -149.3 148.07 19.06 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.572 ' HD3' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -143.25 143.31 31.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.659 -0.906 . . . . 0.0 110.16 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.53 ' HG2' HG22 ' A' ' 77' ' ' THR . 1.6 ppp? -148.64 150.25 32.93 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.255 -0.903 . . . . 0.0 111.137 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.553 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 46.7 p90 -164.02 152.11 12.86 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.785 -0.572 . . . . 0.0 110.376 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 75.7 m -111.16 92.45 15.54 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.209 -0.932 . . . . 0.0 110.71 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.553 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 48.9 Cg_endo -74.21 88.61 1.11 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.903 1.475 . . . . 0.0 110.192 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 146.49 -47.22 0.71 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -71.1 -50.89 28.86 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.549 -0.971 . . . . 0.0 110.19 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.515 ' CB ' HD11 ' A' ' 90' ' ' LEU . 14.3 t -151.96 -169.89 3.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.632 -0.668 . . . . 0.0 109.901 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.63 61.97 0.78 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 0.0 110.367 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.733 HD11 ' HB3' ' A' ' 84' ' ' LYS . 10.5 tt -137.91 150.52 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.336 -0.852 . . . . 0.0 109.99 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.34 155.97 49.32 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.806 . . . . 0.0 110.594 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.5 151.36 21.15 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.572 ' HB3' ' HD3' ' A' ' 52' ' ' ARG . 1.8 pp20? -156.38 158.65 37.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.391 -1.064 . . . . 0.0 110.738 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.48 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -146.42 148.36 32.21 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.586 -0.696 . . . . 0.0 110.81 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.427 ' O ' ' HB ' ' A' ' 67' ' ' THR . 1.4 m -138.04 139.14 39.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.368 -0.833 . . . . 0.0 110.331 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 66' ' ' SER . 6.1 t 179.63 -163.34 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.843 -0.535 . . . . 0.0 109.819 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.94 -23.79 14.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.4 -0.813 . . . . 0.0 110.334 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.2 m -61.91 153.32 29.46 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.108 -0.995 . . . . 0.0 110.454 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.455 ' O ' HG12 ' A' ' 73' ' ' VAL . 38.5 tt0 -93.15 -56.92 2.79 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.643 -0.661 . . . . 0.0 110.412 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.2 p -81.42 -28.58 34.2 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.376 -0.828 . . . . 0.0 110.475 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.1 -45.01 96.75 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 70' ' ' GLN . 2.5 p -58.8 -38.07 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.498 -1.001 . . . . 0.0 110.538 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.4 ' N ' ' CG1' ' A' ' 73' ' ' VAL . . . -65.25 -47.6 76.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.467 -0.771 . . . . 0.0 109.801 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -63.49 -39.77 98.05 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.48 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -62.87 -42.02 99.61 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.571 -0.958 . . . . 0.0 110.285 179.372 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.53 HG22 ' HG2' ' A' ' 53' ' ' MET . 47.6 m -62.12 -41.25 98.06 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.257 -0.902 . . . . 0.0 109.978 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.615 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -76.45 -36.85 57.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.526 -0.734 . . . . 0.0 110.037 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 75' ' ' GLY . 0.1 OUTLIER -69.11 -38.36 78.88 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.531 -0.731 . . . . 0.0 110.137 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -69.12 -35.54 76.51 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.442 ' CE2' HG23 ' A' ' 61' ' ' ILE . 42.7 t80 -66.62 -41.0 89.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.569 -0.707 . . . . 0.0 109.68 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 78' ' ' ALA . 84.3 t -64.7 -38.62 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.538 -0.726 . . . . 0.0 109.738 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.1 tpt85 -63.82 -39.52 94.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.565 -0.71 . . . . 0.0 109.73 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.733 ' HB3' HD11 ' A' ' 61' ' ' ILE . 36.4 mtpt -69.35 -33.86 73.74 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.379 -0.826 . . . . 0.0 109.529 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.47 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -76.28 -27.69 56.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.306 -0.871 . . . . 0.0 109.231 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.48 -41.9 72.11 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.719 -0.613 . . . . 0.0 110.019 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.435 ' HG3' ' N ' ' A' ' 88' ' ' LYS . 6.0 pt20 -67.48 -36.22 80.69 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.378 -0.826 . . . . 0.0 110.585 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.715 ' HD2' HD12 ' A' ' 61' ' ' ILE . 10.5 mttt -74.4 -54.81 6.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.297 -0.877 . . . . 0.0 110.004 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.98 52.37 0.07 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.515 HD11 ' CB ' ' A' ' 59' ' ' THR . 6.1 mt -119.32 -61.64 1.6 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.245 -1.15 . . . . 0.0 109.893 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 82' ' ' VAL . 72.9 mt -89.5 75.46 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.505 -0.747 . . . . 0.0 109.237 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.2 t -62.13 178.97 0.33 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.753 -0.592 . . . . 0.0 110.535 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -62.03 -54.63 38.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.472 -0.768 . . . . 0.0 110.217 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -67.85 -29.44 68.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.623 -0.673 . . . . 0.0 110.675 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.632 ' HG3' HD11 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -63.78 -45.41 89.86 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.357 -0.84 . . . . 0.0 110.188 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.66 -38.04 89.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.514 -0.741 . . . . 0.0 109.622 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -66.65 -36.79 83.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.503 -0.748 . . . . 0.0 110.307 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -41.41 90.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.342 -0.849 . . . . 0.0 109.761 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.639 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 13.6 t90 -67.26 -40.96 86.29 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.354 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.663 HD23 ' HE3' ' A' ' 17' ' ' LYS . 43.3 mt . . . . . 0 N--CA 1.497 1.92 0 O-C-N 121.631 -0.668 . . . . 0.0 109.62 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.466 ' O ' HG23 ' A' ' 14' ' ' VAL . 77.8 t -64.49 -39.56 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.596 -0.69 . . . . 0.0 109.202 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.686 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -63.54 -39.56 94.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.759 -0.588 . . . . 0.0 109.813 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.63 99.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.534 -0.729 . . . . 0.0 109.648 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.13 99.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.603 -0.686 . . . . 0.0 109.671 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 10' ' ' VAL . 91.5 t -62.98 -40.8 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.521 -0.737 . . . . 0.0 109.431 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.68 -38.71 92.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.544 -0.722 . . . . 0.0 109.536 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.1 t -62.46 -41.76 98.99 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.661 -0.65 . . . . 0.0 109.627 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.44 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 11.8 tttm -65.35 -32.49 74.15 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.433 -0.792 . . . . 0.0 110.063 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.495 HG21 ' HB2' ' A' ' 78' ' ' ALA . 8.7 mm -64.94 -45.86 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.419 -0.801 . . . . 0.0 109.66 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.56 -40.77 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.546 -0.721 . . . . 0.0 110.206 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.18 -19.27 78.66 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.276 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 tp -120.41 21.15 11.75 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.865 -1.374 . . . . 0.0 111.945 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.547 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 18.6 t90 -90.88 137.74 32.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.902 -1.124 . . . . 0.0 109.948 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.64 -169.14 1.79 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.41 -0.806 . . . . 0.0 109.369 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -45.54 -44.04 12.42 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.153 -0.967 . . . . 0.0 110.311 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.475 ' O ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -158.39 33.31 0.24 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.579 -0.7 . . . . 0.0 110.828 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -141.5 152.73 44.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.12 -0.987 . . . . 0.0 111.001 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.541 HG23 ' CB ' ' A' ' 34' ' ' CYS . 2.1 t -155.07 167.32 30.76 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.629 -0.669 . . . . 0.0 109.476 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -136.55 119.13 15.95 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.275 -0.89 . . . . 0.0 109.992 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.595 HD13 ' CE2' ' A' ' 81' ' ' PHE . 5.2 mt -108.64 120.74 43.33 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.333 -0.854 . . . . 0.0 110.456 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.412 ' HB3' ' CD2' ' A' ' 32' ' ' HIS . 5.0 tp 56.52 31.06 18.3 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.582 -0.699 . . . . 0.0 111.007 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.44 -11.78 64.85 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.594 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 59.8 m-70 -84.63 141.52 30.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.028 -1.278 . . . . 0.0 110.006 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -72.2 135.74 46.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.391 -0.818 . . . . 0.0 110.305 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.546 ' SG ' HD12 ' A' ' 29' ' ' LEU . 45.1 m -139.15 168.57 19.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.614 -0.679 . . . . 0.0 110.059 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.475 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER -129.7 121.21 26.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.511 -0.743 . . . . 0.0 110.051 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.547 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 26.8 t80 -120.42 136.77 54.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.555 -0.716 . . . . 0.0 109.364 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.1 p -140.36 151.0 44.64 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.061 -1.025 . . . . 0.0 111.503 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.7 t -132.64 129.25 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 mtmm -142.56 117.33 6.56 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.159 -0.963 . . . . 0.0 110.938 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 C--N 1.313 -1.289 0 O-C-N 123.954 1.502 . . . . 0.0 110.251 179.358 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.338 0.59 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.485 ' CZ ' ' HG3' ' A' ' 70' ' ' GLN . 0.5 OUTLIER -124.28 131.62 53.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.476 -0.765 . . . . 0.0 110.028 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -135.69 157.14 47.6 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.449 -0.782 . . . . 0.0 110.495 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.91 147.58 17.55 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.491 ' HD3' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -141.16 145.52 35.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.826 -0.808 . . . . 0.0 110.033 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.646 ' HG2' HG22 ' A' ' 77' ' ' THR . 2.2 ptm -143.99 151.88 40.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.078 -1.014 . . . . 0.0 111.079 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.472 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 48.6 p90 -155.84 150.56 26.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.7 -0.625 . . . . 0.0 110.32 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 87.1 m -113.53 90.49 17.83 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.214 -0.929 . . . . 0.0 110.964 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.472 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.4 Cg_endo -78.66 84.8 1.96 Allowed 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.957 1.504 . . . . 0.0 110.108 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.49 -47.6 0.41 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.594 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 19.4 t90 -77.08 -54.66 6.25 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.449 -1.03 . . . . 0.0 110.384 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.556 HG21 HD13 ' A' ' 90' ' ' LEU . 8.9 t -153.74 -161.83 1.33 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.558 -0.714 . . . . 0.0 110.022 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.24 48.57 1.39 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.518 -0.739 . . . . 0.0 110.212 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.735 HD12 HD12 ' A' ' 90' ' ' LEU . 34.4 mt -118.36 146.57 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.366 -0.834 . . . . 0.0 109.83 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.16 161.72 35.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.365 -0.835 . . . . 0.0 110.98 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.68 131.76 5.89 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HG2' ' HD3' ' A' ' 52' ' ' ARG . 12.9 mp0 -126.44 160.25 31.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.644 -0.915 . . . . 0.0 109.914 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.738 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -171.76 152.34 3.06 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.414 -0.804 . . . . 0.0 111.188 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.1 143.44 31.13 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.516 -0.74 . . . . 0.0 110.115 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.8 t -173.25 155.42 2.92 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.52 -0.738 . . . . 0.0 110.323 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.41 -35.88 70.6 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.532 -0.73 . . . . 0.0 111.411 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.406 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 0.9 OUTLIER -62.31 135.6 57.54 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.32 -0.863 . . . . 0.0 110.354 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.509 ' O ' HG12 ' A' ' 73' ' ' VAL . 4.6 mp0 -70.23 -61.39 1.79 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.705 -0.622 . . . . 0.0 109.98 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.2 t -72.93 -28.76 62.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.24 -0.913 . . . . 0.0 109.879 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -58.27 -39.66 92.86 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 70' ' ' GLN . 0.5 OUTLIER -64.97 -35.81 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.377 -1.072 . . . . 0.0 109.992 179.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.96 -39.76 87.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.433 -0.792 . . . . 0.0 110.036 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.05 -34.34 76.13 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.738 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -70.36 -42.22 72.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.62 -0.929 . . . . 0.0 110.177 179.502 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.646 HG22 ' HG2' ' A' ' 53' ' ' MET . 66.5 m -62.49 -40.01 95.33 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.286 -0.884 . . . . 0.0 109.419 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -73.47 -37.02 65.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.514 -0.741 . . . . 0.0 109.685 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -38.78 86.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.505 -0.747 . . . . 0.0 109.693 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -41.97 99.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.565 -0.709 . . . . 0.0 110.001 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.595 ' CE2' HD13 ' A' ' 29' ' ' LEU . 51.5 t80 -65.72 -40.8 92.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.443 -0.785 . . . . 0.0 109.973 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.686 HG11 ' HA ' ' A' ' 11' ' ' ALA . 97.1 t -66.1 -36.04 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.484 -0.76 . . . . 0.0 109.915 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -67.04 -40.66 87.23 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.47 -0.769 . . . . 0.0 109.982 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -37.11 80.56 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.535 -0.728 . . . . 0.0 109.869 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.707 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -68.98 -35.27 76.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.385 -0.822 . . . . 0.0 110.134 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.9 -36.22 72.64 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.477 -0.764 . . . . 0.0 109.687 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -63.1 -29.05 70.5 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.601 -0.687 . . . . 0.0 110.412 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -55.29 3.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.43 -0.794 . . . . 0.0 110.332 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 136.61 56.53 0.06 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.735 HD12 HD12 ' A' ' 61' ' ' ILE . 11.5 mt -125.44 -46.41 1.76 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.336 -1.096 . . . . 0.0 110.579 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.707 HD12 ' HB3' ' A' ' 85' ' ' ALA . 89.0 mt -96.78 112.38 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 109.741 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.5 m -91.25 162.63 14.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.542 -0.724 . . . . 0.0 110.353 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -63.29 -53.72 48.34 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.526 -0.734 . . . . 0.0 110.259 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -61.64 -42.74 99.31 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.481 -0.762 . . . . 0.0 110.733 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -59.27 -41.66 89.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.317 -0.864 . . . . 0.0 110.176 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.06 -40.24 97.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.381 -0.824 . . . . 0.0 109.741 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -64.21 -39.88 94.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.567 -0.708 . . . . 0.0 109.868 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -63.26 -40.48 97.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.668 -0.645 . . . . 0.0 109.745 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.44 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 15.1 t90 -68.45 -36.54 79.17 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.591 -0.693 . . . . 0.0 109.9 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.428 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 14.1 mt . . . . . 0 N--CA 1.499 1.982 0 O-C-N 121.699 -0.626 . . . . 0.0 110.548 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.536 ' O ' HG23 ' A' ' 14' ' ' VAL . 97.4 t -68.5 -38.79 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.809 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -64.19 -39.74 94.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.611 -0.681 . . . . 0.0 109.647 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.58 -41.56 99.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.551 -0.718 . . . . 0.0 109.79 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.49 -40.43 89.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.397 -0.814 . . . . 0.0 109.693 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 10' ' ' VAL . 95.0 t -64.96 -40.78 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.439 -0.788 . . . . 0.0 109.137 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -62.13 -40.27 95.35 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.687 -0.633 . . . . 0.0 109.75 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 t -61.39 -41.78 97.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.563 -0.711 . . . . 0.0 109.755 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.461 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 14.4 tttm -68.36 -30.44 69.39 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.472 -0.767 . . . . 0.0 110.215 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.533 HG21 ' HB2' ' A' ' 78' ' ' ALA . 12.9 mm -68.1 -44.32 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.423 -0.798 . . . . 0.0 109.702 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.77 -39.24 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.342 -0.849 . . . . 0.0 110.196 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.57 -27.58 69.14 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.68 28.73 8.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.1 -1.235 . . . . 0.0 111.613 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -95.65 132.69 40.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.929 -1.107 . . . . 0.0 110.48 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -98.09 -166.04 1.33 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -48.0 -41.95 26.71 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.161 -0.962 . . . . 0.0 110.26 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -161.97 37.83 0.12 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.725 -0.609 . . . . 0.0 110.261 179.566 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -146.12 158.83 43.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.188 -0.945 . . . . 0.0 111.205 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.562 HG23 ' HB2' ' A' ' 34' ' ' CYS . 8.0 t -163.61 154.3 15.97 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.682 -0.636 . . . . 0.0 109.406 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -110.94 111.11 22.01 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.21 -0.932 . . . . 0.0 110.302 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.446 HD21 HD11 ' A' ' 18' ' ' ILE . 2.8 mt -107.06 128.86 54.75 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.355 -0.841 . . . . 0.0 110.763 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 30' ' ' LEU . 4.7 tp 54.48 36.0 24.63 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.599 -0.688 . . . . 0.0 111.17 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.32 23.49 78.01 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.567 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 51.6 m-70 -123.14 151.67 41.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -1.087 . . . . 0.0 109.895 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.46 127.43 32.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.312 -0.868 . . . . 0.0 110.597 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.562 ' HB2' HG23 ' A' ' 27' ' ' THR . 59.9 m -129.33 171.25 12.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.685 -0.635 . . . . 0.0 109.996 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 7.9 tptm -128.06 100.68 5.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.526 -0.734 . . . . 0.0 110.276 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.474 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 3.8 t80 -112.85 136.1 52.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.755 -0.591 . . . . 0.0 109.703 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.01 170.85 16.85 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.343 -0.848 . . . . 0.0 111.045 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.506 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 76.0 t -133.41 130.64 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -137.84 93.74 11.96 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.158 -0.964 . . . . 0.0 111.192 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.477 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 56.5 Cg_endo . . . . . 0 C--N 1.312 -1.355 0 O-C-N 123.916 1.482 . . . . 0.0 110.316 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.336 0.589 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.548 ' CE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -108.98 156.86 19.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.456 -0.778 . . . . 0.0 110.195 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -156.78 149.75 23.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.312 -0.867 . . . . 0.0 110.189 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -145.87 149.97 22.15 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HD3' ' CB ' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -148.42 145.05 27.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.7 -0.882 . . . . 0.0 110.113 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.508 ' HG2' HG22 ' A' ' 77' ' ' THR . 5.4 ptm -144.54 151.3 38.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.374 -0.829 . . . . 0.0 111.123 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.496 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 42.8 p90 -153.93 147.93 25.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.786 -0.571 . . . . 0.0 109.888 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 58' ' ' TRP . 87.5 m -111.58 89.9 11.6 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.222 -0.924 . . . . 0.0 111.449 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -77.06 85.72 1.73 Allowed 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.856 1.451 . . . . 0.0 110.091 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.83 -46.63 0.64 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.567 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 12.1 t90 -70.31 -57.43 4.88 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.672 -0.899 . . . . 0.0 109.996 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -152.1 -164.37 1.95 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.61 -0.681 . . . . 0.0 109.901 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.63 56.83 0.88 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.356 -0.84 . . . . 0.0 109.767 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.565 HD11 ' HE2' ' A' ' 88' ' ' LYS . 31.7 mt -130.55 158.71 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.608 -0.683 . . . . 0.0 109.699 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -135.93 171.04 15.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.45 -0.781 . . . . 0.0 110.695 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.56 127.96 1.83 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.432 ' CB ' ' HD3' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -147.48 156.06 42.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.608 -0.937 . . . . 0.0 110.709 -179.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.582 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -158.4 155.57 28.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.458 -0.776 . . . . 0.0 110.614 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.501 ' HA ' HG23 ' A' ' 73' ' ' VAL . 0.7 OUTLIER -133.42 145.45 50.3 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.418 -0.801 . . . . 0.0 110.688 -179.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 t -172.7 152.29 2.49 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.629 -0.669 . . . . 0.0 109.67 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -26.97 61.23 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.361 -0.837 . . . . 0.0 111.346 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.8 133.24 51.55 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.28 -0.888 . . . . 0.0 110.618 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.548 ' HA ' ' CE2' ' A' ' 49' ' ' TYR . 1.0 OUTLIER -70.36 -53.12 17.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.56 -0.712 . . . . 0.0 110.559 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.9 m -80.88 -28.31 36.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.331 -0.856 . . . . 0.0 110.082 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.17 -44.16 98.49 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' A' ' 66' ' ' SER . 0.5 OUTLIER -58.37 -36.37 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.461 -1.023 . . . . 0.0 110.321 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.449 ' HA ' ' HZ ' ' A' ' 36' ' ' PHE . . . -71.75 -43.3 66.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.589 -0.694 . . . . 0.0 109.653 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.58 -38.5 93.37 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.582 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -65.38 -40.47 93.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.643 -0.916 . . . . 0.0 109.996 179.433 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.508 HG22 ' HG2' ' A' ' 53' ' ' MET . 23.3 m -60.19 -43.51 95.84 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.542 -0.724 . . . . 0.0 109.32 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.533 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -68.7 -37.57 79.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.624 -0.673 . . . . 0.0 109.76 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.79 -40.17 94.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.559 -0.713 . . . . 0.0 109.61 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.53 -40.41 94.55 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.666 . . . . 0.0 110.049 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -70.18 -38.51 75.39 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.426 -0.797 . . . . 0.0 110.004 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.825 HG13 HG21 ' A' ' 91' ' ' ILE . 85.7 t -71.86 -33.4 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 0.0 110.027 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -41.27 80.67 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.282 -0.886 . . . . 0.0 109.361 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -36.67 67.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.494 -0.754 . . . . 0.0 108.983 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.37 -37.01 80.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.449 -0.782 . . . . 0.0 109.271 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -43.47 98.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.548 -0.72 . . . . 0.0 109.352 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -68.21 -37.1 80.52 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.659 -0.651 . . . . 0.0 110.534 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.565 ' HE2' HD11 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -72.37 -52.19 17.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.327 -0.858 . . . . 0.0 110.474 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.4 53.99 0.1 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 90' ' ' LEU . 12.4 mt -129.0 -49.88 1.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.487 -1.008 . . . . 0.0 110.521 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.825 HG21 HG13 ' A' ' 82' ' ' VAL . 32.5 mm -94.51 90.81 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 109.833 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -77.78 169.63 17.97 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.552 -0.718 . . . . 0.0 109.705 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.515 ' HG3' HG21 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -64.64 -54.47 31.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.404 -0.81 . . . . 0.0 110.462 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -69.29 -36.91 77.54 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.406 -0.809 . . . . 0.0 110.563 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.0 OUTLIER -62.4 -43.19 99.42 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.293 -0.879 . . . . 0.0 110.054 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.85 87.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.444 -0.785 . . . . 0.0 109.12 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -62.93 -41.15 99.38 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.81 -0.556 . . . . 0.0 109.889 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -41.46 96.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.445 -0.785 . . . . 0.0 109.288 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.461 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 29.6 t90 -66.74 -36.64 82.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.349 -0.844 . . . . 0.0 109.069 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 100' ' ' LEU . 21.1 tp . . . . . 0 N--CA 1.494 1.775 0 O-C-N 121.932 -0.48 . . . . 0.0 109.955 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 14' ' ' VAL . 64.4 t -67.04 -42.07 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.1 94.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.582 -0.699 . . . . 0.0 109.186 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.39 94.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.711 -0.618 . . . . 0.0 109.715 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.478 ' O ' HD21 ' A' ' 100' ' ' LEU . . . -62.5 -39.76 94.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.561 -0.712 . . . . 0.0 110.02 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.605 ' CG2' ' HB1' ' A' ' 96' ' ' ALA . 48.8 t -69.45 -39.65 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.329 -0.857 . . . . 0.0 109.237 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.68 -39.25 88.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.542 -0.724 . . . . 0.0 109.902 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 p -65.63 -35.97 82.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.406 -0.808 . . . . 0.0 109.923 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.79 ' HD3' HD23 ' A' ' 100' ' ' LEU . 4.7 tptt -65.78 -35.49 80.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.473 -0.767 . . . . 0.0 109.7 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.772 HD12 ' HB1' ' A' ' 78' ' ' ALA . 4.9 mt -65.52 -47.11 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.507 -0.746 . . . . 0.0 109.18 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.6 t -64.45 -39.49 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.523 -0.736 . . . . 0.0 110.051 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.58 -25.01 75.2 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.8 tp -120.68 31.39 6.45 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.289 -1.124 . . . . 0.0 111.021 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.423 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 23.5 t90 -93.28 136.71 33.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.987 -1.07 . . . . 0.0 110.479 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.07 -167.79 1.56 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.605 -0.685 . . . . 0.0 109.253 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.81 -43.02 18.03 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.24 -0.913 . . . . 0.0 110.206 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 1.4 pp20? -159.5 33.56 0.19 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.479 -0.763 . . . . 0.0 110.848 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -140.81 147.9 39.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.129 -0.982 . . . . 0.0 110.78 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 t -154.71 161.95 41.33 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.437 -0.789 . . . . 0.0 109.553 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -111.35 152.72 26.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.197 -0.939 . . . . 0.0 110.183 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.546 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 3.4 mt -146.18 119.02 8.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.405 -0.81 . . . . 0.0 109.971 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 tp 54.71 32.48 17.45 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.779 -0.576 . . . . 0.0 111.188 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.29 22.28 63.17 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 70.0 m-70 -124.89 147.14 48.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -1.143 . . . . 0.0 110.151 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.83 132.92 40.69 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.435 -0.79 . . . . 0.0 110.416 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.546 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 84.4 m -135.37 164.34 27.99 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.561 -0.712 . . . . 0.0 110.179 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.573 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 1.5 tptt -117.9 124.01 47.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.343 -0.848 . . . . 0.0 110.53 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.465 ' CZ ' ' HB ' ' A' ' 77' ' ' THR . 7.3 t80 -124.49 123.93 41.19 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.709 -0.619 . . . . 0.0 109.512 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.3 p -131.37 154.32 48.74 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.202 -0.937 . . . . 0.0 111.578 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 p -122.29 142.35 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.632 -0.667 . . . . 0.0 109.75 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.57 107.56 4.08 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.081 -1.012 . . . . 0.0 110.868 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 C--N 1.315 -1.224 0 O-C-N 123.762 1.401 . . . . 0.0 110.509 179.336 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 121.341 0.591 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 67' ' ' THR . 1.7 m-85 -122.57 132.13 54.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.548 -0.72 . . . . 0.0 109.95 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -132.26 162.99 29.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.427 -0.796 . . . . 0.0 110.381 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -158.0 141.95 8.14 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.53 147.36 52.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.799 -0.824 . . . . 0.0 109.805 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.674 ' HG2' HG22 ' A' ' 77' ' ' THR . 2.4 ppp? -149.05 157.24 43.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.109 -0.995 . . . . 0.0 111.05 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.573 ' CE2' ' HB3' ' A' ' 35' ' ' LYS . 47.3 p90 -164.5 176.6 8.84 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.826 -0.546 . . . . 0.0 110.117 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 58' ' ' TRP . 67.5 m -129.06 94.86 32.78 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.213 -0.929 . . . . 0.0 110.614 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 49.8 Cg_endo -77.01 81.61 2.56 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.902 1.475 . . . . 0.0 110.468 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.36 -46.24 0.64 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.494 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 12.6 t90 -68.61 -57.72 5.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.604 -0.939 . . . . 0.0 110.155 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -150.64 -166.23 2.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.471 -0.768 . . . . 0.0 109.939 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.19 50.6 1.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.382 -0.824 . . . . 0.0 110.225 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.4 mt -123.01 149.53 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.739 . . . . 0.0 109.781 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -129.37 165.58 21.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -0.902 . . . . 0.0 111.0 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.22 152.5 24.1 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 65' ' ' ALA . 27.3 tt0 -153.2 158.77 42.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.482 -1.01 . . . . 0.0 110.069 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.553 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -168.63 148.55 4.45 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.989 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.415 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 1.7 m -137.61 147.53 45.09 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.612 -0.68 . . . . 0.0 110.107 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.431 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 6.6 t -170.97 171.37 5.92 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.584 -0.698 . . . . 0.0 110.11 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -69.16 -42.24 76.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.423 -0.798 . . . . 0.0 111.26 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.74 138.97 57.77 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.358 -0.839 . . . . 0.0 110.848 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.566 ' O ' HG12 ' A' ' 73' ' ' VAL . 19.5 tt0 -73.01 -52.14 15.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.76 -0.587 . . . . 0.0 110.282 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.0 m -72.46 -34.8 68.0 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.311 -0.868 . . . . 0.0 110.106 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.04 -36.63 92.59 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 70' ' ' GLN . 0.4 OUTLIER -63.3 -37.91 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.364 -1.08 . . . . 0.0 110.392 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.66 -38.02 80.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.462 -0.774 . . . . 0.0 109.835 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.82 95.59 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.553 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 4.0 tttm -68.1 -40.91 82.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.539 -0.977 . . . . 0.0 110.402 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.674 HG22 ' HG2' ' A' ' 53' ' ' MET . 62.1 m -61.48 -38.22 86.48 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.074 -1.016 . . . . 0.0 109.871 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.772 ' HB1' HD12 ' A' ' 18' ' ' ILE . . . -77.36 -36.17 53.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.585 -0.697 . . . . 0.0 109.899 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -68.64 -39.08 80.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.357 -0.839 . . . . 0.0 109.858 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -67.46 -34.5 77.32 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.514 -0.741 . . . . 0.0 109.562 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.429 ' CD2' ' SD ' ' A' ' 53' ' ' MET . 41.7 t80 -68.07 -41.16 82.35 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.487 -0.758 . . . . 0.0 109.702 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.541 HG13 HG21 ' A' ' 91' ' ' ILE . 83.9 t -66.87 -36.47 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.496 -0.752 . . . . 0.0 109.496 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.26 -41.67 99.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.601 -0.687 . . . . 0.0 109.456 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.68 -40.11 88.41 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.47 -0.769 . . . . 0.0 109.34 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.64 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -68.24 -35.35 77.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.79 -0.569 . . . . 0.0 109.647 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.68 -35.94 81.34 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.646 -0.659 . . . . 0.0 109.689 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -61.59 -39.9 92.83 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.633 -0.667 . . . . 0.0 110.207 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -82.17 -59.1 2.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.439 -0.788 . . . . 0.0 110.176 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.43 51.16 0.05 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.483 ' HA ' HD23 ' A' ' 90' ' ' LEU . 10.0 mt -115.11 -46.47 2.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.33 -1.1 . . . . 0.0 110.297 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 85' ' ' ALA . 89.9 mt -106.66 89.96 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.434 -0.792 . . . . 0.0 109.936 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 17.0 m -71.62 163.87 26.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.436 -0.79 . . . . 0.0 109.632 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.432 ' HG2' HG11 ' A' ' 10' ' ' VAL . 7.2 tm0? -60.29 -51.15 70.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.438 -0.789 . . . . 0.0 110.105 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -41.81 96.39 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.726 -0.609 . . . . 0.0 110.315 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.3 OUTLIER -59.15 -41.53 88.54 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.493 -0.754 . . . . 0.0 110.037 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.605 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -61.39 -42.12 98.21 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.489 -0.757 . . . . 0.0 109.669 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -63.06 -42.63 99.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.548 -0.72 . . . . 0.0 109.614 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -40.28 91.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.574 -0.703 . . . . 0.0 109.598 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.581 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 24.3 t90 -65.42 -38.37 89.71 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.738 -0.601 . . . . 0.0 109.622 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.79 HD23 ' HD3' ' A' ' 17' ' ' LYS . 4.3 mt . . . . . 0 N--CA 1.499 1.999 0 O-C-N 121.749 -0.594 . . . . 0.0 110.261 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.0 t -69.35 -39.62 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.52 -0.737 . . . . 0.0 109.033 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.535 ' HB1' ' HE2' ' A' ' 79' ' ' LYS . . . -67.19 -40.71 86.55 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.63 -40.7 92.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.618 -0.676 . . . . 0.0 109.795 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.42 -43.16 97.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.555 -0.716 . . . . 0.0 109.528 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.681 ' CG2' ' HB1' ' A' ' 96' ' ' ALA . 44.0 t -62.43 -44.52 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.564 -0.71 . . . . 0.0 109.309 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.33 92.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.631 -0.668 . . . . 0.0 109.99 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 t -63.55 -38.66 91.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.515 -0.741 . . . . 0.0 110.042 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.549 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 7.1 tttt -67.0 -33.83 76.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.95 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.614 HD12 ' HB1' ' A' ' 78' ' ' ALA . 10.2 mt -61.48 -48.31 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.449 -0.782 . . . . 0.0 109.757 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.3 t -62.14 -39.13 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.389 -0.819 . . . . 0.0 109.978 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.66 -28.29 73.25 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 tp -115.78 37.3 3.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.363 -1.081 . . . . 0.0 110.95 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -99.19 135.16 41.0 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.187 -0.946 . . . . 0.0 110.617 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.1 mtt-85 -98.49 -167.29 1.48 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -48.37 -43.23 33.46 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.984 -1.072 . . . . 0.0 110.385 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -158.89 36.5 0.22 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.641 -0.662 . . . . 0.0 110.476 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -150.33 157.79 43.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.305 -0.872 . . . . 0.0 110.49 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.403 HG23 ' HB2' ' A' ' 34' ' ' CYS . 12.1 t -157.6 -179.81 8.52 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.337 -0.852 . . . . 0.0 109.868 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -127.44 143.0 51.26 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.437 -0.789 . . . . 0.0 110.231 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.482 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 3.1 mt -137.54 123.49 20.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.296 -0.877 . . . . 0.0 109.835 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.544 HD22 ' HZ2' ' A' ' 58' ' ' TRP . 4.0 tp 56.39 30.09 16.33 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.736 -0.603 . . . . 0.0 111.066 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.31 19.01 65.39 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -118.61 163.69 16.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.151 -1.205 . . . . 0.0 110.208 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.2 133.98 34.21 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.477 -0.765 . . . . 0.0 109.896 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.617 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 90.1 m -135.41 165.8 24.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.466 -0.771 . . . . 0.0 110.875 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.33 118.29 31.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.547 -0.72 . . . . 0.0 110.387 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -129.32 126.51 39.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.577 -0.702 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.19 171.45 18.48 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.033 -1.042 . . . . 0.0 111.293 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.61 148.42 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.931 -0.48 . . . . 0.0 109.971 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -157.62 117.39 1.95 Allowed Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.21 -0.931 . . . . 0.0 110.36 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 C--N 1.314 -1.257 0 O-C-N 123.821 1.432 . . . . 0.0 110.885 179.873 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.148 0.499 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.48 130.19 46.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.425 -0.797 . . . . 0.0 109.984 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -130.84 164.68 24.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.414 -0.803 . . . . 0.0 110.087 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -155.83 152.14 23.61 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.39 134.02 19.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.429 -1.042 . . . . 0.0 110.161 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.418 ' CE ' HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -138.95 158.74 43.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.495 -0.753 . . . . 0.0 110.82 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.584 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 43.9 p90 -168.81 -169.1 0.95 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.774 -0.579 . . . . 0.0 109.984 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 68.2 m -133.18 94.42 20.31 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.253 -0.905 . . . . 0.0 110.708 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.617 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 49.0 Cg_endo -74.87 80.94 2.28 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.986 1.519 . . . . 0.0 110.21 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.34 -45.09 0.64 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.544 ' HZ2' HD22 ' A' ' 30' ' ' LEU . 13.0 t90 -70.77 -55.56 8.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.649 -0.912 . . . . 0.0 110.09 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -151.14 -165.93 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.497 -0.752 . . . . 0.0 109.744 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.57 47.74 1.57 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.299 -0.876 . . . . 0.0 110.183 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.51 HD12 HD12 ' A' ' 90' ' ' LEU . 23.1 mt -123.44 150.9 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.345 -0.847 . . . . 0.0 109.993 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.71 164.38 30.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.316 -0.865 . . . . 0.0 111.328 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.87 130.27 3.83 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.35 170.09 16.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.436 -1.038 . . . . 0.0 111.095 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.556 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -166.34 173.02 10.42 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.385 0.612 . . . . 0.0 110.836 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.43 148.48 24.58 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.391 -0.818 . . . . 0.0 110.87 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.5 t -171.22 169.17 6.51 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.661 -0.649 . . . . 0.0 110.138 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -37.94 88.68 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.288 -0.882 . . . . 0.0 110.529 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.3 t -67.56 162.95 22.27 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.498 -0.751 . . . . 0.0 110.859 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.553 ' O ' HG12 ' A' ' 73' ' ' VAL . 34.0 mt-30 -97.81 -56.24 2.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.899 -0.5 . . . . 0.0 110.122 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 m -67.24 -29.65 69.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.399 -0.813 . . . . 0.0 110.519 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.04 -41.14 97.85 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 110.174 -1.171 . . . . 0.0 110.174 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 70' ' ' GLN . 0.5 OUTLIER -65.51 -34.09 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.455 -1.027 . . . . 0.0 110.47 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.04 -39.38 86.94 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.632 -0.667 . . . . 0.0 110.375 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.07 -33.43 69.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.556 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 8.5 mmmt -73.45 -39.62 64.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.524 -0.986 . . . . 0.0 110.432 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.62 -45.45 81.51 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.105 -0.997 . . . . 0.0 109.641 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.614 ' HB1' HD12 ' A' ' 18' ' ' ILE . . . -72.3 -34.92 68.51 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.736 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.574 ' HZ2' ' HA ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -72.95 -36.45 67.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.445 -0.784 . . . . 0.0 110.702 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.91 -35.23 74.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.451 -0.781 . . . . 0.0 110.315 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.44 ' CE2' HD13 ' A' ' 29' ' ' LEU . 61.1 t80 -71.09 -40.5 71.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 110.243 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.52 HG13 HD13 ' A' ' 91' ' ' ILE . 68.8 t -67.62 -35.06 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.297 -0.877 . . . . 0.0 109.814 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -68.4 -39.07 81.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.515 -0.741 . . . . 0.0 109.733 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.46 ' HB2' ' HE3' ' A' ' 84' ' ' LYS . 1.6 tppp? -64.24 -41.13 97.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.553 -0.717 . . . . 0.0 110.109 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.71 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -69.98 -34.51 73.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.503 -0.748 . . . . 0.0 109.643 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -40.76 95.68 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.682 -0.636 . . . . 0.0 109.646 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -66.5 -38.46 87.3 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.547 -0.72 . . . . 0.0 110.362 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.64 -50.36 21.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.376 -0.827 . . . . 0.0 110.4 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.91 53.49 0.13 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.51 HD12 HD12 ' A' ' 61' ' ' ILE . 12.4 mt -125.74 -51.59 1.59 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.364 -1.08 . . . . 0.0 110.447 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.71 HD12 ' HB3' ' A' ' 85' ' ' ALA . 74.5 mt -86.75 104.85 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.714 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 58.2 m -83.77 171.98 12.65 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.527 -0.733 . . . . 0.0 109.971 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -68.16 -56.91 7.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.469 -0.769 . . . . 0.0 110.357 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -37.35 87.3 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.437 -0.789 . . . . 0.0 110.489 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 1.4 mm-40 -53.67 -42.15 67.6 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.455 -0.778 . . . . 0.0 110.017 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.681 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -63.77 -40.28 96.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.471 -0.768 . . . . 0.0 109.523 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -68.24 -38.77 82.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.694 -0.629 . . . . 0.0 109.395 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -62.89 -40.05 96.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.587 -0.695 . . . . 0.0 109.836 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.549 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 28.1 t90 -71.98 -39.03 69.58 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.4 tp . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.782 -0.574 . . . . 0.0 109.647 179.044 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.7 t -63.12 -41.5 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.723 . . . . 0.0 109.121 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.58 -39.75 95.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.662 -0.649 . . . . 0.0 109.823 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.61 -40.47 96.99 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.537 -0.727 . . . . 0.0 109.765 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.51 -40.77 97.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.502 -0.749 . . . . 0.0 109.667 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.615 HG21 ' CG2' ' A' ' 91' ' ' ILE . 90.6 t -61.62 -42.31 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.583 -0.698 . . . . 0.0 109.227 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.96 95.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.617 -0.677 . . . . 0.0 109.597 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 t -61.31 -38.93 88.61 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.606 -0.684 . . . . 0.0 109.809 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.439 ' HD3' HD23 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -67.12 -36.1 81.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 109.6 179.324 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.547 HG21 ' HB2' ' A' ' 78' ' ' ALA . 21.3 mm -58.22 -41.9 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.465 -0.772 . . . . 0.0 110.39 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.65 -45.88 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.384 -0.822 . . . . 0.0 110.096 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.09 -15.8 79.82 Favored Glycine 0 N--CA 1.501 2.981 0 C-N-CA 120.26 -0.971 . . . . 0.0 111.035 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.652 HD21 ' O ' ' A' ' 28' ' ' GLU . 15.4 tp -99.06 -21.5 16.16 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.118 -1.225 . . . . 0.0 111.285 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.595 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 21.9 t90 -65.7 130.89 44.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 0.0 111.197 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.9 ttt-85 -99.47 -160.97 0.84 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -48.55 -45.98 38.25 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.165 -0.959 . . . . 0.0 110.198 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.93 29.29 0.31 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.47 -0.769 . . . . 0.0 111.249 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.49 157.48 43.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.046 -1.034 . . . . 0.0 110.953 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.493 HG23 ' HB2' ' A' ' 34' ' ' CYS . 12.8 t -153.81 145.53 23.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.497 -0.752 . . . . 0.0 109.651 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.71 ' C ' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -102.22 108.24 19.56 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.385 -0.822 . . . . 0.0 109.794 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 28' ' ' GLU . 6.3 mt -114.05 129.37 56.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.183 -0.948 . . . . 0.0 110.924 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.839 HD12 ' HD1' ' A' ' 99' ' ' TRP . 0.4 OUTLIER 58.73 28.58 17.49 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.505 -0.747 . . . . 0.0 110.899 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.31 21.56 77.52 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.441 ' NE2' HD23 ' A' ' 30' ' ' LEU . 58.6 m-70 -121.18 155.28 34.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.442 -1.034 . . . . 0.0 109.916 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -86.43 116.2 24.43 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.172 -0.955 . . . . 0.0 109.68 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.493 ' HB2' HG23 ' A' ' 27' ' ' THR . 20.1 m -116.16 173.51 6.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.574 -0.703 . . . . 0.0 109.66 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 4.9 tptt -132.87 108.96 9.28 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.525 -0.734 . . . . 0.0 111.065 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.595 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 47.4 t80 -108.82 139.25 43.9 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 p -144.65 152.91 41.15 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.931 -1.105 . . . . 0.0 111.721 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.412 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 88.3 t -133.2 123.17 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -138.21 117.41 9.73 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.185 -0.947 . . . . 0.0 110.664 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 55.2 Cg_endo . . . . . 0 C--N 1.312 -1.377 0 O-C-N 124.018 1.536 . . . . 0.0 110.633 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.321 0.581 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.431 ' CD1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -109.87 131.34 55.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.452 -0.78 . . . . 0.0 109.664 179.317 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -129.42 159.65 35.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.19 -0.944 . . . . 0.0 110.457 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -153.56 142.82 9.51 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.455 ' HG2' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -138.77 149.99 45.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.922 -0.752 . . . . 0.0 109.85 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.0 ptm -145.69 156.44 43.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.966 -1.084 . . . . 0.0 111.433 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.613 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 23.4 p90 -166.42 164.56 17.34 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.885 -0.51 . . . . 0.0 110.301 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.3 m -128.08 98.42 27.03 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.248 -0.908 . . . . 0.0 110.312 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.613 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.6 Cg_endo -75.13 84.65 1.65 Allowed 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.833 1.438 . . . . 0.0 110.577 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 143.22 -43.99 0.99 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -70.19 -59.84 2.64 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.472 -1.016 . . . . 0.0 110.1 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.3 t -150.07 -170.11 3.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.464 -0.773 . . . . 0.0 110.044 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.53 41.06 2.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.509 -0.744 . . . . 0.0 110.302 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.432 HD11 ' HB3' ' A' ' 84' ' ' LYS . 2.7 tt -118.24 153.97 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.51 -0.744 . . . . 0.0 109.666 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.09 171.62 14.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.103 -0.998 . . . . 0.0 111.405 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.557 ' HA3' ' HB2' ' A' ' 81' ' ' PHE . . . -141.2 126.91 3.21 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.455 ' HG2' ' HG2' ' A' ' 52' ' ' ARG . 6.2 mt-10 -135.57 153.01 51.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.459 -1.024 . . . . 0.0 110.441 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.483 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -170.7 164.43 8.12 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.592 -0.693 . . . . 0.0 110.713 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.476 ' HA ' HG23 ' A' ' 73' ' ' VAL . 1.0 OUTLIER -153.05 149.95 28.66 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.459 -0.776 . . . . 0.0 111.03 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.414 HG22 HG23 ' A' ' 73' ' ' VAL . 9.7 t -173.89 156.98 2.91 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 mtm105 -60.5 -24.27 65.19 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.263 -0.898 . . . . 0.0 111.026 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.25 139.45 54.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.237 -0.914 . . . . 0.0 110.545 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.401 ' O ' HG12 ' A' ' 73' ' ' VAL . 70.7 mt-30 -75.82 -53.72 8.03 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.531 -0.731 . . . . 0.0 110.358 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 t -81.07 -30.34 34.77 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.392 -0.818 . . . . 0.0 109.937 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.93 -36.52 88.24 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 66' ' ' SER . 0.5 OUTLIER -63.16 -35.41 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.446 -1.032 . . . . 0.0 110.344 179.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.47 87.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.441 -0.787 . . . . 0.0 110.119 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.06 -30.91 71.95 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.483 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -73.55 -39.96 64.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.55 -0.971 . . . . 0.0 110.235 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 63' ' ' GLY . 99.3 m -64.59 -40.17 95.04 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.279 -0.888 . . . . 0.0 109.117 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.547 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -67.17 -39.27 86.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.623 -0.673 . . . . 0.0 109.657 178.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -59.75 -41.75 91.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.536 -0.727 . . . . 0.0 110.007 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.87 -41.22 95.84 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.462 -0.774 . . . . 0.0 109.653 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.557 ' HB2' ' HA3' ' A' ' 63' ' ' GLY . 43.3 t80 -69.7 -38.39 76.96 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.55 -0.719 . . . . 0.0 109.813 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.0 -37.79 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.417 -0.802 . . . . 0.0 109.93 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.37 -40.02 85.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.303 -0.873 . . . . 0.0 109.67 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HB3' HD11 ' A' ' 61' ' ' ILE . 77.7 mttt -67.71 -40.22 84.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.536 -0.727 . . . . 0.0 109.388 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.45 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -67.78 -36.81 81.14 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.632 -0.667 . . . . 0.0 109.774 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -33.38 74.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.594 -0.691 . . . . 0.0 109.956 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -64.25 -31.23 72.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.384 -0.823 . . . . 0.0 110.653 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.3 -66.83 0.89 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.379 -0.826 . . . . 0.0 110.135 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 151.39 51.6 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 90' ' ' LEU . 6.3 mt -112.0 -38.97 4.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.229 -1.159 . . . . 0.0 110.472 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.615 ' CG2' HG21 ' A' ' 14' ' ' VAL . 80.9 mt -103.82 69.42 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 109.757 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.544 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 72.1 m -73.3 -178.61 3.02 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.516 -0.74 . . . . 0.0 110.353 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.62 -59.68 3.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.199 -0.938 . . . . 0.0 110.651 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -63.25 -39.63 95.15 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.359 -0.838 . . . . 0.0 109.94 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 11.4 mt-10 -61.57 -42.66 99.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.576 -0.703 . . . . 0.0 109.493 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.06 -37.03 81.22 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.619 -0.676 . . . . 0.0 109.714 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -62.2 -44.79 95.8 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -30.96 63.45 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.513 -0.742 . . . . 0.0 109.011 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.839 ' HD1' HD12 ' A' ' 30' ' ' LEU . 30.2 t90 -68.55 -40.4 80.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.705 -0.622 . . . . 0.0 109.958 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.439 HD23 ' HD3' ' A' ' 17' ' ' LYS . 21.2 mt . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.533 -0.729 . . . . 0.0 110.346 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 120.984 0.421 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.05 -42.09 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.525 -0.734 . . . . 0.0 109.459 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.54 ' HB1' ' CG1' ' A' ' 82' ' ' VAL . . . -69.13 -36.9 77.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.514 -0.742 . . . . 0.0 109.485 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.6 89.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.642 -0.661 . . . . 0.0 109.79 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.81 -41.17 95.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.404 -0.81 . . . . 0.0 109.46 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.579 HG13 ' CZ3' ' A' ' 99' ' ' TRP . 25.5 t -62.32 -40.7 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.639 -0.663 . . . . 0.0 109.41 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.542 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -63.87 -39.39 94.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.573 -0.705 . . . . 0.0 109.408 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.8 m -62.5 -39.53 93.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.65 -0.656 . . . . 0.0 109.684 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.448 ' HB3' ' HZ3' ' A' ' 99' ' ' TRP . 0.5 OUTLIER -63.39 -37.78 88.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.506 -0.747 . . . . 0.0 109.773 179.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.501 HD12 ' HB1' ' A' ' 78' ' ' ALA . 2.5 mt -61.84 -37.51 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.556 -0.715 . . . . 0.0 109.984 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.2 t -63.67 -48.58 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.232 -0.917 . . . . 0.0 109.789 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.4 -15.42 81.48 Favored Glycine 0 N--CA 1.5 2.918 0 C-N-CA 120.271 -0.966 . . . . 0.0 110.698 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.66 HD21 ' O ' ' A' ' 28' ' ' GLU . 11.9 tp -99.38 -16.83 18.27 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.232 -1.158 . . . . 0.0 111.203 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.582 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 24.5 t90 -69.44 137.02 52.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.177 -0.952 . . . . 0.0 111.308 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.49 -162.2 0.87 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -45.68 -45.17 13.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.309 -0.869 . . . . 0.0 110.635 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.5 31.83 0.19 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.437 -0.79 . . . . 0.0 111.28 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -153.15 162.76 40.94 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.066 -1.021 . . . . 0.0 110.792 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.611 HG23 ' HB2' ' A' ' 34' ' ' CYS . 11.4 t -157.44 144.28 18.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.395 -0.816 . . . . 0.0 109.996 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.675 ' C ' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -102.56 109.4 21.01 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.517 -0.739 . . . . 0.0 109.621 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.675 HD23 ' C ' ' A' ' 28' ' ' GLU . 7.9 mt -114.04 130.34 56.56 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.221 -0.924 . . . . 0.0 110.797 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.525 HD22 ' CZ2' ' A' ' 58' ' ' TRP . 7.1 tp 56.58 30.33 17.13 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.563 -0.71 . . . . 0.0 110.671 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.82 24.84 73.31 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 59.6 m-70 -124.54 159.89 29.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -1.038 . . . . 0.0 109.723 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -91.46 121.92 33.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 110.545 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.611 ' HB2' HG23 ' A' ' 27' ' ' THR . 23.0 m -122.36 164.14 18.49 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 5.5 tptm -125.58 110.48 13.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.36 -0.838 . . . . 0.0 111.146 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.582 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 12.8 t80 -110.66 138.49 46.98 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.9 p -143.05 157.43 44.54 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.025 -1.047 . . . . 0.0 111.389 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.451 HG12 ' HD3' ' A' ' 40' ' ' PRO . 99.6 t -129.09 130.06 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.63 -0.669 . . . . 0.0 109.872 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 83.67 64.71 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 0.0 110.451 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.451 ' HD3' HG12 ' A' ' 38' ' ' VAL . 55.5 Cg_endo . . . . . 0 C--N 1.31 -1.448 0 O-C-N 123.855 1.45 . . . . 0.0 110.627 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.217 0.532 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.599 ' CD2' ' HA ' ' A' ' 70' ' ' GLN . 2.1 m-85 -105.72 131.7 52.76 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.555 -0.715 . . . . 0.0 110.42 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.93 156.57 37.79 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.399 -0.813 . . . . 0.0 109.597 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -159.46 141.16 7.32 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.569 -1.301 . . . . 0.0 110.671 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HG3' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -141.03 146.96 37.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.88 -0.776 . . . . 0.0 109.756 179.5 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.579 ' HG2' HG22 ' A' ' 77' ' ' THR . 5.1 ptm -139.05 155.92 47.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 111.327 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.474 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 45.6 p90 -155.91 145.75 21.26 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.916 -0.49 . . . . 0.0 109.797 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 87.3 m -111.98 89.42 11.6 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.236 -0.915 . . . . 0.0 111.066 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -77.74 82.85 2.3 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 123.703 1.37 . . . . 0.0 110.149 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.34 -45.14 0.61 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.525 ' CZ2' HD22 ' A' ' 30' ' ' LEU . 11.2 t90 -75.0 -63.28 1.3 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.533 -0.98 . . . . 0.0 110.096 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.2 t -142.41 -162.92 1.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.5 -0.75 . . . . 0.0 109.52 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.7 44.95 2.5 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.296 -0.878 . . . . 0.0 110.395 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.505 HG23 ' HD3' ' A' ' 84' ' ' LYS . 74.0 mt -123.14 140.71 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.361 -0.837 . . . . 0.0 110.234 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.57 170.88 10.49 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.414 -0.804 . . . . 0.0 110.514 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.02 136.21 4.69 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.405 ' HB2' ' HG3' ' A' ' 52' ' ' ARG . 13.1 tt0 -139.6 161.19 38.12 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.809 -0.818 . . . . 0.0 110.357 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.469 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -165.89 151.01 8.59 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.768 -0.582 . . . . 0.0 110.229 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.406 ' HA ' HG23 ' A' ' 73' ' ' VAL . 0.7 OUTLIER -141.71 142.07 33.31 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.426 -0.796 . . . . 0.0 110.601 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.6 t -168.03 172.65 8.66 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.404 -0.81 . . . . 0.0 110.224 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -71.18 -24.8 62.3 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.371 -0.831 . . . . 0.0 110.904 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.74 139.73 56.69 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.277 -0.889 . . . . 0.0 110.743 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.599 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 5.8 tt0 -76.27 -53.78 7.73 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.724 -0.61 . . . . 0.0 110.349 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -84.26 -30.29 25.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.43 -0.794 . . . . 0.0 110.02 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.68 -39.4 93.44 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 70' ' ' GLN . 3.3 p -61.56 -37.39 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.371 -1.076 . . . . 0.0 110.5 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.92 82.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.526 -0.734 . . . . 0.0 110.036 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.97 -36.91 91.7 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.469 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 8.1 mttp -66.61 -39.94 88.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.519 -0.989 . . . . 0.0 110.267 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.579 HG22 ' HG2' ' A' ' 53' ' ' MET . 53.4 m -63.49 -42.16 98.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.269 -0.895 . . . . 0.0 109.02 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.542 ' HB1' ' HA ' ' A' ' 15' ' ' ALA . . . -70.2 -38.59 75.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.579 -0.7 . . . . 0.0 109.541 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.567 ' O ' HG12 ' A' ' 82' ' ' VAL . 7.3 ttmt -62.82 -39.69 95.1 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.613 -0.679 . . . . 0.0 110.157 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -68.54 -38.56 80.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 0.0 109.738 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -70.81 -38.42 73.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 109.422 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -68.77 -34.29 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.391 -0.818 . . . . 0.0 109.748 179.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -42.14 89.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.292 -0.88 . . . . 0.0 109.211 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.505 ' HD3' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -67.2 -39.06 86.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.565 -0.709 . . . . 0.0 109.195 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.85 -34.86 77.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.706 -0.621 . . . . 0.0 109.669 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.53 -39.57 91.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.673 -0.642 . . . . 0.0 109.316 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -64.83 -40.18 94.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.633 -0.667 . . . . 0.0 110.448 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -75.51 -54.09 7.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.419 -0.801 . . . . 0.0 110.297 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.01 53.98 0.08 OUTLIER Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.521 ' HA ' HD23 ' A' ' 90' ' ' LEU . 7.6 mt -118.83 -48.83 2.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.307 -1.113 . . . . 0.0 110.171 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 35.1 mm -88.9 75.77 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.365 -0.834 . . . . 0.0 109.706 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.628 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 19.6 t -73.9 175.91 6.89 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.431 -0.793 . . . . 0.0 110.287 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -67.2 -58.75 4.27 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.292 -0.88 . . . . 0.0 110.834 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -65.57 -39.76 92.03 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.415 -0.803 . . . . 0.0 110.08 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 0.7 OUTLIER -64.09 -39.6 94.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.635 -0.665 . . . . 0.0 109.69 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.44 80.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.503 -0.748 . . . . 0.0 109.328 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -63.25 -46.04 88.76 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -36.09 73.43 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.579 ' CZ3' HG13 ' A' ' 14' ' ' VAL . 50.7 t90 -62.76 -41.75 99.36 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.1 mt . . . . . 0 N--CA 1.495 1.818 0 O-C-N 121.56 -0.712 . . . . 0.0 109.733 179.409 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.165 0.507 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.5 114.48 9.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.464 -0.773 . . . . 0.0 110.122 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.443 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 45.4 p90 -132.6 142.97 49.38 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.433 -0.792 . . . . 0.0 110.495 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 3' ' ' TYR . 97.5 t 62.61 -71.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 O-C-N 122.044 -0.41 . . . . 0.0 110.895 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 3' ' ' TYR . 1.0 OUTLIER -86.48 62.8 7.63 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.106 -0.996 . . . . 0.0 110.27 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.05 -42.76 98.04 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -62.37 -36.33 81.91 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.585 -0.95 . . . . 0.0 110.717 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -67.38 -38.58 84.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.301 -0.875 . . . . 0.0 109.396 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.64 -39.86 91.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.539 -0.725 . . . . 0.0 109.517 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 14' ' ' VAL . 46.9 t -63.53 -39.76 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.609 -0.682 . . . . 0.0 109.486 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.471 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -63.88 -39.84 95.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.528 -0.732 . . . . 0.0 109.642 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.593 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . . . -63.5 -41.12 98.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.635 -0.666 . . . . 0.0 109.745 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.58 94.54 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.548 -0.72 . . . . 0.0 109.696 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 10' ' ' VAL . 79.2 t -64.38 -39.79 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.544 -0.723 . . . . 0.0 109.536 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.473 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -64.43 -39.62 94.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.397 -0.814 . . . . 0.0 109.749 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.39 -39.51 93.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.432 -0.793 . . . . 0.0 109.651 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.768 ' HD2' HD23 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -65.82 -31.24 72.09 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.543 -0.723 . . . . 0.0 110.068 179.297 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.546 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.2 mm -63.87 -43.42 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.431 -0.793 . . . . 0.0 109.651 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.689 HG22 ' HB1' ' A' ' 74' ' ' ALA . 54.6 t -68.02 -40.47 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.458 -0.776 . . . . 0.0 110.029 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.88 -25.26 75.4 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.22 36.33 4.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.321 -1.105 . . . . 0.0 110.939 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 23.8 t90 -102.95 137.76 40.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.18 -0.95 . . . . 0.0 110.984 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -168.57 1.67 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -46.34 -44.55 16.92 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.199 -0.938 . . . . 0.0 110.31 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.401 ' HB2' ' CG2' ' A' ' 37' ' ' THR . 12.9 pt-20 -158.64 36.48 0.23 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.537 -0.727 . . . . 0.0 110.619 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.29 151.13 31.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.198 -0.939 . . . . 0.0 110.584 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 t -152.69 175.48 12.78 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.473 -0.767 . . . . 0.0 109.625 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.95 126.4 31.97 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.334 -0.854 . . . . 0.0 110.379 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.546 ' HG ' HD11 ' A' ' 18' ' ' ILE . 2.8 mt -111.62 124.4 52.24 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.359 -0.838 . . . . 0.0 110.206 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.466 HD12 ' HB2' ' A' ' 99' ' ' TRP . 2.5 tp 56.71 29.81 16.48 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.647 -0.658 . . . . 0.0 111.175 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.03 -6.84 82.96 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -91.09 158.79 16.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.977 -1.308 . . . . 0.0 110.222 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -84.17 138.32 33.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.423 -0.798 . . . . 0.0 110.12 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.535 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 91.5 m -142.11 167.52 21.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.364 -0.835 . . . . 0.0 110.455 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -122.89 113.38 19.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.485 -0.76 . . . . 0.0 110.718 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 1.6 t80 -114.67 130.14 56.77 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -140.67 162.38 35.53 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.947 -1.096 . . . . 0.0 111.733 -178.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.26 152.68 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.86 -0.525 . . . . 0.0 109.875 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -157.17 102.42 1.9 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.11 -0.994 . . . . 0.0 110.388 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -78.08 151.04 26.82 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.898 1.473 . . . . 0.0 111.101 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -126.17 -173.31 2.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.61 -0.681 . . . . 0.0 109.634 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.419 ' CD1' HG22 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -139.72 144.72 37.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.636 -0.665 . . . . 0.0 111.099 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -115.21 173.6 6.42 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 -45.35 -33.21 2.38 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.685 -0.634 . . . . 0.0 111.289 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -155.34 41.53 0.43 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.535 -0.728 . . . . 0.0 110.314 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -158.65 170.34 22.39 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.204 -0.935 . . . . 0.0 110.998 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.419 HG22 ' CD1' ' A' ' 42' ' ' LEU . 80.3 t -133.21 124.31 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -114.12 147.78 38.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.202 -0.936 . . . . 0.0 111.07 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.499 ' O ' HG21 ' A' ' 73' ' ' VAL . 0.3 OUTLIER -111.58 117.4 32.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.597 -0.689 . . . . 0.0 109.887 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.11 162.81 14.53 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.605 -0.684 . . . . 0.0 109.776 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.55 157.32 29.66 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.847 -1.168 . . . . 0.0 110.287 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.487 ' CD ' ' HB3' ' A' ' 64' ' ' GLU . 0.6 OUTLIER -153.91 141.26 19.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.698 -0.884 . . . . 0.0 109.854 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.575 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 2.8 ppp? -142.74 148.77 37.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.34 -0.85 . . . . 0.0 110.903 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.51 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 47.3 p90 -155.28 171.1 20.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.836 -0.54 . . . . 0.0 109.871 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 61.7 m -121.59 91.12 48.39 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 0.0 110.808 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.535 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 46.9 Cg_endo -76.9 83.93 2.02 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.939 1.494 . . . . 0.0 109.9 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.26 -47.23 0.49 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -73.29 -53.83 9.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.533 -0.98 . . . . 0.0 110.096 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.9 t -152.67 -160.9 1.2 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.531 -0.731 . . . . 0.0 109.963 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.7 68.95 0.97 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.285 -0.884 . . . . 0.0 110.345 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.446 HD12 HD12 ' A' ' 90' ' ' LEU . 41.1 mt -138.88 155.83 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.386 -0.822 . . . . 0.0 110.072 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.66 166.0 25.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.464 -0.772 . . . . 0.0 110.891 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.433 ' HA3' ' N ' ' A' ' 81' ' ' PHE . . . -159.53 128.77 2.07 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.487 ' HB3' ' CD ' ' A' ' 52' ' ' ARG . 1.4 pt-20 -137.66 165.33 26.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.596 -0.943 . . . . 0.0 110.897 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.564 ' HB1' ' CG ' ' A' ' 76' ' ' LYS . . . -158.53 161.08 37.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.716 -0.615 . . . . 0.0 110.632 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.5 m -143.4 151.63 40.62 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.465 -0.772 . . . . 0.0 110.282 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.0 t -174.6 -177.31 1.16 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.65 -0.657 . . . . 0.0 110.148 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -82.77 -31.77 28.13 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.258 -0.902 . . . . 0.0 110.125 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.91 146.92 53.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.352 -0.843 . . . . 0.0 110.353 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.493 ' O ' HG12 ' A' ' 73' ' ' VAL . 34.4 mt-30 -83.49 -54.78 4.71 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.516 -0.74 . . . . 0.0 110.316 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 m -75.26 -30.83 60.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.453 -0.78 . . . . 0.0 110.237 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.86 -39.7 94.25 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 49' ' ' TYR . 0.8 OUTLIER -63.32 -34.03 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.273 -1.134 . . . . 0.0 110.471 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.689 ' HB1' HG22 ' A' ' 19' ' ' VAL . . . -64.78 -47.4 78.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.518 -0.739 . . . . 0.0 109.869 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.79 -32.32 77.62 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.564 ' CG ' ' HB1' ' A' ' 65' ' ' ALA . 11.5 tptp -69.55 -40.9 76.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.599 -0.942 . . . . 0.0 110.224 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.535 HG22 ' HG2' ' A' ' 53' ' ' MET . 5.7 m -64.99 -41.04 95.76 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.471 -0.768 . . . . 0.0 109.919 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.525 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -70.37 -34.56 72.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.405 -0.809 . . . . 0.0 110.114 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.593 ' HE3' ' HA ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -67.36 -39.69 85.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 110.239 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.471 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 0.7 OUTLIER -67.09 -38.47 85.76 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.453 -0.78 . . . . 0.0 109.935 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.433 ' N ' ' HA3' ' A' ' 63' ' ' GLY . 39.6 t80 -67.18 -40.48 86.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.482 -0.761 . . . . 0.0 109.445 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.48 ' HA ' ' CD1' ' A' ' 91' ' ' ILE . 55.8 t -67.14 -36.83 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.44 -0.787 . . . . 0.0 109.829 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.471 ' NH1' ' HA ' ' A' ' 80' ' ' ASP . 4.1 ttp180 -65.26 -39.2 92.34 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.369 -0.832 . . . . 0.0 110.142 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -67.49 -39.91 85.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.276 -0.89 . . . . 0.0 110.04 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.819 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -73.59 -29.53 62.45 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.43 -0.794 . . . . 0.0 110.139 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 1.8 t80 -74.1 -37.69 64.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.488 -0.758 . . . . 0.0 110.295 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -37.08 84.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.362 -0.836 . . . . 0.0 110.234 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -73.96 -53.92 9.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.279 -0.888 . . . . 0.0 110.054 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.87 53.27 0.07 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' A' ' 90' ' ' LEU . 11.0 mt -122.31 -56.92 1.79 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.364 -1.08 . . . . 0.0 110.346 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.819 HD12 ' HB3' ' A' ' 85' ' ' ALA . 82.4 mt -77.72 109.6 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.33 -0.856 . . . . 0.0 109.911 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.6 m -93.8 167.19 11.8 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.357 -0.839 . . . . 0.0 110.286 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -48.5 70.39 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.492 -0.755 . . . . 0.0 110.424 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -63.56 -42.59 98.34 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.537 -0.727 . . . . 0.0 110.728 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.08 -43.59 98.5 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.416 -0.802 . . . . 0.0 110.245 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.32 87.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.584 -0.697 . . . . 0.0 109.94 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -67.34 -38.3 84.66 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.61 -0.682 . . . . 0.0 110.313 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.99 -38.78 86.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.343 -0.848 . . . . 0.0 109.652 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.578 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 15.4 t90 -66.06 -40.94 91.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.548 -0.72 . . . . 0.0 109.861 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.768 HD23 ' HD2' ' A' ' 17' ' ' LYS . 16.4 mt -66.81 -32.93 74.53 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.603 -0.686 . . . . 0.0 110.148 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 74.5 m -66.26 -55.51 15.78 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.538 -0.726 . . . . 0.0 110.107 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.7 p . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.425 179.738 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 121.137 0.494 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.14 171.06 15.06 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.507 -0.746 . . . . 0.0 110.372 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.93 -62.57 1.32 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.311 -0.868 . . . . 0.0 110.226 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.62 18.36 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.395 -0.815 . . . . 0.0 110.753 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -96.58 85.92 3.99 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.217 -0.927 . . . . 0.0 109.973 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.05 50.82 0.04 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -59.24 -35.74 74.21 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.643 -0.916 . . . . 0.0 110.17 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.497 ' HG3' ' HE2' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -65.6 -36.25 83.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.48 -0.762 . . . . 0.0 109.807 179.272 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.01 -42.7 89.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.433 -0.792 . . . . 0.0 109.445 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 14' ' ' VAL . 99.1 t -66.1 -40.83 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.05 -40.01 95.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.695 -0.628 . . . . 0.0 109.383 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.463 ' HA ' ' HG3' ' A' ' 79' ' ' LYS . . . -62.44 -41.32 98.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.71 -0.619 . . . . 0.0 109.486 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.93 97.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.617 -0.677 . . . . 0.0 109.55 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 10' ' ' VAL . 84.9 t -64.59 -41.37 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.541 -0.724 . . . . 0.0 109.237 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.18 -38.37 87.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.665 -0.647 . . . . 0.0 109.548 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.8 m -63.85 -39.03 93.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.575 -0.703 . . . . 0.0 109.698 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.46 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 17.4 tttm -66.01 -34.63 78.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.458 -0.776 . . . . 0.0 109.843 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.884 HD12 ' HB1' ' A' ' 78' ' ' ALA . 10.1 mt -65.07 -46.8 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.5 -0.75 . . . . 0.0 109.288 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.8 t -62.72 -40.18 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.656 -0.652 . . . . 0.0 109.965 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.49 -27.85 73.55 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.6 tp -115.75 38.47 3.29 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.405 -1.056 . . . . 0.0 110.725 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -101.81 137.68 39.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.241 -0.912 . . . . 0.0 110.458 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.98 -166.92 1.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.461 -0.774 . . . . 0.0 109.215 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -49.31 -41.53 38.68 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.185 -0.947 . . . . 0.0 110.442 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.7 33.81 0.19 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.615 -0.678 . . . . 0.0 110.609 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.23 153.57 37.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.199 -0.938 . . . . 0.0 110.849 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.5 t -155.56 151.78 28.0 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.392 -0.818 . . . . 0.0 109.876 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -105.61 121.27 43.63 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.179 -0.95 . . . . 0.0 110.782 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.608 HD21 HD11 ' A' ' 18' ' ' ILE . 1.3 mt -114.29 126.83 55.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.564 -0.71 . . . . 0.0 110.053 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.544 HD11 ' HG2' ' A' ' 95' ' ' GLU . 1.7 tp 54.17 33.7 18.54 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.649 -0.657 . . . . 0.0 111.016 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.09 23.94 74.88 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.405 ' CD2' ' HB3' ' A' ' 30' ' ' LEU . 39.7 m-70 -123.14 145.01 48.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -1.093 . . . . 0.0 109.942 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 123.7 24.57 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.422 -0.799 . . . . 0.0 110.404 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.517 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 83.5 m -128.43 161.94 28.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.658 -0.651 . . . . 0.0 109.25 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.57 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -116.32 117.51 30.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.358 -0.839 . . . . 0.0 110.916 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.456 ' HE2' ' HB2' ' A' ' 78' ' ' ALA . 7.0 t80 -118.75 125.19 49.09 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.75 154.58 51.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.12 -0.988 . . . . 0.0 111.496 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.5 t -137.18 142.69 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.701 -0.625 . . . . 0.0 109.872 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.81 123.95 2.48 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.243 -0.911 . . . . 0.0 110.592 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HB3' ' CD2' ' A' ' 49' ' ' TYR . 51.2 Cg_endo -78.56 158.55 28.75 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 O-C-N 123.903 1.475 . . . . 0.0 110.954 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -133.3 -168.39 2.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.629 -0.67 . . . . 0.0 109.765 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -125.51 146.62 49.57 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.537 0.684 . . . . 0.0 110.803 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.407 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -118.64 174.07 6.48 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -41.28 -33.93 0.44 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.894 -0.504 . . . . 0.0 111.511 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -162.3 42.37 0.13 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.46 -0.775 . . . . 0.0 110.48 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -165.11 154.17 12.49 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.113 -0.992 . . . . 0.0 111.224 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.5 t -99.35 122.07 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.493 -0.754 . . . . 0.0 109.03 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -110.26 162.65 14.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.215 -0.928 . . . . 0.0 111.139 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.486 ' CZ ' ' HG2' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -122.39 128.93 51.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 110.152 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -132.28 151.73 51.7 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.53 -0.732 . . . . 0.0 110.088 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.22 154.86 26.13 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.44 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.425 ' HD3' ' HB2' ' A' ' 64' ' ' GLU . 8.0 ttp180 -146.19 143.67 29.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.718 -0.872 . . . . 0.0 110.059 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.885 ' HG2' HG22 ' A' ' 77' ' ' THR . 0.4 OUTLIER -143.48 157.72 44.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.366 -0.834 . . . . 0.0 111.133 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.57 ' CE2' ' HB3' ' A' ' 35' ' ' LYS . 42.9 p90 -161.43 -175.47 4.81 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.726 -0.609 . . . . 0.0 109.773 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 58' ' ' TRP . 69.6 m -133.19 95.91 18.02 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.102 -0.999 . . . . 0.0 110.644 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.564 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.3 Cg_endo -74.32 77.97 2.75 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.991 1.522 . . . . 0.0 110.333 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.26 -45.52 0.66 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.522 ' HB3' ' HB3' ' A' ' 55' ' ' CYS . 15.3 t90 -68.65 -53.32 23.13 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.475 -1.015 . . . . 0.0 110.267 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.1 t -153.64 -168.56 3.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.553 -0.717 . . . . 0.0 109.754 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.22 45.96 1.89 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.322 -0.861 . . . . 0.0 110.447 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.3 mt -121.15 150.8 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.373 -0.829 . . . . 0.0 109.851 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 ptt-85 -131.15 163.16 28.29 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.284 -0.885 . . . . 0.0 110.834 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.85 155.55 23.26 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.425 ' HB2' ' HD3' ' A' ' 52' ' ' ARG . 6.7 tt0 -158.39 154.31 26.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -1.112 . . . . 0.0 110.508 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.664 ' HB1' ' HG2' ' A' ' 76' ' ' LYS . . . -166.19 152.97 9.43 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.52 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.422 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 3.6 m -139.08 150.77 46.12 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 110.594 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.502 HG22 HG23 ' A' ' 73' ' ' VAL . 10.0 t -172.71 164.63 5.34 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.705 -0.622 . . . . 0.0 109.994 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -63.29 -31.75 72.98 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.506 -0.746 . . . . 0.0 110.16 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.05 136.64 56.28 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.511 -0.743 . . . . 0.0 110.63 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.501 ' O ' HG12 ' A' ' 73' ' ' VAL . 12.1 mt-30 -77.17 -56.35 4.65 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.581 -0.699 . . . . 0.0 110.362 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 t -76.67 -31.44 57.29 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.312 -0.868 . . . . 0.0 110.037 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.91 -38.36 93.99 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.502 HG23 HG22 ' A' ' 67' ' ' THR . 0.8 OUTLIER -58.19 -35.76 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.456 -1.026 . . . . 0.0 110.577 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.16 84.29 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.561 -0.712 . . . . 0.0 109.809 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -64.4 -36.37 93.11 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.664 ' HG2' ' HB1' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -70.8 -39.02 73.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.384 -1.068 . . . . 0.0 110.274 179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.885 HG22 ' HG2' ' A' ' 53' ' ' MET . 18.7 m -66.52 -37.8 85.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.336 -0.852 . . . . 0.0 110.026 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.884 ' HB1' HD12 ' A' ' 18' ' ' ILE . . . -78.47 -35.49 46.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.525 -0.735 . . . . 0.0 110.232 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.497 ' HE2' ' HG3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -71.88 -38.7 69.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.386 -0.821 . . . . 0.0 109.651 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.6 -36.5 83.91 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.522 -0.737 . . . . 0.0 109.512 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -67.96 -39.89 83.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.711 . . . . 0.0 109.671 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 78' ' ' ALA . 72.5 t -66.41 -37.76 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.542 -0.724 . . . . 0.0 109.718 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -38.62 91.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.419 -0.8 . . . . 0.0 109.669 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -38.43 72.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.535 -0.728 . . . . 0.0 109.315 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.405 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -67.53 -34.92 78.07 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.539 -0.725 . . . . 0.0 109.799 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.08 -38.39 82.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 109.542 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -66.87 -39.3 87.49 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.496 -0.753 . . . . 0.0 110.342 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -72.96 -54.48 8.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.404 -0.81 . . . . 0.0 110.256 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.54 54.33 0.08 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.498 ' HA ' HD23 ' A' ' 90' ' ' LEU . 8.4 mt -121.17 -49.08 2.19 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -1.091 . . . . 0.0 110.494 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.405 HD12 ' HB3' ' A' ' 85' ' ' ALA . 95.8 mt -94.23 112.14 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.379 -0.826 . . . . 0.0 110.199 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 4.0 m -83.14 179.5 7.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.435 -0.79 . . . . 0.0 110.411 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -75.41 -60.23 2.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.337 -0.852 . . . . 0.0 110.245 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -63.08 -38.2 90.23 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.423 -0.798 . . . . 0.0 110.153 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 17.7 tt0 -55.09 -44.89 75.28 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.749 -0.594 . . . . 0.0 110.2 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.78 94.02 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.492 -0.755 . . . . 0.0 109.786 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.533 ' HA ' HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -65.41 -38.43 89.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.562 -0.711 . . . . 0.0 109.956 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -64.89 -40.89 95.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.803 . . . . 0.0 109.599 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.46 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 15.0 t90 -68.53 -39.27 81.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.448 -0.783 . . . . 0.0 109.155 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.533 HD12 ' HA ' ' A' ' 97' ' ' ASN . 24.9 mt -55.05 -40.78 70.64 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.1 m -72.45 -43.74 63.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.549 -0.719 . . . . 0.0 109.807 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.219 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 120.935 0.398 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.97 75.3 0.28 Allowed 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.332 0.587 . . . . 0.0 110.739 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -147.75 156.31 42.61 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.28 -0.887 . . . . 0.0 110.519 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' A' ' 9' ' ' ALA . 10.6 p -131.84 32.28 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.458 -0.776 . . . . 0.0 110.579 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 58.65 -173.28 0.1 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.521 -0.737 . . . . 0.0 111.359 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -108.71 -63.62 0.55 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -58.96 -46.59 87.66 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.614 -0.933 . . . . 0.0 110.01 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.09 -39.36 85.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.774 -0.579 . . . . 0.0 109.949 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -62.63 -41.25 98.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.586 -0.696 . . . . 0.0 109.722 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.3 t -66.19 -39.45 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.445 -0.784 . . . . 0.0 109.11 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.695 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -66.46 -38.72 87.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.673 -0.642 . . . . 0.0 109.487 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.2 95.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.652 -0.655 . . . . 0.0 109.841 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.43 -41.57 98.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.459 -0.776 . . . . 0.0 109.648 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 10' ' ' VAL . 62.2 t -64.94 -39.2 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.448 -0.783 . . . . 0.0 109.241 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.38 -37.03 86.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.587 -0.696 . . . . 0.0 109.853 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -66.97 -39.28 87.19 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.476 -0.765 . . . . 0.0 109.58 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.553 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 16.6 tptt -66.44 -31.1 71.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.444 -0.785 . . . . 0.0 109.724 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.585 HG21 ' HB2' ' A' ' 78' ' ' ALA . 11.2 mm -62.56 -50.4 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.412 -0.805 . . . . 0.0 109.1 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.82 -37.75 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.722 . . . . 0.0 109.878 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.58 -27.72 73.64 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.41 36.41 4.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.262 -1.14 . . . . 0.0 110.805 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.476 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 23.6 t90 -102.75 135.36 44.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.133 -0.98 . . . . 0.0 110.943 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.12 -164.02 1.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -48.86 -45.91 41.54 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.075 -1.016 . . . . 0.0 109.891 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -156.77 34.14 0.3 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.712 -0.617 . . . . 0.0 110.45 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.83 150.07 41.16 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.1 -1.0 . . . . 0.0 111.154 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.542 HG23 ' CB ' ' A' ' 34' ' ' CYS . 2.1 t -151.7 165.66 33.71 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -128.95 115.36 17.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.094 -1.004 . . . . 0.0 110.411 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.509 HD12 ' SG ' ' A' ' 34' ' ' CYS . 3.7 mt -100.94 119.79 39.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.463 -0.773 . . . . 0.0 110.166 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' A' ' 99' ' ' TRP . 3.7 tp 56.67 30.45 17.52 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.743 -0.598 . . . . 0.0 111.127 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.63 -11.85 67.18 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 87.8 m-70 -83.98 146.77 27.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.128 -1.219 . . . . 0.0 110.121 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -73.79 133.0 43.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.463 -0.773 . . . . 0.0 110.02 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.542 ' CB ' HG23 ' A' ' 27' ' ' THR . 15.2 m -136.08 171.28 14.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.553 -0.717 . . . . 0.0 110.042 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.524 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -132.9 120.42 21.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.475 -0.765 . . . . 0.0 110.339 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.453 ' HB2' HG21 ' A' ' 27' ' ' THR . 40.6 t80 -122.92 135.48 54.51 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.8 p -141.78 150.99 42.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.004 -1.06 . . . . 0.0 111.598 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.1 t -137.5 130.22 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -152.71 123.94 3.66 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.079 -1.013 . . . . 0.0 110.794 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.407 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 52.8 Cg_endo -77.08 151.29 30.4 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.871 1.459 . . . . 0.0 110.997 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 50' ' ' LYS . 20.7 m-85 -121.32 -170.35 2.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.643 -0.661 . . . . 0.0 109.499 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.46 ' CD1' HG22 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -131.19 143.37 50.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.48 -0.763 . . . . 0.0 111.135 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.45 ' HD2' ' CE2' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -116.79 177.65 4.63 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -39.59 -41.76 1.08 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.849 -0.532 . . . . 0.0 111.4 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.64 37.8 0.37 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.403 -0.811 . . . . 0.0 110.737 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -160.29 141.97 12.59 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.161 -0.962 . . . . 0.0 110.979 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.46 HG22 ' CD1' ' A' ' 42' ' ' LEU . 80.0 t -97.33 125.2 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.397 -0.815 . . . . 0.0 109.472 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.45 ' CE2' ' HD2' ' A' ' 43' ' ' LYS . 44.7 m-85 -109.61 158.38 18.1 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.407 -0.808 . . . . 0.0 110.768 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.407 ' CD1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -114.71 133.07 56.17 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.442 -0.786 . . . . 0.0 109.918 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.557 ' HB3' ' CE2' ' A' ' 41' ' ' TYR . 49.1 tttt -142.27 148.63 38.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.494 -0.754 . . . . 0.0 110.366 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -143.53 153.61 24.98 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -145.25 150.53 36.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.764 -0.845 . . . . 0.0 110.112 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.442 ' HB3' ' CD2' ' A' ' 36' ' ' PHE . 22.4 ptm -144.19 153.45 42.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.244 -0.91 . . . . 0.0 110.977 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.524 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 41.6 p90 -152.83 146.4 25.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.782 -0.574 . . . . 0.0 110.288 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 67.2 m -116.29 90.53 29.78 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.231 -0.918 . . . . 0.0 111.1 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -79.22 82.02 2.63 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.87 1.458 . . . . 0.0 110.266 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.89 -46.81 0.48 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 13.9 t90 -70.49 -53.5 16.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.623 -0.928 . . . . 0.0 109.912 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.45 HG21 ' CD1' ' A' ' 90' ' ' LEU . 7.4 t -158.82 -160.7 0.89 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.748 -0.595 . . . . 0.0 109.888 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.19 46.5 1.78 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.342 -0.849 . . . . 0.0 109.931 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.429 HD12 HD12 ' A' ' 90' ' ' LEU . 59.7 mt -122.45 144.68 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.512 -0.742 . . . . 0.0 109.882 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.49 170.96 13.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.304 -0.872 . . . . 0.0 110.92 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.11 156.55 26.99 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.511 ' HG2' ' N ' ' A' ' 65' ' ' ALA . 14.4 tt0 -163.17 154.66 17.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.516 -0.99 . . . . 0.0 109.996 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.561 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -168.56 155.0 7.12 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.031 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.569 ' HA ' HG23 ' A' ' 73' ' ' VAL . 7.0 m -137.02 153.29 50.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.614 -0.679 . . . . 0.0 110.382 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -175.16 159.18 2.53 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.592 -0.693 . . . . 0.0 110.49 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -36.36 71.31 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.661 -0.649 . . . . 0.0 111.332 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.59 142.95 57.91 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.326 -0.859 . . . . 0.0 110.904 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.439 ' O ' HG12 ' A' ' 73' ' ' VAL . 0.9 OUTLIER -77.82 -49.03 15.12 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.618 -0.676 . . . . 0.0 109.986 179.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.9 m -82.41 -29.38 30.82 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.479 -0.763 . . . . 0.0 109.744 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.02 -38.71 94.66 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' A' ' 66' ' ' SER . 0.8 OUTLIER -60.59 -36.65 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.395 -1.062 . . . . 0.0 110.307 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.61 -38.59 77.33 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.55 -0.719 . . . . 0.0 109.739 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.72 -32.52 78.28 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.561 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 42.6 mtpt -72.75 -40.12 66.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.473 -1.016 . . . . 0.0 110.065 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.1 m -66.44 -38.41 87.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -0.975 . . . . 0.0 109.657 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.585 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -75.08 -37.69 61.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.6 -0.687 . . . . 0.0 110.333 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.6 -39.19 73.95 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.357 -0.84 . . . . 0.0 109.715 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -65.75 -36.25 83.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.681 -0.637 . . . . 0.0 109.715 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -68.84 -40.19 79.54 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 0.0 109.266 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.695 HG11 ' HA ' ' A' ' 11' ' ' ALA . 54.6 t -65.71 -38.9 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.549 -0.719 . . . . 0.0 109.968 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -64.78 -40.29 95.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.509 -0.744 . . . . 0.0 109.949 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -67.63 -39.37 84.66 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.416 -0.803 . . . . 0.0 109.619 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.565 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -70.52 -35.64 73.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.596 -0.69 . . . . 0.0 109.659 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -40.68 95.8 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.606 -0.684 . . . . 0.0 109.706 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.41 -35.9 78.32 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.562 -0.711 . . . . 0.0 110.456 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -74.56 -52.49 11.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.304 -0.873 . . . . 0.0 110.203 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.94 52.49 0.11 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 90' ' ' LEU . 11.8 mt -122.98 -49.93 1.95 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.394 -1.062 . . . . 0.0 110.293 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.565 HD12 ' HB3' ' A' ' 85' ' ' ALA . 89.5 mt -86.24 81.24 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.345 -0.847 . . . . 0.0 109.505 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -64.71 153.67 38.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 109.181 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.433 ' NE2' HG21 ' A' ' 10' ' ' VAL . 1.8 mt-30 -56.47 -47.81 78.43 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.529 -0.732 . . . . 0.0 110.281 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.43 -41.11 76.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.46 -0.775 . . . . 0.0 110.476 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.8 OUTLIER -63.03 -40.57 98.14 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.492 -0.755 . . . . 0.0 110.101 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.33 -43.29 92.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.591 -0.693 . . . . 0.0 109.872 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -65.42 -39.11 91.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.544 -0.723 . . . . 0.0 109.452 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -42.36 95.05 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.715 -0.616 . . . . 0.0 109.738 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.553 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 24.1 t90 -67.51 -39.48 85.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.503 -0.748 . . . . 0.0 109.444 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.2 mt -58.65 -35.99 73.41 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.714 -0.616 . . . . 0.0 109.804 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.5 m -62.44 -38.34 89.36 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.629 -0.669 . . . . 0.0 110.376 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.6 p . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 117.8 -1.095 . . . . 0.0 110.321 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.831 0.348 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.24 119.07 17.94 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.375 -0.828 . . . . 0.0 110.307 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -159.25 -53.72 0.06 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.399 -0.813 . . . . 0.0 110.468 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.1 p -75.02 142.44 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.453 -0.78 . . . . 0.0 110.468 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -137.18 146.92 45.5 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.47 -0.769 . . . . 0.0 110.396 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 10' ' ' VAL . . . 162.09 -73.01 0.2 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -59.69 -46.43 89.08 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.598 -0.942 . . . . 0.0 110.583 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -61.21 -42.96 99.5 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.491 -0.756 . . . . 0.0 109.615 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.12 -40.17 88.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.651 -0.655 . . . . 0.0 110.226 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.644 HG21 ' HG2' ' A' ' 93' ' ' GLN . 85.9 t -66.04 -39.63 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.466 -0.771 . . . . 0.0 109.517 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.569 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -64.69 -39.29 93.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.467 -0.771 . . . . 0.0 109.904 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.68 -38.84 87.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.61 -0.681 . . . . 0.0 109.739 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.01 96.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.586 -0.697 . . . . 0.0 109.783 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 10' ' ' VAL . 77.7 t -62.69 -41.68 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.426 -0.796 . . . . 0.0 109.043 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.57 -39.45 93.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.498 -0.752 . . . . 0.0 109.612 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 54.4 m -61.7 -41.31 97.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.557 -0.715 . . . . 0.0 109.658 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.613 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 6.4 tptm -67.37 -31.21 71.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.428 -0.795 . . . . 0.0 109.765 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.638 HG21 ' HB2' ' A' ' 78' ' ' ALA . 4.8 mm -63.27 -47.26 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.395 -0.816 . . . . 0.0 109.617 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.4 t -63.62 -38.71 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.45 -0.781 . . . . 0.0 109.852 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.75 -26.89 71.88 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 tp -113.8 32.62 5.71 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.239 -1.154 . . . . 0.0 111.448 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 18.4 t90 -94.2 131.6 39.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.952 -1.092 . . . . 0.0 110.197 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.13 -172.73 2.41 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -43.53 -39.84 3.63 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.229 -0.92 . . . . 0.0 110.609 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.431 ' HB2' ' CG2' ' A' ' 37' ' ' THR . 12.4 pt-20 -164.67 37.19 0.07 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.401 0.62 . . . . 0.0 109.781 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -150.77 161.23 43.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.492 -0.755 . . . . 0.0 110.721 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.568 HG23 ' HB2' ' A' ' 34' ' ' CYS . 14.5 t -156.89 151.45 25.53 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.358 -0.838 . . . . 0.0 109.868 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.58 110.59 22.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.43 -0.794 . . . . 0.0 109.832 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.619 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 2.4 mt -105.21 123.8 48.46 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.255 -0.903 . . . . 0.0 110.559 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.736 HD11 ' HG3' ' A' ' 95' ' ' GLU . 2.8 tp 55.1 34.72 23.18 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.648 -0.657 . . . . 0.0 110.862 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.81 7.54 87.37 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -106.1 160.48 15.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.089 -1.242 . . . . 0.0 110.025 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.79 125.79 34.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.378 -0.826 . . . . 0.0 110.198 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.659 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 84.9 m -130.77 168.21 17.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.426 -0.796 . . . . 0.0 110.261 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.403 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 9.2 tttm -123.55 115.05 20.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.397 -0.814 . . . . 0.0 111.378 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 1.3 t80 -115.49 122.34 45.43 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 25' ' ' GLU . 1.9 p -140.46 158.3 44.21 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.985 -1.072 . . . . 0.0 112.203 -178.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 8.7 p -129.31 147.08 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.813 -0.554 . . . . 0.0 109.865 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.84 110.75 2.71 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.085 -1.009 . . . . 0.0 110.711 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -79.92 158.19 24.13 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.815 1.429 . . . . 0.0 110.697 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.509 ' CE2' ' HB3' ' A' ' 50' ' ' LYS . 18.9 m-85 -126.44 -176.5 3.69 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.492 -0.755 . . . . 0.0 109.778 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.98 143.02 31.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.602 -0.686 . . . . 0.0 110.841 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.28 177.98 4.61 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -42.13 -36.76 1.25 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.858 -0.526 . . . . 0.0 111.545 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.35 39.34 0.35 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.389 -0.819 . . . . 0.0 110.612 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -157.12 135.87 11.58 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.107 -0.996 . . . . 0.0 111.257 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.6 t -98.36 125.18 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.436 -0.79 . . . . 0.0 109.212 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -107.73 161.14 15.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.515 -0.74 . . . . 0.0 110.686 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.519 ' CD2' ' HA ' ' A' ' 70' ' ' GLN . 0.3 OUTLIER -128.92 142.97 50.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.301 -0.874 . . . . 0.0 110.582 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.509 ' HB3' ' CE2' ' A' ' 41' ' ' TYR . 30.9 tttt -154.11 151.04 28.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -0.827 . . . . 0.0 110.216 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -148.25 150.05 22.18 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.509 ' CG ' ' HB3' ' A' ' 64' ' ' GLU . 8.9 ttp180 -143.04 144.93 32.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.68 -0.894 . . . . 0.0 110.256 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.614 ' HG2' HG22 ' A' ' 77' ' ' THR . 2.3 ppp? -144.04 147.1 33.38 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.436 -0.79 . . . . 0.0 110.818 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.607 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 49.2 p90 -154.29 -168.9 3.08 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.797 -0.564 . . . . 0.0 110.113 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.3 m -134.15 92.79 20.85 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.857 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.659 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 47.9 Cg_endo -72.91 80.91 1.72 Allowed 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 123.86 1.453 . . . . 0.0 110.083 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.06 -43.24 0.79 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 55' ' ' CYS . 18.5 t90 -74.34 -52.88 10.89 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.524 -0.986 . . . . 0.0 110.425 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.437 HG21 ' CD1' ' A' ' 90' ' ' LEU . 7.9 t -153.72 -168.14 2.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.535 -0.728 . . . . 0.0 110.007 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.55 45.3 2.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.439 -0.788 . . . . 0.0 110.39 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.579 HD12 HD12 ' A' ' 90' ' ' LEU . 69.4 mt -117.86 156.85 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.394 -0.816 . . . . 0.0 109.466 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.78 165.99 27.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.287 -0.883 . . . . 0.0 111.339 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.55 127.36 2.29 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.509 ' HB3' ' CG ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -144.87 160.62 41.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.8 -0.824 . . . . 0.0 110.634 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.57 163.84 38.8 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.649 -0.657 . . . . 0.0 110.904 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.62 141.95 35.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.516 -0.74 . . . . 0.0 110.193 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.457 HG22 HG23 ' A' ' 73' ' ' VAL . 8.8 t -173.07 170.22 4.45 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.504 -0.748 . . . . 0.0 110.396 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.499 ' HG3' ' N ' ' A' ' 69' ' ' SER . 2.2 ptm85 -64.67 -35.09 79.92 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.438 -0.789 . . . . 0.0 110.249 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.499 ' N ' ' HG3' ' A' ' 68' ' ' ARG . 3.4 m -58.78 153.73 16.29 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.377 0.608 . . . . 0.0 110.754 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.519 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 45.2 mt-30 -101.17 -60.74 1.47 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.802 -0.561 . . . . 0.0 110.088 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -29.91 61.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.285 -0.885 . . . . 0.0 110.398 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.61 -38.75 96.37 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.457 HG23 HG22 ' A' ' 67' ' ' THR . 0.4 OUTLIER -63.54 -34.93 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.429 -1.042 . . . . 0.0 110.434 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.76 -45.75 85.07 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.355 -0.841 . . . . 0.0 109.482 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.36 -37.65 94.96 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -69.75 -38.76 76.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.609 -0.936 . . . . 0.0 109.64 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.614 HG22 ' HG2' ' A' ' 53' ' ' MET . 15.5 m -55.98 -44.47 78.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.326 -0.859 . . . . 0.0 109.245 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.638 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -70.35 -38.93 74.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.681 -0.637 . . . . 0.0 109.748 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -39.23 84.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.683 . . . . 0.0 110.039 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 0.7 OUTLIER -67.03 -31.14 71.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.599 -0.688 . . . . 0.0 110.185 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.4 ' CD2' ' SD ' ' A' ' 53' ' ' MET . 54.5 t80 -80.74 -36.52 31.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.045 -1.034 . . . . 0.0 109.046 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 11' ' ' ALA . 46.3 t -68.05 -38.4 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.671 -0.643 . . . . 0.0 110.246 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 2.6 ptm85 -67.45 -39.19 85.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.266 -0.896 . . . . 0.0 109.557 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.417 ' N ' ' HG3' ' A' ' 83' ' ' ARG . 0.7 OUTLIER -65.91 -40.54 91.58 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.496 -0.753 . . . . 0.0 109.268 178.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.562 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -70.0 -32.45 70.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.644 -0.66 . . . . 0.0 109.373 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.98 -41.99 94.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.623 -0.673 . . . . 0.0 109.238 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -67.92 -37.61 81.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.521 -0.737 . . . . 0.0 110.159 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.419 ' CD ' HD11 ' A' ' 61' ' ' ILE . 1.7 mmpp? -70.89 -51.93 23.27 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.374 -0.829 . . . . 0.0 110.382 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.96 49.45 0.17 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.579 HD12 HD12 ' A' ' 61' ' ' ILE . 13.0 mt -121.33 -48.59 2.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.289 -1.124 . . . . 0.0 110.405 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.562 HD12 ' HB3' ' A' ' 85' ' ' ALA . 81.6 mt -99.53 77.76 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.458 -0.776 . . . . 0.0 109.244 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.0 p -76.26 -176.8 3.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.496 -0.753 . . . . 0.0 110.353 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.644 ' HG2' HG21 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -69.59 -53.1 20.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.43 -0.794 . . . . 0.0 110.563 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.9 -42.53 97.4 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.416 -0.802 . . . . 0.0 110.96 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.736 ' HG3' HD11 ' A' ' 30' ' ' LEU . 1.7 tp10 -66.54 -38.5 87.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.267 -0.895 . . . . 0.0 110.219 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.2 -39.88 86.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.397 -0.815 . . . . 0.0 109.498 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -65.72 -39.03 90.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.596 -0.69 . . . . 0.0 109.955 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -61.56 -42.77 99.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.569 -0.707 . . . . 0.0 109.439 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.613 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 20.8 t90 -67.85 -38.61 83.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.473 -0.767 . . . . 0.0 109.641 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.583 HD23 ' HD3' ' A' ' 17' ' ' LYS . 50.6 mt -68.04 -38.79 82.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.693 -0.629 . . . . 0.0 110.193 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 102' ' ' SER . 57.9 m -70.41 -47.84 58.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.42 -0.8 . . . . 0.0 110.277 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 101' ' ' SER . 40.0 m . . . . . 0 N--CA 1.501 2.117 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.765 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.103 0.478 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.54 -66.63 1.06 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.436 -0.79 . . . . 0.0 110.075 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -94.5 118.6 31.92 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.364 -0.835 . . . . 0.0 110.293 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 m -94.62 54.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.426 -0.796 . . . . 0.0 110.188 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -98.67 28.65 4.12 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.355 -0.84 . . . . 0.0 110.673 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 10' ' ' VAL . . . -62.62 -51.92 52.53 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -64.07 -43.69 94.7 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.614 -0.933 . . . . 0.0 109.827 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -62.29 -38.76 90.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.497 -0.752 . . . . 0.0 109.806 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.5 -40.79 97.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.584 -0.697 . . . . 0.0 109.884 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 14' ' ' VAL . 84.5 t -64.15 -43.16 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.461 -0.775 . . . . 0.0 109.217 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.512 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -65.08 -39.5 93.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.509 -0.744 . . . . 0.0 109.3 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.41 -40.75 98.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.688 -0.632 . . . . 0.0 109.792 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.29 96.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.407 -0.808 . . . . 0.0 109.668 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 10' ' ' VAL . 91.2 t -64.11 -40.46 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.504 -0.748 . . . . 0.0 109.348 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.21 -40.14 96.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.584 -0.698 . . . . 0.0 110.127 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 t -65.04 -38.95 92.53 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.371 -0.831 . . . . 0.0 109.706 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.517 ' HD2' HD22 ' A' ' 100' ' ' LEU . 3.5 ttmm -65.98 -32.38 73.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.502 -0.749 . . . . 0.0 109.951 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.756 HD11 ' HG ' ' A' ' 29' ' ' LEU . 3.3 mm -62.82 -48.26 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.598 -0.688 . . . . 0.0 109.981 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.15 -38.92 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.399 -0.813 . . . . 0.0 109.833 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.84 -31.22 75.25 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.44 36.78 3.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.287 -1.125 . . . . 0.0 110.796 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.552 ' HH2' HG12 ' A' ' 38' ' ' VAL . 25.7 t90 -100.51 138.52 37.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 110.668 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -97.71 -169.66 1.87 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -43.14 -42.95 4.33 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.663 -0.648 . . . . 0.0 110.255 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -162.66 38.84 0.11 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.636 -0.665 . . . . 0.0 110.39 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -157.67 140.34 14.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.252 -0.905 . . . . 0.0 110.699 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.473 HG21 HD12 ' A' ' 18' ' ' ILE . 10.0 t -147.65 159.45 43.77 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.411 -0.806 . . . . 0.0 109.823 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -100.16 143.18 30.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.431 -0.793 . . . . 0.0 110.513 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.756 ' HG ' HD11 ' A' ' 18' ' ' ILE . 7.1 mt -126.34 113.21 16.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.537 -0.727 . . . . 0.0 109.43 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' ' 99' ' ' TRP . 4.6 tp 59.36 27.06 16.05 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.69 -0.631 . . . . 0.0 110.635 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.46 -15.7 62.34 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -87.59 153.31 21.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.986 -1.302 . . . . 0.0 110.337 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -83.95 137.56 33.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.387 -0.82 . . . . 0.0 109.751 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 29' ' ' LEU . 96.3 m -138.01 170.91 15.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.89 . . . . 0.0 111.251 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -122.3 104.5 9.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.677 -0.64 . . . . 0.0 110.025 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.53 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 3.2 t80 -109.9 132.74 53.88 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.1 p -140.8 153.98 46.05 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.099 -1.001 . . . . 0.0 111.367 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.552 HG12 ' HH2' ' A' ' 22' ' ' TRP . 4.9 p -141.53 143.85 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.663 -0.648 . . . . 0.0 109.953 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.45 128.24 6.1 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.161 -0.962 . . . . 0.0 111.235 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.542 ' HB3' ' CE1' ' A' ' 49' ' ' TYR . 49.0 Cg_endo -76.93 148.84 28.47 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.88 1.463 . . . . 0.0 110.227 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.449 ' CE2' ' HB3' ' A' ' 50' ' ' LYS . 27.8 m-85 -134.43 -171.89 2.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.283 -0.885 . . . . 0.0 110.345 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.471 HD11 HG22 ' A' ' 47' ' ' VAL . 2.4 tp -151.01 145.79 25.78 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.5 0.666 . . . . 0.0 110.88 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -112.46 -179.79 3.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.703 -0.623 . . . . 0.0 109.398 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -41.56 -38.12 1.27 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.867 -0.52 . . . . 0.0 111.522 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.73 45.57 0.47 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.395 -0.815 . . . . 0.0 110.502 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.452 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -162.15 166.38 25.72 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.104 -0.997 . . . . 0.0 111.402 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.471 HG22 HD11 ' A' ' 42' ' ' LEU . 41.0 t -114.68 136.04 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.536 -0.727 . . . . 0.0 109.222 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.452 ' CE2' ' HB3' ' A' ' 46' ' ' GLN . 45.0 m-85 -138.26 127.84 24.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.412 -0.805 . . . . 0.0 110.211 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.542 ' CE1' ' HB3' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -92.95 151.7 19.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.595 -0.691 . . . . 0.0 109.99 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.449 ' HB3' ' CE2' ' A' ' 41' ' ' TYR . 8.7 ttpp -149.3 149.09 30.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.395 -0.816 . . . . 0.0 110.181 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.15 161.53 29.13 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.59 137.17 13.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.782 -0.834 . . . . 0.0 109.75 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.555 ' HG2' HG22 ' A' ' 77' ' ' THR . 1.4 ppp? -136.73 152.1 49.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.264 -0.898 . . . . 0.0 111.144 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.487 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 49.4 p90 -159.58 154.29 24.42 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.744 -0.598 . . . . 0.0 110.183 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 69.3 m -112.33 91.53 16.68 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.183 -0.948 . . . . 0.0 110.56 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.487 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 48.0 Cg_endo -76.11 91.79 1.09 Allowed 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.807 1.425 . . . . 0.0 110.217 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.46 -48.36 0.58 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.516 ' CZ2' HD22 ' A' ' 90' ' ' LEU . 25.6 t90 -76.26 -53.5 8.14 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.404 -1.056 . . . . 0.0 110.376 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 t -145.46 -170.01 3.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.581 -0.699 . . . . 0.0 109.991 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.62 60.54 0.8 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.449 -0.782 . . . . 0.0 109.887 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.7 mt -128.12 155.08 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.481 -0.762 . . . . 0.0 109.845 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.43 160.29 39.53 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.415 -0.803 . . . . 0.0 110.492 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 135.75 7.26 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -136.2 151.82 50.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.554 -0.968 . . . . 0.0 110.112 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.66 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -163.13 135.57 5.36 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.388 -0.82 . . . . 0.0 110.56 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.575 ' HA ' HG23 ' A' ' 73' ' ' VAL . 1.1 m -136.71 142.65 43.12 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.546 -0.721 . . . . 0.0 110.37 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.8 t -167.44 177.48 5.98 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.573 -0.704 . . . . 0.0 110.142 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -31.32 67.74 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.33 -0.856 . . . . 0.0 110.66 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.74 143.15 58.07 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.427 -0.795 . . . . 0.0 110.916 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.543 ' O ' HG12 ' A' ' 73' ' ' VAL . 38.4 mt-30 -80.65 -50.71 9.59 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.637 -0.665 . . . . 0.0 110.408 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m -86.36 -29.3 23.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.386 -0.822 . . . . 0.0 109.914 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.06 -38.97 95.1 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.575 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.7 p -62.3 -36.83 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.407 -1.055 . . . . 0.0 110.297 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.426 ' HB1' ' HZ ' ' A' ' 36' ' ' PHE . . . -68.8 -44.84 72.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.55 -0.719 . . . . 0.0 109.768 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.31 -35.74 92.06 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.66 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 15.4 mmtt -69.76 -38.72 76.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.473 -1.016 . . . . 0.0 109.942 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.555 HG22 ' HG2' ' A' ' 53' ' ' MET . 3.4 m -60.25 -44.91 94.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.501 -0.749 . . . . 0.0 109.498 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.459 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -69.91 -36.31 75.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.555 -0.716 . . . . 0.0 109.865 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -39.76 86.88 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.463 -0.773 . . . . 0.0 109.876 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.16 -40.9 98.89 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.475 -0.766 . . . . 0.0 110.086 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -69.33 -41.13 77.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.336 -0.853 . . . . 0.0 109.343 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 11' ' ' ALA . 49.8 t -66.04 -38.14 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.566 -0.708 . . . . 0.0 109.591 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -38.79 87.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.514 -0.741 . . . . 0.0 109.708 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -39.27 91.22 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.386 -0.821 . . . . 0.0 109.853 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.641 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -69.82 -35.51 74.86 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.589 -0.694 . . . . 0.0 109.464 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -41.9 99.61 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.678 -0.639 . . . . 0.0 109.634 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -67.84 -36.97 81.29 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.499 -0.75 . . . . 0.0 110.332 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -73.49 -55.43 6.35 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.37 -0.831 . . . . 0.0 110.453 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.04 52.36 0.08 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.516 HD22 ' CZ2' ' A' ' 58' ' ' TRP . 9.7 mt -122.95 -49.83 1.96 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.377 -1.072 . . . . 0.0 110.259 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.641 HD12 ' HB3' ' A' ' 85' ' ' ALA . 96.3 mt -97.09 101.59 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.538 -0.726 . . . . 0.0 109.55 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.614 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 32.4 m -78.23 173.78 11.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.475 -0.766 . . . . 0.0 109.965 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -71.16 -53.08 15.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.605 -0.684 . . . . 0.0 109.925 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -65.09 -29.52 70.39 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.478 -0.764 . . . . 0.0 110.57 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.0 OUTLIER -67.99 -43.5 78.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.267 -0.896 . . . . 0.0 109.821 179.377 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.406 ' O ' HD23 ' A' ' 100' ' ' LEU . . . -61.29 -40.64 94.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.609 -0.682 . . . . 0.0 109.168 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -62.46 -38.98 91.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.641 -0.662 . . . . 0.0 109.763 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -40.16 94.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.572 -0.705 . . . . 0.0 109.697 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.513 ' HB2' HD12 ' A' ' 30' ' ' LEU . 15.6 t90 -71.08 -36.05 72.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.315 -0.865 . . . . 0.0 109.889 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.517 HD22 ' HD2' ' A' ' 17' ' ' LYS . 3.4 mm? -71.12 -33.97 70.61 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.71 -0.619 . . . . 0.0 110.697 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 74.5 p -69.29 -42.91 74.84 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.203 -0.936 . . . . 0.0 110.467 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.499 1.977 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.788 179.854 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 120.928 0.394 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.08 -176.42 4.12 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.467 -0.771 . . . . 0.0 110.251 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -71.01 100.62 2.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.428 -0.795 . . . . 0.0 109.968 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 4' ' ' VAL . 7.1 p -143.78 78.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.523 -0.736 . . . . 0.0 109.98 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -101.13 177.19 5.01 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.322 -0.862 . . . . 0.0 110.356 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.02 -8.85 7.57 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 120.192 -1.004 . . . . 0.0 110.956 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -54.86 -45.89 74.63 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 118.748 1.274 . . . . 0.0 110.257 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.49 -37.55 87.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.714 -0.616 . . . . 0.0 109.707 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.71 -40.1 94.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.65 -0.656 . . . . 0.0 109.945 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 14' ' ' VAL . 95.1 t -66.08 -40.87 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.521 -0.737 . . . . 0.0 109.185 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.42 -39.76 95.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.593 -0.692 . . . . 0.0 109.533 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.74 -41.38 99.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.684 -0.635 . . . . 0.0 109.806 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.3 -39.3 94.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.474 -0.766 . . . . 0.0 109.827 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.643 ' CG2' ' HB1' ' A' ' 96' ' ' ALA . 61.2 t -66.04 -39.93 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.425 -0.797 . . . . 0.0 109.105 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.576 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -64.06 -38.43 91.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.466 -0.771 . . . . 0.0 109.636 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.6 m -63.96 -41.31 97.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.51 -0.743 . . . . 0.0 109.595 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.602 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 1.9 ttmt -63.74 -32.8 74.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.547 -0.721 . . . . 0.0 109.898 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.6 HG21 ' HB2' ' A' ' 78' ' ' ALA . 5.1 mm -62.25 -48.13 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -0.875 . . . . 0.0 109.071 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.49 -40.4 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.71 -0.619 . . . . 0.0 109.429 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.79 -32.18 83.29 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.484 HD23 ' HB2' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -109.38 35.39 3.32 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.45 -1.029 . . . . 0.0 110.612 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.403 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 25.0 t90 -103.98 132.98 49.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.133 -0.979 . . . . 0.0 111.01 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.34 -163.85 1.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -45.78 -45.64 14.83 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.255 -0.903 . . . . 0.0 110.587 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.435 ' HB2' ' CG2' ' A' ' 37' ' ' THR . 6.6 pt-20 -157.75 35.9 0.26 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.679 -0.638 . . . . 0.0 110.5 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.41 151.88 38.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.311 -0.868 . . . . 0.0 110.668 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.447 HG23 ' HB2' ' A' ' 34' ' ' CYS . 7.9 t -153.77 172.9 16.6 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.308 -0.87 . . . . 0.0 109.866 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.484 ' HB2' HD23 ' A' ' 21' ' ' LEU . 3.9 mp0 -124.43 143.34 50.68 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.245 -0.909 . . . . 0.0 110.228 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.746 HD12 ' SG ' ' A' ' 55' ' ' CYS . 10.0 mt -127.44 113.6 16.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 109.457 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 99' ' ' TRP . 1.0 OUTLIER 57.01 27.26 12.98 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.765 -0.584 . . . . 0.0 110.735 -179.244 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.84 -16.9 60.21 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -80.97 149.89 29.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.171 -1.193 . . . . 0.0 110.444 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -79.41 139.91 37.56 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.74 . . . . 0.0 109.822 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 81.4 m -139.96 166.37 24.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.515 -0.741 . . . . 0.0 110.726 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -122.15 101.09 7.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.404 -0.81 . . . . 0.0 109.835 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.583 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 4.3 t80 -108.37 131.13 55.07 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.435 ' CG2' ' HB2' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -134.75 157.16 47.43 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.302 -0.874 . . . . 0.0 111.015 -179.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.403 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 87.1 t -129.36 129.32 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.568 -0.707 . . . . 0.0 109.635 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -144.06 101.23 4.89 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.367 -0.833 . . . . 0.0 110.425 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.507 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 54.1 Cg_endo -75.25 161.88 37.35 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.81 1.426 . . . . 0.0 110.585 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -126.53 -174.34 3.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.421 -0.799 . . . . 0.0 109.929 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.405 ' CD1' HG22 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -133.73 143.17 48.32 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.36 0.6 . . . . 0.0 110.374 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -117.72 174.83 5.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.595 -0.691 . . . . 0.0 109.835 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -43.91 -36.11 2.27 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.911 -0.493 . . . . 0.0 111.105 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -154.9 37.31 0.4 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.489 -0.757 . . . . 0.0 110.957 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.52 137.9 6.02 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.879 -1.138 . . . . 0.0 111.312 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.405 HG22 ' CD1' ' A' ' 42' ' ' LEU . 45.0 t -101.45 123.81 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.486 -0.759 . . . . 0.0 109.493 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -112.31 143.67 43.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.375 -0.828 . . . . 0.0 110.332 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.507 ' CD1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -96.14 157.17 16.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -0.877 . . . . 0.0 110.111 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.48 ' HG3' ' N ' ' A' ' 51' ' ' GLY . 2.1 tttt -156.6 150.17 24.59 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.254 -0.904 . . . . 0.0 109.9 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.48 ' N ' ' HG3' ' A' ' 50' ' ' LYS . . . -149.59 147.67 18.22 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.45 138.64 34.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.67 -0.9 . . . . 0.0 109.836 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.583 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 3.0 ppp? -137.95 157.73 45.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.344 -0.848 . . . . 0.0 111.25 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.427 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 49.0 p90 -160.88 145.88 14.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.844 -0.535 . . . . 0.0 109.951 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.746 ' SG ' HD12 ' A' ' 29' ' ' LEU . 76.6 m -112.49 91.2 16.21 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.261 -0.899 . . . . 0.0 110.871 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.427 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 48.3 Cg_endo -75.71 85.81 1.57 Allowed 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.78 1.411 . . . . 0.0 110.056 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.42 -50.3 0.29 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -78.16 -43.71 27.95 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.537 -0.978 . . . . 0.0 109.76 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.419 ' HB ' HD11 ' A' ' 90' ' ' LEU . 10.1 t -153.67 -173.85 4.73 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.278 0.561 . . . . 0.0 109.733 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.46 49.04 1.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.569 -0.707 . . . . 0.0 109.62 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.4 mt -119.02 155.99 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.473 -0.767 . . . . 0.0 110.009 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.19 160.16 38.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.447 -0.783 . . . . 0.0 110.438 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.23 148.27 19.89 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 0.9 OUTLIER -151.13 157.07 42.25 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.551 -0.97 . . . . 0.0 110.269 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.443 ' HB1' ' CG ' ' A' ' 76' ' ' LYS . . . -159.75 146.75 16.51 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.699 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.511 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -140.1 141.74 36.12 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.469 -0.769 . . . . 0.0 110.812 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.605 HG22 HG23 ' A' ' 73' ' ' VAL . 9.3 t -169.16 176.9 5.05 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.6 -0.688 . . . . 0.0 110.341 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.5 mtm-85 -73.14 -35.29 66.47 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.389 -0.82 . . . . 0.0 110.261 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.85 136.92 58.15 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.497 -0.752 . . . . 0.0 110.127 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.409 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 1.0 OUTLIER -74.31 -59.11 2.88 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.584 -0.697 . . . . 0.0 110.406 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -79.17 -28.83 42.77 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.308 -0.87 . . . . 0.0 110.05 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.62 -38.14 90.83 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.605 HG23 HG22 ' A' ' 67' ' ' THR . 0.5 OUTLIER -62.07 -38.11 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.437 -1.037 . . . . 0.0 110.379 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HA ' ' HZ ' ' A' ' 36' ' ' PHE . . . -66.81 -44.5 81.02 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.524 -0.735 . . . . 0.0 109.655 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.65 -37.78 95.25 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.443 ' CG ' ' HB1' ' A' ' 65' ' ' ALA . 0.1 OUTLIER -63.3 -40.1 96.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.589 -0.948 . . . . 0.0 110.282 179.559 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.9 m -63.44 -43.91 96.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.83 . . . . 0.0 109.149 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.6 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -66.27 -39.08 89.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.602 -0.686 . . . . 0.0 109.64 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.98 -38.96 89.89 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.34 -0.85 . . . . 0.0 109.96 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.518 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 2.8 m-20 -68.87 -29.8 68.17 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.461 -0.774 . . . . 0.0 110.172 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -78.38 -33.73 48.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.225 -0.922 . . . . 0.0 109.864 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 78' ' ' ALA . 65.4 t -70.43 -38.5 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 110.476 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -70.23 -36.42 74.52 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.271 -0.893 . . . . 0.0 109.793 179.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.46 -40.83 93.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.6 -0.688 . . . . 0.0 109.335 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.719 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -69.78 -32.88 71.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.618 -0.676 . . . . 0.0 109.379 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.3 -41.1 97.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.55 -0.719 . . . . 0.0 109.513 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -65.38 -36.58 84.4 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.661 -0.649 . . . . 0.0 110.538 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -79.72 -54.13 6.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.195 -0.941 . . . . 0.0 110.28 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.72 53.72 0.07 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' A' ' 90' ' ' LEU . 11.1 mt -123.56 -47.78 1.96 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.375 -1.074 . . . . 0.0 110.645 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.719 HD12 ' HB3' ' A' ' 85' ' ' ALA . 80.7 mt -105.2 98.84 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.235 -0.916 . . . . 0.0 109.555 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 4.9 t -78.49 -177.06 5.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.443 -0.785 . . . . 0.0 110.556 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -70.76 -59.82 2.59 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.519 -0.738 . . . . 0.0 110.472 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -63.73 -34.67 78.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.391 -0.818 . . . . 0.0 110.63 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 1.9 mt-10 -58.79 -42.93 90.19 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.489 -0.757 . . . . 0.0 110.278 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.643 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -63.09 -39.13 93.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.448 -0.783 . . . . 0.0 109.809 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -36.81 78.05 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.498 -0.751 . . . . 0.0 109.677 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -62.86 -42.83 99.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.522 -0.736 . . . . 0.0 109.379 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.675 ' HB2' HD12 ' A' ' 30' ' ' LEU . 25.3 t90 -63.97 -41.93 97.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.462 -0.774 . . . . 0.0 109.153 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HA ' ' CE ' ' A' ' 17' ' ' LYS . 12.9 mt -59.39 -37.04 76.96 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.763 -0.586 . . . . 0.0 110.155 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.8 m -65.92 -38.6 89.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.51 -0.744 . . . . 0.0 110.316 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.504 2.237 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.847 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 120.917 0.389 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.94 -175.58 2.75 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.404 -0.81 . . . . 0.0 110.207 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.489 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -102.2 -165.24 1.17 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.365 -0.835 . . . . 0.0 110.335 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 3' ' ' TYR . 23.9 t 68.79 -65.59 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 O-C-N 121.96 -0.463 . . . . 0.0 110.948 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -97.94 57.79 1.32 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.093 -1.004 . . . . 0.0 110.104 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.39 -37.88 93.86 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -63.59 -42.79 98.24 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.402 -1.058 . . . . 0.0 109.878 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.65 -37.21 83.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.808 -0.558 . . . . 0.0 110.328 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.65 -43.26 80.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.564 -0.71 . . . . 0.0 109.895 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.598 HG11 ' HA ' ' A' ' 93' ' ' GLN . 78.2 t -68.82 -38.68 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.544 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -63.66 -46.19 86.73 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.481 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . . . -52.05 -45.11 64.56 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.744 -0.597 . . . . 0.0 109.959 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.09 90.51 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.561 -0.712 . . . . 0.0 109.391 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 10' ' ' VAL . 89.0 t -61.14 -44.25 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.589 -0.695 . . . . 0.0 109.324 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.958 ' HB2' ' HE2' ' A' ' 79' ' ' LYS . . . -58.29 -43.2 87.92 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.599 -0.688 . . . . 0.0 109.999 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.2 m -59.24 -41.8 89.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.65 -0.656 . . . . 0.0 109.484 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.638 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 1.3 tpmp? -69.74 -32.5 71.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.627 -0.671 . . . . 0.0 110.059 179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 22' ' ' TRP . 5.4 mt -72.26 -46.77 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.401 -0.812 . . . . 0.0 109.811 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.6 t -68.13 -39.03 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.395 -0.816 . . . . 0.0 110.04 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.28 -16.41 75.32 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.47 24.06 6.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.978 -1.307 . . . . 0.0 111.452 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.437 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 22.7 t90 -92.03 135.58 33.85 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.886 -1.134 . . . . 0.0 110.337 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.67 -167.19 1.46 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.534 -0.729 . . . . 0.0 109.449 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -49.77 -41.76 44.93 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.231 -0.918 . . . . 0.0 110.615 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.45 37.73 0.24 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.574 -0.704 . . . . 0.0 110.456 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -146.75 147.53 31.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.32 -0.863 . . . . 0.0 110.72 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.547 HG21 ' HB2' ' A' ' 36' ' ' PHE . 8.2 t -156.7 155.52 31.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.462 -0.774 . . . . 0.0 109.643 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -111.68 149.83 31.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.173 -0.954 . . . . 0.0 110.168 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.423 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 6.7 mt -143.28 123.85 14.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.371 -0.831 . . . . 0.0 110.022 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.453 HD12 ' HB2' ' A' ' 99' ' ' TRP . 1.7 tp 53.07 35.06 18.6 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.673 -0.642 . . . . 0.0 111.22 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.39 26.88 62.61 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -125.91 163.5 22.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -1.163 . . . . 0.0 109.996 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.0 130.4 36.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.458 -0.776 . . . . 0.0 109.893 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.6 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 68.2 m -134.08 167.22 21.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.51 -0.744 . . . . 0.0 110.079 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.591 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 0.9 OUTLIER -126.32 110.07 12.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 110.901 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.547 ' HB2' HG21 ' A' ' 27' ' ' THR . 20.0 t80 -111.11 136.09 50.66 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.38 157.88 43.53 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.061 -1.024 . . . . 0.0 111.968 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.3 t -132.82 145.04 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.15 136.55 11.38 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.238 -0.914 . . . . 0.0 110.927 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.484 ' HB3' ' CE1' ' A' ' 49' ' ' TYR . 48.1 Cg_endo -78.2 154.16 28.55 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.905 1.476 . . . . 0.0 110.406 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -142.64 -169.26 2.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.355 -0.84 . . . . 0.0 110.736 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.4 tp -142.67 160.52 40.14 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.384 0.612 . . . . 0.0 110.693 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.18 178.0 7.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.532 -0.73 . . . . 0.0 109.669 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.452 ' HB3' ' CD2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -40.92 -37.82 0.86 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.884 -0.51 . . . . 0.0 111.799 -179.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.452 ' CD2' ' HB3' ' A' ' 44' ' ' ARG . 11.1 p90 -156.08 35.85 0.34 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.348 -0.845 . . . . 0.0 111.417 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.459 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -162.52 162.58 27.44 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.865 -1.147 . . . . 0.0 111.152 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.4 t -101.83 141.79 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.424 -0.798 . . . . 0.0 109.379 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 46' ' ' GLN . 33.6 m-85 -140.51 136.22 32.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.255 -0.903 . . . . 0.0 110.404 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -96.64 135.28 38.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.572 -0.705 . . . . 0.0 110.19 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.558 ' HA ' HG21 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -129.39 156.73 43.6 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.332 -0.855 . . . . 0.0 109.857 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.19 150.5 22.7 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.753 ' HG2' ' HB3' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -149.56 136.36 19.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.491 -1.005 . . . . 0.0 109.837 179.529 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.705 ' HG2' HG22 ' A' ' 77' ' ' THR . 1.0 OUTLIER -135.12 152.58 51.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.439 -0.788 . . . . 0.0 110.835 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.603 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 46.1 p90 -149.32 -177.13 5.67 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.576 -0.703 . . . . 0.0 110.044 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 34.7 m -133.94 93.81 19.68 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.102 -0.999 . . . . 0.0 110.701 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.603 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.6 Cg_endo -76.09 89.58 1.23 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.951 1.5 . . . . 0.0 110.107 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.27 -46.51 0.87 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.436 ' CZ2' HD22 ' A' ' 30' ' ' LEU . 10.4 t90 -71.61 -57.78 4.08 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.476 -1.014 . . . . 0.0 110.139 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.496 HG21 HD13 ' A' ' 90' ' ' LEU . 8.1 t -153.96 -160.37 1.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.578 -0.701 . . . . 0.0 109.902 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.88 44.92 2.52 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.253 -0.904 . . . . 0.0 110.546 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.63 HD11 ' HG3' ' A' ' 88' ' ' LYS . 1.5 tt -125.15 154.4 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.25 -0.906 . . . . 0.0 109.701 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.451 ' HB3' ' CB ' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -153.68 169.21 23.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.166 -0.959 . . . . 0.0 111.202 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.457 ' HA2' ' HE2' ' A' ' 84' ' ' LYS . . . -135.45 153.03 21.09 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.753 ' HB3' ' HG2' ' A' ' 52' ' ' ARG . 1.2 pm0 -145.51 155.39 43.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.632 -0.922 . . . . 0.0 110.227 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -143.23 162.48 35.51 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.518 -0.738 . . . . 0.0 110.89 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -147.12 136.98 23.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.574 -0.704 . . . . 0.0 110.438 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.7 t -175.51 165.25 3.18 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.699 -0.625 . . . . 0.0 110.002 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -68.55 -28.13 66.69 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.182 -0.949 . . . . 0.0 110.595 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.67 149.46 50.47 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.191 -0.943 . . . . 0.0 110.463 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.426 ' O ' HG12 ' A' ' 73' ' ' VAL . 6.6 mp0 -83.66 -64.91 1.08 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.672 -0.642 . . . . 0.0 110.087 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 t -73.32 -22.79 60.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.26 -0.9 . . . . 0.0 110.02 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.82 -45.38 95.02 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' A' ' 50' ' ' LYS . 0.7 OUTLIER -61.04 -36.96 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.495 -1.003 . . . . 0.0 110.064 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.46 -45.08 94.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.524 -0.735 . . . . 0.0 110.034 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -60.64 -37.21 93.09 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.442 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -74.92 -37.69 61.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.391 -1.064 . . . . 0.0 110.245 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.705 HG22 ' HG2' ' A' ' 53' ' ' MET . 22.7 m -59.93 -38.04 81.24 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.195 -0.941 . . . . 0.0 109.683 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.67 -28.04 40.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.425 -0.797 . . . . 0.0 110.184 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.958 ' HE2' ' HB2' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -80.76 -37.64 30.05 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.267 -0.895 . . . . 0.0 109.826 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.75 -31.51 66.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.785 -0.572 . . . . 0.0 109.694 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 35.4 t80 -70.36 -42.19 72.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 0.0 109.695 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 11' ' ' ALA . 58.6 t -71.24 -30.89 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.799 . . . . 0.0 109.467 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -38.4 63.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.459 -0.776 . . . . 0.0 109.756 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.457 ' HE2' ' HA2' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -67.3 -36.78 82.2 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.33 -0.856 . . . . 0.0 109.777 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.669 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -71.69 -34.2 69.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.486 -0.759 . . . . 0.0 109.528 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.21 -39.28 86.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.595 -0.69 . . . . 0.0 109.585 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -64.37 -40.4 95.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.717 -0.614 . . . . 0.0 109.901 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.63 ' HG3' HD11 ' A' ' 61' ' ' ILE . 9.1 mmmt -73.72 -57.15 4.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.425 -0.797 . . . . 0.0 109.781 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.7 53.98 0.05 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.496 HD13 HG21 ' A' ' 59' ' ' THR . 9.7 mt -123.41 -57.41 1.67 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.303 -1.116 . . . . 0.0 110.65 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.669 HD12 ' HB3' ' A' ' 85' ' ' ALA . 12.4 mt -92.74 115.83 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.0 110.167 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.6 t -99.46 -175.91 3.13 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.663 -0.648 . . . . 0.0 110.637 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.598 ' HA ' HG11 ' A' ' 10' ' ' VAL . 2.6 mt-30 -74.85 -52.07 12.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.423 -0.798 . . . . 0.0 110.263 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -64.15 -41.04 97.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.575 -0.703 . . . . 0.0 110.189 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -56.09 -45.85 79.26 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.649 -0.657 . . . . 0.0 109.993 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.43 93.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.62 -0.675 . . . . 0.0 109.43 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -64.16 -37.83 88.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.643 -0.66 . . . . 0.0 109.717 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -64.97 -42.04 94.92 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.638 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 18.6 t90 -64.49 -43.1 95.21 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.162 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.462 HD23 ' HD2' ' A' ' 17' ' ' LYS . 12.2 mt -53.59 -38.04 63.56 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.776 -0.578 . . . . 0.0 109.562 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.3 t -79.48 -43.38 23.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.617 -0.677 . . . . 0.0 109.731 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.997 179.428 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 120.888 0.375 . . . . 0.0 110.459 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.49 147.72 47.49 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.37 -0.831 . . . . 0.0 110.483 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -108.42 145.36 34.72 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.502 -0.749 . . . . 0.0 110.196 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 p -137.24 138.7 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.361 -0.837 . . . . 0.0 110.304 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -84.1 -42.19 16.33 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.419 -0.801 . . . . 0.0 110.407 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.18 0.49 86.95 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -58.46 -48.52 80.47 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.174 -1.192 . . . . 0.0 110.262 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.17 -39.35 82.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.592 -0.693 . . . . 0.0 110.108 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.39 -39.68 94.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.587 -0.695 . . . . 0.0 109.983 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 14' ' ' VAL . 65.5 t -65.07 -41.3 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.502 -0.749 . . . . 0.0 109.31 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.493 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -63.11 -39.59 95.14 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.597 -0.689 . . . . 0.0 109.79 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.88 98.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.548 -0.72 . . . . 0.0 109.56 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.99 98.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.634 -0.666 . . . . 0.0 109.5 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 10' ' ' VAL . 60.5 t -62.69 -41.07 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.545 -0.722 . . . . 0.0 109.299 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.588 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -63.28 -40.13 96.52 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.694 -0.629 . . . . 0.0 109.42 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 56.5 m -63.47 -38.88 92.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.649 -0.657 . . . . 0.0 109.443 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.516 ' HB3' ' HZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.63 -37.79 82.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.518 -0.739 . . . . 0.0 109.356 178.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.784 HD12 ' HB1' ' A' ' 78' ' ' ALA . 17.1 mt -66.57 -33.33 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.678 -0.639 . . . . 0.0 109.857 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.5 t -62.51 -49.86 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.252 -0.905 . . . . 0.0 109.736 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.03 -13.12 83.38 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 120.293 -0.956 . . . . 0.0 110.82 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.688 HD21 ' O ' ' A' ' 28' ' ' GLU . 11.5 tp -98.09 -23.0 15.93 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.019 -1.283 . . . . 0.0 110.825 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.554 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 17.4 t90 -67.4 131.36 45.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.73 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.96 -161.27 0.86 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -47.94 -45.07 30.67 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.132 -0.98 . . . . 0.0 110.444 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.13 36.54 0.14 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.611 -0.681 . . . . 0.0 110.848 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -156.54 155.49 32.02 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.194 -0.941 . . . . 0.0 110.027 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.571 HG23 ' HB2' ' A' ' 34' ' ' CYS . 7.2 t -156.41 155.29 31.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.164 -0.96 . . . . 0.0 110.132 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.688 ' O ' HD21 ' A' ' 21' ' ' LEU . 8.0 mp0 -116.09 109.39 17.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.4 -0.813 . . . . 0.0 109.494 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.533 HD23 ' C ' ' A' ' 28' ' ' GLU . 10.7 mt -112.19 129.79 56.13 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.316 -0.865 . . . . 0.0 110.576 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.874 HD12 ' HD1' ' A' ' 99' ' ' TRP . 0.3 OUTLIER 60.09 30.64 20.08 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.442 -0.786 . . . . 0.0 110.301 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.02 22.21 78.43 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 30' ' ' LEU . 50.0 m-70 -120.77 160.07 24.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.379 -1.071 . . . . 0.0 109.992 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.43 126.72 34.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.359 -0.838 . . . . 0.0 110.549 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.571 ' HB2' HG23 ' A' ' 27' ' ' THR . 23.9 m -130.17 166.88 19.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.69 -0.631 . . . . 0.0 109.687 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 6.1 tptt -128.33 105.64 8.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.465 -0.772 . . . . 0.0 110.637 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.554 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 29.9 t80 -108.23 137.34 46.37 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.6 p -147.57 152.32 37.75 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.031 -1.043 . . . . 0.0 111.816 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.8 t -125.17 133.92 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.415 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -136.15 119.16 12.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.127 -0.983 . . . . 0.0 111.224 -178.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -78.99 154.29 25.69 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.77 1.405 . . . . 0.0 110.655 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -140.77 -170.6 3.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.285 -0.884 . . . . 0.0 110.207 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.49 160.47 43.04 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.406 0.622 . . . . 0.0 110.772 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.65 177.0 7.55 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.65 -0.656 . . . . 0.0 109.649 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -42.61 -38.28 1.96 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.82 -0.55 . . . . 0.0 111.276 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.19 45.28 0.49 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.487 -0.758 . . . . 0.0 109.994 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.64 171.07 17.47 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.235 -0.916 . . . . 0.0 111.125 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.7 t -121.47 133.46 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.532 -0.73 . . . . 0.0 109.368 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -130.3 124.5 32.49 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.334 -0.854 . . . . 0.0 110.161 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 70' ' ' GLN . 3.3 m-85 -98.39 133.53 42.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.505 -0.747 . . . . 0.0 110.311 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.6 164.63 17.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.449 -0.782 . . . . 0.0 110.085 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -156.86 135.67 4.57 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.596 ' HG3' ' HG3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -138.92 144.82 39.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.582 -0.952 . . . . 0.0 110.426 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.584 ' HG2' HG22 ' A' ' 77' ' ' THR . 2.5 ppp? -140.49 148.74 41.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.325 -0.859 . . . . 0.0 110.315 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.509 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 44.8 p90 -152.29 146.65 25.55 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.651 -0.656 . . . . 0.0 110.41 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 98.0 m -112.38 88.93 11.54 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.303 -0.873 . . . . 0.0 110.953 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -77.59 84.33 1.99 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.843 1.444 . . . . 0.0 110.278 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.73 -46.63 0.59 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 10.3 t90 -71.35 -58.13 3.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.6 -0.941 . . . . 0.0 110.045 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.429 HG21 ' CD1' ' A' ' 90' ' ' LEU . 9.1 t -153.7 -160.66 1.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.577 -0.702 . . . . 0.0 109.941 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.87 47.69 1.61 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.397 -0.815 . . . . 0.0 110.127 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.406 HG22 ' CD1' ' A' ' 81' ' ' PHE . 72.9 mt -123.63 151.41 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.471 -0.768 . . . . 0.0 109.878 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -139.33 169.87 16.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.904 . . . . 0.0 110.962 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.557 ' O ' HG23 ' A' ' 77' ' ' THR . . . -137.35 127.58 4.03 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.596 ' HG3' ' HG3' ' A' ' 52' ' ' ARG . 1.8 mp0 -121.7 169.02 11.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.571 -0.959 . . . . 0.0 110.695 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.441 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -166.41 156.57 12.06 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.486 0.66 . . . . 0.0 111.336 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -156.44 131.86 9.39 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.633 -0.667 . . . . 0.0 110.037 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.3 t -175.63 -176.71 0.9 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.598 -0.689 . . . . 0.0 109.987 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -82.48 -39.18 22.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.221 -0.924 . . . . 0.0 110.466 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.31 135.74 52.36 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.591 -0.693 . . . . 0.0 110.607 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.434 ' HB3' ' CE2' ' A' ' 49' ' ' TYR . 15.4 pt20 -75.79 -34.96 60.22 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.628 -0.67 . . . . 0.0 110.648 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.0 m -82.22 -34.12 29.04 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.151 -0.968 . . . . 0.0 109.925 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.68 -36.74 90.75 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 70' ' ' GLN . 0.3 OUTLIER -69.99 -35.53 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.3 -1.118 . . . . 0.0 110.004 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.38 94.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.179 -0.951 . . . . 0.0 109.94 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -66.46 -39.44 94.08 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.441 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -67.6 -43.22 81.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.651 -0.911 . . . . 0.0 110.397 179.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.584 HG22 ' HG2' ' A' ' 53' ' ' MET . 94.4 m -58.99 -36.33 74.72 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.192 -0.943 . . . . 0.0 109.578 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.784 ' HB1' HD12 ' A' ' 18' ' ' ILE . . . -80.33 -32.71 37.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.525 -0.735 . . . . 0.0 109.876 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 75' ' ' GLY . 1.3 ttpm? -75.71 -34.47 60.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.461 -0.774 . . . . 0.0 110.102 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -39.58 86.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.481 -0.762 . . . . 0.0 109.626 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.406 ' CD1' HG22 ' A' ' 61' ' ' ILE . 51.3 t80 -70.12 -38.48 75.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.375 -0.828 . . . . 0.0 109.082 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.493 HG11 ' HA ' ' A' ' 11' ' ' ALA . 39.0 t -66.68 -39.15 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.652 -0.655 . . . . 0.0 109.662 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.44 -44.77 96.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.356 -0.84 . . . . 0.0 109.414 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -68.95 -37.11 78.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.53 -0.731 . . . . 0.0 109.516 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.68 -37.2 76.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.565 -0.71 . . . . 0.0 109.747 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -64.68 -41.45 96.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.582 -0.699 . . . . 0.0 109.734 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -69.19 -34.42 74.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.51 -0.744 . . . . 0.0 110.616 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.95 -51.84 12.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.271 -0.893 . . . . 0.0 110.239 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.07 52.55 0.13 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 90' ' ' LEU . 6.0 mt -114.87 -48.87 2.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.267 -1.137 . . . . 0.0 110.225 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.451 HD13 HG11 ' A' ' 14' ' ' VAL . 82.4 mt -103.81 94.57 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 110.06 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.486 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 5.0 m -78.11 178.37 7.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.329 -0.857 . . . . 0.0 109.898 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -57.86 7.2 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.284 -0.885 . . . . 0.0 110.479 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -63.13 -35.56 80.68 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.24 -0.913 . . . . 0.0 110.134 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.4 OUTLIER -70.26 -32.31 70.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.393 -0.817 . . . . 0.0 109.547 178.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.7 -40.71 93.24 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.411 -0.806 . . . . 0.0 109.353 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -63.33 -46.64 85.69 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -66.01 -37.3 85.57 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.874 ' HD1' HD12 ' A' ' 30' ' ' LEU . 58.5 t90 -65.26 -38.89 91.72 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.02 0.438 . . . . 0.0 109.855 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.509 ' HA ' ' HG3' ' A' ' 17' ' ' LYS . 11.8 mt -66.92 -38.94 87.12 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.655 -0.653 . . . . 0.0 109.78 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 62.3 m -74.84 -45.28 44.27 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.366 -0.834 . . . . 0.0 110.326 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.821 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.284 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.079 0.466 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.35 44.62 0.71 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.549 -0.72 . . . . 0.0 110.324 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -163.38 127.09 2.79 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.401 -0.812 . . . . 0.0 110.149 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.565 HG12 ' HB3' ' A' ' 8' ' ' GLU . 32.2 m -121.08 160.88 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.555 -0.716 . . . . 0.0 110.453 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.0 tm0? -101.27 -46.17 5.12 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.359 -0.838 . . . . 0.0 110.151 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.69 -68.49 0.03 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -69.42 -27.8 65.59 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.55 -0.971 . . . . 0.0 110.38 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.565 ' HB3' HG12 ' A' ' 4' ' ' VAL . 1.4 mm-40 -59.95 -35.28 74.61 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.369 -0.832 . . . . 0.0 109.702 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.99 -40.89 87.47 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.486 -0.759 . . . . 0.0 109.334 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 14' ' ' VAL . 40.2 t -63.07 -39.65 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.78 -41.35 97.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.653 -0.655 . . . . 0.0 109.429 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.31 -41.64 93.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.681 -0.637 . . . . 0.0 109.685 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.7 99.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.525 -0.734 . . . . 0.0 109.41 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 10' ' ' VAL . 86.9 t -65.99 -40.73 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -65.11 -38.56 91.1 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.459 -0.776 . . . . 0.0 109.49 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -38.56 91.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.455 -0.778 . . . . 0.0 109.44 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.663 ' HE3' HD23 ' A' ' 100' ' ' LEU . 4.9 tppt? -67.2 -32.3 73.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.543 -0.723 . . . . 0.0 109.686 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.544 HG21 ' HB2' ' A' ' 78' ' ' ALA . 6.5 mm -61.53 -49.38 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.416 -0.802 . . . . 0.0 109.262 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.7 t -61.66 -39.12 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.58 -0.7 . . . . 0.0 109.935 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.46 -33.41 86.39 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 tp -112.05 36.89 3.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.396 -1.061 . . . . 0.0 110.581 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.408 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 25.2 t90 -102.44 136.97 41.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 111.266 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -99.35 -166.43 1.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -51.19 -40.13 57.99 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.043 -1.035 . . . . 0.0 110.245 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -158.6 34.61 0.23 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.584 -0.698 . . . . 0.0 110.605 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -154.35 141.2 19.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.251 -0.905 . . . . 0.0 111.021 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.5 t -145.52 157.7 43.95 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.301 -0.875 . . . . 0.0 109.594 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 32' ' ' HIS . 9.7 mt-10 -101.23 122.95 44.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.359 -0.838 . . . . 0.0 111.229 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.622 HD12 ' SG ' ' A' ' 34' ' ' CYS . 7.2 mt -108.17 116.36 31.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.569 -0.707 . . . . 0.0 109.396 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.632 HD11 ' HG3' ' A' ' 95' ' ' GLU . 1.2 tp 58.48 31.1 20.61 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.784 -0.572 . . . . 0.0 110.73 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.32 -8.19 79.41 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 54.6 m-70 -91.33 163.64 14.14 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.121 -1.223 . . . . 0.0 110.273 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.58 127.98 38.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.569 -0.707 . . . . 0.0 110.324 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.622 ' SG ' HD12 ' A' ' 29' ' ' LEU . 64.3 m -127.61 170.74 12.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.674 -0.641 . . . . 0.0 110.04 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -123.22 99.94 6.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.543 -0.723 . . . . 0.0 110.312 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.492 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 5.4 t80 -112.53 135.08 53.66 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.23 171.37 16.59 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.11 -0.993 . . . . 0.0 110.841 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.452 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 44.7 t -129.35 135.36 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.788 -0.57 . . . . 0.0 109.619 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.25 87.22 39.25 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.286 -0.884 . . . . 0.0 110.776 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -79.55 158.97 25.46 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.826 1.435 . . . . 0.0 110.475 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -123.66 -179.94 4.55 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.375 -0.828 . . . . 0.0 110.195 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.783 HD12 HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -147.83 146.95 29.31 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.681 -0.637 . . . . 0.0 110.654 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.53 176.59 8.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.643 -0.66 . . . . 0.0 109.742 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -42.37 -39.48 2.19 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.4 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 35.3 p90 -152.04 30.49 0.56 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.366 -0.834 . . . . 0.0 110.772 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 45' ' ' PHE . 50.6 mt-30 -144.99 135.87 24.68 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.134 -0.979 . . . . 0.0 110.526 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.783 HG13 HD12 ' A' ' 42' ' ' LEU . 18.3 t -114.75 118.21 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.287 -0.883 . . . . 0.0 109.472 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -98.44 154.76 17.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.515 -0.74 . . . . 0.0 110.102 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -127.99 128.7 45.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.026 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -135.54 157.39 47.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -0.941 . . . . 0.0 110.18 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -149.3 148.07 19.06 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.572 ' HD3' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -143.25 143.31 31.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.659 -0.906 . . . . 0.0 110.16 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.53 ' HG2' HG22 ' A' ' 77' ' ' THR . 1.6 ppp? -148.64 150.25 32.93 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.255 -0.903 . . . . 0.0 111.137 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.553 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 46.7 p90 -164.02 152.11 12.86 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.785 -0.572 . . . . 0.0 110.376 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 75.7 m -111.16 92.45 15.54 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.209 -0.932 . . . . 0.0 110.71 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.553 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 48.9 Cg_endo -74.21 88.61 1.11 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.903 1.475 . . . . 0.0 110.192 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 146.49 -47.22 0.71 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -71.1 -50.89 28.86 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.549 -0.971 . . . . 0.0 110.19 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.515 ' CB ' HD11 ' A' ' 90' ' ' LEU . 14.3 t -151.96 -169.89 3.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.632 -0.668 . . . . 0.0 109.901 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.63 61.97 0.78 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 0.0 110.367 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.733 HD11 ' HB3' ' A' ' 84' ' ' LYS . 10.5 tt -137.91 150.52 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.336 -0.852 . . . . 0.0 109.99 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.34 155.97 49.32 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.806 . . . . 0.0 110.594 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.5 151.36 21.15 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.572 ' HB3' ' HD3' ' A' ' 52' ' ' ARG . 1.8 pp20? -156.38 158.65 37.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.391 -1.064 . . . . 0.0 110.738 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.48 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -146.42 148.36 32.21 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.586 -0.696 . . . . 0.0 110.81 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.427 ' O ' ' HB ' ' A' ' 67' ' ' THR . 1.4 m -138.04 139.14 39.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.368 -0.833 . . . . 0.0 110.331 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 66' ' ' SER . 6.1 t 179.63 -163.34 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.843 -0.535 . . . . 0.0 109.819 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.94 -23.79 14.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.4 -0.813 . . . . 0.0 110.334 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.2 m -61.91 153.32 29.46 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.108 -0.995 . . . . 0.0 110.454 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.455 ' O ' HG12 ' A' ' 73' ' ' VAL . 38.5 tt0 -93.15 -56.92 2.79 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.643 -0.661 . . . . 0.0 110.412 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.2 p -81.42 -28.58 34.2 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.376 -0.828 . . . . 0.0 110.475 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.1 -45.01 96.75 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 70' ' ' GLN . 2.5 p -58.8 -38.07 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.498 -1.001 . . . . 0.0 110.538 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.4 ' N ' ' CG1' ' A' ' 73' ' ' VAL . . . -65.25 -47.6 76.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.467 -0.771 . . . . 0.0 109.801 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -63.49 -39.77 98.05 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.48 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -62.87 -42.02 99.61 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.571 -0.958 . . . . 0.0 110.285 179.372 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.53 HG22 ' HG2' ' A' ' 53' ' ' MET . 47.6 m -62.12 -41.25 98.06 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.257 -0.902 . . . . 0.0 109.978 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.615 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -76.45 -36.85 57.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.526 -0.734 . . . . 0.0 110.037 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 75' ' ' GLY . 0.1 OUTLIER -69.11 -38.36 78.88 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.531 -0.731 . . . . 0.0 110.137 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -69.12 -35.54 76.51 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.442 ' CE2' HG23 ' A' ' 61' ' ' ILE . 42.7 t80 -66.62 -41.0 89.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.569 -0.707 . . . . 0.0 109.68 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 78' ' ' ALA . 84.3 t -64.7 -38.62 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.538 -0.726 . . . . 0.0 109.738 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.1 tpt85 -63.82 -39.52 94.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.565 -0.71 . . . . 0.0 109.73 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.733 ' HB3' HD11 ' A' ' 61' ' ' ILE . 36.4 mtpt -69.35 -33.86 73.74 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.379 -0.826 . . . . 0.0 109.529 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.47 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -76.28 -27.69 56.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.306 -0.871 . . . . 0.0 109.231 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.48 -41.9 72.11 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.719 -0.613 . . . . 0.0 110.019 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.435 ' HG3' ' N ' ' A' ' 88' ' ' LYS . 6.0 pt20 -67.48 -36.22 80.69 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.378 -0.826 . . . . 0.0 110.585 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.715 ' HD2' HD12 ' A' ' 61' ' ' ILE . 10.5 mttt -74.4 -54.81 6.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.297 -0.877 . . . . 0.0 110.004 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.98 52.37 0.07 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.515 HD11 ' CB ' ' A' ' 59' ' ' THR . 6.1 mt -119.32 -61.64 1.6 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.245 -1.15 . . . . 0.0 109.893 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 82' ' ' VAL . 72.9 mt -89.5 75.46 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.505 -0.747 . . . . 0.0 109.237 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.2 t -62.13 178.97 0.33 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.753 -0.592 . . . . 0.0 110.535 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -62.03 -54.63 38.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.472 -0.768 . . . . 0.0 110.217 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -67.85 -29.44 68.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.623 -0.673 . . . . 0.0 110.675 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.632 ' HG3' HD11 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -63.78 -45.41 89.86 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.357 -0.84 . . . . 0.0 110.188 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.66 -38.04 89.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.514 -0.741 . . . . 0.0 109.622 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -66.65 -36.79 83.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.503 -0.748 . . . . 0.0 110.307 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -41.41 90.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.342 -0.849 . . . . 0.0 109.761 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.639 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 13.6 t90 -67.26 -40.96 86.29 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.354 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.663 HD23 ' HE3' ' A' ' 17' ' ' LYS . 43.3 mt -57.12 -38.31 73.26 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.631 -0.668 . . . . 0.0 109.62 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.6 t -76.78 -42.8 39.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.493 -0.754 . . . . 0.0 109.757 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.408 -0.806 . . . . 0.0 110.172 179.86 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.471 0.653 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.43 170.68 19.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.268 -0.895 . . . . 0.0 110.514 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 68.67 -67.01 0.22 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 122.02 -0.425 . . . . 0.0 111.045 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.5 t -80.18 137.82 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.214 -0.929 . . . . 0.0 109.93 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.97 151.28 45.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.452 -0.78 . . . . 0.0 110.754 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.58 -22.23 60.53 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -60.4 -46.08 91.28 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.224 -1.163 . . . . 0.0 110.458 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -60.87 -39.55 89.61 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.337 -0.852 . . . . 0.0 109.986 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.69 -40.87 97.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.514 -0.741 . . . . 0.0 109.642 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.466 ' O ' HG23 ' A' ' 14' ' ' VAL . 77.8 t -64.49 -39.56 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.596 -0.69 . . . . 0.0 109.202 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.686 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -63.54 -39.56 94.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.759 -0.588 . . . . 0.0 109.813 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.63 99.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.534 -0.729 . . . . 0.0 109.648 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.13 99.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.603 -0.686 . . . . 0.0 109.671 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 10' ' ' VAL . 91.5 t -62.98 -40.8 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.521 -0.737 . . . . 0.0 109.431 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.68 -38.71 92.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.544 -0.722 . . . . 0.0 109.536 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.1 t -62.46 -41.76 98.99 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.661 -0.65 . . . . 0.0 109.627 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.44 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 11.8 tttm -65.35 -32.49 74.15 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.433 -0.792 . . . . 0.0 110.063 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.495 HG21 ' HB2' ' A' ' 78' ' ' ALA . 8.7 mm -64.94 -45.86 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.419 -0.801 . . . . 0.0 109.66 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.56 -40.77 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.546 -0.721 . . . . 0.0 110.206 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.18 -19.27 78.66 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.276 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 tp -120.41 21.15 11.75 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.865 -1.374 . . . . 0.0 111.945 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.547 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 18.6 t90 -90.88 137.74 32.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.902 -1.124 . . . . 0.0 109.948 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.64 -169.14 1.79 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.41 -0.806 . . . . 0.0 109.369 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -45.54 -44.04 12.42 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.153 -0.967 . . . . 0.0 110.311 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.475 ' O ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -158.39 33.31 0.24 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.579 -0.7 . . . . 0.0 110.828 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -141.5 152.73 44.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.12 -0.987 . . . . 0.0 111.001 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.541 HG23 ' CB ' ' A' ' 34' ' ' CYS . 2.1 t -155.07 167.32 30.76 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.629 -0.669 . . . . 0.0 109.476 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -136.55 119.13 15.95 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.275 -0.89 . . . . 0.0 109.992 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.595 HD13 ' CE2' ' A' ' 81' ' ' PHE . 5.2 mt -108.64 120.74 43.33 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.333 -0.854 . . . . 0.0 110.456 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.412 ' HB3' ' CD2' ' A' ' 32' ' ' HIS . 5.0 tp 56.52 31.06 18.3 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.582 -0.699 . . . . 0.0 111.007 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.44 -11.78 64.85 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.594 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 59.8 m-70 -84.63 141.52 30.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.028 -1.278 . . . . 0.0 110.006 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -72.2 135.74 46.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.391 -0.818 . . . . 0.0 110.305 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.546 ' SG ' HD12 ' A' ' 29' ' ' LEU . 45.1 m -139.15 168.57 19.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.614 -0.679 . . . . 0.0 110.059 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.475 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER -129.7 121.21 26.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.511 -0.743 . . . . 0.0 110.051 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.547 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 26.8 t80 -120.42 136.77 54.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.555 -0.716 . . . . 0.0 109.364 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.1 p -140.36 151.0 44.64 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.061 -1.025 . . . . 0.0 111.503 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.7 t -132.64 129.25 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 mtmm -142.56 117.33 6.56 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.159 -0.963 . . . . 0.0 110.938 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.03 157.62 34.27 Favored 'Trans proline' 0 C--N 1.313 -1.289 0 O-C-N 123.954 1.502 . . . . 0.0 110.251 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -131.79 -169.2 2.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.418 -0.801 . . . . 0.0 110.091 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 tp -139.21 144.29 38.43 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.543 0.687 . . . . 0.0 111.009 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.404 ' HD3' ' CE2' ' A' ' 48' ' ' TYR . 5.9 tptt -115.15 177.8 4.52 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -40.73 -39.71 1.15 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.907 -0.496 . . . . 0.0 111.204 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -157.45 47.33 0.4 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.543 -0.723 . . . . 0.0 110.218 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.83 149.86 13.08 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.111 -0.993 . . . . 0.0 111.45 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 79.6 t -98.48 136.81 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.508 -0.745 . . . . 0.0 109.157 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.404 ' CE2' ' HD3' ' A' ' 43' ' ' LYS . 15.6 m-85 -124.54 159.85 29.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.32 -0.862 . . . . 0.0 110.773 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.485 ' CZ ' ' HG3' ' A' ' 70' ' ' GLN . 0.5 OUTLIER -124.28 131.62 53.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.476 -0.765 . . . . 0.0 110.028 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -135.69 157.14 47.6 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.449 -0.782 . . . . 0.0 110.495 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.91 147.58 17.55 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.491 ' HD3' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -141.16 145.52 35.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.826 -0.808 . . . . 0.0 110.033 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.646 ' HG2' HG22 ' A' ' 77' ' ' THR . 2.2 ptm -143.99 151.88 40.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.078 -1.014 . . . . 0.0 111.079 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.472 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 48.6 p90 -155.84 150.56 26.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.7 -0.625 . . . . 0.0 110.32 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 87.1 m -113.53 90.49 17.83 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.214 -0.929 . . . . 0.0 110.964 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.472 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.4 Cg_endo -78.66 84.8 1.96 Allowed 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.957 1.504 . . . . 0.0 110.108 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.49 -47.6 0.41 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.594 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 19.4 t90 -77.08 -54.66 6.25 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.449 -1.03 . . . . 0.0 110.384 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.556 HG21 HD13 ' A' ' 90' ' ' LEU . 8.9 t -153.74 -161.83 1.33 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.558 -0.714 . . . . 0.0 110.022 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.24 48.57 1.39 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.518 -0.739 . . . . 0.0 110.212 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.735 HD12 HD12 ' A' ' 90' ' ' LEU . 34.4 mt -118.36 146.57 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.366 -0.834 . . . . 0.0 109.83 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.16 161.72 35.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.365 -0.835 . . . . 0.0 110.98 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.68 131.76 5.89 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HG2' ' HD3' ' A' ' 52' ' ' ARG . 12.9 mp0 -126.44 160.25 31.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.644 -0.915 . . . . 0.0 109.914 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.738 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -171.76 152.34 3.06 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.414 -0.804 . . . . 0.0 111.188 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.1 143.44 31.13 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.516 -0.74 . . . . 0.0 110.115 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.8 t -173.25 155.42 2.92 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.52 -0.738 . . . . 0.0 110.323 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.41 -35.88 70.6 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.532 -0.73 . . . . 0.0 111.411 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.406 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 0.9 OUTLIER -62.31 135.6 57.54 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.32 -0.863 . . . . 0.0 110.354 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.509 ' O ' HG12 ' A' ' 73' ' ' VAL . 4.6 mp0 -70.23 -61.39 1.79 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.705 -0.622 . . . . 0.0 109.98 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.2 t -72.93 -28.76 62.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.24 -0.913 . . . . 0.0 109.879 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -58.27 -39.66 92.86 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 70' ' ' GLN . 0.5 OUTLIER -64.97 -35.81 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.377 -1.072 . . . . 0.0 109.992 179.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.96 -39.76 87.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.433 -0.792 . . . . 0.0 110.036 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.05 -34.34 76.13 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.738 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -70.36 -42.22 72.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.62 -0.929 . . . . 0.0 110.177 179.502 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.646 HG22 ' HG2' ' A' ' 53' ' ' MET . 66.5 m -62.49 -40.01 95.33 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.286 -0.884 . . . . 0.0 109.419 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -73.47 -37.02 65.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.514 -0.741 . . . . 0.0 109.685 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -38.78 86.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.505 -0.747 . . . . 0.0 109.693 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -41.97 99.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.565 -0.709 . . . . 0.0 110.001 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.595 ' CE2' HD13 ' A' ' 29' ' ' LEU . 51.5 t80 -65.72 -40.8 92.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.443 -0.785 . . . . 0.0 109.973 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.686 HG11 ' HA ' ' A' ' 11' ' ' ALA . 97.1 t -66.1 -36.04 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.484 -0.76 . . . . 0.0 109.915 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -67.04 -40.66 87.23 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.47 -0.769 . . . . 0.0 109.982 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -37.11 80.56 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.535 -0.728 . . . . 0.0 109.869 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.707 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -68.98 -35.27 76.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.385 -0.822 . . . . 0.0 110.134 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.9 -36.22 72.64 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.477 -0.764 . . . . 0.0 109.687 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -63.1 -29.05 70.5 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.601 -0.687 . . . . 0.0 110.412 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -55.29 3.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.43 -0.794 . . . . 0.0 110.332 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 136.61 56.53 0.06 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.735 HD12 HD12 ' A' ' 61' ' ' ILE . 11.5 mt -125.44 -46.41 1.76 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.336 -1.096 . . . . 0.0 110.579 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.707 HD12 ' HB3' ' A' ' 85' ' ' ALA . 89.0 mt -96.78 112.38 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 109.741 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.5 m -91.25 162.63 14.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.542 -0.724 . . . . 0.0 110.353 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -63.29 -53.72 48.34 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.526 -0.734 . . . . 0.0 110.259 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -61.64 -42.74 99.31 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.481 -0.762 . . . . 0.0 110.733 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -59.27 -41.66 89.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.317 -0.864 . . . . 0.0 110.176 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.06 -40.24 97.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.381 -0.824 . . . . 0.0 109.741 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -64.21 -39.88 94.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.567 -0.708 . . . . 0.0 109.868 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -63.26 -40.48 97.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.668 -0.645 . . . . 0.0 109.745 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.44 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 15.1 t90 -68.45 -36.54 79.17 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.591 -0.693 . . . . 0.0 109.9 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.428 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 14.1 mt -66.71 -30.91 71.26 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.699 -0.626 . . . . 0.0 110.548 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.3 m -55.4 -41.67 73.0 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.429 -0.795 . . . . 0.0 110.582 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.436 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 2.6 mt-10 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 120.75 0.309 . . . . 0.0 110.534 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 1' ' ' GLU . . . 58.19 -155.47 0.34 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.566 -0.709 . . . . 0.0 110.454 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -67.51 140.54 57.03 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.306 -0.872 . . . . 0.0 110.32 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.4 t -116.93 -50.63 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.447 -0.783 . . . . 0.0 110.444 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -80.97 155.85 26.23 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.239 -0.913 . . . . 0.0 110.433 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.65 -82.42 0.04 OUTLIER Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -65.14 -21.75 66.83 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.417 -1.049 . . . . 0.0 110.799 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -40.05 85.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.233 -0.917 . . . . 0.0 109.401 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.28 -39.45 71.52 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.536 ' O ' HG23 ' A' ' 14' ' ' VAL . 97.4 t -68.5 -38.79 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.809 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -64.19 -39.74 94.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.611 -0.681 . . . . 0.0 109.647 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.58 -41.56 99.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.551 -0.718 . . . . 0.0 109.79 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.49 -40.43 89.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.397 -0.814 . . . . 0.0 109.693 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 10' ' ' VAL . 95.0 t -64.96 -40.78 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.439 -0.788 . . . . 0.0 109.137 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -62.13 -40.27 95.35 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.687 -0.633 . . . . 0.0 109.75 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 t -61.39 -41.78 97.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.563 -0.711 . . . . 0.0 109.755 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.461 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 14.4 tttm -68.36 -30.44 69.39 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.472 -0.767 . . . . 0.0 110.215 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.533 HG21 ' HB2' ' A' ' 78' ' ' ALA . 12.9 mm -68.1 -44.32 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.423 -0.798 . . . . 0.0 109.702 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.77 -39.24 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.342 -0.849 . . . . 0.0 110.196 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.57 -27.58 69.14 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.68 28.73 8.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.1 -1.235 . . . . 0.0 111.613 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -95.65 132.69 40.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.929 -1.107 . . . . 0.0 110.48 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -98.09 -166.04 1.33 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -48.0 -41.95 26.71 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.161 -0.962 . . . . 0.0 110.26 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -161.97 37.83 0.12 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.725 -0.609 . . . . 0.0 110.261 179.566 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -146.12 158.83 43.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.188 -0.945 . . . . 0.0 111.205 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.562 HG23 ' HB2' ' A' ' 34' ' ' CYS . 8.0 t -163.61 154.3 15.97 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.682 -0.636 . . . . 0.0 109.406 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -110.94 111.11 22.01 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.21 -0.932 . . . . 0.0 110.302 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.446 HD21 HD11 ' A' ' 18' ' ' ILE . 2.8 mt -107.06 128.86 54.75 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.355 -0.841 . . . . 0.0 110.763 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 30' ' ' LEU . 4.7 tp 54.48 36.0 24.63 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.599 -0.688 . . . . 0.0 111.17 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.32 23.49 78.01 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.567 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 51.6 m-70 -123.14 151.67 41.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -1.087 . . . . 0.0 109.895 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.46 127.43 32.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.312 -0.868 . . . . 0.0 110.597 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.562 ' HB2' HG23 ' A' ' 27' ' ' THR . 59.9 m -129.33 171.25 12.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.685 -0.635 . . . . 0.0 109.996 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 7.9 tptm -128.06 100.68 5.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.526 -0.734 . . . . 0.0 110.276 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.474 ' CD1' ' HB3' ' A' ' 53' ' ' MET . 3.8 t80 -112.85 136.1 52.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.755 -0.591 . . . . 0.0 109.703 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.01 170.85 16.85 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.343 -0.848 . . . . 0.0 111.045 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.506 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 76.0 t -133.41 130.64 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -137.84 93.74 11.96 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.158 -0.964 . . . . 0.0 111.192 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.477 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 56.5 Cg_endo -77.57 169.75 20.44 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.916 1.482 . . . . 0.0 110.316 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -151.7 -178.21 6.57 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.255 -0.903 . . . . 0.0 110.443 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.69 150.62 34.96 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.395 0.617 . . . . 0.0 110.637 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -120.53 177.97 4.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.793 -0.567 . . . . 0.0 109.618 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -40.42 -40.26 1.16 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.877 -0.514 . . . . 0.0 111.563 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -155.56 36.1 0.37 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.328 -0.858 . . . . 0.0 110.993 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.86 145.87 10.83 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.987 -1.071 . . . . 0.0 110.884 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.06 122.83 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.282 -0.886 . . . . 0.0 109.355 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -108.69 150.84 26.99 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.487 -0.758 . . . . 0.0 110.756 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.548 ' CE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -108.98 156.86 19.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.456 -0.778 . . . . 0.0 110.195 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -156.78 149.75 23.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.312 -0.867 . . . . 0.0 110.189 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -145.87 149.97 22.15 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HD3' ' CB ' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -148.42 145.05 27.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.7 -0.882 . . . . 0.0 110.113 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.508 ' HG2' HG22 ' A' ' 77' ' ' THR . 5.4 ptm -144.54 151.3 38.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.374 -0.829 . . . . 0.0 111.123 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.496 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 42.8 p90 -153.93 147.93 25.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.786 -0.571 . . . . 0.0 109.888 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 58' ' ' TRP . 87.5 m -111.58 89.9 11.6 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.222 -0.924 . . . . 0.0 111.449 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -77.06 85.72 1.73 Allowed 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.856 1.451 . . . . 0.0 110.091 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.83 -46.63 0.64 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.567 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 12.1 t90 -70.31 -57.43 4.88 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.672 -0.899 . . . . 0.0 109.996 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -152.1 -164.37 1.95 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.61 -0.681 . . . . 0.0 109.901 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.63 56.83 0.88 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.356 -0.84 . . . . 0.0 109.767 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.565 HD11 ' HE2' ' A' ' 88' ' ' LYS . 31.7 mt -130.55 158.71 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.608 -0.683 . . . . 0.0 109.699 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -135.93 171.04 15.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.45 -0.781 . . . . 0.0 110.695 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.56 127.96 1.83 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.432 ' CB ' ' HD3' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -147.48 156.06 42.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.608 -0.937 . . . . 0.0 110.709 -179.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.582 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -158.4 155.57 28.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.458 -0.776 . . . . 0.0 110.614 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.501 ' HA ' HG23 ' A' ' 73' ' ' VAL . 0.7 OUTLIER -133.42 145.45 50.3 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.418 -0.801 . . . . 0.0 110.688 -179.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 t -172.7 152.29 2.49 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.629 -0.669 . . . . 0.0 109.67 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -26.97 61.23 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.361 -0.837 . . . . 0.0 111.346 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.8 133.24 51.55 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.28 -0.888 . . . . 0.0 110.618 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.548 ' HA ' ' CE2' ' A' ' 49' ' ' TYR . 1.0 OUTLIER -70.36 -53.12 17.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.56 -0.712 . . . . 0.0 110.559 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.9 m -80.88 -28.31 36.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.331 -0.856 . . . . 0.0 110.082 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.17 -44.16 98.49 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' A' ' 66' ' ' SER . 0.5 OUTLIER -58.37 -36.37 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.461 -1.023 . . . . 0.0 110.321 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.449 ' HA ' ' HZ ' ' A' ' 36' ' ' PHE . . . -71.75 -43.3 66.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.589 -0.694 . . . . 0.0 109.653 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.58 -38.5 93.37 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.582 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -65.38 -40.47 93.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.643 -0.916 . . . . 0.0 109.996 179.433 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.508 HG22 ' HG2' ' A' ' 53' ' ' MET . 23.3 m -60.19 -43.51 95.84 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.542 -0.724 . . . . 0.0 109.32 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.533 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -68.7 -37.57 79.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.624 -0.673 . . . . 0.0 109.76 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.79 -40.17 94.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.559 -0.713 . . . . 0.0 109.61 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.53 -40.41 94.55 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.666 . . . . 0.0 110.049 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -70.18 -38.51 75.39 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.426 -0.797 . . . . 0.0 110.004 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.825 HG13 HG21 ' A' ' 91' ' ' ILE . 85.7 t -71.86 -33.4 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 0.0 110.027 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -41.27 80.67 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.282 -0.886 . . . . 0.0 109.361 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -36.67 67.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.494 -0.754 . . . . 0.0 108.983 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.37 -37.01 80.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.449 -0.782 . . . . 0.0 109.271 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -43.47 98.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.548 -0.72 . . . . 0.0 109.352 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -68.21 -37.1 80.52 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.659 -0.651 . . . . 0.0 110.534 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.565 ' HE2' HD11 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -72.37 -52.19 17.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.327 -0.858 . . . . 0.0 110.474 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.4 53.99 0.1 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 90' ' ' LEU . 12.4 mt -129.0 -49.88 1.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.487 -1.008 . . . . 0.0 110.521 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.825 HG21 HG13 ' A' ' 82' ' ' VAL . 32.5 mm -94.51 90.81 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 109.833 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -77.78 169.63 17.97 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.552 -0.718 . . . . 0.0 109.705 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.515 ' HG3' HG21 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -64.64 -54.47 31.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.404 -0.81 . . . . 0.0 110.462 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -69.29 -36.91 77.54 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.406 -0.809 . . . . 0.0 110.563 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.0 OUTLIER -62.4 -43.19 99.42 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.293 -0.879 . . . . 0.0 110.054 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.85 87.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.444 -0.785 . . . . 0.0 109.12 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -62.93 -41.15 99.38 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.81 -0.556 . . . . 0.0 109.889 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -41.46 96.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.445 -0.785 . . . . 0.0 109.288 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.461 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 29.6 t90 -66.74 -36.64 82.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.349 -0.844 . . . . 0.0 109.069 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 100' ' ' LEU . 21.1 tp -58.71 -43.48 90.1 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.932 -0.48 . . . . 0.0 109.955 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 99.6 p -78.65 -48.26 15.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.527 -0.733 . . . . 0.0 109.814 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 117.777 -1.106 . . . . 0.0 109.887 179.754 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.061 0.457 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.53 126.49 19.49 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.41 -0.806 . . . . 0.0 110.471 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -157.71 -59.46 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.516 -0.74 . . . . 0.0 110.287 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.9 p -101.16 -28.98 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.42 -0.8 . . . . 0.0 110.36 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -116.57 140.3 49.53 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.311 -0.868 . . . . 0.0 110.149 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 141.92 57.4 0.03 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -87.85 -37.79 16.23 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.549 -0.971 . . . . 0.0 110.305 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -62.45 -37.38 85.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.73 . . . . 0.0 110.164 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.1 -40.85 97.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.546 -0.721 . . . . 0.0 109.72 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 14' ' ' VAL . 64.4 t -67.04 -42.07 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.1 94.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.582 -0.699 . . . . 0.0 109.186 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.39 94.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.711 -0.618 . . . . 0.0 109.715 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.478 ' O ' HD21 ' A' ' 100' ' ' LEU . . . -62.5 -39.76 94.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.561 -0.712 . . . . 0.0 110.02 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.605 ' CG2' ' HB1' ' A' ' 96' ' ' ALA . 48.8 t -69.45 -39.65 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.329 -0.857 . . . . 0.0 109.237 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.68 -39.25 88.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.542 -0.724 . . . . 0.0 109.902 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 p -65.63 -35.97 82.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.406 -0.808 . . . . 0.0 109.923 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.79 ' HD3' HD23 ' A' ' 100' ' ' LEU . 4.7 tptt -65.78 -35.49 80.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.473 -0.767 . . . . 0.0 109.7 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.772 HD12 ' HB1' ' A' ' 78' ' ' ALA . 4.9 mt -65.52 -47.11 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.507 -0.746 . . . . 0.0 109.18 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.6 t -64.45 -39.49 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.523 -0.736 . . . . 0.0 110.051 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.58 -25.01 75.2 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.8 tp -120.68 31.39 6.45 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.289 -1.124 . . . . 0.0 111.021 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.423 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 23.5 t90 -93.28 136.71 33.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.987 -1.07 . . . . 0.0 110.479 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.07 -167.79 1.56 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.605 -0.685 . . . . 0.0 109.253 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.81 -43.02 18.03 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.24 -0.913 . . . . 0.0 110.206 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 1.4 pp20? -159.5 33.56 0.19 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.479 -0.763 . . . . 0.0 110.848 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -140.81 147.9 39.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.129 -0.982 . . . . 0.0 110.78 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 t -154.71 161.95 41.33 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.437 -0.789 . . . . 0.0 109.553 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -111.35 152.72 26.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.197 -0.939 . . . . 0.0 110.183 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.546 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 3.4 mt -146.18 119.02 8.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.405 -0.81 . . . . 0.0 109.971 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 tp 54.71 32.48 17.45 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.779 -0.576 . . . . 0.0 111.188 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.29 22.28 63.17 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 70.0 m-70 -124.89 147.14 48.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -1.143 . . . . 0.0 110.151 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.83 132.92 40.69 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.435 -0.79 . . . . 0.0 110.416 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.546 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 84.4 m -135.37 164.34 27.99 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.561 -0.712 . . . . 0.0 110.179 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.573 ' HB3' ' CE2' ' A' ' 54' ' ' TRP . 1.5 tptt -117.9 124.01 47.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.343 -0.848 . . . . 0.0 110.53 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.465 ' CZ ' ' HB ' ' A' ' 77' ' ' THR . 7.3 t80 -124.49 123.93 41.19 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.709 -0.619 . . . . 0.0 109.512 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.3 p -131.37 154.32 48.74 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.202 -0.937 . . . . 0.0 111.578 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 p -122.29 142.35 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.632 -0.667 . . . . 0.0 109.75 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.57 107.56 4.08 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.081 -1.012 . . . . 0.0 110.868 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -78.49 161.26 28.4 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 O-C-N 123.762 1.401 . . . . 0.0 110.509 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -132.17 -175.71 3.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.393 -0.817 . . . . 0.0 109.813 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.05 159.61 42.87 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.532 0.682 . . . . 0.0 110.946 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -135.85 176.36 8.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.745 -0.597 . . . . 0.0 109.586 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 61.8 mtt-85 -43.6 -35.48 1.76 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.661 -0.649 . . . . 0.0 111.032 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.57 42.14 0.42 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.539 -0.726 . . . . 0.0 110.018 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 43' ' ' LYS . 1.8 mt-30 -151.99 152.16 32.11 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.304 -0.872 . . . . 0.0 111.208 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.1 t -122.77 139.58 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -135.57 156.62 48.59 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.348 -0.845 . . . . 0.0 110.911 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 67' ' ' THR . 1.7 m-85 -122.57 132.13 54.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.548 -0.72 . . . . 0.0 109.95 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -132.26 162.99 29.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.427 -0.796 . . . . 0.0 110.381 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -158.0 141.95 8.14 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.53 147.36 52.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.799 -0.824 . . . . 0.0 109.805 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.674 ' HG2' HG22 ' A' ' 77' ' ' THR . 2.4 ppp? -149.05 157.24 43.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.109 -0.995 . . . . 0.0 111.05 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.573 ' CE2' ' HB3' ' A' ' 35' ' ' LYS . 47.3 p90 -164.5 176.6 8.84 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.826 -0.546 . . . . 0.0 110.117 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 58' ' ' TRP . 67.5 m -129.06 94.86 32.78 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.213 -0.929 . . . . 0.0 110.614 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 49.8 Cg_endo -77.01 81.61 2.56 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.902 1.475 . . . . 0.0 110.468 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.36 -46.24 0.64 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.494 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 12.6 t90 -68.61 -57.72 5.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.604 -0.939 . . . . 0.0 110.155 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -150.64 -166.23 2.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.471 -0.768 . . . . 0.0 109.939 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.19 50.6 1.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.382 -0.824 . . . . 0.0 110.225 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.4 mt -123.01 149.53 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.739 . . . . 0.0 109.781 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -129.37 165.58 21.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -0.902 . . . . 0.0 111.0 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.22 152.5 24.1 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 65' ' ' ALA . 27.3 tt0 -153.2 158.77 42.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.482 -1.01 . . . . 0.0 110.069 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.553 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -168.63 148.55 4.45 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.989 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.415 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 1.7 m -137.61 147.53 45.09 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.612 -0.68 . . . . 0.0 110.107 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.431 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 6.6 t -170.97 171.37 5.92 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.584 -0.698 . . . . 0.0 110.11 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -69.16 -42.24 76.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.423 -0.798 . . . . 0.0 111.26 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.74 138.97 57.77 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.358 -0.839 . . . . 0.0 110.848 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.566 ' O ' HG12 ' A' ' 73' ' ' VAL . 19.5 tt0 -73.01 -52.14 15.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.76 -0.587 . . . . 0.0 110.282 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.0 m -72.46 -34.8 68.0 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.311 -0.868 . . . . 0.0 110.106 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.04 -36.63 92.59 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 70' ' ' GLN . 0.4 OUTLIER -63.3 -37.91 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.364 -1.08 . . . . 0.0 110.392 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.66 -38.02 80.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.462 -0.774 . . . . 0.0 109.835 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.82 95.59 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.553 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 4.0 tttm -68.1 -40.91 82.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.539 -0.977 . . . . 0.0 110.402 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.674 HG22 ' HG2' ' A' ' 53' ' ' MET . 62.1 m -61.48 -38.22 86.48 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.074 -1.016 . . . . 0.0 109.871 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.772 ' HB1' HD12 ' A' ' 18' ' ' ILE . . . -77.36 -36.17 53.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.585 -0.697 . . . . 0.0 109.899 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -68.64 -39.08 80.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.357 -0.839 . . . . 0.0 109.858 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -67.46 -34.5 77.32 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.514 -0.741 . . . . 0.0 109.562 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.429 ' CD2' ' SD ' ' A' ' 53' ' ' MET . 41.7 t80 -68.07 -41.16 82.35 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.487 -0.758 . . . . 0.0 109.702 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.541 HG13 HG21 ' A' ' 91' ' ' ILE . 83.9 t -66.87 -36.47 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.496 -0.752 . . . . 0.0 109.496 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.26 -41.67 99.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.601 -0.687 . . . . 0.0 109.456 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.68 -40.11 88.41 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.47 -0.769 . . . . 0.0 109.34 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.64 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -68.24 -35.35 77.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.79 -0.569 . . . . 0.0 109.647 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.68 -35.94 81.34 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.646 -0.659 . . . . 0.0 109.689 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -61.59 -39.9 92.83 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.633 -0.667 . . . . 0.0 110.207 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -82.17 -59.1 2.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.439 -0.788 . . . . 0.0 110.176 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.43 51.16 0.05 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.483 ' HA ' HD23 ' A' ' 90' ' ' LEU . 10.0 mt -115.11 -46.47 2.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.33 -1.1 . . . . 0.0 110.297 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 85' ' ' ALA . 89.9 mt -106.66 89.96 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.434 -0.792 . . . . 0.0 109.936 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 17.0 m -71.62 163.87 26.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.436 -0.79 . . . . 0.0 109.632 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.432 ' HG2' HG11 ' A' ' 10' ' ' VAL . 7.2 tm0? -60.29 -51.15 70.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.438 -0.789 . . . . 0.0 110.105 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -41.81 96.39 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.726 -0.609 . . . . 0.0 110.315 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 0.3 OUTLIER -59.15 -41.53 88.54 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.493 -0.754 . . . . 0.0 110.037 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.605 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -61.39 -42.12 98.21 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.489 -0.757 . . . . 0.0 109.669 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -63.06 -42.63 99.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.548 -0.72 . . . . 0.0 109.614 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -40.28 91.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.574 -0.703 . . . . 0.0 109.598 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.581 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 24.3 t90 -65.42 -38.37 89.71 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.738 -0.601 . . . . 0.0 109.622 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.79 HD23 ' HD3' ' A' ' 17' ' ' LYS . 4.3 mt -65.06 -39.28 93.04 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.749 -0.594 . . . . 0.0 110.261 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.2 m -79.43 -51.15 9.74 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.495 -0.753 . . . . 0.0 110.491 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.504 2.239 0 CA-C-O 118.059 -0.972 . . . . 0.0 111.356 -179.966 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.448 0.642 . . . . 0.0 110.291 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.83 140.14 30.67 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.171 -0.956 . . . . 0.0 110.272 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -79.01 145.68 33.77 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.501 -0.75 . . . . 0.0 110.13 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.47 150.33 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.42 -0.8 . . . . 0.0 110.365 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 8' ' ' GLU . 17.6 mt-30 -103.81 173.76 6.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.482 -0.761 . . . . 0.0 110.238 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.95 -68.16 0.81 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -67.59 -36.79 81.55 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.559 -0.965 . . . . 0.0 110.23 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -66.69 -36.53 82.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.46 -0.775 . . . . 0.0 110.022 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.3 -41.89 84.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.494 -0.754 . . . . 0.0 109.841 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.0 t -69.35 -39.62 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.52 -0.737 . . . . 0.0 109.033 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.535 ' HB1' ' HE2' ' A' ' 79' ' ' LYS . . . -67.19 -40.71 86.55 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.63 -40.7 92.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.618 -0.676 . . . . 0.0 109.795 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.42 -43.16 97.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.555 -0.716 . . . . 0.0 109.528 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.681 ' CG2' ' HB1' ' A' ' 96' ' ' ALA . 44.0 t -62.43 -44.52 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.564 -0.71 . . . . 0.0 109.309 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.33 92.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.631 -0.668 . . . . 0.0 109.99 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 t -63.55 -38.66 91.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.515 -0.741 . . . . 0.0 110.042 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.549 ' HB3' ' CZ3' ' A' ' 99' ' ' TRP . 7.1 tttt -67.0 -33.83 76.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.95 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.614 HD12 ' HB1' ' A' ' 78' ' ' ALA . 10.2 mt -61.48 -48.31 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.449 -0.782 . . . . 0.0 109.757 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.3 t -62.14 -39.13 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.389 -0.819 . . . . 0.0 109.978 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.66 -28.29 73.25 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 tp -115.78 37.3 3.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.363 -1.081 . . . . 0.0 110.95 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -99.19 135.16 41.0 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.187 -0.946 . . . . 0.0 110.617 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.1 mtt-85 -98.49 -167.29 1.48 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -48.37 -43.23 33.46 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.984 -1.072 . . . . 0.0 110.385 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -158.89 36.5 0.22 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.641 -0.662 . . . . 0.0 110.476 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -150.33 157.79 43.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.305 -0.872 . . . . 0.0 110.49 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.403 HG23 ' HB2' ' A' ' 34' ' ' CYS . 12.1 t -157.6 -179.81 8.52 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.337 -0.852 . . . . 0.0 109.868 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -127.44 143.0 51.26 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.437 -0.789 . . . . 0.0 110.231 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.482 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 3.1 mt -137.54 123.49 20.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.296 -0.877 . . . . 0.0 109.835 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.544 HD22 ' HZ2' ' A' ' 58' ' ' TRP . 4.0 tp 56.39 30.09 16.33 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.736 -0.603 . . . . 0.0 111.066 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.31 19.01 65.39 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -118.61 163.69 16.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.151 -1.205 . . . . 0.0 110.208 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.2 133.98 34.21 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.477 -0.765 . . . . 0.0 109.896 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.617 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 90.1 m -135.41 165.8 24.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.466 -0.771 . . . . 0.0 110.875 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.33 118.29 31.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.547 -0.72 . . . . 0.0 110.387 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -129.32 126.51 39.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.577 -0.702 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.19 171.45 18.48 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.033 -1.042 . . . . 0.0 111.293 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.61 148.42 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.931 -0.48 . . . . 0.0 109.971 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -157.62 117.39 1.95 Allowed Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.21 -0.931 . . . . 0.0 110.36 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.33 154.06 36.07 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.821 1.432 . . . . 0.0 110.885 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.517 ' CE2' ' HB3' ' A' ' 50' ' ' LYS . 31.0 m-85 -128.43 -168.96 1.99 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.573 -0.704 . . . . 0.0 109.454 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.31 147.75 42.04 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.554 0.692 . . . . 0.0 110.826 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.66 177.16 4.8 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -38.43 -41.47 0.65 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 122.023 -0.423 . . . . 0.0 111.523 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.2 35.0 0.38 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.477 -0.764 . . . . 0.0 110.899 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.66 141.01 15.43 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.079 -1.013 . . . . 0.0 110.838 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 72.9 t -97.01 148.18 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.388 -0.82 . . . . 0.0 109.702 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -140.85 151.45 44.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.423 -0.798 . . . . 0.0 110.82 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.48 130.19 46.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.425 -0.797 . . . . 0.0 109.984 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.517 ' HB3' ' CE2' ' A' ' 41' ' ' TYR . 5.3 tttp -130.84 164.68 24.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.414 -0.803 . . . . 0.0 110.087 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -155.83 152.14 23.61 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.39 134.02 19.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.429 -1.042 . . . . 0.0 110.161 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.418 ' CE ' HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -138.95 158.74 43.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.495 -0.753 . . . . 0.0 110.82 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.584 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 43.9 p90 -168.81 -169.1 0.95 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.774 -0.579 . . . . 0.0 109.984 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 68.2 m -133.18 94.42 20.31 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.253 -0.905 . . . . 0.0 110.708 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.617 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 49.0 Cg_endo -74.87 80.94 2.28 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.986 1.519 . . . . 0.0 110.21 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.34 -45.09 0.64 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.544 ' HZ2' HD22 ' A' ' 30' ' ' LEU . 13.0 t90 -70.77 -55.56 8.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.649 -0.912 . . . . 0.0 110.09 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -151.14 -165.93 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.497 -0.752 . . . . 0.0 109.744 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.57 47.74 1.57 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.299 -0.876 . . . . 0.0 110.183 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.51 HD12 HD12 ' A' ' 90' ' ' LEU . 23.1 mt -123.44 150.9 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.345 -0.847 . . . . 0.0 109.993 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.71 164.38 30.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.316 -0.865 . . . . 0.0 111.328 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.87 130.27 3.83 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.35 170.09 16.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.436 -1.038 . . . . 0.0 111.095 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.556 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -166.34 173.02 10.42 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.385 0.612 . . . . 0.0 110.836 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.43 148.48 24.58 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.391 -0.818 . . . . 0.0 110.87 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.5 t -171.22 169.17 6.51 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.661 -0.649 . . . . 0.0 110.138 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -37.94 88.68 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.288 -0.882 . . . . 0.0 110.529 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.3 t -67.56 162.95 22.27 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.498 -0.751 . . . . 0.0 110.859 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.553 ' O ' HG12 ' A' ' 73' ' ' VAL . 34.0 mt-30 -97.81 -56.24 2.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.899 -0.5 . . . . 0.0 110.122 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 m -67.24 -29.65 69.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.399 -0.813 . . . . 0.0 110.519 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.04 -41.14 97.85 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 110.174 -1.171 . . . . 0.0 110.174 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 70' ' ' GLN . 0.5 OUTLIER -65.51 -34.09 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.455 -1.027 . . . . 0.0 110.47 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.04 -39.38 86.94 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.632 -0.667 . . . . 0.0 110.375 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.07 -33.43 69.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.556 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 8.5 mmmt -73.45 -39.62 64.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.524 -0.986 . . . . 0.0 110.432 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.62 -45.45 81.51 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.105 -0.997 . . . . 0.0 109.641 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.614 ' HB1' HD12 ' A' ' 18' ' ' ILE . . . -72.3 -34.92 68.51 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.736 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.574 ' HZ2' ' HA ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -72.95 -36.45 67.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.445 -0.784 . . . . 0.0 110.702 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.91 -35.23 74.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.451 -0.781 . . . . 0.0 110.315 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.44 ' CE2' HD13 ' A' ' 29' ' ' LEU . 61.1 t80 -71.09 -40.5 71.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 110.243 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.52 HG13 HD13 ' A' ' 91' ' ' ILE . 68.8 t -67.62 -35.06 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.297 -0.877 . . . . 0.0 109.814 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -68.4 -39.07 81.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.515 -0.741 . . . . 0.0 109.733 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.46 ' HB2' ' HE3' ' A' ' 84' ' ' LYS . 1.6 tppp? -64.24 -41.13 97.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.553 -0.717 . . . . 0.0 110.109 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.71 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -69.98 -34.51 73.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.503 -0.748 . . . . 0.0 109.643 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -40.76 95.68 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.682 -0.636 . . . . 0.0 109.646 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -66.5 -38.46 87.3 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.547 -0.72 . . . . 0.0 110.362 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.64 -50.36 21.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.376 -0.827 . . . . 0.0 110.4 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.91 53.49 0.13 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.51 HD12 HD12 ' A' ' 61' ' ' ILE . 12.4 mt -125.74 -51.59 1.59 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.364 -1.08 . . . . 0.0 110.447 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.71 HD12 ' HB3' ' A' ' 85' ' ' ALA . 74.5 mt -86.75 104.85 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.714 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 58.2 m -83.77 171.98 12.65 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.527 -0.733 . . . . 0.0 109.971 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -68.16 -56.91 7.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.469 -0.769 . . . . 0.0 110.357 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -37.35 87.3 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.437 -0.789 . . . . 0.0 110.489 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 1.4 mm-40 -53.67 -42.15 67.6 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.455 -0.778 . . . . 0.0 110.017 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.681 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -63.77 -40.28 96.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.471 -0.768 . . . . 0.0 109.523 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -68.24 -38.77 82.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.694 -0.629 . . . . 0.0 109.395 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -62.89 -40.05 96.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.587 -0.695 . . . . 0.0 109.836 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.549 ' CZ3' ' HB3' ' A' ' 17' ' ' LYS . 28.1 t90 -71.98 -39.03 69.58 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.4 tp -66.66 -39.58 88.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.782 -0.574 . . . . 0.0 109.647 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.5 t -72.32 -58.1 3.68 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.757 -0.589 . . . . 0.0 110.257 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.041 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.618 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.203 0.525 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.44 125.73 40.25 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.428 -0.795 . . . . 0.0 110.25 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -96.42 -53.58 3.55 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.482 -0.761 . . . . 0.0 110.168 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 99.8 t -103.39 155.84 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.427 -0.796 . . . . 0.0 109.916 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.8 172.79 5.96 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.37 -0.831 . . . . 0.0 110.161 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.98 -59.33 0.24 Allowed Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -57.07 -40.94 77.87 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.682 -0.893 . . . . 0.0 110.229 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.04 -38.65 89.52 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.479 -0.763 . . . . 0.0 109.841 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.49 -40.3 95.41 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.572 -0.705 . . . . 0.0 109.632 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.7 t -63.12 -41.5 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.723 . . . . 0.0 109.121 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.58 -39.75 95.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.662 -0.649 . . . . 0.0 109.823 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.61 -40.47 96.99 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.537 -0.727 . . . . 0.0 109.765 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.51 -40.77 97.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.502 -0.749 . . . . 0.0 109.667 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.615 HG21 ' CG2' ' A' ' 91' ' ' ILE . 90.6 t -61.62 -42.31 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.583 -0.698 . . . . 0.0 109.227 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.96 95.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.617 -0.677 . . . . 0.0 109.597 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 t -61.31 -38.93 88.61 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.606 -0.684 . . . . 0.0 109.809 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.439 ' HD3' HD23 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -67.12 -36.1 81.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 109.6 179.324 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.547 HG21 ' HB2' ' A' ' 78' ' ' ALA . 21.3 mm -58.22 -41.9 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.465 -0.772 . . . . 0.0 110.39 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.65 -45.88 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.384 -0.822 . . . . 0.0 110.096 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.09 -15.8 79.82 Favored Glycine 0 N--CA 1.501 2.981 0 C-N-CA 120.26 -0.971 . . . . 0.0 111.035 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.652 HD21 ' O ' ' A' ' 28' ' ' GLU . 15.4 tp -99.06 -21.5 16.16 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.118 -1.225 . . . . 0.0 111.285 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.595 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 21.9 t90 -65.7 130.89 44.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 0.0 111.197 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.9 ttt-85 -99.47 -160.97 0.84 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -48.55 -45.98 38.25 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.165 -0.959 . . . . 0.0 110.198 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.93 29.29 0.31 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.47 -0.769 . . . . 0.0 111.249 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.49 157.48 43.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.046 -1.034 . . . . 0.0 110.953 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.493 HG23 ' HB2' ' A' ' 34' ' ' CYS . 12.8 t -153.81 145.53 23.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.497 -0.752 . . . . 0.0 109.651 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.71 ' C ' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -102.22 108.24 19.56 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.385 -0.822 . . . . 0.0 109.794 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 28' ' ' GLU . 6.3 mt -114.05 129.37 56.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.183 -0.948 . . . . 0.0 110.924 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.839 HD12 ' HD1' ' A' ' 99' ' ' TRP . 0.4 OUTLIER 58.73 28.58 17.49 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.505 -0.747 . . . . 0.0 110.899 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.31 21.56 77.52 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.441 ' NE2' HD23 ' A' ' 30' ' ' LEU . 58.6 m-70 -121.18 155.28 34.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.442 -1.034 . . . . 0.0 109.916 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -86.43 116.2 24.43 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.172 -0.955 . . . . 0.0 109.68 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.493 ' HB2' HG23 ' A' ' 27' ' ' THR . 20.1 m -116.16 173.51 6.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.574 -0.703 . . . . 0.0 109.66 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 4.9 tptt -132.87 108.96 9.28 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.525 -0.734 . . . . 0.0 111.065 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.595 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 47.4 t80 -108.82 139.25 43.9 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 p -144.65 152.91 41.15 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.931 -1.105 . . . . 0.0 111.721 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.412 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 88.3 t -133.2 123.17 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -138.21 117.41 9.73 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.185 -0.947 . . . . 0.0 110.664 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 55.2 Cg_endo -81.49 157.52 19.27 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 124.018 1.536 . . . . 0.0 110.633 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -133.11 -169.17 2.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.61 -0.681 . . . . 0.0 109.22 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.08 149.16 50.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.475 -0.765 . . . . 0.0 110.897 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 44' ' ' ARG . 1.3 tttm -123.08 179.61 4.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.818 -0.551 . . . . 0.0 109.773 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 43' ' ' LYS . 12.6 mmt-85 -35.37 -45.94 0.35 Allowed 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 121.045 0.45 . . . . 0.0 111.582 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -155.07 37.3 0.4 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.57 -0.707 . . . . 0.0 110.774 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -156.0 142.44 18.52 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.167 -0.958 . . . . 0.0 111.049 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.5 t -97.38 124.44 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.463 -0.773 . . . . 0.0 109.251 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -109.35 149.7 29.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.395 -0.816 . . . . 0.0 110.88 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.431 ' CD1' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -109.87 131.34 55.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.452 -0.78 . . . . 0.0 109.664 179.317 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -129.42 159.65 35.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.19 -0.944 . . . . 0.0 110.457 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -153.56 142.82 9.51 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.455 ' HG2' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -138.77 149.99 45.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.922 -0.752 . . . . 0.0 109.85 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.0 ptm -145.69 156.44 43.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.966 -1.084 . . . . 0.0 111.433 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.613 ' CD1' ' HD3' ' A' ' 56' ' ' PRO . 23.4 p90 -166.42 164.56 17.34 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.885 -0.51 . . . . 0.0 110.301 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.3 m -128.08 98.42 27.03 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.248 -0.908 . . . . 0.0 110.312 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.613 ' HD3' ' CD1' ' A' ' 54' ' ' TRP . 49.6 Cg_endo -75.13 84.65 1.65 Allowed 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.833 1.438 . . . . 0.0 110.577 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 143.22 -43.99 0.99 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -70.19 -59.84 2.64 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.472 -1.016 . . . . 0.0 110.1 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.3 t -150.07 -170.11 3.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.464 -0.773 . . . . 0.0 110.044 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.53 41.06 2.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.509 -0.744 . . . . 0.0 110.302 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.432 HD11 ' HB3' ' A' ' 84' ' ' LYS . 2.7 tt -118.24 153.97 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.51 -0.744 . . . . 0.0 109.666 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.09 171.62 14.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.103 -0.998 . . . . 0.0 111.405 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.557 ' HA3' ' HB2' ' A' ' 81' ' ' PHE . . . -141.2 126.91 3.21 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.455 ' HG2' ' HG2' ' A' ' 52' ' ' ARG . 6.2 mt-10 -135.57 153.01 51.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.459 -1.024 . . . . 0.0 110.441 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.483 ' CB ' ' HB3' ' A' ' 76' ' ' LYS . . . -170.7 164.43 8.12 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.592 -0.693 . . . . 0.0 110.713 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.476 ' HA ' HG23 ' A' ' 73' ' ' VAL . 1.0 OUTLIER -153.05 149.95 28.66 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.459 -0.776 . . . . 0.0 111.03 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.414 HG22 HG23 ' A' ' 73' ' ' VAL . 9.7 t -173.89 156.98 2.91 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 mtm105 -60.5 -24.27 65.19 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.263 -0.898 . . . . 0.0 111.026 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.25 139.45 54.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.237 -0.914 . . . . 0.0 110.545 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.401 ' O ' HG12 ' A' ' 73' ' ' VAL . 70.7 mt-30 -75.82 -53.72 8.03 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.531 -0.731 . . . . 0.0 110.358 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 t -81.07 -30.34 34.77 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.392 -0.818 . . . . 0.0 109.937 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.93 -36.52 88.24 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 66' ' ' SER . 0.5 OUTLIER -63.16 -35.41 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.446 -1.032 . . . . 0.0 110.344 179.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.47 87.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.441 -0.787 . . . . 0.0 110.119 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.06 -30.91 71.95 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.483 ' HB3' ' CB ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -73.55 -39.96 64.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.55 -0.971 . . . . 0.0 110.235 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 63' ' ' GLY . 99.3 m -64.59 -40.17 95.04 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.279 -0.888 . . . . 0.0 109.117 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.547 ' HB2' HG21 ' A' ' 18' ' ' ILE . . . -67.17 -39.27 86.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.623 -0.673 . . . . 0.0 109.657 178.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -59.75 -41.75 91.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.536 -0.727 . . . . 0.0 110.007 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.87 -41.22 95.84 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.462 -0.774 . . . . 0.0 109.653 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.557 ' HB2' ' HA3' ' A' ' 63' ' ' GLY . 43.3 t80 -69.7 -38.39 76.96 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.55 -0.719 . . . . 0.0 109.813 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.0 -37.79 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.417 -0.802 . . . . 0.0 109.93 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.37 -40.02 85.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.303 -0.873 . . . . 0.0 109.67 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HB3' HD11 ' A' ' 61' ' ' ILE . 77.7 mttt -67.71 -40.22 84.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.536 -0.727 . . . . 0.0 109.388 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.45 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -67.78 -36.81 81.14 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.632 -0.667 . . . . 0.0 109.774 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -33.38 74.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.594 -0.691 . . . . 0.0 109.956 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -64.25 -31.23 72.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.384 -0.823 . . . . 0.0 110.653 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.3 -66.83 0.89 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.379 -0.826 . . . . 0.0 110.135 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 151.39 51.6 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 90' ' ' LEU . 6.3 mt -112.0 -38.97 4.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.229 -1.159 . . . . 0.0 110.472 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.615 ' CG2' HG21 ' A' ' 14' ' ' VAL . 80.9 mt -103.82 69.42 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 109.757 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.544 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 72.1 m -73.3 -178.61 3.02 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.516 -0.74 . . . . 0.0 110.353 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.62 -59.68 3.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.199 -0.938 . . . . 0.0 110.651 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -63.25 -39.63 95.15 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.359 -0.838 . . . . 0.0 109.94 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 11.4 mt-10 -61.57 -42.66 99.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.576 -0.703 . . . . 0.0 109.493 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.06 -37.03 81.22 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.619 -0.676 . . . . 0.0 109.714 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -62.2 -44.79 95.8 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -30.96 63.45 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.513 -0.742 . . . . 0.0 109.011 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.839 ' HD1' HD12 ' A' ' 30' ' ' LEU . 30.2 t90 -68.55 -40.4 80.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.705 -0.622 . . . . 0.0 109.958 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.439 HD23 ' HD3' ' A' ' 17' ' ' LYS . 21.2 mt -81.99 -31.89 30.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.533 -0.729 . . . . 0.0 110.346 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 43.9 t -88.31 -67.64 0.82 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.454 -0.779 . . . . 0.0 110.587 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.118 0 CA-C-O 118.137 -0.935 . . . . 0.0 110.762 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 120.836 0.35 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.89 85.64 2.14 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.383 -0.823 . . . . 0.0 110.108 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.0 t80 58.61 89.9 0.05 Allowed 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.344 0.592 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 p -116.95 155.89 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.316 -0.865 . . . . 0.0 110.363 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -81.42 147.65 29.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.456 -0.778 . . . . 0.0 109.946 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 10' ' ' VAL . . . -161.9 39.08 0.39 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -62.12 -37.53 85.47 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.456 -1.026 . . . . 0.0 109.834 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -63.83 -41.84 97.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.686 -0.634 . . . . 0.0 109.47 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.37 92.55 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.729 -0.607 . . . . 0.0 110.013 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 6' ' ' GLY . 94.4 t -65.05 -42.09 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.525 -0.734 . . . . 0.0 109.459 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.54 ' HB1' ' CG1' ' A' ' 82' ' ' VAL . . . -69.13 -36.9 77.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.514 -0.742 . . . . 0.0 109.485 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.6 89.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.642 -0.661 . . . . 0.0 109.79 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.81 -41.17 95.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.404 -0.81 . . . . 0.0 109.46 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.579 HG13 ' CZ3' ' A' ' 99' ' ' TRP . 25.5 t -62.32 -40.7 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.639 -0.663 . . . . 0.0 109.41 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.542 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -63.87 -39.39 94.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.573 -0.705 . . . . 0.0 109.408 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.8 m -62.5 -39.53 93.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.65 -0.656 . . . . 0.0 109.684 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.448 ' HB3' ' HZ3' ' A' ' 99' ' ' TRP . 0.5 OUTLIER -63.39 -37.78 88.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.506 -0.747 . . . . 0.0 109.773 179.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.501 HD12 ' HB1' ' A' ' 78' ' ' ALA . 2.5 mt -61.84 -37.51 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.556 -0.715 . . . . 0.0 109.984 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.2 t -63.67 -48.58 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.232 -0.917 . . . . 0.0 109.789 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.4 -15.42 81.48 Favored Glycine 0 N--CA 1.5 2.918 0 C-N-CA 120.271 -0.966 . . . . 0.0 110.698 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.66 HD21 ' O ' ' A' ' 28' ' ' GLU . 11.9 tp -99.38 -16.83 18.27 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.232 -1.158 . . . . 0.0 111.203 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.582 ' CD1' ' HB3' ' A' ' 36' ' ' PHE . 24.5 t90 -69.44 137.02 52.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.177 -0.952 . . . . 0.0 111.308 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.49 -162.2 0.87 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -45.68 -45.17 13.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.309 -0.869 . . . . 0.0 110.635 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.5 31.83 0.19 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.437 -0.79 . . . . 0.0 111.28 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -153.15 162.76 40.94 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.066 -1.021 . . . . 0.0 110.792 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.611 HG23 ' HB2' ' A' ' 34' ' ' CYS . 11.4 t -157.44 144.28 18.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.395 -0.816 . . . . 0.0 109.996 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.675 ' C ' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -102.56 109.4 21.01 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.517 -0.739 . . . . 0.0 109.621 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.675 HD23 ' C ' ' A' ' 28' ' ' GLU . 7.9 mt -114.04 130.34 56.56 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.221 -0.924 . . . . 0.0 110.797 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.525 HD22 ' CZ2' ' A' ' 58' ' ' TRP . 7.1 tp 56.58 30.33 17.13 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.563 -0.71 . . . . 0.0 110.671 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.82 24.84 73.31 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 58' ' ' TRP . 59.6 m-70 -124.54 159.89 29.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -1.038 . . . . 0.0 109.723 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -91.46 121.92 33.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 110.545 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.611 ' HB2' HG23 ' A' ' 27' ' ' THR . 23.0 m -122.36 164.14 18.49 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 5.5 tptm -125.58 110.48 13.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.36 -0.838 . . . . 0.0 111.146 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.582 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 12.8 t80 -110.66 138.49 46.98 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.9 p -143.05 157.43 44.54 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.025 -1.047 . . . . 0.0 111.389 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.451 HG12 ' HD3' ' A' ' 40' ' ' PRO . 99.6 t -129.09 130.06 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.63 -0.669 . . . . 0.0 109.872 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 83.67 64.71 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 0.0 110.451 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.451 ' HD3' HG12 ' A' ' 38' ' ' VAL . 55.5 Cg_endo -79.49 158.82 25.65 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.855 1.45 . . . . 0.0 110.627 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -139.65 177.34 8.01 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.232 -0.918 . . . . 0.0 110.128 178.529 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.489 ' CD1' HG22 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -136.67 155.72 49.5 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.568 0.699 . . . . 0.0 111.257 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.96 178.68 6.49 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -41.46 -38.89 1.37 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.875 -0.516 . . . . 0.0 111.622 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.99 28.15 0.47 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.307 -0.871 . . . . 0.0 110.737 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -142.58 140.05 31.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.097 -1.002 . . . . 0.0 110.913 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.489 HG22 ' CD1' ' A' ' 42' ' ' LEU . 38.3 t -121.06 125.08 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.443 -0.786 . . . . 0.0 109.411 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.507 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 62.5 m-85 -119.68 139.03 52.88 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.331 -0.856 . . . . 0.0 110.58 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.599 ' CD2' ' HA ' ' A' ' 70' ' ' GLN . 2.1 m-85 -105.72 131.7 52.76 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.555 -0.715 . . . . 0.0 110.42 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.93 156.57 37.79 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.399 -0.813 . . . . 0.0 109.597 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 38' ' ' VAL . . . -159.46 141.16 7.32 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.569 -1.301 . . . . 0.0 110.671 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HG3' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -141.03 146.96 37.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.88 -0.776 . . . . 0.0 109.756 179.5 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.579 ' HG2' HG22 ' A' ' 77' ' ' THR . 5.1 ptm -139.05 155.92 47.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 111.327 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.474 ' CZ2' ' HG2' ' A' ' 35' ' ' LYS . 45.6 p90 -155.91 145.75 21.26 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.916 -0.49 . . . . 0.0 109.797 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 87.3 m -111.98 89.42 11.6 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.236 -0.915 . . . . 0.0 111.066 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -77.74 82.85 2.3 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 123.703 1.37 . . . . 0.0 110.149 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.34 -45.14 0.61 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.525 ' CZ2' HD22 ' A' ' 30' ' ' LEU . 11.2 t90 -75.0 -63.28 1.3 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.533 -0.98 . . . . 0.0 110.096 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.2 t -142.41 -162.92 1.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.5 -0.75 . . . . 0.0 109.52 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.7 44.95 2.5 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.296 -0.878 . . . . 0.0 110.395 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.505 HG23 ' HD3' ' A' ' 84' ' ' LYS . 74.0 mt -123.14 140.71 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.361 -0.837 . . . . 0.0 110.234 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.57 170.88 10.49 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.414 -0.804 . . . . 0.0 110.514 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.02 136.21 4.69 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.405 ' HB2' ' HG3' ' A' ' 52' ' ' ARG . 13.1 tt0 -139.6 161.19 38.12 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.809 -0.818 . . . . 0.0 110.357 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.469 ' HB1' ' HB3' ' A' ' 76' ' ' LYS . . . -165.89 151.01 8.59 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.768 -0.582 . . . . 0.0 110.229 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.406 ' HA ' HG23 ' A' ' 73' ' ' VAL . 0.7 OUTLIER -141.71 142.07 33.31 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.426 -0.796 . . . . 0.0 110.601 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.6 t -168.03 172.65 8.66 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.404 -0.81 . . . . 0.0 110.224 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -71.18 -24.8 62.3 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.371 -0.831 . . . . 0.0 110.904 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.74 139.73 56.69 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.277 -0.889 . . . . 0.0 110.743 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.599 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 5.8 tt0 -76.27 -53.78 7.73 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.724 -0.61 . . . . 0.0 110.349 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -84.26 -30.29 25.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.43 -0.794 . . . . 0.0 110.02 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.68 -39.4 93.44 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 70' ' ' GLN . 3.3 p -61.56 -37.39 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.371 -1.076 . . . . 0.0 110.5 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.92 82.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.526 -0.734 . . . . 0.0 110.036 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.97 -36.91 91.7 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.469 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 8.1 mttp -66.61 -39.94 88.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.519 -0.989 . . . . 0.0 110.267 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.579 HG22 ' HG2' ' A' ' 53' ' ' MET . 53.4 m -63.49 -42.16 98.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.269 -0.895 . . . . 0.0 109.02 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.542 ' HB1' ' HA ' ' A' ' 15' ' ' ALA . . . -70.2 -38.59 75.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.579 -0.7 . . . . 0.0 109.541 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.567 ' O ' HG12 ' A' ' 82' ' ' VAL . 7.3 ttmt -62.82 -39.69 95.1 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.613 -0.679 . . . . 0.0 110.157 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -68.54 -38.56 80.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 0.0 109.738 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -70.81 -38.42 73.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 109.422 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -68.77 -34.29 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.391 -0.818 . . . . 0.0 109.748 179.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -42.14 89.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.292 -0.88 . . . . 0.0 109.211 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.505 ' HD3' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -67.2 -39.06 86.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.565 -0.709 . . . . 0.0 109.195 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.85 -34.86 77.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.706 -0.621 . . . . 0.0 109.669 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.53 -39.57 91.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.673 -0.642 . . . . 0.0 109.316 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -64.83 -40.18 94.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.633 -0.667 . . . . 0.0 110.448 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -75.51 -54.09 7.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.419 -0.801 . . . . 0.0 110.297 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.01 53.98 0.08 OUTLIER Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.521 ' HA ' HD23 ' A' ' 90' ' ' LEU . 7.6 mt -118.83 -48.83 2.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.307 -1.113 . . . . 0.0 110.171 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 35.1 mm -88.9 75.77 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.365 -0.834 . . . . 0.0 109.706 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.628 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 19.6 t -73.9 175.91 6.89 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.431 -0.793 . . . . 0.0 110.287 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -67.2 -58.75 4.27 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.292 -0.88 . . . . 0.0 110.834 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -65.57 -39.76 92.03 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.415 -0.803 . . . . 0.0 110.08 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 0.7 OUTLIER -64.09 -39.6 94.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.635 -0.665 . . . . 0.0 109.69 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.44 80.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.503 -0.748 . . . . 0.0 109.328 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -63.25 -46.04 88.76 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -36.09 73.43 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.579 ' CZ3' HG13 ' A' ' 14' ' ' VAL . 50.7 t90 -62.76 -41.75 99.36 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.1 mt -73.53 -32.5 64.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.56 -0.712 . . . . 0.0 109.733 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.1 m -62.96 -48.1 80.35 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.415 -0.803 . . . . 0.0 109.647 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.165 179.415 . . . . . . . . 0 0 . 1 stop_ save_